1 00:00:06,546 --> 00:00:10,316 >> ALL RIGHT, I THINK IT IS 2 00:00:10,316 --> 00:00:11,885 10:00 RIGHT NOW SO I WANT TO 3 00:00:11,885 --> 00:00:14,053 START ON TIME. GOOD MORNING, 4 00:00:14,053 --> 00:00:16,956 WELCOME TO THE NATIONAL HEART 5 00:00:16,956 --> 00:00:20,527 AND LUNG PULMONARY WORKPLACE 6 00:00:20,527 --> 00:00:25,165 ENTITLED DISPARITY ACROSS 7 00:00:25,165 --> 00:00:28,468 SPECTRUM OF PULMONARY DISEASE. 8 00:00:28,468 --> 00:00:33,273 I'M DR. XIAO FOR THE PULMONARY 9 00:00:33,273 --> 00:00:35,074 DISEASE ORGANIZING COMMITTEE 10 00:00:35,074 --> 00:00:36,876 MEMBER FOR THIS WORKSHOP. ON 11 00:00:36,876 --> 00:00:40,079 BE HALF OF THE WORKSHOP 12 00:00:40,079 --> 00:00:41,414 ORGANIZATION COMMITTEE AND NHLBI 13 00:00:41,414 --> 00:00:44,317 COMMISSION I WOULD LIKE TO 14 00:00:44,317 --> 00:00:45,852 WELCOME EVERYONE TO THIS 15 00:00:45,852 --> 00:00:49,389 IMPORTANT NHLBI WORKSHOP 16 00:00:49,389 --> 00:00:51,591 RESEARCHING AREAS SUCH AS 17 00:00:51,591 --> 00:00:53,459 DISPARITIES IN PVD. I WOULD LIKE 18 00:00:53,459 --> 00:00:56,196 TO THANK EVERYONE FOR TAKING 19 00:00:56,196 --> 00:00:58,164 YOUR PRECIOUS TIME TO 20 00:00:58,164 --> 00:00:59,365 PARTICIPATE, ESPECIALLY FOR 21 00:00:59,365 --> 00:01:01,401 SPEAKERS AND CO-CHAIRS AND 22 00:01:01,401 --> 00:01:02,435 EVERYONE WHO HAS SPENT MANY 23 00:01:02,435 --> 00:01:03,670 HOURS OF THEIR PERSONAL TIME 24 00:01:03,670 --> 00:01:06,906 WORKING ON THE PRESENTATIONS. WE 25 00:01:06,906 --> 00:01:08,474 APPRECIATE YOUR EFFORT AND 26 00:01:08,474 --> 00:01:09,676 CONTRIBUTION TO THIS 27 00:01:09,676 --> 00:01:12,545 WORKSHOP .ENTER ALSO I WANT A 28 00:01:12,545 --> 00:01:15,281 SPECIAL THANKS TO OUR WORKSHOP 29 00:01:15,281 --> 00:01:17,584 SUPPORT TEAM, ESPECIALLY JACKIE 30 00:01:17,584 --> 00:01:24,624 AND HER SUPPORT TEAM, SHAUN, I 31 00:01:24,624 --> 00:01:25,892 APPRECIATE YOUR WORK FOR SETTING 32 00:01:25,892 --> 00:01:29,629 UP THE WORKSHOP. THANK YOU, 33 00:01:29,629 --> 00:01:32,999 JACKIE AND THE SUPPORT TEAM FOR 34 00:01:32,999 --> 00:01:35,869 WONDERFUL JOB WELL DONE. ANOTHER 35 00:01:35,869 --> 00:01:37,637 IMPORTANT PEOPLE IS THE WORKSHOP 36 00:01:37,637 --> 00:01:40,740 CO -CHAIRS. I THINK MOST OF YOU 37 00:01:40,740 --> 00:01:42,108 ALREADY KNOW THEM. TWO 38 00:01:42,108 --> 00:01:45,378 CO -CHAIRS ARE DR. RISCHARD FROM 39 00:01:45,378 --> 00:01:49,616 UNIVERSITY OF ARIZONA AND ALSO 40 00:01:49,616 --> 00:01:54,854 DR. LEOPOLD FROM BRIGHAM AND 41 00:01:54,854 --> 00:01:57,156 HARVARD. THEY ARE THE MAIN 42 00:01:57,156 --> 00:01:59,359 DRIVING WORKFORCE FOR THIS 43 00:01:59,359 --> 00:02:03,229 WORKSHOP. REAL APPRECIATE YOU 44 00:02:03,229 --> 00:02:05,231 GUYS. SO EVERYBODY HAS A CHANCE 45 00:02:05,231 --> 00:02:07,734 TO DO A SELF-INTRODUCTION. IN 46 00:02:07,734 --> 00:02:10,370 ORDER TO MAKE SURE WE STAY ON 47 00:02:10,370 --> 00:02:13,373 TIME I'M ASKING EVERYONE JUST 48 00:02:13,373 --> 00:02:15,308 TRY TO LIMIT YOUR INTRODUCTION 49 00:02:15,308 --> 00:02:18,344 TO 15 SECONDS, AROUND THAT TIME. 50 00:02:18,344 --> 00:02:20,513 LIKE A STUDY SESSION, 51 00:02:20,513 --> 00:02:27,987 INTRODUCTION. NAME, TITLE, 52 00:02:27,987 --> 00:02:29,455 INSTITUTION AND YOUR RESEARCH 53 00:02:29,455 --> 00:02:31,124 INTEREST OR CLINICAL 54 00:02:31,124 --> 00:02:33,159 SPECIALTIES, IF APPLICABLE. ONCE 55 00:02:33,159 --> 00:02:35,228 YOUR NAME IS CALLED TURN DOWN 56 00:02:35,228 --> 00:02:37,063 YOUR CAMERA AND MICROPHONE SO 57 00:02:37,063 --> 00:02:39,332 YOU CAN START INTRODUCE 58 00:02:39,332 --> 00:02:41,267 YOURSELF, OKAY. SO LET'S MOVE ON 59 00:02:41,267 --> 00:02:45,605 TO THE ROSTER. STARTING WITH THE 60 00:02:45,605 --> 00:02:50,043 TWO CO -CHAIRS, FRANZ. 61 00:02:50,043 --> 00:02:51,644 >> HI, EVERYONE. GOOD MORNING, 62 00:02:51,644 --> 00:02:54,013 THANKS FOR ATTENDING. I'M AT THE 63 00:02:54,013 --> 00:02:57,083 UNIVERSITY OF ARIZONA, WHERE 64 00:02:57,083 --> 00:02:58,418 I'VE BEEN HERE FOR ABOUT 25 65 00:02:58,418 --> 00:03:01,621 YEARS. I'M THE DIRECTOR OF PH 66 00:03:01,621 --> 00:03:05,058 AND ASSOCIATE DEAN OF CLINICAL 67 00:03:05,058 --> 00:03:07,493 TRANSLATIONAL RESEARCH HERE. MY 68 00:03:07,493 --> 00:03:13,266 RESEARCH INTERESTS LIE OUTSIDE 69 00:03:13,266 --> 00:03:15,735 OF HEALTH DISPARITIES WITH 70 00:03:15,735 --> 00:03:17,236 EFFECTIVE HISPANIC HEALTH 71 00:03:17,236 --> 00:03:19,639 DISPARITIES, GIVEN OUR LOCATION 72 00:03:19,639 --> 00:03:22,475 AND RV FUNCTION, COUPLING AND 73 00:03:22,475 --> 00:03:24,610 EXERCISE PHYSIOLOGY. THANKS 74 00:03:24,610 --> 00:03:25,311 AGAIN. 75 00:03:25,311 --> 00:03:28,648 >> THANKS, FRANZ. JANE. 76 00:03:28,648 --> 00:03:36,222 >> HI. I'M JANE LEOPOLD AT 77 00:03:36,222 --> 00:03:38,925 BRIGHAM, HARVARD. 20 YEARS OR SO 78 00:03:38,925 --> 00:03:41,661 HERE, A CARDIOLOGIST WITH 79 00:03:41,661 --> 00:03:43,062 INTEREST IN PRECISION 80 00:03:43,062 --> 00:03:46,199 PHENOTYPING WHICH HAS NOW 81 00:03:46,199 --> 00:03:52,605 EXTENDED TO INCLUDE DISPARITIES 82 00:03:52,605 --> 00:03:53,172 AND SOCIAL DETERMINANTS OF 83 00:03:53,172 --> 00:03:55,108 HEALTH AS THEY AFFECT CLINICAL 84 00:03:55,108 --> 00:03:56,709 PHENOTYPING. SO I WANT TO THANK 85 00:03:56,709 --> 00:03:58,578 EVERYONE FOR ALL OF YOUR EFFORTS 86 00:03:58,578 --> 00:04:00,313 YOU PUT INTO THIS AND WELCOME 87 00:04:00,313 --> 00:04:01,514 YOU TO THIS GREAT WORKSHOP. 88 00:04:01,514 --> 00:04:04,884 >> THANK YOU, JANE. NOW LET'S 89 00:04:04,884 --> 00:04:08,755 INTRODUCE THE WORKSHOP SPEAKERS. 90 00:04:08,755 --> 00:04:12,992 THOSE ARE THE NHLBI SPEAKERS. WE 91 00:04:12,992 --> 00:04:14,360 WILL START WITH DR. GOEL. 92 00:04:14,360 --> 00:04:17,797 >> HI, EVERYONE. MY NAME IS 93 00:04:17,797 --> 00:04:18,931 KHUSHBOO GOEL, ASSISTANT 94 00:04:18,931 --> 00:04:21,034 PROFESSOR OF MEDICINE AT 95 00:04:21,034 --> 00:04:22,402 CEDARS-SINAI AND INTERESTS 96 00:04:22,402 --> 00:04:25,638 INCLUDE IDENTIFYING MECHANISMS 97 00:04:25,638 --> 00:04:34,547 OF PULMONARY MODELLING IN THIS 98 00:04:34,547 --> 00:04:37,550 ANDER DISPARITIES AND IMPROVING 99 00:04:37,550 --> 00:04:38,718 ACCESS TO CARE. 100 00:04:38,718 --> 00:04:40,353 >> SORRY IF I MESSED UP THE 101 00:04:40,353 --> 00:04:40,586 NAME. 102 00:04:40,586 --> 00:04:41,421 >> NOT AT ALL. 103 00:04:41,421 --> 00:04:42,855 >> CORRECT ME, I THINK I RUN 104 00:04:42,855 --> 00:04:48,461 INTO THE SAME THING. THE NEXT IS 105 00:04:48,461 --> 00:04:54,834 DR. ESTRADA. 106 00:04:54,834 --> 00:04:59,305 >> GOOD MORNING, I'M RODOLFO 107 00:04:59,305 --> 00:05:02,675 FROM SAN STOANTONIO AND MY INTET 108 00:05:02,675 --> 00:05:05,144 LIES IN HISPANICS AS WELL. VERY 109 00:05:05,144 --> 00:05:06,846 EXCITED TO BE PART OF THIS 110 00:05:06,846 --> 00:05:08,448 WORKSHOP, THANK YOU. 111 00:05:08,448 --> 00:05:14,654 >> NEXT, DR. SAHAY. 112 00:05:14,654 --> 00:05:17,857 >> GOOD MORNING, SANDEEP SAHAY. 113 00:05:17,857 --> 00:05:18,925 I HOPE TO -- 114 00:05:18,925 --> 00:05:20,760 >> TURN ON THE CAMERA. 115 00:05:20,760 --> 00:05:22,662 >> I DID. CAN YOU SEE ME? 116 00:05:22,662 --> 00:05:24,430 >> HERE NOW I CAN SEE. 117 00:05:24,430 --> 00:05:26,265 >> OKAY. GOOD MORNING, EVERYONE. 118 00:05:26,265 --> 00:05:28,434 THANK YOU FOR THE KIND 119 00:05:28,434 --> 00:05:29,735 INVITATION. I'M SANDEEP SAHAY, 120 00:05:29,735 --> 00:05:33,439 DR. OF PH PROGRAM AT HOUSTON AT 121 00:05:33,439 --> 00:05:35,374 METHODIST, HOUSTON, TEXAS. MY 122 00:05:35,374 --> 00:05:39,045 CLINICAL INTEREST, OF COURSE I'M 123 00:05:39,045 --> 00:05:41,581 CLINICIAN AND MAINLY IN CLINICAL 124 00:05:41,581 --> 00:05:43,616 TRIALS IN HYPERTENSION. I THINK 125 00:05:43,616 --> 00:05:46,986 THAT IS WHERE I NOTICE 126 00:05:46,986 --> 00:05:50,356 SIGNIFICANT DISPARITY OF THE 127 00:05:50,356 --> 00:05:53,426 PATIENT POPULATION, CLINICAL 128 00:05:53,426 --> 00:05:55,294 TRIALS. THAT DRIVES MY INTEREST 129 00:05:55,294 --> 00:05:57,096 IN THIS TOPIC. I'M HAPPY TO BE 130 00:05:57,096 --> 00:06:00,566 HERE AND PARTICIPATE IN THIS 131 00:06:00,566 --> 00:06:03,402 WORKS 132 00:06:03,402 --> 00:06:03,703 WORKSHOP. 133 00:06:03,703 --> 00:06:08,841 >> HELLO, MY NAME IS HEATHER 134 00:06:08,841 --> 00:06:13,613 STRAH, ASSOCIATE PROFESSOR OF 135 00:06:13,613 --> 00:06:14,313 MEDICINE UNIVERSITY OF NEBRASKA 136 00:06:14,313 --> 00:06:16,916 AND MEDICAL DIRECTOR LUNG 137 00:06:16,916 --> 00:06:18,784 TRANSPLANT RESEARCH. MY INTEREST 138 00:06:18,784 --> 00:06:22,822 IS PULMONARY MECHANICS IN 139 00:06:22,822 --> 00:06:23,589 TRANSGENDER INDIVIDUALS. 140 00:06:23,589 --> 00:06:31,531 >> THANK YOU, NEXT ONE, DR. 141 00:06:31,531 --> 00:06:32,031 EGHB 142 00:06:32,031 --> 00:06:32,298 EGHBALI. 143 00:06:32,298 --> 00:06:35,801 >> THANK YOU, MY NAME IS 144 00:06:35,801 --> 00:06:43,009 MANSOUREH EGHBALI AT UNIVERSITY 145 00:06:43,009 --> 00:06:45,378 OF CALIFORNIA AND MY INTEREST IS 146 00:06:45,378 --> 00:06:47,146 (?) AND SEX DIFFERENCE, IN 147 00:06:47,146 --> 00:06:50,750 PARTICULAR ROLE OF ESTROGEN AND 148 00:06:50,750 --> 00:06:52,985 SEX CHROMOSOME, THANK YOU. 149 00:06:52,985 --> 00:06:59,825 >> THANK YOU, NEXT IS DR. COREY 150 00:06:59,825 --> 00:07:00,159 VENTETUOLO. 151 00:07:00,159 --> 00:07:03,396 >> I'M COREY VENTETUOLO, 152 00:07:03,396 --> 00:07:05,765 PROFESSOR AT BROWN UNIVERSITY. 153 00:07:05,765 --> 00:07:08,100 MY INTERESTS ARE IN SEXUAL 154 00:07:08,100 --> 00:07:14,440 INTERESTS IN DIMORPHISM AND 155 00:07:14,440 --> 00:07:14,941 HYPERTENSION. 156 00:07:14,941 --> 00:07:17,543 >> I APOLOGIZE FOR YOUR NAME, A 157 00:07:17,543 --> 00:07:20,613 TYPO ON THE SLIDE. I OVERLOOKED 158 00:07:20,613 --> 00:07:27,753 THAT. THE NEXT IS DR. BERNARDO. 159 00:07:27,753 --> 00:07:35,962 >> GOOD MORNING, BERNARDO (LOW 160 00:07:35,962 --> 00:07:39,298 AUDIO) 161 00:07:39,298 --> 00:07:39,599 162 00:07:39,599 --> 00:07:43,269 >> ALL RIGHT, THANK YOU. NEXT 163 00:07:43,269 --> 00:07:53,746 ONE IS DR. VINIVIO PEREZ, A 164 00:08:01,187 --> 00:08:03,522 TYPO, I APOLOGIZE FOR THAT. YOU 165 00:08:03,522 --> 00:08:04,957 THERE? PROBABLY STILL TOO EARLY 166 00:08:04,957 --> 00:08:07,827 FOR HIM. THIS IS WEST COAST. SO 167 00:08:07,827 --> 00:08:12,632 LET'S MOVE ON TO THE NEXT 168 00:08:12,632 --> 00:08:18,771 SPEAKER. DR. BRITTAIN? 169 00:08:18,771 --> 00:08:20,539 >> GOOD MORNING, I'M A 170 00:08:20,539 --> 00:08:23,175 CARDIOLOGIST. I STUDY THE 171 00:08:23,175 --> 00:08:26,245 MECHANISMS OF THIS INCLUDING THE 172 00:08:26,245 --> 00:08:27,747 VETERAN'S AFFAIRS SYSTEM. 173 00:08:27,747 --> 00:08:37,657 >> THANK YOU, EVAN. DR. GOLD. 174 00:08:37,657 --> 00:08:41,894 DR. RACHEL GOLD, ARE YOU THERE? 175 00:08:41,894 --> 00:08:46,832 ALL RIGHT. IT IS ALSO WEST 176 00:08:46,832 --> 00:08:49,735 COAST. LET'S MOVE ON TO THE NEXT 177 00:08:49,735 --> 00:08:51,737 ONE. DR. MARON. I BELIEVE YOU 178 00:08:51,737 --> 00:08:54,740 ARE HERE ON THE EAST COAST. 179 00:08:54,740 --> 00:08:59,979 >> HEY, EVERYONE, BRAD MARON, 180 00:08:59,979 --> 00:09:01,280 PROFESSOR OF MEDICINE MARYLAND 181 00:09:01,280 --> 00:09:03,149 AND EXECUTIVE CO -DIRECTOR FOR 182 00:09:03,149 --> 00:09:04,784 INSTITUTE FOR HEALTH COMPUTING 183 00:09:04,784 --> 00:09:09,588 HERE. I HAVE A BASIC AND 184 00:09:09,588 --> 00:09:15,428 TRANSLATIONAL INTEREST IN 185 00:09:15,428 --> 00:09:17,029 PULMONARY VASCULAR DISEASE AND 186 00:09:17,029 --> 00:09:18,831 HEALTH DISPARITIES IN POPULATION 187 00:09:18,831 --> 00:09:19,165 HEALTH. 188 00:09:19,165 --> 00:09:23,302 >> THANK YOU, BRAD. NEXT ONE, 189 00:09:23,302 --> 00:09:33,412 DR. LIM. IS DR. LIM HERE? I KNOW 190 00:09:33,412 --> 00:09:35,147 HE FAMILY LEAVE NOW, BUT THAT IS 191 00:09:35,147 --> 00:09:42,421 OKAY. THE NEXT SPEAKER, DR. 192 00:09:42,421 --> 00:09:47,526 MATHAI. HE HERE? ALL RIGHT. SO 193 00:09:47,526 --> 00:09:49,762 NOT YET. DR. DESAI. 194 00:09:49,762 --> 00:09:52,598 >> THANK YOU, WELCOME, EVERYONE. 195 00:09:52,598 --> 00:09:55,134 PROFESSOR OF MEDICINE AT INDIANA 196 00:09:55,134 --> 00:09:58,771 UNIVERSITY AND CARDIOLOGIST. 197 00:09:58,771 --> 00:10:01,707 RELATED TO THIS CONFERENCE I 198 00:10:01,707 --> 00:10:04,810 (AUDIO INTERRUPTION) 199 00:10:04,810 --> 00:10:08,914 >> THANK YOU, ANKIT. DR. ORTEGA. 200 00:10:08,914 --> 00:10:13,652 >> I'M PROFESSOR OF MEDICINE AT 201 00:10:13,652 --> 00:10:16,455 THE MAYO CLINIC, PULL MONDAY OL 202 00:10:16,455 --> 00:10:20,626 GIST AND EPIDEMIOLOGIST AND LEAD 203 00:10:20,626 --> 00:10:23,229 STUDIES FOR DIFFERENT NHLBI 204 00:10:23,229 --> 00:10:24,530 NETWORKS BASED ON RARE AND 205 00:10:24,530 --> 00:10:26,599 COMMON AIRWAY DISEASES WITH A 206 00:10:26,599 --> 00:10:29,535 FOCUS ON ANCESTRAL DIVERSITY AND 207 00:10:29,535 --> 00:10:34,507 RARE VARIANTS AND POLYGENIC RISK 208 00:10:34,507 --> 00:10:37,243 SCORES AND ONE OF DIRECTORS OF 209 00:10:37,243 --> 00:10:40,379 CENTERS FOR CENTER OF MEDICINE 210 00:10:40,379 --> 00:10:42,248 AND RARE UNDIAGNOSED DISEASES 211 00:10:42,248 --> 00:10:44,984 AND RISK IMPLEMENTATION. 212 00:10:44,984 --> 00:10:50,890 >> THANK YOU. NEXT SPEAKER IS 213 00:10:50,890 --> 00:10:56,729 DR. GLENN. IS DR. GLENN HERE? IF 214 00:10:56,729 --> 00:11:01,400 NOT LET'S MOVE ON TO THE NEXT 215 00:11:01,400 --> 00:11:03,436 SPEAKER. DR. HEMNES. 216 00:11:03,436 --> 00:11:07,506 >> GOOD MORNING, ANNA HEMNES, 217 00:11:07,506 --> 00:11:08,307 PROFESSOR OF MEDICINE AT 218 00:11:08,307 --> 00:11:09,575 VANDERBILT SCHOOL OF MEDICINE. 219 00:11:09,575 --> 00:11:11,777 I'M INTERESTED BROADLY IN HOW 220 00:11:11,777 --> 00:11:16,048 SEX HORMONES MODIFY PULMONARY 221 00:11:16,048 --> 00:11:17,416 VASCULAR DISEASE AND RIGHT HEART 222 00:11:17,416 --> 00:11:18,184 RESPONSES. 223 00:11:18,184 --> 00:11:21,020 >> THANK YOU, ANNA. THE NEXT 224 00:11:21,020 --> 00:11:23,389 SPEAKER IS DR. HORN. 225 00:11:23,389 --> 00:11:27,226 >> GOOD MORNING, EVERYBODY. 226 00:11:27,226 --> 00:11:29,161 EVELYN HORN AT CORNELL AS 227 00:11:29,161 --> 00:11:31,397 PROFESSOR OF MEDICINE AND 228 00:11:31,397 --> 00:11:33,199 ADVANCE THE DEPARTMENT OF CARD 229 00:11:33,199 --> 00:11:38,971 VALLECULAR DISEASE AND REALIZE 230 00:11:38,971 --> 00:11:40,739 -- CARDIOVASCULAR DISEASE AND 231 00:11:40,739 --> 00:11:43,876 RELEVANT TO THIS IN MIXED 232 00:11:43,876 --> 00:11:51,083 DISEASE IN CARDIO-PULMONARY IN 233 00:11:51,083 --> 00:11:53,118 IN MIXED SPACE AND IN GENDER. 234 00:11:53,118 --> 00:11:54,353 >> I BELIEVE ALL THE SPEAKERS 235 00:11:54,353 --> 00:11:55,888 ARE HERE, SOME ARE MISSING. 236 00:11:55,888 --> 00:11:57,690 PROBABLY TOO EARLY ON THE WEST 237 00:11:57,690 --> 00:11:59,725 COAST. WE WILL INTRODUCE THEM 238 00:11:59,725 --> 00:12:02,795 WHEN THEY ARE HERE. NEXT WE WILL 239 00:12:02,795 --> 00:12:05,164 GO TO THE NHLBI WORKSHOP 240 00:12:05,164 --> 00:12:07,700 DISCUSSIONS. SO WE WILL START 241 00:12:07,700 --> 00:12:10,836 AROUND THE LIST. SO DR. WAWUT. 242 00:12:10,836 --> 00:12:17,843 >> I'M A PREFERENCE F PROFESS / 243 00:12:17,843 --> 00:12:18,677 /* PROFESSOR AT PENNY AND 244 00:12:18,677 --> 00:12:23,649 INTEREST IN SEXUAL DIMORPHISM 245 00:12:23,649 --> 00:12:25,217 AND DISPARITIES AND EXCITED TO 246 00:12:25,217 --> 00:12:26,418 BE HERE. 247 00:12:26,418 --> 00:12:28,554 >> THANK YOU, STEVE. 248 00:12:28,554 --> 00:12:34,460 >> GOOD EVENING, KARIM EL-KERSH. 249 00:12:34,460 --> 00:12:36,395 I'M WITH THE UNIVERSITY OF 250 00:12:36,395 --> 00:12:40,799 ARIZONA, PHOENIX CAMPUS. 251 00:12:40,799 --> 00:12:43,936 DIRECTOR OF PH PROGRAM. MY 252 00:12:43,936 --> 00:12:45,204 INTEREST IS IN SOCIAL 253 00:12:45,204 --> 00:12:47,139 DETERMINANTS OF HEALTH AND 254 00:12:47,139 --> 00:12:49,241 PALLIATIVE CARE IN HYPERTENSION, 255 00:12:49,241 --> 00:12:52,278 ALSO WITH INTERESTS IN HEALTH 256 00:12:52,278 --> 00:12:53,812 CARE UTILIZATION IN PULMONARY 257 00:12:53,812 --> 00:12:55,314 HYPERTENSION. GLAD TO BE HERE. 258 00:12:55,314 --> 00:13:02,821 >> THANK YOU. NEXT DR. TSUANG. 259 00:13:02,821 --> 00:13:05,057 >> GOOD MORNING, THANK YOU. MY 260 00:13:05,057 --> 00:13:06,825 NAME IS WAYNE. I'M ASSOCIATE 261 00:13:06,825 --> 00:13:09,795 PROFESSOR AT THE CLEVELAND 262 00:13:09,795 --> 00:13:12,998 CLINIC. I'M A TRANSPLANT PULL 263 00:13:12,998 --> 00:13:14,199 MONDAY OL GIST AND INTERESTS IN 264 00:13:14,199 --> 00:13:16,068 THE NEIGHBORHOOD EFFECTS ON 265 00:13:16,068 --> 00:13:17,603 IN-STAGE CHRONIC LUNG DISEASES 266 00:13:17,603 --> 00:13:28,013 AND EXCITED TO BE HERE. 267 00:13:31,150 --> 00:13:36,689 >> DR. SAMAR FARHA AT CLEVELAND 268 00:13:36,689 --> 00:13:38,958 CLINIC AND INTERESTED IN 269 00:13:38,958 --> 00:13:42,595 HYPERTENSION AND HAVE BEEN 270 00:13:42,595 --> 00:13:45,331 WORKING WITH DR. WAYNE AND 271 00:13:45,331 --> 00:13:46,532 SOCIAL DISPARITY IN OUR 272 00:13:46,532 --> 00:13:47,299 HYPERTENSION POPULATION. LOOKING 273 00:13:47,299 --> 00:13:48,767 FORWARD TO LEARNING FROM ALL OF 274 00:13:48,767 --> 00:13:50,536 YOU TODAY, THANK YOU. 275 00:13:50,536 --> 00:14:00,279 >> THANK YOU. NEXT ONE IS DR. 276 00:14:00,279 --> 00:14:00,512 NICKEL. 277 00:14:00,512 --> 00:14:03,382 >> GOOD MORNING, MY NAME IS 278 00:14:03,382 --> 00:14:06,885 (AUDIO DISRUPTION) -- BECAUSE WE 279 00:14:06,885 --> 00:14:09,254 HAVE A MAJORITY OF HISPANIC 280 00:14:09,254 --> 00:14:10,089 UNDERSERVED PATIENTS SO I'M 281 00:14:10,089 --> 00:14:13,192 GRATEFUL TO BE PART OF THIS 282 00:14:13,192 --> 00:14:16,328 WORKSHOP TODAY, THANK YOU. 283 00:14:16,328 --> 00:14:20,866 >> THANK YOU. LAST DISCUSSANT IS 284 00:14:20,866 --> 00:14:22,267 DR. ELWING. 285 00:14:22,267 --> 00:14:23,936 >> THANK YOU, I'M EXCITED. 286 00:14:23,936 --> 00:14:28,073 DIRECTOR OF MEDICINE THE 287 00:14:28,073 --> 00:14:29,975 PULMONARY PROGRAM IN CINCINNATI. 288 00:14:29,975 --> 00:14:31,877 MY FOCUS IS ON SOCIAL 289 00:14:31,877 --> 00:14:33,379 DETERMINANTS OF HEALTH WITH A 290 00:14:33,379 --> 00:14:35,714 SPECIAL INTEREST IN HOW RURALITY 291 00:14:35,714 --> 00:14:38,083 AFFECTS OUTCOMES, SO THAT IS 292 00:14:38,083 --> 00:14:41,620 WHAT AFFECTS MY PATIENTS, TO A 293 00:14:41,620 --> 00:14:43,355 GREAT DEGREE. 294 00:14:43,355 --> 00:14:45,424 >> ALL RIGHT, LET'S MOVE ON TO 295 00:14:45,424 --> 00:14:50,663 THE INTRODUCTION OF MY NHLBI 296 00:14:50,663 --> 00:14:54,933 COLLEAGUE. FIRST IS LEADERSHIP 297 00:14:54,933 --> 00:14:56,435 FROM NHLBI, DR. GUSTAVO 298 00:14:56,435 --> 00:15:01,440 MATUTE-BELLO, WHO IS THE ACTING 299 00:15:01,440 --> 00:15:06,779 DIRECTOR FOR DIVISION OF LUNG 300 00:15:06,779 --> 00:15:13,252 DISEASE. GUS. 301 00:15:13,252 --> 00:15:15,354 >> SURE, I'M HAPPY TO BE HERE 302 00:15:15,354 --> 00:15:18,891 AND THANKS FOR YOUR LEADERSHIP 303 00:15:18,891 --> 00:15:21,360 AND FOR MAKING THIS POSSIBLE. 304 00:15:21,360 --> 00:15:26,665 >> THANK YOU. THE BRANCH CHIEF, 305 00:15:26,665 --> 00:15:30,536 LUNG DISEASE BRANCH CHIEF, DR. 306 00:15:30,536 --> 00:15:32,838 JOHN SHERIDAN. 307 00:15:32,838 --> 00:15:35,074 >> HELLO, THANK YOU FOR THE 308 00:15:35,074 --> 00:15:36,208 INTRODUCTION. HI, EVERYONE. 309 00:15:36,208 --> 00:15:37,409 LOOKING FORWARD TO THE 310 00:15:37,409 --> 00:15:39,111 DISCUSSION. I JOINED NHLBI ON 311 00:15:39,111 --> 00:15:42,281 THE LUNG DIVISION AS THE CHIEF 312 00:15:42,281 --> 00:15:44,983 OF THE RESTRICTIVE AND VASCULAR 313 00:15:44,983 --> 00:15:47,086 BRANCH A FEW MONTHS AGO, SO 314 00:15:47,086 --> 00:15:48,287 LOOKING FORWARD TO DISCUSSION. 315 00:15:48,287 --> 00:15:50,055 >> THANK YOU, JOHN. WE ALSO HAVE 316 00:15:50,055 --> 00:15:51,390 OTHER COLLEAGUES HERE. I 317 00:15:51,390 --> 00:15:54,126 PROBABLY DON'T HAVE THE TIME TO 318 00:15:54,126 --> 00:15:56,528 INTRODUCE EVERYONE. WE WILL MOVE 319 00:15:56,528 --> 00:15:59,031 ON TO THE NEXT. BASICALLY AGAIN 320 00:15:59,031 --> 00:16:00,299 THANK YOU EVERYONE FOR STAYING 321 00:16:00,299 --> 00:16:02,501 ON TIME. I WOULD LIKE TO WELCOME 322 00:16:02,501 --> 00:16:06,071 OUR ACTING DIRECTOR OF THE 323 00:16:06,071 --> 00:16:15,981 DIVISION OF LUNG DISEASE, DR. 324 00:16:15,981 --> 00:16:17,683 GUSTAVO MATUTE-BELLO FOR THE 325 00:16:17,683 --> 00:16:19,518 NHLBI LEADERSHIP PERSPECTIVE. 326 00:16:19,518 --> 00:16:21,553 THANK YOU, GUS. 327 00:16:21,553 --> 00:16:23,922 >> THANK YOU. GOOD MORNING, 328 00:16:23,922 --> 00:16:25,557 EVERYBODY. AS ACTING DIRECTOR OF 329 00:16:25,557 --> 00:16:27,960 DIVISION OF LUNG DISEASES AT 330 00:16:27,960 --> 00:16:30,529 NHLBI, IT IS MY GREAT PLEASURE 331 00:16:30,529 --> 00:16:33,365 TO WELCOME YOU ALL TO THIS NHLBI 332 00:16:33,365 --> 00:16:35,801 WORKSHOP ENTITLED HEALTH 333 00:16:35,801 --> 00:16:39,605 DISPARITIES ACROSS SPECTRUM OF 334 00:16:39,605 --> 00:16:42,508 PULMONARY VASCULAR DISEASE, PVD. 335 00:16:42,508 --> 00:16:45,144 THIS WORKSHOP WILL EXAMINE THE 336 00:16:45,144 --> 00:16:48,113 RELATIONSHIP BETWEEN HEALTH 337 00:16:48,113 --> 00:16:53,552 DISPARITIES AND PULMONARY 338 00:16:53,552 --> 00:16:55,721 VASCULAR DISEASE, HOW THEY 339 00:16:55,721 --> 00:16:59,324 AFFECT AND THE RELEVANCE OF 340 00:16:59,324 --> 00:17:01,860 CARDIO PULMONARY VASCULAR 341 00:17:01,860 --> 00:17:03,462 HEALTH. ONE OF THE KEYS IS 342 00:17:03,462 --> 00:17:05,097 IDENTIFY FACTORS THAT ACCOUNT 343 00:17:05,097 --> 00:17:07,065 FOR INDIVIDUAL DIFFERENCES AMONG 344 00:17:07,065 --> 00:17:09,101 PEOPLE OF DIFFERENT SEX, GENDER, 345 00:17:09,101 --> 00:17:13,238 RACE AND ETHNICITY IN TERMS OF 346 00:17:13,238 --> 00:17:18,443 DISEASE PATHOBIOLOGY AND 347 00:17:18,443 --> 00:17:22,181 TREATMENT. WE HAVE SIGNIFICANT 348 00:17:22,181 --> 00:17:24,016 PROGRESS IN HEALTH DISPARITIES 349 00:17:24,016 --> 00:17:26,718 AMONG MARGINALIZED GROUPS WITH 350 00:17:26,718 --> 00:17:32,024 DISEASES LIKE HEART FAILURE AND 351 00:17:32,024 --> 00:17:34,326 ASTHMA BUT LITTLE KNOWN HOW 352 00:17:34,326 --> 00:17:36,161 AFFECT PATIENTS WITH PVD AND 353 00:17:36,161 --> 00:17:38,864 GAPS INCLUDE UNDERSTANDING HOW 354 00:17:38,864 --> 00:17:40,299 GENETICS AND PRECISION MEDICINE 355 00:17:40,299 --> 00:17:44,937 SHOULD BE APPLIED TO RACIAL AND 356 00:17:44,937 --> 00:17:46,605 ETHNIC GROUPS IN GROUPS AND O 357 00:17:46,605 --> 00:17:52,144 HOW TO OPERATIONAL IZE BASED ON 358 00:17:52,144 --> 00:17:52,911 SOCIAL DETERMINANTS OF HEALTH, A 359 00:17:52,911 --> 00:17:56,415 FIELD OF SCIENCE. IT IS KNOWN 360 00:17:56,415 --> 00:17:56,982 THAT SOCIAL DETERMINANTS OF 361 00:17:56,982 --> 00:17:59,685 HEALTH ARE IMPORTANT 362 00:17:59,685 --> 00:18:05,390 CONTRIBUTIONS (AUDIO DISRUPTION) 363 00:18:05,390 --> 00:18:06,225 AND RELATIONSHIPS ARE NOT 364 00:18:06,225 --> 00:18:08,026 KNOWN .ENTERIF WE WANT TO 365 00:18:08,026 --> 00:18:11,230 DEVELOP AND DEFINE APPROACHES TO 366 00:18:11,230 --> 00:18:21,740 PULMONARY HYPERTENSION SUCH 367 00:18:24,977 --> 00:18:25,477 TAILOR THERAPIES WE NEED TO 368 00:18:25,477 --> 00:18:28,780 UNDERSTAND INTERACTIONS BETWEEN 369 00:18:28,780 --> 00:18:29,348 DISPARITIES AND PULMONARY 370 00:18:29,348 --> 00:18:31,917 VASCULAR DISEASE, UNDERSTANDING 371 00:18:31,917 --> 00:18:32,484 HOW SOCIAL DETERMINANTS OF 372 00:18:32,484 --> 00:18:33,919 HEALTH AFFECT ANALYSIS OF THE 373 00:18:33,919 --> 00:18:36,255 DATA AS WELL AS DEVELOPING NEW 374 00:18:36,255 --> 00:18:39,458 APPROACHES TO ANALYZE GENETIC 375 00:18:39,458 --> 00:18:43,128 DATABASE AND ANCESTRAL ORIGINS. 376 00:18:43,128 --> 00:18:45,364 TO HELP US MOVE FORWARD THE 377 00:18:45,364 --> 00:18:47,399 NHLBI WORKSHOP WITH GOALS OF 378 00:18:47,399 --> 00:18:49,134 DISCUSSING THE STATE OF 379 00:18:49,134 --> 00:18:52,137 KNOWLEDGE OF HEALTH DISPARITIES 380 00:18:52,137 --> 00:18:54,907 AND IMPACT ON PVD, IDENTIFY 381 00:18:54,907 --> 00:18:56,275 AREAS WHERE FURTHER RESEARCH IS 382 00:18:56,275 --> 00:18:58,110 NEEDED AND EXPLORE NEW 383 00:18:58,110 --> 00:19:01,246 INTERVENTIONS TO ADDRESS HOW 384 00:19:01,246 --> 00:19:02,114 HEALTH DISPARITIES AFFECT PVD. 385 00:19:02,114 --> 00:19:03,949 AT THIS TIME I WOULD LIKE TO ASK 386 00:19:03,949 --> 00:19:09,521 OUR DOCTOR TO INTRODUCE DR. 387 00:19:09,521 --> 00:19:11,690 LEOPOLD, THE CO -CHAIR TO 388 00:19:11,690 --> 00:19:13,025 DISCUSS WORKSHOP GOALS AND 389 00:19:13,025 --> 00:19:15,527 FUTURE OBJECTIVES, THANK YOU. 390 00:19:15,527 --> 00:19:16,995 >> THANK YOU, GUS. I WENT 391 00:19:16,995 --> 00:19:19,097 THROUGH THE SELF-INTRODUCTION 392 00:19:19,097 --> 00:19:20,866 EARLIER SO WE WILL TRY TO STAY 393 00:19:20,866 --> 00:19:25,037 ON TIME. NEXT WET WILL HAVE OUR 394 00:19:25,037 --> 00:19:29,508 CO -CHAIRS, DR. RISCHARD, TO 395 00:19:29,508 --> 00:19:38,550 GIVE US HIS PERSPECTIVE ON GOALS 396 00:19:38,550 --> 00:19:41,320 AND FUTURE PERSPECTIVE. 397 00:19:41,320 --> 00:19:48,827 >> THANK YOU DR. XIAO AND DR. 398 00:19:48,827 --> 00:19:50,429 BELLO FOR THAT WELCOME. I WANT 399 00:19:50,429 --> 00:19:53,832 TO THE GIVE A SPECIAL 400 00:19:53,832 --> 00:19:55,400 INTRODUCTION AND REMIND EVERYONE 401 00:19:55,400 --> 00:19:58,236 THAT IT IS COMING UP NOW ALMOST 402 00:19:58,236 --> 00:19:59,504 NINE-YEAR ANNIVERSARY OF WHEN I 403 00:19:59,504 --> 00:20:04,643 SAT DOWN WITH THE OTHER PVDOMIX 404 00:20:04,643 --> 00:20:05,844 INVESTIGATORS. FOR THOSE WHO 405 00:20:05,844 --> 00:20:09,448 DON'T KNOW IT IS AN 406 00:20:09,448 --> 00:20:10,882 NHLBI-SPONSORED PROJECT. NINE 407 00:20:10,882 --> 00:20:12,985 YEARS AGO WE SAT DOWN AND WENT 408 00:20:12,985 --> 00:20:16,288 THROUGH THE PROTOCOL TOGETHER. 409 00:20:16,288 --> 00:20:19,157 ALMOST A YEAR PROTOCOL. PVDOMIX 410 00:20:19,157 --> 00:20:22,761 WILL BE HIGHLIGHTED LATER IN THE 411 00:20:22,761 --> 00:20:26,164 SESSION. DR. LEOPOLD AND I MET 412 00:20:26,164 --> 00:20:27,866 BACK THEN. I'M PROUD TO SAY AS 413 00:20:27,866 --> 00:20:30,335 MUCH AS SHE IS A GREAT COLLEAGUE 414 00:20:30,335 --> 00:20:33,038 AND EXPERT IN CARDIOVASCULAR AND 415 00:20:33,038 --> 00:20:36,775 PH DISEASE, SHE IS A GREAT 416 00:20:36,775 --> 00:20:42,614 FRIEND AS WELL. OUTSIDE THE 417 00:20:42,614 --> 00:20:44,549 OBVIOUS I'M A WHITE MALE 418 00:20:44,549 --> 00:20:46,385 CHAIRING A SESSION ON DIVERSITY. 419 00:20:46,385 --> 00:20:48,954 MY IMPOSTER SYNDROME IS GOING IN 420 00:20:48,954 --> 00:20:50,055 HIGH GEAR BECAUSE WE HAVE SO 421 00:20:50,055 --> 00:20:55,460 MANY TALENTED -- 19 OTHER 422 00:20:55,460 --> 00:20:56,228 SPEAKERS AND 6 EXPERT 423 00:20:56,228 --> 00:20:58,363 DISCUSSANTS. SOMETIMES IT MAKES 424 00:20:58,363 --> 00:21:01,333 ME NERVOUS WITH THE AMOUNT OF 425 00:21:01,333 --> 00:21:03,235 BRAIN POWER WE HAVE THAT 426 00:21:03,235 --> 00:21:04,770 CONFERENCE, BUT I'M VERY 427 00:21:04,770 --> 00:21:06,805 EXCITED. THE DEPTH AND BREADTH 428 00:21:06,805 --> 00:21:09,875 OF THE GROUP IS ASTOUNDING. WE 429 00:21:09,875 --> 00:21:13,145 ARE ALL READY FOR A TREAT. ANY 430 00:21:13,145 --> 00:21:15,080 ONLY ARE THEY DIVERSE IN SUBJECT 431 00:21:15,080 --> 00:21:18,250 AREA AND EXPERTISE, DR. XIAO, 432 00:21:18,250 --> 00:21:21,787 DR. LEOPOLD AND I MADE A 433 00:21:21,787 --> 00:21:24,723 CONCERTED EFFORT TO BRING IN 434 00:21:24,723 --> 00:21:29,194 PEOPLE OF DIVERSE GENDER, 435 00:21:29,194 --> 00:21:31,029 RACIAL, ETHNIC AND CAREER LEVELS 436 00:21:31,029 --> 00:21:41,573 AS WELL. WHAT WE WILL NOTICE IS 437 00:21:42,107 --> 00:21:45,577 THERE ARE CROSS-CUTTING THEMES, 438 00:21:45,577 --> 00:21:46,078 GENETICS, ENVIRONMENT, 439 00:21:46,078 --> 00:21:47,879 VULNERABILITY AMONG OTHERS WITH 440 00:21:47,879 --> 00:21:50,248 A LARGE FOUNDATION OF RESEARCH 441 00:21:50,248 --> 00:21:51,450 OUTSIDE OF PH. THEREFORE YOU 442 00:21:51,450 --> 00:21:54,453 WILL SEE A BODY OF EVIDENCE 443 00:21:54,453 --> 00:21:57,789 PRESENTED IN THESE TOPICS THAT I 444 00:21:57,789 --> 00:22:01,126 HAVE -- HAVE A -- HAVE GAINED 445 00:22:01,126 --> 00:22:03,728 SOME REPETITION THROUGHOUT THE 446 00:22:03,728 --> 00:22:04,529 CONFERENCE. BUT WILL OFFER 447 00:22:04,529 --> 00:22:08,567 DIFFERENT PERSPECTIVES ON THAT. 448 00:22:08,567 --> 00:22:11,336 OBVIOUSLY BECAUSE PH IS A RARE 449 00:22:11,336 --> 00:22:15,774 DISEASE THERE IS NOT A LARGE 450 00:22:15,774 --> 00:22:18,910 BREADTH OF EVIDENCE ON ASSOCIATE 451 00:22:18,910 --> 00:22:19,978 DISPARITIES ON EVIDENCE SO, 452 00:22:19,978 --> 00:22:22,347 AGAIN, WE HAVE A DIVERSE FACULTY 453 00:22:22,347 --> 00:22:24,049 WHO WILL DISCUSS AREAS OUTSIDE 454 00:22:24,049 --> 00:22:26,518 OF PH. BUT I THINK WE WILL ALL 455 00:22:26,518 --> 00:22:28,120 DO A GOOD JOB OF BRINGING IT 456 00:22:28,120 --> 00:22:31,623 BACK TO PH ON ALL THE DIFFERENT 457 00:22:31,623 --> 00:22:33,091 SUBJECTS AND SESSIONS. 458 00:22:33,091 --> 00:22:35,160 I THINK WE MUST RECOGNIZE 459 00:22:35,160 --> 00:22:39,898 THAT THE IMPACTS THAT WE HAVE, 460 00:22:39,898 --> 00:22:44,769 INTENDED OR UNINTENDED ON PUBLIC 461 00:22:44,769 --> 00:22:48,173 POLICY AND GUIDELINE FOUNDATION 462 00:22:48,173 --> 00:22:58,817 ARE IMPORTANT. ANNE RAND SAID 463 00:22:58,817 --> 00:23:00,352 THE GREATEST THING SCIENCE 464 00:23:00,352 --> 00:23:04,289 TEACHES IS LAW OF UNINTENDED 465 00:23:04,289 --> 00:23:05,090 CONSEQUENCES. ONE THING THAT IS 466 00:23:05,090 --> 00:23:06,758 IMPORTANT, I THINK, TO 467 00:23:06,758 --> 00:23:09,661 ILLUSTRATE SOME OF THESE 468 00:23:09,661 --> 00:23:11,696 UNINTENDED CONSEQUENCES ARE 469 00:23:11,696 --> 00:23:15,100 SOMETHING THAT'S COME UP FAIRLY 470 00:23:15,100 --> 00:23:18,203 REC 471 00:23:18,203 --> 00:23:19,704 RECENTLY. TWO UNDERLYING 472 00:23:19,704 --> 00:23:21,606 HYPOTHESES EXIST WHEN WE LOOK AT 473 00:23:21,606 --> 00:23:24,743 ROLE OF RACE IN HEALTH 474 00:23:24,743 --> 00:23:26,444 DISPARITIES. ONE ON THE TOP ON 475 00:23:26,444 --> 00:23:29,748 THE LEFT YOU CAN SEE 476 00:23:29,748 --> 00:23:33,919 TRADITIONALLY RACE HAS BEEN A -- 477 00:23:33,919 --> 00:23:44,362 CON FLATED WITH JEANETTE 478 00:23:49,968 --> 00:23:51,136 HETEROGENAITY WITHIN RACE. THIS 479 00:23:51,136 --> 00:23:55,373 HAS LARGELY BEEN DEBUNKED. THE 480 00:23:55,373 --> 00:24:01,379 SECOND HYPOTHESIS IS STRUCTURAL 481 00:24:01,379 --> 00:24:03,181 RACISM HAVING ROOTS IN POLICY AS 482 00:24:03,181 --> 00:24:05,150 WELL AS DECISIONS IN THE -- DOWN 483 00:24:05,150 --> 00:24:07,319 TO THE DECISIONS IN THE 484 00:24:07,319 --> 00:24:17,762 COMMUNITY LEAD TO SOCIAL 485 00:24:21,099 --> 00:24:22,400 DIVERSITIES AND OTHER THINGS 486 00:24:22,400 --> 00:24:24,936 THAT LEAD TO HEALTH DISPARITIES. 487 00:24:24,936 --> 00:24:30,842 ONE IMPORTANT EXAMPLE OF HOW 488 00:24:30,842 --> 00:24:33,979 THE LINEAGE OF RESEARCH BASED IN 489 00:24:33,979 --> 00:24:37,549 A LARGELY DEBUNKED HYPOTHESIS 490 00:24:37,549 --> 00:24:39,851 MAY BE APPLIED TO CURRENT 491 00:24:39,851 --> 00:24:43,221 RESEARCH IS IN A RECENT 492 00:24:43,221 --> 00:24:47,259 PUBLICATION IN CHEST. EXERCISE 493 00:24:47,259 --> 00:24:49,694 DYNAMICS PREDICT HYPERTENSION IN 494 00:24:49,694 --> 00:24:52,564 MUTATION CARRIERS. FOR THOSE WHO 495 00:24:52,564 --> 00:24:54,799 DON'T KNOW BM2R MUTATION IS ONE 496 00:24:54,799 --> 00:24:59,904 OF THE MAIN MUTATIONS FOUND 497 00:24:59,904 --> 00:25:01,706 RELATED TO PULMONARY 498 00:25:01,706 --> 00:25:04,876 HYPERTENSION. THIS STUDY LOOKED 499 00:25:04,876 --> 00:25:07,279 AT EXERCISE CATHETERIZATION TO 500 00:25:07,279 --> 00:25:08,647 DETECT EARLY CHANGES AND 501 00:25:08,647 --> 00:25:10,582 THEREFORE POTENTIALLY A MARK 502 00:25:10,582 --> 00:25:13,318 TORE EXAMINE AND SCREEN FOR 503 00:25:13,318 --> 00:25:17,622 FUTURE DEVELOPMENT OF PULMONARY 504 00:25:17,622 --> 00:25:19,624 HYPERTENSION. IF YOU ARE NOT 505 00:25:19,624 --> 00:25:22,861 FAMILIAR THIS IS OBTAINED 506 00:25:22,861 --> 00:25:23,728 THROUGH EXERCISE 507 00:25:23,728 --> 00:25:24,763 CATHETERIZATION. IF YOU MAY LOOK 508 00:25:24,763 --> 00:25:28,633 AT THE LIST OF AUTHORS ON THIS 509 00:25:28,633 --> 00:25:33,405 PAPER YOU REALIZE THIS GROUP IS 510 00:25:33,405 --> 00:25:35,473 VERY INFLUENTIAL IN TERMS OF 511 00:25:35,473 --> 00:25:37,909 WORLD SYMPOSIUM, GUIDELINE 512 00:25:37,909 --> 00:25:39,811 FORMATION, AMONG OTHERS. ONE 513 00:25:39,811 --> 00:25:41,746 THING THEY PERHAPS HAVE NOT 514 00:25:41,746 --> 00:25:43,014 CONSIDERED IS BELOW THIS. THERE 515 00:25:43,014 --> 00:25:48,219 WAS A STUDY IN 1985 LOOKING AT 516 00:25:48,219 --> 00:25:56,494 THE DIFFERENCES BETWEEN WHITE 517 00:25:56,494 --> 00:25:56,895 K 518 00:25:56,895 --> 00:25:58,463 CAUCASIANS AND SUB SAHARAN 519 00:25:58,463 --> 00:26:00,265 AFRICANS FROM BELGIAN GROUP AND 520 00:26:00,265 --> 00:26:04,402 STUDIES THE PREMISE ONE CAN 521 00:26:04,402 --> 00:26:05,470 HYPOTHESIZE BLACK 522 00:26:05,470 --> 00:26:06,938 AFRICAN-AMERICANS -- NOT ONLY 523 00:26:06,938 --> 00:26:08,473 LOOKING AT BLACK SUB SAHARAN 524 00:26:08,473 --> 00:26:10,141 AFRICANS WHO HAVE LIVED IN 525 00:26:10,141 --> 00:26:14,813 BELGIUM A SHORT PERIOD BUT CON 526 00:26:14,813 --> 00:26:18,216 FLATING THAT WITH 527 00:26:18,216 --> 00:26:18,850 AFRICAN-AMERICANS. THIS MADE 528 00:26:18,850 --> 00:26:21,653 LESS CIRCULATION. WHEN WE LOOK 529 00:26:21,653 --> 00:26:24,689 AT THE DIFFERENT FACTORS THAT 530 00:26:24,689 --> 00:26:27,325 INFLUENCE DISTENSIBILITY, ONE OF 531 00:26:27,325 --> 00:26:27,992 THOSE POTENTIALLY BEING WHETHER 532 00:26:27,992 --> 00:26:30,095 OR NOT YOU ARE BORN AND RAISED 533 00:26:30,095 --> 00:26:32,797 IN SUB SAHARAN AFRICA, WAS 534 00:26:32,797 --> 00:26:34,165 PROBABLY AND LIKELY NOT 535 00:26:34,165 --> 00:26:36,701 CONSIDERED BY THE GROUP THAT 536 00:26:36,701 --> 00:26:42,006 LOOKED AT THE DISTENSIBILITY 537 00:26:42,006 --> 00:26:44,376 HERE AMONG THE DETECT RESEARCH 538 00:26:44,376 --> 00:26:47,512 GROUP, WHICH IS THE RECENTLY 539 00:26:47,512 --> 00:26:51,249 PUBLISHED ARTICLE IN CHEST. THEY 540 00:26:51,249 --> 00:26:53,885 ESSENTIALLY CUT OFF THE HEALTHY 541 00:26:53,885 --> 00:26:56,388 SUB SAHARAN AFRICAN MEN IN 542 00:26:56,388 --> 00:26:59,657 PREVIOUS STUDY ARE BELOW 1.5 543 00:26:59,657 --> 00:27:00,725 BEST CUT-OFF FOR DEVELOPMENT OF 544 00:27:00,725 --> 00:27:02,927 LATER PH. THIS MIGHT BE RINGING 545 00:27:02,927 --> 00:27:05,663 SOME BELLS WITH REGARD TO HOW WE 546 00:27:05,663 --> 00:27:08,199 HAVE RECENTLY BEEN DEBATING THE 547 00:27:08,199 --> 00:27:12,871 ROLE OF RACE CUT-OFFS IN 548 00:27:12,871 --> 00:27:16,307 SPIROMETRY. AND THIS SAME DEBATE 549 00:27:16,307 --> 00:27:17,609 APPLIES NOW IN PULMONARY 550 00:27:17,609 --> 00:27:21,012 HYPERTENSION, IF WE DON'T 551 00:27:21,012 --> 00:27:23,348 EXAMINE WHAT POPULATIONS METRIC 552 00:27:23,348 --> 00:27:25,049 HAS BEEN TESTED IN, PARTICULARLY 553 00:27:25,049 --> 00:27:29,220 IN RACES, WHEN WE BRING THIS UP 554 00:27:29,220 --> 00:27:31,356 AND SUBSEQUENTLY POTENTIALLY 555 00:27:31,356 --> 00:27:33,925 GUIDELINE FORMATION, WE MAY 556 00:27:33,925 --> 00:27:35,827 PERPETUATE EVEN UNKNOWINGLY 557 00:27:35,827 --> 00:27:44,002 STRUCTURAL RACISM. CAN WE MOVE 558 00:27:44,002 --> 00:27:45,570 TO THE NEXT SLIDE? 559 00:27:45,570 --> 00:27:47,005 THERE WILL BE SEVERAL KEY 560 00:27:47,005 --> 00:27:53,511 QUESTIONS WE WILL BE 561 00:27:53,511 --> 00:27:55,814 APPROACHING. WITH A PASSION IN 562 00:27:55,814 --> 00:27:58,450 THIS FIELD. WE WILL BE STARTING 563 00:27:58,450 --> 00:28:05,190 OFF WITH DR. GOEL, DR. ESTRADA 564 00:28:05,190 --> 00:28:13,531 AND DR. HAY. DOCTORS BERNARDO, 565 00:28:13,531 --> 00:28:14,699 JESUS, PEREZ, BRITAIN WILL 566 00:28:14,699 --> 00:28:15,333 DISCUSS SOCIAL DETERMINANTS OF 567 00:28:15,333 --> 00:28:17,135 HEALTH, HEALTH IN PH PATIENTS 568 00:28:17,135 --> 00:28:21,506 AND DR. GOEL WILL BE FINISHING 569 00:28:21,506 --> 00:28:22,841 OFF WITH SOCIAL DETERMINANTS OF 570 00:28:22,841 --> 00:28:25,910 HEALTH IMPLEMENTATION RESEARCH. 571 00:28:25,910 --> 00:28:27,178 DR. SHAH WILL DISCUSS SEX AND 572 00:28:27,178 --> 00:28:29,481 GENDER DISPARITIES, DR. EGHBALI 573 00:28:29,481 --> 00:28:32,617 SOME BASIC SCIENCE ON SEX 574 00:28:32,617 --> 00:28:34,285 HORMONES AND DR. VENTETUOLO WILL 575 00:28:34,285 --> 00:28:36,788 FINISH OFF WITH INTERVENTIONS 576 00:28:36,788 --> 00:28:41,192 AIMED AT THESE DISPARITIES. DR. 577 00:28:41,192 --> 00:28:44,462 DEASI WILL GIVE A LOOK WITH HOW 578 00:28:44,462 --> 00:28:45,797 GENETICS INTERACT WITH 579 00:28:45,797 --> 00:28:46,865 ENVIRONMENTAL FACTORS AND I LOOK 580 00:28:46,865 --> 00:28:48,867 FORWARD TO DR. ORTEGA PROVIDING 581 00:28:48,867 --> 00:28:51,069 OVERVIEW OF GENETICS AND 582 00:28:51,069 --> 00:28:52,770 ANCESTRY, PARTICULARLY RELEVANT 583 00:28:52,770 --> 00:28:55,507 TO THE PREVIOUS SCENARIO I JUST 584 00:28:55,507 --> 00:28:57,208 DISCUSSED. DR. GLENN WILL GIVE 585 00:28:57,208 --> 00:28:59,210 US AN IDEA ON HOW CUMULATIVE 586 00:28:59,210 --> 00:29:01,946 STRESS, TRAUMA IS MEASURED BY 587 00:29:01,946 --> 00:29:04,949 ALOE STATIC LOAD AFFECTS OUR 588 00:29:04,949 --> 00:29:10,188 HEALTH AND DR. LIM AND MATHAI ON 589 00:29:10,188 --> 00:29:12,257 ENVIRONMENTAL EXPOSURES 590 00:29:12,257 --> 00:29:13,892 DISPROPORTIONATELY FELT BY 591 00:29:13,892 --> 00:29:14,792 MARGINALIZED COMMUNITIES AND 592 00:29:14,792 --> 00:29:22,667 WAYS TO MITIGATE BY DR. MATHAI 593 00:29:22,667 --> 00:29:23,301 AND LOOK BACK AT MY COLLEAGUES 594 00:29:23,301 --> 00:29:28,039 IN THE STUDY, MYSELF, HORN AND 595 00:29:28,039 --> 00:29:30,775 HEMNIS DISCUSS THE RACIAL AND 596 00:29:30,775 --> 00:29:35,513 AGE-RELATED ISSUES FROM THE 597 00:29:35,513 --> 00:29:38,316 PVDOMIX STUDY. YOU WILL NOTICE 598 00:29:38,316 --> 00:29:40,919 YOU WILL HAVE FIVE MINUTES FOR 599 00:29:40,919 --> 00:29:42,220 DISCUSSION. THIS IS MOSTLY FOR 600 00:29:42,220 --> 00:29:45,990 TRANSITION. WE WILL HAVE A 601 00:29:45,990 --> 00:29:46,958 20-MINUTE INTERVAL TO ALSO 602 00:29:46,958 --> 00:29:48,927 DISCUSS IN A TWO-HOUR DISCUSSION 603 00:29:48,927 --> 00:29:55,133 SESSION AT THE END OF THE SECOND 604 00:29:55,133 --> 00:30:02,640 D 605 00:30:02,640 --> 00:30:06,978 DAY. WE ARE TALKING ABOUT RACE, 606 00:30:06,978 --> 00:30:07,979 ETHNICITY AND GENDER AND THESE 607 00:30:07,979 --> 00:30:10,582 CAN BE CHARGED. I WOULD URGE YOU 608 00:30:10,582 --> 00:30:14,285 TO CRITICIZE POLICIES RATHER 609 00:30:14,285 --> 00:30:17,889 THAN INDIVIDUALS. LASTLY WE WILL 610 00:30:17,889 --> 00:30:19,457 BE DEVELOPING A WORKSHOP 611 00:30:19,457 --> 00:30:23,127 MANUSCRIPT. IF YOU HAVE IDEAS, 612 00:30:23,127 --> 00:30:24,796 EMAIL ME, SEND COMMENTS IN CHAT 613 00:30:24,796 --> 00:30:27,332 OR TEXT OR PING ME WITH THOSE 614 00:30:27,332 --> 00:30:30,602 IDEAS. WITH THAT LET'S GET 615 00:30:30,602 --> 00:30:35,473 STARTED. I WILL INTRODUCE DR. 616 00:30:35,473 --> 00:30:39,310 GOEL, GIVING US A TALK ON THE 617 00:30:39,310 --> 00:30:42,914 RELATIONSHIP BETWEEN HEALTH DIRT 618 00:30:42,914 --> 00:30:47,385 DISPARITIES, RACE, ETHNICITY AND 619 00:30:47,385 --> 00:30:51,823 ANDING ACCENTUATED BY RARE 620 00:30:51,823 --> 00:30:52,457 DISEASES LIKE PH. 621 00:30:52,457 --> 00:30:54,959 >> I SEE SOME OF THE SPEAKERS 622 00:30:54,959 --> 00:30:57,028 ARE HERE, MISSING FROM THE 623 00:30:57,028 --> 00:30:58,329 INTRODUCTION SECTION. MAYBE WE 624 00:30:58,329 --> 00:31:01,699 WILL ASK THEM TO DO A QUICK 625 00:31:01,699 --> 00:31:04,902 SELF-INTRODUCTION FIRST BEFORE 626 00:31:04,902 --> 00:31:13,978 THE SESSION START. I SEE DR. 627 00:31:13,978 --> 00:31:16,147 GLENN AND DE-JESUS. MAY BE MORE. 628 00:31:16,147 --> 00:31:18,650 DR. GLENN, IF YOU ARE HERE YOU 629 00:31:18,650 --> 00:31:20,818 TURN ON YOUR CAMERA AND 630 00:31:20,818 --> 00:31:24,922 MICROPHONE AND GIVE A 15-SECOND 631 00:31:24,922 --> 00:31:27,458 SELF-INTRODUCTION. BASICALLY -- 632 00:31:27,458 --> 00:31:27,692 YEP. 633 00:31:27,692 --> 00:31:31,029 >> GOOD MORNING. I'M JASON GLENN 634 00:31:31,029 --> 00:31:31,929 ASSOCIATE PROFESSOR IN 635 00:31:31,929 --> 00:31:33,498 DEPARTMENT OF HISTORY AND 636 00:31:33,498 --> 00:31:34,399 PHILOSOPHITY AT DEPARTMENT OF 637 00:31:34,399 --> 00:31:36,300 MEDICINE AT UNIVERSITY OF KANSAS 638 00:31:36,300 --> 00:31:37,702 MEDICAL CENTER AND ALSO 639 00:31:37,702 --> 00:31:39,637 ASSOCIATE DIRECTOR OF CENTER FOR 640 00:31:39,637 --> 00:31:41,005 AFRICAN-AMERICAN HEALTH. IT IS 641 00:31:41,005 --> 00:31:42,874 WONDERFUL TO BE WITH YOU ALL 642 00:31:42,874 --> 00:31:43,641 THIS MORNING. 643 00:31:43,641 --> 00:31:52,684 >> THANK YOU, DR. GLENN. 644 00:31:52,684 --> 00:31:53,618 VENICIO, ARE YOU HERE? 645 00:31:53,618 --> 00:31:54,619 >> CAN YOU HEAR ME? 646 00:31:54,619 --> 00:31:57,755 >> YES, I CAN HEAR YOU. 647 00:31:57,755 --> 00:32:08,299 >> WONDERFUL. I'M AT THE STAFF 648 00:32:09,834 --> 00:32:12,770 UNIVERSITY AND SPECIALIZE IN 649 00:32:12,770 --> 00:32:15,907 PULMONARY HYPERTENSION AND HAVE 650 00:32:15,907 --> 00:32:19,610 INTEREST IN DRUG INDUCED 651 00:32:19,610 --> 00:32:20,545 HYPERTENSION AND SOCIAL 652 00:32:20,545 --> 00:32:21,079 DETERMINANTS OF HEALTH. 653 00:32:21,079 --> 00:32:26,918 >> THANKS, VENICIO. NOT SURE 654 00:32:26,918 --> 00:32:34,125 WHETHER DR. GODE AND MATHAI ARE 655 00:32:34,125 --> 00:32:35,993 HERE. IF YOU ARE PUT ON YOUR 656 00:32:35,993 --> 00:32:37,628 MICROPHONE AND PROCEED. PROBABLY 657 00:32:37,628 --> 00:32:40,565 NOT HERE. LET'S MOVE ON TO DR. 658 00:32:40,565 --> 00:32:44,068 GOEL TO START HER PRESENTATION, 659 00:32:44,068 --> 00:32:47,705 THANK YOU. 660 00:32:47,705 --> 00:32:50,508 >> PERFECT. HI, EVERYONE. I 661 00:32:50,508 --> 00:32:51,075 REALLY APPRECIATE THE 662 00:32:51,075 --> 00:32:53,077 OPPORTUNITY TO SPEAK WITH YOU 663 00:32:53,077 --> 00:32:55,580 ALL TODAY.LY BE DISCUSSING HOW 664 00:32:55,580 --> 00:32:56,881 DISPARITIES ASSOCIATED WITH RACE 665 00:32:56,881 --> 00:33:01,452 AND ETHNICITY ARE ACCENTUATED 666 00:33:01,452 --> 00:33:04,055 AMONG PATIENTS WITH PULMONARY 667 00:33:04,055 --> 00:33:11,329 VASCULAR DISEASE AND 668 00:33:11,329 --> 00:33:13,231 SPECIFICALLY ON PULMONARY 669 00:33:13,231 --> 00:33:14,132 HYPERTENSION.LY START WITH A 670 00:33:14,132 --> 00:33:16,601 RARE DISEASE SUCH AS PH AND INTO 671 00:33:16,601 --> 00:33:18,703 THE ROLE RACE AND ETHNICITY PLAY 672 00:33:18,703 --> 00:33:20,705 IN PERPETUATING THESE HEALTH 673 00:33:20,705 --> 00:33:23,508 CARE DISPARITIES. I WILL TALK 674 00:33:23,508 --> 00:33:27,245 ABOUT AN IMPORTANT MANIFESTATION 675 00:33:27,245 --> 00:33:30,014 CONSEQUENCE DISPARITIES, 676 00:33:30,014 --> 00:33:31,349 UNDERREPRESENTATION IN PH 677 00:33:31,349 --> 00:33:32,750 REGISTRIES AND CLINICAL TRIAL. 678 00:33:32,750 --> 00:33:34,819 THEN GET INTO FUTURE DIRECTIONS 679 00:33:34,819 --> 00:33:37,722 AND QUESTIONS. ONE OF MY BIG 680 00:33:37,722 --> 00:33:39,991 GOALS FOR THIS TALK IS TO SET 681 00:33:39,991 --> 00:33:43,427 THE STAGE FOR ALL THE SUBSEQUENT 682 00:33:43,427 --> 00:33:44,929 TALKS, WHICH WILL DELVE DEEPER 683 00:33:44,929 --> 00:33:47,131 INTO TALKS I BRING UP TODAY. 684 00:33:47,131 --> 00:33:47,365 NEXT. 685 00:33:47,365 --> 00:33:51,102 I DID WANT TO START OFF WITH 686 00:33:51,102 --> 00:33:53,437 THE STORY OF ONE OF MY PATIENTS. 687 00:33:53,437 --> 00:33:58,843 SO HE IS A 58 -YEAR-OLD MAN WITH 688 00:33:58,843 --> 00:34:04,682 HISTORY OF METH AND ADMITTED 689 00:34:04,682 --> 00:34:06,984 WITH SEPTIC SHOCK. HE HAD AN 690 00:34:06,984 --> 00:34:08,219 ECHO CARD GRAM, WHICH WAS 691 00:34:08,219 --> 00:34:10,988 CONCERNING FOR PH. HE ENDED UP 692 00:34:10,988 --> 00:34:12,690 NEEDING A CATHETER, SHOWING 693 00:34:12,690 --> 00:34:15,259 ELEVATED ARTERY PRESSURE. HE WAS 694 00:34:15,259 --> 00:34:20,097 DIRE EASED, NEEDED ANDOBUTAMINE 695 00:34:20,097 --> 00:34:25,536 AND IVOPROSTENAL. HE WAS ABLE TO 696 00:34:25,536 --> 00:34:26,971 SAFELY UNDERGO SURGERY AND 697 00:34:26,971 --> 00:34:32,410 TRANSFERRED TO CEDARS FOR 698 00:34:32,410 --> 00:34:34,312 FURTHER MANAGEMENT OF PH. WHEN 699 00:34:34,312 --> 00:34:39,984 HE CAME TO WE CONTINUED TO 700 00:34:39,984 --> 00:34:41,219 DIURESE AND WEAN HIM OFF AND 701 00:34:41,219 --> 00:34:43,521 WORK UP FOR CAUSES OF PH, AFTER 702 00:34:43,521 --> 00:34:46,457 WHICH WE PERFORMED A FORMAL 703 00:34:46,457 --> 00:34:47,225 RIGHT HEART CATEGORY IZATION 704 00:34:47,225 --> 00:34:49,694 WHICH DID CONFIRM PRECAPILLARY 705 00:34:49,694 --> 00:34:52,597 PH AND WE WERE ABLE TO START HIM 706 00:34:52,597 --> 00:34:58,903 AS AN INPATIENT ON SILDYNAFIL. 707 00:34:58,903 --> 00:35:00,338 GREAT NEWS IS EVERYTHING 708 00:35:00,338 --> 00:35:03,140 IMPROVED DURING HIS HOSPITAL 709 00:35:03,140 --> 00:35:05,409 STAY. NEXT. SO THIS REALLY FELT 710 00:35:05,409 --> 00:35:08,379 LIKE A SUCCESS STORY. THIS, 711 00:35:08,379 --> 00:35:10,915 AGAIN, IS A GREAT EXAMPLE OF 712 00:35:10,915 --> 00:35:12,183 PEOPLE RECOGNIZING PH AND 713 00:35:12,183 --> 00:35:14,418 APPROPRIATELY TRANSFERRING TO AN 714 00:35:14,418 --> 00:35:16,854 EXPERT PH CENTER, WHICH ALLOWED 715 00:35:16,854 --> 00:35:21,192 US TO COMPLETE A THOROUGH 716 00:35:21,192 --> 00:35:24,395 WORKUP. ULTIMATELY INITIATE 717 00:35:24,395 --> 00:35:28,466 TREATMENT DIRECTED AT PAH. NEXT. 718 00:35:28,466 --> 00:35:31,202 THEN, YOU KNOW, AFTER WE 719 00:35:31,202 --> 00:35:32,536 FINISHED GIVING HIGH-FIVES AND 720 00:35:32,536 --> 00:35:33,804 PATTING OURSELVES ON THE BACK WE 721 00:35:33,804 --> 00:35:35,773 HAD TO THINK WHERE DO WE GO FROM 722 00:35:35,773 --> 00:35:37,541 HERE, WHAT ARE THE NEXT STEPS. 723 00:35:37,541 --> 00:35:39,043 REALLY THE NEXT STEP WAS TO 724 00:35:39,043 --> 00:35:41,879 START COORDINATING OUTPATIENT PH 725 00:35:41,879 --> 00:35:43,347 FOLLOW-UP SO TO FOLLOW HIM 726 00:35:43,347 --> 00:35:45,950 CLOSELY AND CONTINUE TO ADD ON 727 00:35:45,950 --> 00:35:55,393 DIFFERENT MEDICATIONS. NEXT. 728 00:35:55,393 --> 00:35:58,429 BISHOP, CALIFORNIA IS CLOSER TO 729 00:35:58,429 --> 00:36:00,364 THE STATE OF NEVADA THAN IT IS 730 00:36:00,364 --> 00:36:01,933 TO ANY OTHER MAJOR CITY IN 731 00:36:01,933 --> 00:36:06,938 CALIFORNIA. FOR HIM TO COME TO 732 00:36:06,938 --> 00:36:07,271 S 733 00:36:07,271 --> 00:36:09,073 CEDARS WOULD BE FOUR HOURS, NOT 734 00:36:09,073 --> 00:36:11,876 INCLUDING L. A. TRAFFIC. NEXT. 735 00:36:11,876 --> 00:36:13,244 SO WHEN WE SEARCHED ON THE 736 00:36:13,244 --> 00:36:15,947 WEBSITE TO LOOK FOR OTHER PH 737 00:36:15,947 --> 00:36:17,682 SPECIALISTS IT RESULTED IN FOUR 738 00:36:17,682 --> 00:36:19,984 PH SPECIALISTS. INTERESTINGLY 739 00:36:19,984 --> 00:36:24,388 ENOUGH, IT WOULD HAVE BEEN AN 740 00:36:24,388 --> 00:36:26,390 EVEN LONGER DRIVE IF HE HAD TO 741 00:36:26,390 --> 00:36:27,925 GO TO FRESNO OR SACRAMENTO, 742 00:36:27,925 --> 00:36:32,396 WHERE THEY WERE LOCATED. NEXT. 743 00:36:32,396 --> 00:36:33,464 FORTUNATELY HE WAS SOMEHOW ABLE 744 00:36:33,464 --> 00:36:37,501 TO MAKE THE LONG DRIVE TO L. A. 745 00:36:37,501 --> 00:36:41,138 TO BE SEEN, WHICH WE WERE ABLE 746 00:36:41,138 --> 00:36:46,444 TO INITIATE MASETINTIN. 747 00:36:46,444 --> 00:36:48,579 INSURANCE CHANGED AND REQUIRED 748 00:36:48,579 --> 00:36:49,747 AUTHORIZATION, WHICH CLASSICALLY 749 00:36:49,747 --> 00:36:52,750 WAS DENIED, RAN OUT IN THE 750 00:36:52,750 --> 00:36:54,518 INTERIM AS WELL, WHICH WAS 751 00:36:54,518 --> 00:36:55,886 CONCERNING. AFTER A FEW MONTHS 752 00:36:55,886 --> 00:36:58,389 HE WAS EVENTUALLY ABLE TO BE 753 00:36:58,389 --> 00:37:00,624 APPROVED AT USC. SO THERE IS A 754 00:37:00,624 --> 00:37:05,429 BIT OF A HAPPY ENDING TO THIS. 755 00:37:05,429 --> 00:37:10,768 NEXT. SO I'M SURE THIS STORY 756 00:37:10,768 --> 00:37:11,736 SOUNDS FAMILIAR BECAUSE I THINK 757 00:37:11,736 --> 00:37:14,205 IT HIGHLIGHTS A LOT OF COMMON 758 00:37:14,205 --> 00:37:16,107 THEMES WE FACE AND SEE. FOR 759 00:37:16,107 --> 00:37:17,308 EXAMPLE, THE FACT THERE IS 760 00:37:17,308 --> 00:37:19,643 VARYING DEGREE OF RESOURCES AND 761 00:37:19,643 --> 00:37:21,679 EXPERTISE TO PROVIDE SPECIALIZED 762 00:37:21,679 --> 00:37:24,415 PH CARE. THERE IS A LIMIT TO HOW 763 00:37:24,415 --> 00:37:27,651 MUCH WE CAN OPTIMIZE ON THE 764 00:37:27,651 --> 00:37:29,286 INPATIENT SIDE. AT SOME POINT WE 765 00:37:29,286 --> 00:37:31,255 HAVE TO LET THEM OUT INTO THE 766 00:37:31,255 --> 00:37:32,857 REAL WORLD. ISSUES OF SAFE 767 00:37:32,857 --> 00:37:35,659 DISCHARGE AND FOLLOW-UP PLANS, 768 00:37:35,659 --> 00:37:40,197 PRESCRIBING AND MONITORING VASO 769 00:37:40,197 --> 00:37:42,633 DILATOR THERAPY, INSURANCE 770 00:37:42,633 --> 00:37:44,568 BARRIERS AND SUBSTANCE USE 771 00:37:44,568 --> 00:37:48,205 DISORDER AS A CAUSE OF PH. NEXT. 772 00:37:48,205 --> 00:37:49,940 THIS IS WHERE WE GET INTO SOME 773 00:37:49,940 --> 00:37:52,009 SAD FACTS ABOUT CARING FOR 774 00:37:52,009 --> 00:37:53,611 PATIENTS WITH A RARE DISEASE 775 00:37:53,611 --> 00:37:57,415 SUCH AS PH. FIRST AND FOREMOST 776 00:37:57,415 --> 00:37:59,316 IS THE FACT WE STILL -- TAKES 777 00:37:59,316 --> 00:38:01,152 PATIENTS A LONG TIME TO GET 778 00:38:01,152 --> 00:38:03,220 DIAGNOSED WITH PH. THE TIME TO 779 00:38:03,220 --> 00:38:05,389 DIAGNOSE IS STILL OVER ONE YEAR. 780 00:38:05,389 --> 00:38:07,758 A STUDY HAS SHOWN APPROXIMATELY 781 00:38:07,758 --> 00:38:09,226 21 PEREZ OF PATIENTS HAD TO LIVE 782 00:38:09,226 --> 00:38:11,095 WITH SYMPTOMS MORE THAN TWO 783 00:38:11,095 --> 00:38:14,532 YEARS BEFORE GETTING A 784 00:38:14,532 --> 00:38:14,832 DIAGNOSIS. 785 00:38:14,832 --> 00:38:16,400 YOU KNOW, CERTAINLY THIS CAN 786 00:38:16,400 --> 00:38:18,969 STEM FROM THE FACT PH HAS PRETTY 787 00:38:18,969 --> 00:38:20,504 NON-SPECIFIC SYMPTOMS. ALSO 788 00:38:20,504 --> 00:38:22,206 THERE IS STILL A LACK OF 789 00:38:22,206 --> 00:38:24,975 AWARENESS ABOUT PH. SO PROVIDERS 790 00:38:24,975 --> 00:38:26,744 MAY, YOU KNOW, MISS THE 791 00:38:26,744 --> 00:38:28,345 DIAGNOSIS OF PH BECAUSE THEY ARE 792 00:38:28,345 --> 00:38:33,551 THINKING OF MUCH MORE COMMON 793 00:38:33,551 --> 00:38:36,287 DISEASES SUCH AS OBESITY, HEART 794 00:38:36,287 --> 00:38:38,255 FAILURE. THE FLIP SIDE IS SOME 795 00:38:38,255 --> 00:38:44,095 PATIENTIES CAN GET MISDIAGNOSED 796 00:38:44,095 --> 00:38:48,332 WITH PH BASED ON ECHO CARD 797 00:38:48,332 --> 00:38:51,302 GRAMS, ENLARGED PULMONARY ARTERY 798 00:38:51,302 --> 00:38:52,736 ON THE SCAN. THAT TOO WITHOUT 799 00:38:52,736 --> 00:38:54,939 THE FORMAL GOLD STANDARD 800 00:38:54,939 --> 00:38:57,374 DIAGNOSTIC TEST, WHICH IS A 801 00:38:57,374 --> 00:38:59,577 RIGHT HEART CATEGORITIZATION, 802 00:38:59,577 --> 00:39:01,245 RESULTING GETTING STARTED ON 803 00:39:01,245 --> 00:39:08,552 SURVEY SEW D SURVEY SOE /* /* V 804 00:39:08,552 --> 00:39:10,621 DILATOR THERAPY, WHICH HAS ME 805 00:39:10,621 --> 00:39:12,623 WORKING BACKWARDS. THERE IS A 806 00:39:12,623 --> 00:39:19,096 STUDY THAT SHOWED 6 PER% HAD 807 00:39:19,096 --> 00:39:21,465 UNDERGONE ALL THE SCREENS, SUCH 808 00:39:21,465 --> 00:39:26,370 AS AUTO IMMUNE, H.I.V., 809 00:39:26,370 --> 00:39:29,673 HYPERTENSION, VQ SCANS, ALL THE 810 00:39:29,673 --> 00:39:31,775 WORKUP TO APPROPRIATELY 811 00:39:31,775 --> 00:39:35,212 PHENOTYPE BECAUSE THAT IS 812 00:39:35,212 --> 00:39:35,880 ULTIMATELY HOW WE DETERMINE THE 813 00:39:35,880 --> 00:39:42,920 TREATMENT APPROACH. NEXT. THE 814 00:39:42,920 --> 00:39:44,321 NEXT BARRIER IS EVEN IF THEY 815 00:39:44,321 --> 00:39:47,191 HAVE GOTTEN A DIAGNOSIS OR PH OR 816 00:39:47,191 --> 00:39:48,859 HAVE HIGH SUSPICION THEY MAY NOT 817 00:39:48,859 --> 00:39:59,403 HAVE ACCESS. OR DON'T HAVE AN 818 00:39:59,937 --> 00:40:03,340 ACCREDITED CENTER. HAVING SAID 819 00:40:03,340 --> 00:40:04,575 THAT THERE ARE STILL PLENTY OF 820 00:40:04,575 --> 00:40:06,110 EXPERT CENTERS THAT DON'T HAVE 821 00:40:06,110 --> 00:40:08,245 THAT FORMAL ACCREDITATION. BUT 822 00:40:08,245 --> 00:40:11,749 MAY STILL BE A LACK OF AWARENESS 823 00:40:11,749 --> 00:40:13,517 IN COMMUNITY KNOWING WHAT ARE 824 00:40:13,517 --> 00:40:15,853 EXPERT PH CENTERS IN MY REGION, 825 00:40:15,853 --> 00:40:20,691 THUS WHO DO I ACTUALLY REFER TO. 826 00:40:20,691 --> 00:40:24,895 NEXT. THEN FINALLY WE HAVE TO 827 00:40:24,895 --> 00:40:26,163 THINK ABOUT EVEN PATIENTS WHO 828 00:40:26,163 --> 00:40:28,599 HAVE MADE THEIR WAY AND GOTTEN 829 00:40:28,599 --> 00:40:32,203 THEMSELVES TO AN EXPERT PH 830 00:40:32,203 --> 00:40:33,604 CENTER THERE IS A TREMENDOUS 831 00:40:33,604 --> 00:40:35,272 BURDEN. FIRST AND FOREMOST FROM 832 00:40:35,272 --> 00:40:36,941 A FINANCIAL PERSPECTIVE. ONE 833 00:40:36,941 --> 00:40:39,510 STUDY SHOWED THE COST PER 834 00:40:39,510 --> 00:40:40,911 PATIENT PER MONTH IS FOUR TO 835 00:40:40,911 --> 00:40:44,949 FIVE TIMES HIGHER FOR PATIENTS 836 00:40:44,949 --> 00:40:45,449 WITH PULMONARY 837 00:40:45,449 --> 00:40:47,384 ARTERIAL HYPERTENSION COMPARED 838 00:40:47,384 --> 00:40:49,753 TO PATIENTS WITHOUT PAH, EVEN 839 00:40:49,753 --> 00:40:52,456 AFTER MATCHING FOR AGE, SEX, 840 00:40:52,456 --> 00:40:54,091 GEOGRAPHICAL AREA AND ANNUAL 841 00:40:54,091 --> 00:40:57,428 INCOME. THIS FINANCIAL BURDEN 842 00:40:57,428 --> 00:40:59,496 COMES IN THE MANIFESTATION OF 843 00:40:59,496 --> 00:41:02,499 THE COST OF MEDICATIONS, EVEN IF 844 00:41:02,499 --> 00:41:04,902 THEY HAVE PRIVATE INSURANCE, TO 845 00:41:04,902 --> 00:41:06,203 THE POINT WHERE MAYBE PATIENTS 846 00:41:06,203 --> 00:41:08,539 HAVE TO START PICKING AND 847 00:41:08,539 --> 00:41:10,841 CHOOSING WHICH MEDICATIONS AND 848 00:41:10,841 --> 00:41:13,811 NOT BEING ADHERE RENT WITH THEIR 849 00:41:13,811 --> 00:41:15,012 REGIMEN. THE COST OF FREQUENT 850 00:41:15,012 --> 00:41:16,880 AND LONG HOSPITALIZATIONS, ALL 851 00:41:16,880 --> 00:41:21,285 THE TESTING THEY HAVE TO UNDERGO 852 00:41:21,285 --> 00:41:22,920 AND FREQUENT OFFICE VISITS THEY 853 00:41:22,920 --> 00:41:24,121 HAVE TO GO TO. 854 00:41:24,121 --> 00:41:27,057 ALSO THE EMOTIONAL BURDEN OF 855 00:41:27,057 --> 00:41:28,626 LIVING WITH PH DUE TO THE 856 00:41:28,626 --> 00:41:31,395 SYMPTOM BURDEN, DUE TO THE FACT 857 00:41:31,395 --> 00:41:33,831 IT TAKES ON THEIR FUNCTIONAL 858 00:41:33,831 --> 00:41:41,605 STATUS AND ALSO FOR T CARRYING 859 00:41:41,605 --> 00:41:44,575 PEEM /* /* CAREGIVERS AND PEOPLE 860 00:41:44,575 --> 00:41:46,877 THAT SUPPORT THEM. I HOPE I HAVE 861 00:41:46,877 --> 00:41:49,346 PROVEN THE OBSTACLES PATIENTS 862 00:41:49,346 --> 00:41:52,249 HAVE TO OVERCOME TO RECEIVE 863 00:41:52,249 --> 00:41:53,984 HIGH-QUALITY PH CARE. NOW WHAT 864 00:41:53,984 --> 00:41:57,254 HAPPENS WHEN WE ADD THE ISSUE OF 865 00:41:57,254 --> 00:42:00,257 HEALTH DISPARITIES TO THE 866 00:42:00,257 --> 00:42:01,091 EQUATION. THIS WAS THE 867 00:42:01,091 --> 00:42:03,560 DEFINITION ADOPTED BY THE ATS 868 00:42:03,560 --> 00:42:06,964 HEALTH EQUITY SUBCOMMITTEE. THEY 869 00:42:06,964 --> 00:42:10,367 DEFINED RESPIRATORY HEALTH 870 00:42:10,367 --> 00:42:11,435 DISPARITIES AS SIGNIFICANT 871 00:42:11,435 --> 00:42:13,404 DIFFERENCES IN RESPIRATORY 872 00:42:13,404 --> 00:42:18,909 HEALTH CLOSELY LINKED TO RACIAL 873 00:42:18,909 --> 00:42:22,613 ANCESTRY, SOCIOECONOMIC AND/OR 874 00:42:22,613 --> 00:42:24,815 ENVIRONMENTAL DIFFERENCES AND 875 00:42:24,815 --> 00:42:26,083 EXPLAIN HEALTH DISPARITIES 876 00:42:26,083 --> 00:42:29,053 AFFECT GROUPS WHO HAVE 877 00:42:29,053 --> 00:42:30,454 EXPERIENCED GREATER OBSTACLES 878 00:42:30,454 --> 00:42:33,457 BASED ON RACIAL AND ETHNIC 879 00:42:33,457 --> 00:42:37,795 GROUPS, WHICH I WILL FOCUS ON, 880 00:42:37,795 --> 00:42:40,564 RELIGION, SOCIOECONOMIC STATUS, 881 00:42:40,564 --> 00:42:42,466 GENDER, SEXUAL ORIENTATION OR 882 00:42:42,466 --> 00:42:44,535 IDENTITY, MENTAL HEALTH, 883 00:42:44,535 --> 00:42:45,969 DISABILITIES AND OTHER 884 00:42:45,969 --> 00:42:47,237 CHARACTERISTICS HISTORICALLY 885 00:42:47,237 --> 00:42:50,974 LINKED TO DISCRIMINATION OR 886 00:42:50,974 --> 00:42:51,608 EXCLUSION. 887 00:42:51,608 --> 00:42:55,679 NOW I DO WANT TO START WITH 888 00:42:55,679 --> 00:42:57,481 OF COURSE ACKNOWLEDGING RACE IS 889 00:42:57,481 --> 00:43:00,017 A SOCIAL CONSTRUCT AND IT IS 890 00:43:00,017 --> 00:43:03,620 DIFFICULT TO CATEGORIZE AND 891 00:43:03,620 --> 00:43:07,091 DEFINE PEOPLE INTO SPECIFIC 892 00:43:07,091 --> 00:43:09,360 BOXES OF RACE OR ETHNICITY. THE 893 00:43:09,360 --> 00:43:11,328 FACT THERE IS A SIGNIFICANT OF 894 00:43:11,328 --> 00:43:13,530 INTER PLAY OF THER FACTORS SUCH 895 00:43:13,530 --> 00:43:16,233 AS SOCIOECONOMIC STATUS, WHICH 896 00:43:16,233 --> 00:43:17,801 SUBSEQUENT TALKS WE WILL GET 897 00:43:17,801 --> 00:43:19,303 INTO. EVEN THEN THERE IS A GOOD 898 00:43:19,303 --> 00:43:22,139 AMOUNT OF DATA TO SHOW THAT RACE 899 00:43:22,139 --> 00:43:25,209 AND ETHNICITY CAN CERTAINLY 900 00:43:25,209 --> 00:43:26,443 EXACERBATE HEALTH DISPARITIES 901 00:43:26,443 --> 00:43:28,645 AND PH, ON TOP OF THIS ALREADY 902 00:43:28,645 --> 00:43:30,748 CHALLENGING PATHWAY WE HAVE 903 00:43:30,748 --> 00:43:32,316 TALKED ABOUT THAT PH PATIENT S 904 00:43:32,316 --> 00:43:42,860 HAVE TO NAVIGATE TO GET CARE. SO 905 00:43:44,294 --> 00:43:46,296 WHEN WE TALK ABOUT DIAGNOSIS A 906 00:43:46,296 --> 00:43:48,432 PERSON'S RACE MAY COMPLICATE 907 00:43:48,432 --> 00:43:49,900 THIS BECAUSE PEOPLE WITH OTHER 908 00:43:49,900 --> 00:43:51,635 RACES OR MINORITIES MAY LIVE IN 909 00:43:51,635 --> 00:43:53,504 MEDICAL DESERTS, WHERE THEY HAVE 910 00:43:53,504 --> 00:43:55,639 EVEN MORE LIMITED ACCESS TO 911 00:43:55,639 --> 00:43:57,574 PRIMARY CARE PHYSICIANS AND EVEN 912 00:43:57,574 --> 00:44:01,011 MORE LIMITED ACCESS TO 913 00:44:01,011 --> 00:44:02,413 PULMONOLOGIST AND CARDIOLOGISTS 914 00:44:02,413 --> 00:44:04,782 WHO MAY BE THE FIRST PIECES OF 915 00:44:04,782 --> 00:44:06,717 THE PUZZLE OF DIAGNOSING PH. 916 00:44:06,717 --> 00:44:10,821 RACE, ETHNICITY AND INCOME ARE 917 00:44:10,821 --> 00:44:13,223 ASSOCIATED WITH SEVERITY AND 918 00:44:13,223 --> 00:44:15,459 THIS CAN MAKE A BIG IMPACT ON 919 00:44:15,459 --> 00:44:17,594 MORTALITY. A STUDY SHOWED BLACK 920 00:44:17,594 --> 00:44:19,096 AND HISPANIC WERE IN THE TWO 921 00:44:19,096 --> 00:44:20,731 LOWEST INCOME CATEGORIES AT A 922 00:44:20,731 --> 00:44:22,332 HIGHER FREQUENCY. PATIENTS IN 923 00:44:22,332 --> 00:44:24,501 THESE LOWER INCOME CATEGORIES, 924 00:44:24,501 --> 00:44:26,370 THERE WAS A MUCH HIGHER 925 00:44:26,370 --> 00:44:28,572 PERCENTAGE OF PATIENTS WITH 926 00:44:28,572 --> 00:44:36,980 FUNCTIONAL CLASS 3 AND 4 927 00:44:36,980 --> 00:44:37,481 SYMPTOMS. NEXT. 928 00:44:37,481 --> 00:44:40,150 AGAIN WHEN WE TALK ABOUT 929 00:44:40,150 --> 00:44:41,919 GETTING TO AN EXPERT PH CENTER 930 00:44:41,919 --> 00:44:45,422 THIS CAN BE IMPACTED BY RACE OR 931 00:44:45,422 --> 00:44:46,256 ETHNICITY. IT MIGHT CONTRIBUTE 932 00:44:46,256 --> 00:44:48,492 TO FINANCIAL STATUS, INSURANCE 933 00:44:48,492 --> 00:44:50,894 STATTY IS. WHEN WE TALK ABOUT 934 00:44:50,894 --> 00:44:54,331 TRANSPORTATION NOT ONLY IS IT A 935 00:44:54,331 --> 00:44:56,033 LONG COMMUTE BUT WHAT IF THEY 936 00:44:56,033 --> 00:44:57,701 RELY ON PUBLIC TRANSPORTATION 937 00:44:57,701 --> 00:45:00,237 AND WHAT IF THEY HAVE HOUSING 938 00:45:00,237 --> 00:45:01,238 INSECURITY? I THINK EVERYONE ON 939 00:45:01,238 --> 00:45:02,840 THE CALL KNOWS AND APPRECIATES 940 00:45:02,840 --> 00:45:04,141 THERE ARE SIGNIFICANT 941 00:45:04,141 --> 00:45:06,610 CONSEQUENCES TO NOT HAVING 942 00:45:06,610 --> 00:45:09,580 ACCESS TO AN EXPERT PH CENTER. 943 00:45:09,580 --> 00:45:11,915 THEY CAN ACUTE DECOMPENSATED 944 00:45:11,915 --> 00:45:13,116 RIGHT HEART FAILURE, I THINK 945 00:45:13,116 --> 00:45:14,852 FROM A CRITICAL CARE PERSPECTIVE 946 00:45:14,852 --> 00:45:17,588 IS ONE OF THE MOST FRIGHTENING 947 00:45:17,588 --> 00:45:20,324 PROBLEMS TO DEAL WITH. FOR 948 00:45:20,324 --> 00:45:23,494 PATIENTS WHO HAVE -- ARE ON 949 00:45:23,494 --> 00:45:24,962 THERAPY, THEY MIGHT GET ADMITTED 950 00:45:24,962 --> 00:45:26,763 INTO A HOSPITAL THAT HAS LIMITED 951 00:45:26,763 --> 00:45:28,599 EXPERIENCE AND EXPOSURE TO 952 00:45:28,599 --> 00:45:31,602 CARING FOR PATIENTS WITH PROSTA 953 00:45:31,602 --> 00:45:34,438 PUMPS AND KNOWING HOW TO 954 00:45:34,438 --> 00:45:38,342 TROUBLESHOOT OR MAY NOT HAVE THE 955 00:45:38,342 --> 00:45:48,852 PULMONARY VASO ON THE PATIENT 956 00:45:49,286 --> 00:45:49,553 FO 957 00:45:49,553 --> 00:45:50,888 FORMULARY. IN DAYS WHERE ACCESS 958 00:45:50,888 --> 00:45:57,394 TO REPRODUCTIVE HEALTH IS PRETTY 959 00:45:57,394 --> 00:46:04,568 LET HETEROGENOUS AT BEST. WHEN 960 00:46:04,568 --> 00:46:07,771 SOMEONE IS ABLE TO GET TO A PH 961 00:46:07,771 --> 00:46:09,172 CENTER I THINK WHAT IS 962 00:46:09,172 --> 00:46:12,042 CONCERNING IS PATIENTS CAN STILL 963 00:46:12,042 --> 00:46:14,344 RECEIVE DIFFERENT TREATMENT 964 00:46:14,344 --> 00:46:15,312 PATTERNS OR EXPERIENCE 965 00:46:15,312 --> 00:46:17,748 DIFFERENCES IN TREATMENT 966 00:46:17,748 --> 00:46:19,216 PATTERNS BASED ON THEIR RACE AND 967 00:46:19,216 --> 00:46:21,118 ETHNICITY. A LOT MAY COME FROM 968 00:46:21,118 --> 00:46:23,120 PERCEIVED CONCERNS ABOUT HEALTH 969 00:46:23,120 --> 00:46:25,155 LITERACY, MEDICATION ADHERENCE, 970 00:46:25,155 --> 00:46:26,790 SOCIAL SUPPORT, LANGUAGE 971 00:46:26,790 --> 00:46:28,091 BARRIERS. YOU KNOW, THESE 972 00:46:28,091 --> 00:46:29,459 MEDICATIONS ARE SO SPECIALIZED 973 00:46:29,459 --> 00:46:32,229 AND REQUIRE A LOT OF FOLLOW-UP 974 00:46:32,229 --> 00:46:33,797 AND EDUCATION AND TEACHING. 975 00:46:33,797 --> 00:46:36,466 THERE WAS AN INTERESTING STUDY 976 00:46:36,466 --> 00:46:38,969 PUBLISHED BY DR. GROVES AND 977 00:46:38,969 --> 00:46:42,339 COLLEAGUES WHO SHOWS THAT BLACK 978 00:46:42,339 --> 00:46:43,507 PATIENTS WERE ACTUALLY 36 PEREZ 979 00:46:43,507 --> 00:46:51,381 LESS LIKELY -- 36 % LESS LIKELY 980 00:46:51,381 --> 00:46:54,151 TO RECEIVE THERAPY. THEY FOUND 981 00:46:54,151 --> 00:46:56,587 THAT BLACK PATIENTS HAD LOWER 982 00:46:56,587 --> 00:46:58,455 TREATMENT ADHERENCE. WHEN THEY 983 00:46:58,455 --> 00:47:00,757 ARE PRESENTING THIS IN AN 984 00:47:00,757 --> 00:47:02,726 ABSTRACT FORM AT A CONFERENCE, I 985 00:47:02,726 --> 00:47:04,895 REMEMBER THEY ALSO HAD SOME DATA 986 00:47:04,895 --> 00:47:06,530 WHICH SUGGESTED THAT HISPANIC 987 00:47:06,530 --> 00:47:09,800 PATIENTS WERE LESS LIKELY TO 988 00:47:09,800 --> 00:47:17,908 RECEIVE PROSTACYCLYN 989 00:47:17,908 --> 00:47:19,977 MEDICATIONS. NEXT. WHAT I FIND 990 00:47:19,977 --> 00:47:21,712 UNACCEPTABLE IS THERE CAN BE 991 00:47:21,712 --> 00:47:23,680 DIFFERENCES IN OUTCOMES BASED ON 992 00:47:23,680 --> 00:47:26,683 RACE OR ETHNICITIES. I THINK ONE 993 00:47:26,683 --> 00:47:28,785 OF KEY EXAMPLES IS IT'S BEEN 994 00:47:28,785 --> 00:47:30,287 SHOWN BLACK PATIENTS HAVE 995 00:47:30,287 --> 00:47:32,522 INCREASED RISK OF DEATH, EVEN 996 00:47:32,522 --> 00:47:36,727 AFTER ADJUSTING FOR AGE AND 997 00:47:36,727 --> 00:47:38,395 FUNCTIONAL CLASS. SOME STUDIES 998 00:47:38,395 --> 00:47:39,463 HAVE SHOWN DIFFERENCES IN 999 00:47:39,463 --> 00:47:41,131 SURVIVAL RATES IN HISPANIC 1000 00:47:41,131 --> 00:47:42,799 POPULATION WERE NOT ABLE TO 1001 00:47:42,799 --> 00:47:49,039 ADJUST FOR DIFFERENCES IN 1002 00:47:49,039 --> 00:47:50,340 SOCIOECONOMIC STATUS. 1003 00:47:50,340 --> 00:47:55,479 SO I THINK ONE OF THE KEY 1004 00:47:55,479 --> 00:47:56,013 MANIFESTATIONS OF HEALTH 1005 00:47:56,013 --> 00:48:02,085 INEQUITY PERPETUATED BY RACE AND 1006 00:48:02,085 --> 00:48:04,788 ETHNICITY IS LACK IN INDUSTRIES 1007 00:48:04,788 --> 00:48:05,822 AND RANDOMIZED CONTROL TRIALS, 1008 00:48:05,822 --> 00:48:07,324 WHICH IS REALLY THE FOUNDATIONS 1009 00:48:07,324 --> 00:48:11,328 OF WHAT IS KNOWN ABOUT 1010 00:48:11,328 --> 00:48:13,597 EPIDEMIOLOGY IN PH AND ALSO 1011 00:48:13,597 --> 00:48:17,200 SERVE TO LAYOUT REALLY WHAT ARE 1012 00:48:17,200 --> 00:48:18,902 TREATMENT ALGORITHMS ARE. 1013 00:48:18,902 --> 00:48:22,639 SO THIS IS A TABLE OF FOUR 1014 00:48:22,639 --> 00:48:25,776 MAJOR REGISTRY USE FOR PH. THE 1015 00:48:25,776 --> 00:48:27,477 TAKEAWAY IS THEY ARE PRIMARILY 1016 00:48:27,477 --> 00:48:29,112 INCLUDING WHITE PATIENTS. WHEN 1017 00:48:29,112 --> 00:48:32,149 WE LOOK AT THE U.S. REVEAL 1018 00:48:32,149 --> 00:48:35,318 REGISTRY, THERE IS A SIGNIFICANT 1019 00:48:35,318 --> 00:48:37,788 UNDERREPRESENTATION OF ASIAN AND 1020 00:48:37,788 --> 00:48:41,792 PACIFIC ISLANDERS COMPARED TO 1021 00:48:41,792 --> 00:48:43,794 THE U.S. CENSUS DATA. I HAVE TO 1022 00:48:43,794 --> 00:48:45,962 POINT OUT AT LEAST IT HAS A 1023 00:48:45,962 --> 00:48:47,931 SLIGHTLY HIGHER REPRESENTATION 1024 00:48:47,931 --> 00:48:52,803 OF BLACK AND HISPANIC PATIENTS. 1025 00:48:52,803 --> 00:48:53,403 NEXT. 1026 00:48:53,403 --> 00:48:55,272 THIS UNDERREPRESENTATION OF 1027 00:48:55,272 --> 00:48:58,241 CERTAIN RACES AND ETHNICITIES IS 1028 00:48:58,241 --> 00:48:59,476 MAGNIFIED ON AN INTERNATIONAL 1029 00:48:59,476 --> 00:49:03,313 SCALE BECAUSE MOST DATA IS 1030 00:49:03,313 --> 00:49:04,347 ACTUALLY COMING FROM THE UNITED 1031 00:49:04,347 --> 00:49:07,684 STATES AND EUROPE. THE PDRA 1032 00:49:07,684 --> 00:49:09,152 REGISTRIES IS AN EXCITING 1033 00:49:09,152 --> 00:49:11,088 INITIATIVE BECAUSE IT IS TRYING 1034 00:49:11,088 --> 00:49:14,591 TO CREATE A WORLDWIDE AND HIGHLY 1035 00:49:14,591 --> 00:49:15,892 PHENOTYPES REGISTRY. THEN SO FAR 1036 00:49:15,892 --> 00:49:18,829 THE MAJORITY OF CENTERS ARE 1037 00:49:18,829 --> 00:49:25,235 STILL FROM AMERICA AND EUROPE. 1038 00:49:25,235 --> 00:49:26,970 NEXT. 1039 00:49:26,970 --> 00:49:29,005 THERE IS A FURTHER 1040 00:49:29,005 --> 00:49:30,540 DISCORDANCE BETWEEN REGISTRY 1041 00:49:30,540 --> 00:49:33,510 ENROLLMENT AND CLINICAL TRIAL 1042 00:49:33,510 --> 00:49:35,145 ENROLLMENT. THIS IS A LIST OR 1043 00:49:35,145 --> 00:49:44,354 GRAPH OF PIVOTAL TRIALS IN PH. 1044 00:49:44,354 --> 00:49:46,590 ONE OF THE LARGEST TRIALS TO 1045 00:49:46,590 --> 00:49:48,692 DATE IS THE GRIFFIN TRIAL, WHICH 1046 00:49:48,692 --> 00:49:52,562 DID NOT PUBLICLY PUBLISH THE 1047 00:49:52,562 --> 00:49:55,265 RACIAL BREAKDOWN -- ETHNIC 1048 00:49:55,265 --> 00:49:56,700 BREAKDOWN OF THAT. THIS IS A 1049 00:49:56,700 --> 00:49:58,301 CONSEQUENCE OF FACT THAT, IN 1050 00:49:58,301 --> 00:50:00,904 PART, MOST OF THESE TRIALS ARE 1051 00:50:00,904 --> 00:50:02,472 ENROLLING IN THE UNITED STATES, 1052 00:50:02,472 --> 00:50:05,809 EUROPE AND AUSTRALIA. THERE IS A 1053 00:50:05,809 --> 00:50:09,546 SIGNIFICANT -- IN COMPARISON, 1054 00:50:09,546 --> 00:50:11,181 UNDERREPRESENTATION OF CENTERS 1055 00:50:11,181 --> 00:50:13,383 FROM SOUTH AMERICA, ASIA AND 1056 00:50:13,383 --> 00:50:14,551 AFRICA. ALSO THIS LACK OF 1057 00:50:14,551 --> 00:50:15,585 REPRESENTATION IN CLINICAL 1058 00:50:15,585 --> 00:50:18,288 TRIALS IS, AGAIN, A CONSEQUENCE 1059 00:50:18,288 --> 00:50:20,090 OF, YOU KNOW, MANY ROOT CAUSES 1060 00:50:20,090 --> 00:50:21,224 COMING TOGETHER. YOU KNOW, SOME 1061 00:50:21,224 --> 00:50:23,360 OF WHICH ARE ASSOCIATED WITH 1062 00:50:23,360 --> 00:50:27,898 SOMEONE'S RACE AND ETHNICITY. 1063 00:50:27,898 --> 00:50:32,803 NEXT. THIS IS COMING FROM AN 1064 00:50:32,803 --> 00:50:35,238 ANALYSIS OF 18 PHASE-3 RAN 1065 00:50:35,238 --> 00:50:37,274 MINORITIZED CONTROLLED TRIALS. 1066 00:50:37,274 --> 00:50:38,775 THE TAKE AWAY IS THEY ARE 1067 00:50:38,775 --> 00:50:41,077 SHOWING THE TRIALS EARLIER ON 1068 00:50:41,077 --> 00:50:42,345 WERE PREDOMINANTLY ENROLLING IN 1069 00:50:42,345 --> 00:50:45,182 WESTERN COUNTRIES AND INCLUDED 1070 00:50:45,182 --> 00:50:46,650 NON-HISPANIC WHITE PATIENTS. 1071 00:50:46,650 --> 00:50:47,984 THOUGH THE PROPORTION HAS 1072 00:50:47,984 --> 00:50:49,653 SLIGHTLY DECREASED OVER TIME 1073 00:50:49,653 --> 00:50:53,890 WITH INCLUSION OF NON-WESTERN 1074 00:50:53,890 --> 00:50:57,494 COUNTRIES. NEXT. THE QUESTION IS 1075 00:50:57,494 --> 00:51:00,330 HOW ARE WE DOING NOW? WE ARE IN 1076 00:51:00,330 --> 00:51:01,898 A GREAT SPACE WHERE WE HAVE HAD 1077 00:51:01,898 --> 00:51:03,099 THREE TRIALS COME OUT IN THE 1078 00:51:03,099 --> 00:51:05,535 LAST FEW YEARS. BUT ANSWERS 1079 00:51:05,535 --> 00:51:07,370 UNFORTUNATELY IN TERMS OF 1080 00:51:07,370 --> 00:51:08,471 REPRESENTATION, ABOUT THE SAME 1081 00:51:08,471 --> 00:51:11,141 IF NOT SLIGHTLY WORSE WITH THE 1082 00:51:11,141 --> 00:51:12,242 TRIALS HAVING OVERWHELMING 1083 00:51:12,242 --> 00:51:13,910 MAJORITY OF WHITE PATIENTS AND 1084 00:51:13,910 --> 00:51:16,713 TRIAL LOOKING AT COME NATION PD5 1085 00:51:16,713 --> 00:51:19,015 AND ERA PILL WAS NOT THE MOST 1086 00:51:19,015 --> 00:51:21,218 CLEAR IN TERMS OF PUTTING OUT 1087 00:51:21,218 --> 00:51:25,088 THE RACIAL AND ETHNIC BREAK DOWN 1088 00:51:25,088 --> 00:51:33,063 OF THAT TRIAL. NEXT. 1089 00:51:33,063 --> 00:51:34,531 AGAIN, REALLY IMPORTANT, 1090 00:51:34,531 --> 00:51:36,666 THERE ARE CONSEQUENCES OF BEING 1091 00:51:36,666 --> 00:51:38,768 UNDERREPRESENTED IN CLINICAL 1092 00:51:38,768 --> 00:51:42,472 TRIALS BECAUSE IT CHALLENGES THE 1093 00:51:42,472 --> 00:51:44,074 INTERNAL AND EXTERNAL VALIDITY 1094 00:51:44,074 --> 00:51:45,508 OF TREATMENT GUIDELINES AND CAN 1095 00:51:45,508 --> 00:51:47,644 CONTRIBUTE TO UNEQUAL ACCESS TO 1096 00:51:47,644 --> 00:51:50,046 NOVEL THERAPIES AND ULTIMATELY 1097 00:51:50,046 --> 00:51:52,415 MAY AFFECT OUTCOMES, IN PART, 1098 00:51:52,415 --> 00:51:56,319 BASED ON RACE AND ETHNICITY. 1099 00:51:56,319 --> 00:51:59,522 NEXT. SO REALLY THE TAKE AWAY IS 1100 00:51:59,522 --> 00:52:01,424 GETTING ACCESS TO SPECIALIZED 1101 00:52:01,424 --> 00:52:03,326 AND EQUITABLE PH CARE IS NOT AS 1102 00:52:03,326 --> 00:52:05,295 SIMPLE AS A REFERRAL. BECAUSE, 1103 00:52:05,295 --> 00:52:07,330 AS I HAVE TALKED ABOUT, THERE 1104 00:52:07,330 --> 00:52:08,798 ARE MULTIPLE FACTORS THAT PLAY A 1105 00:52:08,798 --> 00:52:11,902 ROLE IN JUST GETTING REFERRED TO 1106 00:52:11,902 --> 00:52:16,806 A PH CENTER. SOMEONE'S RACE AND 1107 00:52:16,806 --> 00:52:20,543 ETHNICITY CAN IMPACT THOSE 1108 00:52:20,543 --> 00:52:22,913 FACTORS. EVEN AFTER GETTING IN, 1109 00:52:22,913 --> 00:52:24,948 PATIENTS CAN FACE IMPLICIT 1110 00:52:24,948 --> 00:52:27,617 BIASES FROM HEALTH CARE 1111 00:52:27,617 --> 00:52:30,353 PROVIDERS PERHAPS DUE TO RACE 1112 00:52:30,353 --> 00:52:31,955 AND ETHNICITY DUE TO REGISTRIES, 1113 00:52:31,955 --> 00:52:33,623 ACCESS TO CLINICAL TRIALS, THIS 1114 00:52:33,623 --> 00:52:36,192 CAN AFFECT TREATMENT PATTERNS, 1115 00:52:36,192 --> 00:52:39,396 POTENTIALLY OUTCOMES AND PER PCH 1116 00:52:39,396 --> 00:52:46,603 WAITS -- PERPETUATES A VICIOUS 1117 00:52:46,603 --> 00:52:49,139 CYCLE. NEXT. THE REASON I THINK 1118 00:52:49,139 --> 00:52:50,774 WE ARE ALL HERE IS WE ARE TRYING 1119 00:52:50,774 --> 00:52:52,475 TO MOVE FROM THIS IDEA OF 1120 00:52:52,475 --> 00:52:54,110 EQUALITY, TRYING TO ACHIEVE 1121 00:52:54,110 --> 00:52:55,645 EQUITY AND ULTIMATELY ACHIEVE 1122 00:52:55,645 --> 00:53:06,189 JUSTICE OR REMOVE THE BARRIERS.. 1123 00:53:07,357 --> 00:53:08,959 THIS WAS THE BLUEPRINT FOR 1124 00:53:08,959 --> 00:53:10,860 ACTION IN 2017, TALKING ABOUT 1125 00:53:10,860 --> 00:53:13,730 COMMON THEMES AND CAPTURING 1126 00:53:13,730 --> 00:53:14,831 INFORMATION ABOUT RACE AND 1127 00:53:14,831 --> 00:53:16,066 ETHNICITY AND SOCIOECONOMIC 1128 00:53:16,066 --> 00:53:17,534 STANDARDS, EDUCATION, 1129 00:53:17,534 --> 00:53:18,535 PARTNERSHIP, YOU KNOW, 1130 00:53:18,535 --> 00:53:21,671 INCREASING AWARENESS ABOUT 1131 00:53:21,671 --> 00:53:27,911 IMPLICIT AND UNCONSCIOUS BUY 1132 00:53:27,911 --> 00:53:28,445 YES, 1133 00:53:28,445 --> 00:53:31,181 BIASES AND FOCUSSING ON CULTURAL 1134 00:53:31,181 --> 00:53:32,716 LANGUAGE APPROPRIATE SERVICES. 1135 00:53:32,716 --> 00:53:32,983 NEXT. 1136 00:53:32,983 --> 00:53:35,618 THERE ARE CERTAINLY MANY 1137 00:53:35,618 --> 00:53:38,088 UNMET NEEDS IN HEALTH 1138 00:53:38,088 --> 00:53:43,927 DISPARITIES IN PH, BUT I THINK 1139 00:53:43,927 --> 00:53:47,664 WITH THE RESOURCES, LIKE I HAVE 1140 00:53:47,664 --> 00:53:49,566 OUTLINED HERE. NEXT. I THINK 1141 00:53:49,566 --> 00:53:51,634 SOME OF THE QUESTIONS THAT ARE 1142 00:53:51,634 --> 00:53:53,169 RAISED FROM THIS IS, YOU KNOW, 1143 00:53:53,169 --> 00:53:55,305 WHAT IS THE MOST EFFECTIVE AND 1144 00:53:55,305 --> 00:53:57,540 ACCURATE WAY TO CATEGORIZE AND 1145 00:53:57,540 --> 00:54:00,410 DOCUMENT RACE AND ETHNICITY. DO 1146 00:54:00,410 --> 00:54:02,445 PATIENTS WITH PH OF CERTAIN RACE 1147 00:54:02,445 --> 00:54:07,217 OR ETHNICITY HAVE CERTAIN 1148 00:54:07,217 --> 00:54:08,151 CHARACTERISTICS OF THE DISEASE 1149 00:54:08,151 --> 00:54:09,619 COURSE OR ASSOCIATED WITH 1150 00:54:09,619 --> 00:54:11,321 WHETHER A PATIENT CAN BE SEEN AT 1151 00:54:11,321 --> 00:54:14,157 EXPERT CENTERS VERSUS TREATED IN 1152 00:54:14,157 --> 00:54:15,525 THEIR COMMUNITY AND DOES THIS 1153 00:54:15,525 --> 00:54:16,760 IMPACT OUTCOME? NEXT. 1154 00:54:16,760 --> 00:54:18,795 I THINK ALTHOUGH WE ALL 1155 00:54:18,795 --> 00:54:25,769 AGREE WE SHOULD AIM FOR ACCURATE 1156 00:54:25,769 --> 00:54:27,804 RACIAL REPRESENTATION IN PH 1157 00:54:27,804 --> 00:54:29,406 TRIALS. THE QUESTION IS WHAT IS 1158 00:54:29,406 --> 00:54:30,974 THE BEST WAY TO CREATE A 1159 00:54:30,974 --> 00:54:33,710 REGISTRY AND BARRIERS FROM 1160 00:54:33,710 --> 00:54:37,614 PREVENTING PATIENTS FROM ASIA, 1161 00:54:37,614 --> 00:54:38,281 EUROPE AND SOUTH AMERICA. THOUGH 1162 00:54:38,281 --> 00:54:40,383 I THINK WE ARE LEFT WITH MORE 1163 00:54:40,383 --> 00:54:41,184 QUESTIONS THAN ANSWER, I THINK 1164 00:54:41,184 --> 00:54:43,920 THAT IS ONE OF THE BIG POINTS OF 1165 00:54:43,920 --> 00:54:45,522 THIS WORKSHOP. I THINK QUESTIONS 1166 00:54:45,522 --> 00:54:48,691 THAT WE WILL BE ABLE TO CHIP 1167 00:54:48,691 --> 00:54:51,327 AWAY AT OVER THE NEXT TWO DAYS. 1168 00:54:51,327 --> 00:54:52,896 I WILL YIELD MY TIME AND HAPPEN 1169 00:54:52,896 --> 00:54:54,898 TO OPEN IT UP FOR DISCUSSION, 1170 00:54:54,898 --> 00:54:55,632 THANK YOU. 1171 00:54:55,632 --> 00:54:55,865 1172 00:54:55,865 --> 00:54:59,469 >> THANK YOU VERY MUCH, DR. 1173 00:54:59,469 --> 00:55:04,240 GOEL. THAT WAS AN EXCELLENT 1174 00:55:04,240 --> 00:55:05,642 TALK. I HAVE A QUICK QUESTION. 1175 00:55:05,642 --> 00:55:07,310 WE HAVE ABOUT FIVE MINUTES FOR 1176 00:55:07,310 --> 00:55:08,278 QUESTIONS. ONE QUESTION I HAVE 1177 00:55:08,278 --> 00:55:11,247 FOR YOU IS, ARE YOU FAMILIAR 1178 00:55:11,247 --> 00:55:14,451 WITH ANY RESEARCH INDICATING 1179 00:55:14,451 --> 00:55:16,886 THAT HEALTH DISPARITIES SUCH AS 1180 00:55:16,886 --> 00:55:18,855 QUALITY OF LIFE IN PH PATIENTS 1181 00:55:18,855 --> 00:55:21,458 ARE WORSE THAN OTHER CHRONIC 1182 00:55:21,458 --> 00:55:22,926 DISEASES LIKE HEART FAILURE AND 1183 00:55:22,926 --> 00:55:24,527 VARIOUS OTHERS, SOMETHING OF 1184 00:55:24,527 --> 00:55:25,462 THAT COMPARISON? 1185 00:55:25,462 --> 00:55:27,030 >> THAT IS A GOOD QUESTION. YOU 1186 00:55:27,030 --> 00:55:28,431 KNOW, I DON'T KNOW WHETHER I 1187 00:55:28,431 --> 00:55:29,666 CAME ACROSS SPECIFICALLY 1188 00:55:29,666 --> 00:55:31,201 COMPARING IT TO OTHER DISEASES 1189 00:55:31,201 --> 00:55:33,203 BUT THERE ARE PLENTY OF STUDIES 1190 00:55:33,203 --> 00:55:34,537 WHICH SHOW THAT EVEN PATIENTS, 1191 00:55:34,537 --> 00:55:37,507 YOU KNOW, WHO ARE ON, QUOTE, 1192 00:55:37,507 --> 00:55:39,576 OPTIMAL THERAPY REGIMENS FOR PH 1193 00:55:39,576 --> 00:55:41,911 STILL EXPERIENCE SIGNIFICANTLY 1194 00:55:41,911 --> 00:55:44,514 REDUCED QUALITY OF LIFE. AND 1195 00:55:44,514 --> 00:55:46,349 HEAVY SYMPTOM BURDEN. I WOULD 1196 00:55:46,349 --> 00:55:48,384 NOT BE SURPRISED IF THE QUALITY 1197 00:55:48,384 --> 00:55:50,186 OF LIFE IS WORSE FOR PATIENTS 1198 00:55:50,186 --> 00:55:52,956 WITH PH THAN, YOU KNOW, OTHER 1199 00:55:52,956 --> 00:56:01,231 MORE COMMON DISEASES OR CO. 1200 00:56:01,231 --> 00:56:04,200 CO MOR /* /* -- CO MORBIDITIES. 1201 00:56:04,200 --> 00:56:05,435 >> THANK YOU FOR THAT EVERYTHING 1202 00:56:05,435 --> 00:56:07,237 TALK. I'M IMPRESSED SEEING HOW 1203 00:56:07,237 --> 00:56:09,606 YOU HAVE OUTLINED THE INCLUSION 1204 00:56:09,606 --> 00:56:11,474 OF UNDERREPRESENTED GROUPS IN 1205 00:56:11,474 --> 00:56:13,109 CLINICAL TRIALS AND REALLY HOW 1206 00:56:13,109 --> 00:56:14,611 THERE HASN'T BEEN A LOT OF 1207 00:56:14,611 --> 00:56:18,982 CHANGE. SO I HAVE TO ASK THE 1208 00:56:18,982 --> 00:56:21,117 QUESTION WHICH IS, WHAT DO WE 1209 00:56:21,117 --> 00:56:23,086 NEED TO DO DIFFERENTLY? IS THIS 1210 00:56:23,086 --> 00:56:24,687 A QUESTION OF THE INVESTIGATORS? 1211 00:56:24,687 --> 00:56:27,423 IS THIS A QUESTION OF TRUST 1212 00:56:27,423 --> 00:56:29,058 AMONG MINORITY GROUPS OR ARE WE 1213 00:56:29,058 --> 00:56:30,527 JUST NOT REACHING THE RIGHT 1214 00:56:30,527 --> 00:56:30,793 PEOPLE? 1215 00:56:30,793 --> 00:56:34,731 >> YEAH. HONESTLY, I THINK IT IS 1216 00:56:34,731 --> 00:56:38,201 A BIT OF THE, D, ALL OF THE 1217 00:56:38,201 --> 00:56:40,503 ABOVE SITUATIONS. IF I HAD TO 1218 00:56:40,503 --> 00:56:43,239 THINK IT, ONE OF THE BIGGEST 1219 00:56:43,239 --> 00:56:44,707 BOTTLENECK S IS GETTING TO AN 1220 00:56:44,707 --> 00:56:46,776 EXPERT CENTER, BECAUSE THAT IS 1221 00:56:46,776 --> 00:56:48,111 WHERE WE ARE ENROLLING THE 1222 00:56:48,111 --> 00:56:49,712 PATIENTS IN THE CLINICAL TRIALS. 1223 00:56:49,712 --> 00:56:52,715 THERE ARE A WHOLE HOST OF 1224 00:56:52,715 --> 00:56:54,951 PROBLEMS FOR SOMEONE TO JUST GET 1225 00:56:54,951 --> 00:56:58,888 TO A CENTER OR A SITE FOR 1226 00:56:58,888 --> 00:57:00,657 ENROLLING PATIENTS IN CLINICAL 1227 00:57:00,657 --> 00:57:02,492 TRIALS. THE FACT THERE IS A 1228 00:57:02,492 --> 00:57:03,560 DIFFERENCE BETWEEN REGISTRIES 1229 00:57:03,560 --> 00:57:05,028 AND CLINICAL TRIALS INDICATES 1230 00:57:05,028 --> 00:57:06,596 THAT JUST GETTING TO A CENTER IS 1231 00:57:06,596 --> 00:57:08,598 NOT ENOUGH. THERE COULD BE A LOT 1232 00:57:08,598 --> 00:57:10,433 OF THINGS LIKE WHETHER IT IS 1233 00:57:10,433 --> 00:57:12,202 DISTRUST IN MEDICAL SYSTEM. FOR 1234 00:57:12,202 --> 00:57:14,003 EXAMPLE HISTORICALLY WITH BLACK 1235 00:57:14,003 --> 00:57:15,805 PATIENTS, ENTRUSTING THE MEDICAL 1236 00:57:15,805 --> 00:57:19,742 SYSTEM. JUST THE BURDEN OF A 1237 00:57:19,742 --> 00:57:21,477 CLINICAL TRIAL AND WHAT THAT 1238 00:57:21,477 --> 00:57:24,280 INVOLVES. ALSO THERE COULD BE 1239 00:57:24,280 --> 00:57:25,882 IMPLICIT BIASES FROM US 1240 00:57:25,882 --> 00:57:27,250 ENROLLING IN THE TRIALS. I THINK 1241 00:57:27,250 --> 00:57:28,885 THE NEED TO HAVE AN OBJECTIVE 1242 00:57:28,885 --> 00:57:30,220 WAY TO SCREEN PATIENTS AND 1243 00:57:30,220 --> 00:57:31,554 ALWAYS PRESENT TRIALS AND NOT 1244 00:57:31,554 --> 00:57:42,098 MAKE ASSUMPTIONS. MANY EUROPEAN 1245 00:57:49,105 --> 00:57:50,773 TRIALS DO NOT RECOGNIZE RACE OR 1246 00:57:50,773 --> 00:57:51,074 ETHNICITY. 1247 00:57:51,074 --> 00:57:52,508 >> GOOD POINT. THIS JUST 1248 00:57:52,508 --> 00:57:54,077 REQUIRED US TO GO THROUGH EVERY 1249 00:57:54,077 --> 00:57:56,379 SINGLE TRIAL AND GO THROUGH ALL 1250 00:57:56,379 --> 00:57:58,248 THE APPENDICES AND EXTRA DATA 1251 00:57:58,248 --> 00:58:00,450 AND SEE WHETHER THEY REPORTED 1252 00:58:00,450 --> 00:58:01,651 BREAK-DOWNS, SO THAT IS HOW THAT 1253 00:58:01,651 --> 00:58:03,419 FIGURE WAS GENERATED. I THINK IT 1254 00:58:03,419 --> 00:58:04,554 IS ALSO IMPORTANT BECAUSE IT IS 1255 00:58:04,554 --> 00:58:07,156 THE IDEA OF WHAT IS PUBLICLY 1256 00:58:07,156 --> 00:58:08,992 AVAILABLE, AS OPPOSED TO GOING 1257 00:58:08,992 --> 00:58:11,427 THROUGH DIFFERENT LAYERS BEHIND 1258 00:58:11,427 --> 00:58:13,029 THE SCENES. 1259 00:58:13,029 --> 00:58:15,999 >> A FOLLOW-UP TO THAT IS, WHY 1260 00:58:15,999 --> 00:58:17,767 DO YOU THINK EUROPEAN CLINICAL 1261 00:58:17,767 --> 00:58:19,102 TRIALS DON'T REPORT ETHNICITY? 1262 00:58:19,102 --> 00:58:20,470 >> I ACTUALLY DON'T KNOW. I 1263 00:58:20,470 --> 00:58:22,272 THINK IT WOULD BE INTERESTING. I 1264 00:58:22,272 --> 00:58:26,009 DON'T KNOW IF THERE ARE RULES 1265 00:58:26,009 --> 00:58:29,479 THAT ARE DIFFERENT 1266 00:58:29,479 --> 00:58:30,113 COUNTRY-TO-COUNTRY, WHERE THEY 1267 00:58:30,113 --> 00:58:31,381 ARE REQUIRED TO OR NOT. THE 1268 00:58:31,381 --> 00:58:32,649 BIGGEST THING IS HOW DO WE 1269 00:58:32,649 --> 00:58:34,951 ACTUALLY REPORT IT, RIGHT. THE 1270 00:58:34,951 --> 00:58:36,052 UNITED STATES MIGHT HAVE A 1271 00:58:36,052 --> 00:58:38,454 CERTAIN WAY OF CATEGORIZING WHAT 1272 00:58:38,454 --> 00:58:39,489 THEY THINK THE APPROPRIATE RACE 1273 00:58:39,489 --> 00:58:43,426 OR ETHNICITIES ARE. OTHER TRIALS 1274 00:58:43,426 --> 00:58:44,994 INCLUDED KIND OF GEOGRAPHIC, 1275 00:58:44,994 --> 00:58:46,896 LIKE EASTERN EUROPE, WESTERN 1276 00:58:46,896 --> 00:58:49,832 EUROPE, SO THERE'S A LOT OF 1277 00:58:49,832 --> 00:58:50,733 DIFFERENCES THERE. 1278 00:58:50,733 --> 00:58:53,469 >> COULD I MAKE A QUICK GUESS? 1279 00:58:53,469 --> 00:58:54,003 >> YES. 1280 00:58:54,003 --> 00:58:58,141 >> ONE THING -- I LOOKED INTO 1281 00:58:58,141 --> 00:58:59,509 THE SAME THING. ESPECIALLY THE 1282 00:58:59,509 --> 00:59:01,711 MORE RECENT TRIALS. WHAT YOU 1283 00:59:01,711 --> 00:59:03,880 DON'T REALIZE IS MANY EUROPEAN 1284 00:59:03,880 --> 00:59:05,748 TRIALS SEE PATIENTS FROM TWO TO 1285 00:59:05,748 --> 00:59:08,184 THREE VERY BIG CENTERS. I WOULD 1286 00:59:08,184 --> 00:59:09,285 ASSUME THEY CONSIDER THEMSELVES 1287 00:59:09,285 --> 00:59:13,122 PRETTY UNIFORM IN TERMS OF 1288 00:59:13,122 --> 00:59:14,557 ETHNICITIES, BASICALLY WHITE 1289 00:59:14,557 --> 00:59:16,326 PATIENTS. I THINK ONE, THERE IS 1290 00:59:16,326 --> 00:59:19,462 LACK OF INCENTIVE TO REALLY 1291 00:59:19,462 --> 00:59:21,097 BREAK IT DOWN. WHEREAS IN REVEAL 1292 00:59:21,097 --> 00:59:23,066 YOU HAVE MULTIPLE CENTERS FROM 1293 00:59:23,066 --> 00:59:24,100 DIFFERENT PART OF THE UNITED 1294 00:59:24,100 --> 00:59:25,802 STATES. SO THAT MAKES IT A 1295 00:59:25,802 --> 00:59:27,670 LITTLE MORE APPEALING TO SAY 1296 00:59:27,670 --> 00:59:29,939 LET'S BREAK IT DOWN BY RACE. 1297 00:59:29,939 --> 00:59:32,375 MANY OF THE BIG PIVOTAL EUROPEAN 1298 00:59:32,375 --> 00:59:34,911 TRIALS COME FROM TWO TO THREE 1299 00:59:34,911 --> 00:59:37,580 MAJOR CENTERS. 1300 00:59:37,580 --> 00:59:41,150 >> REAL QUICK, DR. KAMET. 1301 00:59:41,150 --> 00:59:42,485 >> JUST A QUICK COMMENT. THAT 1302 00:59:42,485 --> 00:59:44,821 WAS AN AMAZING TALK. YOU REALLY 1303 00:59:44,821 --> 00:59:47,023 COVERED SO MUCH. TO THE POINT 1304 00:59:47,023 --> 00:59:48,858 HOW DO WE COLLECT RACE AND 1305 00:59:48,858 --> 00:59:50,626 ETHNICITY DATA. WE SHOULD BE 1306 00:59:50,626 --> 00:59:55,131 USING COMMON DATA ELEMENTS, 1307 00:59:55,131 --> 00:59:59,569 SHARED COLLECTION METHODOLOGIES 1308 00:59:59,569 --> 01:00:01,471 SO WE CAN HARMONIZE STUDIES AND 1309 01:00:01,471 --> 01:00:03,005 KNOW MAKEUP OF STUDIES. 1310 01:00:03,005 --> 01:00:12,749 SOMETIMES WE DON'T EVEN DO THAT. 1311 01:00:12,749 --> 01:00:16,686 >> FOR THOSE OF YOU DONE STUDY 1312 01:00:16,686 --> 01:00:18,721 DESIGN, OF COURSE, THAT SHOULD 1313 01:00:18,721 --> 01:00:20,623 BE IN OUR MINDS, I THINK, WHEN 1314 01:00:20,623 --> 01:00:24,193 WE ARE DESIGNING STUDIES; IS HOW 1315 01:00:24,193 --> 01:00:25,828 TO STANDARDIZE THAT ACROSS 1316 01:00:25,828 --> 01:00:26,863 CENTERS, WHICH IS SOMETHING I 1317 01:00:26,863 --> 01:00:28,364 THINK WE WILL NEED TO DISCUSS AS 1318 01:00:28,364 --> 01:00:30,166 WE MOVE ON. BUT THAT'S BEEN 1319 01:00:30,166 --> 01:00:33,269 PARTICULARLY AN ISSUE DOWN HERE 1320 01:00:33,269 --> 01:00:34,837 IN ARIZONA AND OTHER CENTERS 1321 01:00:34,837 --> 01:00:37,840 INVOLVED IN OUR STUDIES, IS HOW 1322 01:00:37,840 --> 01:00:41,511 DO WE DEFINE HISPANIC ETHNICITY. 1323 01:00:41,511 --> 01:00:42,912 THAT GETS DOWN TO THE HEART OF 1324 01:00:42,912 --> 01:00:47,183 THE DIVERSITY, RIGHT. SO LET'S 1325 01:00:47,183 --> 01:00:52,255 MOVE ON. OUR NEXT SPEAKER IS DR. 1326 01:00:52,255 --> 01:00:57,059 ESTRADA. HE WILL BE SPEAKING ON 1327 01:00:57,059 --> 01:01:02,465 CONVERGENCE OF DISPARITIES AND 1328 01:01:02,465 --> 01:01:06,369 PULMONARY VASCULAR PHENOTYPES 1329 01:01:06,369 --> 01:01:09,972 AMONG BLACK, AFRICA, NATIVE 1330 01:01:09,972 --> 01:01:16,345 AMERICAN, HISPANIC AND M 1331 01:01:16,345 --> 01:01:18,114 AND MORE PHENOTYPES, WOW. 1332 01:01:18,114 --> 01:01:21,217 >> THANK YOU. I WANT TO THANK 1333 01:01:21,217 --> 01:01:22,652 THE CHAIR AND EXCITED TO 1334 01:01:22,652 --> 01:01:23,853 CONTRIBUTE AND ACKNOWLEDGE THERE 1335 01:01:23,853 --> 01:01:25,755 ARE EXPERTS IN THE FIELD, IN 1336 01:01:25,755 --> 01:01:26,856 TODAY'S MEETING WITH US HERE 1337 01:01:26,856 --> 01:01:28,191 TODAY. MY OBJECTIVES ARE GOING 1338 01:01:28,191 --> 01:01:31,294 TO BE DISCUSSING THE RACIAL AND 1339 01:01:31,294 --> 01:01:33,796 ETHNIC DISPARITIES, HOW THEY 1340 01:01:33,796 --> 01:01:36,899 INFLUENCE TREATMENT AND 1341 01:01:36,899 --> 01:01:41,237 OUTCOMES, MAINLY FOCUSSING ON 1342 01:01:41,237 --> 01:01:42,171 PULMONARY HYPERTENSION AND 1343 01:01:42,171 --> 01:01:47,743 (AUDIO DISRUPTION) AS DR. GOEL 1344 01:01:47,743 --> 01:01:49,846 POINTED OUT THIS LAYS FOUNDATION 1345 01:01:49,846 --> 01:01:53,015 FOR FUTURE DISCUSSIONS FOR THIS 1346 01:01:53,015 --> 01:01:55,551 WORKSHOP . OUR GOAL IS PROVIDE 1347 01:01:55,551 --> 01:01:56,919 EQUAL HEALTH CARE DELIVERY. 1348 01:01:56,919 --> 01:01:58,554 DISPARITY MEANS WE HAVE NOT 1349 01:01:58,554 --> 01:02:01,491 REACHED THIS GOAL. I THINK TO 1350 01:02:01,491 --> 01:02:02,492 UNDERSTAND DISPARITIES WE HAVE 1351 01:02:02,492 --> 01:02:04,026 TO FIRST LEARN WHAT GROUPS WE 1352 01:02:04,026 --> 01:02:05,862 ARE TALKING ABOUT. SO WHERE DOES 1353 01:02:05,862 --> 01:02:11,901 THIS -- SO SORRY. THE NEXT 1354 01:02:11,901 --> 01:02:12,568 SLIDE. 1355 01:02:12,568 --> 01:02:13,970 WHERE DOES THIS CURRENT RACE 1356 01:02:13,970 --> 01:02:15,404 AND ETHNIC CLASSIFICATION COME 1357 01:02:15,404 --> 01:02:19,041 FROM? OFFICE OF MANAGEMENT AND 1358 01:02:19,041 --> 01:02:22,278 BUDGET IN' 97 ESTABLISHED WHITE, 1359 01:02:22,278 --> 01:02:25,915 ASIAN, BLACK, AMERICAN INDIAN, 1360 01:02:25,915 --> 01:02:29,519 ALASKAN, NATIVE HAWAIIAN OR 1361 01:02:29,519 --> 01:02:31,053 ISLANDER AND HISPANIC OR 1362 01:02:31,053 --> 01:02:33,789 NON-HISPANIC. USED FOR 1363 01:02:33,789 --> 01:02:39,061 STATISTICAL AND KEN SUS PUR SEN 1364 01:02:39,061 --> 01:02:40,630 CENSUS TRIALS BUT WERE REQUIRED 1365 01:02:40,630 --> 01:02:41,831 FOR TRIALS. 1366 01:02:41,831 --> 01:02:44,200 THE DEFINITION OF DIFFERENT 1367 01:02:44,200 --> 01:02:45,935 TERMS ARE ETHNICITY, CULTURAL 1368 01:02:45,935 --> 01:02:48,137 IDENTITY. SO LANGUAGE, RELIGION. 1369 01:02:48,137 --> 01:02:50,506 RACE IS ANCESTRAL ORIGIN, 1370 01:02:50,506 --> 01:02:52,742 PHYSICAL CHARACTERISTICS. 1371 01:02:52,742 --> 01:02:54,377 ANCESTRY REFERS TO REGION OF 1372 01:02:54,377 --> 01:02:56,612 ORIGIN, OR LINEAGE OF DECENT, 1373 01:02:56,612 --> 01:02:59,115 AND GENETIC MIXTURE IS EXCHANGE 1374 01:02:59,115 --> 01:03:01,751 FROM PEOPLE FROM DIFFERENT 1375 01:03:01,751 --> 01:03:02,051 ANCESTRIES. 1376 01:03:02,051 --> 01:03:04,687 I THINK ONE OF THE KEY 1377 01:03:04,687 --> 01:03:06,188 CONCEPTS TO MOVE FROM IS, WE 1378 01:03:06,188 --> 01:03:07,623 WOULD LIKE IT TO BE LIKE THE 1379 01:03:07,623 --> 01:03:10,092 IMAGE ON THE LEFT, THE CRAYONS. 1380 01:03:10,092 --> 01:03:11,794 WHEN REALITY IT LOOKS MORE LIKE 1381 01:03:11,794 --> 01:03:14,330 THE IMAGE ON THE RIGHT. HOW DO 1382 01:03:14,330 --> 01:03:16,999 WE TEASE THIS APART? AS DR. GOEL 1383 01:03:16,999 --> 01:03:19,435 POINTED OUT, THESE ARE SOCIAL 1384 01:03:19,435 --> 01:03:21,804 CONSTRUCTS THAT DON'T HAVE 1385 01:03:21,804 --> 01:03:25,608 BIOLOGICAL MEAN BUT ARE DYNAMIC 1386 01:03:25,608 --> 01:03:28,144 AND SHAPED BY POLITICAL AND GEO 1387 01:03:28,144 --> 01:03:29,579 FORCES. 1388 01:03:29,579 --> 01:03:31,347 IN THIS PAPER IN 21 IT GIVES 1389 01:03:31,347 --> 01:03:32,715 GUIDANCE HOW TO REPORT. THEY 1390 01:03:32,715 --> 01:03:33,983 SAID REPORTING RACE AND 1391 01:03:33,983 --> 01:03:35,718 ETHNICITY SHOULD NOT BE 1392 01:03:35,718 --> 01:03:37,219 CONSIDERED IN ISOLATION; USUALLY 1393 01:03:37,219 --> 01:03:38,888 SHOULD BE ACCOMPANIED OR 1394 01:03:38,888 --> 01:03:42,792 REPORTING OF OTHER SOCIAL 1395 01:03:42,792 --> 01:03:45,061 DEMOGRAPHIC OR DETERMINANTS. 1396 01:03:45,061 --> 01:03:46,729 THESE TYPICALLY RELY ON 1397 01:03:46,729 --> 01:03:47,463 INDIVIDUAL'S PARTICIPATION 1398 01:03:47,463 --> 01:03:49,098 SELF-REPORT OR ASSIGNMENT BY 1399 01:03:49,098 --> 01:03:50,533 INVESTIGATORS, BUT THEY ARE BOTH 1400 01:03:50,533 --> 01:03:52,535 FROM TRULY HIGHLY PRONE TO 1401 01:03:52,535 --> 01:03:54,170 ERROR, ESPECIALLY WHEN COMPARED 1402 01:03:54,170 --> 01:03:57,273 TO D.N.A.-BASED DETERMINATIONS. 1403 01:03:57,273 --> 01:04:00,076 THIS PAPER, THE AUTHOR ASSESSED 1404 01:04:00,076 --> 01:04:02,011 SELF-IDENTIFY HISPANICS IN YOUR 1405 01:04:02,011 --> 01:04:04,447 CITY, SHOWN TO BE 29 PEREZ 1406 01:04:04,447 --> 01:04:07,683 EUROPEAN, 26 PEREZ AFRICAN, 45 1407 01:04:07,683 --> 01:04:08,985 PEREZ NATIVE AMERICAN WHEN 1408 01:04:08,985 --> 01:04:12,755 ASSESSED BY ANCESTRY AND 1409 01:04:12,755 --> 01:04:14,357 MARKERS. HOWEVER THE REPORT 1410 01:04:14,357 --> 01:04:16,258 RAISED IN ETHNICITY MEDICAL 1411 01:04:16,258 --> 01:04:18,427 RESEARCH DISREGARDS REALITY OF 1412 01:04:18,427 --> 01:04:21,097 SOCIAL CERTIFICATION, 1413 01:04:21,097 --> 01:04:21,931 INJUSTICES, INEQUITIES FOR 1414 01:04:21,931 --> 01:04:24,300 POPULATION HEALTH. TRULY 1415 01:04:24,300 --> 01:04:27,870 REMOVING RACE AND ETHNICITY MAY 1416 01:04:27,870 --> 01:04:28,904 CONCEAL THESE DISPARITIES. THAT 1417 01:04:28,904 --> 01:04:30,673 IS WHY WE ARE HERE TO DISCUSS 1418 01:04:30,673 --> 01:04:31,140 ABOUT IT. 1419 01:04:31,140 --> 01:04:33,376 HOW HAS OUR POPULATION 1420 01:04:33,376 --> 01:04:35,578 CHANGED IN THE UNITED STATES? 1421 01:04:35,578 --> 01:04:37,780 COMPARED TO 2010 THE CENSUS IN 1422 01:04:37,780 --> 01:04:39,415 2020 HAS DECREASE IN WHITE 1423 01:04:39,415 --> 01:04:41,350 POPULATION, INCREASE IN P 1424 01:04:41,350 --> 01:04:43,052 HISPANIC POPULATION AND MAPS ON 1425 01:04:43,052 --> 01:04:46,656 THE LEFT REFLECT MAJORITY BY 1426 01:04:46,656 --> 01:04:49,025 COUNTY. SO THE LARGEST GROUP BY 1427 01:04:49,025 --> 01:04:51,560 COUNTY IN THE UPPER IMAGE IS 1428 01:04:51,560 --> 01:04:56,032 MOSTLY WHITE ALONE, NON-HISPANIC 1429 01:04:56,032 --> 01:04:57,900 ACCEPT IN BORDER TOWNS, WHERE IS 1430 01:04:57,900 --> 01:04:59,869 THE MOST MAJORITY, THE HISPANIC. 1431 01:04:59,869 --> 01:05:03,305 THE SECOND LARGEST IS HISPANIC 1432 01:05:03,305 --> 01:05:06,509 OR LATINO OF ANY RACE. NEXT. 1433 01:05:06,509 --> 01:05:07,910 WHEN COMES TO DISPARITIES 1434 01:05:07,910 --> 01:05:10,112 THERE IS A BIG SOCIAL COST. THE 1435 01:05:10,112 --> 01:05:13,516 COST TO U.S. IS ESTIMATED TO BE 1436 01:05:13,516 --> 01:05:15,918 ABOUT $450 BILLION. LOOKS LIKE 1437 01:05:15,918 --> 01:05:21,157 IT IS LARGELY DRIVEN BY 1438 01:05:21,157 --> 01:05:22,491 DISPARITIES IN AFRICAN-AMERICAN 1439 01:05:22,491 --> 01:05:23,826 POPULATION, SPECIFICALLY FOR 1440 01:05:23,826 --> 01:05:27,897 EXCESS PREMATURE DEATHS. NEXT. 1441 01:05:27,897 --> 01:05:30,800 HOW DOES IT LOOK LIKE IN 1442 01:05:30,800 --> 01:05:34,003 PULMONARY HEART DOES CEASE? THIS 1443 01:05:34,003 --> 01:05:40,910 REVIEW 2024, BETWEEN 2009 AND 1444 01:05:40,910 --> 01:05:42,511 2020 THE AGE INCREASED THROUGH 1445 01:05:42,511 --> 01:05:47,349 ABOUT 2026. THEY HAD STEADY 1446 01:05:47,349 --> 01:05:48,918 INCREASE UNTIL 2020. ON THE 1447 01:05:48,918 --> 01:05:59,028 RIGHT IMAGE THERE SIGNIFICANT 1448 01:05:59,028 --> 01:05:59,495 RAC 1449 01:05:59,495 --> 01:06:00,830 DISPARITIES ESPECIALLY IN THE 1450 01:06:00,830 --> 01:06:03,966 BLACK POPULATION. HOW DOES 1451 01:06:03,966 --> 01:06:10,072 OUTCOME FARE IN ETHNICITY. THE 1452 01:06:10,072 --> 01:06:12,141 DATABASE USING CODES TO IDENTIFY 1453 01:06:12,141 --> 01:06:13,676 INDIVIDUALS WITH PH IDENTIFIED 1454 01:06:13,676 --> 01:06:15,878 ABOUT 430,000 DEATHS. DESPITE 1455 01:06:15,878 --> 01:06:18,280 ADVANCES IN THERAPY FOR PAH THE 1456 01:06:18,280 --> 01:06:21,150 OVERALL MORTALITY INCREASED FROM 1457 01:06:21,150 --> 01:06:27,690 8 PER 100,000 TO UP TO 24 BY 1458 01:06:27,690 --> 01:06:29,759 100,000. INTERESTINGLY, THOUGH, 1459 01:06:29,759 --> 01:06:35,030 USING THIS SAME DATABASE FROM 1460 01:06:35,030 --> 01:06:35,631 2003-2020 AND USING THE 1461 01:06:35,631 --> 01:06:37,666 MORTALITY RATES, IT APPEARS 1462 01:06:37,666 --> 01:06:42,004 DEATHS WERE LARGELY RELATED TO 1463 01:06:42,004 --> 01:06:43,205 LEFT-HEARTED LUNG DISEASE, OR 1464 01:06:43,205 --> 01:06:45,641 GROUP 2 TO 5. THOSE HAVE BEEN 1465 01:06:45,641 --> 01:06:46,909 RISING OVER THE LAST TWO 1466 01:06:46,909 --> 01:06:48,177 DECADES, ACCOUNTING FOR THE 1467 01:06:48,177 --> 01:06:50,179 MAJORITY OF THIS MORTALITY 1468 01:06:50,179 --> 01:06:52,047 BURDEN. THOUGH THERE HAS BEEN A 1469 01:06:52,047 --> 01:06:53,983 DECLINE IN GROUP ONE MORTALITY 1470 01:06:53,983 --> 01:06:56,252 RATES. AS YOU CAN TELL FROM ALL 1471 01:06:56,252 --> 01:06:57,353 COHORTS THE BLACK POPULATION HAS 1472 01:06:57,353 --> 01:07:01,157 HAD THE WORST OUTCOMES. NEXT 1473 01:07:01,157 --> 01:07:01,390 SLIDE. 1474 01:07:01,390 --> 01:07:08,564 WHEN IT COMES TO THE REVEAL 1475 01:07:08,564 --> 01:07:10,866 REGISTRY, YOU WILL FIND THE 1476 01:07:10,866 --> 01:07:13,803 FIVE-YEAR SURVIVAL ON THE LEFT, 1477 01:07:13,803 --> 01:07:16,972 HIGHEST AMONG HISPANIC AMONG 1478 01:07:16,972 --> 01:07:17,807 PREVIOUSLY DIAGNOSED PATIENTS. 1479 01:07:17,807 --> 01:07:19,475 IN THIS STUDY THEY ANALYZED 1480 01:07:19,475 --> 01:07:21,610 OUTCOMES BASED ON ETHNICITY AND 1481 01:07:21,610 --> 01:07:24,079 FOUND THOSE IMPROVED SURVIVAL 1482 01:07:24,079 --> 01:07:30,219 HISPANIC IN THE UNI-VARIANT 1483 01:07:30,219 --> 01:07:34,657 ANALYSIS TBUT WHEN THEY ADJUSTE, 1484 01:07:34,657 --> 01:07:36,992 THERE WAS NO DIFFERENCE -- IS 1485 01:07:36,992 --> 01:07:38,561 STUDY COULD NOT ACCOUNT IN 1486 01:07:38,561 --> 01:07:40,629 SOCIOECONOMIC FACTORS, SINCE 1487 01:07:40,629 --> 01:07:41,931 THIS INFORMATION WAS NOT 1488 01:07:41,931 --> 01:07:46,035 AVAILABLE ON THE REVEAL 1489 01:07:46,035 --> 01:07:48,037 REGISTRY. NEXT. 1490 01:07:48,037 --> 01:07:50,506 AS DR. GOEL POINTED OUT, 1491 01:07:50,506 --> 01:07:51,373 REPRESENTATION, REGISTRIES AND 1492 01:07:51,373 --> 01:07:53,242 FILES IS ONE OF THE KEY ASPECTS 1493 01:07:53,242 --> 01:07:56,445 TO BE ADDRESSED. ON LEFT SIDE, 1494 01:07:56,445 --> 01:07:57,713 DISCREPANCY BETWEEN WHAT IS 1495 01:07:57,713 --> 01:07:59,081 EXPECTED IN CENSUS POPULATION 1496 01:07:59,081 --> 01:08:02,084 AND THE REALITY WITHIN THE 1497 01:08:02,084 --> 01:08:04,086 REGISTRY, IT IS STARK. ON THE 1498 01:08:04,086 --> 01:08:07,556 RIGHT SIDE IT IS A CONDENSED 1499 01:08:07,556 --> 01:08:10,292 CHART ABOUT THE TRIALS. MOST HAD 1500 01:08:10,292 --> 01:08:17,433 GREATER THAN 75 PEREZ OF WH % /% 1501 01:08:17,433 --> 01:08:20,102 OF WHITE POPULATION THEN IN U.S. 1502 01:08:20,102 --> 01:08:25,975 54 TO 58 PEREZ. AND NEXT SLIDE, 1503 01:08:25,975 --> 01:08:29,311 PLEASE. SO WHEN COMES TO THE 1504 01:08:29,311 --> 01:08:32,281 ETIOLOGY ON ETHNICITY, ANALYZING 1505 01:08:32,281 --> 01:08:36,485 THE PH BIOBANK, ONGOING FUNDED 1506 01:08:36,485 --> 01:08:39,488 SAMPLE OF PATIENTS ENROLLED IN 1507 01:08:39,488 --> 01:08:41,657 34 U.S. CENTERS, THIS BIOBANK 1508 01:08:41,657 --> 01:08:43,893 HAS CLINICAL DATA AND SAMPLES 1509 01:08:43,893 --> 01:08:47,997 AND GENETIC DATA OF ABOUT 1,800, 1510 01:08:47,997 --> 01:08:58,641 80 PEREZ ROUGHLY WERE -- 80 % H 1511 01:08:58,641 --> 01:09:00,209 THIS SEEMS LIKE THE HISPANIC 1512 01:09:00,209 --> 01:09:03,612 COHORTS WERE YOUNGER. IN REVEAL 1513 01:09:03,612 --> 01:09:07,549 REGISTRY APPEARS HISPANIC AND 1514 01:09:07,549 --> 01:09:09,351 ASIAN WERE YOUNGER. MAJORITY 1515 01:09:09,351 --> 01:09:12,554 WITH CONNECTIVE TISSUE DISEASE 1516 01:09:12,554 --> 01:09:13,656 WERE MOST AFRICAN-AMERICAN OR 1517 01:09:13,656 --> 01:09:15,891 BLACK. NON-HISPANIC OR WHITE 1518 01:09:15,891 --> 01:09:17,426 HOUSE HAS FAMILIAR PH RELATED TO 1519 01:09:17,426 --> 01:09:20,329 DRUG OR TOXINS. HISPANICS WERE 1520 01:09:20,329 --> 01:09:22,731 YOUNGER, HAD HIGHER INCIDENCE OF 1521 01:09:22,731 --> 01:09:24,266 CONGENITAL HEART DISEASE 1522 01:09:24,266 --> 01:09:25,467 ASSOCIATED. THEY WERE LESS 1523 01:09:25,467 --> 01:09:27,636 LIKELY TO BE DESCRIBED PH 1524 01:09:27,636 --> 01:09:31,307 MEDICATION AS WELL. IN THE REAL 1525 01:09:31,307 --> 01:09:35,311 REGISTRY MOST ASSOCIATED WITH 1526 01:09:35,311 --> 01:09:36,745 PULMONARY HYPERTENSION. 1527 01:09:36,745 --> 01:09:42,151 >> IN THE MESA CORE STUDY, STUDY 1528 01:09:42,151 --> 01:09:47,523 OF AT HER ROW SCLEROSIS, ABOUT 1529 01:09:47,523 --> 01:09:48,657 6800, AFRICAN-AMERICAN, 1530 01:09:48,657 --> 01:09:50,326 HISPANIC, WHITE AND CHINESE 1531 01:09:50,326 --> 01:09:55,064 AMERICAN, THEY ANALYZED THE 1532 01:09:55,064 --> 01:09:57,366 INCIDENCE OF CONGESTIVE HEART 1533 01:09:57,366 --> 01:09:59,635 FAILURE AND FOUND HIGHER 1534 01:09:59,635 --> 01:10:00,803 INCIDENCE OF BLACK AND 1535 01:10:00,803 --> 01:10:03,739 AFRICAN-AMERICANS, MOSTLY 1536 01:10:03,739 --> 01:10:05,507 RELATED TO HYPERTENSION, 1537 01:10:05,507 --> 01:10:07,142 DIABETES AND SOCIOECONOMIC 1538 01:10:07,142 --> 01:10:10,646 STATUS. IN 2017 THIS PAPER 1539 01:10:10,646 --> 01:10:12,514 ANALYZED RATE OF HEART FAILURE 1540 01:10:12,514 --> 01:10:13,749 HOSPITALIZATIONS. IT WAS ABOUT 1541 01:10:13,749 --> 01:10:18,887 230 PEREZ HIGHER IN BLACK MEN, 1542 01:10:18,887 --> 01:10:20,456 240 PEREZ HIGHER IN BLACK WOMEN 1543 01:10:20,456 --> 01:10:22,891 COMPARED TO WHITES IN 2013. 1544 01:10:22,891 --> 01:10:24,994 THESE PERSISTED ACROSS THE 1545 01:10:24,994 --> 01:10:26,695 DECADE. IN CONTRAST DIFFERENCE 1546 01:10:26,695 --> 01:10:27,730 OF HEART FAILURE 1547 01:10:27,730 --> 01:10:29,865 HOSPITALIZATIONS NARROWED WITHIN 1548 01:10:29,865 --> 01:10:31,934 THE HISPANICS DURING THE SAME 1549 01:10:31,934 --> 01:10:35,304 TIME PERIOD. ASIAN AND PACIFIC 1550 01:10:35,304 --> 01:10:37,406 ISLANDERS HAVE MAINTAINED THE 1551 01:10:37,406 --> 01:10:39,675 LOWEST RATES COMPARED TO OTHER 1552 01:10:39,675 --> 01:10:41,577 RACIAL ETHNIC GROUPS. THERE IS 1553 01:10:41,577 --> 01:10:43,412 AN INTERESTING STUDY IN 1554 01:10:43,412 --> 01:10:44,580 CALIFORNIA THAT SHOW YOUNG BLACK 1555 01:10:44,580 --> 01:10:46,382 ADULTS WERE NOT ONLY SIX TIMES 1556 01:10:46,382 --> 01:10:48,951 MORE LIKELY TO BE HOSPITALIZED 1557 01:10:48,951 --> 01:10:50,652 FOR HEART FAILURE COMPARED TO 1558 01:10:50,652 --> 01:10:52,388 WHITE INDIVIDUALS BUT WERE ALSO 1559 01:10:52,388 --> 01:10:54,623 YOUNGER AT THE TIME OF 1560 01:10:54,623 --> 01:10:55,024 HOSPITALIZATION. 1561 01:10:55,024 --> 01:10:58,193 SO SOME KEY POINTS -- NEXT 1562 01:10:58,193 --> 01:11:01,630 SLIDE, THANK YOU. SOME KEY 1563 01:11:01,630 --> 01:11:04,333 POINTS FOR BLACK POPULATION, 1564 01:11:04,333 --> 01:11:09,438 EVIDENCE IN 1986 SHOWED HIGHER 1565 01:11:09,438 --> 01:11:13,709 LEVELS IN THE BLACK COHORT. 1566 01:11:13,709 --> 01:11:18,247 NOTICE IN 2004 TESTED IMBALANCE 1567 01:11:18,247 --> 01:11:20,849 AND QUESTIONED WHETHER IT WAS 1568 01:11:20,849 --> 01:11:24,219 RELATED. GABULAR USED SIX RANDOM 1569 01:11:24,219 --> 01:11:26,088 TRIALS OF ERA SUBMITTED TO FDA 1570 01:11:26,088 --> 01:11:28,424 AND FOUND THERE WAS A BLUNTED 1571 01:11:28,424 --> 01:11:34,897 RESPONSE TO TREATMENT TO ERA IN 1572 01:11:34,897 --> 01:11:37,366 THE STUDY, THE LONGITUDINAL 1573 01:11:37,366 --> 01:11:39,234 PERSPECTIVE OBSERVATIONAL COHORT 1574 01:11:39,234 --> 01:11:44,206 OF AFRICAN-AMERICANS, ABOUT 3200 1575 01:11:44,206 --> 01:11:47,109 SELF-IDENTIFY AND POTENTIAL BY 1576 01:11:47,109 --> 01:11:48,777 ECHO AND FOUND HIGHER LEVEL ONE 1577 01:11:48,777 --> 01:11:51,947 WERE ASSOCIATED WITH HIGHER 1578 01:11:51,947 --> 01:11:52,881 HYPERTENSION AND HEART FAILURE 1579 01:11:52,881 --> 01:11:56,652 AND HIGHER MORTALITY. STUDY IN 1580 01:11:56,652 --> 01:12:00,389 2024 USING NATIONAL IN-PATIENT 1581 01:12:00,389 --> 01:12:05,027 SAMPLE FROM 2015 E 2019 AND 1582 01:12:05,027 --> 01:12:07,162 CODES OF HIV AND PULMONARY 1583 01:12:07,162 --> 01:12:09,865 HYPERTENSION, NOTICE OVER 1584 01:12:09,865 --> 01:12:12,668 900,000 OF HIV, 3 PEREZ HAS THE 1585 01:12:12,668 --> 01:12:13,669 HYPERTENSION. WHEN COMPARED TO 1586 01:12:13,669 --> 01:12:16,505 HIV ALONE, THE PH PATIENTS WERE 1587 01:12:16,505 --> 01:12:18,941 OLDER, MORE LIKELY TO BE BLACK, 1588 01:12:18,941 --> 01:12:23,312 MALE AND HAD A HIGHER INCIDENCE 1589 01:12:23,312 --> 01:12:29,885 OF CO. MORBIDITIES. IN 2019 1590 01:12:29,885 --> 01:12:32,454 THERE WAS A HIGHER PERCENTAGE OF 1591 01:12:32,454 --> 01:12:35,524 BLACK CHILDREN LARGELY DRIVEN BY 1592 01:12:35,524 --> 01:12:37,493 LUNG DISEASE WITH PULMONARY 1593 01:12:37,493 --> 01:12:39,128 HYPERTENSION. NEXT PLEASE. 1594 01:12:39,128 --> 01:12:42,331 SO CONNECTIVE TISSUE DISEASE 1595 01:12:42,331 --> 01:12:45,534 PULMONARY HYPERTENSION IN BLACKS 1596 01:12:45,534 --> 01:12:48,971 LARGELY RELATED TO INCIDENCE OF 1597 01:12:48,971 --> 01:12:50,639 THIS AND LUPUS IN BLACK PP 1598 01:12:50,639 --> 01:12:53,509 ALLEGATION ARE HIGHER AND SHOWS 1599 01:12:53,509 --> 01:12:55,144 THIS IN AFRICAN-AMERICANS WERE 1600 01:12:55,144 --> 01:12:57,679 ASSOCIATED WITH MORE SEVERE PH, 1601 01:12:57,679 --> 01:13:00,048 THOUGH MORTALITY ASSOCIATED WITH 1602 01:13:00,048 --> 01:13:01,750 SOCIOECONOMIC STATUS, NOT RACE. 1603 01:13:01,750 --> 01:13:04,786 THIS STUDY WAS A RETROSPECTIVE 1604 01:13:04,786 --> 01:13:06,288 STUDY COMPARING 1605 01:13:06,288 --> 01:13:08,590 AFRICAN-AMERICANS TO 1606 01:13:08,590 --> 01:13:09,224 NON-AFRICAN-AMERICAN PATIENTS 1607 01:13:09,224 --> 01:13:10,759 WITH THIS. THE COHORT ANALYSIS 1608 01:13:10,759 --> 01:13:13,428 FROM THE HOPKINS PROGRAM FROM 1609 01:13:13,428 --> 01:13:15,097 ABOUT 160 PATIENTS SHOWED BLACK 1610 01:13:15,097 --> 01:13:17,332 PATIENTS WITHER FOUND TO HAVE 1611 01:13:17,332 --> 01:13:19,902 WORST FUNCTIONAL CLASS UPON 1612 01:13:19,902 --> 01:13:22,171 PRESENTATION, LOWER EXERCISE, 1613 01:13:22,171 --> 01:13:23,872 HIGHER NATURAL PEPTIDES, MORE 1614 01:13:23,872 --> 01:13:28,377 SEVERE HUMAN DYNAMIC METHODS AND 1615 01:13:28,377 --> 01:13:30,812 TRANSITORY TOWARDS SURVIVAL. 1616 01:13:30,812 --> 01:13:31,246 NEXT SLIDE. 1617 01:13:31,246 --> 01:13:33,482 DO BLACKS HAVE WORSE 1618 01:13:33,482 --> 01:13:36,518 OUTCOMES IN PH? THIS IS VERY 1619 01:13:36,518 --> 01:13:37,920 INTERESTING STUDY FROM THE 1620 01:13:37,920 --> 01:13:40,889 VANDERBILT GROUP ASSESSING THE 1621 01:13:40,889 --> 01:13:42,891 CATH IN IN-PATIENT AND 1622 01:13:42,891 --> 01:13:46,028 OUTPATIENT SETTINGS FROM 1623 01:13:46,028 --> 01:13:48,997 2008-2014. ABOUT 4,500 PATIENTER 1624 01:13:48,997 --> 01:13:56,004 WERE INCLUDED, OF THE ONES 13 % 1625 01:13:56,004 --> 01:14:03,812 ANAPHYLACTIC. THEY W AFZ /* -- 1626 01:14:03,812 --> 01:14:05,981 AFRICAN-AMERICAN AND HAD HIGHER 1627 01:14:05,981 --> 01:14:08,450 PREVALENCE OF ALL ETIOLOGIES OF 1628 01:14:08,450 --> 01:14:11,386 HYPERTENSION, 41 HIGHER RISK OF 1629 01:14:11,386 --> 01:14:15,857 PH AND 24 PERCENT ADJUST RISK TO 1630 01:14:15,857 --> 01:14:17,793 MORTALITY. THIS OTHER STUDY IN 1631 01:14:17,793 --> 01:14:19,928 2017 WAS MENTIONED ALREADY. 1632 01:14:19,928 --> 01:14:21,263 INCLUDED 250PH PATIENTS 1633 01:14:21,263 --> 01:14:23,999 ANALYZING TWO COHORTS. THEY ONLY 1634 01:14:23,999 --> 01:14:26,201 USED BLACK AND WHITE RACE, 1635 01:14:26,201 --> 01:14:27,703 OTHERS WERE EXCLUDED. IF THEY 1636 01:14:27,703 --> 01:14:31,039 HAD -- WERE OUT OF THIS TWO 1637 01:14:31,039 --> 01:14:32,441 COHORTS. AFTER ADJUSTMENT FOR 1638 01:14:32,441 --> 01:14:34,876 AGE AND FUNCTION OF CLASS, 1639 01:14:34,876 --> 01:14:36,511 BLACKS HAD HIGHER, GREATER 1640 01:14:36,511 --> 01:14:38,013 MORTALITY RISK BUT DISAPPEARED 1641 01:14:38,013 --> 01:14:39,848 WHEN ADJUSTED FOR INSURANCE 1642 01:14:39,848 --> 01:14:41,049 STATUS. THIS PAPER IS GOING TO 1643 01:14:41,049 --> 01:14:50,826 BE QUOTED LATER ON AS WELL. PH 1644 01:14:50,826 --> 01:14:51,960 IS MORE PREVALENCE IN BLACKS 1645 01:14:51,960 --> 01:15:00,202 WITH SARCODOSIS IN REGISTRY AND 1646 01:15:00,202 --> 01:15:03,171 12% HIGHER THAN IN CAUCASIANS 1647 01:15:03,171 --> 01:15:05,173 AND IN THIS OBSERVATIONAL 1648 01:15:05,173 --> 01:15:06,341 REGISTRY IN THE U.S. 1649 01:15:06,341 --> 01:15:10,279 INITIATE ED IN 2011, ABOUT 200 1650 01:15:10,279 --> 01:15:11,480 PATIENTS WERE DIAGNOSED WITH 1651 01:15:11,480 --> 01:15:16,718 THIS, 55% WERE OF BLACK RACE IN 1652 01:15:16,718 --> 01:15:20,922 THE SARCODOSIS COHORT. WHEN 1653 01:15:20,922 --> 01:15:25,027 COMES TO HUMAN DYNAMICS BLACK 1654 01:15:25,027 --> 01:15:28,130 HAVE HIGHER MPAP PRESSURES AND 1655 01:15:28,130 --> 01:15:32,434 THIS STUDY, THE CORONARY RISK 1656 01:15:32,434 --> 01:15:36,872 DEVELOPMENT IN YOUNG ADULT. 1657 01:15:36,872 --> 01:15:39,341 BETWEEN 1985, OVER 5,000 1658 01:15:39,341 --> 01:15:41,677 PATIENTS WERE ENROLLED, USUALLY 1659 01:15:41,677 --> 01:15:43,912 BLACK OR WHITE. 18 TO 30 YEARS 1660 01:15:43,912 --> 01:15:46,014 OLD THEY WERE ENROLLED IN FOUR 1661 01:15:46,014 --> 01:15:49,151 SITES. IN 2017 THIS STUDY FOUND 1662 01:15:49,151 --> 01:15:50,886 THE ASSOCIATION BETWEEN BLACK 1663 01:15:50,886 --> 01:15:52,254 AND HIGHER PULMONARY PRESSURES 1664 01:15:52,254 --> 01:15:54,856 IN ECHO, IT WAS REGARDLESS OF 1665 01:15:54,856 --> 01:15:56,425 AGE. ON THE RIGHT SIDE WE SEE 1666 01:15:56,425 --> 01:15:59,328 THE JACKSON HEART STUDY, THE 1667 01:15:59,328 --> 01:16:01,930 LONGITUDINAL POPULATION BASED 1668 01:16:01,930 --> 01:16:03,632 COHORT, AND THIS FOR PATIENTS 1669 01:16:03,632 --> 01:16:06,368 RESIDING IN JACKSON, 1670 01:16:06,368 --> 01:16:07,502 MISSISSIPPI, FOUND HIGH 1671 01:16:07,502 --> 01:16:08,303 ARTERIAL PRESSURE WAS 1672 01:16:08,303 --> 01:16:13,075 SIGNIFICANT RISK FACTOR FOR 1673 01:16:13,075 --> 01:16:14,276 HOSPITALIZATION. NEXT SLIDE, 1674 01:16:14,276 --> 01:16:14,576 PLEASE. 1675 01:16:14,576 --> 01:16:17,012 >> THIS IS WHEN WE TALK ABOUT 1676 01:16:17,012 --> 01:16:20,849 AMERICAN INDIAN AND ALASKAN 1677 01:16:20,849 --> 01:16:22,951 NATIVE WITH CARDIOVASCULAR 1678 01:16:22,951 --> 01:16:24,720 DISEASE, THERE WAS A SCARCITY. 1679 01:16:24,720 --> 01:16:29,624 THIS IS ONE OF THE PAPERS FROM 1680 01:16:29,624 --> 01:16:37,666 GEMA. 50% HAS CARDIOVASCULAR 1681 01:16:37,666 --> 01:16:41,970 DISEASE AND USING THIS COHORT 1682 01:16:41,970 --> 01:16:43,205 NOTICE THERE IS DECREASE IN CD, 1683 01:16:43,205 --> 01:16:44,539 INCREASE IN MI AND HEART 1684 01:16:44,539 --> 01:16:49,378 FAILURE. RATE OF CVA AND AFIB 1685 01:16:49,378 --> 01:16:51,546 STAYED THE SAME. INTERESTING, 1686 01:16:51,546 --> 01:16:54,216 20% MORTALITY RATE WITHIN THIS 1687 01:16:54,216 --> 01:17:00,055 COHORT. NEXT SLIDE. IN THE 1688 01:17:00,055 --> 01:17:04,426 KOREAN STUDY PATIENTS, ABOUT 1.9 1689 01:17:04,426 --> 01:17:05,494 PER YEAR PER MILLION. THE 1690 01:17:05,494 --> 01:17:08,029 SURVIVAL WAS ABOUT 90%. FOR 1691 01:17:08,029 --> 01:17:10,232 COMPARISON I PUT REVEAL OF 1692 01:17:10,232 --> 01:17:13,268 REGISTRY 1 SURVIVAL ABOUT 90% AS 1693 01:17:13,268 --> 01:17:18,774 WELL. THIS KOREAN CORE RECEIVED 1694 01:17:18,774 --> 01:17:20,208 LESS INTENSIVE THERAPY THOUGHT 1695 01:17:20,208 --> 01:17:23,712 DUE TO INSURANCE. IN JAPAN, MORE 1696 01:17:23,712 --> 01:17:28,183 PREVALENT, ABOUT TWO-THIRDS. BUT 1697 01:17:28,183 --> 01:17:29,418 THREE-YEAR, PRE-SURVIVAL RATE 1698 01:17:29,418 --> 01:17:31,319 WAS ABOUT SAME IN REVEAL 1699 01:17:31,319 --> 01:17:35,190 REGISTRY, AROUND 70s. IN INDIAN 1700 01:17:35,190 --> 01:17:36,191 CONGENITAL HEART DISEASE WAS 1701 01:17:36,191 --> 01:17:39,361 MOST PREVALENT AND MORTALITY 8% 1702 01:17:39,361 --> 01:17:42,731 IN PERIOD BETWEEN 2015 AND 2023. 1703 01:17:42,731 --> 01:17:45,066 IN PHILIPPINES, THIS WAS MOSTLY 1704 01:17:45,066 --> 01:17:50,739 ASSOCIATED WITH LUPUS. HIGHEST 1705 01:17:50,739 --> 01:17:53,642 MORTALITY WITH SCLERODERMA. 1706 01:17:53,642 --> 01:17:55,777 WHEN COMES TO ASIAN OUTCOMES 1707 01:17:55,777 --> 01:17:57,412 THESE REGISTRIES ARE 1708 01:17:57,412 --> 01:17:58,780 INTERESTING. ONE ON LEFT IS 1709 01:17:58,780 --> 01:18:02,784 SINGAPORE WITH MULTI -ETHNIC 1710 01:18:02,784 --> 01:18:10,826 ASIAN COHORT FROM 2003-2016. 1711 01:18:10,826 --> 01:18:13,328 THESE ARE BETTER WHEN COMPARED 1712 01:18:13,328 --> 01:18:17,032 TO FRENCH AND KOREAN. MOST 1713 01:18:17,032 --> 01:18:18,967 COMMON CON GENERATIVE HEART 1714 01:18:18,967 --> 01:18:23,338 DISEASE, IDIOPATHIC AND 1715 01:18:23,338 --> 01:18:25,106 CONNECTIVE TISSUE DISEASE, 1716 01:18:25,106 --> 01:18:27,909 MAJORITY CLASS 2, 50% FUNCTIONAL 1717 01:18:27,909 --> 01:18:33,081 AND MOST WERE ON MONOTHERAPY. 1718 01:18:33,081 --> 01:18:41,556 54%. THE ETHNICITY WERE A MIX OF 1719 01:18:41,556 --> 01:18:44,559 CHINESE, MALAI AND OTHERS. I 1720 01:18:44,559 --> 01:18:45,760 THOUGHT IT INTERESTING TO SEE 1721 01:18:45,760 --> 01:18:47,729 WHAT OTHER PARTS OF THE WORLD 1722 01:18:47,729 --> 01:18:48,997 ARE DOING WELL, SAME CHALLENGES 1723 01:18:48,997 --> 01:18:51,800 THEY ARE FACING. IN THIS CHINESE 1724 01:18:51,800 --> 01:19:00,041 REGISTRY FROM 199 9 TO 2004 1725 01:19:00,041 --> 01:19:04,279 TLUZ WITH A DELAY AND WORSE THAN 1726 01:19:04,279 --> 01:19:07,516 REGISTRIES. AT THE TIME THEY 1727 01:19:07,516 --> 01:19:11,453 DIDN'T HAVE (?) IN THAT REGION. 1728 01:19:11,453 --> 01:19:12,153 NEXT SLIDE. 1729 01:19:12,153 --> 01:19:14,823 WHAT DO WE DO ABOUT HISPANIC 1730 01:19:14,823 --> 01:19:16,558 SURVIVAL AND HISPANIC COHORT? 1731 01:19:16,558 --> 01:19:19,895 THE EVENT DISAPPEARED SOCIAL 1732 01:19:19,895 --> 01:19:21,496 WROTE ECONOMIC STATUS ADJUSTMENT 1733 01:19:21,496 --> 01:19:24,633 IN THIS PAPER BY BERNARDO, 1734 01:19:24,633 --> 01:19:26,735 QUOTED LATER ON, HAD A HIGHER 1735 01:19:26,735 --> 01:19:29,838 REPRESENTATION OF MINORITIES 1736 01:19:29,838 --> 01:19:35,176 FROM THE FAR REGISTRY COMPARED 1737 01:19:35,176 --> 01:19:37,245 TO THE OTHER SHEET. HISPANIC 1738 01:19:37,245 --> 01:19:39,447 PATIENTS WERE MOST COMMON 1739 01:19:39,447 --> 01:19:41,216 ASSOCIATED TO DRUG OR CONGENITAL 1740 01:19:41,216 --> 01:19:43,251 HEART DISEASE. THERE WAS A HIGH 1741 01:19:43,251 --> 01:19:45,253 IMPAIRED ACCESS TO HEALTH, LOWER 1742 01:19:45,253 --> 01:19:48,623 ANNUAL INCOME, LOWER EDUCATIONAL 1743 01:19:48,623 --> 01:19:50,425 LEVEL, HIGHER UNEMPLOYMENT, 1744 01:19:50,425 --> 01:19:51,526 HIGHER FREQUENCY OF EMERGENCY 1745 01:19:51,526 --> 01:19:52,827 VISITS AND HIGHER 1746 01:19:52,827 --> 01:19:54,930 HOSPITALIZATIONS DESPITE SIMILAR 1747 01:19:54,930 --> 01:19:57,999 FUNCTIONAL CLASS, RISK, EXERCISE 1748 01:19:57,999 --> 01:20:00,435 CAPACITY AND SPECIFIC THERAPY. 1749 01:20:00,435 --> 01:20:02,170 THIS SURVIVAL ANALYSIS WAS NO 1750 01:20:02,170 --> 01:20:03,805 LONGER PRESENT AFTER ADJUSTMENT 1751 01:20:03,805 --> 01:20:07,342 FOR AGE, SEX, PH SUB TYPE AND 1752 01:20:07,342 --> 01:20:08,176 SOCIAL DETERMINANTS OF HEALTH. 1753 01:20:08,176 --> 01:20:09,844 SOME LIMITATIONS IS IT IS A 1754 01:20:09,844 --> 01:20:12,180 SMALLER DATA SET THAN THE 1755 01:20:12,180 --> 01:20:14,316 REVEAL. THIS FROM PATIENTS 1756 01:20:14,316 --> 01:20:15,717 REFERRED TO PH, WHICH I THINK IS 1757 01:20:15,717 --> 01:20:19,554 GOING TO BE A PROBLEM WE WILL BE 1758 01:20:19,554 --> 01:20:21,189 TALKING ABOUT OVER AND OVER 1759 01:20:21,189 --> 01:20:24,926 AGAIN. NEXT SLIDE. HOW DO 1760 01:20:24,926 --> 01:20:26,428 HISPANICS DO IN GENERAL? THEY 1761 01:20:26,428 --> 01:20:28,463 HAVE A BETTER PROFILE. ON THE 1762 01:20:28,463 --> 01:20:33,134 LEFT YOU WILL FIND TWO PAPERS 1763 01:20:33,134 --> 01:20:35,670 THAT SHOW THAT A RETROSPECTIVE 1764 01:20:35,670 --> 01:20:36,638 ANALYSIS WITH CATEGORY IZATION 1765 01:20:36,638 --> 01:20:39,541 OF COHORT OVER TEN YEARS, ABOUT 1766 01:20:39,541 --> 01:20:41,676 200 PATIENTS AND 61% WERE 1767 01:20:41,676 --> 01:20:42,944 HISPANIC. HISPANIC PATIENTS HAD 1768 01:20:42,944 --> 01:20:47,382 LOWER PRESSURES, LOWER PDR AND 1769 01:20:47,382 --> 01:20:48,516 HIGHER CARE COMPLIANCE AND TREND 1770 01:20:48,516 --> 01:20:55,357 OF BETTER SURVIVAL ALSO BASED ON 1771 01:20:55,357 --> 01:20:58,793 THE LEVELS. THE RIGHT SIDE, A 1772 01:20:58,793 --> 01:21:00,695 PAPER BY DR. WOODS' GROUP AND 1773 01:21:00,695 --> 01:21:03,965 NOTICED DIFFERENCES BASED ON 1774 01:21:03,965 --> 01:21:05,767 CARDIAC MRI FROM THE STUDY. THEY 1775 01:21:05,767 --> 01:21:08,003 HAD COMPARED TO WHITES, HISPANIC 1776 01:21:08,003 --> 01:21:12,841 HAD GREATER AND LARGER DIASTOLIC 1777 01:21:12,841 --> 01:21:14,542 VOLUME AND MASS, BLACKS HAD 1778 01:21:14,542 --> 01:21:17,379 LOWER RV MASS WHEN ADJUSTING TO 1779 01:21:17,379 --> 01:21:20,515 CO. VARIANTS INCLUDING LP MASS 1780 01:21:20,515 --> 01:21:21,983 AND HISPANIC HAD HIGHER COMPARED 1781 01:21:21,983 --> 01:21:24,219 TO WHITES. QUESTION REMAINS 1782 01:21:24,219 --> 01:21:25,954 WHERE THESE ARE DIFFERENCES 1783 01:21:25,954 --> 01:21:31,693 REFLECT ADAPTIVE OR MALADAPTIVE 1784 01:21:31,693 --> 01:21:33,428 MODELLING BUT DATA SUGGEST THIS 1785 01:21:33,428 --> 01:21:35,263 ARE KNOWN TO HAVE PROGNOSTIC 1786 01:21:35,263 --> 01:21:39,367 SIGNIFICANCE INCLUDING RV MASS. 1787 01:21:39,367 --> 01:21:41,136 NEXT SLIDE. SO HISPANICS HAVE 1788 01:21:41,136 --> 01:21:45,740 IMPROVED SURVIVAL DESPITE WORSE 1789 01:21:45,740 --> 01:21:47,008 HEMODYNAMICS, BUT THE DOCTOR, 1790 01:21:47,008 --> 01:21:48,810 WHO IS WITH US. COLLECTED DATA 1791 01:21:48,810 --> 01:21:51,146 FROM FOUR COHORTS AND COMPARE 1792 01:21:51,146 --> 01:21:53,281 HISPANIC, WHITE, BLACKS. THEY 1793 01:21:53,281 --> 01:21:55,383 DID IT BETWEEN IDIOPATHIC AND 1794 01:21:55,383 --> 01:21:57,686 HEREDITARY PH. ETHNICITY WAS 1795 01:21:57,686 --> 01:21:59,421 SELF-REPORTED BY INDIVIDUALS. 1796 01:21:59,421 --> 01:22:02,257 THOSE GENOMIC DATA GATHERED TO 1797 01:22:02,257 --> 01:22:04,659 DETERMINE THEIR ANCESTRY. 1798 01:22:04,659 --> 01:22:06,294 HISPANICS HAD SURVIVAL BENEFIT 1799 01:22:06,294 --> 01:22:11,166 AFTER ADJUSTING FOR AGE, SEX AND 1800 01:22:11,166 --> 01:22:16,738 PDR. ALSO (?) USE LOWEST AMONG 1801 01:22:16,738 --> 01:22:20,341 THE GROUP WITH HIGHEST AND 1802 01:22:20,341 --> 01:22:23,311 LOWEST PRESSURES, THE SLIDE I 1803 01:22:23,311 --> 01:22:23,978 MENTIONED. AFRICAN-AMERICAN HAD 1804 01:22:23,978 --> 01:22:26,915 LOWEST AVERAGES AND LOWEST 1805 01:22:26,915 --> 01:22:29,551 AVERAGE WALK DISTANCE. IN IMAGE 1806 01:22:29,551 --> 01:22:31,453 ON THE RIGHT THE GRAPH REFLECTS 1807 01:22:31,453 --> 01:22:35,490 COMBINED ESTIMATE OF PERCENTAGE 1808 01:22:35,490 --> 01:22:39,561 OF AFRICAN, EUROPEAN AND DAY AND 1809 01:22:39,561 --> 01:22:41,763 INDICATED SELF-REPORTED RACE AND 1810 01:22:41,763 --> 01:22:43,698 ETHNICITY. WHEN TWO CORES WERE 1811 01:22:43,698 --> 01:22:45,333 OVER LAID FOR MAGNITUDE IT WAS 1812 01:22:45,333 --> 01:22:47,135 NOTICED TO BE HIGHER FOR 1813 01:22:47,135 --> 01:22:50,438 NATIVE-AMERICAN AND LOWER FOR 1814 01:22:50,438 --> 01:22:55,910 AFRICAN ANCESTRY. NEXT SLIDE. 1815 01:22:55,910 --> 01:22:58,713 WHAT HAPPENS TO HISPANIC IN 1816 01:22:58,713 --> 01:22:59,814 LATIN AMERICA BUT NOT UNITED 1817 01:22:59,814 --> 01:23:02,250 STATES. REGISTRY SHOWS THEY ARE 1818 01:23:02,250 --> 01:23:05,386 DIAGNOSED AT YOUNGER AGE, AROUND 1819 01:23:05,386 --> 01:23:07,489 34. MORE FEMALE THAN MALE. MORE 1820 01:23:07,489 --> 01:23:09,591 ADVANCED STAGES OF PH, PROBABLY 1821 01:23:09,591 --> 01:23:12,393 DUE TO LIMITED ACCESS TO HEALTH 1822 01:23:12,393 --> 01:23:14,129 FACILITY AND DIAGNOSTIC. 1823 01:23:14,129 --> 01:23:15,797 COMPARED TO REVEAL IN FRENCH 1824 01:23:15,797 --> 01:23:19,167 REGISTRIES, THEY ARE SIMILAR. IN 1825 01:23:19,167 --> 01:23:25,106 BRAZIL N ADDITION OF (?) AND 1826 01:23:25,106 --> 01:23:27,509 REGIONAL OUTCOMES ARE SIMILAR TO 1827 01:23:27,509 --> 01:23:31,179 OTHER WELL-KNOWN REGISTRIES. I 1828 01:23:31,179 --> 01:23:38,920 WANT TO POINT OUT (AUDIO 1829 01:23:38,920 --> 01:23:39,754 DISRUPTION) AND IN THE LAST 1830 01:23:39,754 --> 01:23:41,823 MINUTE I WANT TO SHOW YOU WHY I 1831 01:23:41,823 --> 01:23:44,058 BECAME INTERESTED. I DID NOT 1832 01:23:44,058 --> 01:23:46,594 RESEARCH THIS BUT BORN IN 1833 01:23:46,594 --> 01:23:48,863 GUATEMALA IT APPEARED MEDICAL 1834 01:23:48,863 --> 01:23:53,701 RESEARCH WAS MISSING GRANULARITY 1835 01:23:53,701 --> 01:23:59,874 OF HOW HETEROGENEOUS THIS IS. I 1836 01:23:59,874 --> 01:24:01,142 WANTED TO INQUIRE FURTHER. NEXT 1837 01:24:01,142 --> 01:24:03,244 SLIDE. THE HISPANIC PARADOX THAT 1838 01:24:03,244 --> 01:24:05,079 TALKS ABOUT LONGER HISPANIC 1839 01:24:05,079 --> 01:24:12,086 SURVIVAL DESPITE WORSENING 1840 01:24:12,086 --> 01:24:15,423 CARDIOVASCULAR RISK FACTORS. I 1841 01:24:15,423 --> 01:24:17,292 FOUND THIS STUDY AT OUR CENTER? 1842 01:24:17,292 --> 01:24:19,694 SAN ANTONIO THAT TESTED THIS, 1843 01:24:19,694 --> 01:24:21,196 LONGITUDINAL STUDY. THEY ASKED 1844 01:24:21,196 --> 01:24:22,964 THE QUESTION, ARE ETHNIC 1845 01:24:22,964 --> 01:24:25,733 DIFFERENCES IN MORTALITY 1846 01:24:25,733 --> 01:24:27,001 CONSISTENT WITHIN HISPANIC 1847 01:24:27,001 --> 01:24:29,904 PARADOX. MEXICAN-AMERICAN VERSUS 1848 01:24:29,904 --> 01:24:32,373 EUROPEAN-AMERICAN COHORTS. NEXT 1849 01:24:32,373 --> 01:24:33,675 SLIDE. VERY IMPORTANTLY, 1850 01:24:33,675 --> 01:24:35,009 CLASSIFICATION BY ETHNIC GROUP 1851 01:24:35,009 --> 01:24:37,512 WAS INVALIDATED STANDARDIZED 1852 01:24:37,512 --> 01:24:46,020 FORM THEY USED PARENTAL 1853 01:24:46,020 --> 01:24:47,589 SURNAMES, BACKGROUNDS OF 1854 01:24:47,589 --> 01:24:49,958 GRANDPARENTS AND CONCLUDED TO 1855 01:24:49,958 --> 01:24:51,326 THE HISPANIC PARADOX HISPANIC 1856 01:24:51,326 --> 01:24:53,394 WERE AT GREATER RISK OF 1857 01:24:53,394 --> 01:24:56,164 MORTALITY. SOCIOECONOMIC STATUS 1858 01:24:56,164 --> 01:24:57,599 DIFFERENCES LARGELY EXPLAINED 1859 01:24:57,599 --> 01:24:59,334 THIS DISPARITY. WHEN ADJUSTED 1860 01:24:59,334 --> 01:25:03,571 FOR THE ANALYSIS, CO MORBIDITY 1861 01:25:03,571 --> 01:25:06,007 AND SYSTEMS WERE MORE PREDICTIVE 1862 01:25:06,007 --> 01:25:08,476 IN MORTALITIES. NEXT SLIDE. 1863 01:25:08,476 --> 01:25:09,677 WITHIN HISPANIC PARADOX, I 1864 01:25:09,677 --> 01:25:11,746 THINK WE HAVE A PARADOX. MANY 1865 01:25:11,746 --> 01:25:13,348 STUDIES THAT SUPPORTED HISPANIC 1866 01:25:13,348 --> 01:25:15,416 PARADOX ARE BASED ON DATA FROM 1867 01:25:15,416 --> 01:25:18,553 NATIONAL AND STATE VITAL 1868 01:25:18,553 --> 01:25:20,188 STATISTICS AND NATIONAL HEALTH 1869 01:25:20,188 --> 01:25:21,956 SERVICE, SO WHY DO WE HAVE THIS 1870 01:25:21,956 --> 01:25:24,392 PARADOX? I THINK IT WOULD BE A 1871 01:25:24,392 --> 01:25:25,627 MISCLASSIFICATION IN DEATH 1872 01:25:25,627 --> 01:25:27,896 RECORDS, HEALTH IN MIGRANT 1873 01:25:27,896 --> 01:25:29,264 EFFECT, JUST THE PEOPLE HEALTHY 1874 01:25:29,264 --> 01:25:31,232 ENOUGH TO TRAVEL COME TO THE 1875 01:25:31,232 --> 01:25:33,868 STATES, COULD BE THE SALMON BIAS 1876 01:25:33,868 --> 01:25:34,836 THAT TALKS ABOUT WHEN PATIENT 1877 01:25:34,836 --> 01:25:36,137 GETS SICK ENOUGH THEY WOULD 1878 01:25:36,137 --> 01:25:38,006 RATHER NOT DIE IN STATES SO GO 1879 01:25:38,006 --> 01:25:39,807 BACK TO THEIR ORIGIN COUNTRY, SO 1880 01:25:39,807 --> 01:25:43,611 WE ARE MISS ING THAT DEATH 1881 01:25:43,611 --> 01:25:46,748 RECORD OR SOCIAL-CULTURAL FACTS 1882 01:25:46,748 --> 01:25:49,951 RELATIVE TO HISPANIC. NEXT 1883 01:25:49,951 --> 01:25:50,184 SLIDES. 1884 01:25:50,184 --> 01:25:52,253 KEY QUESTIONS WILL BE HOW DO 1885 01:25:52,253 --> 01:25:54,088 WE CLASSIFY THESE GROUPS? HOW DO 1886 01:25:54,088 --> 01:25:57,358 WE NEED TO ADJUST AND ADAPT 1887 01:25:57,358 --> 01:26:00,295 REGISTRY, TRUE DISTINCTIONS 1888 01:26:00,295 --> 01:26:03,097 BETWEEN BIOLOGICAL AND SOCIAL 1889 01:26:03,097 --> 01:26:07,335 DETERMINANTS AND CONCENTRATE 1890 01:26:07,335 --> 01:26:13,741 OMIC PATTERNS WITHIN THIS? NEXT 1891 01:26:13,741 --> 01:26:17,912 SLIDE. P 1892 01:26:17,912 --> 01:26:19,247 THIS IS HOW WE UNPACK THIS. 1893 01:26:19,247 --> 01:26:23,217 TALK ABOUT THE COUNTRIES OF 1894 01:26:23,217 --> 01:26:23,651 BIR 1895 01:26:23,651 --> 01:26:25,553 BIRTH, CITIZEN STATUS, LANGUAGE 1896 01:26:25,553 --> 01:26:27,355 SPOKEN, SURVEY AND THIS IS FROM 1897 01:26:27,355 --> 01:26:29,123 RESEARCH AND EVALUATION FROM 1898 01:26:29,123 --> 01:26:30,325 WASHINGTON, TRYING TO UNPACK HOW 1899 01:26:30,325 --> 01:26:34,929 WE UNDERSTAND THESE COHORTS 1900 01:26:34,929 --> 01:26:36,297 BETTER. SO DR. HYDE WILL TALK 1901 01:26:36,297 --> 01:26:38,266 ABOUT THE NEXT INTERVENTIONS TO 1902 01:26:38,266 --> 01:26:40,201 ADDRESS DISPARITIES. WANT TO 1903 01:26:40,201 --> 01:26:41,402 LEAVE YOU WITH THIS LAST 1904 01:26:41,402 --> 01:26:43,338 THOUGHT. SO OUR GOAL SHOULD BE 1905 01:26:43,338 --> 01:26:45,873 TO PROVIDE A PRECISE FRAMEWORK 1906 01:26:45,873 --> 01:26:49,844 FOR CLASSIFYING RACE AND 1907 01:26:49,844 --> 01:26:50,611 ETHNICITY IN PULMONARY VASCULAR 1908 01:26:50,611 --> 01:26:56,184 RESEARCH THAT CAPTURES GENETIC 1909 01:26:56,184 --> 01:26:57,251 INFORMATION AND SOCIAL 1910 01:26:57,251 --> 01:26:58,453 DETERMINANTS TO ADDRESS THIS. I 1911 01:26:58,453 --> 01:26:59,821 WENT OVER THE TIME BUT 1912 01:26:59,821 --> 01:27:01,656 APPRECIATE THE TIME TO SPEND 1913 01:27:01,656 --> 01:27:02,924 WITH Y'ALL AND OPEN FOR 1914 01:27:02,924 --> 01:27:04,359 QUESTIONS AND DISCUSSIONS. 1915 01:27:04,359 --> 01:27:05,326 THANKS SO MUCH. 1916 01:27:05,326 --> 01:27:07,862 >> THANK YOU, DR. ESTRADA. THAT 1917 01:27:07,862 --> 01:27:11,132 WAS AN INCREDIBLE SUMMARY OF THE 1918 01:27:11,132 --> 01:27:13,501 DISPARITIES IN THE DIFFERENT 1919 01:27:13,501 --> 01:27:14,936 GROUPS. IT REALLY HIGHLIGHTS, I 1920 01:27:14,936 --> 01:27:18,339 THINK, SOME OF THE ISSUES THAT 1921 01:27:18,339 --> 01:27:21,542 WERE BROUGHT UP BY DR. KAY AND 1922 01:27:21,542 --> 01:27:22,977 MYSELF WITH REGARD TO 1923 01:27:22,977 --> 01:27:24,245 CLASSIFICATION. WE DON'T HAVE A 1924 01:27:24,245 --> 01:27:26,147 LOT OF TIME FOR QUESTIONS RIGHT 1925 01:27:26,147 --> 01:27:28,316 NOW, JUST A COUPLE MINUTES. WHAT 1926 01:27:28,316 --> 01:27:29,784 I'M GOING TO DO IS MOVE ON TO 1927 01:27:29,784 --> 01:27:32,053 THE NEXT TALK. THEN WE WILL HAVE 1928 01:27:32,053 --> 01:27:33,421 20 MINUTES TO DISCUSS SOME OF 1929 01:27:33,421 --> 01:27:35,323 THE QUESTIONS. I'M SURE THERE 1930 01:27:35,323 --> 01:27:38,159 ARE LOTS OF QUESTIONS THAT ARE 1931 01:27:38,159 --> 01:27:41,896 STARTING TO POP UP. SO WITH THAT 1932 01:27:41,896 --> 01:27:46,100 LET'S MOVE ON TO INTERVENTIONS 1933 01:27:46,100 --> 01:27:50,171 WITH RACE, ETHNICITY AND 1934 01:27:50,171 --> 01:27:52,707 IMPLEMENTATION BY DR. SAHAY. 1935 01:27:52,707 --> 01:27:55,009 >> THANKS, EVERYONE. THANKS 1936 01:27:55,009 --> 01:27:56,744 ORGANIZERS FOR INVITING ME HERE 1937 01:27:56,744 --> 01:28:01,816 TO DISCUSS THIS INTERESTING 1938 01:28:01,816 --> 01:28:07,055 TOPIC. SOME OF THE THINGS ARE 1939 01:28:07,055 --> 01:28:09,424 DISCUSSED BY THE PREVIOUS TWO 1940 01:28:09,424 --> 01:28:11,225 SPEAKERS. I WILL TRY TO GO 1941 01:28:11,225 --> 01:28:14,295 QUICKLY FROM THEM BUT HIGHLIGHT 1942 01:28:14,295 --> 01:28:19,667 AREAS WE CAN WORK ON TOGETHER TO 1943 01:28:19,667 --> 01:28:20,935 IMPROVE REPRESENTATION OF 1944 01:28:20,935 --> 01:28:23,738 RESEARCH AND IMPROVE CARE OF THE 1945 01:28:23,738 --> 01:28:24,405 PATIENTS. NEXT SLIDE. 1946 01:28:24,405 --> 01:28:29,077 THESE ARE MY DISCLOSURES. 1947 01:28:29,077 --> 01:28:31,979 NEXT SLIDE. LET'S FIRST CLARIFY 1948 01:28:31,979 --> 01:28:35,049 SOME OF THE TERMINOLOGY WE ARE 1949 01:28:35,049 --> 01:28:36,417 DISCUSSING SINCE MORNING IN 1950 01:28:36,417 --> 01:28:38,286 DIFFERENT TALKS. NEXT SLIDE. 1951 01:28:38,286 --> 01:28:40,822 SO WHAT ARE WE REALLY 1952 01:28:40,822 --> 01:28:44,358 UNDERSTAND BY RACE, ETHNICITY 1953 01:28:44,358 --> 01:28:45,493 AND DISPARITIES AND SOCIAL 1954 01:28:45,493 --> 01:28:46,227 DETERMINANTS OF HEALTH? I WILL 1955 01:28:46,227 --> 01:28:50,565 GO ONE-BY-ONE ON EACH OF THESE. 1956 01:28:50,565 --> 01:28:51,232 NEXT SLIDE. 1957 01:28:51,232 --> 01:28:54,001 SO THE FIRST DESCRIPTION OF 1958 01:28:54,001 --> 01:28:56,938 RACE ACTUALLY STARTED IN AROUND 1959 01:28:56,938 --> 01:29:02,677 THE 15TH CENTURY, BUT FORMALLY 1960 01:29:02,677 --> 01:29:12,687 DOCUMENTED BY THE SWEDISH 1961 01:29:12,687 --> 01:29:13,521 TOKSTOK 1962 01:29:13,521 --> 01:29:15,323 TAXONOMIST. EUROPEANS ARE FAIR, 1963 01:29:15,323 --> 01:29:19,060 GENTLE, ACUTE. AMERICANS 1964 01:29:19,060 --> 01:29:20,995 COPPER-COLORED, OBSTINATE. 1965 01:29:20,995 --> 01:29:26,868 ASIAN, SOOTY, SEVERE, HAUGHTY... 1966 01:29:26,868 --> 01:29:29,437 IT IS WHAT DIFFERENCE RACES 1967 01:29:29,437 --> 01:29:32,974 MEANS HERE AND LET'S GO TO THE 1968 01:29:32,974 --> 01:29:38,880 NEXT SLIDE. THIS IS PART OF THE 1969 01:29:38,880 --> 01:29:45,853 DISCUSSED BY JOHANN BLUMENBACH, 1970 01:29:45,853 --> 01:29:48,489 AROUND 17TH AND 18TH CENTURY, 1971 01:29:48,489 --> 01:29:56,330 DEFINED IT MORTGAGEE GRAPHI-- 1972 01:29:56,330 --> 01:29:57,331 GEOGRAPHICALLY AND HE WAS THE 1973 01:29:57,331 --> 01:30:00,201 FIRST TO USE THE TERM CAUCASIAN, 1974 01:30:00,201 --> 01:30:01,536 DESCRIBED THEM AS BEAUTIFUL 1975 01:30:01,536 --> 01:30:04,272 PEOPLE. REST DEPENDING WHERE THE 1976 01:30:04,272 --> 01:30:10,144 REGION THEY BELONGED TO. NEXT 1977 01:30:10,144 --> 01:30:12,046 SLIDE. TECHNICALLY, THERE IS NOT 1978 01:30:12,046 --> 01:30:14,448 REALLY A LOT OF EVIDENCE AND 1979 01:30:14,448 --> 01:30:16,784 DATA THAT THE RACE IS 1980 01:30:16,784 --> 01:30:20,655 GENETICALLY DIVERSE. RACES IN 1981 01:30:20,655 --> 01:30:29,797 21ST CENTURY ARE A 1982 01:30:29,797 --> 01:30:31,566 SOCIO-POLITICAL CONSTRUCT AND 1983 01:30:31,566 --> 01:30:34,268 DOES NOT HAVE A SCIENTIFIC OR 1984 01:30:34,268 --> 01:30:39,006 BIOLOGICAL BASIS. WHAT IS AN 1985 01:30:39,006 --> 01:30:42,843 ETHNICITY, IT IS A CONCEPT TO 1986 01:30:42,843 --> 01:30:47,048 IDENTIFY INDIVIDUAL PEOPLE OR 1987 01:30:47,048 --> 01:30:48,182 POPULATION, REFERENCE TO 1988 01:30:48,182 --> 01:30:50,685 LANGUAGE, ATTRIBUTES OR 1989 01:30:50,685 --> 01:30:52,653 RELIGION. RACE AND ETHNICITY MAY 1990 01:30:52,653 --> 01:30:58,926 OVERLAP BUT ON THE PHENOTYPE 1991 01:30:58,926 --> 01:31:00,728 RELATED TO ETHNICITY. LIKE RACE 1992 01:31:00,728 --> 01:31:04,632 IT IS A SOCIAL CONSTRUCT WITH NO 1993 01:31:04,632 --> 01:31:06,734 BIOLOGICAL BASIS. NEXT SLIDE. 1994 01:31:06,734 --> 01:31:07,802 WHEN WE TALK ABOUT 1995 01:31:07,802 --> 01:31:08,736 DISPARITIES WHAT DO WE 1996 01:31:08,736 --> 01:31:11,973 UNDERSTAND? THIS IS FROM THE NIH 1997 01:31:11,973 --> 01:31:14,709 BACK IN 2014. HEALTH DISPARITIES 1998 01:31:14,709 --> 01:31:17,178 ARE DIFFERENCES THAT EXIST AMONG 1999 01:31:17,178 --> 01:31:18,379 SPECIFIC POPULATION IN 2000 01:31:18,379 --> 01:31:19,847 ATTAINMENT OF FULL HEALTH 2001 01:31:19,847 --> 01:31:22,583 POTENTIAL THAT CAN BE MEASURED 2002 01:31:22,583 --> 01:31:23,584 BY DIFFERENCES IN INCIDENCE, 2003 01:31:23,584 --> 01:31:25,519 PREF LANCE, MORTALITY, BURDEN OF 2004 01:31:25,519 --> 01:31:28,089 DISEASE AND OTHER ADVERSE HEALTH 2005 01:31:28,089 --> 01:31:29,957 CONDITIONS. WHILE THE TERM OFTEN 2006 01:31:29,957 --> 01:31:32,960 USED OR INTERPRETED TO REFLECT 2007 01:31:32,960 --> 01:31:33,995 DIFFERENCES BETWEEN RACIAL OR 2008 01:31:33,995 --> 01:31:36,130 ETHNIC GROUPS, DISPARITIES CAN 2009 01:31:36,130 --> 01:31:38,199 EXIST ACROSS MANY OTHER 2010 01:31:38,199 --> 01:31:39,600 DIMENSIONS SUCH AS GENDER, 2011 01:31:39,600 --> 01:31:42,903 SEXUAL ORIENTATION, AGE, 2012 01:31:42,903 --> 01:31:45,206 DISABILITY STATUS, SOCIOECONOMIC 2013 01:31:45,206 --> 01:31:47,041 AND GEOGRAPHIC LOCATION. WE WILL 2014 01:31:47,041 --> 01:31:50,044 TOUCH ON SOME DURING THESE 2015 01:31:50,044 --> 01:31:52,546 TWO-DAYS WORKSHOP. NEXT SLIDE. 2016 01:31:52,546 --> 01:31:54,115 WHAT IS SOCIAL DETERMINANTS 2017 01:31:54,115 --> 01:31:57,218 OF HEALTH? ACCORDING TO THE WHO 2018 01:31:57,218 --> 01:31:59,053 ARE DEFINED AS CIRCUMSTANCES IN 2019 01:31:59,053 --> 01:32:01,722 WHICH HUMANS ARE BORN, DEVELOP, 2020 01:32:01,722 --> 01:32:05,159 LIVE, EARN AND AGE. IN THE 2021 01:32:05,159 --> 01:32:06,294 INTERNATIONAL REGIONAL, STATE OR 2022 01:32:06,294 --> 01:32:07,762 LOCAL LEVEL, THE DISTRIBUTION OF 2023 01:32:07,762 --> 01:32:11,932 MONEY, POWER AND RESOURCES SHAPE 2024 01:32:11,932 --> 01:32:14,001 THESE CIRCUMSTANCES. NEXT SLIDE. 2025 01:32:14,001 --> 01:32:19,573 WHAT DO WE KNOW ABOUT HEALTH 2026 01:32:19,573 --> 01:32:21,942 DISPARITIES RELATED TO RACE, 2027 01:32:21,942 --> 01:32:25,913 ETHNICITY IN PAH? ACTUALLY, NOT 2028 01:32:25,913 --> 01:32:30,618 ENOUGH. NEXT. I THINK DR. GOEL 2029 01:32:30,618 --> 01:32:32,486 AND DR. ESTRADA COVERED A LITTLE 2030 01:32:32,486 --> 01:32:33,587 BIT. I'M NOT GOING SPEND TOO 2031 01:32:33,587 --> 01:32:34,288 MUCH TIME . 2032 01:32:34,288 --> 01:32:37,625 THE MESSAGE IS CLEAR THAT 2033 01:32:37,625 --> 01:32:39,260 DIFFERENT HISTORIES AND 2034 01:32:39,260 --> 01:32:41,028 DIFFERENT TRIALS OVER THE YEARS 2035 01:32:41,028 --> 01:32:46,634 ARE OVER-REPRESENTED BY THE WIDE 2036 01:32:46,634 --> 01:32:46,934 POPULATION . 2037 01:32:46,934 --> 01:32:51,105 THE REAL PH, THE SCIENTIFIC 2038 01:32:51,105 --> 01:32:53,174 REGISTRY, FAR REGISTRY AND 2039 01:32:53,174 --> 01:32:54,942 DIFFERENT TRIALS ARE 2040 01:32:54,942 --> 01:32:57,511 PREDOMINANTLY OVER-REPRESENTED 2041 01:32:57,511 --> 01:33:00,648 BY THE WHITE POPULATION, 2042 01:33:00,648 --> 01:33:02,983 INDICATED BY THE BLUE BARS IN 2043 01:33:02,983 --> 01:33:05,619 THESE FIGURES. NEXT SLIDE. 2044 01:33:05,619 --> 01:33:08,689 AGAIN, THE MESSAGE CONTINUES 2045 01:33:08,689 --> 01:33:12,526 SINCE THE FIRST INITIAL ORAL 2046 01:33:12,526 --> 01:33:15,930 THERAPY (?) PREDOMINANTLY WHITE 2047 01:33:15,930 --> 01:33:19,633 AND THESE ARE PREDOMINANTLY 2048 01:33:19,633 --> 01:33:24,972 WHITE. NEXT SLIDE. 2049 01:33:24,972 --> 01:33:28,042 NOTHING HAS REALLY CHANGED 2050 01:33:28,042 --> 01:33:29,844 OVER THE LAST TWO DECADES. THAT 2051 01:33:29,844 --> 01:33:31,812 IS SOMETHING WHAT WE SHOULD BE 2052 01:33:31,812 --> 01:33:33,347 DISCUSSING TODAY, WHY THESE 2053 01:33:33,347 --> 01:33:36,884 CLINICAL TRIALS HAVE REMAINED 2054 01:33:36,884 --> 01:33:43,791 THE SAME, WERE ENROLLING EVEN IN 2055 01:33:43,791 --> 01:33:44,392 2024, STARTING BACK IN 2000. 2056 01:33:44,392 --> 01:33:44,725 NEXT SLIDE. 2057 01:33:44,725 --> 01:33:46,494 THIS STORY IS NOT RELATED TO 2058 01:33:46,494 --> 01:33:48,896 PH BUT IF YOU LOOK, THIS IS THE 2059 01:33:48,896 --> 01:33:52,032 DATA FROM THE FDA IN 2020. THIS 2060 01:33:52,032 --> 01:33:54,402 IS DATA FROM ALL THE TRIAL DATA 2061 01:33:54,402 --> 01:33:57,071 WHICH WAS PRESENTED TO FDA IN 2062 01:33:57,071 --> 01:34:01,575 2020. YOU WILL SEE THAT 75% OF 2063 01:34:01,575 --> 01:34:03,444 PATIENTS WERE WHITE. SO THIS 2064 01:34:03,444 --> 01:34:05,913 ISSUE IS NOT RELATED TO THE PH 2065 01:34:05,913 --> 01:34:08,549 CLINICAL TRIALS BUT IN GENERAL 2066 01:34:08,549 --> 01:34:10,651 RELATED TO THE WAY WE CONDUCT 2067 01:34:10,651 --> 01:34:14,021 OUR RESEARCH, AT LEAST IN THE 2068 01:34:14,021 --> 01:34:18,959 UNITED STATES. NEXT SLIDE. IF 2069 01:34:18,959 --> 01:34:21,762 YOU FOCUS ON THE PULMONARY 2070 01:34:21,762 --> 01:34:24,198 HYPERTENSION, THE OLDER DATA, 2071 01:34:24,198 --> 01:34:28,903 FROM' 79 TO' 96 WHEN TERM FOR 2072 01:34:28,903 --> 01:34:32,006 HYPERTENSION WAS USED. AGAIN THE 2073 01:34:32,006 --> 01:34:32,640 AFRICAN-AMERICAN BLACK PEOPLE 2074 01:34:32,640 --> 01:34:36,177 HAD HIGHER MORTALITY IN 1980 TO 2075 01:34:36,177 --> 01:34:39,280 2002 DATA, SHOWING THAT PRIMARY 2076 01:34:39,280 --> 01:34:41,348 AND SECONDARY PULMONARY 2077 01:34:41,348 --> 01:34:42,817 HYPERTENSION, HIGHER MORTALITY 2078 01:34:42,817 --> 01:34:44,118 IN AFRICAN-AMERICAN POPULATION. 2079 01:34:44,118 --> 01:34:46,253 I'M NOT GOING INTO DETAIL 2080 01:34:46,253 --> 01:34:47,588 BECAUSE DR. ESTRADA WENT INTO 2081 01:34:47,588 --> 01:34:48,823 QUITE BIT OF DETAIL DISCUSSING 2082 01:34:48,823 --> 01:34:52,993 THESE TOPICS. GO AHEAD, NEXT 2083 01:34:52,993 --> 01:34:53,294 SLIDE. 2084 01:34:53,294 --> 01:34:55,796 AGAIN, IF WE LOOK AT MORE 2085 01:34:55,796 --> 01:34:57,731 CONTEMPORARY DATA, AGAIN IT IS 2086 01:34:57,731 --> 01:34:59,467 SHOWING THAT NON-HISPANIC BLACK 2087 01:34:59,467 --> 01:35:00,701 PATIENT, THIS IS THE U.S. 2088 01:35:00,701 --> 01:35:02,403 EPIDEMIOLOGICAL DATA AGAIN 2089 01:35:02,403 --> 01:35:05,005 SHOWING THE HIGHER MORTALITY IN 2090 01:35:05,005 --> 01:35:06,774 NON-HISPANIC BLACK PATIENT 2091 01:35:06,774 --> 01:35:08,742 POPULATION. THIS IS AGNOSTIC TO 2092 01:35:08,742 --> 01:35:10,411 PH; THIS IS TALKING GENERAL 2093 01:35:10,411 --> 01:35:14,148 DISEASE AND MORTALITY DATA IN 2094 01:35:14,148 --> 01:35:15,115 THE UNITED STATES. NEXT SLIDE. 2095 01:35:15,115 --> 01:35:17,985 SO WE TRY TO ASSESS THIS IN 2096 01:35:17,985 --> 01:35:19,553 THE REVEAL REGISTRY AND 2097 01:35:19,553 --> 01:35:21,055 PUBLISHED THIS PAPER A FEW YEARS 2098 01:35:21,055 --> 01:35:22,890 AGO, WHERE WE WANTED TO ASSESS 2099 01:35:22,890 --> 01:35:26,327 THE IMPACT OF RACE ON THE 2100 01:35:26,327 --> 01:35:30,831 SURVIVAL IN PH. WE DID NOT FIND 2101 01:35:30,831 --> 01:35:33,133 ANY SIGNIFICANT DIFFERENCE IN 2102 01:35:33,133 --> 01:35:35,970 THE SURVIVAL WHEN ADJUSTED FOR 2103 01:35:35,970 --> 01:35:41,542 AGE, SUBTYPE AND TIME FOR 2104 01:35:41,542 --> 01:35:44,979 DIAGNOSIS. I THINK ROBERTO'S 2105 01:35:44,979 --> 01:35:46,680 PAPER DID NOT FIND SIGNIFICANT 2106 01:35:46,680 --> 01:35:49,183 DIFFERENCE IN HISPANIC MORTALITY 2107 01:35:49,183 --> 01:35:50,484 VERSUS OTHERS AFTER THE 2108 01:35:50,484 --> 01:35:53,053 ADJUSTING FOR VARIABLES. NEXT 2109 01:35:53,053 --> 01:35:53,654 SLIDE. 2110 01:35:53,654 --> 01:35:55,222 HOWEVER, THERE WERE CERTAIN 2111 01:35:55,222 --> 01:35:58,726 OBSERVATIONS IN THIS ANALYSIS 2112 01:35:58,726 --> 01:36:01,795 THAT THE ERAs WERE LOWER USED IN 2113 01:36:01,795 --> 01:36:03,264 HISPANIC PATIENTS. NOT EXACTLY 2114 01:36:03,264 --> 01:36:05,533 CLEAR WHY. ONE OF THE 2115 01:36:05,533 --> 01:36:07,735 ASSUMPTIONS WAS BECAUSE THEY HAD 2116 01:36:07,735 --> 01:36:10,905 MORE HYPERTENSION, PERHAPS ERA 2117 01:36:10,905 --> 01:36:13,274 WAS LESS USED, AFRICAN-AMERICAN 2118 01:36:13,274 --> 01:36:17,444 PEOPLE HAD LESS USE OF 2119 01:36:17,444 --> 01:36:22,983 PHOSPHOROUS DIESTERASE INHIBITOR 2120 01:36:22,983 --> 01:36:26,053 AND LESS USED IN THIS ANALYSIS. 2121 01:36:26,053 --> 01:36:26,487 NEXT SLIDE. 2122 01:36:26,487 --> 01:36:28,455 THIS IS ANOTHER 2123 01:36:28,455 --> 01:36:31,458 SINGLE-CENTER STUDY, MAINLY 2124 01:36:31,458 --> 01:36:37,731 FOCUSED ON IDIOPATHIC AND 2125 01:36:37,731 --> 01:36:47,474 ANOREXIG E /* EN PATIENTS. MORE 2126 01:36:47,474 --> 01:36:48,576 CONFLICTS WITH THIS RESEARCH, 2127 01:36:48,576 --> 01:36:51,378 THE MORE YOU WILL FIND. THAT 2128 01:36:51,378 --> 01:36:55,182 SHOULD BE THOUGHT-PROVOKING SO 2129 01:36:55,182 --> 01:36:56,183 CLEARLY HERE THE 2130 01:36:56,183 --> 01:36:57,551 AFRICAN-AMERICAN AND 2131 01:36:57,551 --> 01:37:00,988 ASIAN-AMERICAN SHOWED HIGHER 2132 01:37:00,988 --> 01:37:02,890 MORTALITY. NEXT SLIDE. 2133 01:37:02,890 --> 01:37:07,194 THIS IS FROM THE PHAR 2134 01:37:07,194 --> 01:37:10,898 REGISTRY, I THINK FROM ROBERTO'S 2135 01:37:10,898 --> 01:37:14,501 PAPER. FOCUSSING ON THE HISPANIC 2136 01:37:14,501 --> 01:37:15,703 POPULATION COMPARED TO THE 2137 01:37:15,703 --> 01:37:19,139 ACCESS TO HEALTH CARE, LOWER 2138 01:37:19,139 --> 01:37:27,548 EDUCATION LEVEL, INCOME. THIS IS 2139 01:37:27,548 --> 01:37:30,951 DESPITE HAVING SIMILAR DISEASE 2140 01:37:30,951 --> 01:37:34,221 SIMILARITY. NEXT SLIDE. BUT AS I 2141 01:37:34,221 --> 01:37:38,792 MENTIONED EARLIER THE ADJUSTED 2142 01:37:38,792 --> 01:37:41,428 MORTALITY ANALYSIS DID NOT FIND 2143 01:37:41,428 --> 01:37:43,230 DIFFERENCE IN THE HISPANIC 2144 01:37:43,230 --> 01:37:44,131 POPULATION. NEXT SLIDE. 2145 01:37:44,131 --> 01:37:47,368 THIS WAS A NICELY DONE STUDY 2146 01:37:47,368 --> 01:37:48,469 FROM CHINA WHERE THEY ACTUALLY 2147 01:37:48,469 --> 01:37:50,871 WANTED TO ASSESS THE IMPACT OF 2148 01:37:50,871 --> 01:37:53,641 THE SOCIOECONOMIC STATUS. AS YOU 2149 01:37:53,641 --> 01:37:55,342 CAN SEE IN THESE FIGURES, A 2150 01:37:55,342 --> 01:38:01,081 WHERE THEY ADJUSTED IT FOR THE 2151 01:38:01,081 --> 01:38:03,851 AGE, SEX, B IS AGE, SEX, 2152 01:38:03,851 --> 01:38:06,153 FUNCTION, CLASS AND PVR THEN 2153 01:38:06,153 --> 01:38:11,158 AGE, SEX, FUNCTION CLASS, PVR 2154 01:38:11,158 --> 01:38:17,131 AND THE PDE5A AND AFFECTED THE 2155 01:38:17,131 --> 01:38:20,567 SURVIVAL IN THE CENTER IN CHINA. 2156 01:38:20,567 --> 01:38:22,436 PUBLISHED IN A JOURNAL. I THINK 2157 01:38:22,436 --> 01:38:25,139 THIS IS ONE OF THE ONLY STUDY I 2158 01:38:25,139 --> 01:38:29,109 I COULD FIND WHERE SOCIOECONOMIC 2159 01:38:29,109 --> 01:38:35,849 STATUS IMPLICATING SURVIVAL OF 2160 01:38:35,849 --> 01:38:36,617 PAH. NEXT SLIDE. 2161 01:38:36,617 --> 01:38:38,852 NOW WHAT IS THE REASON THAT 2162 01:38:38,852 --> 01:38:41,321 WHY WE ARE SEEING THESE ISSUES 2163 01:38:41,321 --> 01:38:44,491 THAT WE ARE NOT ABLE TO SEE MUCH 2164 01:38:44,491 --> 01:38:48,228 OF THE PRESENTATION OF THER 2165 01:38:48,228 --> 01:38:50,197 RACES IN THE CLINICAL TRIALS? 2166 01:38:50,197 --> 01:38:53,033 I'M GOING TO -- IN THE NEXT FEW 2167 01:38:53,033 --> 01:38:54,568 SLIDES I'M GOING TO TALK SOME OF 2168 01:38:54,568 --> 01:38:57,037 THESE AREAS AND SOME OF THESE 2169 01:38:57,037 --> 01:38:58,639 POINTS WILL BE PROVOCATIVE TO 2170 01:38:58,639 --> 01:39:01,075 THINK AND THE REALITY OF OUR 2171 01:39:01,075 --> 01:39:03,811 LIVES. THERE MAY BE A PERCEIVED 2172 01:39:03,811 --> 01:39:05,979 PERSONAL RISK OR FEAR, TRUST IN 2173 01:39:05,979 --> 01:39:08,782 MEDICAL COMMUNITY, ETHNIC OR 2174 01:39:08,782 --> 01:39:10,384 CULTURAL BACKGROUND OR DIVERSITY 2175 01:39:10,384 --> 01:39:12,019 IN HEALTH CARE. I'M SURE 2176 01:39:12,019 --> 01:39:15,222 EVERYONE WHO IS PRESENT HERE IS 2177 01:39:15,222 --> 01:39:19,326 FAMILIAR ABOUT THE TUSKEGEE 2178 01:39:19,326 --> 01:39:21,762 STUDY, WHERE THE 100 2179 01:39:21,762 --> 01:39:23,330 AFRICAN-AMERICAN PEOPLE, MALES 2180 01:39:23,330 --> 01:39:26,333 ACTUALLY, DIED DURING THE PERIOD 2181 01:39:26,333 --> 01:39:29,603 OF THIS STUDY. AS YOU MAY KNOW 2182 01:39:29,603 --> 01:39:32,072 PENICILLIN WAS APPROVED IN 1947 2183 01:39:32,072 --> 01:39:38,011 BUT THEY WERE INJECTED WITH THE 2184 01:39:38,011 --> 01:39:41,048 SYPHILIS AND -- THE ORGANISM, 2185 01:39:41,048 --> 01:39:43,517 NOT TREATED AND OBSERVED FOR THE 2186 01:39:43,517 --> 01:39:45,486 NATURAL PROGRESSION OF THE 2187 01:39:45,486 --> 01:39:48,589 DISEASE. THE STUDY ACTUALLY 2188 01:39:48,589 --> 01:39:53,026 CONTINUED UNTIL 1972. CLEARLY 2189 01:39:53,026 --> 01:39:57,364 STUDIES LIKE THIS LEADS TO THE 2190 01:39:57,364 --> 01:39:59,967 MISTRUST IN HEALTH CARE IN 2191 01:39:59,967 --> 01:40:03,003 GENERAL AND CLINICAL RESEARCH. 2192 01:40:03,003 --> 01:40:03,570 NEXT SLIDE. 2193 01:40:03,570 --> 01:40:07,007 I WOULD ALSO WANT TO 2194 01:40:07,007 --> 01:40:15,783 HIGHLIGHT THIS STUDY, FROM JOHNS 2195 01:40:15,783 --> 01:40:24,558 HOPKINS. HENRY HENRIETTA LACKS, 2196 01:40:24,558 --> 01:40:26,660 WHERE THE BIO COMPANIES 2197 01:40:26,660 --> 01:40:28,028 BENEFITTED, NEVER GAVE CONSENT, 2198 01:40:28,028 --> 01:40:33,467 DIED AT 31, FAMILY NEVER 2199 01:40:33,467 --> 01:40:36,870 COMPENSATED. IN 2020 FINALLY 2200 01:40:36,870 --> 01:40:38,305 JOHNS HOPKINS HAD SORT OF LIKE A 2201 01:40:38,305 --> 01:40:42,776 DEAL OR CONTRACT WITH HER FAMILY 2202 01:40:42,776 --> 01:40:45,245 MEMBERS, CAME UP -- AND NIH WAS 2203 01:40:45,245 --> 01:40:48,982 INVOLVED TO APPROVE THE RESULTS 2204 01:40:48,982 --> 01:40:50,350 OF WHATEVER RESEARCH THEY HAD 2205 01:40:50,350 --> 01:40:51,819 CONDUCTED OVER THE YEARS. SO 2206 01:40:51,819 --> 01:40:56,623 THESE ARE THE STORIES WHICH ARE 2207 01:40:56,623 --> 01:40:58,625 REAL LIFE AND NOT REALLY OLD. 2208 01:40:58,625 --> 01:41:01,295 THIS CENTURY, THE LAST FEW 2209 01:41:01,295 --> 01:41:02,896 YEARS. MANY OF US WERE PROBABLY 2210 01:41:02,896 --> 01:41:05,432 BORN WHEN THESE STUDIES WERE 2211 01:41:05,432 --> 01:41:06,934 ONGOING, SO THEY DEFINITELY LEAD 2212 01:41:06,934 --> 01:41:10,370 TO LACK OF TRUST IN THE HEALTH 2213 01:41:10,370 --> 01:41:19,146 CARE SYSTEM. NEXT SLIDE. 2214 01:41:19,146 --> 01:41:21,315 THIS IS SOMETHING I WANT TO 2215 01:41:21,315 --> 01:41:24,051 SHOW CONTEMPORARY, CURRENTLY 2216 01:41:24,051 --> 01:41:29,022 WHAT WE ARE DOING IN THIS 2217 01:41:29,022 --> 01:41:33,060 EXAMINATION SURVEY. I WANT TO 2218 01:41:33,060 --> 01:41:34,661 SHOW YOU THE GRAY BOX. I DON'T 2219 01:41:34,661 --> 01:41:36,597 KNOW IF YOU CAN SEE MY CURSOR, 2220 01:41:36,597 --> 01:41:41,969 BUT THE NON-HISPANIC BLACK HAVE 2221 01:41:41,969 --> 01:41:42,970 SIGNIFICANTLY HIGHER OBESITY, 2222 01:41:42,970 --> 01:41:50,010 MALES AND FEMALES, 49 FOR MALES, 2223 01:41:50,010 --> 01:41:50,344 56 2224 01:41:50,344 --> 01:41:52,412 56.9 IN BLACK WOMEN. WHEN WE ARE 2225 01:41:52,412 --> 01:41:53,981 DESIGNING OUR CLINICAL TRIAL 2226 01:41:53,981 --> 01:41:56,416 PROTOCOLS, HOW ARE WE USING OUR 2227 01:41:56,416 --> 01:41:58,352 INCLUSION CRITERIA WITH 2228 01:41:58,352 --> 01:42:01,755 SYSTEMATICALLY EXCLUDE THESE 2229 01:42:01,755 --> 01:42:02,222 PATIENTS. NEXT SLIDE 2230 01:42:02,222 --> 01:42:04,391 THIS IS ONE OF THE EXAMPLES 2231 01:42:04,391 --> 01:42:07,527 I WANT TO PUT IT THERE. THE 2232 01:42:07,527 --> 01:42:10,998 SERAPHIN STUDY USED A BMI CUT OF 2233 01:42:10,998 --> 01:42:14,468 30. THIS IS THE U.S. DATA WHERE 2234 01:42:14,468 --> 01:42:18,205 THE OBESITY IS DEFINED BMI30. IF 2235 01:42:18,205 --> 01:42:20,574 YOU PUT 30 AUTOMATICALLY YOU ARE 2236 01:42:20,574 --> 01:42:21,375 EXCLUDING THE BLACK PATIENT 2237 01:42:21,375 --> 01:42:22,743 POPULATION. THAT IS ONE OF THE 2238 01:42:22,743 --> 01:42:24,778 REASON YOU ARE NOT ABLE TO SEE 2239 01:42:24,778 --> 01:42:26,880 THESE PATIENTS IN YOUR CLINICAL 2240 01:42:26,880 --> 01:42:33,887 TRIALS. I'M NOT SAY ING THIS IS 2241 01:42:33,887 --> 01:42:39,192 THE ONLY REASON BUT 2242 01:42:39,192 --> 01:42:49,736 COMORBIDITIES IS A BIG FACTOR. I 2243 01:42:52,806 --> 01:42:54,107 WANT TO HIGHLIGHT THE 2244 01:42:54,107 --> 01:42:57,611 COMORBIDITY, THE PREF LANCE OF 2245 01:42:57,611 --> 01:43:03,116 -- THIS IS FROM CDC. THE 2246 01:43:03,116 --> 01:43:07,454 PREVALANCE IS HIGHER IN BLACK 2247 01:43:07,454 --> 01:43:17,998 SIGNIFICANTLY THAN WHITE. SO IF 2248 01:43:18,498 --> 01:43:20,200 YOU HAVE LESS THAN 70, THIS IS 2249 01:43:20,200 --> 01:43:24,705 FROM OUR DATA THAT 33% WERE 2250 01:43:24,705 --> 01:43:26,306 INELIGIBLE BECAUSE OF THE (?) 2251 01:43:26,306 --> 01:43:27,874 LESS THAN 70. POINT I'M TRYING 2252 01:43:27,874 --> 01:43:30,344 TO HIGHLIGHT, IF WE ARE GOING TO 2253 01:43:30,344 --> 01:43:32,412 HAVE SUCH INCLUSION OF 2254 01:43:32,412 --> 01:43:34,514 EXCLUSIONARY CRITERIA WE ARE 2255 01:43:34,514 --> 01:43:35,582 AUTOMATICALLY GOING DISQUALIFY 2256 01:43:35,582 --> 01:43:38,352 BLACK POPULATION. SIMILARLY IN 2257 01:43:38,352 --> 01:43:42,756 THE GRIFFIN, SERAPHIN AND 2258 01:43:42,756 --> 01:43:44,825 CUT-OFF 85% WILL AUTOMATICALLY 2259 01:43:44,825 --> 01:43:45,993 EXCLUDE BLACK POPULATION. THIS 2260 01:43:45,993 --> 01:43:48,795 IS FROM MY CENTER DATA, AROUND 2261 01:43:48,795 --> 01:43:51,665 350 PATIENTS, WHEN APPLIED 2262 01:43:51,665 --> 01:43:53,533 INCLUSION-EXCLUSION CRITERIA ON 2263 01:43:53,533 --> 01:43:57,004 THE REAL WORLD PH POPULATION WE 2264 01:43:57,004 --> 01:44:05,212 EXTRUDED THESE. I HAVE NOT GONE 2265 01:44:05,212 --> 01:44:07,047 IN BUT QUITE CONFIDENT WE WILL 2266 01:44:07,047 --> 01:44:10,884 FIND SIMILAR RESULTS. THIS IS AN 2267 01:44:10,884 --> 01:44:11,918 ONGOING ANALYSIS. NEXT SLIDE. 2268 01:44:11,918 --> 01:44:14,488 SO WHAT ARE THE OTHER 2269 01:44:14,488 --> 01:44:16,223 FACTORS OF LACK OF HEALTH, 2270 01:44:16,223 --> 01:44:17,524 EDUCATION AND KNOWLEDGE OF 2271 01:44:17,524 --> 01:44:18,992 CLINICAL TRIALS, TIME 2272 01:44:18,992 --> 01:44:20,794 COMMITMENT, COST OF 2273 01:44:20,794 --> 01:44:22,863 PARTICIPATION, EDUCATION LEVEL, 2274 01:44:22,863 --> 01:44:23,930 SOCIOECONOMIC STATUS AND 2275 01:44:23,930 --> 01:44:25,599 INSTITUTIONAL BARRIERS? I WILL 2276 01:44:25,599 --> 01:44:26,700 DISCUSS THOSE IN A MINUTE ABOUT 2277 01:44:26,700 --> 01:44:28,935 THE INSTITUTIONAL BARRIER 2278 01:44:28,935 --> 01:44:30,871 BECAUSE THAT IS SOMETHING WHICH 2279 01:44:30,871 --> 01:44:33,473 I EXPERIENCED AT MY INSTITUTE 2280 01:44:33,473 --> 01:44:36,843 AND HAVE TRIED TO HELP TO SOME 2281 01:44:36,843 --> 01:44:47,387 EXTENT BUT NOT COMPLETELY. NEXT 2282 01:44:49,256 --> 01:44:56,496 SLIDE. PRSO WHAT GUIDING THIS? 2283 01:44:56,496 --> 01:45:00,834 CERTAIN BIOLOGICAL DIFFERENCES 2284 01:45:00,834 --> 01:45:02,235 WHICH MAY CONTRIBUTE, 2285 01:45:02,235 --> 01:45:04,805 INFLUENCING TO THE TREATMENT. I 2286 01:45:04,805 --> 01:45:06,940 THINK DR. ESTRADA AND GOEL 2287 01:45:06,940 --> 01:45:08,542 HIGHLIGHTED THE (?) OVER 2288 01:45:08,542 --> 01:45:09,776 EXPRESSED IN AFRICAN-AMERICAN 2289 01:45:09,776 --> 01:45:12,446 POPULATION BUT BLUNTED RESPONSE 2290 01:45:12,446 --> 01:45:14,581 WITH THE ER, I THINK THOSE COULD 2291 01:45:14,581 --> 01:45:16,683 BE VARIATIONS WHICH WE THINK 2292 01:45:16,683 --> 01:45:19,052 RACE AND ETHNICITY ARE COMPLEX 2293 01:45:19,052 --> 01:45:27,994 AND SOCIAL CONSTRUCT AND OVERLAP 2294 01:45:27,994 --> 01:45:29,129 VERIAL WITH DONE WHICH CLEARLY 2295 01:45:29,129 --> 01:45:36,303 SHOWS IMPACT OF SOCIAL OWE 2296 01:45:36,303 --> 01:45:38,271 IMPACT. SOME ARE SHOWN TO LIVE 2297 01:45:38,271 --> 01:45:41,842 IN DEPRIVED COMMUNITIES AND DR. 2298 01:45:41,842 --> 01:45:43,643 (?) STUDY SHOWED THE PATIENT WHO 2299 01:45:43,643 --> 01:45:45,612 LIVED FAR FROM THE EXPERT CARE 2300 01:45:45,612 --> 01:45:49,182 CENTER SO IMPACTS THEIR ACCESS 2301 01:45:49,182 --> 01:45:51,284 AND HEALTH CARE AND DIFFERENCES 2302 01:45:51,284 --> 01:45:53,820 IN OUTCOME MAY NOT ONLY REFLECT 2303 01:45:53,820 --> 01:45:55,255 BIOLOGICAL SYSTEMS BUT SHAPED BY 2304 01:45:55,255 --> 01:46:03,430 SYSTEM INEQUITIES IN THE THEIR 2305 01:46:03,430 --> 01:46:04,631 ACCESS TO HEALTH CARE. I THINK 2306 01:46:04,631 --> 01:46:06,666 WE HAVE COVERED ALL THIS 2307 01:46:06,666 --> 01:46:07,300 MORNING. NEXT SLIDE. 2308 01:46:07,300 --> 01:46:10,303 THIS IS ONE SLIDE. I THINK 2309 01:46:10,303 --> 01:46:13,473 DR. ESTRADA PRESENTED EARLIER. 2310 01:46:13,473 --> 01:46:15,675 JUST WANT TO HIGHLIGHT, IF YOU 2311 01:46:15,675 --> 01:46:18,044 FOCUS ON RED AND ORANGE LINES 2312 01:46:18,044 --> 01:46:20,413 HERE, THEY PRESENT THE BLACK AND 2313 01:46:20,413 --> 01:46:23,250 HISPANIC PATIENT POPULATION AND 2314 01:46:23,250 --> 01:46:25,719 JUST SHOWING THE U.S. CENSUS 2315 01:46:25,719 --> 01:46:27,287 DATA, WHICH CLEARLY SHOWS THAT 2316 01:46:27,287 --> 01:46:29,689 THE PER-CAPITA INCOME OF THE 2317 01:46:29,689 --> 01:46:30,957 BLACK AND HISPANIC PATIENT 2318 01:46:30,957 --> 01:46:33,560 POPULATION IS MUCH LESS THAN THE 2319 01:46:33,560 --> 01:46:36,296 OTHER RACES IN THE UNITED 2320 01:46:36,296 --> 01:46:36,796 STATES. NEXT SLIDE. 2321 01:46:36,796 --> 01:46:38,565 SO WHAT ARE THE 2322 01:46:38,565 --> 01:46:40,200 INTERVENTIONS? WHAT CAN WE DO? 2323 01:46:40,200 --> 01:46:42,702 THERE COULD BE SOME 2324 01:46:42,702 --> 01:46:44,070 DISEASE-AGNOSTIC INTERVENTION 2325 01:46:44,070 --> 01:46:45,839 WHICH COULD BE WIDESPREAD INTO 2326 01:46:45,839 --> 01:46:47,874 HEALTH CARE AND DISEASE-SPECIFIC 2327 01:46:47,874 --> 01:46:50,076 WHICH ARE RELATED TO PULMONARY 2328 01:46:50,076 --> 01:46:51,545 DISEASES. I WILL PROVIDE A 2329 01:46:51,545 --> 01:46:55,949 LITTLE OVERVIEW OF THAT. NEXT 2330 01:46:55,949 --> 01:46:56,449 SLIDE. 2331 01:46:56,449 --> 01:47:04,457 CULTURALLY TAYLORED -- 2332 01:47:04,457 --> 01:47:06,126 TAILORED INTERVENTION AND 2333 01:47:06,126 --> 01:47:07,827 MATERIAL AND WORKSHOP ON 2334 01:47:07,827 --> 01:47:09,796 CLINICAL RESEARCH, I THINK THAT 2335 01:47:09,796 --> 01:47:11,131 IS AT THE GROUND LEVEL, WE 2336 01:47:11,131 --> 01:47:13,066 SHOULD BE INVOLVING THESE 2337 01:47:13,066 --> 01:47:15,001 ORGANIZATIONS IF WE ARE TALKING 2338 01:47:15,001 --> 01:47:17,771 ABOUT CLINICAL TRIALS OR THEIR 2339 01:47:17,771 --> 01:47:21,074 HEALTH CARE NEEDS OR RESOURCES 2340 01:47:21,074 --> 01:47:23,643 FOR THESE PATIENT -- THESE 2341 01:47:23,643 --> 01:47:25,011 ECONOMICALLY OR SOCIALLY 2342 01:47:25,011 --> 01:47:26,479 DEPRIVED PATIENT POPULATION. 2343 01:47:26,479 --> 01:47:28,281 THEN ENGAGE PROVIDERS FROM 2344 01:47:28,281 --> 01:47:30,817 SIMILAR BACK GROUNDS. I THINK 2345 01:47:30,817 --> 01:47:33,153 THAT HAS A BIG IMPACT. I LIVE IN 2346 01:47:33,153 --> 01:47:36,556 HOUSTON. WHEN I HAVE PHYSICIAN 2347 01:47:36,556 --> 01:47:38,058 WHO CAN SPEAK SPANISH WITH THE 2348 01:47:38,058 --> 01:47:40,227 PATIENT, UNFORTUNATELY I'M NOT 2349 01:47:40,227 --> 01:47:42,862 ABLE TO, BUT THEY ARE -- THEY 2350 01:47:42,862 --> 01:47:43,863 DEFINITELY FEEL CONNECTED WITH 2351 01:47:43,863 --> 01:47:46,700 THOSE PHYSICIANS OR MY 2352 01:47:46,700 --> 01:47:48,401 COLLEAGUES WHO CAN SPEAK SPAN, 2353 01:47:48,401 --> 01:47:50,103 AS THEY ARE MORE TRUSTED BY THE 2354 01:47:50,103 --> 01:47:52,405 MINORITY POPULATION AND BETTER 2355 01:47:52,405 --> 01:47:53,340 POSITIONED TO DISCUSS 2356 01:47:53,340 --> 01:47:56,910 PARTICIPATION BENEFITS AND 2357 01:47:56,910 --> 01:47:59,246 RISKS. NEXT SLIDE. 2358 01:47:59,246 --> 01:48:01,214 INCLUSIVE INSTITUTIONAL 2359 01:48:01,214 --> 01:48:02,716 POLICIES REQUIRING INFORMED 2360 01:48:02,716 --> 01:48:04,150 CONSENT FORMS IN DIFFERENT 2361 01:48:04,150 --> 01:48:06,720 LANGUAGES, PATIENT FACING 2362 01:48:06,720 --> 01:48:08,088 MATERIAL, MULTIPLE LANGUAGE 2363 01:48:08,088 --> 01:48:10,123 RELEVANT TO LOCATION'S 2364 01:48:10,123 --> 01:48:11,358 DEMOGRAPHIC. THIS IS ONE 2365 01:48:11,358 --> 01:48:12,926 CHALLENGE AT MY PLACE, WHICH WAS 2366 01:48:12,926 --> 01:48:14,961 THERE FEW YEARS AGO. I'M NOT 2367 01:48:14,961 --> 01:48:18,498 GOING TO SAY IT IS COMPLETELY 2368 01:48:18,498 --> 01:48:20,100 ELIMINATED, BUT MY PRIMARY GOAL 2369 01:48:20,100 --> 01:48:25,071 HERE IS AS A CLINICAL TRIAL 2370 01:48:25,071 --> 01:48:31,411 IS'-IT IS A BIG CENTER IN 2371 01:48:31,411 --> 01:48:33,947 PULMONARY HYPERTENSION, I 2372 01:48:33,947 --> 01:48:44,491 REALIZED SPONSOR DO NOT PRO ARE 2373 01:48:45,058 --> 01:48:45,425 VIE 2374 01:48:45,425 --> 01:48:46,159 PROVIDE THE FORM IN SPANISH AND 2375 01:48:46,159 --> 01:48:48,128 INSTITUTE DOES NOT SUPPORT 2376 01:48:48,128 --> 01:48:50,930 BILINGUAL FORMS OR ANYTHING LIKE 2377 01:48:50,930 --> 01:48:52,499 THAT. IN A HISPANIC PREDOMINANT 2378 01:48:52,499 --> 01:48:55,302 AREA YOU ARE AUTOMATICALLY 2379 01:48:55,302 --> 01:48:56,536 EXCLUDING THAT BIG PATIENT 2380 01:48:56,536 --> 01:48:59,272 POPULATION TO PARTICIPATE IN 2381 01:48:59,272 --> 01:49:00,340 CLINICAL TRIALS. CLEARLY, IF YOU 2382 01:49:00,340 --> 01:49:03,877 LOOK AT MY SIDE DATA, CLEARLY 2383 01:49:03,877 --> 01:49:05,712 REPRESENTED BY JUST THE WIDE 2384 01:49:05,712 --> 01:49:06,446 PATIENT POPULATION. 2385 01:49:06,446 --> 01:49:08,882 SO FEW YEARS AGO, AT LEAST 2386 01:49:08,882 --> 01:49:11,785 THREE, FOUR YEARS AGO, I STARTED 2387 01:49:11,785 --> 01:49:13,386 IMPOSE ING THAT ANY NEW RESEARCH 2388 01:49:13,386 --> 01:49:17,924 STAFF WE ARE GOING TO HIRE MUST 2389 01:49:17,924 --> 01:49:22,462 BE BILINGUAL. CERTIFIED IN DOING 2390 01:49:22,462 --> 01:49:24,931 THE CONSENTING PROCESS. THERE IS 2391 01:49:24,931 --> 01:49:26,900 A WHOLE INSTITUTIONAL PROCESS. 2392 01:49:26,900 --> 01:49:29,002 AGAIN, I FEEL LIKE THERE IS A 2393 01:49:29,002 --> 01:49:30,937 LOT OF RED TAPE FROM THE 2394 01:49:30,937 --> 01:49:32,138 INSTITUTE ALSO FROM THAT, PEOPLE 2395 01:49:32,138 --> 01:49:37,243 WHO ARE SPECIFICALLY NATIVE 2396 01:49:37,243 --> 01:49:38,912 SPANISH SPEAKING THEY HAD TO 2397 01:49:38,912 --> 01:49:43,683 UNDERGO TRAININGS TO PROVE THEY 2398 01:49:43,683 --> 01:49:45,085 COULD SPEAK SPANISH. REGARDLESS 2399 01:49:45,085 --> 01:49:48,088 I WILL SAY WE ARE FAR FROM A BIG 2400 01:49:48,088 --> 01:49:51,424 SUCCESS BUT I IN ALL HONESTY ONE 2401 01:49:51,424 --> 01:49:52,492 TOTALLY SPANISH SPEAKING PATIENT 2402 01:49:52,492 --> 01:49:54,294 IN A CLINICAL TRIAL. IT IS STILL 2403 01:49:54,294 --> 01:49:56,563 NOT A SUCCESS BUT A CHANGE FROM 2404 01:49:56,563 --> 01:49:59,299 ZERO TO ONE. AS I MENTIONED 2405 01:49:59,299 --> 01:50:01,735 ABOUT EMPLOYING BILINGUAL STAFF 2406 01:50:01,735 --> 01:50:05,038 INVOLVING RESEARCH, 2407 01:50:05,038 --> 01:50:09,175 INCORPORATING TELEHEALTH, IT IS 2408 01:50:09,175 --> 01:50:10,543 A BIG STATE AND PEOPLE DRIVE 2409 01:50:10,543 --> 01:50:18,017 EASILY, SO INCORPORATING 2410 01:50:18,017 --> 01:50:20,086 TELEHEALTH CAN HELP AND REDUCE 2411 01:50:20,086 --> 01:50:24,958 TRIAL -- REDUCE BURDEN ON THE 2412 01:50:24,958 --> 01:50:26,493 TRIAL AND CARE PROVIDER. THESE 2413 01:50:26,493 --> 01:50:28,294 SHOULD BE INCORPORATED IN TRIALS 2414 01:50:28,294 --> 01:50:30,597 KEEPING THESE THINGS IN MIND. WE 2415 01:50:30,597 --> 01:50:33,867 TALK ABOUT STIPEND 2416 01:50:33,867 --> 01:50:38,538 REIMBURSEMENT. THIS RECENTLY WAS 2417 01:50:38,538 --> 01:50:41,007 DOCTOR BRAND ABOUT COMPENSATION 2418 01:50:41,007 --> 01:50:42,876 FOR LOST WAGES. MANY OF TRIALS 2419 01:50:42,876 --> 01:50:48,114 AND INSTITUTES DO NOT MANDATE 2420 01:50:48,114 --> 01:50:49,516 COMPENSATED FOR THEIR LOST WAGES 2421 01:50:49,516 --> 01:50:54,621 IF COMING FOR TRIAL OR RESEARCH 2422 01:50:54,621 --> 01:50:56,756 VISIT. THAT IS SOMETHING SHOULD 2423 01:50:56,756 --> 01:50:58,758 BE VERY IMPORTANT THING, COMING 2424 01:50:58,758 --> 01:51:01,628 TO A CLINICAL TRIAL VISIT HAD ME 2425 01:51:01,628 --> 01:51:03,229 LEASE ONE DAY SALARY, I DO NOT 2426 01:51:03,229 --> 01:51:05,498 WANT TO PARTICIPATE IN THE 2427 01:51:05,498 --> 01:51:07,567 CLINICAL TRIAL. OF COURSE THE 2428 01:51:07,567 --> 01:51:11,271 ADDITIONAL STIPEND FOR CARE 2429 01:51:11,271 --> 01:51:18,978 PROVIDERS. NEXT SLIDE. WE TALK 2430 01:51:18,978 --> 01:51:21,981 ABOUT AFFORDABLE CARE ACT. THE 2431 01:51:21,981 --> 01:51:23,283 GOVERNMENT SHOULD HAVE 2432 01:51:23,283 --> 01:51:27,053 LEGISLATION, REMOTE CULTURALLY 2433 01:51:27,053 --> 01:51:29,756 TAILORED OUTREACH TO HELP 2434 01:51:29,756 --> 01:51:34,194 ECONOMIC AND SOCIALLY DEPRIVED 2435 01:51:34,194 --> 01:51:35,161 PATIENT POPULATION. NEXT SLIDE. 2436 01:51:35,161 --> 01:51:37,130 WE TALKED ABOUT THE CULTURALLY 2437 01:51:37,130 --> 01:51:42,368 COMPETENT CARE OF TRAINED 2438 01:51:42,368 --> 01:51:44,370 PHYSICIANS WHO ARE COGNIZANT 2439 01:51:44,370 --> 01:51:46,072 ABOUT THESE DIFFERENCES AND CAN 2440 01:51:46,072 --> 01:51:47,073 ADDRESS THOSE DIFFERENCES WITH 2441 01:51:47,073 --> 01:51:50,176 PATIENT, INCREASED 2442 01:51:50,176 --> 01:51:50,777 REPRESENTATION IN THE HEALTH 2443 01:51:50,777 --> 01:51:54,247 CARE FROM THE MINORITY PEOPLE 2444 01:51:54,247 --> 01:51:56,115 WILL DEFINITELY HELP DEVELOP 2445 01:51:56,115 --> 01:51:56,816 MORE CONVERSATION IN HEALTH CARE 2446 01:51:56,816 --> 01:51:59,919 IN GENERAL AND PARTICIPATION IN 2447 01:51:59,919 --> 01:52:01,287 CLINICAL RESEARCH. NEXT SLIDE. 2448 01:52:01,287 --> 01:52:04,057 HEALTH LITERACY AND LANGUAGE 2449 01:52:04,057 --> 01:52:06,860 SERVICES, TRANSLATORS SHOULD BE 2450 01:52:06,860 --> 01:52:08,294 EASILY AVAILABLE, ESPECIALLY FOR 2451 01:52:08,294 --> 01:52:10,196 CONSENTING PROCESS IN CLINICAL 2452 01:52:10,196 --> 01:52:14,234 TRIALS, WHICH IS VERY CONVO 2453 01:52:14,234 --> 01:52:15,301 CONVOLUTED, PERHAPS HAVING 2454 01:52:15,301 --> 01:52:17,003 DEDICATED SERVICE DEPENDING ON 2455 01:52:17,003 --> 01:52:19,305 WHAT PREDOMINANT LANGUAGE 2456 01:52:19,305 --> 01:52:21,174 SERVICE, THAT MIGHT HELP. AND 2457 01:52:21,174 --> 01:52:23,343 ENCOURAGE PARTICIPATION IN 2458 01:52:23,343 --> 01:52:26,279 CLINICAL TRIALS. NEXT SLIDE. 2459 01:52:26,279 --> 01:52:27,914 THIS IS ONE IMPORTANT SLIDE, 2460 01:52:27,914 --> 01:52:29,315 WHICH I WANTED TO HIGHLIGHT. I 2461 01:52:29,315 --> 01:52:33,419 THINK THIS IS NOT GOING TO BE 2462 01:52:33,419 --> 01:52:37,190 JUST AN INDIVIDUAL 2463 01:52:37,190 --> 01:52:38,024 INVESTIGATOR-DEPENDENT THING BUT 2464 01:52:38,024 --> 01:52:39,425 SHOULD BE MULTIPLE STAKEHOLDER 2465 01:52:39,425 --> 01:52:41,928 FROM PUBLIC, PRIVATE AND 2466 01:52:41,928 --> 01:52:47,367 NONPROFIT ORGANIZATIONS LIKE PHA 2467 01:52:47,367 --> 01:52:49,936 SHOULD COME TOGETHER TO ADDRESS 2468 01:52:49,936 --> 01:52:52,171 DISPARITIES IN CLINICAL TRIAL 2469 01:52:52,171 --> 01:52:53,139 PARTICIPATION, PERHAPS PROVIDE 2470 01:52:53,139 --> 01:52:55,074 GUIDANCE FOR NEW SPONSORS COMING 2471 01:52:55,074 --> 01:52:57,911 UP WITH NEWER DRUG TRIALS, 2472 01:52:57,911 --> 01:52:58,778 IDENTIFY ROOT CAUSE OF 2473 01:52:58,778 --> 01:53:00,313 DISPARITIES IN MAKING CRITICAL 2474 01:53:00,313 --> 01:53:03,082 POLICY CHANGES. I THINK WE 2475 01:53:03,082 --> 01:53:04,450 SHOULD WORK ON MAKING CLINICAL 2476 01:53:04,450 --> 01:53:06,619 TRIALS MORE RESPONSIVE TO 2477 01:53:06,619 --> 01:53:10,089 ACKNOWLEDGE THE CHANGING 2478 01:53:10,089 --> 01:53:11,858 EPIDEMIOLOGY. 20 YEARS AGO 2479 01:53:11,858 --> 01:53:13,493 PATIENTS WERE MUCH YOUNGER, 2480 01:53:13,493 --> 01:53:20,700 MAYBE DID NOT HAVE THAT MUCH 2481 01:53:20,700 --> 01:53:22,368 COMORBIDITIES, MAYBE LIVING 2482 01:53:22,368 --> 01:53:23,836 LONGER. SO TRIAL SHOULD BE 2483 01:53:23,836 --> 01:53:26,339 CHANGED OR ADAPTED ACCORDING TO 2484 01:53:26,339 --> 01:53:28,074 CHANGING EPIDEMIOLOGY OF DISEASE 2485 01:53:28,074 --> 01:53:30,043 TO ENCOURAGE MORE INVOLVEMENT OF 2486 01:53:30,043 --> 01:53:31,377 SUCH PATIENTS. 2487 01:53:31,377 --> 01:53:33,646 I'M NOT ENTIRELY SURE HOW 2488 01:53:33,646 --> 01:53:37,817 MUCH FDA OR NIH MANDATES OR 2489 01:53:37,817 --> 01:53:38,484 PROVIDES INSTRUCTIONS TO THESE 2490 01:53:38,484 --> 01:53:41,154 FOLKS WHO ARE CONDUCTING THE 2491 01:53:41,154 --> 01:53:43,056 CLINICAL TRIALS OR NEW DRUG 2492 01:53:43,056 --> 01:53:45,892 TRIALS OR ANY KIND OF REGISTRY, 2493 01:53:45,892 --> 01:53:49,362 THAT THEY SHOULD HAVE 2494 01:53:49,362 --> 01:53:50,597 PARTICIPATION OF HISPANIC 2495 01:53:50,597 --> 01:53:52,465 POPULATION OR BLACK POPULATION. 2496 01:53:52,465 --> 01:53:54,767 I'M NOT ENTIRELY SURE. PERHAPS 2497 01:53:54,767 --> 01:53:57,704 THE EXPERTS HERE FROM NIH CAN 2498 01:53:57,704 --> 01:53:59,472 PROVIDE INSIGHT. BUT THIS SHOULD 2499 01:53:59,472 --> 01:54:04,777 BE MANDATED TO EVEN A PRIVATELY 2500 01:54:04,777 --> 01:54:07,313 SPONSORED TRIAL OR NIH STUDY. 2501 01:54:07,313 --> 01:54:08,548 SUBSTANTIAL INCENTIVES FOR 2502 01:54:08,548 --> 01:54:11,985 APPROPRIATE INCLUSION PLANS. 2503 01:54:11,985 --> 01:54:13,319 NEXT SLIDE. 2504 01:54:13,319 --> 01:54:17,156 AGAIN, REQUIRE FURTHER GOING 2505 01:54:17,156 --> 01:54:18,825 INTO THIS REQUIRE DEMONSTRATION 2506 01:54:18,825 --> 01:54:20,960 AND PROTOCOL METHODS, PROTOCOLS 2507 01:54:20,960 --> 01:54:23,229 OF METHODS AND MEASURES TO 2508 01:54:23,229 --> 01:54:25,765 ENSURE MEANINGFUL COMMUNITY 2509 01:54:25,765 --> 01:54:26,966 PARTICIPATION THROUGHOUT THE 2510 01:54:26,966 --> 01:54:29,369 PROCESS, REQUIRE DETAILED PLAN 2511 01:54:29,369 --> 01:54:30,803 TO BUILD COMMUNITY CAPACITY FOR 2512 01:54:30,803 --> 01:54:32,805 UNDERSTANDING AND SUPPORTING THE 2513 01:54:32,805 --> 01:54:34,707 CLINICAL RESEARCH. REQUIRE THAT 2514 01:54:34,707 --> 01:54:37,977 ALL LOCAL CLINICAL TRIAL TEAMS 2515 01:54:37,977 --> 01:54:42,849 CONVENE COMMITTEE -- RETENTION 2516 01:54:42,849 --> 01:54:44,250 COMMITTEE TO REVISE PART OF THE 2517 01:54:44,250 --> 01:54:46,419 PLAN. I THINK THIS IS VERY MUCH 2518 01:54:46,419 --> 01:54:48,087 LACKING. AT LEAST I CAN SPEAK 2519 01:54:48,087 --> 01:54:54,293 FOR MY PLACE. PROJECTS LIKE 2520 01:54:54,293 --> 01:54:55,662 EDICT, I REALLY LIKE AND READ A 2521 01:54:55,662 --> 01:54:57,130 LOT. I THINK IT IS TIME TO COME 2522 01:54:57,130 --> 01:55:00,466 UP WITH SOMETHING LIKE THIS, 2523 01:55:00,466 --> 01:55:01,300 ELIMINATING DISPARITIES IN 2524 01:55:01,300 --> 01:55:02,301 CLINICAL TRIALS. THIS IS 2525 01:55:02,301 --> 01:55:03,603 ACTUALLY IN CANCER TRIALS, WHERE 2526 01:55:03,603 --> 01:55:05,571 I LEARNED MORE ABOUT IT, ARE 2527 01:55:05,571 --> 01:55:08,741 NEEDED IN PH AS WELL. WHERE THEY 2528 01:55:08,741 --> 01:55:19,218 HAVE IDENTIFIED THE ROOT CAUSES. 2529 01:55:19,218 --> 01:55:21,587 AWARE ONE OF MY ONCOLOGY FRIEND 2530 01:55:21,587 --> 01:55:26,125 TELL US THE NCI RECOGNITION, 2531 01:55:26,125 --> 01:55:29,962 WHICH CANCER CENTERS GET -- TO 2532 01:55:29,962 --> 01:55:31,664 GET, TO OBTAIN THAT RECOGNITION 2533 01:55:31,664 --> 01:55:35,835 THE CENS CENTERS NEED TO SHOW H 2534 01:55:35,835 --> 01:55:37,570 MANY THEY HAVE ENROLLED FROM 2535 01:55:37,570 --> 01:55:40,807 MINORITIES OR SOCIALLY OR 2536 01:55:40,807 --> 01:55:42,041 ECONOMICALLY DEPRIVED 2537 01:55:42,041 --> 01:55:45,211 ETHNICITIES IN THEIR CLINICAL 2538 01:55:45,211 --> 01:55:48,214 TRIALS. I DO NOT KNOW IF WE 2539 01:55:48,214 --> 01:55:49,449 COULD COME UP WITH SOMETHING 2540 01:55:49,449 --> 01:55:54,954 LIKE THAT, EVEN PHCC 2541 01:55:54,954 --> 01:55:57,623 ACCREDITATION OR ORIENTATION 2542 01:55:57,623 --> 01:55:58,691 PROCESS. NEXT SLIDE. 2543 01:55:58,691 --> 01:56:00,159 TO CONCLUDE RACIAL AND 2544 01:56:00,159 --> 01:56:02,328 ETHNIC MINORITIES ARE 2545 01:56:02,328 --> 01:56:04,297 UNDERREPRESENTED IN CLINICAL 2546 01:56:04,297 --> 01:56:08,735 TRIALS, LIMITING INSIGHT INTO 2547 01:56:08,735 --> 01:56:11,804 HEALTH DISPARITIES AND DRIVEN BY 2548 01:56:11,804 --> 01:56:13,172 ECONOMIC, LEVEL OF EDUCATION AND 2549 01:56:13,172 --> 01:56:15,274 LIMITED ACCESS TO HEALTH CARE. 2550 01:56:15,274 --> 01:56:18,444 BOTH DISEASE-AGNOSTIC AND 2551 01:56:18,444 --> 01:56:19,645 DISEASE-SPECIFIC INTERVENTIONS 2552 01:56:19,645 --> 01:56:21,547 ARE NEEDED FOR DISPARITIES. 2553 01:56:21,547 --> 01:56:22,949 THANK YOU FOR YOUR ATTENTION, 2554 01:56:22,949 --> 01:56:24,851 SORRY TO TAKE COUPLE MINUTES 2555 01:56:24,851 --> 01:56:28,087 EXTRA. I'M OPEN FOR ANY 2556 01:56:28,087 --> 01:56:30,823 QUESTIONS, THANK YOU. 2557 01:56:30,823 --> 01:56:32,892 >> THEY VERY MUCH, DR. SAHAY. 2558 01:56:32,892 --> 01:56:36,562 THAT WAS EXCELLENT. LOOKS LIKE 2559 01:56:36,562 --> 01:56:38,064 THERE IS A BIT OF AN ISSUE WITH 2560 01:56:38,064 --> 01:56:40,600 THE AGENDA. WE ARE SUPPOSED TO 2561 01:56:40,600 --> 01:56:43,302 BREAK FOR LUNCH FOR FIVE MINUTES 2562 01:56:43,302 --> 01:56:44,804 ON THE EAST COAST, MAYBE 2563 01:56:44,804 --> 01:56:50,343 BREAKFAST ON THE WEST. I WILL 2564 01:56:50,343 --> 01:56:52,812 MAKE THE EXECUTIVE DECISION TO 2565 01:56:52,812 --> 01:56:55,114 EXTEND 15 MINUTES INTO LUNCH. IF 2566 01:56:55,114 --> 01:56:57,784 EVERYONE IS OKAY. IF NOT, SIGN 2567 01:56:57,784 --> 01:57:02,889 OFF AND WE WILL SEE YOU AT 1:00. 2568 01:57:02,889 --> 01:57:04,090 LET'S TAKE 20 MINUTES TO FIELD 2569 01:57:04,090 --> 01:57:07,059 QUESTIONS. I WILL START THINGS 2570 01:57:07,059 --> 01:57:09,428 OFF BY DR. SAHAY. ASKING YOU A 2571 01:57:09,428 --> 01:57:12,498 QUESTION. DR. ESTRADA ALSO YOU 2572 01:57:12,498 --> 01:57:15,601 CAN JUMP IN. YOU BOTH AS WELL AS 2573 01:57:15,601 --> 01:57:19,205 DR. GOEL, ALLUDED TO THE FACT 2574 01:57:19,205 --> 01:57:22,308 THAT SOCIOECONOMIC STATUS, 2575 01:57:22,308 --> 01:57:23,709 PERHAPS SOCIAL DETERMINANTS, 2576 01:57:23,709 --> 01:57:26,179 WHICH WE WILL GET INTO NEXT 2577 01:57:26,179 --> 01:57:27,880 SESSION, ARE VERY IMPORTANT. 2578 01:57:27,880 --> 01:57:30,316 WHEN WE DESIGNED CLINICAL 2579 01:57:30,316 --> 01:57:33,719 TRIALS, COHORT STUDIES AND CASE 2580 01:57:33,719 --> 01:57:38,891 CONTROL STUDIES, WE DON'T 2581 01:57:38,891 --> 01:57:41,961 TYPICALLY ASSESS SOCIAL 2582 01:57:41,961 --> 01:57:45,798 DETERMINANTS OR SOCIOECONOMIC 2583 01:57:45,798 --> 01:57:49,168 STATUS. YOU HAVE MENTIONED IN 2584 01:57:49,168 --> 01:57:51,904 TERMS OF HETEROGENEITY AND HOW 2585 01:57:51,904 --> 01:57:53,573 TO ASSESS RACE. IS IT IMPORTANT 2586 01:57:53,573 --> 01:57:56,742 FOR US TO TRACK THOSE IN ALL 2587 01:57:56,742 --> 01:57:58,277 THOSE SITUATIONS AND IF THERE 2588 01:57:58,277 --> 01:58:01,047 ARE -- YOU KNOW, NORMALLY IN 2589 01:58:01,047 --> 01:58:02,682 RANDOMIZED CONTROL TRIAL WHEN WE 2590 01:58:02,682 --> 01:58:05,251 DESIGN THE TRIAL WE ASSUME BOTH 2591 01:58:05,251 --> 01:58:06,919 TREATMENT ARM AND CONTROL ARM 2592 01:58:06,919 --> 01:58:11,123 ARE THROUGH RANDOM IZATION 2593 01:58:11,123 --> 01:58:12,792 PROCESS THERE IS MATCHING OF IN 2594 01:58:12,792 --> 01:58:23,202 BOTH ARMS. IF THIS IS A 2595 01:58:24,937 --> 01:58:27,306 MISMATCH, HOW DO WE ASSESS IT 2596 01:58:27,306 --> 01:58:29,041 AND NUMBER TWO, HOW DO WE 2597 01:58:29,041 --> 01:58:32,645 APPROACH THAT? LET'S START OFF 2598 01:58:32,645 --> 01:58:34,180 WITH DR. SAHAY. 2599 01:58:34,180 --> 01:58:37,717 >> SO YOU ARE EXACTLY ASKING HOW 2600 01:58:37,717 --> 01:58:40,019 DO WE ASSESS WITH LIKE THE 2601 01:58:40,019 --> 01:58:41,320 SOCIOECONOMIC STATUS OF THE 2602 01:58:41,320 --> 01:58:45,524 PATIENT WHEN WE ARE -- 2603 01:58:45,524 --> 01:58:48,794 >> SHOULD WE BE ASSESSING 2604 01:58:48,794 --> 01:58:52,965 SOCIOECONOMIC STATUS AND SOCIAL 2605 01:58:52,965 --> 01:58:55,902 DETERMINE NANTS AND HOW TO ADDR 2606 01:58:55,902 --> 01:58:56,068 IT? 2607 01:58:56,068 --> 01:58:58,304 >> I THINK THE SHORT ANSWER IS 2608 01:58:58,304 --> 01:58:59,138 YES BECAUSE THIS MORNING IN 2609 01:58:59,138 --> 01:59:01,407 THREE DIFFERENT TALKS WE HAVE 2610 01:59:01,407 --> 01:59:03,643 CLEARLY DEMONSTRATED THAT THIS 2611 01:59:03,643 --> 01:59:14,186 AFFECTS THEIR OUTCOMES. NO DOUBT 2612 01:59:19,725 --> 01:59:23,596 OF SOCIOECONOMICS STATUS SO TO 2613 01:59:23,596 --> 01:59:25,698 COLLECT FAR BETTER THAN PRIOR 2614 01:59:25,698 --> 01:59:28,901 DATA, TO COLLECT THE INFORMATION 2615 01:59:28,901 --> 01:59:30,903 ABOUT THEIR -- ADMIT PERSONAL 2616 01:59:30,903 --> 01:59:31,971 INFORMATION ABOUT THEIR INCOME, 2617 01:59:31,971 --> 01:59:33,839 WHERE THEY LIVE, IF THEY HAVE 2618 01:59:33,839 --> 01:59:36,008 BARRIERS TO COME TO THE DOCTOR'S 2619 01:59:36,008 --> 01:59:38,277 OFFICE OR GETTING THE 2620 01:59:38,277 --> 01:59:41,280 MEDICATIONS. I DO NOT REMEMBER 2621 01:59:41,280 --> 01:59:43,916 ME ASKING EVERY PATIENT WHEN I 2622 01:59:43,916 --> 01:59:45,484 SEE THEM OR THOSE PARTICIPATING 2623 01:59:45,484 --> 01:59:47,820 IN THE CLINICAL TRIAL HAVE THEY 2624 01:59:47,820 --> 01:59:50,122 -- DO THEY ROUTINELY HAVE TO 2625 01:59:50,122 --> 01:59:52,325 UNDERGO BARRIERS TO OBTAIN 2626 01:59:52,325 --> 01:59:54,327 MEDICATIONS OR PICK UP THEIR 2627 01:59:54,327 --> 01:59:55,895 MEDICATIONS? I THINK THESE ARE 2628 01:59:55,895 --> 01:59:56,729 IMPORTANT INFORMATION THAT WE 2629 01:59:56,729 --> 01:59:58,531 SHOULD BE COLLECTING. BECAUSE IF 2630 01:59:58,531 --> 02:00:00,433 WE ARE NOT ASKING THESE 2631 02:00:00,433 --> 02:00:02,234 QUESTIONS, FOR US THEY DO NOT 2632 02:00:02,234 --> 02:00:04,603 EXIST. I THINK THAT IS A BIG 2633 02:00:04,603 --> 02:00:06,639 CHALLENGE THERE. ONE OF THE WAYS 2634 02:00:06,639 --> 02:00:08,140 WHICH CURRENTLY WE ARE WORKING 2635 02:00:08,140 --> 02:00:10,876 WITH PDRI IS TO COME UP. I THINK 2636 02:00:10,876 --> 02:00:12,478 WHILE I WAS LISTENING TO THE 2637 02:00:12,478 --> 02:00:16,215 TALK THIS MORNING, WE ARE COMING 2638 02:00:16,215 --> 02:00:24,023 UP WITH A GLOBAL SORT OF -- YOU 2639 02:00:24,023 --> 02:00:26,659 KNOW, WHERE THE CONSENSUS ON THE 2640 02:00:26,659 --> 02:00:28,794 VARIABLES TO BE COLLECTED IN ANY 2641 02:00:28,794 --> 02:00:32,031 OF THE REGISTRY STUDY FOR PH. 2642 02:00:32,031 --> 02:00:34,834 CURRENTLY DIFFERENT LOGISTICS 2643 02:00:34,834 --> 02:00:36,168 COLLECT VARIABLES DIFFERENTLY 2644 02:00:36,168 --> 02:00:38,938 ALSO. AFTER THESE FIRST FEW 2645 02:00:38,938 --> 02:00:40,973 TAKES I SUDDENLY REALIZED IN 2646 02:00:40,973 --> 02:00:44,977 PROPOSALAL WE HAVE NOT TALKED 2647 02:00:44,977 --> 02:00:45,444 ABOUT DISPARITIESES, 2648 02:00:45,444 --> 02:00:48,681 SOCIOECONOMIC STATUS OR THE RACE 2649 02:00:48,681 --> 02:00:50,116 DATA. IT ACTUALLY HIS QUESTION, 2650 02:00:50,116 --> 02:00:51,984 WHEN HE MENTIONED ABOUT THAT 2651 02:00:51,984 --> 02:00:53,619 EUROPEANS DO NOT TALK ABOUT IT. 2652 02:00:53,619 --> 02:00:57,523 IT SUDDENLY DAWNEDED ON ME, YES. 2653 02:00:57,523 --> 02:00:58,724 BECAUSE IT IS A GLOBAL THING WE 2654 02:00:58,724 --> 02:01:01,427 ARE DOING. THIS WAS NOT BROUGHT 2655 02:01:01,427 --> 02:01:04,663 UP INTO THE CONVERSATION SO THIS 2656 02:01:04,663 --> 02:01:08,834 IS SOMETHING I'M GOING TO SEND 2657 02:01:08,834 --> 02:01:13,806 AN EMAIL THAT WE SHOULD BE 2658 02:01:13,806 --> 02:01:14,707 INCLUDING OR ASKING. IT STARTS 2659 02:01:14,707 --> 02:01:18,611 WITH US, THAT WE NEED TO START 2660 02:01:18,611 --> 02:01:20,713 COLLECTING THAT INFORMATION MORE 2661 02:01:20,713 --> 02:01:22,715 SYSTEMATICALLY, WHICH WE ARE NOT 2662 02:01:22,715 --> 02:01:23,282 DOING CURRENTLY. 2663 02:01:23,282 --> 02:01:25,618 >> DR. ESTRADA DO YOU HAVE A 2664 02:01:25,618 --> 02:01:28,187 STANDARDIZED WAY YOU LOOK AT 2665 02:01:28,187 --> 02:01:30,489 THESE VARIABLES WITH YOUR 2666 02:01:30,489 --> 02:01:32,024 PATIENTS IN SAN ANTONIO? 2667 02:01:32,024 --> 02:01:37,496 >> YEAH, I WANT TO TAKE A LITTLE 2668 02:01:37,496 --> 02:01:39,865 WHAT DR. HYDE SAID, I TOOK AWAY 2669 02:01:39,865 --> 02:01:41,734 A SLIDE WE ARE CREATING A MODEL 2670 02:01:41,734 --> 02:01:43,836 FOR THE U.S. BUT TRYING TO 2671 02:01:43,836 --> 02:01:50,042 CREATE SOMETHING THAT IS 2672 02:01:50,042 --> 02:01:51,110 REPLICABLE. THESE ARE 2673 02:01:51,110 --> 02:01:52,278 CHARACTERISTIC OF WHAT WE HAVE 2674 02:01:52,278 --> 02:01:55,714 NOW. THESE HAPPENED, AS I 2675 02:01:55,714 --> 02:01:56,882 MENTIONED IN THE SINGAPORE 2676 02:01:56,882 --> 02:01:58,317 PEOPLE THROUGHOUT THE WORLD. IF 2677 02:01:58,317 --> 02:02:00,686 WE CAN CAPTURE DATA AND HAVE IT 2678 02:02:00,686 --> 02:02:01,454 REPLICATED, THE SPECIFIC 2679 02:02:01,454 --> 02:02:02,888 QUESTION, WHEN I STARTED LOOKING 2680 02:02:02,888 --> 02:02:05,191 INTO THE SUBJECT, THAT LAST 2681 02:02:05,191 --> 02:02:06,559 SLIDE I MENTIONED WHERE THE 2682 02:02:06,559 --> 02:02:09,428 CENSUS IS REALLY TRYING TO 2683 02:02:09,428 --> 02:02:15,801 GATHER THE GRAN YULARITY, 2684 02:02:15,801 --> 02:02:17,303 SPECIFICALLY THE HISPANIC 2685 02:02:17,303 --> 02:02:19,305 POPULATION, THESE ARE SENSITIVE 2686 02:02:19,305 --> 02:02:29,081 QUESTIONS. THESE ARE SPECIFIC 2687 02:02:29,081 --> 02:02:31,550 BUT COULD DETER, TO ANSWER 2688 02:02:31,550 --> 02:02:33,652 FAITH FULLY. WHAT WE P SPEAK THE 2689 02:02:33,652 --> 02:02:35,187 MOST ABOUT ONE SPECIFIC CHANGE 2690 02:02:35,187 --> 02:02:37,089 IS MIGRATION PATTERNS ARE 2691 02:02:37,089 --> 02:02:38,591 SOMEWHAT DIFFERENT THAN OTHER 2692 02:02:38,591 --> 02:02:40,793 COHORTS BECAUSE OF PROXIMITY. 2693 02:02:40,793 --> 02:02:42,361 WHEN COMES TO SOCIOECONOMIC 2694 02:02:42,361 --> 02:02:45,464 STATUS, EMPLOYMENT OR INCOME, 2695 02:02:45,464 --> 02:02:46,932 EVEN THOUGH THEY ARE 2696 02:02:46,932 --> 02:02:49,034 MEASUREMENT, MAY NOT BE RELIABLY 2697 02:02:49,034 --> 02:02:51,170 STENTLY MEASURED WITHIN 2698 02:02:51,170 --> 02:02:53,939 THE POPULATION WHO MAY NOT HAVE 2699 02:02:53,939 --> 02:02:56,375 A STABLE JOB OR STABLE INCOME. 2700 02:02:56,375 --> 02:02:58,644 THEY GET MISSED. THESE ARE THE 2701 02:02:58,644 --> 02:03:00,179 PATIENTS WE ARE SEEING AND 2702 02:03:00,179 --> 02:03:02,181 PROBABLY ACCESS THE CARE. I 2703 02:03:02,181 --> 02:03:04,116 THINK THE FRAMEWORK WHERE WE CAN 2704 02:03:04,116 --> 02:03:06,185 CAPTURE POPULATION, NOT 2705 02:03:06,185 --> 02:03:07,920 ROUTINELY CAPTURED IN BIGGER 2706 02:03:07,920 --> 02:03:09,121 CENTERS, WOULD BE THE IDEAL 2707 02:03:09,121 --> 02:03:18,831 SCENARIO. I THINK A SURVEY 2708 02:03:18,831 --> 02:03:20,833 GRANDPARENT HERITAGE, KIND OF 2709 02:03:20,833 --> 02:03:22,601 ABOUT MIGRATION PATTERNS, WOULD 2710 02:03:22,601 --> 02:03:28,574 BE KEY COMPONENT TO THAT 2711 02:03:28,574 --> 02:03:30,676 QUESTION. 2712 02:03:30,676 --> 02:03:31,677 >> THANK YOU. 2713 02:03:31,677 --> 02:03:36,081 >> I HAVE TWO QUESTIONS FOR YOU. 2714 02:03:36,081 --> 02:03:38,417 BOTH WHICH YOU SORT OF ALLUDED 2715 02:03:38,417 --> 02:03:41,220 TO EARLIER. YOU KNOW, WHAT DO WE 2716 02:03:41,220 --> 02:03:44,223 KNOW ABOUT THE PROVIDERS, THE 2717 02:03:44,223 --> 02:03:46,592 CLINICAL TRIALISTS AND 2718 02:03:46,592 --> 02:03:47,826 INSTITUTIONS ENROLLING PATIENTS 2719 02:03:47,826 --> 02:03:50,529 AND PARTICIPANTS IN STUDIES AND 2720 02:03:50,529 --> 02:03:52,164 REGISTRIES? BECAUSE IF YOU ARE 2721 02:03:52,164 --> 02:03:56,068 COMING FROM AN INSTITUTION WHERE 2722 02:03:56,068 --> 02:04:00,539 YOU ONLY SEE 95% WHITE PEOPLE 2723 02:04:00,539 --> 02:04:03,309 AND, YOU KNOW, YOUR EXPOSURE TO 2724 02:04:03,309 --> 02:04:05,177 MINORITIES IS VERY SMALL, VERSUS 2725 02:04:05,177 --> 02:04:08,414 ANOTHER CENTER WHERE YOU MAY SEE 2726 02:04:08,414 --> 02:04:11,116 ALMOST EXCLUSIVELY 2727 02:04:11,116 --> 02:04:12,351 UNDERREPRESENTED GROUPS. YOU 2728 02:04:12,351 --> 02:04:14,553 KNOW, THE ABILITY TO ENROLL IS 2729 02:04:14,553 --> 02:04:15,888 GOING TO BE VERY DIFFERENT. SO 2730 02:04:15,888 --> 02:04:20,059 DO WE KNOW ANYTHING ABOUT THESE 2731 02:04:20,059 --> 02:04:23,295 MAJOR CLINICAL TRIALS AND PEOPLE 2732 02:04:23,295 --> 02:04:25,998 WHO ARE ENROLLING? 2733 02:04:25,998 --> 02:04:27,600 >> YES. I WOULD LIKE TO TAKE 2734 02:04:27,600 --> 02:04:30,069 THAT QUESTION. I LIVE IN 2735 02:04:30,069 --> 02:04:33,272 HOUSTON, WHICH IS A VERY DIVERSE 2736 02:04:33,272 --> 02:04:34,840 CITY. CULTURALLY, ETHNICITY, 2737 02:04:34,840 --> 02:04:37,509 RACE, WHATEVER YOU WANT TO SAY. 2738 02:04:37,509 --> 02:04:40,079 IT IS A VERY DIVERSE CITY, THE 2739 02:04:40,079 --> 02:04:41,747 FOURTH LARGEST CITY IN THE 2740 02:04:41,747 --> 02:04:43,649 COUNTRY. I CAN TELL YOU 2741 02:04:43,649 --> 02:04:45,784 HISTORICALLY, AND THERE WERE 2742 02:04:45,784 --> 02:04:47,486 BARRIERS THAT -- THERE ARE STILL 2743 02:04:47,486 --> 02:04:49,822 MULTIPLE BARRIERS TO ENROLL 2744 02:04:49,822 --> 02:04:52,891 PATIENTS. IT IS ALL ALONG THE 2745 02:04:52,891 --> 02:04:56,495 BARRIERS THAT ARE INSTITUTIONAL, 2746 02:04:56,495 --> 02:05:01,000 SITE AND ALSO THE CLINICAL 2747 02:05:01,000 --> 02:05:02,901 TRIALS. SOME OF THE POINTS I 2748 02:05:02,901 --> 02:05:04,136 HIGHLIGHTED AND FINE TO 2749 02:05:04,136 --> 02:05:06,005 HIGHLIGHT IN THE PROTOCOLS, LIKE 2750 02:05:06,005 --> 02:05:08,974 FOR EXAMPLE, BMI CUT-OFF OF 30, 2751 02:05:08,974 --> 02:05:13,045 TO ME IT APPEARS VERY 2752 02:05:13,045 --> 02:05:13,846 CONSERVATIVE. ESPECIALLY, I LIVE 2753 02:05:13,846 --> 02:05:15,881 IN TEXAS. IF YOU HAVE A CUT-OFF 2754 02:05:15,881 --> 02:05:19,785 OF 30 AND I SHOWED YOU THE DATA 2755 02:05:19,785 --> 02:05:22,721 FROM THE U.S. CENSUS DATA OR 2756 02:05:22,721 --> 02:05:25,424 CDC DATA THAT PREDOMINANTLY THE 2757 02:05:25,424 --> 02:05:27,026 AFRICAN-AMERICAN POPULATION HAD, 2758 02:05:27,026 --> 02:05:30,929 THAT WHOLE 60% OF BLACK WOMEN 2759 02:05:30,929 --> 02:05:35,868 AND ALMOST 50% OF BLACK MEN HAD 2760 02:05:35,868 --> 02:05:38,237 BMI ABOVE 30. THIS IS 2761 02:05:38,237 --> 02:05:39,371 NATIONALLY. YOU ARE 2762 02:05:39,371 --> 02:05:41,473 AUTOMATICALLY DISQUALIFYING 2763 02:05:41,473 --> 02:05:42,474 SIGNIFICANT AMOUNT OF BLACK 2764 02:05:42,474 --> 02:05:43,275 PATIENT POPULATION. 2765 02:05:43,275 --> 02:05:47,746 SIMILARLY I USE THE PFD 2766 02:05:47,746 --> 02:05:50,282 EXAMPLE, THE OTHER 2767 02:05:50,282 --> 02:05:51,817 COMORBIDITIES. IF YOU PICK UP 2768 02:05:51,817 --> 02:05:58,257 LAST FIVE CLINIC CAL TRIALS ACCT 2769 02:05:58,257 --> 02:06:00,459 DRUG TESTED DIFFERENT, TO ME 2770 02:06:00,459 --> 02:06:02,461 LOOK LIKE COPY EXACTLY THE SAME. 2771 02:06:02,461 --> 02:06:13,005 SAME EXCLUSIONARY CRITERIA, SAME 2772 02:06:14,473 --> 02:06:15,307 INELECTROC 2773 02:06:15,307 --> 02:06:15,974 INCLUSION AND DIFFERENT IN 3 BUT 2774 02:06:15,974 --> 02:06:17,543 IF YOU ARE LOOKING AT THE 2775 02:06:17,543 --> 02:06:18,610 PREDOMINANT DATA THEY ARE PRETTY 2776 02:06:18,610 --> 02:06:27,720 MUCH DONE THE SAME WAY. PD, FB 2777 02:06:27,720 --> 02:06:29,922 EXCLUDES AFRICAN-AMERICANS AND 2778 02:06:29,922 --> 02:06:31,623 OBESITY IS PREVALENT IN HISPANIC 2779 02:06:31,623 --> 02:06:32,958 POPULATION. WE EXCLUDE THEM. WE 2780 02:06:32,958 --> 02:06:36,328 KNOW INCREASE RISK FOR 2781 02:06:36,328 --> 02:06:38,297 OBSTRUCTIVE AIRWAY DISEASES. SO 2782 02:06:38,297 --> 02:06:39,898 CLEARLY YOU ARE -- WE ARE NOT 2783 02:06:39,898 --> 02:06:42,000 TALKING ABOUT THE LANGUAGE ISSUE 2784 02:06:42,000 --> 02:06:44,002 BUT EVEN WITH THE CO. MORBID 2785 02:06:44,002 --> 02:06:45,237 CONDITIONS WHICH MAY OR MAY NOT 2786 02:06:45,237 --> 02:06:48,507 HAVE THAT IMPLICATION OF 2787 02:06:48,507 --> 02:06:52,111 PERMANENT VASCULAR DISEASE BUT 2788 02:06:52,111 --> 02:06:55,547 THESE PATIENTS ARE BEING 2789 02:06:55,547 --> 02:06:58,283 EXCLUDED. SO THE QUESTION IS, 2790 02:06:58,283 --> 02:06:59,952 WHAT SHOULD WE DO? I FEEL WE 2791 02:06:59,952 --> 02:07:01,954 NEED TO BE MORE ADAPTIVE TO 2792 02:07:01,954 --> 02:07:02,955 CHANGING EPIDEMIOLOGY OF 2793 02:07:02,955 --> 02:07:06,225 DISEASE. WE ARE NOT DOING THE 2794 02:07:06,225 --> 02:07:08,494 TRI 2795 02:07:08,494 --> 02:07:13,966 TRIALS WHEN EVERYONE THE CLASSIC 2796 02:07:13,966 --> 02:07:16,568 DEFINITION WAS EVERYONE WAS 2797 02:07:16,568 --> 02:07:19,938 YOUNG-WE KNOW ALL AGE GROUPS WE 2798 02:07:19,938 --> 02:07:21,707 ARE SEEING SO PERHAPS NEED TO 2799 02:07:21,707 --> 02:07:23,475 CHANGE THOSE PROTOCOLS. SOME OF 2800 02:07:23,475 --> 02:07:27,246 THE POINTS I HIGHLIGHTED ABOUT 2801 02:07:27,246 --> 02:07:29,314 INSTITUTION ALSO INVOLVING MORE 2802 02:07:29,314 --> 02:07:33,252 BILINGUAL STAFF, WE DIDN'T HAVE 2803 02:07:33,252 --> 02:07:34,820 EARLIER, HIRED BILINGUAL STAFF 2804 02:07:34,820 --> 02:07:40,993 TO ENCOURAGE ENROLLMENT. THERE 2805 02:07:40,993 --> 02:07:42,428 ARE INSTITUTIONAL BARRIERS AS 2806 02:07:42,428 --> 02:07:42,761 WELL. 2807 02:07:42,761 --> 02:07:46,932 >> AGREED. MY QUESTION IS DO WE 2808 02:07:46,932 --> 02:07:49,201 KNOW ANYTHING ABOUT THE RACE AND 2809 02:07:49,201 --> 02:07:51,336 ETHNICITY OF CLINICAL TRIALISTS, 2810 02:07:51,336 --> 02:07:53,739 MAYBE THOSE DESIGNING THE STUDY 2811 02:07:53,739 --> 02:07:57,009 PROTOCOLS AND MAKEUP OF THE SAY 2812 02:07:57,009 --> 02:08:01,280 INSTITUTIONS THAT ARE ENROLLING? 2813 02:08:01,280 --> 02:08:03,949 WE TALK A LOT ABOUT 2814 02:08:03,949 --> 02:08:05,250 UNDERREPRESENTATION IN CLINICAL 2815 02:08:05,250 --> 02:08:08,420 TRIALS, ET CETERA, BUT, YOU 2816 02:08:08,420 --> 02:08:11,657 KNOW, THERE IS MORE THAN ONE 2817 02:08:11,657 --> 02:08:16,862 SIDE TO THIS THAT NEEDS TO BE 2818 02:08:16,862 --> 02:08:17,830 ADDRESSED SO I'M ASKING ON THE 2819 02:08:17,830 --> 02:08:18,897 FLIP SIDE OF THINGS. 2820 02:08:18,897 --> 02:08:21,500 >> I CANNOT SPEAK FOR THE WHOLE 2821 02:08:21,500 --> 02:08:25,237 COUNTRY BUT I CAN SPEAK ABOUT MY 2822 02:08:25,237 --> 02:08:30,309 PROGRAM, WHICH IS IN TERMS OF 2823 02:08:30,309 --> 02:08:32,978 HEALTH CARE PROVIDERS IS FAIRLY 2824 02:08:32,978 --> 02:08:34,513 DIVERSE. LIKE RIGHTLY POINTED 2825 02:08:34,513 --> 02:08:38,116 OUT THAT FOLKS INVOLVED IN TRIAL 2826 02:08:38,116 --> 02:08:41,153 DESIGN AND ALSO THE INDIVIDUAL 2827 02:08:41,153 --> 02:08:43,188 HEALTH CARE PROVIDER SHOULD BE 2828 02:08:43,188 --> 02:08:45,290 EQUALLY DIVERSE TOO TO 2829 02:08:45,290 --> 02:08:46,558 ACKNOWLEDGE THAT DIVERSITY IN 2830 02:08:46,558 --> 02:08:48,927 THE PATIENT POPULATION. THAT IS 2831 02:08:48,927 --> 02:08:50,329 A FAIR POINT. 2832 02:08:50,329 --> 02:08:52,364 >> MAY I ADD SOMETHING TO IT? I 2833 02:08:52,364 --> 02:08:54,867 THINK IT IS A GREAT POINT. THE 2834 02:08:54,867 --> 02:08:56,702 CULTURAL COMPETENCY TO ADDRESS 2835 02:08:56,702 --> 02:08:58,303 QUESTIONS WITHIN TRIALS, IF YOU 2836 02:08:58,303 --> 02:08:59,304 DON'T KNOW WHAT YOU DON'T KNOW, 2837 02:08:59,304 --> 02:09:01,340 IT IS HARD TO HAVE THAT 2838 02:09:01,340 --> 02:09:02,875 CONVERSATION. I THINK ONE POINT 2839 02:09:02,875 --> 02:09:04,543 OF THAT AND SOMETHING WE CAN 2840 02:09:04,543 --> 02:09:05,844 THINK ABOUT INTERVENTION IS IF 2841 02:09:05,844 --> 02:09:07,479 YOU THINK ABOUT PLACES THAT HAVE 2842 02:09:07,479 --> 02:09:09,181 TRIALS, ARE USUALLY THE SIGN TO 2843 02:09:09,181 --> 02:09:11,283 DO TRIALS. WHETHER A BIGGER 2844 02:09:11,283 --> 02:09:12,317 INSTITUTION, BIGGER ECONOMIC 2845 02:09:12,317 --> 02:09:14,620 CENTER, THERE ARE PROVIDERS WHO 2846 02:09:14,620 --> 02:09:17,189 DO WANT TO DO TRIALS BUT DON'T 2847 02:09:17,189 --> 02:09:19,191 KNOW HOW TO START. I HAD 2848 02:09:19,191 --> 02:09:25,497 PERSONAL EXPERIENCE WHEN I JO 2849 02:09:25,497 --> 02:09:26,131 JOINED WE DIDN'T KNOW AND I HAD 2850 02:09:26,131 --> 02:09:26,832 GREAT MENTORS THAT COULD HELP. 2851 02:09:26,832 --> 02:09:30,669 MAYBE AS COMMUNITY WE COULD DO A 2852 02:09:30,669 --> 02:09:31,737 MENTORSHIP PROGRAM, IF SOMEONE 2853 02:09:31,737 --> 02:09:33,405 WANTS TO DO A TRIAL, NEW MEXICO 2854 02:09:33,405 --> 02:09:35,140 OR SOMEWHERE ELSE, WHERE WE MAY 2855 02:09:35,140 --> 02:09:37,643 HAVE CERTAIN MORE DIVERSE 2856 02:09:37,643 --> 02:09:39,244 POPULATION THAT WE ARE NOT 2857 02:09:39,244 --> 02:09:40,312 GETTING TO AND THERE IS AN 2858 02:09:40,312 --> 02:09:41,747 INTERESTING PROVIDER, WE CAN 2859 02:09:41,747 --> 02:09:43,181 SUPPORT THEM IN A WAY THEY DON'T 2860 02:09:43,181 --> 02:09:45,050 FEEL THEY ARE BY THEMSELVES 2861 02:09:45,050 --> 02:09:47,653 TRYING TO BUILD UP A RESEARCH, 2862 02:09:47,653 --> 02:09:49,388 GROUP OR TRIAL GROUP. 2863 02:09:49,388 --> 02:09:52,891 >> I HAVE A FOLLOW-UP COMMENT ON 2864 02:09:52,891 --> 02:09:55,394 THIS. IN ONE OF THE SLIDES I DID 2865 02:09:55,394 --> 02:10:01,366 MAKE A POINT THAT DO WE KNOW 2866 02:10:01,366 --> 02:10:07,272 REGARDLESS OF THE PVD ANY OTHER 2867 02:10:07,272 --> 02:10:11,777 DISEASES THAT NIH OR FDA 2868 02:10:11,777 --> 02:10:13,378 MANDATES PRIVATE SPONSORS OR 2869 02:10:13,378 --> 02:10:16,615 STUDIES THAT YOU NEED TO HAVE 2870 02:10:16,615 --> 02:10:19,251 CERTAIN PERCENTAGE OF PATIENT 2871 02:10:19,251 --> 02:10:21,453 POPULATION REPRESENTING HISPANIC 2872 02:10:21,453 --> 02:10:24,957 OR BLACK, INCONSISTENT WITH 2873 02:10:24,957 --> 02:10:26,592 POPULATION OR DEMOGRAPHICS. I'M 2874 02:10:26,592 --> 02:10:31,730 NOT AWARE OF THAT. I FEEL UNLESS 2875 02:10:31,730 --> 02:10:36,168 NIH OR FDA MANDATES THAT TYPE OF 2876 02:10:36,168 --> 02:10:37,636 THING, I THINK THAT IS ONE OF 2877 02:10:37,636 --> 02:10:39,538 THE ROOT CAUSE ISSUES WHICH CAN 2878 02:10:39,538 --> 02:10:41,306 ADD TRESZ THERE. I DON'T KNOW 2879 02:10:41,306 --> 02:10:42,007 ABOUT THAT PART. 2880 02:10:42,007 --> 02:10:46,044 >> I CAN HELP TO ADDRESS THAT. I 2881 02:10:46,044 --> 02:10:49,414 WAS INTENDING TO ANSWER A 2882 02:10:49,414 --> 02:10:51,483 QUESTION. I CAN'T HELP ON THE 2883 02:10:51,483 --> 02:10:53,385 FDA BUT NIH, THIS IS WHILE 2884 02:10:53,385 --> 02:10:56,822 MAINTAINED REQUIRED ISSUE FOR 2885 02:10:56,822 --> 02:11:01,293 THE OLDER (?) TRIAL ENROLL 2886 02:11:01,293 --> 02:11:03,295 PATIENTS. IF YOU GET FUNDED 2887 02:11:03,295 --> 02:11:05,764 BEFORE FOR THIS TYPE STUDY THERE 2888 02:11:05,764 --> 02:11:08,333 WILL BE INCLUSION ENROLLMENT 2889 02:11:08,333 --> 02:11:09,968 RECORD TABLE WHEN YOU SUBMIT 2890 02:11:09,968 --> 02:11:13,872 YOUR APPLICATION. THAT IS A 2891 02:11:13,872 --> 02:11:15,240 TABLE SPECIFICALLY MENTIONED, 2892 02:11:15,240 --> 02:11:16,908 YOU HAVE TO DESCRIBE HOW MANY 2893 02:11:16,908 --> 02:11:19,745 YOU PLAN TO ENROLL AND ONCE 2894 02:11:19,745 --> 02:11:23,315 RACIAL AND ETHNICITY DIVERSITY 2895 02:11:23,315 --> 02:11:27,753 FOR THIS. SO ASK THE SPECIFIC 2896 02:11:27,753 --> 02:11:30,355 FOR MEMBERS IN EACH CATEGORY. 2897 02:11:30,355 --> 02:11:33,158 THIS WILL BE AN ANNUAL REPORT. 2898 02:11:33,158 --> 02:11:35,560 WE AS PO, PROGRAM OFFICER, WE 2899 02:11:35,560 --> 02:11:38,130 WILL REVIEW ENROLLMENT IN 2900 02:11:38,130 --> 02:11:40,399 PROGRAM. NOT ONLY TOTAL NUMBER 2901 02:11:40,399 --> 02:11:42,501 BUT DIVERSITY. THIS IS A 2902 02:11:42,501 --> 02:11:44,002 REQUIREMENT FOR US IN THAT JOB. 2903 02:11:44,002 --> 02:11:45,971 OF COURSE WE HAVEN'T HAD A FIXED 2904 02:11:45,971 --> 02:11:47,873 NUMBER FOR EACH RULE HOW MANY 2905 02:11:47,873 --> 02:11:49,941 PATIENT WE HAVE. THIS IS 2906 02:11:49,941 --> 02:11:54,613 PROBABLY NOT REALISTIC FOR 2907 02:11:54,613 --> 02:11:56,415 CERTAIN INVESTIGATORS IN CERTAIN 2908 02:11:56,415 --> 02:11:57,816 AREA, BUT THIS IS DEFINITELY YOU 2909 02:11:57,816 --> 02:11:59,518 HAVE TO PUT IT IN THERE. SO THAT 2910 02:11:59,518 --> 02:12:04,056 IS WHY THIS IS REQUIRED ITEMS 2911 02:12:04,056 --> 02:12:07,092 FOR CLINICAL STUDY. IF YOU -- 2912 02:12:07,092 --> 02:12:08,360 JUST SAY YOU APPLICATION ONLY 2913 02:12:08,360 --> 02:12:10,095 INCLUDES SAY WE ARE ENROLLED 2914 02:12:10,095 --> 02:12:13,031 TOTALLY CAUCASIAN POPULATION, 2915 02:12:13,031 --> 02:12:14,466 YOUR GRANT WILL NOT BE FUNDED SO 2916 02:12:14,466 --> 02:12:17,969 THIS IS THE PRESSURE ABOUT THAT. 2917 02:12:17,969 --> 02:12:20,272 SO YEAH, THAT IS -- TRY -- I 2918 02:12:20,272 --> 02:12:22,007 THINK FDA HAVE SIMILAR PROBABLY 2919 02:12:22,007 --> 02:12:24,142 POLICY, BUT I COULD NOT ANSWER 2920 02:12:24,142 --> 02:12:27,446 ON BE HALF OF THEM. 2921 02:12:27,446 --> 02:12:32,818 >> THANK YOU. DR. ORTEGA. 2922 02:12:32,818 --> 02:12:34,953 >> YOU KNOW, MY COMMENT IS MORE 2923 02:12:34,953 --> 02:12:42,194 AS WE LOOKOUT -- LOOK OUTWARD 2924 02:12:42,194 --> 02:12:43,929 TO INCREASE CLINICAL TRIALS IT 2925 02:12:43,929 --> 02:12:45,831 IS IMPORTANT TO LOOK INWARDS FOR 2926 02:12:45,831 --> 02:12:47,232 TRIALS. WE ARE TRYING TO RECRUIT 2927 02:12:47,232 --> 02:12:49,101 AS MANY PATIENTS AS FAST AS 2928 02:12:49,101 --> 02:12:50,502 POSSIBLE. THAT USUALLY DEFAULTS 2929 02:12:50,502 --> 02:12:51,837 TO THE MOST CONVENIENT SAMPLE. 2930 02:12:51,837 --> 02:12:53,538 YOU KNOW WHAT I MEAN? OUR 2931 02:12:53,538 --> 02:12:55,373 PATIENTS THAT ARE THE MOST 2932 02:12:55,373 --> 02:12:56,475 CONSISTENTLY, OH THIS IS THE 2933 02:12:56,475 --> 02:12:58,176 BEST PATIENT WE HAVE. INSTEAD OF 2934 02:12:58,176 --> 02:12:59,578 TAKING ALL YOUR PATIENTS, 2935 02:12:59,578 --> 02:13:01,079 THROWING ALL IN A HAT AND 2936 02:13:01,079 --> 02:13:06,818 RANDOMLY PICKING YOUR NEXT 2937 02:13:06,818 --> 02:13:08,854 PATIENT TO DO THE BEST JOB, THE 2938 02:13:08,854 --> 02:13:10,655 MOST AVAILABLE, THE MOST 2939 02:13:10,655 --> 02:13:12,591 CONVENIENT. I THINK WE HAVE TO 2940 02:13:12,591 --> 02:13:14,025 LOOK IN MORE AND BE MORE WILLING 2941 02:13:14,025 --> 02:13:15,427 TO TAKE ON PATIENTS THAT ARE 2942 02:13:15,427 --> 02:13:17,028 GOING TO BE HARDER TO BRING IN. 2943 02:13:17,028 --> 02:13:18,630 THAT ALSO IS HARD ON 2944 02:13:18,630 --> 02:13:19,431 INFRASTRUCTURE, RIGHT. LIKE WE 2945 02:13:19,431 --> 02:13:22,167 REALLY HAVE TO HAVE PEOPLE WORK 2946 02:13:22,167 --> 02:13:23,168 ON WEEKENDS. BECAUSE THOSE 2947 02:13:23,168 --> 02:13:25,771 POPULATIONS THAT ARE HIT THE 2948 02:13:25,771 --> 02:13:27,038 HARDEST DON'T NECESSARILY -- 2949 02:13:27,038 --> 02:13:28,573 MAYBE THEY ARE WORKING TWO JOBS. 2950 02:13:28,573 --> 02:13:31,777 THERE'S REASONS. IT IS -- 2951 02:13:31,777 --> 02:13:34,780 UNFORTUNATELY, IT IS A VICIOUS 2952 02:13:34,780 --> 02:13:35,781 CYCLE THAT FEEDS ONTO ITSELF FOR 2953 02:13:35,781 --> 02:13:38,116 THIS. I THINK WE HAVE TO LOOK 2954 02:13:38,116 --> 02:13:40,318 INWARD, LOOK AT OUR STRATEGIES 2955 02:13:40,318 --> 02:13:43,188 AS WELL. AND I HEARD THE BELL. 2956 02:13:43,188 --> 02:13:45,257 >> YEAH, ACTUALLY I AGREE WITH 2957 02:13:45,257 --> 02:13:47,926 DR. ORTEGA'S COMMENT. WE HAVE -- 2958 02:13:47,926 --> 02:13:51,429 I JUST WANT TO SHARE WITH YOU, 2959 02:13:51,429 --> 02:13:53,398 SOME OF THE (?) MANAGING THE 2960 02:13:53,398 --> 02:13:57,269 TRIAL, THERE WAS A STUDY 2961 02:13:57,269 --> 02:14:00,305 REALIZED CAUCASIAN IS LIMITED TO 2962 02:14:00,305 --> 02:14:01,506 SHOULD HAVE AND LACK IN BLACK 2963 02:14:01,506 --> 02:14:02,874 POPULATION SO TELL THE 2964 02:14:02,874 --> 02:14:04,342 INVESTIGATORS OF THE STUDY TO 2965 02:14:04,342 --> 02:14:09,247 START RECRUITING MORE CAUCASIAN 2966 02:14:09,247 --> 02:14:10,782 PATIENT, THEY HAVE ONLY FOCUSED 2967 02:14:10,782 --> 02:14:13,819 ON MINORITIES BECAUSE THEY ARE 2968 02:14:13,819 --> 02:14:16,922 -- OVER THE QUOTA FOR CAUCASIAN 2969 02:14:16,922 --> 02:14:18,056 POPULATION. THIS IS REALLY 2970 02:14:18,056 --> 02:14:20,192 HAPPENING FOR THE NIH-FUNDED 2971 02:14:20,192 --> 02:14:22,828 STUDY. AS YOU SAID SOME OF -- IT 2972 02:14:22,828 --> 02:14:27,065 IS MORE CONVENIENT -- DEPENDS ON 2973 02:14:27,065 --> 02:14:28,567 WHERE THEY ARE LOCATION -- 2974 02:14:28,567 --> 02:14:31,002 PROBABLY EASIER FOR INVESTIGATOR 2975 02:14:31,002 --> 02:14:33,238 IN CERTAIN POPULATION BUT SINCE 2976 02:14:33,238 --> 02:14:34,973 FUNDED BY NIH THIS IS REQUIRED 2977 02:14:34,973 --> 02:14:36,107 SO HAVE CERTAIN TIME THEY HAVE 2978 02:14:36,107 --> 02:14:38,677 TO MAKE SURE THEY ARE CATCHING 2979 02:14:38,677 --> 02:14:40,478 UP WITH THE MINORITY POPULATION 2980 02:14:40,478 --> 02:14:42,747 TOO, SO THAT IS PART OF THE 2981 02:14:42,747 --> 02:14:43,148 REQUIREMENT. 2982 02:14:43,148 --> 02:14:47,719 >> IN LITERATURE THERE ARE 2983 02:14:47,719 --> 02:14:49,721 EXAMPLE OF MINORITY GIVEN LESS 2984 02:14:49,721 --> 02:14:52,624 OR COMBINATION DRUGS. THERE ARE 2985 02:14:52,624 --> 02:14:53,625 INHERENT BIASES THAT EXIST AND 2986 02:14:53,625 --> 02:14:56,127 APPLY TO THERAPIES IN MORE 2987 02:14:56,127 --> 02:14:58,830 ADVANCED CLINICAL TRIALS. WHY IT 2988 02:14:58,830 --> 02:15:01,633 EXISTS, WHO KNOWS BUT WE NEED TO 2989 02:15:01,633 --> 02:15:02,968 RECOGNIZE AND GO FOR THAT 2990 02:15:02,968 --> 02:15:03,235 EXAMPLE. 2991 02:15:03,235 --> 02:15:06,238 >> YOU CAN ADD TOO, THAT MAY BE 2992 02:15:06,238 --> 02:15:08,840 PROVIDER BIAS. YOU KNOW, BECAUSE 2993 02:15:08,840 --> 02:15:11,109 OF DIVERSE -- YEP, SO THOSE 2994 02:15:11,109 --> 02:15:14,312 THINGS NEED TO BE INCORPORATED 2995 02:15:14,312 --> 02:15:15,513 AS WELL. 2996 02:15:15,513 --> 02:15:18,049 >> I ALWAYS SAY PHYSICIAN BIAS, 2997 02:15:18,049 --> 02:15:19,384 WHEN YOU DECIDE WHAT TREATMENT 2998 02:15:19,384 --> 02:15:23,655 IS GOOD FOR YOU INSTEAD OF 2999 02:15:23,655 --> 02:15:25,757 PATIENT TELLING YOU WHAT THEY 3000 02:15:25,757 --> 02:15:26,858 DESIRE OR WHAT GUIDELINE 3001 02:15:26,858 --> 02:15:27,559 RECOMMENDS THAT PATIENT SHOULD 3002 02:15:27,559 --> 02:15:29,594 BE ON. I THINK YOU BROUGHT UP A 3003 02:15:29,594 --> 02:15:31,997 VERY REALISTIC -- DR. ORTEGA, 3004 02:15:31,997 --> 02:15:35,867 YOUR POINT IS VERY WELL TAKEN. 3005 02:15:35,867 --> 02:15:39,271 THIS IS A VERY REAL -- RUNNING A 3006 02:15:39,271 --> 02:15:41,172 CLINICAL TRIAL ISSUE THAT YOU 3007 02:15:41,172 --> 02:15:43,141 BROUGHT UP. THIS IS LIKE AN 3008 02:15:43,141 --> 02:15:44,109 EVERYDAY CONVERSATION WITH MY 3009 02:15:44,109 --> 02:15:45,710 TEAM. OH, WHICH PATIENT SHOULD 3010 02:15:45,710 --> 02:15:47,545 WE ENROLL, WHETHER THIS PATIENT 3011 02:15:47,545 --> 02:15:50,382 IS GOING TO BE RELIABLE TO 3012 02:15:50,382 --> 02:15:52,350 PARTICIPATE IN THE CLINICAL 3013 02:15:52,350 --> 02:15:54,519 TRIAL. SOME WERE RANDOMLY, SOME 3014 02:15:54,519 --> 02:15:56,288 WERE IN THE CHART DOCUMENTED FOR 3015 02:15:56,288 --> 02:15:57,689 WHATEVER REASON, THE PATIENT 3016 02:15:57,689 --> 02:16:01,960 MISSED TWO DOSES OR 3017 02:16:01,960 --> 02:16:03,261 NON-COMPLIANT, LIKE DOCUMENTED 3018 02:16:03,261 --> 02:16:05,363 IN OUR RECORDS AND THIS PATIENT 3019 02:16:05,363 --> 02:16:07,666 FOREVER IS LABELED AS 3020 02:16:07,666 --> 02:16:09,134 NON-COMPLIANT. WHEN I GO AND I 3021 02:16:09,134 --> 02:16:10,635 HAVE A DIFFERENT OPINION AND MY 3022 02:16:10,635 --> 02:16:12,570 RESEARCH NURSE REVIEWS THE CART 3023 02:16:12,570 --> 02:16:13,571 AND SHE WILL HAVE A DIFFERENT 3024 02:16:13,571 --> 02:16:15,140 OPINION AND I HAVE TO HAVE THIS 3025 02:16:15,140 --> 02:16:16,341 CONVERSATION AGAIN THAT NO, THIS 3026 02:16:16,341 --> 02:16:18,877 COULD BE. BUT I THINK THIS IS A 3027 02:16:18,877 --> 02:16:21,713 VERY MUCH REAL LIFE ISSUE, WHAT 3028 02:16:21,713 --> 02:16:25,083 YOU BROUGHT UP. THAT IS WHERE 3029 02:16:25,083 --> 02:16:28,219 THE BIASES START, PRETTY MUCH. 3030 02:16:28,219 --> 02:16:30,155 >> I THINK WE ARE NEARING OUR 3031 02:16:30,155 --> 02:16:32,457 POINT WHERE WE MAY HAVE TO 3032 02:16:32,457 --> 02:16:34,759 ADJOURN, BUT I THINK DR. ORTEGA 3033 02:16:34,759 --> 02:16:38,129 BROUGHT UP A VERY IMPORTANT 3034 02:16:38,129 --> 02:16:39,931 POINT, JUST TO REITERATE. AND 3035 02:16:39,931 --> 02:16:41,533 PART OF MY INITIAL POINT OF 3036 02:16:41,533 --> 02:16:43,134 MAKING THAT WE DON'T KNOW 3037 02:16:43,134 --> 02:16:49,040 SOMETIMES OUR OWN BIASES. THE 3038 02:16:49,040 --> 02:16:50,675 BIASES WE INCORPORATE WHEN WE 3039 02:16:50,675 --> 02:16:52,677 ARE DESIGNING TRIALS OR 3040 02:16:52,677 --> 02:16:53,979 GUIDELINES THAT MAY BE RELIANT 3041 02:16:53,979 --> 02:16:56,614 ON PREVIOUS RESEARCH THAT WAS 3042 02:16:56,614 --> 02:16:56,881 BIASSED. 3043 02:16:56,881 --> 02:16:58,483 IS THERE ANYTHING -- BEFORE 3044 02:16:58,483 --> 02:17:01,953 WE ADJOURN IS THERE ANYTHING WE 3045 02:17:01,953 --> 02:17:07,525 CAN DO IN THE DESIGN PHASE OF A 3046 02:17:07,525 --> 02:17:09,928 TRIAL, WHETHER IT IS US OR 3047 02:17:09,928 --> 02:17:11,563 INDUSTRY OR WHATEVER ELSE, 3048 02:17:11,563 --> 02:17:14,532 SHOULD WE BRING IN MORE OPINIONS 3049 02:17:14,532 --> 02:17:17,435 TO EXAMINE OUR OWN BIASES AND 3050 02:17:17,435 --> 02:17:21,039 HOW THOSE MIGHT LAYOUT WHEN IT 3051 02:17:21,039 --> 02:17:23,475 COMES TO THE TRIAL RESULTS OR 3052 02:17:23,475 --> 02:17:25,910 WHAT ARE YOUR RECOMMENDATIONS? 3053 02:17:25,910 --> 02:17:27,879 >> I DON'T THINK WE -- I JUST 3054 02:17:27,879 --> 02:17:30,749 HAVE ONE COMMENT TO MAKE ON THAT 3055 02:17:30,749 --> 02:17:32,951 PART. I SEE SO MANY CLINICAL 3056 02:17:32,951 --> 02:17:36,287 TRIALS PROTOCOLS ON REGULAR 3057 02:17:36,287 --> 02:17:37,789 BASIS, FROM DIFFERENT INDUSTRY 3058 02:17:37,789 --> 02:17:41,359 SPONSORS OR ANYONE. I AM YET TO 3059 02:17:41,359 --> 02:17:46,464 SEE A PROTOCOL WHERE ANY OF THE 3060 02:17:46,464 --> 02:17:50,735 SPONSORS HAVE SPECIFIED THAT NOT 3061 02:17:50,735 --> 02:17:54,939 AS A TOOL BUT AS ENCOURAGEMENT. 3062 02:17:54,939 --> 02:17:56,908 THAT WE ENCOURAGE PARTICIPATION 3063 02:17:56,908 --> 02:17:59,210 FROM A DIVERSE PATIENT 3064 02:17:59,210 --> 02:18:02,347 POPULATION, AS REQUIRED BY THE 3065 02:18:02,347 --> 02:18:04,349 FDA, OR EXPECTED BY THE FDA NOT 3066 02:18:04,349 --> 02:18:08,119 EVEN REQUIRED. I DON'T THINK -- 3067 02:18:08,119 --> 02:18:09,287 WE DON'T EVEN TALK ABOUT THAT. 3068 02:18:09,287 --> 02:18:11,523 WHEN YOU DO NOT TALK ABOUT THAT, 3069 02:18:11,523 --> 02:18:13,291 THIS IS DEFINITELY OVERLOOKED. I 3070 02:18:13,291 --> 02:18:14,392 THINK WE NEED TO START 3071 02:18:14,392 --> 02:18:18,063 CONVERSATIONS SOMEWHERE THAT WE 3072 02:18:18,063 --> 02:18:19,264 START DOCUMENTING THESE IN THESE 3073 02:18:19,264 --> 02:18:21,032 -- I DON'T THINK THERE IS GOING 3074 02:18:21,032 --> 02:18:22,901 O BE ANY HARM OR DOWNSIDE OF 3075 02:18:22,901 --> 02:18:24,569 THAT. BUT IF YOU START 3076 02:18:24,569 --> 02:18:27,238 DOCUMENTING THAT HEY, WE 3077 02:18:27,238 --> 02:18:31,409 ENCOURAGE THE PATIENT -- IF YOU 3078 02:18:31,409 --> 02:18:34,512 ARE LOOKING A SITE IN TEXAS OR 3079 02:18:34,512 --> 02:18:36,414 ARIZONA, HEAVILY HISPANIC 3080 02:18:36,414 --> 02:18:38,316 POPULATION, PREDOMINANT AREAS, 3081 02:18:38,316 --> 02:18:41,653 WE ENCOURAGE THAT YOU ENROLL 3082 02:18:41,653 --> 02:18:42,654 MORE HISPANIC PATIENT 3083 02:18:42,654 --> 02:18:44,089 POPULATION. SUDDENLY, PEOPLE 3084 02:18:44,089 --> 02:18:46,458 WILL START TO THINK ABOUT IT. 3085 02:18:46,458 --> 02:18:47,725 BECAUSE CURRENTLY NO ONE EVEN 3086 02:18:47,725 --> 02:18:50,495 THINKS ABOUT IT. THAT IS JUST MY 3087 02:18:50,495 --> 02:18:52,197 COMMENT. I DON'T KNOW WE CAN 3088 02:18:52,197 --> 02:18:54,365 MANDATE TO THE PRIVATE SPONSORS, 3089 02:18:54,365 --> 02:18:57,936 BUT AT LEAST MAKING THIS 3090 02:18:57,936 --> 02:18:59,037 REQUIREMENT AT LEAST DO 3091 02:18:59,037 --> 02:19:00,472 DOCUMENT, SO THAT THE 3092 02:19:00,472 --> 02:19:01,840 INVESTIGATOR OR THE RESEARCH 3093 02:19:01,840 --> 02:19:04,676 TEAM, WHOEVER IS REVIEWING THOSE 3094 02:19:04,676 --> 02:19:05,643 PROTOCOLS, CAN START THINKING 3095 02:19:05,643 --> 02:19:08,313 ABOUT IT. I CAN MAKE IT PART. 3096 02:19:08,313 --> 02:19:11,549 THE IRB, WHO KNOWS HOW THEY WILL 3097 02:19:11,549 --> 02:19:13,651 DIFFERENTIATE THE INDIVIDUAL 3098 02:19:13,651 --> 02:19:14,119 IRBs. 3099 02:19:14,119 --> 02:19:15,987 >> THANK YOU. YOU KNOW, INDUSTRY 3100 02:19:15,987 --> 02:19:16,988 HAS THEIR GOALS. 3101 02:19:16,988 --> 02:19:17,522 >> YEAH. 3102 02:19:17,522 --> 02:19:20,125 >> THEY HAVE THEIR GOALS. THEY 3103 02:19:20,125 --> 02:19:21,693 ARE IN THE PRESSURE COOKER LIKE 3104 02:19:21,693 --> 02:19:23,761 WE ARE. IF YOU ARE IN A PRESSURE 3105 02:19:23,761 --> 02:19:25,597 COOKER AND GOT TO RECRUIT YOU 3106 02:19:25,597 --> 02:19:26,998 WILL BE LESS LIKELY TO RECRUIT 3107 02:19:26,998 --> 02:19:29,434 PEOPLE YOU THINK ARE LESS LIKELY 3108 02:19:29,434 --> 02:19:30,969 TO BE HARD OR LIKELY TO FOLLOW. 3109 02:19:30,969 --> 02:19:32,737 THAT IS THE WAY IT IS. THERE HAS 3110 02:19:32,737 --> 02:19:35,607 TO BE AWARENESS AND HAS TO BE 3111 02:19:35,607 --> 02:19:37,475 ACCOUNTABILITY TO THOSE BODIES, 3112 02:19:37,475 --> 02:19:41,045 THOSE INDUSTRIAL BODIES. NHLBI 3113 02:19:41,045 --> 02:19:42,714 DOES PROVIDE ACCOUNTABILITY. I 3114 02:19:42,714 --> 02:19:43,948 HAVE HAD TO FILL THOSE TABLES 3115 02:19:43,948 --> 02:19:45,617 OUT A LONG TIME. I DON'T KNOW 3116 02:19:45,617 --> 02:19:48,119 HOW MANY GET REJECTED BASED -- I 3117 02:19:48,119 --> 02:19:49,821 DON'T KNOW THE FORMULA FOR 3118 02:19:49,821 --> 02:19:51,055 REJECTION. IF THERE IS ANY 3119 02:19:51,055 --> 02:19:53,725 USEFUL USE FOR THESE 3120 02:19:53,725 --> 02:19:56,027 NON-BIOLOGIC RACE/ETHNICITY 3121 02:19:56,027 --> 02:19:57,629 THINGS IT IS TO MAKE SURE WE ARE 3122 02:19:57,629 --> 02:19:58,897 ACTUALLY FILLING THOSE TABLES 3123 02:19:58,897 --> 02:20:00,899 OUT AND RECRUITING DIVERSELY. IF 3124 02:20:00,899 --> 02:20:02,133 THERE IS ANY GOOD USE, THAT 3125 02:20:02,133 --> 02:20:05,670 WOULD BE ONE FOR SURE, BECAUSE 3126 02:20:05,670 --> 02:20:07,605 IT IS NOT GREAT PRINCIPLE WE'VE 3127 02:20:07,605 --> 02:20:09,607 GOT BUT IT IS A MATTER OF -- 3128 02:20:09,607 --> 02:20:11,242 DON'T KNOW HOW WE DO THIS, BUT 3129 02:20:11,242 --> 02:20:13,645 THAT AWARENESS, I CAN'T GET AWAY 3130 02:20:13,645 --> 02:20:15,613 FROM THE FACT THIS BEHAVIOR IS 3131 02:20:15,613 --> 02:20:16,748 JUST SOMETHING THAT WE'VE ALL 3132 02:20:16,748 --> 02:20:19,551 PROBABLY DONE IT. WE WANT TO 3133 02:20:19,551 --> 02:20:21,085 RECRUIT. WE HAVE OUR PATIENTS 3134 02:20:21,085 --> 02:20:22,487 THAT ARE OUR FAVORITE PATIENTS. 3135 02:20:22,487 --> 02:20:24,355 THAT IS NOT FAIR. WHAT IS FAIR 3136 02:20:24,355 --> 02:20:27,258 IS TAKING ALL THE PATIENTS, 3137 02:20:27,258 --> 02:20:28,860 PUTTING THEIR NAMES IN A HAT AND 3138 02:20:28,860 --> 02:20:30,195 RANDOMLY PICKING A NUMBER. OH, 3139 02:20:30,195 --> 02:20:33,164 THIS ONE IS... WHO CARES, THIS 3140 02:20:33,164 --> 02:20:34,766 IS JUST, THIS IS FAIR TO INCLUDE 3141 02:20:34,766 --> 02:20:36,901 THESE PATIENTS. THOUGH IT WILL 3142 02:20:36,901 --> 02:20:38,836 BE HARDER TO MAKE SURE THIS 3143 02:20:38,836 --> 02:20:41,739 PATIENT IS COMPLIANT. THAT IS AN 3144 02:20:41,739 --> 02:20:42,707 INHERENT BIAS. WOULD THEY REALLY 3145 02:20:42,707 --> 02:20:44,776 BE THAT HARD TO BE IN A TRIAL? 3146 02:20:44,776 --> 02:20:47,111 THAT IS ACTUALLY A BIAS. I JUST 3147 02:20:47,111 --> 02:20:50,248 SAID IT, A BIAS. I DID THAT 3148 02:20:50,248 --> 02:20:51,382 INTENTIONALLY, LIKE I'M AWARE OF 3149 02:20:51,382 --> 02:20:55,453 THE BIAS. THERE ARE 3150 02:20:55,453 --> 02:20:57,855 SELF-ADMINISTERED TESTS ON BIAS 3151 02:20:57,855 --> 02:21:00,058 I WOULD ENCOURAGE. IT IS A 3152 02:21:00,058 --> 02:21:02,327 MATTER OF AWARENESS IN INDUSTRY 3153 02:21:02,327 --> 02:21:06,130 AT ALL LEVELS BUT WHAT IS THE 3154 02:21:06,130 --> 02:21:09,167 MAGIC FORMULA? WE ALSO HAVE TO 3155 02:21:09,167 --> 02:21:12,804 LOOK INWARD. WE ARE PEOPLE WHO 3156 02:21:12,804 --> 02:21:15,206 TALK TO INDUSTRY, CONNECTED TO 3157 02:21:15,206 --> 02:21:17,175 THOSE CLINICAL TRIALS. IT IS 3158 02:21:17,175 --> 02:21:19,043 REALLY -- WISH I HAD A BETTER 3159 02:21:19,043 --> 02:21:22,013 ANSWER THAN THAT BUT PROBABLY 3160 02:21:22,013 --> 02:21:22,580 WHAT I GOT. 3161 02:21:22,580 --> 02:21:23,915 >> ALL RIGHT. THANK YOU VERY 3162 02:21:23,915 --> 02:21:26,584 MUCH, DR. ORTEGA. I WANT TO 3163 02:21:26,584 --> 02:21:27,452 ENCOURAGE EVERYONE TO LOOK AT 3164 02:21:27,452 --> 02:21:31,956 THE GREAT COMMENTS WE HAVE FROM 3165 02:21:31,956 --> 02:21:33,324 DOCTORS GLEN AND VENTETUOLO IN 3166 02:21:33,324 --> 02:21:35,526 THE CHAT. ALSO THERE IS A 3167 02:21:35,526 --> 02:21:39,163 QUESTION REALLY QUICK ON 3168 02:21:39,163 --> 02:21:46,371 DISTENSIBILITY AND DEMOGRAPHY. 3169 02:21:46,371 --> 02:21:50,308 DID TENSABILITY IS DETERMINED BY 3170 02:21:50,308 --> 02:21:54,345 RIGHT HEART CATEGORITIZATION AND 3171 02:21:54,345 --> 02:21:56,948 RELATIONSHIP TO DISTENSIBILITY, 3172 02:21:56,948 --> 02:21:58,549 SEX, AGE, ALTITUDE. NONE OF 3173 02:21:58,549 --> 02:22:02,120 THOSE FACTORS WERE REFERENCED BY 3174 02:22:02,120 --> 02:22:04,289 THE CHEST PUBLICATION. IN ANY 3175 02:22:04,289 --> 02:22:10,261 CASE, THE POINT HERE IS THAT 3176 02:22:10,261 --> 02:22:11,462 AFRICAN-SUB SAHARANS MAY 3177 02:22:11,462 --> 02:22:12,864 INFLUENCE DISTENSIBILITY BY 3178 02:22:12,864 --> 02:22:14,432 ENVIRONMENT IN WHICH THEY GREW 3179 02:22:14,432 --> 02:22:16,301 UP. THAT WAS OVERLOOKED BY THE 3180 02:22:16,301 --> 02:22:19,871 INITIAL STUDY IN 1985. IF IT IS 3181 02:22:19,871 --> 02:22:21,906 OVERLOOKED CONTINUOUSLY THROUGH 3182 02:22:21,906 --> 02:22:24,842 GUIDELINE PRESENTATION, THEN WE 3183 02:22:24,842 --> 02:22:26,711 MAY MISS THE BALL THERE. SO IN 3184 02:22:26,711 --> 02:22:29,347 ANY CASE, LET'S ADJOURN. SORRY 3185 02:22:29,347 --> 02:22:32,116 FOR THE DELAY FOR YOUR LUNCH ON 3186 02:22:32,116 --> 02:22:35,453 THE EAST COAST. WE WILL 3187 02:22:35,453 --> 02:22:41,259 RECONVENE IN APPROXIMATELY 40 3188 02:22:41,259 --> 02:22:43,261 MINUTES-ISH WITH THE SEX AND 3189 02:22:43,261 --> 02:22:44,156 GENDER DIFFERENCES SESSION, THANK YOU. (LUNCH BREAK) 3190 02:22:47,192 --> 02:22:48,994 >> AFTER GOOD LUNCH ON EAST 3191 02:22:48,994 --> 02:22:51,163 COAST, BREAKFAST ON THE WEST AND 3192 02:22:51,163 --> 02:22:53,332 SOMEWHERE IN BETWEEN... IF WE 3193 02:22:53,332 --> 02:22:55,634 ARE READY, CAN WE -- ARE WE 3194 02:22:55,634 --> 02:22:58,070 READY, SHAUN, TO START? 3195 02:22:58,070 --> 02:22:59,939 >> YES, SIR, WE ARE. 3196 02:22:59,939 --> 02:23:05,411 >> OKAY, GREAT. WITH THAT I WILL 3197 02:23:05,411 --> 02:23:07,346 INTRODUCE THE NEXT SESSION, SEX 3198 02:23:07,346 --> 02:23:14,153 AND GENDER DIFFERENCES WITH 3199 02:23:14,153 --> 02:23:21,460 THOSE WITH PULMONARY VASCULAR 3200 02:23:21,460 --> 02:23:29,168 DISEASE. 3201 02:23:29,168 --> 02:23:39,712 DISEASE. TAKE IT AWAY, DR. 3202 02:23:49,355 --> 02:23:51,256 STHAH. 3203 02:23:51,256 --> 02:23:53,826 >> WE DON'T SEE THEM YET. 3204 02:23:53,826 --> 02:23:56,462 >> I THOUGHT IT WAS ME. 3205 02:23:56,462 --> 02:23:58,764 >> THAT ODD, BECAUSE I DO SEE 3206 02:23:58,764 --> 02:23:58,998 THEM. 3207 02:23:58,998 --> 02:24:01,300 >> DR. HORN SEES THEM. 3208 02:24:01,300 --> 02:24:04,703 >> DON'T SEE THEM. MOST 3209 02:24:04,703 --> 02:24:15,214 IMPORTANT THING IS DR. STRAH. 3210 02:24:20,119 --> 02:24:23,389 >> AT THE TOP OF THE SCREEN. 3211 02:24:23,389 --> 02:24:31,997 >> WONDERFUL, THANK YOU. 3212 02:24:31,997 --> 02:24:35,667 >> I WANT TO THANK YOU. IT IS AN 3213 02:24:35,667 --> 02:24:42,174 HONOR. I'M HEATHER STRAH FROM 3214 02:24:42,174 --> 02:24:44,543 THE UNIVERSITY OF NEBRASKA AND 3215 02:24:44,543 --> 02:24:47,913 TALKING ABOUT INTERSECTION OF 3216 02:24:47,913 --> 02:24:53,852 SEX, GENDER AND PULMONARY 3217 02:24:53,852 --> 02:24:58,257 DISEASE. NEXT SLIDE, PLEASE. 3218 02:24:58,257 --> 02:25:06,532 OKAY. FIRST I WOULD LIKE TO 3219 02:25:06,532 --> 02:25:09,068 CLARIFY THIS A BROAD TERM THAT 3220 02:25:09,068 --> 02:25:11,303 REFER TO A BROAD GROUP OF 3221 02:25:11,303 --> 02:25:12,371 INDIVIDUALS THAT DO NOT IDENTIFY 3222 02:25:12,371 --> 02:25:18,143 TO SEX ASSIGNED AT BIRTH, 3223 02:25:18,143 --> 02:25:19,912 TRANSGENDER HAVE VARYING DEGREES 3224 02:25:19,912 --> 02:25:21,713 OF EXPRESSION AND ALL ARE 3225 02:25:21,713 --> 02:25:23,682 INDEPENDENT OF MEDICAL CARE AND 3226 02:25:23,682 --> 02:25:30,322 PHYSICAL APPEARANCE. I MIGHT USE 3227 02:25:30,322 --> 02:25:33,926 TRANSGENDER, GENDER-DIVERSE, TGT 3228 02:25:33,926 --> 02:25:34,793 SYNONYMOUSLY DURING THIS TIME 3229 02:25:34,793 --> 02:25:36,695 AND WILL BE BEST TO BE CLEAR IF 3230 02:25:36,695 --> 02:25:40,299 I'M REFERRING TO A 3231 02:25:40,299 --> 02:25:50,809 GENDER-SPECIFIC GROUP. SHAUN, 3232 02:25:53,912 --> 02:25:55,314 WILL YOU PROVIDE GUIDANCE FOR 3233 02:25:55,314 --> 02:25:56,648 PEOPLE IN THE CHAT TO SEE 3234 02:25:56,648 --> 02:25:57,249 SLIDES. 3235 02:25:57,249 --> 02:25:59,351 >> IF YOU ARE NOT SEEING SLIDES 3236 02:25:59,351 --> 02:26:02,721 AT THE TOP OF YOUR ZOOM, WHERE 3237 02:26:02,721 --> 02:26:10,162 YOU SEE YOUR NAME, SHAUN PATTON, 3238 02:26:10,162 --> 02:26:12,431 IF YOU CLICK ON THAT IT SHOULD 3239 02:26:12,431 --> 02:26:19,438 LET YOU SEE MY SCREEN. 3240 02:26:19,438 --> 02:26:27,679 >> OKAY. DURING THIS TALK I WILL 3241 02:26:27,679 --> 02:26:28,213 SMEVE 3242 02:26:28,213 --> 02:26:28,881 MENTION THE TRANSGENDER SURVEY 3243 02:26:28,881 --> 02:26:31,150 BY THE CENTER FOR EQUALITY. THE 3244 02:26:31,150 --> 02:26:32,518 TRANSGENDER SURVEY WAS PERFORMED 3245 02:26:32,518 --> 02:26:39,625 IN 2015, UPDATED IN 2022. IT 3246 02:26:39,625 --> 02:26:40,225 INCLUDED ALMOST 85,000 ADULT 3247 02:26:40,225 --> 02:26:42,327 TRANSGENDER INDIVIDUALS. DATA IS 3248 02:26:42,327 --> 02:26:43,862 STILL BEING ANALYZED AND 3249 02:26:43,862 --> 02:26:45,697 PROVIDES INVALUABLE INSIGHTS 3250 02:26:45,697 --> 02:26:48,700 INTO THE EXPERIENCES AND NEEDS 3251 02:26:48,700 --> 02:26:50,335 OF THE TRANSGENDER COMMUNITY. I 3252 02:26:50,335 --> 02:26:51,436 WANTED TO PROVIDE THIS CONTEXT 3253 02:26:51,436 --> 02:26:55,707 NOW FOR WHEN IT IS REFERENCED 3254 02:26:55,707 --> 02:26:57,476 LATER. NEXT SLIDE, PLEASE. OKAY. 3255 02:26:57,476 --> 02:27:00,412 WHILE OTHERS WILL SPEAK MORE 3256 02:27:00,412 --> 02:27:03,482 SUBSTANTIALLY ABOUT SEX 3257 02:27:03,482 --> 02:27:06,051 DIFFERENCES AND PULMONARY 3258 02:27:06,051 --> 02:27:07,386 HYPERTENSION I WANT TO TOUCH ON 3259 02:27:07,386 --> 02:27:09,922 THIS TALK AS IT WILL INFORM THE 3260 02:27:09,922 --> 02:27:10,455 DISCUSSION. 3261 02:27:10,455 --> 02:27:13,025 THERE'S BEEN LONGSTANDING 3262 02:27:13,025 --> 02:27:14,359 KNOWLEDGE FEMALE SEX IS A RISK 3263 02:27:14,359 --> 02:27:23,001 FAR TOR. REGISN FACTOR. REGISTR 3264 02:27:23,001 --> 02:27:24,836 ILLUSTRATED THE PREDOMINANCE. 3265 02:27:24,836 --> 02:27:26,972 DESPITE THIS MALES HAVE WORSE 3266 02:27:26,972 --> 02:27:28,607 LONG-TIME SURVIVAL. THE 3267 02:27:28,607 --> 02:27:30,742 ASSOCIATION REGISTRY IS NO 3268 02:27:30,742 --> 02:27:33,712 DIFFERENT, AND IT TOO 3269 02:27:33,712 --> 02:27:38,784 DEMONST 3270 02:27:38,784 --> 02:27:41,220 DEMONSTRATES THAT PH SEEMS MORE 3271 02:27:41,220 --> 02:27:44,289 EQUAL. IN THE JLT PUBLICATION 3272 02:27:44,289 --> 02:27:46,925 THE PULMONARY HYPERTENSION 3273 02:27:46,925 --> 02:27:48,293 REGISTRY INVESTIGATORS 3274 02:27:48,293 --> 02:27:56,902 DEMONSTRATED AND PROVED SURVIVAL 3275 02:27:56,902 --> 02:27:59,304 IN FEMALE PATIENTS. 25 3276 02:27:59,304 --> 02:28:00,606 TRANSGENDER WERE EXCLUDED FROM 3277 02:28:00,606 --> 02:28:04,543 THE ANALYSIS. WHILE I'M GREATLY 3278 02:28:04,543 --> 02:28:06,245 OVERSIMPLIFYING THIS ELEGANT 3279 02:28:06,245 --> 02:28:08,080 WORK, THE AUTHORS, ONE OF WHOM 3280 02:28:08,080 --> 02:28:09,681 WE WILL HAVE THE PLEASURE OF 3281 02:28:09,681 --> 02:28:14,152 HEAR ING FROM, NOTE MALE WITH 3282 02:28:14,152 --> 02:28:16,955 PAH MORE OFTEN HAD DRUG AND 3283 02:28:16,955 --> 02:28:18,957 TOXIN DISEASE FOR PULMONARY 3284 02:28:18,957 --> 02:28:21,994 HYPERTENSION AND HIV-RELATED 3285 02:28:21,994 --> 02:28:24,363 DISEASE AND SUGGEST PERHAPS A 3286 02:28:24,363 --> 02:28:27,165 MORE SIGNIFICANT ASSAULT WAS 3287 02:28:27,165 --> 02:28:29,968 REQUIRED TO REQUIRE PH IN MALE 3288 02:28:29,968 --> 02:28:32,004 PATIENTS THAN IN FEMALE 3289 02:28:32,004 --> 02:28:34,406 COUNTERPARTS WHICH CONTRIBUTES 3290 02:28:34,406 --> 02:28:37,442 TO THE POORER OUTCOME. IN TWO 3291 02:28:37,442 --> 02:28:39,478 PUBLICATIONS LOOKING AT HORMONES 3292 02:28:39,478 --> 02:28:44,216 IN MALES WITH PAH, HIGHER 3293 02:28:44,216 --> 02:28:50,289 ESTRADIOL AND LO LOWER 3294 02:28:50,289 --> 02:28:53,058 TESTOSTERONE WERE ASSOCIATED. 3295 02:28:53,058 --> 02:28:58,096 THE PDOLPIC SUGGESTED LONGER 3296 02:28:58,096 --> 02:29:00,666 EXPOSURE WAS ASSOCIATED WITH 3297 02:29:00,666 --> 02:29:03,468 BETTER PRESSURE AND RF FUNCTION 3298 02:29:03,468 --> 02:29:09,174 IN FEMALES. WHAT WE KNOW IN CIS 3299 02:29:09,174 --> 02:29:12,444 GENDER THAT IT IS FAR FROM 3300 02:29:12,444 --> 02:29:13,945 RESOLVED. I WOULD LIKE TO 3301 02:29:13,945 --> 02:29:15,480 DISTINGUISH BETWEEN SEX AND 3302 02:29:15,480 --> 02:29:19,184 GENDER AND DEFINE TERMS. SEX 3303 02:29:19,184 --> 02:29:21,987 WITH A BIOLOGICAL CONSTRUCT 3304 02:29:21,987 --> 02:29:26,925 DEFINED BY GENETIC, AN MATOMY A 3305 02:29:26,925 --> 02:29:31,029 HORMONES AND ASSIGNED. GENDER IS 3306 02:29:31,029 --> 02:29:33,031 A SOCIAL CONSTRUCT IN WHICH 3307 02:29:33,031 --> 02:29:34,866 RULES AND NORMS, EXPECTATIONS 3308 02:29:34,866 --> 02:29:37,636 AND POWER STRUCTURES ARE BASED. 3309 02:29:37,636 --> 02:29:41,707 HOW PEOPLE EXPRESS GENDER VARIES 3310 02:29:41,707 --> 02:29:44,109 GEOGRAPHICALLY, EVOLVES 3311 02:29:44,109 --> 02:29:45,077 GENERATIONALLY, DIFFERS WITHIN 3312 02:29:45,077 --> 02:29:47,612 SUBSETS OF SAME SOCIETY AND 3313 02:29:47,612 --> 02:29:49,181 DIFFERENT SOCIETIES. THERE ARE 3314 02:29:49,181 --> 02:29:51,083 OVER 1.4 MILLION PEOPLE IN U.S. 3315 02:29:51,083 --> 02:29:58,357 THAT IDENTIFY AS TRANSGENDER OR 3316 02:29:58,357 --> 02:29:59,358 GENDER-DIVERSE. 2% IN HIGH 3317 02:29:59,358 --> 02:30:01,026 SCHOOLS ARE QUESTIONING THEIR 3318 02:30:01,026 --> 02:30:05,063 GENDER. 0.5 ADULTS ARE 3319 02:30:05,063 --> 02:30:10,602 TRANSGENDER. CIS GENDER IS ONE 3320 02:30:10,602 --> 02:30:13,772 WHO IDENTIFIES WITH THE GENDER 3321 02:30:13,772 --> 02:30:17,676 AT BIRTH. CIS NORMA TIFFTY 3322 02:30:17,676 --> 02:30:22,080 ASSUMES CIS GENDER IS NORMAL OR 3323 02:30:22,080 --> 02:30:23,482 REFERENCE STATE AND TRANSGENDER 3324 02:30:23,482 --> 02:30:31,423 IS THE ALTERNATIVE STATE. 3325 02:30:31,423 --> 02:30:35,527 PERVASIVENESS IS FOUND IN HEALTH 3326 02:30:35,527 --> 02:30:38,463 CARE, AND RESEARCH, INCLUDING 3327 02:30:38,463 --> 02:30:39,931 SOME OF THE RESEARCH PRESENTED 3328 02:30:39,931 --> 02:30:49,708 HERE. GENDER AFFIRMATION IS 3329 02:30:49,708 --> 02:30:51,543 ACCEPTING INTERNALLY AND 3330 02:30:51,543 --> 02:30:53,011 EXPRESSING OUTWARDLY GENDER. 3331 02:30:53,011 --> 02:30:56,314 THIS IS A PROCESS THAT MAY BE 3332 02:30:56,314 --> 02:30:57,416 PSYCHOLOGICAL AND ACCEPTING 3333 02:30:57,416 --> 02:31:00,352 ONE'S IDENTITY, REJECTING 3334 02:31:00,352 --> 02:31:01,620 INTERNALIZED STIGMA AND 3335 02:31:01,620 --> 02:31:03,288 INTERNATIONALIZING PRIDE. MAY BE 3336 02:31:03,288 --> 02:31:05,123 SOCIAL BY CHANGING ONE'S NAMES 3337 02:31:05,123 --> 02:31:07,125 AND PRONOUNS, SEEKING SOCIAL 3338 02:31:07,125 --> 02:31:10,495 SUPPORT, CHANGING ONE'S GENDER 3339 02:31:10,495 --> 02:31:12,297 EXPRESSION. LEGAL, BY LEGALLY 3340 02:31:12,297 --> 02:31:13,698 CHANGING ONE'S GENDER AND 3341 02:31:13,698 --> 02:31:15,567 MARKER. MAY BE MEDICAL, BY 3342 02:31:15,567 --> 02:31:18,670 SEEKING GENDER-AFFIRMING MEDICAL 3343 02:31:18,670 --> 02:31:20,572 CARE, PROTOCOLS FOR CROSS-SEX 3344 02:31:20,572 --> 02:31:22,474 HORMONE THERAPY ARE BASED ON 3345 02:31:22,474 --> 02:31:24,643 DECADES OF EXPERIENCE OF WHAT 3346 02:31:24,643 --> 02:31:27,779 HAS BEEN EFFECTIVE BUT THOSE 3347 02:31:27,779 --> 02:31:30,582 FINDING, RCTs, HAVE NEVER BEEN 3348 02:31:30,582 --> 02:31:41,126 PERFORMED. IT IS ASSUMED (AUDIO 3349 02:31:41,526 --> 02:31:43,261 INTERRUPTION) TOWARD MALE OR 3350 02:31:43,261 --> 02:31:45,597 MALE-FEMALE BUT UNKNOWN IF THESE 3351 02:31:45,597 --> 02:31:46,932 TARGET LEVELS ARE APPROPRIATE. 3352 02:31:46,932 --> 02:31:48,700 UP TO ONE QUARTER OF TRANSWOMEN 3353 02:31:48,700 --> 02:31:51,603 DO NOT ACHIEVE THE DESIRED 3354 02:31:51,603 --> 02:31:53,638 DEGREE OF ANDROGEN SUPPRESSION 3355 02:31:53,638 --> 02:31:58,043 EVEN WITH ESTROGEN LEVELS 3356 02:31:58,043 --> 02:32:00,579 COMPARABLE TO MALE-FEMALES. 3357 02:32:00,579 --> 02:32:01,847 CROSS-SEX HORMONE THERAPY IS 3358 02:32:01,847 --> 02:32:03,882 TAKEN FOR SUBSTANTIALLY LONGER 3359 02:32:03,882 --> 02:32:05,050 THAN HORMONE THERAPY S HAVE EVER 3360 02:32:05,050 --> 02:32:08,086 BEEN STUDIED IN ANY PATIENT 3361 02:32:08,086 --> 02:32:09,754 POPULATION. LITERATURE DOES SHOW 3362 02:32:09,754 --> 02:32:13,325 THAT GENDER AFFIRMATION, IN 3363 02:32:13,325 --> 02:32:14,459 PARTICULAR MEDICAL AFFIRMATION, 3364 02:32:14,459 --> 02:32:16,995 IS ASSOCIATED WITH IMPROVED 3365 02:32:16,995 --> 02:32:18,296 OUTCOMES BOTH PSYCHOLOGICALLY 3366 02:32:18,296 --> 02:32:27,072 AND MEDICALLY. NEXT SLIDE, 3367 02:32:27,072 --> 02:32:27,639 PLEASE. 3368 02:32:27,639 --> 02:32:29,841 OKAY. THESE SLIDES ARE 3369 02:32:29,841 --> 02:32:32,344 DIFFERENT FROM THE ONES I SENT 3370 02:32:32,344 --> 02:32:36,381 YOU SO WE ARE GOING TO WORK 3371 02:32:36,381 --> 02:32:42,621 THROUGH THIS. OKAY. THE 3372 02:32:42,621 --> 02:32:45,557 INTERSECTION ALLTY OF GENDER 3373 02:32:45,557 --> 02:32:51,129 STATUS ALONG WITH OTHER 3374 02:32:51,129 --> 02:32:54,099 CONDITIONS SUCH AS SOCIOECONOMIC 3375 02:32:54,099 --> 02:32:55,634 STATUS AND RACE PUTS PEOPLE AT 3376 02:32:55,634 --> 02:32:57,302 RISK. SURVEYS EXAMINING THE 3377 02:32:57,302 --> 02:32:58,136 SOCIAL DETERMINANTS OF HEALTH 3378 02:32:58,136 --> 02:33:01,006 OUTLINED IN HEALTHY PEOPLE 2030 3379 02:33:01,006 --> 02:33:01,773 HAVE SHOWN THE TRANSGENDER 3380 02:33:01,773 --> 02:33:06,678 COMMUNITY IS AMONG THE HIGHEST 3381 02:33:06,678 --> 02:33:08,713 RISK FOR HEALTH DISPARITIES. 3382 02:33:08,713 --> 02:33:09,981 LIVING WITHIN THE INTERSECTION 3383 02:33:09,981 --> 02:33:12,584 OF RACE, GENDER MINORITY AND 3384 02:33:12,584 --> 02:33:15,687 FEMALE DISEMPOWERMENT BLACK AND 3385 02:33:15,687 --> 02:33:16,922 LATINA TRANSWOMEN EXPERIENCE 3386 02:33:16,922 --> 02:33:19,291 HIGHER RATES OF VIOLENCE, 3387 02:33:19,291 --> 02:33:21,026 SUICIDE AND H.I.V. A.I.D.S. THAN 3388 02:33:21,026 --> 02:33:23,328 ANY OTHER SEGMENT OF THE 3389 02:33:23,328 --> 02:33:24,329 POPULATION. BECAUSE GENDER 3390 02:33:24,329 --> 02:33:26,231 IDENTITY IS NOT REPORTED ON U.S. 3391 02:33:26,231 --> 02:33:29,568 DEATH CERTIFICATES THE EXACT 3392 02:33:29,568 --> 02:33:33,572 STATISTICS ARE NOT KNOWN. 3393 02:33:33,572 --> 02:33:36,541 GENDER-DIVERSE INDIVIDUALS 3394 02:33:36,541 --> 02:33:40,011 EXPERIENCE STARTGINGLY HIGH RATS 3395 02:33:40,011 --> 02:33:42,581 OF POVERTY, ISOLATION, HOUSING 3396 02:33:42,581 --> 02:33:45,083 INSECURITY AND VICTIMIZATION, 3397 02:33:45,083 --> 02:33:47,519 WHEN COMPARED WITH THE GENERAL 3398 02:33:47,519 --> 02:33:51,156 POPULATION. SPEAKING 3399 02:33:51,156 --> 02:33:55,727 SPECIFICALLY TO HEALTH, MANY 3400 02:33:55,727 --> 02:33:59,130 TRANSGENDER INDIVIDUALS REPORT 3401 02:33:59,130 --> 02:33:59,664 DELAY 3402 02:33:59,664 --> 02:34:01,032 DELAYING SEEKING MEDICAL CARE 3403 02:34:01,032 --> 02:34:06,171 DUE TO REFUSAL OF CARE OR 3404 02:34:06,171 --> 02:34:09,608 MISTREATMENT. MANY TRANSMEN 3405 02:34:09,608 --> 02:34:15,046 REQUIRE ROUTINE GENE LOGIC CARE. 3406 02:34:15,046 --> 02:34:18,516 IT IS HARD TO FIND BECAUSE THEY 3407 02:34:18,516 --> 02:34:21,386 MAYBE ARE REFUSED CARE OR A 3408 02:34:21,386 --> 02:34:24,456 PROVIDER MAY HAVE MORAL 3409 02:34:24,456 --> 02:34:26,958 OBJECTIONS AND DECIDE THEY WON'T 3410 02:34:26,958 --> 02:34:31,696 PROVIDE A ROUTINE PHYSICAL EXAM. 3411 02:34:31,696 --> 02:34:33,932 FURTHER RECEIVING CARE AT A 3412 02:34:33,932 --> 02:34:39,804 WOMEN'S HEALTH CLINIC IS 3413 02:34:39,804 --> 02:34:41,072 GENDER-NON-AFFIRMING. SO MANY 3414 02:34:41,072 --> 02:34:43,575 TRANSMEN JUST AVOID TREATMENT IN 3415 02:34:43,575 --> 02:34:45,477 GENERAL. SIMILARLY, CHANGING 3416 02:34:45,477 --> 02:34:49,481 ONE'S GENDER MARKER ON LEGAL 3417 02:34:49,481 --> 02:34:51,383 DOCUMENTS IS GENDER-AFFIRMING 3418 02:34:51,383 --> 02:34:54,252 AND ASSOCIATED WITH APPROVED -- 3419 02:34:54,252 --> 02:34:57,489 IMPROVED OUTCOMES. ON THE OTHER 3420 02:34:57,489 --> 02:35:00,525 HAND, INSURANCE COMPANIES MAY 3421 02:35:00,525 --> 02:35:08,299 DENY MEDICALLY APPROPRIATE 3422 02:35:08,299 --> 02:35:10,368 PROCEDURES IF INCONGRUENT WITH 3423 02:35:10,368 --> 02:35:11,603 THE MARKER THEREFORE TRANSGENDER 3424 02:35:11,603 --> 02:35:20,945 MEMBERS MAY BE DEPRIVED AN 3425 02:35:20,945 --> 02:35:25,116 ANATOMICALLY APPROPRIATE 3426 02:35:25,116 --> 02:35:25,750 SCREEN 3427 02:35:25,750 --> 02:35:26,851 SCREENINGS. NEXT SLIDE, PLEASE. 3428 02:35:26,851 --> 02:35:30,488 SO GENDER-AFFIRMING MEDICAL 3429 02:35:30,488 --> 02:35:38,897 CARE STARTS WITH MEDICAL CARE, 3430 02:35:38,897 --> 02:35:42,600 PROVIDING -- OR NOT PROVIDING 3431 02:35:42,600 --> 02:35:43,635 GENDER-AFFIRMED MEDICAL CARE 3432 02:35:43,635 --> 02:35:45,970 THROUGH LACK OF AWARENESS. FOR 3433 02:35:45,970 --> 02:35:48,606 INSTANCE, BY USING THE TERM SEX 3434 02:35:48,606 --> 02:35:50,508 AND GENDER INTERCHANGEABLY. 3435 02:35:50,508 --> 02:35:54,746 IN THE 2022 UPDATE OF THE 3436 02:35:54,746 --> 02:35:57,649 U.S. TRANSGENDER SURVEY, ALMOST 3437 02:35:57,649 --> 02:36:00,018 HALF OF TRANSGENDER INDIVIDUALS 3438 02:36:00,018 --> 02:36:02,454 WERE REPORTED NEGATIVE HEALTH 3439 02:36:02,454 --> 02:36:03,888 CARE EXPERIENCE. ONE-THIRD 3440 02:36:03,888 --> 02:36:06,658 REPORTED A NEGATIVE HEALTH CARE 3441 02:36:06,658 --> 02:36:11,362 EXPERIENCE IN THE LAST YEAR. 3442 02:36:11,362 --> 02:36:13,565 NEGATIVE HEALTH CARE EXPERIENCES 3443 02:36:13,565 --> 02:36:18,436 RANGE FROM BEING MIS-GENDERED OR 3444 02:36:18,436 --> 02:36:21,806 DEAD NAMED TO EXPLAIN AND BE 3445 02:36:21,806 --> 02:36:22,974 DENIED APPROPRIATE CARE BECAUSE 3446 02:36:22,974 --> 02:36:24,943 OF YOUR TRANSGENDER STATUS. 3447 02:36:24,943 --> 02:36:26,311 MISPERCEPTIONS ABOUT WHAT IT 3448 02:36:26,311 --> 02:36:28,046 MEANS TO BE TRANSGENDER ARE 3449 02:36:28,046 --> 02:36:30,381 PERVASIVE, WITH WIDESPREAD 3450 02:36:30,381 --> 02:36:32,450 ASSUMPTIONS THAT TRANSGENDER 3451 02:36:32,450 --> 02:36:34,085 PEOPLE ALL WANT OR RECEIVE 3452 02:36:34,085 --> 02:36:36,087 CROSS-SEX HORMONE THERAPY. IN 3453 02:36:36,087 --> 02:36:38,890 REALITY APPROXIMATELY 78% OF 3454 02:36:38,890 --> 02:36:41,626 TRANSGENDER AND GENDER-DIVERSE 3455 02:36:41,626 --> 02:36:42,694 INDIVIDUALS WANT HORMONE 3456 02:36:42,694 --> 02:36:46,131 THERAPY. ONLY 44% ARE CURRENTLY 3457 02:36:46,131 --> 02:36:47,565 TAKING CROSS-SEX HORMONE 3458 02:36:47,565 --> 02:36:50,835 THERAPY. INSURANCE IS A 3459 02:36:50,835 --> 02:36:53,872 SIGNIFICANT BARRIER TO OBTAINING 3460 02:36:53,872 --> 02:36:56,875 HORMONE THERAPY. 25% OF PATIENTS 3461 02:36:56,875 --> 02:36:58,777 HAVE HAD CROSS-SEX HORMONE 3462 02:36:58,777 --> 02:37:02,247 THERAPY REFUSED BY THEIR 3463 02:37:02,247 --> 02:37:05,250 INSURANCE CARRIER. 14% OF 3464 02:37:05,250 --> 02:37:09,053 PATIENTS IN THE USTS SURVEY IN 3465 02:37:09,053 --> 02:37:10,688 2015 WERE UNINSURED, COMPARE ED 3466 02:37:10,688 --> 02:37:12,857 WITH 11% OF THE U.S. POPULATION 3467 02:37:12,857 --> 02:37:16,361 THAT YEAR. ONLY 25% OF 3468 02:37:16,361 --> 02:37:18,963 TRANSGENDER INDIVIDUALS HAVE HAD 3469 02:37:18,963 --> 02:37:20,565 GENDER-AFFIRMING SURGERIES. MANY 3470 02:37:20,565 --> 02:37:23,935 DON'T DESIRE GENDER-AFFIRMING 3471 02:37:23,935 --> 02:37:25,870 SURGERIES. SO AS HEALTH CARE 3472 02:37:25,870 --> 02:37:27,605 PROVIDERS PROVIDING PH CARE, WE 3473 02:37:27,605 --> 02:37:29,307 NEED TO RECOGNIZE THAT BECAUSE 3474 02:37:29,307 --> 02:37:31,810 PREVALENCE AND OUTCOMES ARE 3475 02:37:31,810 --> 02:37:33,278 INFLUENCED BY SEX ASSIGNED AT 3476 02:37:33,278 --> 02:37:35,180 BIRTH AND HORMONES WE SHOULD 3477 02:37:35,180 --> 02:37:38,550 OBTAIN A SURGICAL HISTORY 3478 02:37:38,550 --> 02:37:42,053 CLARIFYING WHETHER OR NOT GONADS 3479 02:37:42,053 --> 02:37:44,856 WERE REMOVED IN THE SURGERIES, 3480 02:37:44,856 --> 02:37:47,826 ALONG WITH MEDICATION HISTORY IN 3481 02:37:47,826 --> 02:37:57,902 ALL TRANSAND NONBINARY, AND 3482 02:37:57,902 --> 02:37:58,837 IMPORTANT FOR WOMEN WHO MAY NOT 3483 02:37:58,837 --> 02:38:04,943 HAVE RECEIVED THE NON-ANDROGEN 3484 02:38:04,943 --> 02:38:06,344 THERAPY. NEXT SLIDE, NEXT, 3485 02:38:06,344 --> 02:38:11,182 PLEASE -- SORRY, CAN YOU GO 3486 02:38:11,182 --> 02:38:13,518 BACK? THANK YOU. OKAY. 3487 02:38:13,518 --> 02:38:16,254 SO WE RECOGNIZE THAT 3488 02:38:16,254 --> 02:38:18,156 TRANSGENDER INDIVIDUALS DO 3489 02:38:18,156 --> 02:38:19,023 EXPERIENCE GREATER PSYCHOLOGICAL 3490 02:38:19,023 --> 02:38:20,592 STRESS THAT AIR FORCE BASES 3491 02:38:20,592 --> 02:38:23,828 PHYSICAL HEALTH, IN ADDITION TO 3492 02:38:23,828 --> 02:38:28,266 RISK CONDITIONS THAT OCCUR WITH 3493 02:38:28,266 --> 02:38:31,169 GREATER FREQUENCY THAN GENDER 3494 02:38:31,169 --> 02:38:32,103 MINORITY INDIVIDUALS. FOR 3495 02:38:32,103 --> 02:38:34,572 INSTANCE SMOKING OCCURS AT 3496 02:38:34,572 --> 02:38:36,007 ROUGHLY TWICE THE RATE OF 3497 02:38:36,007 --> 02:38:37,675 GENERAL POPULATION PRIMARILY AS 3498 02:38:37,675 --> 02:38:41,713 A RESULT OF TARGETED MARKETING 3499 02:38:41,713 --> 02:38:45,516 BY THE TOBACCO INDUSTRY. IN THE 3500 02:38:45,516 --> 02:38:48,653 FOUR PATH SURVEY PUBLISHED IN 3501 02:38:48,653 --> 02:38:50,989 22, 40% WERE CURRENT TOBACCO 3502 02:38:50,989 --> 02:38:54,125 USERS COMPARED TO 19% OF 3503 02:38:54,125 --> 02:38:55,927 CISGENDER INDIVIDUALS. OBESITY 3504 02:38:55,927 --> 02:38:58,963 HAS A HIGHER PREVALENCE IN 3505 02:38:58,963 --> 02:39:00,198 TRANSGENDER ADULTS. BOTH 3506 02:39:00,198 --> 02:39:02,300 TRANSGENDER MEN AND WOMEN 3507 02:39:02,300 --> 02:39:03,201 EXPERIENCE WEIGHT GAIN AS A 3508 02:39:03,201 --> 02:39:03,801 RESULT OF THE TRANSGENDER 3509 02:39:03,801 --> 02:39:06,437 HORMONE THERAPY. IN A 3510 02:39:06,437 --> 02:39:07,672 LONGITUDINAL STUDY OF TDG 3511 02:39:07,672 --> 02:39:10,541 PATIENTS ON GENDER-AFFIRMING 3512 02:39:10,541 --> 02:39:13,778 THERAPY, UP TO 30% OF PATIENTS 3513 02:39:13,778 --> 02:39:16,047 EXPERIENCED GREATER OF FIVE KILO 3514 02:39:16,047 --> 02:39:17,949 WEIGHT GAIN IN 21 MONTHS 3515 02:39:17,949 --> 02:39:19,350 FOLLOWING INITIATION OF HORMONE 3516 02:39:19,350 --> 02:39:22,086 THERAPY. STUDIES ARE NEEDED TO 3517 02:39:22,086 --> 02:39:24,255 BETTER UNDERSTAND BODY 3518 02:39:24,255 --> 02:39:27,358 COMPOSITION CHANGES WITH 3519 02:39:27,358 --> 02:39:27,992 GENDER-AFFIRMING THERAPY. IN 3520 02:39:27,992 --> 02:39:30,628 CROSS SECTIONAL SURVEYS COLLEGE 3521 02:39:30,628 --> 02:39:32,530 STUDENTS AND ADOLESCENTS ARE 3522 02:39:32,530 --> 02:39:34,465 MORE LIKELY TO REPORT POOR SLEEP 3523 02:39:34,465 --> 02:39:37,535 QUALITY. ADDITIONALLY SIMILAR 3524 02:39:37,535 --> 02:39:39,037 REPORTS REPORT FREQUENT EXERCISE 3525 02:39:39,037 --> 02:39:41,306 AND AVOIDANCE OF 3526 02:39:41,306 --> 02:39:43,041 GENDER-SEGREGATED ACTIVITIES. 3527 02:39:43,041 --> 02:39:45,176 FINALLY A SUBSTANTIAL RISK 3528 02:39:45,176 --> 02:39:49,781 FACTOR FOR PAH, WORTH NOTING AS 3529 02:39:49,781 --> 02:39:53,351 HI DISEASE, WITHIN THE GENERAL 3530 02:39:53,351 --> 02:39:54,919 POPULATION THE ADULT PREVALENCE 3531 02:39:54,919 --> 02:39:58,823 OF H.I.V. IS 0.4%, ACCORDINGS TO 3532 02:39:58,823 --> 02:40:00,858 THE CDC. EARLIER THE CDC 3533 02:40:00,858 --> 02:40:02,894 REPORTED 2% OF INCIDENT H.I.V. 3534 02:40:02,894 --> 02:40:05,463 CASES IN 2023 WERE IN 3535 02:40:05,463 --> 02:40:08,466 TRANSGENDER INDIVIDUALS. 3536 02:40:08,466 --> 02:40:09,100 DISPROPORTIONATELY AFFECTING THE 3537 02:40:09,100 --> 02:40:12,770 TRANSGENDER POPULATION. IN THE 3538 02:40:12,770 --> 02:40:15,840 CDC'S NHBS TRANSSAMPLE OF 1600 3539 02:40:15,840 --> 02:40:18,276 TRANSWOMEN LIVING IN SEVEN URBAN 3540 02:40:18,276 --> 02:40:20,478 CITIES WITH HIGH H.I.V. RATES, 3541 02:40:20,478 --> 02:40:23,448 44% OF WOMEN SURVEYED AND 3542 02:40:23,448 --> 02:40:26,284 SUBSEQUENTLY TESTED FOR H.I.V. 3543 02:40:26,284 --> 02:40:33,591 WERE POSITIVE. NEXT SLIDE, 3544 02:40:33,591 --> 02:40:37,428 PLEASE. PULMONARY CARE IN 3545 02:40:37,428 --> 02:40:40,064 TRANSGENDER PATIENTS IS AN OPEN 3546 02:40:40,064 --> 02:40:43,634 FIELD AND OPPORTUNITY FOR US. IN 3547 02:40:43,634 --> 02:40:45,837 THE DRAFTEST WAY THIS IS A 3548 02:40:45,837 --> 02:40:47,438 RETROSPECTIVE COHORT FROM THE 3549 02:40:47,438 --> 02:40:48,973 AMSTERDAM GENDER IDENTITY CLINIC 3550 02:40:48,973 --> 02:40:54,312 THAT INCLUDED OVER 2,900 3551 02:40:54,312 --> 02:40:54,979 TRANSGENDER WOMEN AND OVER 1,600 3552 02:40:54,979 --> 02:40:56,481 TRANSGENDER MEN. THE STUDY RAN 3553 02:40:56,481 --> 02:41:00,318 FROM 1972 TO 2018. THE MORTALITY 3554 02:41:00,318 --> 02:41:03,021 RATE FOR TRANSMEN WAS HIGHER 3555 02:41:03,021 --> 02:41:03,988 THAN EXPECTED FOR CISGENDER 3556 02:41:03,988 --> 02:41:05,990 WOMEN BUT NOT FOR CISGENDER MEN. 3557 02:41:05,990 --> 02:41:09,660 ON THE OTHER HAND, THE MORTALITY 3558 02:41:09,660 --> 02:41:11,129 RATE FOR TRANSWOMEN WAS 3559 02:41:11,129 --> 02:41:12,230 SIGNIFICANTLY HIGHER THAN 3560 02:41:12,230 --> 02:41:15,933 EXPECTED FOR THE POPULATION AS A 3561 02:41:15,933 --> 02:41:16,167 WHOLE. 3562 02:41:16,167 --> 02:41:17,235 TRANSGENDER WOMEN 3563 02:41:17,235 --> 02:41:20,438 EXPERIENCED HIGHER RATES OF 3564 02:41:20,438 --> 02:41:24,475 CAUSE-SPECIFIC MORTALITY FROM 3565 02:41:24,475 --> 02:41:27,645 CARDIOVASCULAR DISEASE, LUNG 3566 02:41:27,645 --> 02:41:38,156 CANCER, H.I.V. THERE ARE MORE 3567 02:41:42,593 --> 02:41:43,294 HIGHER RISK IN INDIVIDUAL AND 3568 02:41:43,294 --> 02:41:45,563 THE RISK FOR MORTALITY IS 3569 02:41:45,563 --> 02:41:48,566 VISIBLE IN TRANSGENDER WOMEN 3570 02:41:48,566 --> 02:41:51,235 WHEN WE COMPARE TO CISGENDER 3571 02:41:51,235 --> 02:41:52,904 WOMEN WITH A CARDIOVASCULAR 3572 02:41:52,904 --> 02:41:58,342 MORTALITY RATE THAT IS 2.6 TIMES 3573 02:41:58,342 --> 02:42:02,547 HIGHER. IN PATIENTS ON CROSS-SEX 3574 02:42:02,547 --> 02:42:03,648 THER 3575 02:42:03,648 --> 02:42:07,618 THERAPY LIPID STUDIES ARE THE 3576 02:42:07,618 --> 02:42:10,254 BEST METABOLIC VARIABLE. 3577 02:42:10,254 --> 02:42:12,223 HOWEVER, CHANGES IN LIPID 3578 02:42:12,223 --> 02:42:15,193 PROFILES VARY BASED ON WHETHER 3579 02:42:15,193 --> 02:42:23,501 THE PERSON IS ON M ASCULINIZING 3580 02:42:23,501 --> 02:42:29,841 OR FEMININE IZING. ALCOHOL, 3581 02:42:29,841 --> 02:42:33,644 DIET, SLEEP AND STRESS ARE 3582 02:42:33,644 --> 02:42:39,650 POORLY STUDIED. NEXT SLIDE, 3583 02:42:39,650 --> 02:42:43,588 PLEASE. 3584 02:42:43,588 --> 02:42:43,754 3585 02:42:43,754 --> 02:42:46,491 AS WE LOOK TO THE FUTURE OF 3586 02:42:46,491 --> 02:42:47,959 ADDRESSING DISPARITIES OF CARE 3587 02:42:47,959 --> 02:42:49,293 IN TRANSGENDER PATIENTS IT IS 3588 02:42:49,293 --> 02:42:52,196 IMPORTANT TO UNDERSTAND WHAT 3589 02:42:52,196 --> 02:42:53,598 LIMITATIONS OF CURRENT RESEARCH 3590 02:42:53,598 --> 02:42:56,467 ARE. SO FIRST MEASUREMENT OF 3591 02:42:56,467 --> 02:42:58,469 TRANSGENDER STATUS NEEDS TO BE 3592 02:42:58,469 --> 02:43:00,872 STANDARDIZED ACROSS HEALTH CARE 3593 02:43:00,872 --> 02:43:02,740 SYSTEMS AND RESEARCH PROTOCOLS 3594 02:43:02,740 --> 02:43:05,743 UTILIZING A TWO-STEP 3595 02:43:05,743 --> 02:43:07,378 IDENTIFICATION PROCESS TO 3596 02:43:07,378 --> 02:43:08,813 SEPARATELY IDENTIFY SEX ASSIGNED 3597 02:43:08,813 --> 02:43:12,550 AT BIRTH AND GENDER IDENTITY, 3598 02:43:12,550 --> 02:43:14,852 IMPROVED ACCURACY AND ALLOWS FOR 3599 02:43:14,852 --> 02:43:18,523 AFFIRMING CARE AND IMPROVED 3600 02:43:18,523 --> 02:43:23,294 RESEARCH QUALITY. SECOND RCTs TO 3601 02:43:23,294 --> 02:43:25,796 EXAMINE DOSAGE IN CROSS-SEX 3602 02:43:25,796 --> 02:43:27,665 HORMONE THERAPY WILL BENEFIT 3603 02:43:27,665 --> 02:43:31,035 TRANSGENDER PATIENTS TO ALLOW 3604 02:43:31,035 --> 02:43:34,939 FOR DOSING TO OPTIMAL EFFECT 3605 02:43:34,939 --> 02:43:37,308 WHILE MINIMALIZING EFFECT. THE 3606 02:43:37,308 --> 02:43:39,877 SCIENTIFIC COMMUNITY NEEDS TO 3607 02:43:39,877 --> 02:43:43,981 HAVE A CONVERSATION ABOUT CIS 3608 02:43:43,981 --> 02:43:45,516 NORMALATIVITY AND SEEK TO DEFINE 3609 02:43:45,516 --> 02:43:47,919 WHAT A APPROPRIATE CONTROL 3610 02:43:47,919 --> 02:43:49,987 POPULATION IS IN A TRANSGENDER 3611 02:43:49,987 --> 02:43:53,057 RESEARCH STUDY. NEXT SLIDE, 3612 02:43:53,057 --> 02:43:53,724 PLEASE. 3613 02:43:53,724 --> 02:43:57,828 WITHIN TRANSGENDER HEALTH 3614 02:43:57,828 --> 02:43:59,697 RESEARCH NONCOMMUNICABLE CHRONIC 3615 02:43:59,697 --> 02:44:02,867 DISEASE HAS ONLY BE GUN TO BE 3616 02:44:02,867 --> 02:44:06,404 INVESTIGATED. IN THIS 2024 META 3617 02:44:06,404 --> 02:44:08,072 ANALYSIS OF ARTICLES OF 3618 02:44:08,072 --> 02:44:11,008 TRANSGENDER HEALTH, ONLY 4% 3619 02:44:11,008 --> 02:44:13,010 EVALUATED RESPIRATORY HEALTH AND 3620 02:44:13,010 --> 02:44:16,814 ONLY 9% EVALUATED CARDIOVASCULAR 3621 02:44:16,814 --> 02:44:22,386 HEALTH. IN A QUICK SEARCH OF 3622 02:44:22,386 --> 02:44:24,589 CLINICALTRIALS.GOV I FOUND FIVE 3623 02:44:24,589 --> 02:44:25,156 RELATED TO CARDIOVASCULAR 3624 02:44:25,156 --> 02:44:26,390 DISEASE AND TRANSGENDER HEALTH 3625 02:44:26,390 --> 02:44:29,293 AND ONE REGISTERED TRIAL RELATED 3626 02:44:29,293 --> 02:44:38,202 TO PULMONARY FUNCTION AND 3627 02:44:38,202 --> 02:44:40,972 GENDER-AFFIRMING CARE. (BELL) 3628 02:44:40,972 --> 02:44:42,039 BECAUSE THERE SO LITTLE 3629 02:44:42,039 --> 02:44:44,475 KNOWLEDGE ABOUT THOUSAND BEST 3630 02:44:44,475 --> 02:44:47,044 CARE FOR TRANSGENDER PATIENTS 3631 02:44:47,044 --> 02:44:47,845 WITH PULMONARY HYPERTENSION I 3632 02:44:47,845 --> 02:44:50,381 WANTED TO THINK OF THIS IN A 3633 02:44:50,381 --> 02:44:52,049 STEPWISE APPROACH SO MY 3634 02:44:52,049 --> 02:44:53,251 RECOMMENDATIONS, I THINK THE 3635 02:44:53,251 --> 02:44:55,086 FIRST THING IS START WITH THE 3636 02:44:55,086 --> 02:45:00,258 BASICS. WE NEED A BETTER 3637 02:45:00,258 --> 02:45:07,164 UNDERSTANDING OF AN ANDOGENOUS 3638 02:45:07,164 --> 02:45:09,300 HORMONE S SO WE UNDERSTAND HOW 3639 02:45:09,300 --> 02:45:11,669 THEY MAY AFFECT DEVELOPMENT OF 3640 02:45:11,669 --> 02:45:12,903 CARDIOVASCULAR DISEASE. I THINK 3641 02:45:12,903 --> 02:45:15,640 GENDER CARE CLINICS AND LARGE 3642 02:45:15,640 --> 02:45:17,208 HEALTH CARE ORGANIZATIONS AS 3643 02:45:17,208 --> 02:45:19,610 WELL AS PH REGISTRIES NEED TO 3644 02:45:19,610 --> 02:45:27,918 WORK TO CREATE PRO SPE PROSPECT 3645 02:45:27,918 --> 02:45:29,987 COHORTS OF GCD PATIENTS AND THE 3646 02:45:29,987 --> 02:45:31,322 STATE OF HEALTH OF THE PATIENTS. 3647 02:45:31,322 --> 02:45:33,291 WITH E NEED TO DEFINE AND 3648 02:45:33,291 --> 02:45:35,826 UNDERSTAND THE BARRIERS TO CARE 3649 02:45:35,826 --> 02:45:38,896 THAT TGD PATIENTS ARE 3650 02:45:38,896 --> 02:45:40,131 EXPERIENCING. I HAVE LISTED HERE 3651 02:45:40,131 --> 02:45:44,368 A FEW OF MY PERCEPTIONS OF 3652 02:45:44,368 --> 02:45:45,369 BARRIERS TO CARE BUT THESE ARE 3653 02:45:45,369 --> 02:45:47,138 ONLY ASSUMPTIONS AND WORKING 3654 02:45:47,138 --> 02:45:50,908 UNDER ASSUMPTIONS DOESN'T HELP 3655 02:45:50,908 --> 02:45:55,746 OUR PATIENTS. WE NEED TO 3656 02:45:55,746 --> 02:45:58,282 EVALUATE RISK-ASSOCIATED 3657 02:45:58,282 --> 02:46:00,284 CONDITIONS AND HOW THOSE THINGS 3658 02:46:00,284 --> 02:46:03,421 MAY AFFECT THE HEALTH OF OUR 3659 02:46:03,421 --> 02:46:06,090 PATIENTS. AND FINALLY WE NEED TO 3660 02:46:06,090 --> 02:46:09,627 LOOK AT MINORITY STRESS AND HOW 3661 02:46:09,627 --> 02:46:11,162 DOES MINORITY STRESS INFLUENCE 3662 02:46:11,162 --> 02:46:17,368 THE RISK OF DEVELOPMENT OF 3663 02:46:17,368 --> 02:46:21,772 PULMONARY HYPERTENSION IN BINARY 3664 02:46:21,772 --> 02:46:25,776 AND NON-BINARY INDIVIDUALS. NEXT 3665 02:46:25,776 --> 02:46:33,718 SLIDE, PLEASE. 3666 02:46:33,718 --> 02:46:35,453 WITHIN THE SEX PARADOX AND 3667 02:46:35,453 --> 02:46:39,724 GENDER, WE NEED TO EVALUATE HOW 3668 02:46:39,724 --> 02:46:42,893 DOES THE CROSS-SEX HORMONE 3669 02:46:42,893 --> 02:46:46,097 THERAPY OUR PATIENTS ARE ON 3670 02:46:46,097 --> 02:46:51,102 ALTER THE RISK OF DEVELOPING 3671 02:46:51,102 --> 02:46:54,505 PAH. FOR INSTANCE, SPURNOLACTONE 3672 02:46:54,505 --> 02:46:58,876 IS USED AS ANTI ANDROGEN IN 3673 02:46:58,876 --> 02:47:01,679 TRANSWOMEN. DOES IT MITIGATE 3674 02:47:01,679 --> 02:47:04,081 EFFECTS OF TESTOSTERONE ON THE 3675 02:47:04,081 --> 02:47:04,882 RIGHT VENTRICLE IF USED BEFORE 3676 02:47:04,882 --> 02:47:07,752 THE DEVELOPMENT OF CLINICALLY 3677 02:47:07,752 --> 02:47:08,953 APPARENT DISEASE? IN PATIENTS 3678 02:47:08,953 --> 02:47:15,126 WITH RISK FACTORS FOR PULMONARY 3679 02:47:15,126 --> 02:47:16,861 HYPERTENSION, FOR INSTANCE A 3680 02:47:16,861 --> 02:47:19,196 TRANSWOMAN WITH H.I.V. SHOULD 3681 02:47:19,196 --> 02:47:23,501 PERIODIC SCREENING FOR PULMONARY 3682 02:47:23,501 --> 02:47:31,542 HYPERTENSION OCCUR. 3683 02:47:31,542 --> 02:47:32,610 FINALLY I WOULD REALLY LIKE 3684 02:47:32,610 --> 02:47:35,513 TO ADVOCATE FOR AN EFFORT TOWARD 3685 02:47:35,513 --> 02:47:45,289 IDENTIFYING A GENDER-NEUTRAL AND 3686 02:47:45,289 --> 02:47:47,224 BODY-COMPOSITION NEUTRAL 3687 02:47:47,224 --> 02:47:50,294 BIO MARKER. THESE ARE AFFECTED 3688 02:47:50,294 --> 02:47:54,432 BY ESTROGEN ANDROGENS AND WE 3689 02:47:54,432 --> 02:47:57,601 SHOULD IDENTIFY THE BRASS RING 3690 02:47:57,601 --> 02:48:05,576 OF BIOMARKERS NOT INFLUENCED BY 3691 02:48:05,576 --> 02:48:12,249 SEX BODY SIZE. NEXT SLIDE. 3692 02:48:12,249 --> 02:48:15,853 FOR PROGRESS IN OUR GENDER 3693 02:48:15,853 --> 02:48:18,522 AFFIRMING CARE, WE NEED TO 3694 02:48:18,522 --> 02:48:20,458 PROVIDE EDUCATION FOR HEALTH 3695 02:48:20,458 --> 02:48:24,061 CARE PROVIDERS TO ENSURE THAT 3696 02:48:24,061 --> 02:48:28,833 KNOWLEDGE GAPS ARE FILLED IN. WE 3697 02:48:28,833 --> 02:48:31,001 NEED TO FOLLOW THE PHILOSOPHY, 3698 02:48:31,001 --> 02:48:34,605 NOTHING ABOUT US WITHOUT US, AND 3699 02:48:34,605 --> 02:48:35,806 CREATE MINORITY INCLUSIVE 3700 02:48:35,806 --> 02:48:37,475 RESEARCH TEAMS. WHEN THOSE 3701 02:48:37,475 --> 02:48:39,577 TEAM S HAVE BEEN CREATED WHICH 3702 02:48:39,577 --> 02:48:44,348 WILL BY EXTENSION GENERATE 3703 02:48:44,348 --> 02:48:45,416 GENDER-EXCLUSIVE RESEARCH 3704 02:48:45,416 --> 02:48:54,024 QUESTIONS AND GOALS. NEXT SLIDE. 3705 02:48:54,024 --> 02:48:56,460 THANK YOU. 3706 02:48:56,460 --> 02:49:00,564 >> THANK YOU VERY MUCH, DR. 3707 02:49:00,564 --> 02:49:01,832 STRAH. THAT WAS EXCELLENT 3708 02:49:01,832 --> 02:49:03,100 PARTICULARLY SINCE YOU HAD TO 3709 02:49:03,100 --> 02:49:04,602 WING IT ON THE FLY THERE. THAT 3710 02:49:04,602 --> 02:49:06,337 IS ALWAYS A BIG STRESSER, BUT 3711 02:49:06,337 --> 02:49:08,639 YOU DID AN EXCELLENT JOB. YOU 3712 02:49:08,639 --> 02:49:10,207 BROUGHT UP SOME INTERESTING 3713 02:49:10,207 --> 02:49:13,677 CONCEPTS THAT I HADN'T THOUGHT 3714 02:49:13,677 --> 02:49:21,218 ABOUT WITH BNP, SPURNALACTONE, 3715 02:49:21,218 --> 02:49:23,654 THAT IS PERTINENT TO OUR 3716 02:49:23,654 --> 02:49:26,891 PRACTICE. ONE QUICK QUESTION I 3717 02:49:26,891 --> 02:49:34,632 HAD FOR YOU IS AS GROUPS ARE NOT 3718 02:49:34,632 --> 02:49:37,468 REPRESENTED IN OUR CLINICAL 3719 02:49:37,468 --> 02:49:39,136 TRIALS AT ALL EITHER, THAT IS 3720 02:49:39,136 --> 02:49:43,407 JUST A GUESS. I'M ASSUMING THAT 3721 02:49:43,407 --> 02:49:46,911 IS CORRECT. OF COURSE SEX IS A 3722 02:49:46,911 --> 02:49:51,282 MAJOR THING THAT WE LOOK AT. 3723 02:49:51,282 --> 02:49:52,783 GENDER NOT NECESSARILY. AND THEY 3724 02:49:52,783 --> 02:49:56,487 ARE CONFLATED. HOW WOULD YOU 3725 02:49:56,487 --> 02:50:05,829 APPROACH THAT ISSUE WITH 3726 02:50:05,829 --> 02:50:07,598 INCLUDING THIS GROUP FOR TRIALS. 3727 02:50:07,598 --> 02:50:09,667 WHAT IS THE MECHANISM FOR THAT? 3728 02:50:09,667 --> 02:50:13,704 >> I THINK THIS IS REALLY 3729 02:50:13,704 --> 02:50:15,172 IMPORTANT. SO THE PULMONARY 3730 02:50:15,172 --> 02:50:17,041 HYPERTENSION ASSOCIATION 3731 02:50:17,041 --> 02:50:20,544 REGISTRY IS THE FIRST REGISTRY 3732 02:50:20,544 --> 02:50:22,479 TO INCLUDE GENDER SEPARATELY 3733 02:50:22,479 --> 02:50:24,915 FROM SEX ASSIGNED AT BIRTH. ALL 3734 02:50:24,915 --> 02:50:29,153 OF OUR PRIOR REGISTRIES ONLY 3735 02:50:29,153 --> 02:50:32,823 INCLUDE SEX OR GENDER. THEY USE 3736 02:50:32,823 --> 02:50:34,858 THE TERM INTERCHANGEABLY. 3737 02:50:34,858 --> 02:50:36,560 >> RIGHT. 3738 02:50:36,560 --> 02:50:40,264 >> SO I THINK THE PULMONARY 3739 02:50:40,264 --> 02:50:42,633 HYPERTENSION REGISTRY HAS MADE A 3740 02:50:42,633 --> 02:50:45,636 REAL STEP FORWARD IN IDENTIFYING 3741 02:50:45,636 --> 02:50:49,506 SEX AND GENDER SEPARATELY. I 3742 02:50:49,506 --> 02:50:51,842 THINK, AS I MENTIONED, THIS 3743 02:50:51,842 --> 02:50:55,713 TWO-STEP IDENTIFICATION PROCESS 3744 02:50:55,713 --> 02:50:57,047 IS REALLY IMPORTANT IN 3745 02:50:57,047 --> 02:51:00,618 IDENTIFYING SEX ASSIGNED AT 3746 02:51:00,618 --> 02:51:04,588 BIRTH AND THEN SEPARATELY ADDING 3747 02:51:04,588 --> 02:51:09,760 TO EVERY REGISTRY GENDER AND NOT 3748 02:51:09,760 --> 02:51:12,429 UTILIZING TRANSGENDER AS A 3749 02:51:12,429 --> 02:51:15,633 GENDER. WE NEED MORE SPECIFIC 3750 02:51:15,633 --> 02:51:21,939 THAN THAT TRANSGENDER COMMA 3751 02:51:21,939 --> 02:51:24,308 FEMALE-TO-MALE, TRANSGENDER, 3752 02:51:24,308 --> 02:51:27,911 MALE-TO-FEMALE, TO VERY CLEARLY 3753 02:51:27,911 --> 02:51:30,948 IDENTIFY AND, FOR LACK OF A 3754 02:51:30,948 --> 02:51:34,985 BETTER WORD, CATEGORIZE OUR 3755 02:51:34,985 --> 02:51:41,825 PATIENTS. THEN WHEN WE HAVE 3756 02:51:41,825 --> 02:51:42,960 PATIENT WHO'S FALL IN THE 3757 02:51:42,960 --> 02:51:45,262 TRANSGENDER CATEGORIES, ASKING 3758 02:51:45,262 --> 02:51:47,898 ABOUT GENDER AFFIRMING HORMONE 3759 02:51:47,898 --> 02:51:51,735 THERAPY. THE AFFECT OF CROSS-SEX 3760 02:51:51,735 --> 02:51:54,972 HORMONE THERAPY INFLUENCES OUR 3761 02:51:54,972 --> 02:51:57,041 CONCEPTS AND PERCEPTIONS OF 3762 02:51:57,041 --> 02:51:58,876 DISEASE DEVELOPMENT. I THINK 3763 02:51:58,876 --> 02:52:02,513 THAT THE ONLY WAY TO LEARN MORE 3764 02:52:02,513 --> 02:52:05,549 ABOUT THIS IS TO ASK. 3765 02:52:05,549 --> 02:52:07,317 >> SO IF I'M HEARING YOU 3766 02:52:07,317 --> 02:52:10,554 CORRECTLY, THE TWO-STEP PROCESS 3767 02:52:10,554 --> 02:52:12,256 IS CLEAR BUT WHEN REPORTING 3768 02:52:12,256 --> 02:52:15,926 RESULTS FROM STUDIES, WE SHOULD 3769 02:52:15,926 --> 02:52:18,429 REPORT BY NOT ONLY SEX BUT 3770 02:52:18,429 --> 02:52:20,097 GENDER AND GENDER AS TO WHETHER 3771 02:52:20,097 --> 02:52:22,132 OR NOT THEY ARE ON HORMONE 3772 02:52:22,132 --> 02:52:24,368 THERAPY AS WELL. IS THAT WHAT 3773 02:52:24,368 --> 02:52:25,536 I'M GETTING -- ALL RIGHT. 3774 02:52:25,536 --> 02:52:27,104 >> YES. 3775 02:52:27,104 --> 02:52:35,813 >> ONE MORE THING. JUST TO 3776 02:52:35,813 --> 02:52:36,714 ORGANIZATIONAL STRUCTURE AND 3777 02:52:36,714 --> 02:52:37,981 MAKING SURE WE HAVE EVERYONE'S 3778 02:52:37,981 --> 02:52:40,184 SLIDES. IF ANY OF THE SPEAKERS 3779 02:52:40,184 --> 02:52:42,119 SENT A SLIDE DECK WITH MULTIPLE 3780 02:52:42,119 --> 02:52:43,153 VERSIONS OR VERSIONS THIS 3781 02:52:43,153 --> 02:52:48,425 MORNING, I WOULD ENCOURAGE YOU 3782 02:52:48,425 --> 02:52:52,796 TO EMAIL JACKIE AND MAKE SURE WE 3783 02:52:52,796 --> 02:52:59,036 HAVE THE CURRENTLY VERSION. 3784 02:52:59,036 --> 02:52:59,570 DIREC 3785 02:52:59,570 --> 02:53:01,205 DIRECTOR LEOPOLD, A QUESTION? 3786 02:53:01,205 --> 02:53:01,839 >> THANK YOU FOR THAT TERRIFIC 3787 02:53:01,839 --> 02:53:02,940 TALK. THIS IS SOMETHING THAT IS 3788 02:53:02,940 --> 02:53:04,475 SO INCREDIBLY NECESSARY FOR US 3789 02:53:04,475 --> 02:53:07,644 TO HEAR BECAUSE THIS IS 3790 02:53:07,644 --> 02:53:08,912 SOMETHING THAT WE DON'T THINK 3791 02:53:08,912 --> 02:53:12,916 ABOUT 90% OF THE TIME, IF NOT 3792 02:53:12,916 --> 02:53:15,018 MORE. I WANTED TO ASK LIKE IS 3793 02:53:15,018 --> 02:53:18,255 THERE SOMETHING WE SHOULD BE 3794 02:53:18,255 --> 02:53:25,963 DOING IN TERMS OF ADVOCACY? YOUR 3795 02:53:25,963 --> 02:53:28,065 COMMENT ABOUT NOTHING ABOUT US 3796 02:53:28,065 --> 02:53:32,903 WITHOUT OUT, HOW DO WE BRING 3797 02:53:32,903 --> 02:53:34,471 THIS TO THE FOREFRONT OF 3798 02:53:34,471 --> 02:53:41,779 CLINICAL TRIALS AND PH? 3799 02:53:41,779 --> 02:53:44,815 >> I THINK THAT IS AN EXCELLENT 3800 02:53:44,815 --> 02:53:48,819 QUESTION. I THINK THE -- I THINK 3801 02:53:48,819 --> 02:53:56,426 THE POLICE TO GO FIND OUT HOW WE 3802 02:53:56,426 --> 02:53:58,962 SHOULD BETTER APPROACH RESEARCH 3803 02:53:58,962 --> 02:54:01,331 AND HOW TO BE MORE INCLUSIVE IS 3804 02:54:01,331 --> 02:54:05,369 TO REACH OUT TO OUR ADVOCACY 3805 02:54:05,369 --> 02:54:07,371 GRO 3806 02:54:07,371 --> 02:54:11,208 GROUPS. AS AN EXAMPLE WHEN I WAS 3807 02:54:11,208 --> 02:54:16,146 DESIGNING MY OWN STUDY I WANTED 3808 02:54:16,146 --> 02:54:18,315 TO MAKE SURE I WAS BEING AS 3809 02:54:18,315 --> 02:54:21,418 INCLUSIVE AS POSSIBLE. SO I 3810 02:54:21,418 --> 02:54:24,488 REACHED OUT TO OUR GENDER CLINIC 3811 02:54:24,488 --> 02:54:28,525 AND OUR GENDER CLINIC CONNECTED 3812 02:54:28,525 --> 02:54:32,162 ME WITH A GENDER MINORITY 3813 02:54:32,162 --> 02:54:42,339 INDIVIDUAL WHO HAS A DEGREE IN 3814 02:54:42,339 --> 02:54:44,208 ADVOCACY. WE WENT THROUGH. HE 3815 02:54:44,208 --> 02:54:45,709 JOINED OUR RESEARCH TEAM. WE 3816 02:54:45,709 --> 02:54:51,148 TOOK ON THAT PHILOSOPHY, NOTHING 3817 02:54:51,148 --> 02:54:52,916 ABOUT US WITHOUT US. HE HAS 3818 02:54:52,916 --> 02:54:56,253 HELPED US IN RECRUITING, HE 3819 02:54:56,253 --> 02:54:58,155 HELPED US IN ENSURING THE 3820 02:54:58,155 --> 02:55:01,725 LANGUAGE APPROPRIATE. SO I THINK 3821 02:55:01,725 --> 02:55:07,931 THAT FINDING ADVOCATES WHO CARE 3822 02:55:07,931 --> 02:55:12,302 ABOUT ADDING PATIENTS TO YOUR 3823 02:55:12,302 --> 02:55:16,506 STUDY (BELL) ARE REALLY -- IS 3824 02:55:16,506 --> 02:55:17,374 PROBABLY STEP ONE. 3825 02:55:17,374 --> 02:55:21,645 >> YEP, I THINK THAT IS 3826 02:55:21,645 --> 02:55:24,748 IMPORTANT. LOOKS LIKE THERE IS A 3827 02:55:24,748 --> 02:55:32,122 COMMENT FROM DR. QUIT. IN PRR 3828 02:55:32,122 --> 02:55:34,391 YOU USED STANDARDIZED QUESTIONS 3829 02:55:34,391 --> 02:55:36,159 THAT WERE STANDARD 11 YEARS AGO 3830 02:55:36,159 --> 02:55:38,061 BUT HAVE EVOLVED. YOU HAVE A 3831 02:55:38,061 --> 02:55:40,397 PLAN FOR INEVITABLE CHANGES OF 3832 02:55:40,397 --> 02:55:45,669 HOW TO COLLECT THE DATA. THAT IS 3833 02:55:45,669 --> 02:55:48,105 GREAT. 3834 02:55:48,105 --> 02:55:54,378 >> BACK TO THAT, DR. KAIL, ARE 3835 02:55:54,378 --> 02:55:59,383 THOSE VARIABLE TO NON-FAR GROUPS 3836 02:55:59,383 --> 02:56:00,284 TO EMULATE THOSE? 3837 02:56:00,284 --> 02:56:02,653 >> ABSOLUTELY, IT IS A GREAT 3838 02:56:02,653 --> 02:56:05,289 QUESTION. I THINK -- ACTUALLY I 3839 02:56:05,289 --> 02:56:08,525 DON'T KNOW IF PVDOMICS USE THAT 3840 02:56:08,525 --> 02:56:10,294 QUESTION, I KNOW THEY USE THE 3841 02:56:10,294 --> 02:56:12,429 RACE, ETHNICITY QUESTIONS, I 3842 02:56:12,429 --> 02:56:12,930 BELIEVE -- 3843 02:56:12,930 --> 02:56:14,531 >> NO, NO. 3844 02:56:14,531 --> 02:56:15,666 >> WE DIDN'T -- 3845 02:56:15,666 --> 02:56:17,668 >> YEAH, BUT THOSE QUESTIONS ARE 3846 02:56:17,668 --> 02:56:19,803 PROBABLY NOW OUTDATED SO ANY OF 3847 02:56:19,803 --> 02:56:21,305 THESE STUDIES YOU NEED TO PLAN 3848 02:56:21,305 --> 02:56:25,776 FOR FUTURE, HOW TO HARMONIZE 3849 02:56:25,776 --> 02:56:28,979 DATA FOR LONG PERIODS OF TIME. 3850 02:56:28,979 --> 02:56:30,480 >> ALONG THOSE LINE, I DON'T 3851 02:56:30,480 --> 02:56:32,482 KNOW IF LEI IS AVAILABLE BUT 3852 02:56:32,482 --> 02:56:35,118 SHOULD NIH BE ADDING THIS TO THE 3853 02:56:35,118 --> 02:56:36,286 TABLES THAT WE ARE ALL FILLING 3854 02:56:36,286 --> 02:56:37,888 OUT, IF WE ARE FILLING OUT ABOUT 3855 02:56:37,888 --> 02:56:41,692 RACE AND ETHNICITY, MIGHT NOT 3856 02:56:41,692 --> 02:56:45,529 INCLUDE TRANSGENDER, GENDER, SEX 3857 02:56:45,529 --> 02:56:46,463 AND TRANSGENDER INDIVIDUALS. 3858 02:56:46,463 --> 02:56:48,899 >> I THINK THAT IS A GOOD 3859 02:56:48,899 --> 02:56:49,967 QUESTION. AFTER THIS WORKSHOP 3860 02:56:49,967 --> 02:56:53,737 THIS IS THE TOPIC THAT WE WILL 3861 02:56:53,737 --> 02:56:56,006 NEED TO DISCUSS. CURRENTLY WE 3862 02:56:56,006 --> 02:56:58,508 DON'T HAVE THAT ON OUR TABLE FOR 3863 02:56:58,508 --> 02:56:59,843 INCLUSION BUT THIS IS GOOD 3864 02:56:59,843 --> 02:57:03,647 DISCUSSION, EYE-OPENING FOR ME 3865 02:57:03,647 --> 02:57:07,417 TOO. I DIDN'T REALIZE THE 3866 02:57:07,417 --> 02:57:09,152 DIFFERENCE BETWEEN SEX AND 3867 02:57:09,152 --> 02:57:10,554 GENDER, NOW VERY CLEAR AND 3868 02:57:10,554 --> 02:57:11,722 TRANSGENDER ISSUE. THIS IS 3869 02:57:11,722 --> 02:57:15,759 SOMETHING WE WILL HAVE MORE 3870 02:57:15,759 --> 02:57:19,429 DISCUSSION AND WITH OUTSIDE 3871 02:57:19,429 --> 02:57:20,030 INVESTIGATOR SO THANK YOU. 3872 02:57:20,030 --> 02:57:23,834 >> ALL RIGHT. WITH THAT WE NEED 3873 02:57:23,834 --> 02:57:34,378 TO MOVE ON. THANKS TO THE TALK, 3874 02:57:35,712 --> 02:57:45,856 DR. STRAUL. 3875 02:57:48,291 --> 02:57:50,027 >> THANKS FOR INCLUDING ME. 3876 02:57:50,027 --> 02:57:53,130 >> THE NEXT IS DR. EGHBALI, 3877 02:57:53,130 --> 02:57:54,398 TALKING ABOUT DIFFERENCE ON 3878 02:57:54,398 --> 02:57:55,766 WORLD SYMPOSIUM GROUPS, 3879 02:57:55,766 --> 02:57:57,200 IMPLICATIONS FOR DIAGNOSIS, 3880 02:57:57,200 --> 02:58:00,637 TREATMENT AND CLINICAL OUTCOMES. 3881 02:58:00,637 --> 02:58:01,471 DR. EGHBALI. 3882 02:58:01,471 --> 02:58:04,074 >> THANK YOU SO MUCH FOR 3883 02:58:04,074 --> 02:58:08,545 INVITING ME. VERY HAPPY TO BE 3884 02:58:08,545 --> 02:58:10,847 HERE. MY TALK IS GOING TO BE A 3885 02:58:10,847 --> 02:58:12,816 BIT DIFFERENT. I'M A PHD 3886 02:58:12,816 --> 02:58:14,951 SCIENTIST WORKING MAINLY 3887 02:58:14,951 --> 02:58:16,153 PRE-CLINICAL AND TRANSLATIONAL 3888 02:58:16,153 --> 02:58:20,690 RESEARCH ANIMAL MODELS. NEXT, 3889 02:58:20,690 --> 02:58:21,758 PLEASE. 3890 02:58:21,758 --> 02:58:32,269 MY TALK I WILL TALK ABOUT 3891 02:58:32,569 --> 02:58:35,205 TRANSLATIONAL KNOWLEDGE IN 3892 02:58:35,205 --> 02:58:37,541 RESEARCH GROUPS, WE HAD SIX 3893 02:58:37,541 --> 02:58:38,842 HORMONES AND SIX CHROMOSOMES, 3894 02:58:38,842 --> 02:58:43,613 THEN LEAVE YOU FEW CLINICAL 3895 02:58:43,613 --> 02:58:45,215 TRIALS TARGETING ESTROGEN 3896 02:58:45,215 --> 02:58:46,550 SIGNALS AND HAVE RECOMMENDATIONS 3897 02:58:46,550 --> 02:58:53,790 AS TO HOW TO COMPREHENSIVELY 3898 02:58:53,790 --> 02:58:56,626 STUDY SEX DIFFERENCES FOR FUTURE 3899 02:58:56,626 --> 02:58:58,395 RESEARCH. 3900 02:58:58,395 --> 02:59:01,531 WE TALK ABOUT SEX IN THIS IS 3901 02:59:01,531 --> 02:59:03,066 UNKNOWN. THERE IS HIGHER KNOWN 3902 02:59:03,066 --> 02:59:05,168 INSTANCE OF PH IN WOMEN, 3903 02:59:05,168 --> 02:59:07,104 PARTICULARLY GROUP ONE. HERE YOU 3904 02:59:07,104 --> 02:59:11,007 SEE A RECENT TABLE FROM 3905 02:59:11,007 --> 02:59:15,745 PUBLICATION OF DR. EARNEST AND 3906 02:59:15,745 --> 02:59:18,448 COLLEAGUE (?) AS YOU SEE THEY 3907 02:59:18,448 --> 02:59:22,152 LOOK AT 750 PATIENTS FROM GROUP 3908 02:59:22,152 --> 02:59:26,189 ONE TO GROUP FIVE. 73% OF 3909 02:59:26,189 --> 02:59:28,692 PATIENTS ARE FEMALE. THE SAME 3910 02:59:28,692 --> 02:59:30,494 ARE ALSO HIGHER FEMALE OVERALL 3911 02:59:30,494 --> 02:59:36,233 IN GROUP TWO, THREE, FOUR EXCEPT 3912 02:59:36,233 --> 02:59:38,268 GROUP FIVE. THEN HIGHER 3913 02:59:38,268 --> 02:59:39,736 INCIDENCE IN WOMEN. WOMEN ARE 3914 02:59:39,736 --> 02:59:43,573 DIAGNOSED WITH PH IS KNOWN THEY 3915 02:59:43,573 --> 02:59:46,510 RESPOND BETTER TO THERAPY. HAVE 3916 02:59:46,510 --> 02:59:48,245 BETTER FUNCTION, WHICH 3917 02:59:48,245 --> 02:59:50,213 TRANSLATES TO HIGHER SURVIVAL IN 3918 02:59:50,213 --> 02:59:52,082 WOMAN. SO THEN WE LOOK AT 3919 02:59:52,082 --> 02:59:55,118 EXPERIMENTAL MODELS OF PH. YOU 3920 02:59:55,118 --> 02:59:59,022 SEE, MOST OF THE TIME THERE IS 3921 02:59:59,022 --> 03:00:00,657 CONFIDENT THAT THE FEMALES ARE 3922 03:00:00,657 --> 03:00:02,492 DOING BETTER OR MORE PROTECTED 3923 03:00:02,492 --> 03:00:05,195 OR ESTROGEN IS PROTECTIVE. 3924 03:00:05,195 --> 03:00:06,897 SOMETHING KNOWN AS SEX PARADOX 3925 03:00:06,897 --> 03:00:11,668 OR ESTROGEN PARADOX NPH. NEXT 3926 03:00:11,668 --> 03:00:12,269 SLIDE. 3927 03:00:12,269 --> 03:00:14,104 I'M GOING TO TALK ABOUT 3928 03:00:14,104 --> 03:00:18,608 GROUP ONE. PAH. HAD DIFFERENT 3929 03:00:18,608 --> 03:00:23,747 SUB TYPES, CONNECTIVE TISSUE, 3930 03:00:23,747 --> 03:00:25,081 ASSOCIATED PULMONARY 3931 03:00:25,081 --> 03:00:26,583 HYPERTENSION AND H.I.V. RELATED. 3932 03:00:26,583 --> 03:00:33,823 AGAIN THERE IS A NEW TABLE FROM 3933 03:00:33,823 --> 03:00:37,527 DR. VENTETUOLO AND MARCO, ALMOST 3934 03:00:37,527 --> 03:00:42,265 2,000 PATIENTS BUT 1,500 FEMALE, 3935 03:00:42,265 --> 03:00:44,000 500 ARE MALE. WHEN YOU LOOK AT 3936 03:00:44,000 --> 03:00:47,437 DIFFERENT SUBTITLES OF PAH, YOU 3937 03:00:47,437 --> 03:00:50,707 SEE MAJORITY OF THEM ARE STILL 3938 03:00:50,707 --> 03:00:56,713 WOMAN EXCEPT IN H.I.V. RELATED 3939 03:00:56,713 --> 03:01:01,251 (?). IT IS WELL ACCEPTED 3940 03:01:01,251 --> 03:01:02,285 INCIDENCE IS MORE COMMON IN 3941 03:01:02,285 --> 03:01:06,356 WOMAN. WE LOOK AT ANIMAL MODELS, 3942 03:01:06,356 --> 03:01:07,557 NEXT SLIDE, PLEASE. 3943 03:01:07,557 --> 03:01:09,893 THESE ARE CLASSICAL ANIMAL 3944 03:01:09,893 --> 03:01:11,962 MODELS USED BY INVESTIGATORS. 3945 03:01:11,962 --> 03:01:15,398 THE MODEL THAT WE PUT THE 3946 03:01:15,398 --> 03:01:16,366 ANIMALS IN HYPOXIA FOR TWO 3947 03:01:16,366 --> 03:01:19,603 WEEKS. ONE OF THE FIRST EARLY 3948 03:01:19,603 --> 03:01:21,905 ONES WAS FROM DR. (?) ALMOST 40 3949 03:01:21,905 --> 03:01:25,575 YEARS AGO SHOWING FEMALE SEX IS 3950 03:01:25,575 --> 03:01:27,310 PROTECTIVE IN HYPOXIA RAT MODEL 3951 03:01:27,310 --> 03:01:29,613 AND OVER ACTIVITY MAKES IT 3952 03:01:29,613 --> 03:01:32,482 WORSE. LATER THE DOCTOR SHOWED 3953 03:01:32,482 --> 03:01:35,952 ESTROGEN APPEARS IN THE HYPOXIA 3954 03:01:35,952 --> 03:01:39,489 IN MAY RATS. OTHER MODEL 3955 03:01:39,489 --> 03:01:42,459 EXTENSIVELY IS MTC MODEL THAT WE 3956 03:01:42,459 --> 03:01:45,695 JUST GAVE THIS TOXIN AND ONE IS 3957 03:01:45,695 --> 03:01:48,031 SUFFICIENT TO INDUCE PULMONARY 3958 03:01:48,031 --> 03:01:49,599 HYPERTENSION. SEVERAL GROUPS 3959 03:01:49,599 --> 03:01:51,001 INCLUDING MY LAB HAVE SHOWN 3960 03:01:51,001 --> 03:01:55,105 FEMALE SEX IS PROTECTIVE IN THE 3961 03:01:55,105 --> 03:02:00,543 MCT RAT MODEL AND OVER ACTIVITY 3962 03:02:00,543 --> 03:02:01,244 MAKE DISEASE WORSE. 3963 03:02:01,244 --> 03:02:02,812 ALSO THERE WAS A WORK ALMOST 3964 03:02:02,812 --> 03:02:05,682 40 YEARS AGO SHOWING WITH 3965 03:02:05,682 --> 03:02:09,219 ESTROGEN METABOLIZED IS ABLE TO 3966 03:02:09,219 --> 03:02:15,558 SLOW DOWN THE DISEASE IN MCT 3967 03:02:15,558 --> 03:02:18,695 MODEL. NEXT SLIDE. SINCE PH IS 3968 03:02:18,695 --> 03:02:21,998 NOT ALWAYS DIAGNOSED EARLY WE 3969 03:02:21,998 --> 03:02:25,502 DECIDED TO SEE IF ESTROGEN COULD 3970 03:02:25,502 --> 03:02:27,971 RESCUE PRE-EXISTING PAH. IN THE 3971 03:02:27,971 --> 03:02:30,240 MCT MODEL AND RESTART ESTROGEN 3972 03:02:30,240 --> 03:02:32,676 TREATMENT THREE WEEKS AFTER MCT, 3973 03:02:32,676 --> 03:02:34,477 NO TYPE OF DISEASES ALREADY 3974 03:02:34,477 --> 03:02:35,979 ESTABLISH ED IN THE ANIMAL. WE 3975 03:02:35,979 --> 03:02:39,015 SHOW ONLY TEN DAYS OF ESTROGEN 3976 03:02:39,015 --> 03:02:41,584 TREATMENT IS ABLE TO RESCUE 3977 03:02:41,584 --> 03:02:43,720 PRE-EXISTING DISEASES YOU SEE 3978 03:02:43,720 --> 03:02:47,057 FROM DISTOL IK PRESSURE AND (?). 3979 03:02:47,057 --> 03:02:49,092 WHAT WAS INTERESTING IS THAT WE 3980 03:02:49,092 --> 03:02:51,161 HAD ANOTHER GROUP THAT WE ONLY 3981 03:02:51,161 --> 03:02:54,764 TREATED THEM FOR TEN DAYS BUT 3982 03:02:54,764 --> 03:02:57,133 DIDN'T SACRIFICE THEM. KEPT THEM 3983 03:02:57,133 --> 03:02:59,002 FOR ANOTHER 12 DAYS TO SEE IF 3984 03:02:59,002 --> 03:03:00,670 PROTECTIVE ACTION OF ESTROGEN IS 3985 03:03:00,670 --> 03:03:03,139 GOING TO BE SUSTAINED. AS YOU 3986 03:03:03,139 --> 03:03:05,542 CAN SEE THE ESTROGEN CONTROL 3987 03:03:05,542 --> 03:03:10,146 GROUP WE SEE SIGNIFICANT 3988 03:03:10,146 --> 03:03:12,482 IMPROVEMENT IN PRESSURE AND THIS 3989 03:03:12,482 --> 03:03:16,453 IMPROVEMENT WAS THERE IN THE 3990 03:03:16,453 --> 03:03:22,826 ABSENCE (AUDIO DISRUPTION) AND 3991 03:03:22,826 --> 03:03:25,428 WE WANTED TO KNOW IF RECEPTOR. 3992 03:03:25,428 --> 03:03:28,098 THAT IS WHY THERE ARE TWO MAIN 3993 03:03:28,098 --> 03:03:34,337 RECEPTIONIST S RECEPTIONIST /* * 3994 03:03:34,337 --> 03:03:42,679 -- RECEPTORS AND COMPARE. THE 3995 03:03:42,679 --> 03:03:45,014 AGONISTS AND AS WE USE B AGONIST 3996 03:03:45,014 --> 03:03:47,317 IN GREEN BARS WE SEE THAT IS 3997 03:03:47,317 --> 03:03:49,652 ALMOST AS EFFECTIVE AS ESTROGEN. 3998 03:03:49,652 --> 03:03:54,124 WHEREAS ESTROGEN RECEPTOR FOR 3999 03:03:54,124 --> 03:03:55,091 AGONIST REALLY HAVE MUCH 4000 03:03:55,091 --> 03:03:56,393 PROTECTION TO OFFER. OUR 4001 03:03:56,393 --> 03:03:58,261 CONCLUSION WAS THAT THE 4002 03:03:58,261 --> 03:04:00,997 PROTECTIVE ACTION OF ESTROGEN IN 4003 03:04:00,997 --> 03:04:06,736 MTC MODEL WE USE IS TO ESTROGEN 4004 03:04:06,736 --> 03:04:10,240 RECEPTOR B. NEXT SLIDE. WE 4005 03:04:10,240 --> 03:04:20,250 PUBLISHED THIS IN JOURNAL IN 4006 03:04:20,250 --> 03:04:22,452 2011 AND THERE WAS EDITORIAL AND 4007 03:04:22,452 --> 03:04:24,053 HAPPY TO SEE THE IMAGE ON THE 4008 03:04:24,053 --> 03:04:27,557 COVER OF THE MAGAZINE. NEXT, 4009 03:04:27,557 --> 03:04:31,795 PLEASE. BUT NOT ONLY ESTROGEN, 4010 03:04:31,795 --> 03:04:34,497 ESTROGEN METABOLITES LIKE 4011 03:04:34,497 --> 03:04:44,908 2METOXY OR 2HYDROXY IS 4012 03:04:46,543 --> 03:04:48,778 PROTECTIVE. THIS IS CONVERTED TO 4013 03:04:48,778 --> 03:04:54,451 TESTOSTERONE AND WITH HELP OF 4014 03:04:54,451 --> 03:04:57,587 AROMATASE IS MAKING ESTROGEN 4015 03:04:57,587 --> 03:04:59,789 CONVERTED TO METABOLITES. THESE 4016 03:04:59,789 --> 03:05:01,724 ARE KNOWN AS GOOD METABOLITES. 4017 03:05:01,724 --> 03:05:03,793 THERE ARE MANY PEOPLE SHOWING 4018 03:05:03,793 --> 03:05:07,330 THESE TWO ARE PROTECTED IN PH, 4019 03:05:07,330 --> 03:05:16,439 WHEREAS ON THE RED 16HYPOXY IS 4020 03:05:16,439 --> 03:05:22,278 SHOWN (?). NEXT ONE, PLEASE. THE 4021 03:05:22,278 --> 03:05:26,149 OTHER MODEL WE HAVE EXTENSIVELY 4022 03:05:26,149 --> 03:05:28,451 USED IS HYPOXIA, THAT MODEL. IN 4023 03:05:28,451 --> 03:05:39,095 MANY WAYS IT IT MY MIK /* /* -- 4024 03:05:42,265 --> 03:05:45,969 IT MIMICS AND WHEN THEY COMPARE 4025 03:05:45,969 --> 03:05:48,171 FEMALE TO MALE THEY HAVE BETTER 4026 03:05:48,171 --> 03:05:49,439 PERFORMANCE AND LOWER 4027 03:05:49,439 --> 03:05:52,408 INFLAMMATORY IN ARTERIES, LOWER 4028 03:05:52,408 --> 03:05:55,378 RV FIBROSIS AND BETTER SURVIVAL. 4029 03:05:55,378 --> 03:05:57,847 IN THE FOLLOW-UP WORK BY DR. TIM 4030 03:05:57,847 --> 03:06:00,283 LAMB AND (?) THEY ACTUALLY SHOW 4031 03:06:00,283 --> 03:06:03,486 THE MECHANISM THAT ESTROGEN IS 4032 03:06:03,486 --> 03:06:07,323 PROTECTIVE, ESTROGEN RECEPTOR 4033 03:06:07,323 --> 03:06:16,733 (?) TO SIGNALLING TO (?) POTENT 4034 03:06:16,733 --> 03:06:18,034 EFFECTECTOR. ANOTHER GROUP USING 4035 03:06:18,034 --> 03:06:20,937 THE SAME HYPOXIA RAT MODEL 4036 03:06:20,937 --> 03:06:22,071 SHOWING COMPLETELY OPPOSITE 4037 03:06:22,071 --> 03:06:24,474 RESULT THAT ACTUALLY INSTEAD OF 4038 03:06:24,474 --> 03:06:27,076 ACTIVATING ESTROGEN RECEPTOR 4039 03:06:27,076 --> 03:06:30,213 THEY SHOW INHIBITION OF RECEPTOR 4040 03:06:30,213 --> 03:06:33,583 HAD THERAPEUTIC EFFECT IN FEMALE 4041 03:06:33,583 --> 03:06:39,756 RATS AND USE OF THE ENZYME THAT 4042 03:06:39,756 --> 03:06:44,060 CONVERT TO ESTROGEN, SHOWN TO 4043 03:06:44,060 --> 03:06:47,931 THE PH DEVELOPMENT. NEXT SLIDE. 4044 03:06:47,931 --> 03:06:49,766 THERE ARE ALSO GENETICALLY 4045 03:06:49,766 --> 03:06:51,467 MODIFIED MICE THAT THEY SHOWED 4046 03:06:51,467 --> 03:06:53,303 THEY DON'T SUPPORT THE FEMALE 4047 03:06:53,303 --> 03:06:55,071 PROTECTION IN PH. MOST OF THIS 4048 03:06:55,071 --> 03:06:58,875 WORK HAS BEEN DONE BY DR. 4049 03:06:58,875 --> 03:07:02,312 MC LAIN. SHE USED PH MODEL USED 4050 03:07:02,312 --> 03:07:07,317 BY OVEREXPRESSION OF THIS IN 4051 03:07:07,317 --> 03:07:09,886 MICE. THEY SHOW ACTUALLY IN THIS 4052 03:07:09,886 --> 03:07:13,623 MODEL ONLY FEMALE MICE DEVELOP 4053 03:07:13,623 --> 03:07:23,866 PH. (?) ACTUALLY MAKES -- IN 4054 03:07:23,866 --> 03:07:27,804 FEMALES. THERE IS ANOTHER MODEL 4055 03:07:27,804 --> 03:07:32,475 INDUCED BY BINDING PROTEINS AND 4056 03:07:32,475 --> 03:07:36,145 SHOW DEVELOPMENT OF LESION ONLY 4057 03:07:36,145 --> 03:07:42,018 BEING SEEN IN FEMALE MICE. NEXT 4058 03:07:42,018 --> 03:07:43,753 SLIDE. 4059 03:07:43,753 --> 03:07:48,091 WE ALSO LOOK AT MODEL FEW 4060 03:07:48,091 --> 03:07:50,927 YEARS AGO BY FEEDING THE WILD 4061 03:07:50,927 --> 03:07:53,496 TYPE MICE WITH DIET RICH IN 4062 03:07:53,496 --> 03:07:56,633 OXIDIZED LIPI D. PUT THE DIET ON 4063 03:07:56,633 --> 03:07:59,035 THIS DIET THREE WEEKS AND 4064 03:07:59,035 --> 03:08:00,403 DEVELOP HYPERTENSION. 4065 03:08:00,403 --> 03:08:03,373 INTERESTINGLY IN THIS MODEL, AS 4066 03:08:03,373 --> 03:08:05,208 YOU CAN SEE IN PANEL C, WE 4067 03:08:05,208 --> 03:08:07,910 COMPARE MALE AND FEMALE. IN THIS 4068 03:08:07,910 --> 03:08:11,814 MODEL WE SEE ACTUALLY FEMALE 4069 03:08:11,814 --> 03:08:14,450 DEVELOP MORE SERIOUS 4070 03:08:14,450 --> 03:08:16,119 HYPERTENSION THAN ME AND PUBLISH 4071 03:08:16,119 --> 03:08:19,689 FOR PEOPLE INTERESTED TO LOOK AT 4072 03:08:19,689 --> 03:08:23,660 THIS MODEL. NEXT SLIDE. THEN 4073 03:08:23,660 --> 03:08:27,363 WHEN COMES TO PH GROUP 2, WHICH 4074 03:08:27,363 --> 03:08:29,866 IS THE PH SECOND TO HEART 4075 03:08:29,866 --> 03:08:31,534 DISEASE, THIS IS ACTUALLY THE 4076 03:08:31,534 --> 03:08:35,238 MOST COMMON TYPE OF PH, EITHER 4077 03:08:35,238 --> 03:08:37,840 SECONDARY TO HEART FAILURE WITH 4078 03:08:37,840 --> 03:08:40,309 (?) OR HEART FAILURE WITH 4079 03:08:40,309 --> 03:08:43,246 REDUCED EJECTION FRACTURE. WHEN 4080 03:08:43,246 --> 03:08:45,782 COMES TO PH SECONDARY TO HEART 4081 03:08:45,782 --> 03:08:47,016 FAILURE REDUCED EJECTION 4082 03:08:47,016 --> 03:08:50,253 FRACTION THERE ARE SEVERAL 4083 03:08:50,253 --> 03:08:52,689 CLINICAL TRIALS THAT THEY SHOW 4084 03:08:52,689 --> 03:08:55,324 MORE MALE TO FEMALE RATIO, 4085 03:08:55,324 --> 03:08:58,795 INDICATING A HIGHER OF GROUP 2. 4086 03:08:58,795 --> 03:09:02,065 THEN YOU LOOK AT THE PH 4087 03:09:02,065 --> 03:09:02,999 SUBPOENAING DARE TO HEART 4088 03:09:02,999 --> 03:09:05,101 FAILURE WITH PRESERVE EJECTION 4089 03:09:05,101 --> 03:09:08,504 FRACTION, THE RESULT IS QUITE 4090 03:09:08,504 --> 03:09:13,342 MIXED. THERE ARE SOME CLINICAL 4091 03:09:13,342 --> 03:09:17,613 TRIALS THEY SHOW HIGHER RATIOS. 4092 03:09:17,613 --> 03:09:20,049 WHEN COMES TO PH GROUP 2 THERE 4093 03:09:20,049 --> 03:09:21,551 IS NOT REALLY MANY ANIMAL 4094 03:09:21,551 --> 03:09:23,820 MODELS. THERE ARE A LOT OF 4095 03:09:23,820 --> 03:09:28,191 ANIMAL MODELS TO INDUCE, REDUCE 4096 03:09:28,191 --> 03:09:31,594 EJECTION FRACTION. THAT IS 4097 03:09:31,594 --> 03:09:33,362 USUALLY DONE BY CONSTRICTION BUT 4098 03:09:33,362 --> 03:09:36,532 NO ONE REALLY LOOKS AT PULMONARY 4099 03:09:36,532 --> 03:09:38,668 VASCULAR REMODELLING IN THESE 4100 03:09:38,668 --> 03:09:40,770 MICE. INSTEAD THERE IS A LOT OF 4101 03:09:40,770 --> 03:09:44,107 WORK THAT NEEDS TO BE DONE IN 4102 03:09:44,107 --> 03:09:49,746 THIS GROUP. NEXT SLIDE. THEN PH 4103 03:09:49,746 --> 03:09:53,316 GROUP THREE IS SECONDARY TO 4104 03:09:53,316 --> 03:09:56,219 CHRONIC LUNG DISEASE. THIS 4105 03:09:56,219 --> 03:09:57,620 REALLY DEPENDS. THERE ARE 4106 03:09:57,620 --> 03:10:00,857 REPORTS WHEN THEY LOOK AT THE 4107 03:10:00,857 --> 03:10:03,793 ENTIRE GROUP THREE THEY SHOW 4108 03:10:03,793 --> 03:10:05,328 THAT FEMALES WERE MOST 4109 03:10:05,328 --> 03:10:06,362 SUSCEPTIBLE MAINLY BECAUSE OF 4110 03:10:06,362 --> 03:10:08,564 MUCH HIGHER ABUNDANCE OF PULL 4111 03:10:08,564 --> 03:10:10,833 MOP NEAR HYPERTENSION ASSOCIATED 4112 03:10:10,833 --> 03:10:12,902 WITH AUTO IMMUNE PULMONARY 4113 03:10:12,902 --> 03:10:16,339 FIBROSIS IN WOMAN. BUT IF YOU 4114 03:10:16,339 --> 03:10:25,248 LOOK AT OTHER OTHER ETIOLOGIES, 4115 03:10:25,248 --> 03:10:27,216 THERE MAY BE MORE SUSCEPTIBLE IN 4116 03:10:27,216 --> 03:10:30,019 GROUP THREE, COPD IS HIGH NER 4117 03:10:30,019 --> 03:10:33,790 MEN DUE TO SMOKING. ALSO IN 4118 03:10:33,790 --> 03:10:35,424 IDIOPATHIC FIBROSIS MEN ARE MORE 4119 03:10:35,424 --> 03:10:38,795 PRONE TO BE AFFECTED THEN WOMEN. 4120 03:10:38,795 --> 03:10:42,031 AGAIN IN IDIOPATHIC PULMONARY 4121 03:10:42,031 --> 03:10:44,300 FIBROSIS REPORTED MALE SEX IS 4122 03:10:44,300 --> 03:10:46,569 RISK FACTOR FOR (?) DYSFUNCTION 4123 03:10:46,569 --> 03:10:54,076 EVEN A CRU ADJUSTING THE PRESSU 4124 03:10:54,076 --> 03:10:54,777 NEXT SLIDE. 4125 03:10:54,777 --> 03:10:56,112 THERE ARE NOT REPORTS TO 4126 03:10:56,112 --> 03:10:58,681 LOOK AT RULE OF ESTROGEN AND 4127 03:10:58,681 --> 03:11:00,116 RECEPTORS IN PH GROUP 3. THIS IS 4128 03:11:00,116 --> 03:11:02,318 ONE OF THE FEW STUDIES FOUND 4129 03:11:02,318 --> 03:11:10,159 THAT THEY LOOKING AT THIS IN 4130 03:11:10,159 --> 03:11:12,028 LUNG OF HEALTHY SUBJECTS, IN 4131 03:11:12,028 --> 03:11:21,370 PATIENTS WITH PH SECONDARY TO 4132 03:11:21,370 --> 03:11:24,507 IPF. ESTROGEN RECEPTOR 4133 03:11:24,507 --> 03:11:25,842 EXPRESSION WAS SIGNIFICANTLY 4134 03:11:25,842 --> 03:11:28,845 HIGHER IN PAH SUBJECTS COMPARED 4135 03:11:28,845 --> 03:11:32,548 TO GROUP 3 HYPERTENSION. NEXTED 4136 03:11:32,548 --> 03:11:34,817 SLIDE. ALSO WHEN COMES TO ANIMAL 4137 03:11:34,817 --> 03:11:36,352 MODELS, THERE ARE NOT MANY 4138 03:11:36,352 --> 03:11:38,054 ANIMAL MODELS COMPARING MALE AND 4139 03:11:38,054 --> 03:11:41,891 FEMALE. THERE IS A STUDY THAT 4140 03:11:41,891 --> 03:11:45,061 THEY INDUCE GROUP THREE 4141 03:11:45,061 --> 03:11:47,296 HYPERTENSION IN RATS BY (?) THAT 4142 03:11:47,296 --> 03:11:49,232 WORK WAS DONE BY (?) MANY YEARS 4143 03:11:49,232 --> 03:11:51,634 AGO. IN THIS ONE, AS RIGHT NOW 4144 03:11:51,634 --> 03:11:57,106 SEE, YOU CAN SEE SURVIVAL WHEN 4145 03:11:57,106 --> 03:11:59,575 THEY (?) THE RATS AND SEE THE 4146 03:11:59,575 --> 03:12:02,778 MORTALITY HAS INCREASED, EVIDENT 4147 03:12:02,778 --> 03:12:06,415 BY HIGHER SYSTOLIC PRESSURE AND 4148 03:12:06,415 --> 03:12:09,986 LONG, BUT WHEN TREAT WITH 4149 03:12:09,986 --> 03:12:18,060 ESTROGEN METABOLITE TO 4150 03:12:18,060 --> 03:12:19,528 METOXYESTRADIOL, SURVIVAL IS 4151 03:12:19,528 --> 03:12:24,233 INCREASED IN PRESSURE AND (?) 4152 03:12:24,233 --> 03:12:26,269 NEXT SLIDE. WE ALSO DECIDED TO 4153 03:12:26,269 --> 03:12:30,439 LOOK AT THE RULE OF SEX 4154 03:12:30,439 --> 03:12:31,073 CHROMO 4155 03:12:31,073 --> 03:12:32,475 CHROMOSOME. WE KNOW INDENSE IS 4156 03:12:32,475 --> 03:12:35,077 HIGHER IN FEMALE IN PAH. MAYBE 4157 03:12:35,077 --> 03:12:37,680 MAY THEY HAVE A PROTECTIVE 4158 03:12:37,680 --> 03:12:40,750 FACTOR. THEN LOOK AT ROLE IN 4159 03:12:40,750 --> 03:12:42,818 COLLABORATION WITH DR. ARNOLD AT 4160 03:12:42,818 --> 03:12:47,223 UCLA. DR. ARNOLD AND HIS 4161 03:12:47,223 --> 03:12:50,793 COLLEAGUE, THEY PIONEERED 4162 03:12:50,793 --> 03:12:53,262 SEVERAL MOUSE MODELS KNOWN AS 4163 03:12:53,262 --> 03:12:54,797 (?). THESE MICE HAVE BEEN USED 4164 03:12:54,797 --> 03:12:56,666 BY MANY INVESTIGATORS LOOKING AT 4165 03:12:56,666 --> 03:13:01,904 DIFFERENT TYPES OF DISEASE AND 4166 03:13:01,904 --> 03:13:03,873 HIGHLIGHTED BY THE NIH 4167 03:13:03,873 --> 03:13:09,745 DIRECTOR'S OFFICE. NEXT SLIDE. 4168 03:13:09,745 --> 03:13:14,684 IN THE (?) ON THE LEFT IT IS 4169 03:13:14,684 --> 03:13:16,185 INTERESTING YOU CAN HAVE A 4170 03:13:16,185 --> 03:13:20,556 FEMALE MICE WITH X, X OR XY 4171 03:13:20,556 --> 03:13:22,124 CHROMOSOME. THE REASON IS 4172 03:13:22,124 --> 03:13:24,794 BECAUSE THE SRY GENE THAT 4173 03:13:24,794 --> 03:13:26,362 DETERMINES THE PRESENCE OF 4174 03:13:26,362 --> 03:13:31,467 TESTES ARE REMOVED FROM THE Y 4175 03:13:31,467 --> 03:13:33,903 CHROMOSOME AND THOUGH MICE HAS 4176 03:13:33,903 --> 03:13:37,306 XY CHROMOSOME, SEEING NOT THERE 4177 03:13:37,306 --> 03:13:38,574 THEY DEVELOP OVARIES AND 4178 03:13:38,574 --> 03:13:41,310 CONSIDERED FEMALE. COULD ALSO 4179 03:13:41,310 --> 03:13:44,347 HAVE MICE WITH XX CHROMOSOME. IN 4180 03:13:44,347 --> 03:13:48,384 THIS CASE WHEN THEY PUT THIS ON 4181 03:13:48,384 --> 03:13:53,923 THE AUTOSOME THEN HAS X AND ONE 4182 03:13:53,923 --> 03:13:55,458 HAS THE GENE AND WHY THEY 4183 03:13:55,458 --> 03:13:58,427 DEVELOP TEST IT. THIS ALLOWS YOU 4184 03:13:58,427 --> 03:13:59,495 LOOK AT ROLE INDEPENDENT 4185 03:13:59,495 --> 03:14:04,400 DEPARTMENT OF THE GONAD AND SEX. 4186 03:14:04,400 --> 03:14:06,335 THE OTHER MOUSE MODEL, IN 4187 03:14:06,335 --> 03:14:10,673 THIS MICE YOU CAN TEST THE ROLE 4188 03:14:10,673 --> 03:14:13,976 OF SEX CHROMOSOME DOSAGE, 1X 4189 03:14:13,976 --> 03:14:16,045 VERSUS 2X. CAN HAVE A FEMALE 4190 03:14:16,045 --> 03:14:19,615 MICE WITH 1X OR 2X AND MALE WITH 4191 03:14:19,615 --> 03:14:21,984 1X OR 2X AND THEN LOOK TO SEE IF 4192 03:14:21,984 --> 03:14:25,521 THE DIFFERENCES THAT WE SEE IS 4193 03:14:25,521 --> 03:14:28,457 BECAUSE OF THE (?) OR BECAUSE OF 4194 03:14:28,457 --> 03:14:33,529 THE ABSENCE OR PRESENCE OF Y 4195 03:14:33,529 --> 03:14:40,836 CHROMOSOME. NEXT SLIDE. 4196 03:14:40,836 --> 03:14:41,437 PARAGR 4197 03:14:41,437 --> 03:14:43,239 ALMOST TEN YEARS AGO WE 4198 03:14:43,239 --> 03:14:45,441 LOOKED AT THESE MICE TO SEE THE 4199 03:14:45,441 --> 03:14:49,645 ROLE IN HYPERTENSION. WE UTILIZE 4200 03:14:49,645 --> 03:14:52,782 ALL THESE DOCTORS FOR (?) SEX 4201 03:14:52,782 --> 03:14:54,784 HORMONES. WE WAITED FOR A MONTH. 4202 03:14:54,784 --> 03:14:58,154 AFTER THAT WE PUT THESE MICE 4203 03:14:58,154 --> 03:15:01,624 EITHER IN AMOXIA OR HYPOXIA A 4204 03:15:01,624 --> 03:15:05,161 FEW WEEKS. AS YOU CAN SEE IN FGC 4205 03:15:05,161 --> 03:15:07,129 MICE THEY ALL LOOK THE SAME BUT 4206 03:15:07,129 --> 03:15:09,432 WHEN PUT IN HYPOXIA, THE MICE 4207 03:15:09,432 --> 03:15:11,667 THEY HAVE XX CHROMOSOME, 4208 03:15:11,667 --> 03:15:19,141 REGARDLESS IF THEY HAD TESTES OR 4209 03:15:19,141 --> 03:15:19,442 O 4210 03:15:19,442 --> 03:15:25,081 OVARIES THEY HAVE HIGH DISTOLIC 4211 03:15:25,081 --> 03:15:26,749 PRESSURE. IT DOESN'T MATTER HERE 4212 03:15:26,749 --> 03:15:34,323 IF THEY HAVE 1X OR 2X. THE MOUSE 4213 03:15:34,323 --> 03:15:37,126 WITH Y CHROMOSOME, THEY ARE 4214 03:15:37,126 --> 03:15:37,793 PROTECTED. NEXT SLIDE. 4215 03:15:37,793 --> 03:15:41,097 WE HAVE PUBLISHED THIS WORK 4216 03:15:41,097 --> 03:15:44,100 IN BLUE JOURNAL IN 2018 SHOWING 4217 03:15:44,100 --> 03:15:51,774 THE Y CHROMOSOME PLAYS ROLE IN 4218 03:15:51,774 --> 03:15:54,043 EXPERIMENT MEN HI POX IK 4219 03:15:54,043 --> 03:15:55,111 PULMONARY HYPERTENSION AND WE 4220 03:15:55,111 --> 03:15:58,781 USED ANALYSIS OF CHROMOSOME Y 4221 03:15:58,781 --> 03:16:01,450 GENE TO SEE WHAT GENES ON Y 4222 03:16:01,450 --> 03:16:03,252 CHROMOSOME ARE EXPRESSED BOTH IN 4223 03:16:03,252 --> 03:16:06,856 THE HEART AND IN THE LUNG. WE 4224 03:16:06,856 --> 03:16:10,092 FIND THERE ARE ONLY FOUR GENES 4225 03:16:10,092 --> 03:16:12,261 ON Y CHROMOSOME EXPRESSED IN 4226 03:16:12,261 --> 03:16:14,096 LUNGS OF THESE MICE. 4227 03:16:14,096 --> 03:16:15,131 INTERESTINGLY, THREE OF THEM ARE 4228 03:16:15,131 --> 03:16:18,100 ALSO EXPRESSED IN HUMAN LUNGS. 4229 03:16:18,100 --> 03:16:20,870 BUT WHAT IS MORE IMPORTANT IS 4230 03:16:20,870 --> 03:16:22,304 THAT WE SEE THESE THREE GENES 4231 03:16:22,304 --> 03:16:26,142 THAT ARE EXPRESSED IN HUMAN 4232 03:16:26,142 --> 03:16:28,110 LUNGS, WHEN THESE PEOPLE HAVE 4233 03:16:28,110 --> 03:16:33,782 PULMONARY HYPERTENSION THE 4234 03:16:33,782 --> 03:16:37,987 EXPRESS ARE DOMINATED IN 4235 03:16:37,987 --> 03:16:39,121 PULMONARY HYPERTENSION. NEXT, 4236 03:16:39,121 --> 03:16:39,455 PLEASE. 4237 03:16:39,455 --> 03:16:43,092 NEXT WHAT WE DID, WE WANTED 4238 03:16:43,092 --> 03:16:45,394 TO KNOW WHAT GENE ON Y 4239 03:16:45,394 --> 03:16:46,462 CHROMOSOME IS RESPONSIBLE FOR 4240 03:16:46,462 --> 03:16:47,963 THIS PROTECTION. SINCE THERE 4241 03:16:47,963 --> 03:16:50,566 WERE ONLY FOUR IT WAS VERY EASY. 4242 03:16:50,566 --> 03:16:52,801 WHAT WE DID, WE SILENCED ONE 4243 03:16:52,801 --> 03:16:55,371 GENE AT THE TIME. FIRST WE GOING 4244 03:16:55,371 --> 03:16:57,573 TO (?) ALL THE MICE. WE WAITED 4245 03:16:57,573 --> 03:17:00,476 30 DAYS. AFTER THAT WE PUT THEM 4246 03:17:00,476 --> 03:17:08,884 IN TAMOXIA OR HYPOXIA AND 4247 03:17:08,884 --> 03:17:12,755 SILENCED ONE AT A TIME BY SNRNA. 4248 03:17:12,755 --> 03:17:15,391 THE THREE ON THE TOP, WHEN WE 4249 03:17:15,391 --> 03:17:16,992 SILENCED THEM WE DIDN'T SEE 4250 03:17:16,992 --> 03:17:19,828 CHANGE IN RV SYSTOLIC PRESSURE 4251 03:17:19,828 --> 03:17:22,698 BUT AS SOON AS WE SILENCED UTY, 4252 03:17:22,698 --> 03:17:24,466 WE SEE THE Y CHROMOSOME 4253 03:17:24,466 --> 03:17:26,602 PROTECTION WAS GONE. AS YOU CAN 4254 03:17:26,602 --> 03:17:31,307 SEE, THERE WAS A HIGHER SYSTOLIC 4255 03:17:31,307 --> 03:17:34,210 PRESSURE AND WE REPEATED THIS 4256 03:17:34,210 --> 03:17:35,844 EXPERIMENT SEVERAL TIME. NEXT 4257 03:17:35,844 --> 03:17:36,812 SLIDE, PLEASE. 4258 03:17:36,812 --> 03:17:39,748 WHAT IS REALLY INTERESTING 4259 03:17:39,748 --> 03:17:42,318 IS WE IDENTIFY ON Y CHROMOSOME 4260 03:17:42,318 --> 03:17:44,653 BUT WHEN LOOK AT DIFFERENT 4261 03:17:44,653 --> 03:17:47,990 ANIMAL MODELS OF PULMONARY 4262 03:17:47,990 --> 03:17:49,525 HYPERTENSION, WE LOOK AT THE 4263 03:17:49,525 --> 03:17:52,695 HYPOXIA MODEL IN MICE WE SEE UTY 4264 03:17:52,695 --> 03:17:55,998 IS DOWN REGULATED IN HYPOXIA IN 4265 03:17:55,998 --> 03:17:58,467 MICE. SEE UTY EXPRESSION IN 4266 03:17:58,467 --> 03:18:02,271 LUNGS OF BOTH MCT AND (?) 4267 03:18:02,271 --> 03:18:05,407 HYPOXIA DOWN-REGULATED. WE SEE 4268 03:18:05,407 --> 03:18:08,410 UTY IS DOWNGRADED IN LUNGS OF 4269 03:18:08,410 --> 03:18:12,014 PATIENTS WITH PULMONARY 4270 03:18:12,014 --> 03:18:13,682 HYPERTENSION. NEXT SLIDE. 4271 03:18:13,682 --> 03:18:17,753 THE NEXT QUESTION WAS, WE 4272 03:18:17,753 --> 03:18:19,121 WANTED TO SEE WHAT ARE DOWN 4273 03:18:19,121 --> 03:18:28,230 STREAM EFFECT TOORS. THAT IS WHE 4274 03:18:28,230 --> 03:18:32,801 EXTEND LUNGS OF THE MICE, UT AND 4275 03:18:32,801 --> 03:18:35,671 WILD TYPE FOR R.N.A. SEQUENCING 4276 03:18:35,671 --> 03:18:36,905 AND IDENTIFY INFLATION AS 4277 03:18:36,905 --> 03:18:42,478 PATHWAY WAS ENRICHED. WE ALSO 4278 03:18:42,478 --> 03:18:43,846 ANTICIPATED WITH ALL ONLINE WITH 4279 03:18:43,846 --> 03:18:47,249 MALE AND FEMALE PH LUNGS AND 4280 03:18:47,249 --> 03:18:52,121 IDENTIFY TWO GENES, CXCL9 AND 4281 03:18:52,121 --> 03:18:56,558 10. THESE ARE TWO PRO 4282 03:18:56,558 --> 03:18:58,761 INFLAMMATORY CYTOKINES REGULATED 4283 03:18:58,761 --> 03:19:01,730 AS OF UT KNOCK-DOWN AND ALSO IN 4284 03:19:01,730 --> 03:19:05,601 FEMALE PATIENTS THAT THEY DON'T 4285 03:19:05,601 --> 03:19:09,238 HAVE UT PART. NEXT SLIDE. 4286 03:19:09,238 --> 03:19:11,874 NEXT WE WANTED TO SEE IF THE 4287 03:19:11,874 --> 03:19:22,351 INHIBITOR ACTIVITY OF CX9, 4288 03:19:22,618 --> 03:19:24,687 BETWEEN THE TWO, CAN WE USE THIS 4289 03:19:24,687 --> 03:19:27,256 AS PRO TEN SHALL THERAPY IN 4290 03:19:27,256 --> 03:19:29,458 FEMALES. IN THIS WE USED FEMALE 4291 03:19:29,458 --> 03:19:34,830 RATS, USED GONAD INTACTS AND 4292 03:19:34,830 --> 03:19:39,401 BOTH MODEL OF THIS AND HYPOXIA 4293 03:19:39,401 --> 03:19:42,171 AND STARTED TWO WEEKS AFTER USE 4294 03:19:42,171 --> 03:19:46,108 OF MCT AND THREE WEEKS AFTER 4295 03:19:46,108 --> 03:19:49,278 SUCHING WHEN WE KNOW DISEASE IS 4296 03:19:49,278 --> 03:19:51,380 STARTING TO ESTABLISH. NEXT 4297 03:19:51,380 --> 03:19:51,613 SLIDE. 4298 03:19:51,613 --> 03:19:53,882 WE ACTUALLY WERE QUITE 4299 03:19:53,882 --> 03:19:57,419 IMPRESSED TO SEE THIS SMALL 4300 03:19:57,419 --> 03:20:01,023 MOLECULE. LOOKING ACTIVITY OF 9 4301 03:20:01,023 --> 03:20:04,360 AND 10 WERE ABLE TO 4302 03:20:04,360 --> 03:20:06,895 SIGNIFICANTLY REDUCE THE MCT IN 4303 03:20:06,895 --> 03:20:08,897 BOTH, MCT AND HYPOXIA. YOU SEE 4304 03:20:08,897 --> 03:20:14,670 THE SYSTOLIC PRESSURE IS (?). 4305 03:20:14,670 --> 03:20:18,440 ALSO SEE PULMONARY INCREASE AND 4306 03:20:18,440 --> 03:20:25,381 SEE THE RV HYPITROPHY WAS 4307 03:20:25,381 --> 03:20:27,216 REVERSED. I REPEATED WORK AND 4308 03:20:27,216 --> 03:20:29,184 DON'T WANT TO GO INTO DETAILS 4309 03:20:29,184 --> 03:20:30,886 BUT THIS WAS PUBLISHED IN BLUE 4310 03:20:30,886 --> 03:20:33,055 JOURNAL TWO YEARS AGO. THERE WAS 4311 03:20:33,055 --> 03:20:40,229 A NICE EDITORIAL BY DR. STEFAN 4312 03:20:40,229 --> 03:20:42,798 CHANT AT U D TO EXPRESS 4313 03:20:42,798 --> 03:20:45,834 DIFFERENCES IN PULMONARY 4314 03:20:45,834 --> 03:20:46,535 HYPERTENSION. NEXT SLIDE. 4315 03:20:46,535 --> 03:20:49,872 NOW I'M GOING TO JUST REVIEW 4316 03:20:49,872 --> 03:20:53,509 A COUPLE OF CLINICAL TRIALS THAT 4317 03:20:53,509 --> 03:20:55,844 THEY ARE LOOKING AT, IF 4318 03:20:55,844 --> 03:20:58,647 TARGETING THE ESTROGEN ACTIVITY, 4319 03:20:58,647 --> 03:21:02,618 ESTROGEN RECEPTOR OR THEY LOOK 4320 03:21:02,618 --> 03:21:09,091 AT THE ESTROGEN BIOCENTIS 4321 03:21:09,091 --> 03:21:14,797 BLOCKING AND CAN USE AS TRIALS. 4322 03:21:14,797 --> 03:21:17,533 (BELL) NEXT. 4323 03:21:17,533 --> 03:21:20,769 MOST CLINICAL TRIALS DONE BY 4324 03:21:20,769 --> 03:21:23,739 DR. (?) SHOWN LOOKING AT THE (?) 4325 03:21:23,739 --> 03:21:25,607 ESTROGEN ANTAGONIST. IN THIS WAS 4326 03:21:25,607 --> 03:21:28,577 A CLINICAL TRIAL. IN THIS ONE 4327 03:21:28,577 --> 03:21:30,646 THEY ONLY SHOW THE LEVEL OF 4328 03:21:30,646 --> 03:21:33,382 SECRETING ESTROGEN REDUCED BUT 4329 03:21:33,382 --> 03:21:35,484 NO REAL SIGNIFICANT IMPROVEMENT 4330 03:21:35,484 --> 03:21:38,353 IN THIS CHANGE. THERE WAS 4331 03:21:38,353 --> 03:21:41,890 ANOTHER CLINICAL TRIAL, AND THIS 4332 03:21:41,890 --> 03:21:43,959 WAS BY DR. (?). IN SHORT JUST 4333 03:21:43,959 --> 03:21:47,830 THREE MONTHS, PUT THEM IN (?) 4334 03:21:47,830 --> 03:21:51,733 FOR JUST ONE PERIOD A DAY. HERE 4335 03:21:51,733 --> 03:21:54,470 THEY SHOW IT WAS SIGNIFICANTLY 4336 03:21:54,470 --> 03:21:58,674 REDUCED BUT THERE WAS NO REALLY 4337 03:21:58,674 --> 03:22:05,113 DIFFERENCE IN (?) BUT WHAT WAS 4338 03:22:05,113 --> 03:22:08,450 INTERESTING WAS (?). 4339 03:22:08,450 --> 03:22:11,019 THERE ARE OTHER CUT WITH 4340 03:22:11,019 --> 03:22:15,691 ERIC AUSTIN AND OTHER WITH DR. 4341 03:22:15,691 --> 03:22:21,063 (?) LOOKING AT (?) AND 4342 03:22:21,063 --> 03:22:22,064 TAMOXOFIN. SOME OF THESE ARE 4343 03:22:22,064 --> 03:22:23,398 FINISHED. WITH E CAN LOOK AT 4344 03:22:23,398 --> 03:22:25,033 DATA ON THE CLINICAL TRIAL BUT 4345 03:22:25,033 --> 03:22:27,636 STILL NOT PUBLISHED BUT LOOKING 4346 03:22:27,636 --> 03:22:29,805 -- DR. CABLE IS LOOKING AT 4347 03:22:29,805 --> 03:22:33,375 BIGGER STUDY, PATIENTS AMEND 4348 03:22:33,375 --> 03:22:34,977 WOMEN AND PUT THEM ON FOR SIX 4349 03:22:34,977 --> 03:22:40,749 MONTHS, UP TO ONE YEAR, LOOKING 4350 03:22:40,749 --> 03:22:48,857 AT SOME PRIMARY AND SECONDARY 4351 03:22:48,857 --> 03:22:53,095 AND THE CLINICAL TRIAL THEY SHOW 4352 03:22:53,095 --> 03:22:57,699 THIS AND IMPROVE THE TEST AND 4353 03:22:57,699 --> 03:23:01,570 NOT MUCH ON TAXI OR TEST AND 4354 03:23:01,570 --> 03:23:04,540 KNOW THE CLINICAL TRIALS ARE 4355 03:23:04,540 --> 03:23:08,677 STILL NOT PUBLISHED. THEN JUST 4356 03:23:08,677 --> 03:23:14,082 TO HAVE SOME RECOMMENDATION, THE 4357 03:23:14,082 --> 03:23:17,986 DIFFERENCES FOR FUTURE CONCERN. 4358 03:23:17,986 --> 03:23:19,221 NEXT. IT IS VERY IMPORTANT TO 4359 03:23:19,221 --> 03:23:22,824 HAVE A PROPER STUDY DESIGN TO 4360 03:23:22,824 --> 03:23:25,827 INTEGRATE AND INVESTIGATE THE 4361 03:23:25,827 --> 03:23:28,564 ROLE OF SEX CHROMOSOME AND 4362 03:23:28,564 --> 03:23:31,033 GONADAL HORMONES IN PRECLINICAL 4363 03:23:31,033 --> 03:23:33,035 MODELS. I'M PART OF A GROUP 4364 03:23:33,035 --> 03:23:35,871 INVITED BY ATS TO WRITE A 4365 03:23:35,871 --> 03:23:36,705 RESEARCH STATEMENT THAT WE ARE 4366 03:23:36,705 --> 03:23:38,307 CURRENTLY WORKING ON THAT. DR. 4367 03:23:38,307 --> 03:23:40,976 ARNOLD IS PART OF THE GROUP. WE 4368 03:23:40,976 --> 03:23:43,011 WANTED TO JUST WRITE SOME 4369 03:23:43,011 --> 03:23:44,546 RESEARCH STATEMENT AS A 4370 03:23:44,546 --> 03:23:46,114 GUIDELINE AS HOW TO ADDRESS SEX 4371 03:23:46,114 --> 03:23:48,850 AS A BIOLOGICAL VARIABLE IN 4372 03:23:48,850 --> 03:23:51,954 PRECLINICAL MODELS OF LUNG 4373 03:23:51,954 --> 03:23:53,589 DISEASE. AS YOU CAN SEE 4374 03:23:53,589 --> 03:23:55,657 SUMMARIZED IN THIS FLOWCHART, IF 4375 03:23:55,657 --> 03:23:58,193 THERE IS A SEX DIFFERENCE WE 4376 03:23:58,193 --> 03:23:59,761 WANT TO LOOK AT ROLE OF SEX 4377 03:23:59,761 --> 03:24:00,929 HORMONES AND SEX CHROMOSOME. ON 4378 03:24:00,929 --> 03:24:02,965 THE NEXT YOU SEE THE FIRST 4379 03:24:02,965 --> 03:24:08,604 OBVIOUSLY THING, THE EASY THING 4380 03:24:08,604 --> 03:24:19,314 TO DO TH IS GONADECTOMY AND ARE 4381 03:24:19,715 --> 03:24:20,882 PLACE HORMONE AND SEE WHICH SUB 4382 03:24:20,882 --> 03:24:24,620 TYPES IS THE TARGET. THEN 4383 03:24:24,620 --> 03:24:27,823 IDENTIFY THE DOWN STREAM EFFECTS 4384 03:24:27,823 --> 03:24:30,425 OF THIS. THEN WHEN WANT TO LOOK 4385 03:24:30,425 --> 03:24:32,361 AT SEX HORMONE THE MOUSE AND 4386 03:24:32,361 --> 03:24:34,262 MODEL VERY POWERFUL, YOU CAN 4387 03:24:34,262 --> 03:24:36,231 IDENTIFY IF IT IS X CHROMOSOME 4388 03:24:36,231 --> 03:24:39,301 OR Y. IF IT IS X OR Y, WHICH 4389 03:24:39,301 --> 03:24:41,470 GENE UNDER X OR Y. THEN YOU ALSO 4390 03:24:41,470 --> 03:24:44,640 WANT TO IDENTIFY THE DOWN STREAM 4391 03:24:44,640 --> 03:24:46,975 EFFECT OF THE SEX CHROMOSOME 4392 03:24:46,975 --> 03:24:48,543 GENE IN A SPECIFIC TEST SIMILAR 4393 03:24:48,543 --> 03:24:52,381 TO WHAT WE DID WHEN WE LOOK AT 4394 03:24:52,381 --> 03:24:54,950 THE RULE OF THE UTY BUT AT THE 4395 03:24:54,950 --> 03:24:57,719 END WE NEED TO BRING EVERYTHING 4396 03:24:57,719 --> 03:24:59,221 BACK TOGETHER, BOTH SEX HORMONE 4397 03:24:59,221 --> 03:25:02,090 AND CHROMOSOME AND LOOK AT THE 4398 03:25:02,090 --> 03:25:12,501 INTERACTION OF BOTH. NEXT SLIDE. 4399 03:25:12,501 --> 03:25:14,703 THIS IS A LARGE MULTI -CENTER 4400 03:25:14,703 --> 03:25:16,672 STUDY TOWARD CENTERS. FOR THE 4401 03:25:16,672 --> 03:25:19,408 FIRST TIME THEY ARE LEVERAGING 4402 03:25:19,408 --> 03:25:23,812 THE LARGEST PH BIOBANK, WE HAD 4403 03:25:23,812 --> 03:25:27,015 96 LUNGS VERSUS 52 CONTROLLED 4404 03:25:27,015 --> 03:25:31,987 LUNGS. WHAT WE DID WAS HAVE RNA, 4405 03:25:31,987 --> 03:25:33,655 GENE NETWORK AND FIND WHICH 4406 03:25:33,655 --> 03:25:37,726 MODULE AND IDENTIFY A GENE AND 4407 03:25:37,726 --> 03:25:42,864 FIND HAS PROTECTIVE WALL. NEXT 4408 03:25:42,864 --> 03:25:48,704 SLIDE. WHAT IS REALLY 4409 03:25:48,704 --> 03:25:50,038 INTERESTING, WE HAVE ALL THE 4410 03:25:50,038 --> 03:25:52,074 CLINICAL DATA FOR ALL THESE 4411 03:25:52,074 --> 03:25:53,175 SAMPLES. ALSO WE HAVE ALL THE 4412 03:25:53,175 --> 03:25:57,446 RAW DATA THAT YOU CAN USE WITH 4413 03:25:57,446 --> 03:26:00,382 THIS ACCESSION NUMBER. IN CASE 4414 03:26:00,382 --> 03:26:05,654 YOU ARE INTERESTED TO LOOK IN 4415 03:26:05,654 --> 03:26:11,193 ANY INTEREST, CONTACT ME OR DR. 4416 03:26:11,193 --> 03:26:13,295 JASON FOR THIS ANALYSIS. NEXT 4417 03:26:13,295 --> 03:26:13,528 SLIDE. 4418 03:26:13,528 --> 03:26:16,198 I JUST WANT TO THANK 4419 03:26:16,198 --> 03:26:17,766 EVERYONE IN MY LAB, 4420 03:26:17,766 --> 03:26:23,505 COLLABORATORS AT UCLA, JASON 4421 03:26:23,505 --> 03:26:28,276 LONG, DR. REDDY AND EVERYONE 4422 03:26:28,276 --> 03:26:33,281 FROM THE LAB. THANK YOU SO MUCH, 4423 03:26:33,281 --> 03:26:33,648 EVERYONE. 4424 03:26:33,648 --> 03:26:37,219 >> THANK YOU VERY MUCH FOR THAT 4425 03:26:37,219 --> 03:26:42,257 WONDERFUL TALK. WE ARE SHORT ON 4426 03:26:42,257 --> 03:26:43,625 TIME SO I'M GOING TO MOVE ON TO 4427 03:26:43,625 --> 03:26:45,260 OUR NEXT SPEAKER. AFTER THAT I 4428 03:26:45,260 --> 03:26:48,764 DO HAVE QUESTIONS FOR YOU, DR. 4429 03:26:48,764 --> 03:26:50,465 EGHBALI. SO EXCELLENT TALK, I 4430 03:26:50,465 --> 03:26:54,302 APPRECIATE YOUR INSIGHTS. 4431 03:26:54,302 --> 03:26:57,272 ALL RIGHT. MOVING ON, LET'S 4432 03:26:57,272 --> 03:27:00,542 GO TO OUR NEXT TALK, WHICH IS 4433 03:27:00,542 --> 03:27:03,745 DR. VENTETUOLO, WHICH IS 4434 03:27:03,745 --> 03:27:04,446 ASSOCIATE PROFESSOR AT BROWN. 4435 03:27:04,446 --> 03:27:06,248 SHE IS SPEAKING ON INTERVENTIONS 4436 03:27:06,248 --> 03:27:10,786 AND IMPLEMENTATION TO REMEDIATE 4437 03:27:10,786 --> 03:27:12,687 SEX-BASED DIFFERENCES IN 4438 03:27:12,687 --> 03:27:16,258 PULMONARY VASCULAR DISEASE. 4439 03:27:16,258 --> 03:27:17,859 >> THANK YOU SO MUCH. THANK YOU 4440 03:27:17,859 --> 03:27:19,628 FOR THE ORGANIZERS FOR PUTTING 4441 03:27:19,628 --> 03:27:21,863 ON THIS GREAT SYMPOSIUM. I HAVE 4442 03:27:21,863 --> 03:27:23,265 LEARNED A LOT AND LOOK FORWARD 4443 03:27:23,265 --> 03:27:26,434 TO CONTINUING TO LEARN. NEXT 4444 03:27:26,434 --> 03:27:32,274 SLIDE, PLEASE. SO I WILL START 4445 03:27:32,274 --> 03:27:34,209 WITH MY DISCLOSURE, PROBABLY THE 4446 03:27:34,209 --> 03:27:35,877 MOST RELEVANT, I'M FUNDED TO DO 4447 03:27:35,877 --> 03:27:37,846 WORK IN THIS AREA, THOUGH I'M 4448 03:27:37,846 --> 03:27:39,447 NOT GOING TO COVER A LOT OF WHAT 4449 03:27:39,447 --> 03:27:43,351 WE ARE FOCUSSING ON TODAY. I 4450 03:27:43,351 --> 03:27:45,187 ALSO WANT TO SAY THAT, YOU KNOW, 4451 03:27:45,187 --> 03:27:47,722 IN THINKING ABOUT DR. STRAH'S 4452 03:27:47,722 --> 03:27:49,591 PRESENTATION EARLIER, IT IS 4453 03:27:49,591 --> 03:27:50,826 IMPORTANT TO KIND OF RECOGNIZE 4454 03:27:50,826 --> 03:27:54,763 TO DATE MUCH OF WHAT HAS BEEN 4455 03:27:54,763 --> 03:27:57,833 PUBLISHED REFERS TO SEX AND 4456 03:27:57,833 --> 03:27:59,568 GENDER INTERCHANGEABLY. I 4457 03:27:59,568 --> 03:28:05,240 ACKNOWLEDGE THAT IS AN OVER 4458 03:28:05,240 --> 03:28:06,708 SIGHT OF MOST PUBLISHED 4459 03:28:06,708 --> 03:28:08,410 LITERATURE TO DATE AND WE ARE 4460 03:28:08,410 --> 03:28:10,545 REGARDING THIS MOSTLY AS A 4461 03:28:10,545 --> 03:28:12,314 BINARY PHENOMENON IN TERMS OF 4462 03:28:12,314 --> 03:28:13,782 GENDER, AS WELL AS BIOLOGICAL 4463 03:28:13,782 --> 03:28:17,552 SEX. THAT, OF COURSE, IS NOT THE 4464 03:28:17,552 --> 03:28:22,190 CASE. NEXT SLIDE, PLEASE. SO THE 4465 03:28:22,190 --> 03:28:23,525 OBJECTIVES ARE TO THINK ABOUT 4466 03:28:23,525 --> 03:28:27,395 HOW TO INTERVENE AND IMPLEMENT 4467 03:28:27,395 --> 03:28:30,665 SOME STRATEGIES TO REMEDIATE 4468 03:28:30,665 --> 03:28:32,834 SEX-BASED DIFFERENCES IN 4469 03:28:32,834 --> 03:28:34,369 PULMONARY VASCULAR DISEASES. I 4470 03:28:34,369 --> 03:28:39,007 WILL NOT HAVE A TON BUT I WOULD 4471 03:28:39,007 --> 03:28:40,642 FOCUS ON NUANCES WE KNOW 4472 03:28:40,642 --> 03:28:41,776 OBSERVED TO DATE AND THINK HOW 4473 03:28:41,776 --> 03:28:45,180 WE CAN PERSPECTIVELY DESIGN, 4474 03:28:45,180 --> 03:28:46,381 PARTICULARLY PATIENTS THAT HAVE 4475 03:28:46,381 --> 03:28:47,649 SEARCHED TO ADDRESS GAPS. WE 4476 03:28:47,649 --> 03:28:49,651 WILL TALK A LITTLE ABOUT 4477 03:28:49,651 --> 03:28:50,785 TRANSLATIONAL BARRIERS FROM 4478 03:28:50,785 --> 03:28:52,821 EXPERIMENTAL MODELS TO HUMAN 4479 03:28:52,821 --> 03:28:53,688 OBSERVATIONS. I'M GOING TO SPEND 4480 03:28:53,688 --> 03:28:55,657 A FEW MINUTES ON SEX 4481 03:28:55,657 --> 03:28:58,126 CHROMOSOMES, AS WE JUST HEARD 4482 03:28:58,126 --> 03:28:59,427 ABOUT FROM DR. EGHBALI, THEN 4483 03:28:59,427 --> 03:29:04,833 SPEND THE BULK OF THE TIME 4484 03:29:04,833 --> 03:29:08,303 TALKING ABOUT IMPACT OR THINKING 4485 03:29:08,303 --> 03:29:12,707 ABOUT THE IMPORTANCE OF RESEARCH 4486 03:29:12,707 --> 03:29:17,746 AT THE END HERE. NEXT SLIDE, 4487 03:29:17,746 --> 03:29:22,584 PLEASE. TO FOCUS ON 4488 03:29:22,584 --> 03:29:23,518 TRANSLATIONAL BARRIER, NEXT 4489 03:29:23,518 --> 03:29:24,152 SLIDE, PLEASE. 4490 03:29:24,152 --> 03:29:25,453 WHEN I FIRST STARTED 4491 03:29:25,453 --> 03:29:28,223 THINKING OF HOW TO RESOLVE 4492 03:29:28,223 --> 03:29:30,392 WHAT'S BEEN LABELED ESTROGEN 4493 03:29:30,392 --> 03:29:33,828 PARADOX OR PUZZLE OF 4494 03:29:33,828 --> 03:29:34,996 ARTERIAL HYPERTENSION, WE KNOW 4495 03:29:34,996 --> 03:29:40,335 THIS IN GROUPS 1, 2, 3, 4496 03:29:40,335 --> 03:29:40,936 PULMONARY HYPERTENSION, MANY 4497 03:29:40,936 --> 03:29:42,637 MORE FEMALES OR WOMEN WHO 4498 03:29:42,637 --> 03:29:44,639 DEVELOP DISEASE AND YET WOMEN 4499 03:29:44,639 --> 03:29:47,108 APPEAR TO HAVE PROTECTIVE RIGHT 4500 03:29:47,108 --> 03:29:48,276 VENTRICLES AND SURVIVE LONGER 4501 03:29:48,276 --> 03:29:49,511 THAN MEN WITH THE DISEASE. AT 4502 03:29:49,511 --> 03:29:51,112 THE TIME THERE ARE A NUMBER OF 4503 03:29:51,112 --> 03:29:55,216 ELEGANT STUDIES IN LITERATURE, 4504 03:29:55,216 --> 03:29:59,387 ONE OF WHICH IS BY DR. FAHA, 4505 03:29:59,387 --> 03:30:01,489 DEMONSTRATING WHEN WE OVARIAN 4506 03:30:01,489 --> 03:30:03,158 ACTIVATE FEMALES AND GIVE BACK 4507 03:30:03,158 --> 03:30:06,628 FIZZ LOGIC DOSES OF ESTROGEN 4508 03:30:06,628 --> 03:30:07,829 THEY DEVELOP LEVELS IN THE 4509 03:30:07,829 --> 03:30:11,032 LUNGS, POTENTIALLY EXPLAINING 4510 03:30:11,032 --> 03:30:13,802 WHY WOMEN WITH PH ARE MORE 4511 03:30:13,802 --> 03:30:15,303 SUSCEPTIBLE. USING SOME OF THE 4512 03:30:15,303 --> 03:30:17,605 SAME STRATEGIES A NUMBER OF LABS 4513 03:30:17,605 --> 03:30:20,141 HAVE SHOWN THAT THE RIGHT AND 4514 03:30:20,141 --> 03:30:22,043 LEFT VENTRICALS ARE PROTECT ED 4515 03:30:22,043 --> 03:30:24,813 WITH MORE CAPILLARY DENSITY AND 4516 03:30:24,813 --> 03:30:28,183 PRESERVED EXERCISE CAPACITY. SO 4517 03:30:28,183 --> 03:30:30,919 THIS TRANSLATES BROADLY TO 4518 03:30:30,919 --> 03:30:31,786 ESTROGEN BEING BAD FOR LUNG, 4519 03:30:31,786 --> 03:30:34,356 GOOD FOR THE HEART. WITH I HAVE 4520 03:30:34,356 --> 03:30:37,993 OTHERWISE EXPLAINED THE 4521 03:30:37,993 --> 03:30:39,527 DESPERATE EPIDEMIOLOGIC 4522 03:30:39,527 --> 03:30:40,895 OBSERVATIONS AND CAN MOVE ON. 4523 03:30:40,895 --> 03:30:44,165 YET WE ARE STILL HERE TALKING 4524 03:30:44,165 --> 03:30:45,800 ABOUT THIS TODAY. NEXT SLIDE. 4525 03:30:45,800 --> 03:30:47,669 WHAT ARE SOME PROBLEMS WITH 4526 03:30:47,669 --> 03:30:51,239 TRANSLATING EXPERIMENTAL MODELS 4527 03:30:51,239 --> 03:30:53,541 TO HUMAN DISEASE? FIRST IF THE 4528 03:30:53,541 --> 03:30:59,881 YOU LOOK ACROSS SEXUAL DID 4529 03:30:59,881 --> 03:31:00,615 MORPHISM, AND DR. EGHBALI 4530 03:31:00,615 --> 03:31:03,284 REFERRED TO SOME OF THIS, THE 4531 03:31:03,284 --> 03:31:04,586 RESULTS DEPEND ON EXPERIMENTAL 4532 03:31:04,586 --> 03:31:08,490 CONDITIONS AND LAB OF DOING THE 4533 03:31:08,490 --> 03:31:11,926 WORK. YOU CAN SHOW VARIABLE 4534 03:31:11,926 --> 03:31:13,495 EFFECTS OF ANIMALS AND AGE OF 4535 03:31:13,495 --> 03:31:16,031 ANIMALS YOU ARE STUDYING. THERE 4536 03:31:16,031 --> 03:31:16,931 IS WORK OUTSIDE PULMONARY 4537 03:31:16,931 --> 03:31:18,199 DISEASE WHICH SHOWS YOU CAN 4538 03:31:18,199 --> 03:31:19,801 ALTER RESULTS OF EXPERIMENTS 4539 03:31:19,801 --> 03:31:23,838 WHEN THE SEX OF THE ANIMAL 4540 03:31:23,838 --> 03:31:28,877 HANDLER CHANGES. NEXT. THINKING 4541 03:31:28,877 --> 03:31:30,278 ABOUT CROSSING THE DIVIDE TO 4542 03:31:30,278 --> 03:31:34,182 HUMAN, WE HAVE TO CONSIDER THESE 4543 03:31:34,182 --> 03:31:37,485 RESULTS WE SEE IN PRECLINICAL 4544 03:31:37,485 --> 03:31:39,687 MODELS. SEX HORMONE AND RECEPTOR 4545 03:31:39,687 --> 03:31:41,256 RELATIONSHIPS ARE INCREDIBLY 4546 03:31:41,256 --> 03:31:42,624 COMPLICATED. THERE ARE TISSUE 4547 03:31:42,624 --> 03:31:43,892 AND COMPARTMENT SPECIFIC EFFECTS 4548 03:31:43,892 --> 03:31:45,393 WE HAVE TO CONSIDER. UNTIL 4549 03:31:45,393 --> 03:31:46,961 RECENTLY WE HAVE HAD A LACK OF 4550 03:31:46,961 --> 03:31:49,697 TISSUE OR CELLS UNLESS WE ARE 4551 03:31:49,697 --> 03:31:50,532 STUDYING INDIVIDUALS WITH 4552 03:31:50,532 --> 03:31:52,300 N-STAGE DISEASE AT THE TIME OF 4553 03:31:52,300 --> 03:31:53,668 DEATH OR LUNG TRANSPLANT. WE 4554 03:31:53,668 --> 03:31:55,570 HAVE TO CONSIDER THE IMPACT OF 4555 03:31:55,570 --> 03:31:59,674 LIFE CYCLE CHANGES. THEN AS HAS 4556 03:31:59,674 --> 03:32:02,877 ALREADY BEEN MENTIONED THIS 4557 03:32:02,877 --> 03:32:07,282 CONCEPT OF INTERSECTION ALT HAS 4558 03:32:07,282 --> 03:32:13,855 NOT BEEN PUBLISHED IN THE 4559 03:32:13,855 --> 03:32:15,223 INTERSECTION OF CARDIOVASCULAR 4560 03:32:15,223 --> 03:32:15,490 DISEASE. 4561 03:32:15,490 --> 03:32:17,258 ONE REASON THIS MAY BE 4562 03:32:17,258 --> 03:32:18,326 IMPORTANT IN INTERPRETING 4563 03:32:18,326 --> 03:32:22,964 RESULTS COMES FROM WORK BY DR. 4564 03:32:22,964 --> 03:32:24,699 COX-FLARITY, PREVIOUSLY IN THE 4565 03:32:24,699 --> 03:32:27,836 GROUP, NOW AT INOVA. ANOTHER BY 4566 03:32:27,836 --> 03:32:30,805 DR. PRUDESCUE'S GROUP WHICH HAS 4567 03:32:30,805 --> 03:32:32,474 SHOWN IN COMMERCIAL CELL LINES 4568 03:32:32,474 --> 03:32:36,678 AND IN CASE OF DR. PRUDESCUE'S 4569 03:32:36,678 --> 03:32:45,353 LAB, THE PULMONARY AND EN 4570 03:32:45,353 --> 03:32:46,988 ENDOTHELIAL CELLS, WHEN WE LOOK 4571 03:32:46,988 --> 03:32:49,090 AT DONORS WITH BIOLOGICAL 4572 03:32:49,090 --> 03:32:50,058 DIFFERENCES THERE ARE 4573 03:32:50,058 --> 03:32:51,893 DIFFERENCES IN SEX. THINKING OF 4574 03:32:51,893 --> 03:32:53,228 COMBINING THESE INTO ONE 4575 03:32:53,228 --> 03:32:55,096 EXPERIMENTAL STRATEGY, THIS MAY 4576 03:32:55,096 --> 03:33:00,235 BECOME PROBLEMATIC. NEXT SLIDE. 4577 03:33:00,235 --> 03:33:06,040 THIS WE RUZ CEN WAS /* -- WAS 4578 03:33:06,040 --> 03:33:09,611 RECENTLY ADDRESSED IN A DOCUMENT 4579 03:33:09,611 --> 03:33:11,779 THAT CAME OUT AND ADVOCATED FOR 4580 03:33:11,779 --> 03:33:13,081 STANDARDIZED REPORTING OF AT 4581 03:33:13,081 --> 03:33:14,482 LEAST AGE AND BIOLOGICAL SEX OF 4582 03:33:14,482 --> 03:33:20,388 THE SAMPLES BEING USED AND P FOR 4583 03:33:20,388 --> 03:33:30,932 STUDY OF SEXUAL DIMORPHISM AND 4584 03:33:32,033 --> 03:33:33,535 METHODS. I WANT TO SPEND TIME 4585 03:33:33,535 --> 03:33:35,803 TALKING ABOUT SEX CHROMOSOMES 4586 03:33:35,803 --> 03:33:37,105 BECAUSE I THINK THIS IS AN 4587 03:33:37,105 --> 03:33:40,308 EMERGING AREA TO THINK HOW TO 4588 03:33:40,308 --> 03:33:43,311 TRANSLATE TO HUMANS. THIS WORK 4589 03:33:43,311 --> 03:33:44,679 HAS ALREADY BEEN HIGHLIGHTED. 4590 03:33:44,679 --> 03:33:46,247 THIS IS A BEAUTIFUL WORK BY DR. 4591 03:33:46,247 --> 03:33:50,652 EGHBALI AND UMAR THAT LEVERAGED 4592 03:33:50,652 --> 03:33:52,487 THIS MODEL TO REALLY TURN THE 4593 03:33:52,487 --> 03:33:55,190 FIELD'S ATTENTION TO WHAT ROLE 4594 03:33:55,190 --> 03:33:59,260 SEX CHROMOSOMES MAY BE HAVING IN 4595 03:33:59,260 --> 03:34:02,230 PREDILECTION AND OUTCOMES OF 4596 03:34:02,230 --> 03:34:05,567 PULMONARY DISEASE. NEXT SLIDE. 4597 03:34:05,567 --> 03:34:08,136 I ALSO WANTED TO DRAW 4598 03:34:08,136 --> 03:34:10,305 ATTENTION TO CONCEPT OF X 4599 03:34:10,305 --> 03:34:12,140 CHROMOSOME AND ACTIVATION, AN 4600 03:34:12,140 --> 03:34:17,045 EMERGING AREA STUDIED I THINK 4601 03:34:17,045 --> 03:34:19,180 MOST ROBUSTLY IN AUTO IMMUNITY 4602 03:34:19,180 --> 03:34:24,252 BUT IMPLICATIONS FOR PULMONARY 4603 03:34:24,252 --> 03:34:25,687 HYPERTENSION. FOR THOSE THAT MAY 4604 03:34:25,687 --> 03:34:27,589 NOT HAVE HEARD EXIST IS 4605 03:34:27,589 --> 03:34:29,757 LONG-CODING R.N.A. WHOSE JOB IS 4606 03:34:29,757 --> 03:34:32,727 TO ACTIVATE ONE X CHROMOSOME TO 4607 03:34:32,727 --> 03:34:37,265 MITIGATE CHAIN DOSAGE EFFECTS IN 4608 03:34:37,265 --> 03:34:40,468 FEMALES, EXIST IN MALES LEADING 4609 03:34:40,468 --> 03:34:45,873 TO AUTO IMMUNE PHENOMENA AND 4610 03:34:45,873 --> 03:34:51,446 REPROMOTES CELLS TO A DIFFERENT 4611 03:34:51,446 --> 03:34:53,781 PARADIGM AND CHARACTERIZE BIAS 4612 03:34:53,781 --> 03:34:56,217 IMMUNITIES, OBSERVED IN LUPUS 4613 03:34:56,217 --> 03:34:58,486 AND OTHER CONNECTIVE TISSUE 4614 03:34:58,486 --> 03:35:04,826 DISEASES AS WELL. NEXT SLIDE. 4615 03:35:04,826 --> 03:35:07,195 THERE TO DATE HAS BEEN VERY 4616 03:35:07,195 --> 03:35:08,229 LITTLE REPORTS IN 4617 03:35:08,229 --> 03:35:09,731 ARTERIAL HYPERTENSION. WE ARE 4618 03:35:09,731 --> 03:35:11,666 WORKING TO STUDY THIS MORE 4619 03:35:11,666 --> 03:35:14,435 ROBUSTLY NOW. I HEAR ONE PIECE 4620 03:35:14,435 --> 03:35:17,972 OF WORK BUT DR. PREDESCUE'S LAB 4621 03:35:17,972 --> 03:35:25,613 IN EFFORT TO ESTABLISH A MODEL, 4622 03:35:25,613 --> 03:35:26,914 TRANSGENIC FOR (?) BUT REPORTED 4623 03:35:26,914 --> 03:35:28,416 ON PRESENCE OF EXIST IN HUMAN 4624 03:35:28,416 --> 03:35:30,618 PAH LUNGS AT THE TIME OF 4625 03:35:30,618 --> 03:35:32,887 EX PLANTS AS COMPARED TO DONORS. 4626 03:35:32,887 --> 03:35:34,522 THERE APPEARS TO BE ENOUGH 4627 03:35:34,522 --> 03:35:44,198 REGULATION OF EXIST IN HUMAN 4628 03:35:44,198 --> 03:35:44,932 PAH. NEXT SLIDE. 4629 03:35:44,932 --> 03:35:46,534 WHEN WE THINK OF STUDYING 4630 03:35:46,534 --> 03:35:48,603 SEX CHROMOSOMES MORE ROBUSTLY, 4631 03:35:48,603 --> 03:35:50,071 PARTICULARLY IN HUMAN DISEASE, 4632 03:35:50,071 --> 03:35:51,873 WE CAN'T JUST STOP AT THE 4633 03:35:51,873 --> 03:35:53,007 CONCEPTS WE HAVE ALREADY HEARD 4634 03:35:53,007 --> 03:35:55,877 ABOUT TODAY. NOT ONLY DO WE HAVE 4635 03:35:55,877 --> 03:35:58,479 TO CONSIDER THE SEX CHROMOSOME 4636 03:35:58,479 --> 03:35:59,614 COMPLEMENTS AS WELL AS 4637 03:35:59,614 --> 03:36:00,815 CHROMOSOME GENE EXPRESSION BUT 4638 03:36:00,815 --> 03:36:02,383 HAVE TO THEN GO ON AND THINK 4639 03:36:02,383 --> 03:36:06,154 ABOUT EPIGENETIC REGULATION, 4640 03:36:06,154 --> 03:36:11,726 THERE ARE KNOWN GONAD ON D.N.A. 4641 03:36:11,726 --> 03:36:14,762 METHYL-CATION AND CONCEPT OF X 4642 03:36:14,762 --> 03:36:18,700 CHROMOSOME ESCAPE, EVIDENCE IN 4643 03:36:18,700 --> 03:36:19,534 CARDIOVASCULAR DISEASE ABOUT SEX 4644 03:36:19,534 --> 03:36:21,302 DIFFERENCES AND IMPRINTING DUE 4645 03:36:21,302 --> 03:36:23,071 TO PARENT OF ORIGIN. FINALLY 4646 03:36:23,071 --> 03:36:26,974 WITH ADVENT OF SINGLE-CELL SEAT 4647 03:36:26,974 --> 03:36:27,308 TE 4648 03:36:27,308 --> 03:36:29,977 TECHNOLOGIES GROUP S HAVE SHOWN, 4649 03:36:29,977 --> 03:36:32,080 PARTICULARLY IN THE HEART, THERE 4650 03:36:32,080 --> 03:36:34,982 ARE DIFFERENCES IN CELL 4651 03:36:34,982 --> 03:36:38,353 POPULATIONS. YOU CAN SEE HERE 4652 03:36:38,353 --> 03:36:43,124 TYPICALLY AN ENDOTHELIAL FIBER 4653 03:36:43,124 --> 03:36:45,827 BLAST WITH HIGH RELEVANCE TO 4654 03:36:45,827 --> 03:36:49,030 PULMONARY DISEASE. NEXT. I WOULD 4655 03:36:49,030 --> 03:36:52,567 ADVOCATE SEX CHROMOSOMES AND 4656 03:36:52,567 --> 03:36:54,402 HUMAN CARDIOVASCULAR DISEASE IS 4657 03:36:54,402 --> 03:36:59,407 UNDERSTUDIED AND WILL TAKE 4658 03:36:59,407 --> 03:36:59,841 NAT 4659 03:36:59,841 --> 03:37:02,343 INNOVATIVE APPROACHES IN HUMANS. 4660 03:37:02,343 --> 03:37:05,480 ACTUALLY ONE PAPER THAT 4661 03:37:05,480 --> 03:37:15,223 CAUGHT MY ATTENTION (AUDIO 4662 03:37:15,223 --> 03:37:17,792 DISRUPTION) DISEASES ARE AMONG 4663 03:37:17,792 --> 03:37:20,194 SOME WE WILL BE SPEAKING OF. 4664 03:37:20,194 --> 03:37:21,896 THIS IS A REPORT USING TWO LARGE 4665 03:37:21,896 --> 03:37:24,065 COHORT STUDIES THAT HAS 4666 03:37:24,065 --> 03:37:25,833 DEMONSTRATED THE PRESENCE OF A 4667 03:37:25,833 --> 03:37:29,103 SUPER NUMARY SEX CHROMOSOME 4668 03:37:29,103 --> 03:37:31,939 INCREASES RISK OF VTE EVENTS 4669 03:37:31,939 --> 03:37:35,510 BOTH IN MY CODE DATA SET AS WELL 4670 03:37:35,510 --> 03:37:37,345 AS U.K. BIOBANK. MAY BE 4671 03:37:37,345 --> 03:37:38,546 DIFFICULT TO TRANSLATE TO THE 4672 03:37:38,546 --> 03:37:42,250 RARE E DISEASES BUT EVIDENCE 4673 03:37:42,250 --> 03:37:45,853 THAT SOME FORMS OF PULMONARY 4674 03:37:45,853 --> 03:37:48,022 VASCULAR DISEASE RISK MAY BE 4675 03:37:48,022 --> 03:37:52,460 CHARACTERIZED BY SEX CHROMOSOME 4676 03:37:52,460 --> 03:37:53,594 ANIPLOYDY. NEXT. 4677 03:37:53,594 --> 03:37:55,363 I WANTED TO SWITCH GEARS AND 4678 03:37:55,363 --> 03:37:57,365 TALK ABOUT LIFE CYCLE CHANGES 4679 03:37:57,365 --> 03:38:02,270 AND PATIENT CENTER RESEARCH AND 4680 03:38:02,270 --> 03:38:04,105 PULMONARY VASCULAR DISEASE. 4681 03:38:04,105 --> 03:38:06,474 THINKING ABOUT OUR YOUNGEST 4682 03:38:06,474 --> 03:38:08,676 PATIENTS, IS FEMALE SEX A RISK 4683 03:38:08,676 --> 03:38:11,045 FACTOR FOR PAH IN CHILDREN? I 4684 03:38:11,045 --> 03:38:13,047 WOULD SAY UNTIL RECENTLY THIS 4685 03:38:13,047 --> 03:38:19,587 WASN'T CLEAR. BUT WITH EM M 4686 03:38:19,587 --> 03:38:20,855 EMERGING OF PEDIATRIC REGISTRIES 4687 03:38:20,855 --> 03:38:22,723 THE ANSWER IS PROBABLY NO. IF 4688 03:38:22,723 --> 03:38:24,358 YOU LOOK ACROSS FOUR REGISTRIES 4689 03:38:24,358 --> 03:38:26,461 ON THIS SLIDE, ON BALANCE, ABOUT 4690 03:38:26,461 --> 03:38:30,264 50% OF CHILDREN AFFECTED BY PAH 4691 03:38:30,264 --> 03:38:36,537 ARE FEMALE. ABOUT 50% ARE MALE. 4692 03:38:36,537 --> 03:38:41,242 NE 4693 03:38:41,242 --> 03:38:42,743 NEXT. YET IN LITERATURE THERE 4694 03:38:42,743 --> 03:38:47,348 ARE CASE REPORTS OF PUBERTY 4695 03:38:47,348 --> 03:38:49,050 ASSOCIATED WITH REGRESSION OF 4696 03:38:49,050 --> 03:38:50,551 PULMONARY VASCULAR DISEASE IN 4697 03:38:50,551 --> 03:38:52,253 MALE WHO WHEN DEVELOPED PUBERTY 4698 03:38:52,253 --> 03:38:54,755 HAD HIS PH RESOLVED. IN TALKING 4699 03:38:54,755 --> 03:38:58,593 TO SOME OF OUR PEDIATRIC 4700 03:38:58,593 --> 03:39:00,495 COLLEAGUES MY UNDERSTANDING IS 4701 03:39:00,495 --> 03:39:02,230 THEIR GENERAL FEELING IS THIS 4702 03:39:02,230 --> 03:39:03,898 TRANSITION IS A RISK TIME FOR 4703 03:39:03,898 --> 03:39:05,199 PATIENTS, ALTHOUGH THIS IS NOT, 4704 03:39:05,199 --> 03:39:07,735 TO MY KNOWLEDGE, BEEN ROBUSTLY 4705 03:39:07,735 --> 03:39:11,806 STUDIED TO DATE. NEXT. WE WANTED 4706 03:39:11,806 --> 03:39:15,743 TO FOCUS ON THE MENSTRUAL CYCLE 4707 03:39:15,743 --> 03:39:19,080 IN PULMONARY HYPERTENSION SINCE 4708 03:39:19,080 --> 03:39:20,448 WE KNOW THIS DISEASE AFFECTS 4709 03:39:20,448 --> 03:39:22,817 YOUNG WOMEN OF CHILD-BEARING 4710 03:39:22,817 --> 03:39:24,819 POTENTIAL. SO WE DESIGNED THIS 4711 03:39:24,819 --> 03:39:28,489 STUDY TO LOOK AT FLUCTUATION 4712 03:39:28,489 --> 03:39:30,958 OVER THE COURSE OF ONE-MONTH 4713 03:39:30,958 --> 03:39:32,793 PERIOD OF TIME. WE ENROLLED 4714 03:39:32,793 --> 03:39:35,897 SUBJECTS FIRST DAY OF MENSES AND 4715 03:39:35,897 --> 03:39:38,399 CAME FOR FOUR VISITS FIXED BY 4716 03:39:38,399 --> 03:39:47,208 ONE WEEK AND FOLLOWED MARKERS OF 4717 03:39:47,208 --> 03:39:49,176 THE BURDEN OVER FACES. AS 4718 03:39:49,176 --> 03:39:50,111 COMPARED TO CONTROLS 4719 03:39:50,111 --> 03:39:53,915 HIGHLIGHT ED IN BLUE, PAH 4720 03:39:53,915 --> 03:39:57,218 FEMALES HAD HIGHER LEVELS OF 4721 03:39:57,218 --> 03:40:01,289 CIRCULATING ESTRADIOL AND MORE 4722 03:40:01,289 --> 03:40:02,056 FLUCTUATIONS IN CONTROL 4723 03:40:02,056 --> 03:40:04,458 INDIVIDUALS AS COMPARED TO PAH 4724 03:40:04,458 --> 03:40:06,494 PATIENT, SUGGESTING THAT PERHAPS 4725 03:40:06,494 --> 03:40:11,666 THERE WAS AN EXOGENOUS SOURCE OF 4726 03:40:11,666 --> 03:40:14,035 ESTRADIOL FROM PULMONARY CAUSING 4727 03:40:14,035 --> 03:40:17,305 HIGHER LEVELS IN PAH WOMEN OR 4728 03:40:17,305 --> 03:40:18,973 FEMALES. PERHAPS MORE ENTERING 4729 03:40:18,973 --> 03:40:20,641 IS DIRECT ASSOCIATIONS WITH 4730 03:40:20,641 --> 03:40:24,045 MARKERS LIKE SIX-MINUTE WALK 4731 03:40:24,045 --> 03:40:26,847 DISTANCE, ANTI PROBE PMT AND 4732 03:40:26,847 --> 03:40:29,150 TAXI WAS PHASE-DEPENDENT SO 4733 03:40:29,150 --> 03:40:31,152 DEPENDING WHERE YOU WERE IN THE 4734 03:40:31,152 --> 03:40:32,353 MENTSRUAL CYCLE, MAY HAVE BEEN 4735 03:40:32,353 --> 03:40:33,721 FAVORABLE OR POSITIVE 4736 03:40:33,721 --> 03:40:36,924 ASSOCIATION BETWEEN YOUR PH 4737 03:40:36,924 --> 03:40:38,559 MARKERS OR UNFAVORABLE 4738 03:40:38,559 --> 03:40:44,465 ASSOCIATION WITH YOUR PAH 4739 03:40:44,465 --> 03:40:46,100 MARKERS. NEXT SLIDE. 4740 03:40:46,100 --> 03:40:48,736 JESSICA BADLUM AT UNIVERSITY 4741 03:40:48,736 --> 03:40:51,739 OF VERMONT TRIED TO CHARACTERIZE 4742 03:40:51,739 --> 03:40:56,744 THIS IN USPHSAR REGISTRY. THEY 4743 03:40:56,744 --> 03:40:59,013 ARE TO BE CREDITED WITH 4744 03:40:59,013 --> 03:41:02,249 COLLECTING DATA ABOUT 4745 03:41:02,249 --> 03:41:12,026 POTENTIALLY AN AN NUS /* /* 4746 03:41:12,026 --> 03:41:14,161 ANDOGENOUS INFORMATION, 4747 03:41:14,161 --> 03:41:15,496 BREASTFEEDING, MENOPAUSE, ET 4748 03:41:15,496 --> 03:41:16,764 CETERA. UNFORTUNATELY BECAUSE OF 4749 03:41:16,764 --> 03:41:18,699 THE WAY THE STUDY WAS DESIGNED 4750 03:41:18,699 --> 03:41:21,268 THERE WAS NO CONTROL POPULATION. 4751 03:41:21,268 --> 03:41:22,903 OF COURSE SOME ARE SUBJECT TO 4752 03:41:22,903 --> 03:41:25,339 RECALL BIAS, AS ARE A LOT OF 4753 03:41:25,339 --> 03:41:29,644 REGISTRY SURVEYS WE USE. THEY 4754 03:41:29,644 --> 03:41:31,846 FAIL TO SHOW CLEAR RELATIONSHIPS 4755 03:41:31,846 --> 03:41:36,550 BETWEEN SUB TYPES OF PH AND ANY 4756 03:41:36,550 --> 03:41:40,588 OF THESE ANDOGENOUS FLUCTUATIONS 4757 03:41:40,588 --> 03:41:42,890 OVER THE COURSE OF A 4758 03:41:42,890 --> 03:41:43,824 INDIVIDUAL'S LIFE. 4759 03:41:43,824 --> 03:41:47,094 SO WE ASKED WHETHER AGE 4760 03:41:47,094 --> 03:41:48,829 COULD BE AN IMPORTANT EFFECT 4761 03:41:48,829 --> 03:41:52,366 MODIFIER OF BASELINE HUMAN 4762 03:41:52,366 --> 03:41:54,468 DYNAMICS. IN THIS STUDY STEVE 4763 03:41:54,468 --> 03:41:55,970 KAYWOOD AND I USED INDIVIDUAL 4764 03:41:55,970 --> 03:41:57,538 PARTICIPANT DATA FROM A NUMBER 4765 03:41:57,538 --> 03:42:00,141 OF CLINICAL TRIALS SUBMITTED TO 4766 03:42:00,141 --> 03:42:02,743 THE FDA FOR DRUG APPROVAL IN 4767 03:42:02,743 --> 03:42:06,347 PAH. WHAT YOU WILL SEE IS AT 4768 03:42:06,347 --> 03:42:07,782 BASELINE MALES AS COMPARED TO 4769 03:42:07,782 --> 03:42:10,418 FEMALES TENDED TO HAVE HIGHER 4770 03:42:10,418 --> 03:42:18,059 PRESSURE, LOWER CARDIAC OUTPUT 4771 03:42:18,059 --> 03:42:20,061 AND HIGHER PULMONARY VASCULAR 4772 03:42:20,061 --> 03:42:23,197 ASSISTANCE ADJUSTED FOR RACE, 4773 03:42:23,197 --> 03:42:26,567 WEIGHT, HEIGHT IN STUDY THEY 4774 03:42:26,567 --> 03:42:32,973 PARTICIPATED. WHEN CAME TO MEAN 4775 03:42:32,973 --> 03:42:34,742 PRESSURE YOU CAN SEE YOUNGER 4776 03:42:34,742 --> 03:42:36,510 MALES HAD HIGHER MEAN COMPARED 4777 03:42:36,510 --> 03:42:38,045 TO FEMALES BUT THIS DIFFERENCE 4778 03:42:38,045 --> 03:42:40,481 AT TEN WAITED BY THE TIME MOST 4779 03:42:40,481 --> 03:42:43,884 U.S. FEMALES UNDERGO THE 4780 03:42:43,884 --> 03:42:44,418 MENOPAUSAL TRANSITION. 4781 03:42:44,418 --> 03:42:46,821 WHILE WE DON'T HAVE DATA ON 4782 03:42:46,821 --> 03:42:48,622 MENOPAUSE DATE IN THIS DATASET 4783 03:42:48,622 --> 03:42:51,092 WE SORT OF A ARGUED AGE IS AN 4784 03:42:51,092 --> 03:42:52,426 IMPORTANT CONSIDERATION WHEN 4785 03:42:52,426 --> 03:42:58,532 THINKING ABOUT SEXUAL DIMORPHISM 4786 03:42:58,532 --> 03:42:59,366 IN INDIVIDUALS WITH PULMONARY 4787 03:42:59,366 --> 03:43:01,502 VASCULAR DISEASE. NEXT SLIDE. WE 4788 03:43:01,502 --> 03:43:03,738 DID A FOLLOW-UP STUDY NOW 4789 03:43:03,738 --> 03:43:06,307 INCLUDING 18 RANDOMIZED TRIALS 4790 03:43:06,307 --> 03:43:08,109 AND ALMOST 7,000 PARTICIPANTS IN 4791 03:43:08,109 --> 03:43:09,677 THESE RANDOMIZED CLINICAL 4792 03:43:09,677 --> 03:43:11,946 TRIALS. WE WANTED TO LOOK 4793 03:43:11,946 --> 03:43:13,848 SPECIFICALLY AT THINGS LIKE AGE 4794 03:43:13,848 --> 03:43:17,752 AND BODY MASS INDEX AND WHETHER 4795 03:43:17,752 --> 03:43:19,954 THESE COULD IMPACT SOME OF THE 4796 03:43:19,954 --> 03:43:21,422 MAJOR SURROGATE OUTCOMES WE USE 4797 03:43:21,422 --> 03:43:23,224 IN CLINICAL TRIALS. HERE I'M 4798 03:43:23,224 --> 03:43:25,092 JUST SHOWING YOU RESULTS FOR 4799 03:43:25,092 --> 03:43:26,393 SIX-MINUTE WALK DISTANCE. AS YOU 4800 03:43:26,393 --> 03:43:29,697 CAN SEE ON THE LEFT PANEL THERE 4801 03:43:29,697 --> 03:43:33,534 WAS NO EFFECT BETWEEN AGE AND 4802 03:43:33,534 --> 03:43:36,003 SIX-MINUTE WALK DISTANCE WHEN WE 4803 03:43:36,003 --> 03:43:38,172 LOOKED AT INTERACTIONS BY SEX. 4804 03:43:38,172 --> 03:43:40,241 IN TERMS OF BMI FEMALES ARE 4805 03:43:40,241 --> 03:43:41,642 REPRESENTED IN RED AS COMPARED 4806 03:43:41,642 --> 03:43:43,010 TO MALES IN BLUE. YOU CAN SEE 4807 03:43:43,010 --> 03:43:46,914 THAT FEMALES IN PARTICULAR AS 4808 03:43:46,914 --> 03:43:48,883 BMI INCREASED HAD MUCH LOWER 4809 03:43:48,883 --> 03:43:50,351 SIX-MINUTE WALK DISTANCE. WE 4810 03:43:50,351 --> 03:43:53,487 FOUND FEMALES HAD LOWER 4811 03:43:53,487 --> 03:43:54,855 PRESSURE, MEAN PRESSURE AND 4812 03:43:54,855 --> 03:43:56,724 HIGHER CARDIAC INDEX AND THESE 4813 03:43:56,724 --> 03:43:59,226 OTHER FACTORS LIKE AGE AND BMI 4814 03:43:59,226 --> 03:44:03,297 REALLY HAD A GREATER IMPACT ON 4815 03:44:03,297 --> 03:44:06,066 THE MALE HEMAMATIC 4816 03:44:06,066 --> 03:44:07,301 RELATIONSHIPS, ALTOGETHER 4817 03:44:07,301 --> 03:44:08,402 SUGGESTING IF WE DON'T CONSIDER 4818 03:44:08,402 --> 03:44:10,004 SOME OF THESE KEY FACTORS WHEN 4819 03:44:10,004 --> 03:44:14,241 WE ANALYZE OUR CLINICAL TRIAL 4820 03:44:14,241 --> 03:44:17,444 RESULTS -- AND BY KEY FACTORS 4821 03:44:17,444 --> 03:44:19,146 AND ANALYSIS I MEAN EFFECT 4822 03:44:19,146 --> 03:44:20,147 MODIFICATION, WE COULD ACTUALLY 4823 03:44:20,147 --> 03:44:23,417 BE REACHING INCORRECT 4824 03:44:23,417 --> 03:44:26,086 CONCLUSIONS WITHOUT APPROPRIATE 4825 03:44:26,086 --> 03:44:27,621 -- THINKING ABOUT CAUSAL 4826 03:44:27,621 --> 03:44:31,859 INFERENCE AND HOW TO MODEL 4827 03:44:31,859 --> 03:44:35,930 EFFECT MODIFICATION. NEXT SLIDE. 4828 03:44:35,930 --> 03:44:38,232 SO THE IMPACT OF THINGS LIKE 4829 03:44:38,232 --> 03:44:41,268 AGE IN THE MENOPAUSAL TRANSITION 4830 03:44:41,268 --> 03:44:47,508 AS WELL AS ANTHROMETRICS GOT ME 4831 03:44:47,508 --> 03:44:49,710 THINKING ABOUT ADIPOSE STORES. 4832 03:44:49,710 --> 03:44:51,979 THIS IS A NICE REVIEW. FOR THOSE 4833 03:44:51,979 --> 03:44:53,581 OF YOU THAT DON'T SPEND TIME 4834 03:44:53,581 --> 03:44:56,450 THINKING ABOUT SEX HORMONES, 4835 03:44:56,450 --> 03:45:00,454 ADIPOSE TISSUE WITH AGE AND 4836 03:45:00,454 --> 03:45:04,792 MENOPAUSE IS ACTIVE SITE HORMONE 4837 03:45:04,792 --> 03:45:08,762 METABOLISM, AROMATISATION. 4838 03:45:08,762 --> 03:45:11,065 THERE'S BEEN WORK SUGGESTS 4839 03:45:11,065 --> 03:45:12,666 ADIPOSE STORES IMPACT WITH 4840 03:45:12,666 --> 03:45:15,903 IMPACT OF SEX HORMONES ON 4841 03:45:15,903 --> 03:45:18,939 PULMONARY REMODELLING AND THOSE 4842 03:45:18,939 --> 03:45:22,309 EFFECTS ARE SEX-SPECIFIC. NEXT. 4843 03:45:22,309 --> 03:45:25,613 THERE'S BEEN SEVERAL NICE 4844 03:45:25,613 --> 03:45:28,148 PUBLICATIONS TO DATE LOOKING AT 4845 03:45:28,148 --> 03:45:33,554 IN PARTICULAR THORACIC ADIPOSE 4846 03:45:33,554 --> 03:45:36,023 BY CT AND M RI AND RISK ON THE 4847 03:45:36,023 --> 03:45:40,027 LEFT IS NICE REPORT BY DR. AMANI 4848 03:45:40,027 --> 03:45:43,063 AND COLLEAGUES AT PENN 4849 03:45:43,063 --> 03:45:43,664 DEMONSTRATING RELATIONSHIP 4850 03:45:43,664 --> 03:45:46,200 BETWEEN VISCERAL ADIPOSE 4851 03:45:46,200 --> 03:45:48,202 CHARACTERIZED BY CT AND RISK OF 4852 03:45:48,202 --> 03:45:50,037 PH IN INDIVIDUALS UNDERGOING 4853 03:45:50,037 --> 03:45:51,906 LUNG TRANSPLANT EVALUATION WITH 4854 03:45:51,906 --> 03:45:55,175 PH OF ALL FORMS. ON THE RIGHT IS 4855 03:45:55,175 --> 03:45:56,944 RECENT PUBLICATION FROM 4856 03:45:56,944 --> 03:45:58,512 INVESTIGATORS IN CHINA WHO 4857 03:45:58,512 --> 03:46:03,117 LOOKED AT EPICARDIAL TISSUE 4858 03:46:03,117 --> 03:46:05,986 CHARACTERIZED BY MRI AROUND R 4859 03:46:05,986 --> 03:46:10,090 AND SHOWED A U-SHAPE IN CLINICAL 4860 03:46:10,090 --> 03:46:12,159 WORSENING AND EPE VOLUME. AT 4861 03:46:12,159 --> 03:46:14,161 EXTREMES INDIVIDUALS WITH PH 4862 03:46:14,161 --> 03:46:14,995 TENDED TO DO WORSE. 4863 03:46:14,995 --> 03:46:19,767 SO WE ARE INTERESTED IN 4864 03:46:19,767 --> 03:46:24,171 DOING DEEP ANTHROPOMETRIC WITH 4865 03:46:24,171 --> 03:46:27,675 PHENOTYPE AND ADIPOMETRIC TISSUE 4866 03:46:27,675 --> 03:46:30,044 AND BONE HEALTH, GOING FORWARD. 4867 03:46:30,044 --> 03:46:30,377 NEXT SLIDE. 4868 03:46:30,377 --> 03:46:32,713 WE HAVE TALKED A LITTLE 4869 03:46:32,713 --> 03:46:36,417 ABOUT NATURAL LIFE EVENTS, AN 4870 03:46:36,417 --> 03:46:38,252 DODGE NOWS EXPOSURE BUT WHAT 4871 03:46:38,252 --> 03:46:42,289 ABOUT OTHER EXPOSURES AND RISK 4872 03:46:42,289 --> 03:46:45,659 OF CARDIOVASCULAR DISEASE. DR. 4873 03:46:45,659 --> 03:46:47,561 BADLUM, AUSTIN AND COLLEAGUES 4874 03:46:47,561 --> 03:46:50,664 LOOK T AT THE VANDERBILT COHORT 4875 03:46:50,664 --> 03:46:55,669 AND LOOKED AT DURATION OF 4876 03:46:55,669 --> 03:47:00,574 CONTRACEPTION AND AN ANDOGENOUS 4877 03:47:00,574 --> 03:47:02,076 HORMONE THERAPY USE AND FOUND NO 4878 03:47:02,076 --> 03:47:06,547 DIFFERENCE IN TERMS OF SOME OF 4879 03:47:06,547 --> 03:47:09,316 THE EXOGENOUS HORMONE EXPOSURE 4880 03:47:09,316 --> 03:47:12,953 OVER SOME OF THE SUBGROUPS. 4881 03:47:12,953 --> 03:47:15,089 SOME YEARS AGO STEVE KAYWOOD 4882 03:47:15,089 --> 03:47:18,025 AND I PUBLISHED IN THE MESA RV 4883 03:47:18,025 --> 03:47:21,895 COHORT THAT THE USE OF HORMONE 4884 03:47:21,895 --> 03:47:23,731 THERAPY MODERATED THE EFFECT OF 4885 03:47:23,731 --> 03:47:28,836 CIRCULATING ESTRADIOL ON RV 4886 03:47:28,836 --> 03:47:30,270 PHENOTYPE. IN BLUE THE 4887 03:47:30,270 --> 03:47:30,971 RELATIONSHIPS BETWEEN 4888 03:47:30,971 --> 03:47:34,775 CIRCULATING ESTRADIOL AND RIGHT 4889 03:47:34,775 --> 03:47:37,077 EJECTION FRACTION THERE WAS NO 4890 03:47:37,077 --> 03:47:38,245 ASSOCIATIONS IN NON-HORMONE 4891 03:47:38,245 --> 03:47:40,114 THERAPY USERS, WHEREAS THOSE 4892 03:47:40,114 --> 03:47:41,415 INDIVIDUALS WHO HAD BEEN USING 4893 03:47:41,415 --> 03:47:43,517 HORMONE THERAPY AT TIME OF THE 4894 03:47:43,517 --> 03:47:45,486 MESA BASELINE WAS CONDUCTED HAD 4895 03:47:45,486 --> 03:47:48,322 A FAVORABLE ASSOCIATION BETWEEN 4896 03:47:48,322 --> 03:47:50,724 CIRCULATING LEVELS OF ESTRADIOL 4897 03:47:50,724 --> 03:47:52,626 AND RAVF. IN FACT, THERE'S BEEN 4898 03:47:52,626 --> 03:47:54,495 TWO REPORTS OF HORMONE 4899 03:47:54,495 --> 03:47:57,364 REPLACEMENT THERAPY IN 4900 03:47:57,364 --> 03:47:58,966 INDIVIDUALS WITH SYSTEMIC 4901 03:47:58,966 --> 03:48:03,370 SCLEROSIS AS IT BEING PROTECTIVE 4902 03:48:03,370 --> 03:48:05,305 AGAINST DEVELOPMENT OF PULMONARY 4903 03:48:05,305 --> 03:48:06,407 HYPERTENSION. ALTHOUGH I WOULD 4904 03:48:06,407 --> 03:48:08,308 SAY THIS IS ANECDOTAL AND NOT 4905 03:48:08,308 --> 03:48:12,479 CONTROLLED DATA. NEXT. 4906 03:48:12,479 --> 03:48:14,715 SO LASTLY IN THE LAST SORT 4907 03:48:14,715 --> 03:48:16,450 OF FEW MINUTES I WANTED TO TURN 4908 03:48:16,450 --> 03:48:19,887 BACK TO THIS CONCEPT OF INTER 4909 03:48:19,887 --> 03:48:22,756 SECTIONAL RESEARCH OBJECTIVES. 4910 03:48:22,756 --> 03:48:28,262 YOU HAVE SEEN THIS SCHEMATIC 4911 03:48:28,262 --> 03:48:29,763 ACKNOWLEDGING SEX AND GENDER ARE 4912 03:48:29,763 --> 03:48:33,400 NOT INTERCHANGEABLE. I THINK TWO 4913 03:48:33,400 --> 03:48:36,070 STUDIES I PARTICIPATED IN THAT 4914 03:48:36,070 --> 03:48:37,805 WERE REALLY ILLUSTRATIVE OF THIS 4915 03:48:37,805 --> 03:48:39,973 FACT WERE SOME OF THE WORK I DID 4916 03:48:39,973 --> 03:48:42,076 WITH INTEGRATIVE BEHAVIORAL 4917 03:48:42,076 --> 03:48:43,410 HEALTH COLLEAGUES TO LOOK AT 4918 03:48:43,410 --> 03:48:45,913 RATES OF SEXUAL DYSFUNCTION IN 4919 03:48:45,913 --> 03:48:48,749 INDIVIDUAL WHO'S IDENTIFY AS 4920 03:48:48,749 --> 03:48:50,951 WOMEN WHO PULMONARY 4921 03:48:50,951 --> 03:48:51,618 ARTERIAL HYPERTENSION AND NOTE 4922 03:48:51,618 --> 03:48:53,787 THEY HAVE HIGH RATES OF SEXUAL 4923 03:48:53,787 --> 03:48:54,788 DYSFUNCTION EVEN AFTER 4924 03:48:54,788 --> 03:48:57,091 ACCOUNTING FOR THINGS LIKE 4925 03:48:57,091 --> 03:48:58,926 ANXIETY AND DEPRESSION. WE 4926 03:48:58,926 --> 03:49:01,895 CONDUCTED INDEPTH INTERVIEWS IN 4927 03:49:01,895 --> 03:49:05,132 THESE INDIVIDUALS AND REALLY 4928 03:49:05,132 --> 03:49:08,068 WERE ABLE TO TIE THAT SEXUAL 4929 03:49:08,068 --> 03:49:09,603 DYSFUNCTION IS RELATE ED WITH 4930 03:49:09,603 --> 03:49:12,106 POOR QUALITY OF LIFE AND OUR PAH 4931 03:49:12,106 --> 03:49:14,475 THERAPIES MAY SPECIFICALLY 4932 03:49:14,475 --> 03:49:16,276 AFFECT THESE DOMAINS DIFFERENTLY 4933 03:49:16,276 --> 03:49:18,112 IN INDIVIDUAL WHO'S IDENTIFY AS 4934 03:49:18,112 --> 03:49:21,548 WOMEN VERSUS MEN. SO DURING 4935 03:49:21,548 --> 03:49:23,250 THESE INTERVIEWS THAT CAME OUT 4936 03:49:23,250 --> 03:49:24,852 THAT MANY WHO IDENTIFIED AS 4937 03:49:24,852 --> 03:49:26,854 WOMEN WERE DOING THINGS LIKE 4938 03:49:26,854 --> 03:49:30,791 TAKING OFF THEIR PROST PUMPS TO 4939 03:49:30,791 --> 03:49:32,493 ENGAGE IN SEXUAL INTERCOURSE 4940 03:49:32,493 --> 03:49:35,295 WHEREAS SOME OF THE BIOLOGICALLY 4941 03:49:35,295 --> 03:49:39,900 MALE (BELL) REPORTED USE OF 4942 03:49:39,900 --> 03:49:42,035 SODANOFIL HELPED IN THIS REGARD. 4943 03:49:42,035 --> 03:49:43,537 ON THE RIGHT, I DON'T MEAN 4944 03:49:43,537 --> 03:49:45,139 TO TALK ABOUT POLITICS BUT I'M 4945 03:49:45,139 --> 03:49:46,740 GOING TO MENTION THAT I THINK WE 4946 03:49:46,740 --> 03:49:50,777 ARE AT A CRITICAL POINT IN 4947 03:49:50,777 --> 03:49:53,247 REALLY HISTORY IN TERMS OF 4948 03:49:53,247 --> 03:49:55,249 LIMITING ACCESS TO REPRODUCTIVE 4949 03:49:55,249 --> 03:49:57,117 CARE ESPECIALLY FOR PAH 4950 03:49:57,117 --> 03:49:58,852 PATIENTS. AND REGIONS OF COUNTRY 4951 03:49:58,852 --> 03:50:01,221 WHERE THIS MAY MOST IMPACT OUR 4952 03:50:01,221 --> 03:50:03,323 PATIENTS ARE THOSE ALSO AT THE 4953 03:50:03,323 --> 03:50:06,460 GREATEST RISK FOR HEALTH CARE 4954 03:50:06,460 --> 03:50:07,394 DISPARITIES WITHOUT 4955 03:50:07,394 --> 03:50:08,795 COMPREHENSIVE PAH CARE AND AT 4956 03:50:08,795 --> 03:50:11,632 THE HIGHEST RISK OF HAVING 4957 03:50:11,632 --> 03:50:13,734 COMPLICATIONS RELATED TO 4958 03:50:13,734 --> 03:50:15,102 PREGNANCY. SO I THINK STUDYING 4959 03:50:15,102 --> 03:50:17,604 THESE THINGS AND HOW THEY FACTOR 4960 03:50:17,604 --> 03:50:18,772 INTO OUR PATIENT'S EVERYDAY 4961 03:50:18,772 --> 03:50:22,643 LIVE S IS GOING TO BE CRITICAL 4962 03:50:22,643 --> 03:50:28,515 GOING FORWARD. NEXT. AS I 4963 03:50:28,515 --> 03:50:30,450 MENTIONED I DON'T HAVE A LOT OF 4964 03:50:30,450 --> 03:50:31,652 SOLUTIONS OTHER THAN I THINK 4965 03:50:31,652 --> 03:50:32,753 THESE ARE ALL IMPORTANT FACTORS 4966 03:50:32,753 --> 03:50:36,356 WE NEED TO THINK ABOUT WHEN 4967 03:50:36,356 --> 03:50:37,724 TALKING ABOUT THIS LINE OF 4968 03:50:37,724 --> 03:50:39,026 INQUIRY. WE NEED TO CONSIDER 4969 03:50:39,026 --> 03:50:41,361 ROLE OF SEX CHROMOSOMES AND 4970 03:50:41,361 --> 03:50:43,864 OTHER THINGS THAT EXIST IN 4971 03:50:43,864 --> 03:50:45,065 ACTIVATION. WE NEED TO CONSIDER 4972 03:50:45,065 --> 03:50:51,705 SEX, GENDER, AGE, ADIPOSE, 4973 03:50:51,705 --> 03:50:55,409 ANTHRO METRICS, ENDOGENOUS AND 4974 03:50:55,409 --> 03:51:02,416 EX DODGE NOWS HORMONES, INTER 4975 03:51:02,416 --> 03:51:05,385 SECTIONALITY, THEN FINALLY 4976 03:51:05,385 --> 03:51:09,156 TRANSPARENT REPORTING OF 4977 03:51:09,156 --> 03:51:10,691 EVERYTHING SO WE CAN LEARN 4978 03:51:10,691 --> 03:51:14,428 TOGETHER GOING FORWARD. NEXT. 4979 03:51:14,428 --> 03:51:16,330 WITH THAT I'LL WRAP UP BY SAYING 4980 03:51:16,330 --> 03:51:18,832 I WANT TO THANK THE RESEARCH 4981 03:51:18,832 --> 03:51:20,500 PARTICIPANTS THAT ENGAGE IN OUR 4982 03:51:20,500 --> 03:51:23,270 HUMAN SUBJECTS RESEARCH. WITHOUT 4983 03:51:23,270 --> 03:51:29,843 THEM, THEIR CAREGIVERS, WE 4984 03:51:29,843 --> 03:51:32,079 WOULDN'T HAVE THE RESOURCE, AS 4985 03:51:32,079 --> 03:51:35,816 WELL AS MY COLLABORATORS AND 4986 03:51:35,816 --> 03:51:39,152 FUNDING SOURCES. 4987 03:51:39,152 --> 03:51:41,054 >> THANK YOU VERY MUCH, DR. 4988 03:51:41,054 --> 03:51:41,955 VENTETUOLO. EXCELLENT TALK 4989 03:51:41,955 --> 03:51:44,091 THERE. I HAVE QUITE A FEW 4990 03:51:44,091 --> 03:51:45,726 QUESTIONS. I'M SURE THE AUDIENCE 4991 03:51:45,726 --> 03:51:49,730 DOES AS WELL. WE HAVE ABOUT HALF 4992 03:51:49,730 --> 03:51:53,667 AN HOUR FOR DISCUSSION. 4993 03:51:53,667 --> 03:51:56,803 BEFORE WE MOVE ON I THINK 4994 03:51:56,803 --> 03:52:00,307 DR. MATHIA HAS JOINED US. I 4995 03:52:00,307 --> 03:52:01,708 WOULD LIVE TO GIVE HIM THE 4996 03:52:01,708 --> 03:52:08,482 OPPORTUNITY TO DO AN 4997 03:52:08,482 --> 03:52:09,316 INTRODUCTION. 4998 03:52:09,316 --> 03:52:14,288 >> HI, STEVE MATHIA. I'M AT 4999 03:52:14,288 --> 03:52:15,822 JOHNS HOPKINS AND THIS IS 5000 03:52:15,822 --> 03:52:17,791 UNDERLYING CONNECTIVE TISSUE 5001 03:52:17,791 --> 03:52:18,692 DISEASES IN PARTICULAR AND LOOK 5002 03:52:18,692 --> 03:52:21,728 FORWARD TO DISCUSSIONS TO TALK 5003 03:52:21,728 --> 03:52:26,933 ABOUT DISPARITIES AND 5004 03:52:26,933 --> 03:52:27,567 CARDIOVASCULAR DISEASE, THANK 5005 03:52:27,567 --> 03:52:27,901 YOU. 5006 03:52:27,901 --> 03:52:34,741 >> THANKS A LOT, STEVE. MY FIRST 5007 03:52:34,741 --> 03:52:39,046 QUESTION IS FOR DR. EGHBALI. MY 5008 03:52:39,046 --> 03:52:43,050 QUESTION IS, IS THERE A -- AN 5009 03:52:43,050 --> 03:52:44,918 EFFORT OR DO YOU KNOW OF ANY 5010 03:52:44,918 --> 03:52:48,989 DATA WITH REGARD TO PRE-CLINICAL 5011 03:52:48,989 --> 03:52:52,793 MODELS USING TRANSGENDER TYPE 5012 03:52:52,793 --> 03:52:57,364 APPROACHES? FOR EXAMPLE, GIVING 5013 03:52:57,364 --> 03:53:00,867 MALE -- BIOLOGICALLY MALE RATS 5014 03:53:00,867 --> 03:53:03,737 FEMALE HORMONES AND VICE VERSA? 5015 03:53:03,737 --> 03:53:14,281 >> THAT IS A VERY GOOD QUESTION. 5016 03:53:14,848 --> 03:53:16,717 I DON'T KNOW ABOUT THAT BUT IN 5017 03:53:16,717 --> 03:53:18,185 SOME OF OUR RATS WE WERE 5018 03:53:18,185 --> 03:53:20,687 TREATING WITH ESTROGEN TO SEE IF 5019 03:53:20,687 --> 03:53:22,389 ESTROGEN CAN REALLY PROTECT THE 5020 03:53:22,389 --> 03:53:25,959 ANIMAL. BUT THAT WAS FOR A VERY 5021 03:53:25,959 --> 03:53:32,766 SHORT TIME. TREATING THE MALE 5022 03:53:32,766 --> 03:53:35,569 RAT TEN DAYS WITH ESTROGEN, BOTH 5023 03:53:35,569 --> 03:53:37,337 MALE AND FEMALE, LOOKING TO SEE 5024 03:53:37,337 --> 03:53:38,372 IF THIS TREATMENT CAN REALLY 5025 03:53:38,372 --> 03:53:40,874 REVERSE THE DISEASE OR REDUCE 5026 03:53:40,874 --> 03:53:43,009 THE SEVERITY OF THE DISEASE. 5027 03:53:43,009 --> 03:53:44,411 YES, WE HAVE SEEN AND WE HAVE 5028 03:53:44,411 --> 03:53:50,550 DONE IN MY LAB. OTHER PEOPLE -- 5029 03:53:50,550 --> 03:53:52,686 I KNOW H TREATING HIS MALE RATS 5030 03:53:52,686 --> 03:53:54,588 WITH ESTROGEN. BUT TO LOOK AT IT 5031 03:53:54,588 --> 03:53:58,458 THE WAY YOU ARE TALKING TODAY, 5032 03:53:58,458 --> 03:54:01,294 NO, I (?) 5033 03:54:01,294 --> 03:54:03,463 >> DO YOU THINK THERE SHOULD BE 5034 03:54:03,463 --> 03:54:05,799 MORE OF AN EFFORT DO THAT? 5035 03:54:05,799 --> 03:54:08,001 >> BECAUSE WHAT WE ARE DOING IS 5036 03:54:08,001 --> 03:54:12,439 JUST FOR A VERY SHORT TIME. I 5037 03:54:12,439 --> 03:54:17,177 THINK WHEN THESE PEOPLE ARE 5038 03:54:17,177 --> 03:54:18,378 GOING THROUGH TRANSGENDER AND 5039 03:54:18,378 --> 03:54:19,613 RECEIVE HORMONE, I THINK IT IS 5040 03:54:19,613 --> 03:54:21,748 FOR A VERY LONG TIME THEY 5041 03:54:21,748 --> 03:54:23,250 RECEIVE THESE. I THINK WHAT IS 5042 03:54:23,250 --> 03:54:24,284 ALSO VERY IMPORTANT FOR OUR 5043 03:54:24,284 --> 03:54:30,023 ANIMAL STUDIES WHEN WE TREAT 5044 03:54:30,023 --> 03:54:34,394 THEM WITH EXOGENOUS ESTROGEN OR 5045 03:54:34,394 --> 03:54:36,096 TESTOSTERONE WE HAVE TO BE 5046 03:54:36,096 --> 03:54:39,199 CAREFUL. WANT TO USE THE DOSE TO 5047 03:54:39,199 --> 03:54:40,667 ACHIEVE PHYSIOLOGICAL CHANGE. 5048 03:54:40,667 --> 03:54:43,937 SOMETHING LIKE ESTROGEN, IF YOU 5049 03:54:43,937 --> 03:54:46,973 USE A LONG TIME IN HIGH DOSE IT 5050 03:54:46,973 --> 03:54:54,514 CAN INDUCE TOMO OR BREAST CANCER 5051 03:54:54,514 --> 03:55:01,254 OR ENDOMETRIAL CANCER THAT. IS 5052 03:55:01,254 --> 03:55:03,690 WHY DOSE TO MAKE SURE LEVEL IS 5053 03:55:03,690 --> 03:55:06,293 AT THE PHYSIOLOGICAL RANGE AND 5054 03:55:06,293 --> 03:55:07,794 NOT VERY HIGH DOSE. 5055 03:55:07,794 --> 03:55:09,763 >> I'M NOT SURE WE ARE GOING TO 5056 03:55:09,763 --> 03:55:12,766 BE UNTANGLE GENDER IN 5057 03:55:12,766 --> 03:55:15,035 PRE-CLINICAL MODELS, 5058 03:55:15,035 --> 03:55:17,437 RESPECT FULLY. I WOULD JUST ADD 5059 03:55:17,437 --> 03:55:20,774 THAT I WAS INTERESTED IN TRYING 5060 03:55:20,774 --> 03:55:23,243 TO LEARN MORE ABOUT THIS 5061 03:55:23,243 --> 03:55:27,714 POTENTIAL EFFECTS ON THE CARDIO 5062 03:55:27,714 --> 03:55:28,482 PULMONARY SYSTEM IN THE 5063 03:55:28,482 --> 03:55:30,016 TRANSGENDER COMMUNITY. I 5064 03:55:30,016 --> 03:55:31,418 PARTNERED WITH COLLEAGUES HERE 5065 03:55:31,418 --> 03:55:32,786 WHO DO TRANSGENDER MEDICINE. I 5066 03:55:32,786 --> 03:55:37,858 THINK ONE OF THE THINGS I WAS 5067 03:55:37,858 --> 03:55:39,326 INTERESTED TO LEARN AND CURIOUS 5068 03:55:39,326 --> 03:55:41,761 ON DR. STRAH'S COMMENTS ABOUT 5069 03:55:41,761 --> 03:55:46,566 THIS, IS THAT WHEN INDIVIDUALS 5070 03:55:46,566 --> 03:55:48,702 UNDERGO TRANSITION, THERE IS NOT 5071 03:55:48,702 --> 03:55:51,338 ROUTINE CLINICAL PHENOTYPING 5072 03:55:51,338 --> 03:55:52,639 NECESSARILY THAT IS DONE WITH 5073 03:55:52,639 --> 03:55:54,474 RESPECT TO HEART OR LUNG 5074 03:55:54,474 --> 03:55:57,911 FUNCTION. I THINK THAT MAKES IT 5075 03:55:57,911 --> 03:55:59,779 POTENTIALLY MORE DIFFICULT TO 5076 03:55:59,779 --> 03:56:04,417 LEARN ABOUT LONGER TERM HEALTH 5077 03:56:04,417 --> 03:56:11,892 EFFECTS IN THESE PEOPLE. 5078 03:56:11,892 --> 03:56:13,493 >> YOU BRING UP A GREAT POINT. I 5079 03:56:13,493 --> 03:56:15,462 THINK THAT IS ONE OF THE THINGS 5080 03:56:15,462 --> 03:56:19,466 THAT IS A QUESTION. YOU KNOW, WE 5081 03:56:19,466 --> 03:56:24,471 ARE GUIDED THAT PATIENTS THAT 5082 03:56:24,471 --> 03:56:28,842 HAVE HISTORY OF THROMBOEMBOLIC 5083 03:56:28,842 --> 03:56:31,878 DISEASES THERE SHOULD BE 5084 03:56:31,878 --> 03:56:34,915 SCREENING. HOWEVER, IN PATIENTS 5085 03:56:34,915 --> 03:56:40,186 THAT HAVE RISK FACTORS SUCH AS 5086 03:56:40,186 --> 03:56:42,122 OBESITY AND INITIATING 5087 03:56:42,122 --> 03:56:44,524 TRANSITION, SHOULD THERE BE 5088 03:56:44,524 --> 03:56:47,961 CLINICAL PHENOTYPING OR IN 5089 03:56:47,961 --> 03:56:49,729 PATIENTS WHO HAVE H.I.V. SHOULD 5090 03:56:49,729 --> 03:56:51,665 THERE BE CLINICAL PHENOTYPING 5091 03:56:51,665 --> 03:56:54,200 PRIOR TO INITIATING. SHOULD BE 5092 03:56:54,200 --> 03:56:55,802 CLINICAL PHENOTYPING 5093 03:56:55,802 --> 03:56:59,506 PERIODICALLY AFTER INITIATING 5094 03:56:59,506 --> 03:57:00,373 GENDER-AFFIRMING HORMONE 5095 03:57:00,373 --> 03:57:03,443 THERAPY. I THINK THAT IS 5096 03:57:03,443 --> 03:57:06,646 SOMETHING WE DON'T KNOW YET. I 5097 03:57:06,646 --> 03:57:07,847 THINK THE OTHER QUESTION THAT 5098 03:57:07,847 --> 03:57:14,387 WILL BE RAISED IS IF WE START 5099 03:57:14,387 --> 03:57:17,691 CLINICAL PHENOTYPING EVENTUALLY, 5100 03:57:17,691 --> 03:57:21,328 THE COST-EFFECTIVENESS OF THAT 5101 03:57:21,328 --> 03:57:26,566 WILL COME INTO QUESTION SO I 5102 03:57:26,566 --> 03:57:27,901 THINK IT IS SOMETHING UNKNOWN. 5103 03:57:27,901 --> 03:57:31,271 ALTHOUGH A VERY INTERESTING 5104 03:57:31,271 --> 03:57:34,274 RESEARCH QUESTION. 5105 03:57:34,274 --> 03:57:36,943 >> I MEAN I WOULD ALSO ADD TOO 5106 03:57:36,943 --> 03:57:40,914 THERE IS GREAT WORK AND NOW VERY 5107 03:57:40,914 --> 03:57:46,086 OLD WORK FROM THE CLINIC AT BMC 5108 03:57:46,086 --> 03:57:49,623 SHOWING THAT BRACHIAL ARTERY 5109 03:57:49,623 --> 03:57:52,859 VASCULAR ACTIVITY, MARKER OF 5110 03:57:52,859 --> 03:57:56,363 VASCULAR HEALTH CHANGED 5111 03:57:56,363 --> 03:57:58,999 SIGNIFICANTLY BOTH IN MEN 5112 03:57:58,999 --> 03:58:02,535 TRANSITIONING TO WOMEN, WOMEN 5113 03:58:02,535 --> 03:58:03,637 TRANSITIONING TO MEN WITH 5114 03:58:03,637 --> 03:58:04,838 HORMONE THERAPY AND THEY WERE 5115 03:58:04,838 --> 03:58:07,073 ABLE TO DOCUMENT PRIOR TO 5116 03:58:07,073 --> 03:58:10,343 HORMONE ARE REPLACEMENT THERAPY 5117 03:58:10,343 --> 03:58:11,978 OR HORMONE THERAPY AND AFTER, 5118 03:58:11,978 --> 03:58:14,881 YOU KNOW, SEVERAL LONGITUDINAL 5119 03:58:14,881 --> 03:58:16,082 SESSIONS. THERE WERE REALLY 5120 03:58:16,082 --> 03:58:19,686 MARKED AND NOTABLE DIFFERENCES. 5121 03:58:19,686 --> 03:58:22,022 SO YOU EXTRAPOLATE WHAT YOU MAY 5122 03:58:22,022 --> 03:58:26,426 THINK IN THE PULMONARY 5123 03:58:26,426 --> 03:58:30,063 VASCULARATUR V, IT WOULD BE 5124 03:58:30,063 --> 03:58:34,401 SOMETHING INFORMATIVE. SO I JUST 5125 03:58:34,401 --> 03:58:37,370 WANT TO TALK A SECOND AND ASK 5126 03:58:37,370 --> 03:58:39,372 DR. VENTETUOLO, I'M REALLY 5127 03:58:39,372 --> 03:58:42,509 IMPRESSED BY THE STUDY YOU WERE 5128 03:58:42,509 --> 03:58:46,279 TALKING ABOUT WITH ENDOTHELIAL 5129 03:58:46,279 --> 03:58:49,516 CELLS, DIFFERENCES BETWEEN MALE 5130 03:58:49,516 --> 03:58:53,953 AND FEMALE PULMONARY CELLS, MADE 5131 03:58:53,953 --> 03:59:00,527 WE START THINKING DO WE KNOW 5132 03:59:00,527 --> 03:59:01,928 ANYTHING -- EVERYTHING WE HAVE 5133 03:59:01,928 --> 03:59:07,067 BEEN DOING IN VITRO IS NOW 5134 03:59:07,067 --> 03:59:07,300 WRONG? 5135 03:59:07,300 --> 03:59:10,236 >> I THINK, IN SHORT, JANE, IT 5136 03:59:10,236 --> 03:59:13,406 DEPENDS ON THE QUESTION THAT YOU 5137 03:59:13,406 --> 03:59:22,549 ARE ASKING. WE STARTED 5138 03:59:22,549 --> 03:59:25,952 DEVELOPING THIS TO EX TRANSIT 5139 03:59:25,952 --> 03:59:27,821 TRACT THESE FROM TIPS OF THE 5140 03:59:27,821 --> 03:59:30,690 CATHETER AND SOMEONE INTERESTED 5141 03:59:30,690 --> 03:59:32,392 I ASKED KATHERINE TO -- ARE 5142 03:59:32,392 --> 03:59:35,995 THERE DIFFERENCES IN COMMERCIAL 5143 03:59:35,995 --> 03:59:38,498 CELLS. I WAS ACTUALLY -- AS A 5144 03:59:38,498 --> 03:59:40,166 TRAINED TRIALIST AND 5145 03:59:40,166 --> 03:59:43,336 EPIDEMIOLOGIST I WAS SHOCKED TO 5146 03:59:43,336 --> 03:59:45,839 LEARN THAT NO ONE HAD PUBLISHED 5147 03:59:45,839 --> 03:59:51,978 THIS IN CELLS FROM THE PULMONARY 5148 03:59:51,978 --> 03:59:52,979 CIRCULATION. THERE IS BEEN A LOT 5149 03:59:52,979 --> 03:59:54,881 FROM OTHER SYSTEMS AND OTHER 5150 03:59:54,881 --> 03:59:56,216 ORGANS. I WAS SHOCKED TO LEARN 5151 03:59:56,216 --> 03:59:58,752 HOW DIFFICULT IT IS TO GET DONOR 5152 03:59:58,752 --> 04:00:02,055 INFORMATION FROM COMMERCIAL CELL 5153 04:00:02,055 --> 04:00:04,991 LINES. SO I THINK WE TALKED 5154 04:00:04,991 --> 04:00:06,493 ABOUT THIS, THE GROUP THAT PUT 5155 04:00:06,493 --> 04:00:08,428 OUT THIS ATS DOCUMENT. I THINK 5156 04:00:08,428 --> 04:00:10,463 IT DEPENDS WHAT YOU ARE 5157 04:00:10,463 --> 04:00:11,698 STUDYING. IF WHAT YOU ARE 5158 04:00:11,698 --> 04:00:13,533 STUDYING TO KNOWN TO POTENTIALLY 5159 04:00:13,533 --> 04:00:16,903 BE SEXUALLY DIMORPHIC I THINK 5160 04:00:16,903 --> 04:00:18,138 EVENTUALLY WE ARE GOING TO HAVE 5161 04:00:18,138 --> 04:00:21,241 TO SORT OF, YOU KNOW, THINK 5162 04:00:21,241 --> 04:00:26,346 ABOUT THOSE PHENOTIWIC 5163 04:00:26,346 --> 04:00:29,349 DIFFERENCES. WE DIDN'T TEST FOR 5164 04:00:29,349 --> 04:00:32,318 CELLULAR CARIOTYPE BUT THAT CAN 5165 04:00:32,318 --> 04:00:34,954 CHANGE IN A DYNAMIC PHENOMENON. 5166 04:00:34,954 --> 04:00:37,457 THE DEEPER YOU GO, SORT OF THE 5167 04:00:37,457 --> 04:00:38,992 DEEPER YOU GO. 5168 04:00:38,992 --> 04:00:40,894 >> YEAH. 5169 04:00:40,894 --> 04:00:42,896 >> THEN I GUESS COMPLETELY 5170 04:00:42,896 --> 04:00:43,663 UNRELATED, SO GIVEN EVERYTHING 5171 04:00:43,663 --> 04:00:45,098 WE HAVE BEEN TALKING ABOUT 5172 04:00:45,098 --> 04:00:48,468 HEESHGS SAY WE ARE DESIGNING A 5173 04:00:48,468 --> 04:00:53,506 NEW TRIAL AND WE WANT TO COLLECT 5174 04:00:53,506 --> 04:00:57,310 INFORMATION. WOMEN, GENDER, SEX, 5175 04:00:57,310 --> 04:00:59,145 HORMONE LEVELS, HORMONE 5176 04:00:59,145 --> 04:01:00,513 REPLACEMENT USE, ALL THAT. WHAT 5177 04:01:00,513 --> 04:01:04,117 DO WE NEED TO INCLUDE IN 5178 04:01:04,117 --> 04:01:05,018 QUESTIONNAIRES, WHAT KIND OF 5179 04:01:05,018 --> 04:01:10,723 INFORMATION DO WE NEED TO 5180 04:01:10,723 --> 04:01:11,558 COLLECT? 5181 04:01:11,558 --> 04:01:13,426 >> YEAH, I THINK THAT IS A GREAT 5182 04:01:13,426 --> 04:01:14,761 QUESTION. I THINK WE NEED TO 5183 04:01:14,761 --> 04:01:16,329 START WITH SOME OF THE THINGS 5184 04:01:16,329 --> 04:01:17,897 HIGHLIGHTED PREVIOUSLY SO 5185 04:01:17,897 --> 04:01:22,468 CERTAINLY BIOLOGICAL SEX AT 5186 04:01:22,468 --> 04:01:24,270 BIRTH. GENDER. WE, YOU KNOW, IN 5187 04:01:24,270 --> 04:01:29,042 OUR TRIAL OF DHEA, WE COLLECTED 5188 04:01:29,042 --> 04:01:32,445 A LOT MORE KIND OF DETAILED 5189 04:01:32,445 --> 04:01:34,247 HISTORICAL INFORMATION ABOUT 5190 04:01:34,247 --> 04:01:42,255 LIFETIME POTENTIAL ANDOGENOUS 5191 04:01:42,255 --> 04:01:44,023 AND ENDOGENOUS TO HORMONES. WHEN 5192 04:01:44,023 --> 04:01:45,758 YOU HAVE A TRIAL WHERE YOU ARE 5193 04:01:45,758 --> 04:01:47,627 MODULATING THINGS THAT ARE 5194 04:01:47,627 --> 04:01:48,528 HORMONES OR COULD DIRECTLY 5195 04:01:48,528 --> 04:01:51,264 IMPACT HORMONES THIS IS DATA 5196 04:01:51,264 --> 04:01:55,602 THAT IS IMPORTANT TO HAVE. EVEN 5197 04:01:55,602 --> 04:01:57,470 IN FACE OF NEGATIVE TRIAL IT IS 5198 04:01:57,470 --> 04:01:59,772 CRITICAL WE TRY TO LEARN 5199 04:01:59,772 --> 04:02:03,943 EVERYTHING WE CAN FROM THE DATA 5200 04:02:03,943 --> 04:02:12,852 WE COLLECT. 5201 04:02:12,852 --> 04:02:14,821 >> GREAT. 5202 04:02:14,821 --> 04:02:19,492 >> SO SORRY, CAN I ASK TECHNICAL 5203 04:02:19,492 --> 04:02:21,761 QUESTION TO DR. EGHBALI. MAY NOT 5204 04:02:21,761 --> 04:02:24,464 DIRECTLY RELATED TO THIS 5205 04:02:24,464 --> 04:02:26,165 WORKSHOP THEME BUT I'M VERY 5206 04:02:26,165 --> 04:02:28,001 INTERESTED IN -- YOU MENTIONED 5207 04:02:28,001 --> 04:02:33,539 YOUR ANIMAL MODEL THAT (?) 5208 04:02:33,539 --> 04:02:36,843 LIPIDS CAN CAUSE PULMONARY 5209 04:02:36,843 --> 04:02:37,944 HYPERTENSION. THIS IS SOMETHING 5210 04:02:37,944 --> 04:02:42,181 NEW. DID YOU SEE ANIMAL HAVE 5211 04:02:42,181 --> 04:02:43,750 SYSTEMIC HYPERTENSION OR UNIQUE 5212 04:02:43,750 --> 04:02:46,252 ONLY FOR THE CAUSE OF PULMONARY 5213 04:02:46,252 --> 04:02:46,586 HYPERTENSION? 5214 04:02:46,586 --> 04:02:48,321 >> YEAH, THAT IS A VERY GOOD 5215 04:02:48,321 --> 04:02:50,390 QUESTION. IN THIS ANIMAL MODEL 5216 04:02:50,390 --> 04:02:53,626 WE USED WILD TYPE MICE. WE PUT 5217 04:02:53,626 --> 04:02:56,629 THEM IN THIS DIET WHICH IS VERY 5218 04:02:56,629 --> 04:03:07,106 HIGH RICH IN THIS. THIS IS 5219 04:03:09,575 --> 04:03:10,543 INTERESTING IN THIS DIET FOR 5220 04:03:10,543 --> 04:03:13,279 THREE WEEKS WE ONLY SEE INCREASE 5221 04:03:13,279 --> 04:03:16,349 IN THE SYSTOLIC PRESSURE AND NOT 5222 04:03:16,349 --> 04:03:19,786 IN LV. THERE ARE OTHER MODELS 5223 04:03:19,786 --> 04:03:26,125 MORE PRONE TO DEVELOP ART 5224 04:03:26,125 --> 04:03:27,327 SCLEROSIS, LIKE DIFFERENT TYPE 5225 04:03:27,327 --> 04:03:31,698 MICE. WHEN WE PUT ON HIGH FAT 5226 04:03:31,698 --> 04:03:34,500 DIET THREE MONTHS ALSO DEVELOP 5227 04:03:34,500 --> 04:03:36,536 HYPERTENSION. DR. RABINICH 5228 04:03:36,536 --> 04:03:39,939 PUBLISHED MANY YEARS AND MY LAB 5229 04:03:39,939 --> 04:03:42,709 PUBLISHED ANOTHER WITH RECEPTOR 5230 04:03:42,709 --> 04:03:45,178 KNOCKOUT MICE. BUT WE PUT THEM 5231 04:03:45,178 --> 04:03:46,879 ON HIGH FAT DIET FOR THREE 5232 04:03:46,879 --> 04:03:50,083 MONTHS. EVERY WEEK WE DID AN 5233 04:03:50,083 --> 04:03:55,989 ECHO. WHAT WE FOUND WAS THAT WE 5234 04:03:55,989 --> 04:03:58,324 ACTUALLY SAW UP CREASE IN 5235 04:03:58,324 --> 04:04:00,393 SYSTOLIC PRESSURE BEFORE WE SAW 5236 04:04:00,393 --> 04:04:02,695 CHANGE IN LV. THAT IS WHY WE ARE 5237 04:04:02,695 --> 04:04:04,864 THINKING MAYBE THIS IS A GOOD 5238 04:04:04,864 --> 04:04:08,735 MODEL FOR GROUP 2. BUT GROUP 2 5239 04:04:08,735 --> 04:04:12,105 USUALLY WANTED TO HAVE (?) FIRST 5240 04:04:12,105 --> 04:04:13,873 AND DEVELOP HYPERTENSION AFTER 5241 04:04:13,873 --> 04:04:17,543 THAT. WHICH IS IN THIS MODEL WE 5242 04:04:17,543 --> 04:04:19,212 ACTUALLY SAW PULMONARY 5243 04:04:19,212 --> 04:04:22,281 HYPERTENSION PRECEDE THE LV 5244 04:04:22,281 --> 04:04:22,548 FAILURE. 5245 04:04:22,548 --> 04:04:24,450 >> YEAH, THAT IS VERY 5246 04:04:24,450 --> 04:04:27,020 INTERESTING. YEARS AGO I DO 5247 04:04:27,020 --> 04:04:28,921 STUDY ON THE LEFT HEART FAILURE 5248 04:04:28,921 --> 04:04:33,693 OR HYPE TROPHY. WE KNOW LIPID 5249 04:04:33,693 --> 04:04:36,262 CAN CAUSE HIGH TROPHY AND 5250 04:04:36,262 --> 04:04:37,630 FAILURE. WE THOUGHT BECAUSE OF 5251 04:04:37,630 --> 04:04:39,298 SYSTEMIC HYPERTENSION. THAT IS 5252 04:04:39,298 --> 04:04:40,900 WHY I'M ASKING QUESTION. YOUR 5253 04:04:40,900 --> 04:04:43,503 FIND ING IS REALLY INTERESTING. 5254 04:04:43,503 --> 04:04:45,972 IF IT IS UNIQUE TO PULMONARY 5255 04:04:45,972 --> 04:04:49,375 ARTERY SYSTEM THAT IS SOMETHINGS 5256 04:04:49,375 --> 04:04:53,646 FOR US TO LOOK INTO IT, THANK 5257 04:04:53,646 --> 04:04:55,248 YOU, THANK YOU. 5258 04:04:55,248 --> 04:05:06,225 >> DR. MARI MR /* MV -- DR. MAR 5259 04:05:10,096 --> 04:05:13,833 >> YOU ARE ON MUTE. STILL CAN'T 5260 04:05:13,833 --> 04:05:24,343 HEAR YOU, BRAD. BRAD, MAY YOU 5261 04:05:34,654 --> 04:05:36,055 DOUBLE-MUTED. YOU HAVE A DEVICE? 5262 04:05:36,055 --> 04:05:37,924 >> ON YOUR AUDIO, BRAD, CHECK TO 5263 04:05:37,924 --> 04:05:41,861 SEE IF YOU ARE USING THE CORRECT 5264 04:05:41,861 --> 04:05:44,263 DEVICE. SO WHERE IT SAYS AUDIO 5265 04:05:44,263 --> 04:05:46,432 CLICK ON THE LITTLE ARROW. SEE 5266 04:05:46,432 --> 04:05:56,943 IF YOU ARE USING THE CORRECT 5267 04:06:00,279 --> 04:06:01,414 DEVICE. 5268 04:06:01,414 --> 04:06:04,917 >> I WILL ASK A QUESTION WHY DR. 5269 04:06:04,917 --> 04:06:06,986 MARON IS WORKING ON HIS AUDIO. 5270 04:06:06,986 --> 04:06:08,020 DR. VENTETUOLO, I HAVE A 5271 04:06:08,020 --> 04:06:12,458 QUESTION. YOU MENTIONED SEVERAL 5272 04:06:12,458 --> 04:06:14,060 STUDIES. I DON'T KNOW WHAT TYPE 5273 04:06:14,060 --> 04:06:18,231 PH THEY WERE. ONE IN SQUARE 5274 04:06:18,231 --> 04:06:20,933 DERMA LOOKING AT HRT. WHICH IS 5275 04:06:20,933 --> 04:06:23,102 INTERESTING. DR. HEMNIS WILL BE 5276 04:06:23,102 --> 04:06:24,670 PRESENTING DAY WE HAVE BEEN 5277 04:06:24,670 --> 04:06:28,241 WORKING ON TOGETHER WITH PVOMICS 5278 04:06:28,241 --> 04:06:31,577 LOOKING AT PROTECTIVE EFFORT OF 5279 04:06:31,577 --> 04:06:36,215 HRT. IS THAT -- HAVE YOU LOOKED 5280 04:06:36,215 --> 04:06:40,453 FURTHER INTO THAT AND WHAT DO 5281 04:06:40,453 --> 04:06:42,922 YOU THINK IS GOING ON? IS THIS A 5282 04:06:42,922 --> 04:06:43,556 ESTROGEN EFFECT? 5283 04:06:43,556 --> 04:06:45,658 >> I THINK ONE OF THE CHALLENGES 5284 04:06:45,658 --> 04:06:47,693 WITH ALL HORMONE THERAPY 5285 04:06:47,693 --> 04:06:48,794 STUDIES, PARTICULARLY HORMONE 5286 04:06:48,794 --> 04:06:52,398 THERAPY STUDIES THAT WERE 5287 04:06:52,398 --> 04:06:53,666 CONDUCTED SORT OF EARLIER WHEN 5288 04:06:53,666 --> 04:06:58,704 WE WERE GIVING A LOT OF 5289 04:06:58,704 --> 04:07:00,673 INDIVIDUALS WHO WERE POST 5290 04:07:00,673 --> 04:07:06,979 MENOPAUSAL, PARTICULARLY OR LATE 5291 04:07:06,979 --> 04:07:08,848 PERIMEN PAUSE THERAPY, THEY 5292 04:07:08,848 --> 04:07:12,218 TENDED TO BE HEALTHY, AS OPPOSED 5293 04:07:12,218 --> 04:07:13,486 TO THOSE THAT AREN'T OFFER ED 5294 04:07:13,486 --> 04:07:17,089 THAT THERAPY. THOSE AT RISK FOR 5295 04:07:17,089 --> 04:07:19,759 CANCER OR CLOTTING, ET CETERA. 5296 04:07:19,759 --> 04:07:25,097 THP THIS DATA AND TWO REPORTS OF 5297 04:07:25,097 --> 04:07:26,732 SCLERADATA, IT COULD BE CON 5298 04:07:26,732 --> 04:07:28,634 FOUNDING. COULD BE IT HAS 5299 04:07:28,634 --> 04:07:31,470 PROTECTIVE EFFECT BECAUSE IT IS 5300 04:07:31,470 --> 04:07:34,941 A VASO DILATOR AND HAS CHANGES 5301 04:07:34,941 --> 04:07:38,144 MORE GENOMIC EFFECTS. I THINK WE 5302 04:07:38,144 --> 04:07:40,413 DON'T YET KNOW BUT OBSERVATIONS 5303 04:07:40,413 --> 04:07:42,548 ARE INTERESTING. ONE OF THE 5304 04:07:42,548 --> 04:07:45,718 THINGS I HOPE COMES FROM WORK 5305 04:07:45,718 --> 04:07:49,755 LIKE PVDOMICS IS WE UNDERSTAND 5306 04:07:49,755 --> 04:07:50,656 TEMPORAL RELATIONSHIPS AS WELL 5307 04:07:50,656 --> 04:07:54,961 AS STUDYING EFFECTS ACROSS ALL 5308 04:07:54,961 --> 04:07:56,162 TYPES OF PULMONARY VASCULAR 5309 04:07:56,162 --> 04:07:58,931 DISEASE TO SEE IF WE CAN 5310 04:07:58,931 --> 04:08:03,202 VALIDATE SMALLER SCALE 5311 04:08:03,202 --> 04:08:03,536 OBSERVATIONS. 5312 04:08:03,536 --> 04:08:05,137 >> GREAT, THANK YOU. DR. MARION, 5313 04:08:05,137 --> 04:08:08,474 ARE YOU WITH US? 5314 04:08:08,474 --> 04:08:10,876 >> CAN YOU HEAR ME? 5315 04:08:10,876 --> 04:08:12,578 >> THERE WE GO, GOTCHA. 5316 04:08:12,578 --> 04:08:13,779 >> SORRY ABOUT THAT. I HAVE A 5317 04:08:13,779 --> 04:08:17,116 NEW SYSTEM THAT I CLICKED OVER. 5318 04:08:17,116 --> 04:08:19,252 DR. STRAH, I WANTED TO ASK YOU A 5319 04:08:19,252 --> 04:08:20,519 QUESTION. I THOUGHT YOU GAVE A 5320 04:08:20,519 --> 04:08:22,989 GREAT PRESENTATION. I WAS ONCE 5321 04:08:22,989 --> 04:08:27,293 READING CARDIO PULMONARY 5322 04:08:27,293 --> 04:08:28,127 EXERCISE REFER TO 43 -YEAR-OLD 5323 04:08:28,127 --> 04:08:30,896 TRANSGENDER WOMAN TRANSITIONING 5324 04:08:30,896 --> 04:08:33,833 MALE TO FEMALE. THE QUESTION OF 5325 04:08:33,833 --> 04:08:41,374 HOW TO CALCULATE, HOW TO REPORT 5326 04:08:41,374 --> 04:08:42,708 WAS RAISED BECAUSE THIS 5327 04:08:42,708 --> 04:08:43,409 PARTICULAR PATIENT WAS IN 5328 04:08:43,409 --> 04:08:47,113 BETWEEN THE TRANSITION. SO THE 5329 04:08:47,113 --> 04:08:55,621 DISCUSSION WITH THE TRANSITION 5330 04:08:55,621 --> 04:08:57,823 AND SEX-AFFIRMING THERAPY THIS 5331 04:08:57,823 --> 04:08:59,392 PATIENT WAS ON SO BASED ON THAT 5332 04:08:59,392 --> 04:09:01,060 WE MADE A DECISION ABOUT WHAT 5333 04:09:01,060 --> 04:09:03,195 THE MOST APPROPRIATE DECISION 5334 04:09:03,195 --> 04:09:04,730 WAS TO STANDARDIZE RESULTS TO A 5335 04:09:04,730 --> 04:09:12,838 MALE OR TO A FEMALE HOP 5336 04:09:12,838 --> 04:09:14,340 ALLEGAT POP /* 5337 04:09:14,340 --> 04:09:17,777 -- POPULATION. SO THAT WAS 5338 04:09:17,777 --> 04:09:19,078 HELPFUL AND REAL WORLD 5339 04:09:19,078 --> 04:09:22,548 APPLICATION TO CONCEPTS YOU WERE 5340 04:09:22,548 --> 04:09:23,816 DISCUSSING. IN THAT SCENARIO 5341 04:09:23,816 --> 04:09:27,553 THERE WAS A NEED TO CALIBRATE 5342 04:09:27,553 --> 04:09:30,523 NORMATIVE VALUES FOR TRANSGENDER 5343 04:09:30,523 --> 04:09:31,957 PEOPLE. YOU HAD MENTIONED 5344 04:09:31,957 --> 04:09:34,960 INTERNAL PROBIANP TO ANOTHER 5345 04:09:34,960 --> 04:09:36,796 DIRECTION OF THE CONVERSATION, 5346 04:09:36,796 --> 04:09:38,297 WHICH I THINK IS GREAT. I GUESS 5347 04:09:38,297 --> 04:09:40,599 THE QUESTION HOW DO YOU KNOW 5348 04:09:40,599 --> 04:09:51,077 WHICH OF THE BIO MARKERS OR 5349 04:09:51,077 --> 04:09:51,744 PARAMETERS IN CARDIOVASCULAR IS 5350 04:09:51,744 --> 04:09:55,848 RIGHT. YOU CAN MAKE THE CASE FOR 5351 04:09:55,848 --> 04:09:57,383 PROBIA, IT IS SO SENSITIVE THAT 5352 04:09:57,383 --> 04:09:59,485 IT IS ELEVATED AND RECRAFTING 5353 04:09:59,485 --> 04:10:01,754 NORMATIVE VALUES MAY NOT BE AS 5354 04:10:01,754 --> 04:10:03,222 CLINICALLY IMPACTFUL AS PEAK 5355 04:10:03,222 --> 04:10:05,224 VOLUME OF OXYGEN CONSUMPTION, 5356 04:10:05,224 --> 04:10:08,994 WHICH IN MY LAB AND COULD EASILY 5357 04:10:08,994 --> 04:10:11,397 LAND IN MY LAB IF I'M READING 5358 04:10:11,397 --> 04:10:13,299 (?) FOR EXAMPLE. I THINK YOU ARE 5359 04:10:13,299 --> 04:10:17,470 EXACTLY RIGHT. I THINK THAT, YOU 5360 04:10:17,470 --> 04:10:21,340 KNOW, REESTABLISHING NORMATIVE 5361 04:10:21,340 --> 04:10:30,216 VALUES FOR THESE WOULD NOT BE 5362 04:10:30,216 --> 04:10:32,618 HELPFUL. IN STUDIES OF 5363 04:10:32,618 --> 04:10:35,988 TRANSGENDER INDIVIDUALS WHO HAD 5364 04:10:35,988 --> 04:10:42,928 CARDIAC EVENTS USING SEX 5365 04:10:42,928 --> 04:10:44,764 ASSIGNED AT BIRTH VERSUS 5366 04:10:44,764 --> 04:10:46,098 AFFIRMED GENDER REALLY DIDN'T 5367 04:10:46,098 --> 04:10:49,702 CHANGE OUTCOMES AND DIDN'T MOVE 5368 04:10:49,702 --> 04:10:57,476 PEOPLE FROM A DIAGNOSIS GROUP. I 5369 04:10:57,476 --> 04:11:01,347 THINK WHAT REALLY -- I GUESS MY 5370 04:11:01,347 --> 04:11:02,748 ASPIRATIONAL RECOMMENDATION 5371 04:11:02,748 --> 04:11:13,292 WOULD BE TO TRY TO REFOCUS ON A 5372 04:11:15,094 --> 04:11:16,162 DIFFERENT BIOMARKER THAT ISN'T 5373 04:11:16,162 --> 04:11:21,500 DEPENDENT ON GENDER OR BODY 5374 04:11:21,500 --> 04:11:24,970 HABITUS, FAT DISTRIBUTION, RENAL 5375 04:11:24,970 --> 04:11:26,705 FUNCTION, SOMETHING THAT IS 5376 04:11:26,705 --> 04:11:29,108 UNIVERSAL AND ACCESSIBLE TO OUR 5377 04:11:29,108 --> 04:11:34,814 ENTIRE POPULATION INDEPENDENT OF 5378 04:11:34,814 --> 04:11:40,886 GENDER, BE PEND INDEPENDENT /* 5379 04:11:40,886 --> 04:11:42,688 INDEPENDENT OF BMI. 5380 04:11:42,688 --> 04:11:44,824 >> I APPRECIATE THAT THAT, IS 5381 04:11:44,824 --> 04:11:45,191 HELPFUL. 5382 04:11:45,191 --> 04:11:49,195 >> I HAD A QUESTION FOR DR. 5383 04:11:49,195 --> 04:11:53,199 EGHBALI. SO MINORITY STRESS IS 5384 04:11:53,199 --> 04:11:59,205 SOMETHING THAT WE IN TRANSGENDER 5385 04:11:59,205 --> 04:12:02,107 HEALTH DISCUSS QUITE BIT. ONE OF 5386 04:12:02,107 --> 04:12:03,809 THE THINGS IS THAT IT IS 5387 04:12:03,809 --> 04:12:06,378 BELIEVED TO EXIST. IT IS HARD TO 5388 04:12:06,378 --> 04:12:12,451 STUDY. SO I'M WONDERING IS THERE 5389 04:12:12,451 --> 04:12:16,889 A WAY TO TAKE THIS BACK TO A 5390 04:12:16,889 --> 04:12:19,992 PRECLINICAL MODEL IN A WAY THAT 5391 04:12:19,992 --> 04:12:30,135 WOULD BE I GUESS FEASIBLE AND 5392 04:12:30,135 --> 04:12:35,307 SAFE FOR AN AN ANIMAL TO ASSESS 5393 04:12:35,307 --> 04:12:36,509 THE STRESS. 5394 04:12:36,509 --> 04:12:38,377 >> WHAT DO YOU MEAN BY MINORITY 5395 04:12:38,377 --> 04:12:42,047 STRESS? TO SEE HOW WE CAN MODEL 5396 04:12:42,047 --> 04:12:46,485 IT IN THE ANIMAL? 5397 04:12:46,485 --> 04:12:56,061 >> SO THE EXPERIENCE OF 5398 04:12:56,061 --> 04:12:57,096 DIFFERENT ENVIRONMENTAL 5399 04:12:57,096 --> 04:13:06,138 STRESSERS THAN THE, YOU KNOW, 5400 04:13:06,138 --> 04:13:08,874 HETERONORMATIVE, CISNORMATIVE 5401 04:13:08,874 --> 04:13:11,610 MAJORITY POPULATION. SO IS THERE 5402 04:13:11,610 --> 04:13:14,513 A WAY TO I GUESS CREATE AN 5403 04:13:14,513 --> 04:13:18,117 ENVIRONMENTAL STRESSOR IN A 5404 04:13:18,117 --> 04:13:20,686 PRE-CLINICAL MODEL? 5405 04:13:20,686 --> 04:13:23,656 >> IN ONE WHEN USING MICE OR 5406 04:13:23,656 --> 04:13:27,192 RATS, THEY NEVER LET US TO HAVE 5407 04:13:27,192 --> 04:13:28,227 A SINGLE CAKE BECAUSE THEY THINK 5408 04:13:28,227 --> 04:13:30,496 WILL CREATE A LOT OF STRESS FOR 5409 04:13:30,496 --> 04:13:31,797 THEM. THAT IS WHY WE ALWAYS HAVE 5410 04:13:31,797 --> 04:13:33,866 TO USE A GROUP OF THEM TOGETHER. 5411 04:13:33,866 --> 04:13:36,468 YOU KNOW, USUALLY YOU HAVE FOUR 5412 04:13:36,468 --> 04:13:39,238 OR FIVE PER CAGE. RATS ALWAYS, 5413 04:13:39,238 --> 04:13:40,573 DEPENDING ON THE SIZE, EITHER 5414 04:13:40,573 --> 04:13:42,741 TWO OR THREE IN THE SAME CAGE. 5415 04:13:42,741 --> 04:13:47,179 THEY NEVER LET US TO USE ANIMAL 5416 04:13:47,179 --> 04:13:47,980 INDIVIDUAL CAGE BECAUSE THEY 5417 04:13:47,980 --> 04:13:50,683 THINK IS GOING TO REALLY AFFECT 5418 04:13:50,683 --> 04:13:53,352 THEIR STRESS LEVEL. THAT IS ONE 5419 04:13:53,352 --> 04:13:56,055 THING. BUT ALSO WE SEE MORE AND 5420 04:13:56,055 --> 04:14:02,261 MORE ABOUT CIRCADIAN EFFORT. ONE 5421 04:14:02,261 --> 04:14:04,463 IS SOCIALIZING. THAT IS WHY WHEN 5422 04:14:04,463 --> 04:14:06,532 WE DO EXPERIMENT. ANOTHER REASON 5423 04:14:06,532 --> 04:14:08,000 WE NEED TO ALWAYS HAVE GROUP OF 5424 04:14:08,000 --> 04:14:09,902 ANIMALS TOGETHER. BECAUSE IT'S 5425 04:14:09,902 --> 04:14:11,737 BEEN ALSO SHOWN IF YOU DON'T PUT 5426 04:14:11,737 --> 04:14:13,939 A GROUP OF ANIMALS TOGETHER IT 5427 04:14:13,939 --> 04:14:16,375 IS GOING TO AFFECT THEIR 5428 04:14:16,375 --> 04:14:17,610 CIRCADIAN RHYTHM. THERE ARE 5429 04:14:17,610 --> 04:14:18,844 CERTAIN GENES THAT ARE SHOWN 5430 04:14:18,844 --> 04:14:29,388 THAT ARE REGULATED BY THE CLOCK 5431 04:14:31,690 --> 04:14:34,293 THAT ARE REGULATED BY ESTROGEN. 5432 04:14:34,293 --> 04:14:36,261 THE TALK TODAY IS REALLY 5433 04:14:36,261 --> 04:14:38,530 INTERESTING AND WE AS BASIC 5434 04:14:38,530 --> 04:14:42,835 SCIENTISTS NEED TO AGREE IN LAB 5435 04:14:42,835 --> 04:14:45,437 TO SEE HOW WE CAN ADDRESS THAT 5436 04:14:45,437 --> 04:14:46,438 EXPERIMENTALLY. NOW I REALLY 5437 04:14:46,438 --> 04:14:48,040 DON'T KNOW BEST WAY. 5438 04:14:48,040 --> 04:14:50,576 >> I LIKE THAT DR. GLEN WILL BE 5439 04:14:50,576 --> 04:14:55,848 TALKING ABOUT ALOSTAIC LOAD AND 5440 04:14:55,848 --> 04:14:58,951 THE SUBJECT YOU BROUGHT UP. SO 5441 04:14:58,951 --> 04:15:00,152 THAT IS SOMETHING -- ANOTHER 5442 04:15:00,152 --> 04:15:02,855 THING THAT IS INTERESTING AND 5443 04:15:02,855 --> 04:15:05,991 COMES TO MIND AND DR. VENTETUOLO 5444 04:15:05,991 --> 04:15:10,295 DISCUSSED THE INFLUENCE OF THE 5445 04:15:10,295 --> 04:15:13,332 HUMAN ANIMAL CAREGIVER, SEX OF 5446 04:15:13,332 --> 04:15:23,876 HUMAN ANIMAL CAREGIVER. I WONDER 5447 04:15:27,479 --> 04:15:30,749 IF THAT IS MORE OR LESS STRESS? 5448 04:15:30,749 --> 04:15:31,984 IT IS THE INTERESTING THAT THAT 5449 04:15:31,984 --> 04:15:33,886 IS A FACTOR. IF YOU HAVE 5450 04:15:33,886 --> 04:15:35,554 COMMENTS OR MAYBE AN 5451 04:15:35,554 --> 04:15:35,888 OBSERVATION. 5452 04:15:35,888 --> 04:15:40,859 >> YEAH, I DON'T KNOW THE 5453 04:15:40,859 --> 04:15:43,762 MECHANISM IS KNOWN BUT CERTAINLY 5454 04:15:43,762 --> 04:15:44,463 COULD BE. 5455 04:15:44,463 --> 04:15:45,464 >> I WILL COMMENT WITH THAT 5456 04:15:45,464 --> 04:15:48,367 BECAUSE I USED TO WORK WITH 5457 04:15:48,367 --> 04:15:49,068 ANIMAL BEFORE. AS DR. EGHBALI 5458 04:15:49,068 --> 04:15:53,205 WAS SAYING, NORMALLY PUT IN SAME 5459 04:15:53,205 --> 04:15:56,608 CAGE BUT ESPECIALLY FOR MICE YOU 5460 04:15:56,608 --> 04:15:58,177 CANNOT PUT DIFFERENT. MALE MICE 5461 04:15:58,177 --> 04:15:59,812 IN SAME CAGE. THEY WILL KILL 5462 04:15:59,812 --> 04:16:02,047 EACH OTHER UNLESS THEY ARE FROM 5463 04:16:02,047 --> 04:16:03,982 SAME LEADER, THEY GROW UP 5464 04:16:03,982 --> 04:16:05,317 TOGETHER, WHERE THEY WERE BORN. 5465 04:16:05,317 --> 04:16:07,586 SO THEY ARE OKAY. OTHERWISE IF 5466 04:16:07,586 --> 04:16:09,321 YOU PUT MALE MICE IN THE SAME 5467 04:16:09,321 --> 04:16:10,789 CAGE FROM DIFFERENT LITTERS, 5468 04:16:10,789 --> 04:16:12,825 THEY WILL EVENTUALLY KILL EACH 5469 04:16:12,825 --> 04:16:14,526 OTHER, ONLY ONE LEFT THAT. IS 5470 04:16:14,526 --> 04:16:16,428 TOTALLY DIFFERENT BEHAVIOR FROM 5471 04:16:16,428 --> 04:16:18,464 THE MODERN HUMAN BEING BEHAVIOR. 5472 04:16:18,464 --> 04:16:21,333 SO THAT IS MAKING IT DIFFICULT 5473 04:16:21,333 --> 04:16:23,402 FOR TO USE ANIMAL MODEL, AT 5474 04:16:23,402 --> 04:16:25,404 LEAST MALE MICE TO STUDY. FEMALE 5475 04:16:25,404 --> 04:16:26,638 YOU CAN PUT IN SAME CAGE THAT, 5476 04:16:26,638 --> 04:16:28,640 IS BETTER. BUT FOR MALE MICE 5477 04:16:28,640 --> 04:16:32,444 THAT IS PROBABLY COULD NOT BE 5478 04:16:32,444 --> 04:16:34,413 DONE. THAT IS MY CONCERN FROM 5479 04:16:34,413 --> 04:16:36,281 WHEN RUNNING MY LAB YEARS AGO. 5480 04:16:36,281 --> 04:16:39,418 >> THANKS, LEI. MAYBE SHOULD BE 5481 04:16:39,418 --> 04:16:43,288 MEASURING MARKERS OF ALOSTAIC 5482 04:16:43,288 --> 04:16:46,859 LOAD IN ANIMALS, JUST AS A 5483 04:16:46,859 --> 04:16:50,229 THOUGHT. AND DOCTOR -- 5484 04:16:50,229 --> 04:16:52,264 >> SURE. 5485 04:16:52,264 --> 04:16:58,003 >> -- DR. DE-JESUS PEREZ, A 5486 04:16:58,003 --> 04:16:58,604 QUESTION? 5487 04:16:58,604 --> 04:17:00,405 >> THANKS FOR THE PRESENTATION. 5488 04:17:00,405 --> 04:17:02,407 I'M ACTUALLY EAGER TO HEAR MORE, 5489 04:17:02,407 --> 04:17:03,909 IF POSSIBLE, ABOUT THE RESULTS 5490 04:17:03,909 --> 04:17:06,645 OF THE PHANTOM STUDY, WHICH WAS 5491 04:17:06,645 --> 04:17:07,713 BROUGHT BY DR. EGHBALI. THIS WAS 5492 04:17:07,713 --> 04:17:13,185 A STUDY USING AN ASTROS TO 5493 04:17:13,185 --> 04:17:19,758 INHIBIT AROMATASE TO SHOW 5494 04:17:19,758 --> 04:17:20,926 SUPPRESSING ESTROGEN PRODUCTION 5495 04:17:20,926 --> 04:17:23,128 THAT COULD LEAD TO THERAPEUTIC 5496 04:17:23,128 --> 04:17:25,330 BENEFIT. I THINK IT IS RELEVANT 5497 04:17:25,330 --> 04:17:26,999 CONSIDERING THE PRESENTATION BY 5498 04:17:26,999 --> 04:17:29,101 DR. VENTETUOLO AND OTHERS 5499 04:17:29,101 --> 04:17:32,070 REGARDING HOW WE MEASURE THE 5500 04:17:32,070 --> 04:17:35,674 EFFECT OF ESTROGEN, ESTROGEN 5501 04:17:35,674 --> 04:17:38,610 METABOLITES. I THINK WE HAVE 5502 04:17:38,610 --> 04:17:42,481 COMPELLING EVIDENCE OF GOOD AND 5503 04:17:42,481 --> 04:17:45,384 BAD ORGAN DEPENDENCE OR 5504 04:17:45,384 --> 04:17:46,451 CELL-SPECIFIC SO AT THE END OF 5505 04:17:46,451 --> 04:17:48,086 THE DAY WILL BE INTERESTING TO 5506 04:17:48,086 --> 04:17:50,122 HEAR ULTIMATELY SINCE THE TRIAL 5507 04:17:50,122 --> 04:17:54,193 WAS COMPLETED A YEAR OR SOING A 5508 04:17:54,193 --> 04:17:56,061 IF THERE'S ANY RESULTS THAT 5509 04:17:56,061 --> 04:17:57,529 POINT OUT TO ULTIMATELY WHAT 5510 04:17:57,529 --> 04:18:03,602 HAPPENS WHEN YOU TARGET ESTROGEN 5511 04:18:03,602 --> 04:18:07,906 PRODUCTION. 5512 04:18:07,906 --> 04:18:11,777 >> DOCTOR KAWUT. DON'T WANT O 5513 04:18:11,777 --> 04:18:13,846 PUT HIM ON THE SPOT. I CAN FEEL 5514 04:18:13,846 --> 04:18:14,246 THE QUESTION. 5515 04:18:14,246 --> 04:18:18,317 >> YOUR NAME IS ALL OVER THOSE 5516 04:18:18,317 --> 04:18:18,584 STUDIES. 5517 04:18:18,584 --> 04:18:24,189 >> SORRY. GO AHEAD, COREY. 5518 04:18:24,189 --> 04:18:26,024 >> DESPITE A POSITIVE EARLY 5519 04:18:26,024 --> 04:18:27,926 PHASE 2 TRIAL OF 18 PARTICIPANTS 5520 04:18:27,926 --> 04:18:29,761 IN WHICH WE IMPROVED SIX-MINUTE 5521 04:18:29,761 --> 04:18:31,563 WALK DISTANCE IN INDIVIDUALS 5522 04:18:31,563 --> 04:18:35,934 GETTING AN ASTROSOL OVER SHORTER 5523 04:18:35,934 --> 04:18:37,336 PERIOD OF TIME THE FOLLOW-UP 5524 04:18:37,336 --> 04:18:39,471 PHANTOM STUDY, EIGHT-CENTER 5525 04:18:39,471 --> 04:18:42,140 CLINICAL TRIAL OF 84 5526 04:18:42,140 --> 04:18:42,774 PARTICIPANTS CONDUCTED DURING 5527 04:18:42,774 --> 04:18:44,243 COVID WAS ACTUALLY NEGATIVE. 5528 04:18:44,243 --> 04:18:46,945 THAT WAS PUBLISHED, WHEN STEVE, 5529 04:18:46,945 --> 04:18:50,215 LAST MONTH IN THE BLUE JOURNAL? 5530 04:18:50,215 --> 04:18:51,984 WHAT WE KNOW -- WELL, WHAT WE 5531 04:18:51,984 --> 04:18:53,051 SPECULATE IS THERE ARE 5532 04:18:53,051 --> 04:18:54,119 DIFFERENCES BETWEEN THE FIRST 5533 04:18:54,119 --> 04:18:56,188 AND SECOND TRIAL. ONE OF THOSE 5534 04:18:56,188 --> 04:18:58,423 DIFFERENCES, FOR EXAMPLE, IS WE 5535 04:18:58,423 --> 04:19:00,225 GAVE INDIVIDUALS -- GAVE ALL 5536 04:19:00,225 --> 04:19:03,795 INDIVIDUALS VITAMIN D 5537 04:19:03,795 --> 04:19:04,696 SUPPLEMENT 5538 04:19:04,696 --> 04:19:05,330 SUPPLEMENTATION, WHETHER THAT 5539 04:19:05,330 --> 04:19:06,498 BIAS POTENTIALLY CHANGED SOME OF 5540 04:19:06,498 --> 04:19:07,966 THESE PATHWAYS THAT INTERACT 5541 04:19:07,966 --> 04:19:10,736 WITH EACH OTHER, WE DON'T KNOW. 5542 04:19:10,736 --> 04:19:13,038 WE KNOW, HOWEVER, ONE OF THE BIG 5543 04:19:13,038 --> 04:19:15,874 QUESTIONS ABOUT REDUCING 5544 04:19:15,874 --> 04:19:17,276 ESTRADIOL IS WHETHER IT WOULD BE 5545 04:19:17,276 --> 04:19:20,012 SAFE FOR THE RIGHT VENTRICLE. AS 5546 04:19:20,012 --> 04:19:21,513 WE HAVE HEARD THERE IS CERTAINLY 5547 04:19:21,513 --> 04:19:23,815 DATA THAT SUGGESTS AS WELL AS 5548 04:19:23,815 --> 04:19:29,955 MESA STUDY IF YOU REDUCE E2 YOU 5549 04:19:29,955 --> 04:19:31,723 COULD HARM RV SO OUT TO A YEAR 5550 04:19:31,723 --> 04:19:34,293 WE HAVE ECHO-BASED PARAMETERS TO 5551 04:19:34,293 --> 04:19:37,663 SUGGEST WHILE WE DIDN'T DO MUCH 5552 04:19:37,663 --> 04:19:40,265 OF ANYTHING, WE DIDN'T HURT THE 5553 04:19:40,265 --> 04:19:41,867 RIGHT VENTRICLE. STEVEN, I DON'T 5554 04:19:41,867 --> 04:19:52,411 KNOW IF YOU HAVE OTHER COMMENTS. 5555 04:19:55,647 --> 04:19:58,784 >> I THINK YOU ANSWERED IT 5556 04:19:58,784 --> 04:19:59,584 NICELY. 5557 04:19:59,584 --> 04:20:02,354 >> ALL RIGHT. WITH THAT I'M 5558 04:20:02,354 --> 04:20:05,090 GOING TO -- BECAUSE DR. RACHEL 5559 04:20:05,090 --> 04:20:06,758 GOLD JUST JOINED US, I'M GOING 5560 04:20:06,758 --> 04:20:09,494 TO ALLOW HER TO INTRODUCE 5561 04:20:09,494 --> 04:20:11,296 HERSELF AS ONE OF OUR SPEAKERS. 5562 04:20:11,296 --> 04:20:13,598 HER TALK WILL BE AT THE END OF 5563 04:20:13,598 --> 04:20:15,200 THE NEXT SESSION. BUT SINCE 5564 04:20:15,200 --> 04:20:22,374 SHE'S JUST JOINED. RACHEL. 5565 04:20:22,374 --> 04:20:24,443 >> THANKS SO MUCH. I HAD A 5566 04:20:24,443 --> 04:20:25,510 MANDATORY MEETING AT MY 5567 04:20:25,510 --> 04:20:26,912 ORGANIZATION ALL MORNING IN 5568 04:20:26,912 --> 04:20:28,447 PORTLAND, OREGON. I'M A SENIOR 5569 04:20:28,447 --> 04:20:30,749 VIOLENTY TOR AT THE KAISER 5570 04:20:30,749 --> 04:20:34,052 PERMANENTE CENTER AND DIRECTOR 5571 04:20:34,052 --> 04:20:37,689 OF THE PROGRAMS AT -- SENIOR 5572 04:20:37,689 --> 04:20:39,458 INVESTIGATOR AT THE KAISER 5573 04:20:39,458 --> 04:20:41,526 PERMANENTE CENTER (CORRECTION) 5574 04:20:41,526 --> 04:20:43,462 AND WE HAVE A PRETTY RIGOROUS 5575 04:20:43,462 --> 04:20:45,998 RESEARCH ENDEAVOR GOING USING 5576 04:20:45,998 --> 04:20:54,172 THE DATA SET THAT IS (AUDIO 5577 04:20:54,172 --> 04:20:56,475 INTERRUPTION) SOCIOECONOMIC 5578 04:20:56,475 --> 04:20:57,576 DISPARITIES IN SAFETY NET 5579 04:20:57,576 --> 04:20:58,944 SETTING AND HOW TO IMPLEMENT 5580 04:20:58,944 --> 04:21:00,045 INTERVENTIONS TO THAT EFFECT. A 5581 04:21:00,045 --> 04:21:02,047 LOT OF EMPHASIS ON SOCIAL 5582 04:21:02,047 --> 04:21:03,215 DETERMINANTS OF HEALTH. THANKS 5583 04:21:03,215 --> 04:21:05,617 VERY MUCH FOR HAVING ME. 5584 04:21:05,617 --> 04:21:07,419 >> THANK YOU, DR. GOLD. I 5585 04:21:07,419 --> 04:21:10,856 ANTICIPATE THERE WILL BE A LOT 5586 04:21:10,856 --> 04:21:14,092 OF QUES 5587 04:21:14,092 --> 04:21:16,161 OF QUESTIONS. WE HAD MANY COME 5588 04:21:16,161 --> 04:21:19,164 IN THROUGH THE DISCUSSANTS HOW 5589 04:21:19,164 --> 04:21:21,967 TO STANDARDIZE. SO THAT (BELL) 5590 04:21:21,967 --> 04:21:24,169 >> GOT A GOOD SENSE OF THAT. 5591 04:21:24,169 --> 04:21:28,740 >> ANY OTHER QUESTIONS FOR OUR 5592 04:21:28,740 --> 04:21:32,411 PANEL HERE EITHER FROM 5593 04:21:32,411 --> 04:21:38,950 DISCUSSANTS OR OTHER SPEAKERS? 5594 04:21:38,950 --> 04:21:42,187 OKAY. WITH THAT WE HAVE A BREAK 5595 04:21:42,187 --> 04:21:45,023 FOR 15 MINUTES. WE WILL ADJOURN 5596 04:21:45,023 --> 04:21:52,697 AND COME BACK AT 3:15 EASTERN TIME. 5597 04:21:52,697 --> 04:22:44,879 5598 04:22:44,879 --> 04:22:53,488 HE WILL BE GIVING AN 5599 04:22:53,488 --> 04:22:58,092 OVERVIEW. WITH THAT DR. 5600 04:22:58,092 --> 04:22:58,359 BERNARDO. 5601 04:22:58,359 --> 04:23:05,800 >> THANK YOU FRANZ AND JAMES ON 5602 04:23:05,800 --> 04:23:09,971 ONE OF MY FAVORITE TOPIC, 5603 04:23:09,971 --> 04:23:11,239 RELATIONSHIP BETWEEN SOCIAL 5604 04:23:11,239 --> 04:23:12,173 DETERMINANTS OF HEALTH AND 5605 04:23:12,173 --> 04:23:13,608 CARDIOVASCULAR DISEASE. THESE 5606 04:23:13,608 --> 04:23:20,147 ARE MY DISCLOSURES. THE NEXT 5607 04:23:20,147 --> 04:23:22,383 SLIDE. I WILL BE GOING THROUGH 5608 04:23:22,383 --> 04:23:23,384 TERMINOLOGY THAT RELATES TO 5609 04:23:23,384 --> 04:23:24,051 SOCIAL DETERMINANTS OF HEALTH. 5610 04:23:24,051 --> 04:23:25,453 WE WILL BE TALKING ABOUT SOME OF 5611 04:23:25,453 --> 04:23:31,459 THE DATA THAT PERTAINS TO SOCIAL 5612 04:23:31,459 --> 04:23:32,093 DETERMINANTS OF HEALTH, SOCIAL 5613 04:23:32,093 --> 04:23:39,500 DEPRIVATION IN PATIENTS WITH 5614 04:23:39,500 --> 04:23:43,704 CARDIOVASCULAR DISEASE AND 5615 04:23:43,704 --> 04:23:45,072 HYPERTENSION. NEXT SLIDE, 5616 04:23:45,072 --> 04:23:45,339 PLEASE. 5617 04:23:45,339 --> 04:23:48,910 AS SPOKE EARLIER MOST OF 5618 04:23:48,910 --> 04:23:52,980 DATA WE USE FOR DECISION-MAKING 5619 04:23:52,980 --> 04:23:56,217 IN PAH COMES FROM LARGE TRIALS. 5620 04:23:56,217 --> 04:23:58,553 HOWEVER, THE REPRESENTATION OF 5621 04:23:58,553 --> 04:24:03,190 MINORS IN CLINICAL TRIALS IS 5622 04:24:03,190 --> 04:24:06,127 SIGNIFICANTLY MINIMAL. NEXT 5623 04:24:06,127 --> 04:24:06,360 SLIDE. 5624 04:24:06,360 --> 04:24:10,064 IN THIS NICE FIGURE WE CAN 5625 04:24:10,064 --> 04:24:13,301 SEE REPRESENTATION OF MINORITIES 5626 04:24:13,301 --> 04:24:15,169 IN DIFFERENT TRIALS BUT AS YOU 5627 04:24:15,169 --> 04:24:18,039 CAN SEE MOST CALLED REGISTRIES 5628 04:24:18,039 --> 04:24:28,583 ARE PREDOMINANTLY WHITE AND MY 5629 04:24:29,884 --> 04:24:32,687 SOME MINORITIES. (?) GROUP OF 5630 04:24:32,687 --> 04:24:33,955 INVESTIGATORS FROM AMERICAN 5631 04:24:33,955 --> 04:24:35,756 THORACIC SOCIETY HAD THIS 5632 04:24:35,756 --> 04:24:37,258 STATEMENT WHERE THEY WERE 5633 04:24:37,258 --> 04:24:38,292 PROVIDING SOME KEY 5634 04:24:38,292 --> 04:24:40,995 RECOMMENDATIONS WHEN COMES TO 5635 04:24:40,995 --> 04:24:45,533 RESEARCH RELATED TO HEALTH CARE 5636 04:24:45,533 --> 04:24:46,734 DISPARITIES AND WERE EMPHASIZING 5637 04:24:46,734 --> 04:24:48,035 SHOULD BE ABLE TO CAPTURE 5638 04:24:48,035 --> 04:24:50,771 INFORMATION RELATED TO RACE, 5639 04:24:50,771 --> 04:24:53,240 ETHNICITY AND SOCIOECONOMIC 5640 04:24:53,240 --> 04:24:55,176 STATUS OF PATIENTS AND SHOULD BE 5641 04:24:55,176 --> 04:24:57,878 INCLUDED SO WE CAN IDENTIFY 5642 04:24:57,878 --> 04:25:00,314 WHICH PATIENTS MAY BE AT GREATER 5643 04:25:00,314 --> 04:25:03,351 RISK FOR NONCOMPLIANCE. NEXT 5644 04:25:03,351 --> 04:25:03,651 SLIDE. 5645 04:25:03,651 --> 04:25:05,219 LET ME GO THROUGH SOME OF 5646 04:25:05,219 --> 04:25:09,023 THE DEFINITIONS. NEXT SLIDE. 5647 04:25:09,023 --> 04:25:11,592 HEALTHY PEOPLE 2030 IS A FEDERAL 5648 04:25:11,592 --> 04:25:14,795 INITIATIVE. IT IS VERY 5649 04:25:14,795 --> 04:25:17,131 INTERESTING. THE RATIONALE FOR 5650 04:25:17,131 --> 04:25:19,066 HEALTHY PEOPLE IS TO HAVE AN 5651 04:25:19,066 --> 04:25:21,402 IDEA OF GOALS OVER A DECADE THAT 5652 04:25:21,402 --> 04:25:23,437 HAVE TO BE PURSUED TO MAXIMIZE 5653 04:25:23,437 --> 04:25:25,006 THE WELL-BEING AND QUALITY OF 5654 04:25:25,006 --> 04:25:27,942 LIFE OF INDIVIDUALS. HEALTHY 5655 04:25:27,942 --> 04:25:29,577 PEOPLE HAVE DIFFERENT DOMAINS. 5656 04:25:29,577 --> 04:25:34,181 FOCUS ON HEALTH CARE EQUALITY, 5657 04:25:34,181 --> 04:25:37,284 HEALTH CARE DISPARITIESES AND 5658 04:25:37,284 --> 04:25:37,952 SOCIAL DETERMINANTS OF HEALTH. 5659 04:25:37,952 --> 04:25:38,285 NEXT SLIDE. 5660 04:25:38,285 --> 04:25:39,854 WHEN COMES TO SOCIAL 5661 04:25:39,854 --> 04:25:41,555 DETERMINANTS OF HEALTH THEY HAVE 5662 04:25:41,555 --> 04:25:45,359 FIVE DOMAINS THAT PERTAIN TO 5663 04:25:45,359 --> 04:25:47,561 ECONOMIC INSTABILITY. UNDER THE 5664 04:25:47,561 --> 04:25:48,896 ASSUMPTION THAT INDIVIDUALS WHO 5665 04:25:48,896 --> 04:25:51,465 HAVE A DIFFERENT INCOME TO 5666 04:25:51,465 --> 04:25:53,768 SATISFY THAT ARE BASIC NEEDS TO 5667 04:25:53,768 --> 04:25:56,170 STAY HEALTHY. BY STAYING HEALTHY 5668 04:25:56,170 --> 04:25:58,139 THATTING WITH BEING IS 5669 04:25:58,139 --> 04:26:00,341 PRESERVED. THE SECOND COMPONENT 5670 04:26:00,341 --> 04:26:02,076 OF SOCIAL DETERMINANTS OF HEALTH 5671 04:26:02,076 --> 04:26:03,444 COMES TO EDUCATION ACCESS. IT 5672 04:26:03,444 --> 04:26:06,313 GOES WITH A SIMILAR CONCEPT. 5673 04:26:06,313 --> 04:26:07,581 INDIVIDUALS WHO HAVE HIGH LEVELS 5674 04:26:07,581 --> 04:26:08,983 OF EDUCATION ARE MORE LIKELY TO 5675 04:26:08,983 --> 04:26:11,852 STAY HEALTHY. THERE IS A STRONG 5676 04:26:11,852 --> 04:26:14,121 DATA SUPPORTING THAT ASSUMPTION. 5677 04:26:14,121 --> 04:26:16,657 A THIRD COMPONENT IS EQUAL 5678 04:26:16,657 --> 04:26:18,859 ACCESS TO HEALTH CARE UNDER THE 5679 04:26:18,859 --> 04:26:20,728 ASSUMPTION, ONCE AGAIN, THAT 5680 04:26:20,728 --> 04:26:23,431 WHOEVER NEEDS ACCESS TO HEALTH 5681 04:26:23,431 --> 04:26:26,967 CARE CAN DO SO WITHOUT AFFECTING 5682 04:26:26,967 --> 04:26:31,405 THEIR FAMILIAR ECONOMY OR SO. 5683 04:26:31,405 --> 04:26:35,242 THE TWO NEXT THINGS THAT ARE 5684 04:26:35,242 --> 04:26:37,678 IMPORTANT IS SAFETY OF 5685 04:26:37,678 --> 04:26:39,213 ENVIRONMENT INDIVIDUALS GROW 5686 04:26:39,213 --> 04:26:42,983 WITH. THOSE ARE COMPONENTS OF 5687 04:26:42,983 --> 04:26:43,617 SOCIAL DETERMINANTS OF HEALTH. 5688 04:26:43,617 --> 04:26:47,621 NEXT SLIDE, PLEASE. WHEN WE TALK 5689 04:26:47,621 --> 04:26:54,829 ABOUT PAH (?) WE TALK ABOUT 5690 04:26:54,829 --> 04:26:58,999 INTER PLAY BETWEEN BIOLOGY AND 5691 04:26:58,999 --> 04:27:03,270 SOCIOECONOMIC FACTORS OF RACIAL 5692 04:27:03,270 --> 04:27:05,740 AND ECONOMIC FACTORS SO LET ME 5693 04:27:05,740 --> 04:27:07,241 TELL YOU ABOUT SOME OF THE DATA 5694 04:27:07,241 --> 04:27:12,246 WHEN COMES TO INTERPLAY BETWEEN 5695 04:27:12,246 --> 04:27:15,416 DISEASE AND SOME OF THE 5696 04:27:15,416 --> 04:27:17,752 SOCIOECONOMIC FACTORS. WHEN I 5697 04:27:17,752 --> 04:27:19,487 GIVE THIS TALK I REFER TO THIS 5698 04:27:19,487 --> 04:27:21,856 MAP. IT IS RELATIVELY OUTDATED. 5699 04:27:21,856 --> 04:27:23,657 WE DON'T HAVE UPDATED YET BUT 5700 04:27:23,657 --> 04:27:26,594 REFERS TO SEGREGATION. IT OCCURS 5701 04:27:26,594 --> 04:27:28,429 IN THE UNITED STATES. BY THAT I 5702 04:27:28,429 --> 04:27:30,498 MEAN PARTS OF U.S. WHERE 5703 04:27:30,498 --> 04:27:31,565 MINORITIES LIVE IN A DIFFERENT 5704 04:27:31,565 --> 04:27:37,304 PART OF TOWN, THE AREAS YOU SEE 5705 04:27:37,304 --> 04:27:43,244 IN PURPLE OR LILAC HAVE HIGH 5706 04:27:43,244 --> 04:27:46,714 INCIDENCE OF SEGREGATION AND 5707 04:27:46,714 --> 04:27:48,048 BLUE ARE WHERE COMMUNITIES 5708 04:27:48,048 --> 04:27:50,518 INTEGRATE VERY WELL. NEXT SLIDE. 5709 04:27:50,518 --> 04:27:52,186 SO WHEN COMES TO BALTIMORE, 5710 04:27:52,186 --> 04:27:55,022 WHERE SOME ARE LOCATED, DOWNTOWN 5711 04:27:55,022 --> 04:27:56,857 BALTIMORE IS HIGHLY SEGREGATED 5712 04:27:56,857 --> 04:27:59,260 AREA AND ACCOUNTS FOR MOST AREAS 5713 04:27:59,260 --> 04:28:00,995 IN THE UNITED STATES. THAT IS 5714 04:28:00,995 --> 04:28:04,165 IMPORTANT TO KEEP IN MIND. AS WE 5715 04:28:04,165 --> 04:28:06,100 TRY UNDERSTAND DIFFERENCES THAT 5716 04:28:06,100 --> 04:28:08,536 COME WITH A CONCEPT OF RACE OR 5717 04:28:08,536 --> 04:28:11,772 ETHNICITY, THOSE HAVE TO BE 5718 04:28:11,772 --> 04:28:18,546 ACCOUNTED FOR THIS LEVEL BECAUSE 5719 04:28:18,546 --> 04:28:21,148 WHEN THEY SEGREGATE, WHICH MOST 5720 04:28:21,148 --> 04:28:22,449 ARE. EXPOSURES ARE DIFFERENT. TO 5721 04:28:22,449 --> 04:28:26,187 POLLUTION, TO CRIME, TO ACCESS 5722 04:28:26,187 --> 04:28:29,957 TO HEALTHY OR -- WITH AMERICANS 5723 04:28:29,957 --> 04:28:31,926 WITH HEALTHY FOOD, THOSE 5724 04:28:31,926 --> 04:28:40,401 DIFFERENCES AFFECT QUALITY UNDER 5725 04:28:40,401 --> 04:28:44,305 WHICH TOGETHER. NEXT SLIDE. WHEN 5726 04:28:44,305 --> 04:28:46,140 WE TRY TO UNDERSTAND 5727 04:28:46,140 --> 04:28:47,308 DIFFERENCES, THEY RELATE NOT 5728 04:28:47,308 --> 04:28:49,009 JUST TO COLOR OF INDIVIDUAL BUT 5729 04:28:49,009 --> 04:28:51,312 RELATE TO DIFFERENCES ABOUT SEX 5730 04:28:51,312 --> 04:28:53,814 AND GENDER AS PRIOR SPEAKERS 5731 04:28:53,814 --> 04:28:55,449 EMPHASIZE ABOUT IT. THEY COME TO 5732 04:28:55,449 --> 04:28:58,319 DIFFERENCES ABOUT GENETICS AND 5733 04:28:58,319 --> 04:29:01,055 BIOLOGY OF SOCIOECONOMIC STATUS, 5734 04:29:01,055 --> 04:29:02,556 ENVIRONMENTAL EXPOSURES, 5735 04:29:02,556 --> 04:29:04,491 DIFFERENCES IN ACCESS TO HEALTH 5736 04:29:04,491 --> 04:29:06,694 CARE, TO EXPOSURE OF THE LEVEL 5737 04:29:06,694 --> 04:29:10,397 AND DIFFERENCES IN LIFESTYLE. 5738 04:29:10,397 --> 04:29:11,799 NEXT SLIDE. 5739 04:29:11,799 --> 04:29:15,769 ONCE AGAIN, WE HAVE FIVE 5740 04:29:15,769 --> 04:29:16,370 DOMAINS WHEN COMES TO SOCIAL 5741 04:29:16,370 --> 04:29:18,205 DETERMINANTS OF HEALTH. WE HAVE 5742 04:29:18,205 --> 04:29:20,341 EDUCATION, ACCESS TO HEALTH 5743 04:29:20,341 --> 04:29:22,276 CARE, SAFETY OF YOUR 5744 04:29:22,276 --> 04:29:24,178 NEIGHBORHOOD, THE SUPPORT 5745 04:29:24,178 --> 04:29:25,746 SUPPORT AND ECONOMIC STABILITY. 5746 04:29:25,746 --> 04:29:27,681 THE NEXT SLIDE. 5747 04:29:27,681 --> 04:29:34,054 NOT SO LONG AGO WITH (?) 5748 04:29:34,054 --> 04:29:35,823 NGOS FROM CINCINNATI WE TRY HAVE 5749 04:29:35,823 --> 04:29:39,560 DIFFERENT APPROACH, SOMETHING WE 5750 04:29:39,560 --> 04:29:41,295 REFER TO AS NOVEL SOCIAL 5751 04:29:41,295 --> 04:29:41,929 DETERMINANTS OF HEALTH, WHICH 5752 04:29:41,929 --> 04:29:44,965 HAVE CERTAIN VARIATIONS OF 5753 04:29:44,965 --> 04:29:46,133 CERTAIN SOCIAL DETERMINANTS OF 5754 04:29:46,133 --> 04:29:48,068 HEALTH THAT PERHAPS APPLY WITH 5755 04:29:48,068 --> 04:29:50,204 MORE PRECISION TO MINORITIES 5756 04:29:50,204 --> 04:29:53,140 WITH PROBLEMATIC HYPERTENSION. 5757 04:29:53,140 --> 04:29:56,377 AND SOME OF PRIOR SPEAKERS HAVE 5758 04:29:56,377 --> 04:29:57,778 REFERRED TO THIS BUT RELATED TO 5759 04:29:57,778 --> 04:30:01,015 DIFFERENCES IN ENVIRONMENTAL 5760 04:30:01,015 --> 04:30:03,684 EXPOSURE FOR INDIVIDUALS WHO ARE 5761 04:30:03,684 --> 04:30:05,753 (?) AND FACTORS THAT AFFECT 5762 04:30:05,753 --> 04:30:08,255 ACCESS TO HEALTH CARE RELATED TO 5763 04:30:08,255 --> 04:30:11,425 IMMIGRATION STATUS OR LANGUAGE 5764 04:30:11,425 --> 04:30:12,626 BARRIERS, DIFFERENCES IN HEALTH 5765 04:30:12,626 --> 04:30:14,862 CARE, DIFFERENCES IN MENTAL 5766 04:30:14,862 --> 04:30:15,996 HEALTH AND TRANSPORTATION AND 5767 04:30:15,996 --> 04:30:19,400 ALL THESE FACTORS COMBINED. ALL 5768 04:30:19,400 --> 04:30:21,302 COMPLEMENT EACH OTHER AND 5769 04:30:21,302 --> 04:30:23,671 CONSTITUTE OPTIMAL MEDICAL CARE 5770 04:30:23,671 --> 04:30:26,073 BARRIERS TO ENGAGEMENT CLINICAL 5771 04:30:26,073 --> 04:30:27,775 TRIALS PARTICIPATION, 5772 04:30:27,775 --> 04:30:29,076 DIFFERENCES ADHERENCE TO 5773 04:30:29,076 --> 04:30:30,644 TREATMENT AND DIFFERENCES IN 5774 04:30:30,644 --> 04:30:32,913 CONTINUITY OF CARE. THE NEXT 5775 04:30:32,913 --> 04:30:33,414 SLIDE. 5776 04:30:33,414 --> 04:30:34,982 LET ME TELL YOU ABOUT WHAT 5777 04:30:34,982 --> 04:30:37,451 WE KNOW ABOUT SOCIOECONOMICS AND 5778 04:30:37,451 --> 04:30:41,622 HYPERTENSION. BACK IN 2013, 12 5779 04:30:41,622 --> 04:30:42,489 YEARS AGO, STUDY ON 200 PATIENTS 5780 04:30:42,489 --> 04:30:44,591 FROM CHINA SHOWED THAT 5781 04:30:44,591 --> 04:30:49,663 INDIVIDUALS AT THE LOWER TILE OF 5782 04:30:49,663 --> 04:30:50,564 SOCIOECONOMIC STATUS HAS LOWER 5783 04:30:50,564 --> 04:30:53,133 AS COMPARED TO TWO OTHER 5784 04:30:53,133 --> 04:30:54,835 DETAILS. DIFFERENCES PERSISTED 5785 04:30:54,835 --> 04:30:59,106 EVEN IF YOU ARE JUST FOR OTHER 5786 04:30:59,106 --> 04:31:08,415 VARIABLES SUCH AS (AUDIO 5787 04:31:08,415 --> 04:31:10,117 INTERRUPTION) BACK IN 2016 A 5788 04:31:10,117 --> 04:31:12,319 STUDY FROM USING DATA FROM LARGE 5789 04:31:12,319 --> 04:31:13,687 HOSPITAL SYSTEM IN NEW YORK 5790 04:31:13,687 --> 04:31:15,556 FOUND INDIVIDUALS WITH THE 5791 04:31:15,556 --> 04:31:17,224 LOWEST ANNUAL INCOME WERE MORE 5792 04:31:17,224 --> 04:31:18,692 LIKELY TO PRESENT WITH MORE 5793 04:31:18,692 --> 04:31:20,494 SEVERE SYMPTOMS SO INDIVIDUALS 5794 04:31:20,494 --> 04:31:22,763 WITH LOWEST INCOMES, THEY WERE 5795 04:31:22,763 --> 04:31:25,666 MORE LIKELY TO PRESENT WITH 5796 04:31:25,666 --> 04:31:27,901 FUNCTIONAL CLASS 3 OR 4 5797 04:31:27,901 --> 04:31:32,806 SYMPTOMS. THE NEXT SLIDE. 5798 04:31:32,806 --> 04:31:35,876 HOWEVER, IN TWO STUDIES IN 5799 04:31:35,876 --> 04:31:39,680 EUROPE, PARTICULARLY SCOTLAND, 5800 04:31:39,680 --> 04:31:43,550 THESE PRIOR FAMILIES WERE (?) 5801 04:31:43,550 --> 04:31:46,353 DIFFERENCES IN SURVIVAL BASED ON 5802 04:31:46,353 --> 04:31:47,888 SOCIOECONOMIC STATUS WERE NOT 5803 04:31:47,888 --> 04:31:51,258 SEEN AND ALSO NO DIFFERENCES 5804 04:31:51,258 --> 04:31:55,462 WHEN COMES TO SEVERITY OF 5805 04:31:55,462 --> 04:31:57,865 SYMPTOMS THAT WERE FOUND. SO WE 5806 04:31:57,865 --> 04:32:02,403 HAVE SOME CONFLICT DATA. WE USE 5807 04:32:02,403 --> 04:32:04,505 DATA FROM THE HYPERTENSION 5808 04:32:04,505 --> 04:32:06,507 INDUSTRY TO NOTE THE 5809 04:32:06,507 --> 04:32:10,010 SIGNIFICANCE OF POVERTY AND 5810 04:32:10,010 --> 04:32:17,885 SOCIAL DEPRIVATION. WE USED DATA 5811 04:32:17,885 --> 04:32:20,320 FROM THE FOG. IT IS A GREAT 5812 04:32:20,320 --> 04:32:21,355 REGISTRY, AS MENTIONED BEFORE, 5813 04:32:21,355 --> 04:32:24,525 BECAUSE THE SYSTEM COLLECTS DATA 5814 04:32:24,525 --> 04:32:25,526 ON SOCIAL DETERMINANTS OF HEALTH 5815 04:32:25,526 --> 04:32:28,796 AND SOCIAL DEMOGRAPHICS. NEXT 5816 04:32:28,796 --> 04:32:29,029 SLIDE. 5817 04:32:29,029 --> 04:32:31,632 FOR THIS ANALYSIS WE ARE 5818 04:32:31,632 --> 04:32:32,800 USING THE ABSOLUTE DIFFERENCE. 5819 04:32:32,800 --> 04:32:34,535 FOR THOSE OF YOU NOT VERY 5820 04:32:34,535 --> 04:32:37,037 FAMILIAR WITH THE STANDARD OF 5821 04:32:37,037 --> 04:32:40,607 DIFFERENCES, ANY VALUE GREATER 5822 04:32:40,607 --> 04:32:41,909 THAN.25, THERE IS A DIFFERENCE 5823 04:32:41,909 --> 04:32:45,279 BETWEEN THOSE TWO GROUPS SO THE 5824 04:32:45,279 --> 04:32:47,181 VALUE OF THE ASD MORE THAN 5825 04:32:47,181 --> 04:32:48,782 LIKELY THERE IS A DIFFERENCE IN 5826 04:32:48,782 --> 04:32:51,251 THE TWO GROUPS. WHAT WE FIND IS 5827 04:32:51,251 --> 04:32:53,954 INDIVIDUALS IN POVERTY ARE LESS 5828 04:32:53,954 --> 04:32:55,789 LIKELY TO HAVE PRIVATE 5829 04:32:55,789 --> 04:32:58,826 INSURANCE, MORE LIKELY TO HAVE 5830 04:32:58,826 --> 04:33:00,527 MEDICAID. ARE INDIVIDUALS LIVING 5831 04:33:00,527 --> 04:33:01,995 UNDER FEDERAL POVERTY LEVELS ARE 5832 04:33:01,995 --> 04:33:07,134 MORE LIKELY TO BE UNEMPLOYED. WE 5833 04:33:07,134 --> 04:33:10,370 SEE ALSO INDIVIDUALS HAVE HIGHER 5834 04:33:10,370 --> 04:33:15,075 FREQUENCY OF REPORTED 5835 04:33:15,075 --> 04:33:16,910 METHAMPHETAMINE USE. WE SEE THAT 5836 04:33:16,910 --> 04:33:20,080 INDIVIDUALS LIVING UNDER FEDERAL 5837 04:33:20,080 --> 04:33:23,817 POVERTY LEVELS HAVE SUGGESTS 5838 04:33:23,817 --> 04:33:26,487 MORE SOCIAL DEPRIVATION WHETHER 5839 04:33:26,487 --> 04:33:28,655 THE SBA OR SOCIAL INDEX WHERE 5840 04:33:28,655 --> 04:33:30,023 HIGHER VALUES WERE FOUND 5841 04:33:30,023 --> 04:33:32,059 INDIVIDUALS LIVING UNDER POVERTY 5842 04:33:32,059 --> 04:33:36,263 LEVELS. THE NEXT SLIDE. 5843 04:33:36,263 --> 04:33:38,465 SOMETHING THAT WE WANTED TO 5844 04:33:38,465 --> 04:33:40,200 SPECIFICALLY STUDY IN THIS 5845 04:33:40,200 --> 04:33:43,237 ANALYSIS WAS TO SEE THAT OTHER 5846 04:33:43,237 --> 04:33:44,238 OF HEALTH CARE INDIVIDUALS IN 5847 04:33:44,238 --> 04:33:46,874 POVERTY OR NOT IN POVERTY. WHAT 5848 04:33:46,874 --> 04:33:50,777 WE FOUND, SIMILAR TO A STUDY I 5849 04:33:50,777 --> 04:33:52,880 WILL TELL YOU LATER TODAY, IS 5850 04:33:52,880 --> 04:33:56,250 INDIVIDUALS IN POVERTY ARE MORE 5851 04:33:56,250 --> 04:33:59,987 LIKELY TO GO TO THE EMERGENCY 5852 04:33:59,987 --> 04:34:01,655 ROOM OR GET HOSPITALIZED THAN 5853 04:34:01,655 --> 04:34:08,061 INDIVIDUALS NOT IN POVERTY. THE 5854 04:34:08,061 --> 04:34:09,897 NEXT SLIDE. WE DON'T SEE 5855 04:34:09,897 --> 04:34:11,064 DIFFERENCES IN SURVIVAL. THE 5856 04:34:11,064 --> 04:34:13,400 CURVE IS BETTER SORT OF POVERTY, 5857 04:34:13,400 --> 04:34:16,537 THIS DIFFERENCE IN CURVES BY THE 5858 04:34:16,537 --> 04:34:18,972 LONG-RUN DID NOT REACH A 5859 04:34:18,972 --> 04:34:20,073 STATISTICAL SIGNIFICANCE. THE 5860 04:34:20,073 --> 04:34:21,241 NEXT SLIDE. 5861 04:34:21,241 --> 04:34:23,343 WHEN WE USE DIFFERENT METRIC 5862 04:34:23,343 --> 04:34:25,812 OF SOCIAL PREVENTIONS SUCH AS 5863 04:34:25,812 --> 04:34:28,682 THE SOCIAL MOBILITY INDEX OR 5864 04:34:28,682 --> 04:34:31,084 FAMILY INCOME RATIO WE DO NOT 5865 04:34:31,084 --> 04:34:33,053 SEE THESE DIFFERENCES. SO 5866 04:34:33,053 --> 04:34:36,757 OVERALL WE SEE INDIVIDUALS 5867 04:34:36,757 --> 04:34:38,292 LIVING UNDER POVERTY LEVEL, EVEN 5868 04:34:38,292 --> 04:34:40,928 IF THEY HAVE A PATTERN OF 5869 04:34:40,928 --> 04:34:42,529 ILLNESS THEY HAVE HIGHER 5870 04:34:42,529 --> 04:34:43,230 FREQUENCIES OF GOING TO AN 5871 04:34:43,230 --> 04:34:46,934 EMERGENCY ROOM OR GETTING 5872 04:34:46,934 --> 04:34:52,239 HOSPITALIZED. THE NEXT SLIDE. 5873 04:34:52,239 --> 04:34:54,141 LET ME TELL YOU WHAT WE KNOW 5874 04:34:54,141 --> 04:34:56,143 BETWEEN RACE, ETHNICITY AND 5875 04:34:56,143 --> 04:35:00,881 SOCIOECONOMIC FACTORS. THE NEXT 5876 04:35:00,881 --> 04:35:02,716 SLIDE. 5877 04:35:02,716 --> 04:35:05,953 (?) REFERRED TO THIS STUDY, 5878 04:35:05,953 --> 04:35:07,955 A PAPER LED BY THE INDIANA 5879 04:35:07,955 --> 04:35:09,756 UNIVERSITY. IT IS A VERY ELEGANT 5880 04:35:09,756 --> 04:35:14,795 STUDY WHERE THEY USED DATA FROM 5881 04:35:14,795 --> 04:35:19,266 PAH BUT ALSO FROM (?) AND USE 5882 04:35:19,266 --> 04:35:24,905 DATA FROM UNIVERSITY (?) NEXT 5883 04:35:24,905 --> 04:35:25,772 SLIDE. 5884 04:35:25,772 --> 04:35:30,077 WHAT THEY FOUND IS HISPANIC 5885 04:35:30,077 --> 04:35:33,380 PATIENTS WITH PAH HAVE BETTER 5886 04:35:33,380 --> 04:35:35,716 SURVIVAL THAN NON-HISPANIC OR 5887 04:35:35,716 --> 04:35:37,951 NON-HISPANIC BLACK PATIENTS. 5888 04:35:37,951 --> 04:35:38,318 NEXT SLIDE. 5889 04:35:38,318 --> 04:35:45,792 SIMILAR PATTERN WAS SEEN BY 5890 04:35:45,792 --> 04:35:47,494 SANDEEP SAHAY FROM HOUSTON 5891 04:35:47,494 --> 04:35:51,331 METHODIST. NEXT SLIDE. IN THIS 5892 04:35:51,331 --> 04:35:53,033 SPECIFIC ANALYSIS IT WAS 5893 04:35:53,033 --> 04:35:55,269 HISPANIC INDIVIDUALS WILL HAVE 5894 04:35:55,269 --> 04:35:57,104 BETTER SURVIVAL OR DO IN THIS 5895 04:35:57,104 --> 04:36:00,274 MUCH LARGER STUDY USING DATA, 5896 04:36:00,274 --> 04:36:02,442 ONCE THEY ADJUSTED FOR AGE OF 5897 04:36:02,442 --> 04:36:04,845 INDIVIDUALS OR SUB TYPE OF PAH, 5898 04:36:04,845 --> 04:36:06,380 DIFFERENCES IN SURVIVOR WERE NO 5899 04:36:06,380 --> 04:36:14,087 LONGER SEEN. NEXT SLIDE. ALSO 5900 04:36:14,087 --> 04:36:16,290 MENTION THIS STUDY FROM PATIENTS 5901 04:36:16,290 --> 04:36:18,925 THAT BELONG TO TWO HOSPITAL 5902 04:36:18,925 --> 04:36:20,193 SYSTEMS WHICH ARE DUKE AND 5903 04:36:20,193 --> 04:36:23,964 CLEVELAND CLINIC, NEXT SLIDE. 5904 04:36:23,964 --> 04:36:26,433 IN THIS SPECIFIC STUDY THEY 5905 04:36:26,433 --> 04:36:30,437 SHOW THAT BLACK PATIENTS HAD 5906 04:36:30,437 --> 04:36:33,507 BETTER SURVIVAL THAN WHITE 5907 04:36:33,507 --> 04:36:36,076 INDIVIDUALS IN THE (?) ANALYSIS, 5908 04:36:36,076 --> 04:36:38,045 TAKING INTO ACCOUNT THE 5909 04:36:38,045 --> 04:36:40,647 INSURANCE OF INDIVIDUALS. THIS 5910 04:36:40,647 --> 04:36:43,817 DIFFERENCES DISAPPEARED, WHICH 5911 04:36:43,817 --> 04:36:45,919 LED TO HYPOTHESIZE THAT PERHAPS 5912 04:36:45,919 --> 04:36:47,654 ANY DIFFERENCE RELATED TO RACE 5913 04:36:47,654 --> 04:36:58,165 AND ETHNICITY HAS TO BE ACCO 5914 04:36:58,165 --> 04:37:00,967 ACCOUNTED. WITH THE STANFORD 5915 04:37:00,967 --> 04:37:03,470 GROUP AND STEVEN KAYWOOD WE USED 5916 04:37:03,470 --> 04:37:05,172 DATA FROM THE FAR A FEW YEARS 5917 04:37:05,172 --> 04:37:08,342 AGO AND WANTED TO ASSESS 5918 04:37:08,342 --> 04:37:10,444 DIFFERENCE IN SURVIVAL IN 5919 04:37:10,444 --> 04:37:13,980 HISPANIC PATIENTS WITH PAH BUT 5920 04:37:13,980 --> 04:37:15,282 WANTED TO CONDUCT THE SOCIAL 5921 04:37:15,282 --> 04:37:16,883 DEMOGRAPHIC AND PROFILE OF THE 5922 04:37:16,883 --> 04:37:20,354 PATIENTS AND TO KNOW WHAT WAS 5923 04:37:20,354 --> 04:37:21,321 THE SIGNIFICANCE OF SOCIAL 5924 04:37:21,321 --> 04:37:21,922 DETERMINANTS OF HEALTH WHEN 5925 04:37:21,922 --> 04:37:24,458 COMES TO SURVIVAL. THE NEXT 5926 04:37:24,458 --> 04:37:24,691 SLIDE. 5927 04:37:24,691 --> 04:37:26,293 WE FOUND, AND NOT SURPRISING 5928 04:37:26,293 --> 04:37:28,228 TO ANY OF YOU, THAT HISPANIC 5929 04:37:28,228 --> 04:37:30,797 INDIVIDUALS HAD LOWER INCOME 5930 04:37:30,797 --> 04:37:32,632 THAN NON-HISPANIC. AS YOU CAN 5931 04:37:32,632 --> 04:37:34,868 SEE, UP TO A THIRD OF PATIENTS 5932 04:37:34,868 --> 04:37:39,539 HAD ANNUAL INCOME OF LESS THAN 5933 04:37:39,539 --> 04:37:41,007 $20,000. NEXT SLIDE. 5934 04:37:41,007 --> 04:37:42,776 WHEN COMES TO SURVIVAL YOU 5935 04:37:42,776 --> 04:37:44,745 HAVE ADJUSTED ANALYSIS SO YOU 5936 04:37:44,745 --> 04:37:46,046 SEE THE HISPANIC INDIVIDUALS. 5937 04:37:46,046 --> 04:37:48,115 HOWEVER ON RIGHT YOU CAN SEE THE 5938 04:37:48,115 --> 04:37:50,951 ADJUSTED CURVE WHERE WE DO A 5939 04:37:50,951 --> 04:37:55,522 MULTI VARIABLE ANALYSIS FOR AGE, 5940 04:37:55,522 --> 04:37:57,691 SEX, (?) EDUCATION LEVEL, INCOME 5941 04:37:57,691 --> 04:38:01,395 AND HEALTH INSURANCE. AFTER WE 5942 04:38:01,395 --> 04:38:03,196 ADJUST FOR THIS VARIABLES WE DO 5943 04:38:03,196 --> 04:38:05,732 NOT SEE ANY DIFFERENCES IN 5944 04:38:05,732 --> 04:38:07,634 SURVIVAL. THIS LED US TO 5945 04:38:07,634 --> 04:38:10,871 HYPOTHESIZE THAT ALTHOUGH IT IS 5946 04:38:10,871 --> 04:38:13,206 POSSIBLE THAT FOR DIFFERENT 5947 04:38:13,206 --> 04:38:15,208 BIOLOGICAL REASONS THAT HISPANIC 5948 04:38:15,208 --> 04:38:17,310 PATIENTS COULD HAVE BETTER 5949 04:38:17,310 --> 04:38:19,413 SURVIVAL. THE SIGNIFICANCE OF 5950 04:38:19,413 --> 04:38:21,314 THIS BETTER SURVIVAL IS 5951 04:38:21,314 --> 04:38:26,186 MITIGATED IN THE PRESENCE OF 5952 04:38:26,186 --> 04:38:28,455 SOCIAL DISADVANTAGE. NEXT SLIDE. 5953 04:38:28,455 --> 04:38:29,756 NOW LET ME TELL YOU ABOUT 5954 04:38:29,756 --> 04:38:31,758 SOME OF THE GAPS IN KNOWLEDGE WE 5955 04:38:31,758 --> 04:38:37,464 HAVE. THE NEXT SLIDE. 5956 04:38:37,464 --> 04:38:42,068 I BELIEVE SEEING THE 2017-18 5957 04:38:42,068 --> 04:38:43,403 STATEMENT THERE HAS BEEN 5958 04:38:43,403 --> 04:38:46,273 IMPROVEMENT AND INCREMENT ON 5959 04:38:46,273 --> 04:38:47,641 PUBLICATIONS LED TO HEALTH 5960 04:38:47,641 --> 04:38:49,776 QUALITY IN PAH BUT MOST STUDIES 5961 04:38:49,776 --> 04:38:51,578 HAVE BEEN FOCUSSING ON THE 5962 04:38:51,578 --> 04:38:52,913 HISPANIC POPULATION, WHICH IS 5963 04:38:52,913 --> 04:38:55,649 IMPORTANT TO DO SO. HISPANIC 5964 04:38:55,649 --> 04:38:57,317 PATIENTS PERCENT LARGEST 5965 04:38:57,317 --> 04:38:58,652 MINORITY GROUP IN THE U.S. BUT 5966 04:38:58,652 --> 04:39:00,053 THERE IS SO MUCH MORE WE DON'T 5967 04:39:00,053 --> 04:39:04,224 KNOW ABOUT OTHER MINORITY GROUPS 5968 04:39:04,224 --> 04:39:06,159 SUCH AS BLACK PATIENTS, BLACK 5969 04:39:06,159 --> 04:39:08,094 AMERICANS, ASIAN AMERICANS AND 5970 04:39:08,094 --> 04:39:10,030 NATIVE AMERICAN PATIENTS WITH 5971 04:39:10,030 --> 04:39:11,998 PH. THERE IS MORE THAN WE NEED 5972 04:39:11,998 --> 04:39:13,934 TO KNOW ABOUT THE SIGNIFICANCE 5973 04:39:13,934 --> 04:39:17,471 OF OMICS IN MINORITIES. I 5974 04:39:17,471 --> 04:39:20,440 BELIEVE DATA FROM PVDOMICS WILL 5975 04:39:20,440 --> 04:39:23,143 BE USEFUL TO UNDERSTAND THAT. WE 5976 04:39:23,143 --> 04:39:24,711 NEED TO UNDERSTAND WHAT IS 5977 04:39:24,711 --> 04:39:26,646 SIGNIFICANCE OF DIFFERENCES IN 5978 04:39:26,646 --> 04:39:27,981 GEOGRAPHIC OR ENVIRONMENTAL 5979 04:39:27,981 --> 04:39:29,749 EXPOSURES. WE NEED TO KNOW MORE 5980 04:39:29,749 --> 04:39:31,651 ABOUT PH OUTSIDE U.S. AND 5981 04:39:31,651 --> 04:39:34,120 OUTSIDE OF EUROPE. I THINK WE 5982 04:39:34,120 --> 04:39:40,093 ALSO NEED TO KNOW MORE ABOUT 5983 04:39:40,093 --> 04:39:41,428 DIFFERENCES IN DEMOGRAPHICS OF 5984 04:39:41,428 --> 04:39:50,504 ALL FORMS, NOT JUST PH OR CTIF. 5985 04:39:50,504 --> 04:39:51,605 I WILL FINALIZE THAT SOCIAL 5986 04:39:51,605 --> 04:39:54,608 DETERMINANTS OF HEALTH IS JUST A 5987 04:39:54,608 --> 04:39:57,310 COMPONENT OF DIFFERENCES, ACCESS 5988 04:39:57,310 --> 04:39:59,746 TO CARE OR DIFFERENCES OF HEALTH 5989 04:39:59,746 --> 04:40:03,850 CARE EQUALITY. BUT PERHAPS WHAT 5990 04:40:03,850 --> 04:40:07,354 MATTERS THE MOST IS HOW 5991 04:40:07,354 --> 04:40:08,955 INDIVIDUALS RECEIVE THESE AT THE 5992 04:40:08,955 --> 04:40:11,591 INDIVIDUAL LEVEL, MEANING IN THE 5993 04:40:11,591 --> 04:40:14,394 PRESENCE OF SOCIAL DISADVANTAGE, 5994 04:40:14,394 --> 04:40:17,163 WHAT IS THE COMMUNITY EFFECT ON 5995 04:40:17,163 --> 04:40:20,300 GLOBAL STRESS. WHAT IS THE 5996 04:40:20,300 --> 04:40:21,868 SIGNIFICANCE OF THESE CHRONIC 5997 04:40:21,868 --> 04:40:23,637 AND MITIGATED STRESS AT THE 5998 04:40:23,637 --> 04:40:24,871 INDIVIDUAL LEVEL. THERE ARE 5999 04:40:24,871 --> 04:40:26,439 DIFFERENT WAYS THAT CAN BE DONE. 6000 04:40:26,439 --> 04:40:28,141 I BELIEVE ONE OF THESE WAYS TO 6001 04:40:28,141 --> 04:40:33,213 DO SO COULD BE THE ALOSTATIC 6002 04:40:33,213 --> 04:40:35,081 LOAD, REFERRING TO A MEASUREMENT 6003 04:40:35,081 --> 04:40:37,751 OF GLOBAL STRESS THAT IS 6004 04:40:37,751 --> 04:40:44,457 REFLECTED BY HYPERACTIVITY. YOUR 6005 04:40:44,457 --> 04:40:45,525 SYMPATHETIC SYSTEM. OUR GROUP 6006 04:40:45,525 --> 04:40:47,360 GOT FUNDED TO STUDY DIFFERENCE 6007 04:40:47,360 --> 04:40:54,467 OF ALOSTATIC LOADS IN HISPANIC 6008 04:40:54,467 --> 04:40:56,369 PATIENTS WITH PAH AND I'M VERY 6009 04:40:56,369 --> 04:40:59,306 MUCH LOOKING FORWARD TO HEAR THE 6010 04:40:59,306 --> 04:41:00,774 NEXT THREE PRESENTATIONS AND THE 6011 04:41:00,774 --> 04:41:05,178 PRESENTATION BY DR. JASON GLENN 6012 04:41:05,178 --> 04:41:05,845 TOMORROW. NEXT SLIDE. 6013 04:41:05,845 --> 04:41:07,881 AS A SUMMARY MINORITIES HAD 6014 04:41:07,881 --> 04:41:09,883 ANNUAL PERCENTAGE IN PAH 6015 04:41:09,883 --> 04:41:11,918 REGISTRIES IN CLINICAL TRIALS 6016 04:41:11,918 --> 04:41:14,020 AND RACE, ETHNICITY AND 6017 04:41:14,020 --> 04:41:15,755 SOCIOECONOMIC FACTORS NEED TO BE 6018 04:41:15,755 --> 04:41:16,756 CONSIDERED WHEN ASSESSING 6019 04:41:16,756 --> 04:41:18,425 INDIVIDUAL OF RISK AND HAS TO BE 6020 04:41:18,425 --> 04:41:20,694 MUCH MORE AWARENESS ABOUT WHAT 6021 04:41:20,694 --> 04:41:23,930 CAN WE DO AS A GLOBAL LEVEL. 6022 04:41:23,930 --> 04:41:25,765 NEXT SLIDE. THANK YOU TO MY 6023 04:41:25,765 --> 04:41:27,100 COLLABORATORS. I THINK WE CAN DO 6024 04:41:27,100 --> 04:41:32,872 A FEW QUESTIONS. NEXT SLIDE. 6025 04:41:32,872 --> 04:41:33,340 THANK YOU. 6026 04:41:33,340 --> 04:41:35,942 >> THANK YOU VERY MUCH, DR. 6027 04:41:35,942 --> 04:41:39,412 BERNARDO. THAT WAS EXCELLENT 6028 04:41:39,412 --> 04:41:41,948 OVERVIEW OF THE SOCIAL 6029 04:41:41,948 --> 04:41:45,218 DETERMINANTS, HOW THEY INTERACT 6030 04:41:45,218 --> 04:41:47,887 WITH HEALTH CARE DISPARITIES AND 6031 04:41:47,887 --> 04:41:49,322 PH. YOU BROUGHT UP ESSENTIALLY 6032 04:41:49,322 --> 04:41:51,224 SEVERAL STUDIES, INCLUDING YOUR 6033 04:41:51,224 --> 04:41:54,761 OWN WITH THE FAR, THAT LOOK AT 6034 04:41:54,761 --> 04:41:55,795 WHEN CONTROLLING -- OF COURSE 6035 04:41:55,795 --> 04:41:56,930 THIS IS PARTICULAR I THINK TO 6036 04:41:56,930 --> 04:41:59,032 THE HISPANIC POPULATION. YOU 6037 04:41:59,032 --> 04:42:01,801 ALLUDED TO SOMETHING WITH THE 6038 04:42:01,801 --> 04:42:08,308 BLACK POPULATION AS WELL. IN 6039 04:42:08,308 --> 04:42:09,809 MODELS, WHEN LOOKING AT 6040 04:42:09,809 --> 04:42:15,415 MULTI -VARIANT MODELS AND 6041 04:42:15,415 --> 04:42:16,850 CONTROLLING FOR SOCIOECONOMIC 6042 04:42:16,850 --> 04:42:22,389 DETERMINANTS YOU SEE SOME OF THE 6043 04:42:22,389 --> 04:42:25,825 RACIAL DISPARITIES ARE NOW 6044 04:42:25,825 --> 04:42:26,893 NON-SIGNIFICANT. IS THAT TRUE TO 6045 04:42:26,893 --> 04:42:28,028 YOUR RESULTS? 6046 04:42:28,028 --> 04:42:29,996 >> YES. ONE OF THE THINGS WE 6047 04:42:29,996 --> 04:42:32,032 NEED TO KEEP IN MIND, BASED ON 6048 04:42:32,032 --> 04:42:34,200 STUDIES WE HAVE DONE, IS WE ARE 6049 04:42:34,200 --> 04:42:40,807 USING DATA FROM THE FAR THAT 6050 04:42:40,807 --> 04:42:43,943 ALTHOUGH I CONSIDER IT THE BEST 6051 04:42:43,943 --> 04:42:50,617 REGISTRY TO UNDERSTAND BEST 6052 04:42:50,617 --> 04:42:51,551 REGISTRY TO UNITED STATES SOCIAL 6053 04:42:51,551 --> 04:42:55,088 DETERMINANTS OF HEALTH ARE 6054 04:42:55,088 --> 04:42:56,122 PATIENTS THAT RECEIVE FROM 6055 04:42:56,122 --> 04:42:57,524 CENTERS OF EXCELLENCE SO DATA 6056 04:42:57,524 --> 04:42:59,059 THAT MAY NOT NECESSARILY REFLECT 6057 04:42:59,059 --> 04:43:01,094 IN THE COMMUNITY OR HAVE MORE 6058 04:43:01,094 --> 04:43:02,262 DIFFICULTIES IN ACCESSING THESE 6059 04:43:02,262 --> 04:43:07,801 TYPE OF CENTERS. SO IT IS 6060 04:43:07,801 --> 04:43:11,271 POSSIBLE THAT WHAT WE DON'T FIND 6061 04:43:11,271 --> 04:43:12,138 DIFFERENCE IN SURVIVAL WHEN 6062 04:43:12,138 --> 04:43:14,441 COMES TO RACE, ETHNICITY AND 6063 04:43:14,441 --> 04:43:20,180 FEDERAL POVERTY LEVELS, PERHAPS 6064 04:43:20,180 --> 04:43:23,683 THAT IS DUE PATIENTS ARE FINALLY 6065 04:43:23,683 --> 04:43:26,119 GETTING STANDARD OF CARE FOR PAH 6066 04:43:26,119 --> 04:43:27,654 PATIENTS. COULD BE DIFFERENT 6067 04:43:27,654 --> 04:43:29,022 REALITY FOR PATIENTS THAT EITHER 6068 04:43:29,022 --> 04:43:32,125 ARE NOT GETTING DIAGNOSED YET OR 6069 04:43:32,125 --> 04:43:35,762 INSURANCES OR PROVIDERS DON'T 6070 04:43:35,762 --> 04:43:38,098 KNOW HOW TO MAKE PROPER WAY TO 6071 04:43:38,098 --> 04:43:41,534 SEND PATIENTS TO CENTERS OF MORE 6072 04:43:41,534 --> 04:43:42,602 EXPERIENCE IN PAH. 6073 04:43:42,602 --> 04:43:46,840 >> THAT IS A FAIR POINT. ONE OF 6074 04:43:46,840 --> 04:43:51,444 MY QUESTIONS TO YOU IS ASSUMING 6075 04:43:51,444 --> 04:43:58,084 THAT POTENTIALLY SOCIOECONOMIC 6076 04:43:58,084 --> 04:44:01,788 STATUS OR SOCIAL DETERMINANTS 6077 04:44:01,788 --> 04:44:04,190 ARE MEDIATORS OF RACIAL 6078 04:44:04,190 --> 04:44:07,427 DIFFERENCES OR ETHNIC 6079 04:44:07,427 --> 04:44:10,130 DIFFERENCES, STRUCTURAL RACISM 6080 04:44:10,130 --> 04:44:13,066 BEING AN PREACH TO STUDIES, OF 6081 04:44:13,066 --> 04:44:15,902 COURSE WHICH IS AN IMPORTANT 6082 04:44:15,902 --> 04:44:17,337 QUESTION AND THEREFORE IN THAT 6083 04:44:17,337 --> 04:44:20,106 CONTEXT PERHAPS IT IS USEFUL TO 6084 04:44:20,106 --> 04:44:23,910 INVESTIGATE RACE. BUT PERHAPS IS 6085 04:44:23,910 --> 04:44:27,547 IT EQUALLY OR PERHAPS MORE 6086 04:44:27,547 --> 04:44:33,486 IMPORTANT THAT WE IDENTIFY THE 6087 04:44:33,486 --> 04:44:36,055 SOCIAL DETERMINANTS AS MEDIATORS 6088 04:44:36,055 --> 04:44:40,093 OF THE OUTCOMES THAN NECESSARILY 6089 04:44:40,093 --> 04:44:44,197 DIVERTING OUR ATTENTION TO 6090 04:44:44,197 --> 04:44:47,567 CATEGORIZING SUBGROUPS WITHIN 6091 04:44:47,567 --> 04:44:55,008 RACE. DOES THAT MAKE SENSE? 6092 04:44:55,008 --> 04:44:58,311 >> ON THE TOPIC, I WAS READING A 6093 04:44:58,311 --> 04:44:59,179 MEDICAL YESTERDAY ABOUT 6094 04:44:59,179 --> 04:45:02,482 MEDIATION ANALYSIS ABOUT THE 6095 04:45:02,482 --> 04:45:05,885 MECHANISMS THAT DRIVE HEALTH 6096 04:45:05,885 --> 04:45:09,455 CARE INEQUALITY. WHILE SOCIAL 6097 04:45:09,455 --> 04:45:10,056 DETERMINANTS OF HEALTH MAY 6098 04:45:10,056 --> 04:45:12,625 EXPLAIN PARTIALLY SOME OF THE 6099 04:45:12,625 --> 04:45:14,327 DIFFERENCES, MEANING BARRIERS OF 6100 04:45:14,327 --> 04:45:16,930 INDIVIDUALS SAY IS TO GET PROPER 6101 04:45:16,930 --> 04:45:18,565 ACCESS TO HEALTH CARE, THERE ARE 6102 04:45:18,565 --> 04:45:22,101 OTHER COMPONENTS THAT CERTAINLY 6103 04:45:22,101 --> 04:45:23,803 MATTER PERHAPS THE SAME OR SOME 6104 04:45:23,803 --> 04:45:27,106 PERHAPS MORE SUCH AS ONE OF THE 6105 04:45:27,106 --> 04:45:31,744 SPEAKERS ALLUDED TO TODAY THAT 6106 04:45:31,744 --> 04:45:34,614 MICRO-TRAUMA, STRESS, SYSTEMIC 6107 04:45:34,614 --> 04:45:37,784 RACISM, DISCRIMINATION, THESE 6108 04:45:37,784 --> 04:45:40,553 OTHER FACTORS THAT PERHAPS 6109 04:45:40,553 --> 04:45:42,622 RELATED MORE TO HOW INTERVIEWER 6110 04:45:42,622 --> 04:45:44,224 PERCEIVES THESE BARE YERS AND 6111 04:45:44,224 --> 04:45:47,460 HOW ALL THESE FACTORS AFFECT 6112 04:45:47,460 --> 04:45:48,661 WELL-BEING OF AN INDIVIDUAL MAY 6113 04:45:48,661 --> 04:45:53,833 HAVE A HIGHER IMPACT INTO THEIR 6114 04:45:53,833 --> 04:45:56,970 DECISION AND HOW THEY ADAPT TO 6115 04:45:56,970 --> 04:46:00,473 THIS. PART OF THE REASON FOR THE 6116 04:46:00,473 --> 04:46:02,508 ALOSTATIC LOAD CONCEPT, 6117 04:46:02,508 --> 04:46:03,910 MEASURING MECHANISM DRIVING 6118 04:46:03,910 --> 04:46:06,613 HEALTH CARE AND EQUALITY IS 6119 04:46:06,613 --> 04:46:10,583 MEASURING MORE ABOUT THE GLOBAL 6120 04:46:10,583 --> 04:46:11,618 UNMITIGATED DISTRESS INDIVIDUALS 6121 04:46:11,618 --> 04:46:15,688 ARE FACING ON A DAILY BASIS. 6122 04:46:15,688 --> 04:46:17,624 THIS SIGNIFICANT STRESS THEY 6123 04:46:17,624 --> 04:46:19,092 FACE MAY PLAY A ROLE INTO HOW 6124 04:46:19,092 --> 04:46:23,863 THEY HAVE A MALADAPTIVE RESPONSE 6125 04:46:23,863 --> 04:46:26,599 TO A CERTAIN PHASE. 6126 04:46:26,599 --> 04:46:31,037 >> THANK YOU. 6127 04:46:31,037 --> 04:46:32,939 >> I WAS INTERESTED IN DATA YOU 6128 04:46:32,939 --> 04:46:35,575 WERE SHOWING, NO DIFFERENCES IN 6129 04:46:35,575 --> 04:46:36,476 TRANSPLANT-FREE SURVIVAL BETWEEN 6130 04:46:36,476 --> 04:46:37,377 DIFFERENT GROUPS WHEN LOOKING AT 6131 04:46:37,377 --> 04:46:40,346 SOME OF THE -- AFTER LOOKING AT 6132 04:46:40,346 --> 04:46:41,514 SOCIOECONOMIC FACTORS AND 6133 04:46:41,514 --> 04:46:43,616 LOOKING AT POVERTY, ET CETERA. 6134 04:46:43,616 --> 04:46:45,652 BUT IT RAISES THE QUESTION, IS 6135 04:46:45,652 --> 04:46:47,654 THAT THE WRONG METRIC TO LOOK AT 6136 04:46:47,654 --> 04:46:51,090 AND SHOULD WE BE LOOKING AT SOME 6137 04:46:51,090 --> 04:46:54,827 MORE LIKE -- MORBIDITY BURDEN? 6138 04:46:54,827 --> 04:46:57,297 SO THAT, YOU KNOW, IF -- 6139 04:46:57,297 --> 04:46:59,065 REGARDLESS OF THE FACT THERE IS 6140 04:46:59,065 --> 04:47:02,001 NO DIFFERENCE IN TRANSPLANT-FREE 6141 04:47:02,001 --> 04:47:03,136 SURVIVAL, ARE THESE PATIENTS 6142 04:47:03,136 --> 04:47:05,939 LIVING THE SAME LIVES TO GET TO 6143 04:47:05,939 --> 04:47:07,607 THAT END POINT BEFORE -- FOR 6144 04:47:07,607 --> 04:47:13,112 THOSE THAT DON'T GET TO THAT END 6145 04:47:13,112 --> 04:47:16,416 POINT, I SHOULD SAY. 6146 04:47:16,416 --> 04:47:18,918 >> I WILL ANSWER THE QUESTION, 6147 04:47:18,918 --> 04:47:20,386 JANE. MAYBE A SIMILAR AMOUNT BUT 6148 04:47:20,386 --> 04:47:22,188 THE WAY THEY LIVE IS PROBABLY 6149 04:47:22,188 --> 04:47:23,790 MORE IMPAIRED. THE FACT THEY ARE 6150 04:47:23,790 --> 04:47:26,893 GOING TO THE EMERGENCY ROOM OR 6151 04:47:26,893 --> 04:47:28,928 GETTING HOSPITALIZED MORE 6152 04:47:28,928 --> 04:47:30,396 FREQUENT MAY SUGGEST THEIR 6153 04:47:30,396 --> 04:47:31,831 DEFICIENCIES ARE NOT PROPERLY 6154 04:47:31,831 --> 04:47:34,000 CONTROLLED. YES, THEY LIVE THE 6155 04:47:34,000 --> 04:47:35,902 SAME BUT THEIR QUALITY OF LIFE 6156 04:47:35,902 --> 04:47:38,471 MAYBE BE FURTHER IMPAIRED WITH 6157 04:47:38,471 --> 04:47:39,672 AT LEAST BASELINE. THEY HAVE 6158 04:47:39,672 --> 04:47:44,110 MORE IMPAIRED QUALITY OF LIFE 6159 04:47:44,110 --> 04:47:45,311 METRICS. BUT ALSO IT RAISES THE 6160 04:47:45,311 --> 04:47:47,013 QUESTION, WHY ARE THESE PATIENTS 6161 04:47:47,013 --> 04:47:47,947 GETTING HOSPITALIZED MORE 6162 04:47:47,947 --> 04:47:52,018 FREQUENT OR GOING O THE ER MORE 6163 04:47:52,018 --> 04:47:54,887 FREQUENT? IS THIS BECAUSE IS NOT 6164 04:47:54,887 --> 04:47:56,022 OPTIMALLY CONTROLLED OR BECAUSE 6165 04:47:56,022 --> 04:47:58,324 THEY ARE HAVING MORE BARRIERS OR 6166 04:47:58,324 --> 04:48:01,627 DIFFICULTIES FROM GETTING ACCESS 6167 04:48:01,627 --> 04:48:05,365 TO COME FROM PROVIDERS. BECAUSE 6168 04:48:05,365 --> 04:48:06,466 IDEALLY WHEN PATIENTS NEEDS 6169 04:48:06,466 --> 04:48:08,134 HAVING MORE SYMPTOMS OR SO, WE 6170 04:48:08,134 --> 04:48:09,535 EXPECT THEM TO CALL OUR CENTER 6171 04:48:09,535 --> 04:48:13,673 SO WE CAN PROVIDE SOME ADVICE OR 6172 04:48:13,673 --> 04:48:16,242 DO SOME TESTING OR ADJUST 6173 04:48:16,242 --> 04:48:18,378 MEDICATIONS TO PREVENT THEM FROM 6174 04:48:18,378 --> 04:48:20,747 HAVING TO GET TREATED. PERHAPS 6175 04:48:20,747 --> 04:48:22,048 MINORITIES ARE FACING BARRIERS 6176 04:48:22,048 --> 04:48:24,217 ABOUT THIS. INCLUDING PATIENTS 6177 04:48:24,217 --> 04:48:26,552 LIVING AT THE POVERTY LEVELS. WE 6178 04:48:26,552 --> 04:48:28,921 DON'T KNOW. I DON'T AGREE THAT 6179 04:48:28,921 --> 04:48:31,491 SURVIVAL MAY NOT BE THE BEST 6180 04:48:31,491 --> 04:48:36,629 METRIC TO ASSESS (BELL) A 6181 04:48:36,629 --> 04:48:38,131 SIGNIFICANCE OF HEALTH CARE 6182 04:48:38,131 --> 04:48:39,198 DISPARITIES. 6183 04:48:39,198 --> 04:48:41,501 >> HAS SOMEONE GONE BACK AND 6184 04:48:41,501 --> 04:48:47,040 SOMETHING SIMPLE LIKE 6185 04:48:47,040 --> 04:48:47,673 CALCULATING THE CHARLESTON 6186 04:48:47,673 --> 04:48:50,843 MORBIDITY INDEX TO SEE IF THERE 6187 04:48:50,843 --> 04:48:57,617 ARE DIFFERENCES DESPITE THE 6188 04:48:57,617 --> 04:49:03,189 (AUDIO INTERRUPTION) MAKES 6189 04:49:03,189 --> 04:49:03,423 SENSE. 6190 04:49:03,423 --> 04:49:09,228 >> DR. SANDEEP, QUESTION? 6191 04:49:09,228 --> 04:49:11,230 >> I WAS WONDERING ABOUT 6192 04:49:11,230 --> 04:49:13,399 SURVIVAL. THESE ARE MULTIPLE 6193 04:49:13,399 --> 04:49:17,970 STUDIES. ANALYSIS, YOUR FOREIGN 6194 04:49:17,970 --> 04:49:19,405 ANALYSIS AND I GUESS THERE WAS 6195 04:49:19,405 --> 04:49:20,540 ANOTHER PAPER. NONE ARE REALLY 6196 04:49:20,540 --> 04:49:22,809 SHOWING THAT RACE-BASED 6197 04:49:22,809 --> 04:49:25,445 DIFFERENCES IN THE SURVIVAL. BUT 6198 04:49:25,445 --> 04:49:28,781 I AGREE WITH YOU THAT ISSUES NOT 6199 04:49:28,781 --> 04:49:31,984 JUST THE SURVIVAL BUT THERE ARE 6200 04:49:31,984 --> 04:49:34,821 MULTIPLE ISSUES LIKE EARLIER 6201 04:49:34,821 --> 04:49:38,157 THIS MORNING THIS WAS ABOUT 6202 04:49:38,157 --> 04:49:41,627 INVOLVEMENT IN ENROLLMENT IN 6203 04:49:41,627 --> 04:49:43,362 TRIALS, ISSUES AND CLINICAL 6204 04:49:43,362 --> 04:49:44,897 TRIALS. SO THAT IS ONE ISSUE. 6205 04:49:44,897 --> 04:49:47,233 DON'T KNOW IF THERE IS DATA 6206 04:49:47,233 --> 04:49:48,935 ABOUT -- PARTICULARLY FOR 6207 04:49:48,935 --> 04:49:49,535 HOSPITALIZATION OR ANYTHING 6208 04:49:49,535 --> 04:49:54,040 BECAUSE IF YOU ARE LOOKING 6209 04:49:54,040 --> 04:49:55,975 PARTICULARLY AT HOSPITALIZATION, 6210 04:49:55,975 --> 04:49:59,445 THEN THEY KNOW THAT SHOULD -- 6211 04:49:59,445 --> 04:50:01,781 SURVIVAL AS WELL. WE SHOULD SEE 6212 04:50:01,781 --> 04:50:03,516 SOME DIFFERENCE IN SURVIVAL. I 6213 04:50:03,516 --> 04:50:07,286 DON'T KNOW WHAT IS THE RIGHT 6214 04:50:07,286 --> 04:50:09,489 ANSWER. I GUESS WE NEED TO LOOK 6215 04:50:09,489 --> 04:50:11,290 BACK INTO THESE DATABASES AGAIN, 6216 04:50:11,290 --> 04:50:13,593 WHY WE ARE NOT SEEING THAT 6217 04:50:13,593 --> 04:50:14,861 SURVIVAL DIFFERENCES. DESPITE OF 6218 04:50:14,861 --> 04:50:18,898 IF WE ARE SAYING THAT 6219 04:50:18,898 --> 04:50:20,099 AFRICAN-AMERICAN, HISPANIC OR 6220 04:50:20,099 --> 04:50:21,567 MINORITIES ARE HAVING MORE 6221 04:50:21,567 --> 04:50:25,738 HOSPITALIZATION, ER VISITS OR IF 6222 04:50:25,738 --> 04:50:30,309 THESE ARE PH LETTER WHY NO 6223 04:50:30,309 --> 04:50:33,679 IMPACT ON SURVIVAL COMPARED TO 6224 04:50:33,679 --> 04:50:34,413 EFFECTS CONSIDERED AS 6225 04:50:34,413 --> 04:50:34,747 CONTROLLED. 6226 04:50:34,747 --> 04:50:37,049 >> THAT IS A GREAT QUESTION, 6227 04:50:37,049 --> 04:50:38,484 SANDEEP. I DON'T HAVE AN ANSWER. 6228 04:50:38,484 --> 04:50:40,119 >> I DON'T HAVE AN ANSWER 6229 04:50:40,119 --> 04:50:42,922 EITHER. BUT I DO BELIEVE THAT 6230 04:50:42,922 --> 04:50:46,192 THERE IS SOMETHING PROBABLY WE 6231 04:50:46,192 --> 04:50:51,931 ARE NOT LOOKING CLEARLY. I SEE 6232 04:50:51,931 --> 04:50:53,533 (?) IS ONLINE BECAUSE HE HAS 6233 04:50:53,533 --> 04:50:55,334 ANALYSIS FOR THAT. I KNOW ABOUT 6234 04:50:55,334 --> 04:50:56,769 IT. GO AHEAD. YOU TALK ABOUT 6235 04:50:56,769 --> 04:50:57,670 YOUR PAPER. 6236 04:50:57,670 --> 04:50:59,705 >> NO, NO, THAT IS OKAY. I LOVE 6237 04:50:59,705 --> 04:51:01,607 THE DISCUSSION. I THINK IT IS 6238 04:51:01,607 --> 04:51:02,775 REALLY IMPORTANT. I DON'T MEAN 6239 04:51:02,775 --> 04:51:08,247 TO CUT YOU GUYS OFF EITHER. I 6240 04:51:08,247 --> 04:51:11,317 THINK THAT SOMEONE WHO DOESN'T 6241 04:51:11,317 --> 04:51:13,686 DO MUCH CLINICAL RESEARCH, I 6242 04:51:13,686 --> 04:51:16,189 WILL HAVE TO DO SOME BASIC 6243 04:51:16,189 --> 04:51:18,591 TRAINING TO UNDERSTAND PRIMARY, 6244 04:51:18,591 --> 04:51:20,092 SECONDARY ENDPOINTS AND WHAT ARE 6245 04:51:20,092 --> 04:51:21,994 THE ENDPOINTS WE NEED TO LOOK AT 6246 04:51:21,994 --> 04:51:23,796 WHEN LOOKING AT POPULATION-LEVEL 6247 04:51:23,796 --> 04:51:25,164 STUDIES. ONE OF THE THINGS I 6248 04:51:25,164 --> 04:51:27,433 LEARNED IS MORTALITY IS ALMOST A 6249 04:51:27,433 --> 04:51:31,404 DREAM WHEN WE TALK ABOUT -- AS 6250 04:51:31,404 --> 04:51:35,474 AN ENDPOINT FOR CARDIOVASCULAR 6251 04:51:35,474 --> 04:51:36,576 DISEASE, ESPECIALLY IF YOU LOOK 6252 04:51:36,576 --> 04:51:39,779 AT THE CLINICAL TRIALS. WE NEVER 6253 04:51:39,779 --> 04:51:41,214 SAY MOST DRUGS LOOK ANYTHING 6254 04:51:41,214 --> 04:51:42,048 LIKE MORTALITY BECAUSE WE DON'T 6255 04:51:42,048 --> 04:51:43,583 HAVE THE POWER. THEN WHEN WE 6256 04:51:43,583 --> 04:51:47,253 TALK ABOUT MORTALITY IN A RARE 6257 04:51:47,253 --> 04:51:49,422 DISEASE IN A SUB POPULATION THAT 6258 04:51:49,422 --> 04:51:52,858 HAS BARELY BEEN REGISTERED, I 6259 04:51:52,858 --> 04:51:55,361 THINK WE HAVE TO BE VERY CAREFUL 6260 04:51:55,361 --> 04:51:57,196 ABOUT OUR CONCLUSIONS. ONE OF 6261 04:51:57,196 --> 04:52:00,399 THE THINGS I HAVE BEEN DINGED 6262 04:52:00,399 --> 04:52:02,668 FOR IN MY PAST HAS BEEN 6263 04:52:02,668 --> 04:52:04,937 OVERCORRECTING AND 6264 04:52:04,937 --> 04:52:06,672 OVERADJUSTING. IF YOU LOOK AT 6265 04:52:06,672 --> 04:52:09,075 YOUR SAMPLE POPULATION ACROSS 6266 04:52:09,075 --> 04:52:12,345 ALL THESE PAPERS, WE ARE TALKING 6267 04:52:12,345 --> 04:52:16,482 A SAMPLE SIZE OF 50 TO 150 6268 04:52:16,482 --> 04:52:18,918 HISPANIC PATIENTS, WHICH HOW 6269 04:52:18,918 --> 04:52:22,388 MANY ACTUALLY DIED. THEN WHEN 6270 04:52:22,388 --> 04:52:24,824 YOU TRY TO START ADDRESSING 6271 04:52:24,824 --> 04:52:26,392 VARIOUS VARIABLES THAT CORRECT 6272 04:52:26,392 --> 04:52:29,328 FOR MORTALITY, I THINK ANY 6273 04:52:29,328 --> 04:52:31,063 NEGATIVE OR POSITIVE DATA, YOU 6274 04:52:31,063 --> 04:52:33,165 HAVE TO BE A LITTLE CAREFUL 6275 04:52:33,165 --> 04:52:34,967 ABOUT WHAT THAT REALLY MEANS. 6276 04:52:34,967 --> 04:52:39,071 YOU KNOW, I DON'T WANT TO -- I 6277 04:52:39,071 --> 04:52:42,008 THINK IT IS ONE OF MY GAPS. I 6278 04:52:42,008 --> 04:52:43,843 THINK WE NEED TO DO A LOT MORE 6279 04:52:43,843 --> 04:52:45,111 STUDIES WHERE OUR SAMPLE SIZE 6280 04:52:45,111 --> 04:52:47,113 WILL HOPEFULLY EVOLVE AND GROW, 6281 04:52:47,113 --> 04:52:54,420 SO WE CAN LOOK AT SOME OF THESE. 6282 04:52:54,420 --> 04:52:58,324 THE UNADJUSTED REMAINS 6283 04:52:58,324 --> 04:52:59,792 DIFFERENT. DESPITE ALL THE 6284 04:52:59,792 --> 04:53:02,161 NOISE, DESPITE THE VARIOUS 6285 04:53:02,161 --> 04:53:04,330 COHORTS. SO, YOU KNOW, WE WILL 6286 04:53:04,330 --> 04:53:05,831 GO INTO MORE OF THIS DISCUSSION 6287 04:53:05,831 --> 04:53:07,033 TOMORROW. I WOULD SAY I DON'T 6288 04:53:07,033 --> 04:53:09,101 KNOW IF WE KNOW THE ANSWER BUT I 6289 04:53:09,101 --> 04:53:12,171 THINK THERE IS A LOT MORE HERE 6290 04:53:12,171 --> 04:53:14,640 THE DISCUSS. I'M REALLY GLAD WE 6291 04:53:14,640 --> 04:53:15,574 ARE HAVING THAT DISCUSSION. 6292 04:53:15,574 --> 04:53:19,845 >> I AGREE WITH YOU. BECAUSE IN 6293 04:53:19,845 --> 04:53:22,281 REVEAL ANALYSIS WHEN WE DID THE 6294 04:53:22,281 --> 04:53:25,017 SURVIVE, WHEN YOU LOOK AT THE 6295 04:53:25,017 --> 04:53:27,820 ORIGINAL PAPER FROM REVEAL, LED 6296 04:53:27,820 --> 04:53:33,125 BY FARBAR, THAT WAS SURVIVAL FOR 6297 04:53:33,125 --> 04:53:35,594 CAUCASIAN POPULATION. BUT OUR 6298 04:53:35,594 --> 04:53:37,830 ANALYSIS DID NOT. THE DIFFERENCE 6299 04:53:37,830 --> 04:53:43,135 WAS BECAUSE ADJUSTED FOR AGE AND 6300 04:53:43,135 --> 04:53:45,037 TYPE. JUST ONE MORE THING. WE 6301 04:53:45,037 --> 04:53:48,307 DID NOT FIND. BUT YOU ARE -- IF 6302 04:53:48,307 --> 04:53:51,911 YOU LOOK AT THE SAMPLE SIZE FOR 6303 04:53:51,911 --> 04:53:53,913 AGING POPULATION, IN THAT IT IS 6304 04:53:53,913 --> 04:53:57,016 LIKE 104 OR 150 PEOPLE. 6305 04:53:57,016 --> 04:54:03,255 CAUCASIAN WAS LIKE AROUND 2,500 6306 04:54:03,255 --> 04:54:03,856 AND AFRICAN-AMERICAN SAW LIKE 6307 04:54:03,856 --> 04:54:05,257 800. LITERALLY LESS THAN HALF. 6308 04:54:05,257 --> 04:54:07,326 REST ARE EVEN LESS THAN THAT. 6309 04:54:07,326 --> 04:54:10,796 PROBABLY NUMBER OF EVENTS ARE 6310 04:54:10,796 --> 04:54:11,831 MUCH LESS. 6311 04:54:11,831 --> 04:54:14,333 >> (?) YOU AND I HAVE SPOKE 6312 04:54:14,333 --> 04:54:17,269 BEFORE. EVEN IF WE DO A META 6313 04:54:17,269 --> 04:54:19,939 ANALYSIS, COMBINE THREE 6314 04:54:19,939 --> 04:54:24,910 REGISTRIES OR SO, THE FORMATION 6315 04:54:24,910 --> 04:54:30,616 BETWEEN REGISTRIES MAKES THESE 6316 04:54:30,616 --> 04:54:33,486 COMBINATION OF DIFFERENT 6317 04:54:33,486 --> 04:54:37,256 DATASETS DIFFICULT. BUT IN THE 6318 04:54:37,256 --> 04:54:38,424 ANALYSIS HISPANIC PATIENTS SEEM 6319 04:54:38,424 --> 04:54:40,192 TO HAVE BETTER SURVIVAL, 6320 04:54:40,192 --> 04:54:41,026 WHATEVER THE MECHANISM OR 6321 04:54:41,026 --> 04:54:42,628 WHATEVER WE ASSUME THAT IS. 6322 04:54:42,628 --> 04:54:45,965 >> I THINK ANKIT YOU BRING UP AN 6323 04:54:45,965 --> 04:54:47,233 INCREDIBLY IMPORTANT POINT. THIS 6324 04:54:47,233 --> 04:54:48,768 IS A GREAT DISCUSSION. I WANT TO 6325 04:54:48,768 --> 04:54:50,569 TABLE IT BECAUSE WE HAVE TO MOVE 6326 04:54:50,569 --> 04:54:53,339 ON. WE HAVE HAD SEVERAL 6327 04:54:53,339 --> 04:54:54,407 QUESTIONS ABOUT THE HISPANIC 6328 04:54:54,407 --> 04:54:57,777 PARADOX. ALSO I'M GOING TO COME 6329 04:54:57,777 --> 04:55:03,282 BACK TO THAT FROM THE 6330 04:55:03,282 --> 04:55:04,917 DISCUSSANTS. JUST TO SORT OF 6331 04:55:04,917 --> 04:55:08,087 REITERATE WHAT YOU ARE SAYING 6332 04:55:08,087 --> 04:55:10,356 AND IS -- I THINK IS INCREDIBLY 6333 04:55:10,356 --> 04:55:12,358 IMPORTANT WITH REGARD TO 6334 04:55:12,358 --> 04:55:15,060 ADJUSTMENT MODELS AND HOW THAT'S 6335 04:55:15,060 --> 04:55:17,363 -- I THINK WE SHOULD COME BACK 6336 04:55:17,363 --> 04:55:20,833 TO THAT POINT TOO ALSO. WE NEED 6337 04:55:20,833 --> 04:55:24,904 TO MOVE ON. SO LET'S MOVE ON TO 6338 04:55:24,904 --> 04:55:30,176 OUR NEXT TALK. IT IS ON SOCIAL 6339 04:55:30,176 --> 04:55:33,579 DISPARITIES, MENTAL HEALTH AND 6340 04:55:33,579 --> 04:55:41,120 RECREATIONAL DRUG USE BY DPEREZ 6341 04:55:41,120 --> 04:55:42,254 WHO DOES KNOW SOMETHING ABOUT 6342 04:55:42,254 --> 04:55:44,290 THIS. HE IS AT STANFORD, 6343 04:55:44,290 --> 04:55:47,493 ASSOCIATE DEAN OF ADMISSIONS AND 6344 04:55:47,493 --> 04:55:58,204 PROFESSOR OF MEDICINE. VENICIO. 6345 04:55:58,204 --> 04:56:00,840 >> THANK YOU. WE WILL TALK ABOUT 6346 04:56:00,840 --> 04:56:04,310 A LITTLE DIFFERENT OF THE TOPIC, 6347 04:56:04,310 --> 04:56:07,446 WHICH IS DRUGS. I REDEFINE TITLE 6348 04:56:07,446 --> 04:56:10,049 TO FOCUS ON SOCIAL DISPARITIES, 6349 04:56:10,049 --> 04:56:11,417 METHAMPHETAMINE USE. THAT IS 6350 04:56:11,417 --> 04:56:13,252 WHERE MY EXPERTISE LIES AND MOST 6351 04:56:13,252 --> 04:56:15,087 OF THE DATA I'M GOING SHARE WITH 6352 04:56:15,087 --> 04:56:16,989 YOU TODAY LIES. LET'S MOVE ON TO 6353 04:56:16,989 --> 04:56:20,860 THE NEXT SLIDE, PLEASE. I WILL 6354 04:56:20,860 --> 04:56:23,796 BEGIN AND END WITH THIS SLIDE. 6355 04:56:23,796 --> 04:56:27,066 THE EXPOSUM, A CONCEPT I WOULD 6356 04:56:27,066 --> 04:56:30,035 LIKE FOR US TO THINK ABOUT AND 6357 04:56:30,035 --> 04:56:32,671 HOPEFULLY INCORPORATE IN ALL THE 6358 04:56:32,671 --> 04:56:36,075 CONVERSATIONS MOVING FORWARD. 6359 04:56:36,075 --> 04:56:38,010 ESPECIALLY AFTER THIS WORKSHOP 6360 04:56:38,010 --> 04:56:39,545 BECAUSE IT INTEGRATES A LOT OF 6361 04:56:39,545 --> 04:56:41,514 WHAT WE HAVE BEEN DISCUSSING BUT 6362 04:56:41,514 --> 04:56:44,917 ALSO ADDS OTHER ELEMENTS THAT 6363 04:56:44,917 --> 04:56:47,853 ARE POTENTIAL MODIFIERS THAT 6364 04:56:47,853 --> 04:56:48,921 INFLUENCE HEALTH OF THE 6365 04:56:48,921 --> 04:56:50,089 POPULATION. WE HAVE BEEN TALKING 6366 04:56:50,089 --> 04:56:52,858 ABOUT SEX, WE HAVE BEEN TALKING 6367 04:56:52,858 --> 04:57:01,066 ABOUT SOCIAL DETERMINE NA 6368 04:57:01,066 --> 04:57:02,535 DETERMINANTS OF HEALTH. WE HAVE 6369 04:57:02,535 --> 04:57:04,703 SPOKEN FROM POLLUTION TO 6370 04:57:04,703 --> 04:57:06,772 POTENTIAL GEOGRAPHIC STRESSORS 6371 04:57:06,772 --> 04:57:10,809 RELATED TO THE WORK THAT THEY DO 6372 04:57:10,809 --> 04:57:12,278 RELATED TO THEIR -- EVEN BEFORE 6373 04:57:12,278 --> 04:57:18,817 THEY WERE BORN, RIGHT. SO 6374 04:57:18,817 --> 04:57:20,152 ULTIMATELY WE HAVE TO THINK OF 6375 04:57:20,152 --> 04:57:23,556 AN INDIVIDUAL IN THE SAME WAY WE 6376 04:57:23,556 --> 04:57:26,759 THINK ABOUT THE OMICS IN 6377 04:57:26,759 --> 04:57:27,693 PARTICULAR. FOR THIS COMPLEXITY 6378 04:57:27,693 --> 04:57:29,328 OF THE PATIENT, WE HAVE TO LOOK 6379 04:57:29,328 --> 04:57:30,763 ALSO AT THE COMPLEXITY OUTSIDE 6380 04:57:30,763 --> 04:57:32,531 OF THE PATIENT AS PART OF OUR 6381 04:57:32,531 --> 04:57:34,500 APPROACH. I'M GOING TO FOCUS ON 6382 04:57:34,500 --> 04:57:36,735 DRUGS BECAUSE THAT IS WHAT I 6383 04:57:36,735 --> 04:57:38,571 HAVE BEEN ASKED TO DISCUSS. 6384 04:57:38,571 --> 04:57:40,372 SINCE WE HAVEN'T TALKED ABOUT 6385 04:57:40,372 --> 04:57:43,842 THIS IN PARTICULAR I THINK IT IS 6386 04:57:43,842 --> 04:57:54,353 IMPORTANT SO WE CAN ACTUALLY 6387 04:57:55,521 --> 04:57:55,988 BROAD 6388 04:57:55,988 --> 04:57:57,189 BROAD -- BROADEN THE CONTEXT OF 6389 04:57:57,189 --> 04:58:00,392 WHAT WE HAVE BEEN TALKING ABOUT. 6390 04:58:00,392 --> 04:58:03,429 DRUGS ARE A PROBLEM AND FROM THE 6391 04:58:03,429 --> 04:58:05,331 SEVEN WORLD SYMPOSIUM AND 6392 04:58:05,331 --> 04:58:06,799 THERE'S QUITE A FEW DRUGS WE 6393 04:58:06,799 --> 04:58:11,604 HAVE COME TO RECOGNIZE, LIKE 6394 04:58:11,604 --> 04:58:18,711 AMENOREX, DEXT, FENFLOURAMINE 6395 04:58:18,711 --> 04:58:20,713 AND METHAMPHETAMINES. THESE 6396 04:58:20,713 --> 04:58:24,116 BELONG TO THE AMPHETAMINE 6397 04:58:24,116 --> 04:58:26,619 FAMILY. THIS IS WHAT I WANT TO 6398 04:58:26,619 --> 04:58:28,587 DEVOTE MY DISCUSSION. THIS 6399 04:58:28,587 --> 04:58:31,624 FAMILY OF DRUGS IS INTIMATELY 6400 04:58:31,624 --> 04:58:35,260 LINKED WITH PULMONARY 6401 04:58:35,260 --> 04:58:37,763 HYPERTENSION. UNLIKE THE OTHER 6402 04:58:37,763 --> 04:58:40,099 AGENTS IT IS PART OF THE 6403 04:58:40,099 --> 04:58:46,238 EVOLVING LANDSCAPE OF DRUG USE 6404 04:58:46,238 --> 04:58:48,741 IN THAT AMPHETAMINES HAVE 6405 04:58:48,741 --> 04:58:51,010 DEFINED THE 20TH CENTURY. 6406 04:58:51,010 --> 04:58:55,814 WHETHER IT IS WORLD WAR 1, WORLD 6407 04:58:55,814 --> 04:58:59,284 WAR II, PRESIDENTIAL 6408 04:58:59,284 --> 04:59:03,389 DECISIONS ABOUT THE CUBAN 6409 04:59:03,389 --> 04:59:05,024 MISSILE CRISIS, ART WORK, 6410 04:59:05,024 --> 04:59:06,091 AMPHETAMINES HAVE BEEN A BIG 6411 04:59:06,091 --> 04:59:07,793 PART. EVEN WHEN THEY ARE 6412 04:59:07,793 --> 04:59:11,096 OUTLAWED THEIR IMPACT REMAINS 6413 04:59:11,096 --> 04:59:13,832 UNSCATHED. IN FACT, WHAT WE ARE 6414 04:59:13,832 --> 04:59:21,774 SEEING NOW IS THE AFTERMATH OF 6415 04:59:21,774 --> 04:59:23,042 RECREATIONAL AND PRACTICAL 6416 04:59:23,042 --> 04:59:24,009 METHAMPHETAMINE USE THAT STARTED 6417 04:59:24,009 --> 04:59:25,811 EARLY IN THE 20TH CENTURY AND 6418 04:59:25,811 --> 04:59:29,815 SEE THAT SHOCK WAVE STILL TO 6419 04:59:29,815 --> 04:59:31,483 THIS DAY. NEXT SLIDE, PLEASE. 6420 04:59:31,483 --> 04:59:32,918 ALL RIGHT, SO WE ARE TALKING 6421 04:59:32,918 --> 04:59:34,353 ABOUT A GLOBAL PROBLEM. I WANT 6422 04:59:34,353 --> 04:59:36,922 TO START THERE BECAUSE IT IS 6423 04:59:36,922 --> 04:59:40,626 VERY EASY TO THINK THAT 6424 04:59:40,626 --> 04:59:44,496 AMPHETAMINE PROBLEM SAN AMERICAN 6425 04:59:44,496 --> 04:59:49,201 PROBLEM. IT IS NOT. TAKE A LOOK, 6426 04:59:49,201 --> 04:59:51,737 THIS IS 2021. THIS IS LEGAL AS 6427 04:59:51,737 --> 04:59:54,506 WELL AS ILLEGAL ABUSE. YOU ARE 6428 04:59:54,506 --> 04:59:56,208 NOT GOING TO SAY AS YOU SEE 6429 04:59:56,208 --> 04:59:59,845 CERTAINLY LEADS IN TERMS OF THE 6430 04:59:59,845 --> 05:00:01,280 GLOBAL PREVALENCE, BUT ACROSS 6431 05:00:01,280 --> 05:00:03,549 THE UNITED STATES -- THE WORLD 6432 05:00:03,549 --> 05:00:07,386 YOU CAN SEE THAT THERE ARE 6433 05:00:07,386 --> 05:00:09,321 CERTAIN FOLKS WHERE THE 6434 05:00:09,321 --> 05:00:18,363 PREVALENCE HAS EXPOUNDED. YOU 6435 05:00:18,363 --> 05:00:20,399 SEE THE CIRCLES EXPAND AS THE 6436 05:00:20,399 --> 05:00:22,501 RIPPLE EFFECT CONTINUES TO 6437 05:00:22,501 --> 05:00:24,269 EVOLVE. SO USE CONTINUES TO 6438 05:00:24,269 --> 05:00:27,940 INCREASE. IT DOESN'T REGRESS. 6439 05:00:27,940 --> 05:00:32,778 NEXT SLIDE, PLEASE. MY FOCUS ON 6440 05:00:32,778 --> 05:00:33,712 METHAMPHETAMINE, I HAVE BEEN 6441 05:00:33,712 --> 05:00:34,947 DEEPLY INVOLVED THERE THE CARE 6442 05:00:34,947 --> 05:00:38,450 OF THESE PATIENTS SINCE I 6443 05:00:38,450 --> 05:00:42,020 STARTED MY CAREER IN PULMONARY 6444 05:00:42,020 --> 05:00:44,323 CAREER AT STANFORD IN 2005. THIS 6445 05:00:44,323 --> 05:00:47,292 IS A TERRIBLE DISEASE. 6446 05:00:47,292 --> 05:00:48,994 METHAMPHETAMINE ADDICTION IS A 6447 05:00:48,994 --> 05:00:50,496 DISEASE. IT IS SOMETHING THAT IS 6448 05:00:50,496 --> 05:00:53,398 VERY DIFFICULT FOR THE PATIENT 6449 05:00:53,398 --> 05:00:55,434 TO KICK. IT REWRITES THE 6450 05:00:55,434 --> 05:00:57,402 COMPLETE LIFESTYLE OF THE 6451 05:00:57,402 --> 05:00:59,571 PATIENT AND ULTIMATELY, EVEN 6452 05:00:59,571 --> 05:01:04,209 THOUGH THE PATIENT IS LITERALLY 6453 05:01:04,209 --> 05:01:05,477 EXPERIENCES A COMPLETE 6454 05:01:05,477 --> 05:01:09,715 DEGRADATION OF MIND, BODY, 6455 05:01:09,715 --> 05:01:13,152 SPIRIT, THE PATIENT HAS A ROUGH 6456 05:01:13,152 --> 05:01:16,255 TIME KICKING THIS OUT. THIS IS 6457 05:01:16,255 --> 05:01:17,556 IMPORTANT, BECAUSE WHEN IT COMES 6458 05:01:17,556 --> 05:01:20,592 TO DEALING WITH THESE PATIENTS, 6459 05:01:20,592 --> 05:01:24,296 THEY ARE REALLY VULNERABLE TO 6460 05:01:24,296 --> 05:01:26,198 EVERY SINGLE SOCIAL DETERMINANT 6461 05:01:26,198 --> 05:01:29,334 YOU CAN THINK ABOUT. AND 6462 05:01:29,334 --> 05:01:30,369 ULTIMATELY, THEY ARE REALLY -- 6463 05:01:30,369 --> 05:01:34,807 YOU KNOW, THEY ARE REALLY AT THE 6464 05:01:34,807 --> 05:01:36,675 MERCY OF THIS DRUG WHEN IT COMES 6465 05:01:36,675 --> 05:01:40,646 TO DEFINING THE AMOUNT OF 6466 05:01:40,646 --> 05:01:45,617 BENEFIT THAT WE CAN OFFER WITH 6467 05:01:45,617 --> 05:01:47,352 OUR INTERVENTIONS. NEXT SLIDE, 6468 05:01:47,352 --> 05:01:47,586 PLEASE. 6469 05:01:47,586 --> 05:01:49,655 I WANT YOU TO LOOK CAREFULLY 6470 05:01:49,655 --> 05:01:51,824 AT THIS DATA. PROBABLY THE MOST 6471 05:01:51,824 --> 05:01:52,891 IMPORTANT SLIDE I'M GOING TO 6472 05:01:52,891 --> 05:01:54,293 SHOW YOU TODAY. LET'S START WITH 6473 05:01:54,293 --> 05:01:56,829 THE RIGHT SIDE. THIS IS THE 6474 05:01:56,829 --> 05:01:59,865 TREND OF METHAMPHETAMINE 6475 05:01:59,865 --> 05:02:03,535 ADMISSIONS IN THE UNITED STATES. 6476 05:02:03,535 --> 05:02:04,236 2010, 2017. LITTLE BIT OUTDATED 6477 05:02:04,236 --> 05:02:05,637 BUT I THINK THE INFORMATION IS 6478 05:02:05,637 --> 05:02:07,739 QUITE CLEAR. FIRST UP, IF YOU 6479 05:02:07,739 --> 05:02:09,374 LOOK ON THE RIGHT SIDE, YOU CAN 6480 05:02:09,374 --> 05:02:11,043 SEE THE TRENDS. INDEED, THE 6481 05:02:11,043 --> 05:02:15,581 WEST, WHERE I WORK, IS WHERE THE 6482 05:02:15,581 --> 05:02:17,716 PREVALENCE HAS BEEN INCREASING. 6483 05:02:17,716 --> 05:02:19,017 BUT I WANT YOU ALSO SEE THAT 6484 05:02:19,017 --> 05:02:22,855 OVER THE LAST COUPLE OF YEARS, 6485 05:02:22,855 --> 05:02:25,357 DURING THIS TIME, ADMISSIONS FOR 6486 05:02:25,357 --> 05:02:27,459 METH USE IN MIDWEST AND THE 6487 05:02:27,459 --> 05:02:29,661 SOUTH HAVE INCREASED. MOVING TO 6488 05:02:29,661 --> 05:02:33,565 THE LEFT, WHEN WE LOOK AT THE 6489 05:02:33,565 --> 05:02:37,302 DIFFERENCE OF RACES, YOU WILL 6490 05:02:37,302 --> 05:02:41,373 SEE THAT, YES, THE WHITES HAVE 6491 05:02:41,373 --> 05:02:49,114 CERTAINLY BEEN (AUDIO 6492 05:02:49,114 --> 05:02:50,749 INTERRUPTION) HAVE INCREASED. 6493 05:02:50,749 --> 05:02:52,918 FOR BLACKS A SMALL INCREASE. 6494 05:02:52,918 --> 05:02:53,785 INTERESTINGLY ENOUGH AMERICAN 6495 05:02:53,785 --> 05:02:55,287 INDIAN S HAVE EXPERIENCED 6496 05:02:55,287 --> 05:02:56,455 REMARKABLE INCREASE IN THE RATE 6497 05:02:56,455 --> 05:02:59,291 OF ADMISSIONS, AS WELL AS 6498 05:02:59,291 --> 05:03:00,826 HISPANICS. WHEN COMES TO AGE 6499 05:03:00,826 --> 05:03:03,428 THEY CAN LOOK AT THAT. ALL AGE 6500 05:03:03,428 --> 05:03:06,231 GROUPS, BUT PARTICULARLY AGES 6501 05:03:06,231 --> 05:03:11,436 BETWEEN 25 AND 34, 35, 44, THESE 6502 05:03:11,436 --> 05:03:12,938 ARE YOUNG PATIENTS. THESE ARE 6503 05:03:12,938 --> 05:03:18,043 NOT YOUR TRADITIONAL IPH, AGE OF 6504 05:03:18,043 --> 05:03:20,679 55. YOUNG PATIENTS. I WANT TO 6505 05:03:20,679 --> 05:03:23,615 POINT OUT, WHICH IS CONCERNING, 6506 05:03:23,615 --> 05:03:26,018 AGES 12 TO 17 AND 55 AND OLDER 6507 05:03:26,018 --> 05:03:27,519 ALSO ARE SHOWING INCREASES IN 6508 05:03:27,519 --> 05:03:29,187 THE RATE OF HOSPITALIZATION. SO 6509 05:03:29,187 --> 05:03:31,023 THIS IS A REAL CONCERN. BECAUSE 6510 05:03:31,023 --> 05:03:32,958 WE ARE SEEING YOUNG PATIENT 6511 05:03:32,958 --> 05:03:36,929 WHO'S ARE ALREADY GETTING PRIMED 6512 05:03:36,929 --> 05:03:40,332 POTENTIALLY TO BECOME ADDICTS 6513 05:03:40,332 --> 05:03:43,869 AND POTENTIAL PH PATIENTS. LAST 6514 05:03:43,869 --> 05:03:46,738 BUT NOT LEAST BOTH SEXES, THE 6515 05:03:46,738 --> 05:03:48,573 RATE OF HOSPITALIZATION HAS 6516 05:03:48,573 --> 05:03:49,708 INCREASED. LOOK CAREFULLY WHEN 6517 05:03:49,708 --> 05:03:50,943 YOU HAVE THE TIME. BECAUSE THIS 6518 05:03:50,943 --> 05:03:52,511 SHOWS YOU THE RAW REALITY OF 6519 05:03:52,511 --> 05:03:55,614 WHAT WE ARE DEALING WITH WITH 6520 05:03:55,614 --> 05:03:56,481 METHAMPHETAMINE USE CURRENTLY. 6521 05:03:56,481 --> 05:03:59,518 NEXT SLIDE, PLEASE. 6522 05:03:59,518 --> 05:04:04,189 DRUG OVERDOSES, THIS IS ALSO 6523 05:04:04,189 --> 05:04:05,290 REVEALING. YOU CAN SEE YOU CAN 6524 05:04:05,290 --> 05:04:06,558 CUT THE UNITED STATES IN HALF. 6525 05:04:06,558 --> 05:04:09,461 THIS GOES IN HAND WITH THE DATA 6526 05:04:09,461 --> 05:04:12,264 REGARDING PREVALENCE OF PH IN 6527 05:04:12,264 --> 05:04:13,865 THE UNITED STATES BASED ON 6528 05:04:13,865 --> 05:04:17,903 FARVA. YOU CAN SEE HOW IT IS 6529 05:04:17,903 --> 05:04:19,638 DIVIDED BETWEEN FENTANYL AND 6530 05:04:19,638 --> 05:04:21,440 METHAMPHETAMINE OVERDOSES. 6531 05:04:21,440 --> 05:04:23,141 UNITED STATES, THIS IS PERFECTLY 6532 05:04:23,141 --> 05:04:24,710 CLEAR. WHAT I CAN ALSO TELL YOU 6533 05:04:24,710 --> 05:04:26,478 IS, AGAIN, THE EVOLUTION SHOWS 6534 05:04:26,478 --> 05:04:30,015 YOU THAT METHAMPHETAMINE IS 6535 05:04:30,015 --> 05:04:31,984 MAKING A SLOW BUT STEADY MOVE 6536 05:04:31,984 --> 05:04:34,186 TOWARDS THE EAST. BUT KEEP THIS 6537 05:04:34,186 --> 05:04:37,389 IN MIND. METHAMPHETAMINE IS 6538 05:04:37,389 --> 05:04:41,760 ACTIVELY INVOLVED IN MANY 6539 05:04:41,760 --> 05:04:42,794 DEATHS. I MEAN THE DEVASTATION. 6540 05:04:42,794 --> 05:04:47,299 WHY IS THAT? IT IS NOT JUST PAH. 6541 05:04:47,299 --> 05:04:49,368 NEXT SLIDE, PLEASE. 6542 05:04:49,368 --> 05:04:53,872 THE PROBLEM HERE IS THAT 6543 05:04:53,872 --> 05:04:57,242 METHAMPHETAMINE IS PART OF A 6544 05:04:57,242 --> 05:04:59,845 ADDICTION CYCLE. THIS ADDICTION 6545 05:04:59,845 --> 05:05:04,249 CYCLE IS DOMINATED BY SOCIAL 6546 05:05:04,249 --> 05:05:06,685 DETERMINANTS THAT FAVOR THE 6547 05:05:06,685 --> 05:05:10,889 PATIENT ENGAGING AND IN THIS 6548 05:05:10,889 --> 05:05:12,724 DISEASE, SUCH AS DOMESTIC 6549 05:05:12,724 --> 05:05:14,860 VIOLENCE, FACTORS WE HAVE 6550 05:05:14,860 --> 05:05:15,927 DISCUSSED, LACK OF FAMILY 6551 05:05:15,927 --> 05:05:16,962 SUPPORT, WHERE THE PATIENT IS 6552 05:05:16,962 --> 05:05:18,563 LIVING, IMMIGRATION STATUS, 6553 05:05:18,563 --> 05:05:21,433 SOCIAL INJUSTICE, HOUSING, 6554 05:05:21,433 --> 05:05:23,435 SCHOOL, ACADEMIC FAILURE. IN 6555 05:05:23,435 --> 05:05:25,804 THIS DAY AND AGE WHEN 6556 05:05:25,804 --> 05:05:27,539 IMMIGRATION AND SOCIAL INJUSTICE 6557 05:05:27,539 --> 05:05:29,574 ARE SUCH A IMPORTANT PART OF OUR 6558 05:05:29,574 --> 05:05:31,009 POLITICAL JARGON YOU CAN IMAGINE 6559 05:05:31,009 --> 05:05:33,945 HOW VULNERABLE SOME INDIVIDUALS 6560 05:05:33,945 --> 05:05:42,087 ARE CURRENTLY TO ENTERING THIS 6561 05:05:42,087 --> 05:05:43,388 ONE THING THAT WE HAVEN'T 6562 05:05:43,388 --> 05:05:45,323 DISCUSSED AND HAS HAD A 6563 05:05:45,323 --> 05:05:47,893 REMARKABLE IMPACT IN OUR CULTURE 6564 05:05:47,893 --> 05:05:49,161 AND OUR PATIENT POPULATION IS 6565 05:05:49,161 --> 05:05:49,928 THE PANDEMIC. 6566 05:05:49,928 --> 05:05:51,797 THE PANDEMIC WAS A TIME OF GREAT 6567 05:05:51,797 --> 05:05:53,665 STRESS TO PEOPLE, AND IT 6568 05:05:53,665 --> 05:05:55,300 CERTAINLY PUSHED A LOT OF PEOPLE 6569 05:05:55,300 --> 05:05:59,337 INTO ADDICTION, PARTICULARLY 6570 05:05:59,337 --> 05:06:02,641 METH ADDICTION, WE SAW AN UPTICK 6571 05:06:02,641 --> 05:06:03,508 IN THE NUMBER OF PATIENTS THAT 6572 05:06:03,508 --> 05:06:04,810 STARTED USING METH AND PATIENTS 6573 05:06:04,810 --> 05:06:07,679 WHO WERE FORMER METH USERS WENT 6574 05:06:07,679 --> 05:06:09,414 BACK TO IT TO DEAL WITH THE 6575 05:06:09,414 --> 05:06:09,748 STRESS. 6576 05:06:09,748 --> 05:06:12,250 SO THIS KIND OF EVENTS ALSO HAS 6577 05:06:12,250 --> 05:06:18,390 TO BE TAKEN INTO CONSIDERATION 6578 05:06:18,390 --> 05:06:19,791 BECAUSE HISTORICALLY THEY COULD 6579 05:06:19,791 --> 05:06:21,893 ACTUALLY CREATE SIGNIFICANT 6580 05:06:21,893 --> 05:06:25,630 INCREASES THAT ARE NOT 6581 05:06:25,630 --> 05:06:29,434 NECESSARILY SEEN AT OTHER TIMES. 6582 05:06:29,434 --> 05:06:30,535 NEXT SLIDE, PLEASE. 6583 05:06:30,535 --> 05:06:38,343 SO WHY DO WE SEE SUCH A HIGH 6584 05:06:38,343 --> 05:06:39,611 MORTALITY WITH METHAMPHETAMINE? 6585 05:06:39,611 --> 05:06:41,313 THE PROBLEM WITH METHAMPHETAMINE 6586 05:06:41,313 --> 05:06:43,548 IS THIS IS A DRUG THAT AFFECTS 6587 05:06:43,548 --> 05:06:45,750 MULTIPLE ORGANS. 6588 05:06:45,750 --> 05:06:48,820 CLASSICALLY WHEN IT COMES THE 6589 05:06:48,820 --> 05:06:53,725 BRAIN, WE SEE STROKES AND 6590 05:06:53,725 --> 05:06:55,894 CATECHOLAMIE TOXICITY, WITH THE 6591 05:06:55,894 --> 05:06:59,064 HEART WE SEE CARDIAC 6592 05:06:59,064 --> 05:07:01,366 ARRHYTHMIAS, DILATED 6593 05:07:01,366 --> 05:07:02,467 CARDIOMYOPATHY, HEART ATTACKS, 6594 05:07:02,467 --> 05:07:04,002 THOSE BY THEMSELVES ARE ALREADY 6595 05:07:04,002 --> 05:07:05,237 ENOUGH TO KILL THESE PATIENTS 6596 05:07:05,237 --> 05:07:06,738 AND INCREASE MORBIDITY, RIGHT? 6597 05:07:06,738 --> 05:07:10,242 BUT WHEN IT COMES TO PULMONARY 6598 05:07:10,242 --> 05:07:12,444 HYPERTENSION, THAT'S A MORE 6599 05:07:12,444 --> 05:07:15,380 NOVEL, IF YOU WILL, SINCE ITS 6600 05:07:15,380 --> 05:07:18,016 FIRST DESCRIPTION IN 1993 UNTIL 6601 05:07:18,016 --> 05:07:21,286 NOW THAT WE ARE ALREADY STARTING 6602 05:07:21,286 --> 05:07:23,155 TO UNRAVEL, BUT IT HAS A 6603 05:07:23,155 --> 05:07:25,223 SIGNIFICANT IMPACT ALSO IN THE 6604 05:07:25,223 --> 05:07:28,293 LIFESTYLE AND THE SURVIVAL OF 6605 05:07:28,293 --> 05:07:29,094 THE PATIENT. 6606 05:07:29,094 --> 05:07:30,896 IT IS INDISTINGUISHABLE 6607 05:07:30,896 --> 05:07:34,099 PATHOLOGICALLY TO THAT OF OTHER 6608 05:07:34,099 --> 05:07:35,066 PATIENTS WHICH IS WHY IT'S 6609 05:07:35,066 --> 05:07:36,601 CONSIDERED A GROUP ONE DISEASE. 6610 05:07:36,601 --> 05:07:38,770 NEXT SLIDE, PLEASE. 6611 05:07:38,770 --> 05:07:42,541 SO IN THIS STUDY IN 2017 WHERE 6612 05:07:42,541 --> 05:07:46,912 WE COLLECTED OUR DATA FROM YEARS 6613 05:07:46,912 --> 05:07:48,747 OF LOOKING AT THESE PATIENTS, WE 6614 05:07:48,747 --> 05:07:52,717 WERE ABLE TO COMPARE IPAH, 97 6615 05:07:52,717 --> 05:07:56,188 PATIENTS, AND 90 PATIENTS, WITH 6616 05:07:56,188 --> 05:07:59,157 METH PH, THIS WAS A STUDY DONE 6617 05:07:59,157 --> 05:08:04,629 WITH ROHAM ZAMANIAN AND STEVE 6618 05:08:04,629 --> 05:08:06,398 KAWUT BASED ON OUR STANFORD 6619 05:08:06,398 --> 05:08:08,333 DATASET AND WHAT WE FOUND WAS 6620 05:08:08,333 --> 05:08:10,068 THAT MOST OF THE PATIENTS WITH 6621 05:08:10,068 --> 05:08:12,370 METH APAH WERE MOSTLY MALE. 6622 05:08:12,370 --> 05:08:13,572 INTERESTINGLY ENOUGH, THEY AT 6623 05:08:13,572 --> 05:08:16,741 LEAST IN OUR GROUP, THE 6624 05:08:16,741 --> 05:08:19,277 SOCIOECONOMIC STATUS WAS 6625 05:08:19,277 --> 05:08:24,316 SIMILAR, THEY HAVE SIMILAR 6626 05:08:24,316 --> 05:08:26,284 HEMODYNAMIC BUT INTERESTINGLY 6627 05:08:26,284 --> 05:08:28,787 ENOUGH THEIR FUNCTION WAS WORSE 6628 05:08:28,787 --> 05:08:32,090 IN ECHO AND STILL FOUND THAT 6629 05:08:32,090 --> 05:08:35,694 METH APAH STAISHTS COMPARED WITH 6630 05:08:35,694 --> 05:08:37,095 IPAH PATIENTS HAD SIGNIFICANT 6631 05:08:37,095 --> 05:08:37,963 INCREASED MORTALITY. 6632 05:08:37,963 --> 05:08:39,731 NEXT SLIDE, PLEASE. 6633 05:08:39,731 --> 05:08:43,001 THIS, AGAIN, IF YOU LOOK AT THE 6634 05:08:43,001 --> 05:08:45,737 FAR REGISTRY, WE NEXT WENT TO 6635 05:08:45,737 --> 05:08:49,241 LOOK AT THE PHAR REGISTRY TO GET 6636 05:08:49,241 --> 05:08:51,076 MORE CLARITY REGARDING THE 6637 05:08:51,076 --> 05:08:51,843 CHARACTERISTICS OF THESE 6638 05:08:51,843 --> 05:08:52,210 PATIENTS. 6639 05:08:52,210 --> 05:08:54,846 WHY THE PHAR REGISTRY? 6640 05:08:54,846 --> 05:08:56,147 BECAUSE IT HAS A GOOD 6641 05:08:56,147 --> 05:08:58,216 REPRESENTATION OF METH APAH 6642 05:08:58,216 --> 05:08:59,217 PATIENTS FROM THE DIFFERENT 6643 05:08:59,217 --> 05:09:00,318 STHEARNTS PROVIDE DATA. 6644 05:09:00,318 --> 05:09:02,120 AGAIN, IF YOU COMPARE THIS MAP 6645 05:09:02,120 --> 05:09:04,789 WITH THE MAP OF METH FELT 6646 05:09:04,789 --> 05:09:06,658 MINIMUM OVERDOSES -- 6647 05:09:06,658 --> 05:09:07,525 METHAMPHETAMINE OVERDOSES YOU 6648 05:09:07,525 --> 05:09:09,594 WILL SEE AGAIN THAT DIVISION IN 6649 05:09:09,594 --> 05:09:12,330 THE MIDDLE WHERE MOST OF YOUR 6650 05:09:12,330 --> 05:09:13,331 METH PATIENTS ARE ON THE WEST 6651 05:09:13,331 --> 05:09:15,300 AND AS YOU MOVE TO THE EAST 6652 05:09:15,300 --> 05:09:17,135 COAST, YOU START SEEING THAT THE 6653 05:09:17,135 --> 05:09:20,305 PREVALENCE OF IPH PATIENTS IS 6654 05:09:20,305 --> 05:09:21,306 ACTUALLY HIGHER. 6655 05:09:21,306 --> 05:09:23,174 SO NEXT SLIDE, PLEASE. 6656 05:09:23,174 --> 05:09:26,244 SO WHEN NOW IN THIS STUDY, LED 6657 05:09:26,244 --> 05:09:29,648 BY NICHOLAS KOLAITIS, WHAT WE 6658 05:09:29,648 --> 05:09:32,050 FOUND IS SOME THINGS THAT ARE 6659 05:09:32,050 --> 05:09:35,420 CLEARLY PUT TO A UNIQUE PATIENT 6660 05:09:35,420 --> 05:09:38,089 PROFILE FOR METH PAH PATIENTS. 6661 05:09:38,089 --> 05:09:40,258 FIRST OFF, THEY'RE YOUNGER, 47 6662 05:09:40,258 --> 05:09:41,660 YEARS VERSUS 55. 6663 05:09:41,660 --> 05:09:44,629 THESE PATIENTS ARE UNINSURED, 6664 05:09:44,629 --> 05:09:47,265 NEVER MARRIED, THEY DID NOT 6665 05:09:47,265 --> 05:09:50,735 FINISH COLLEGE, AND MOST OF THEM 6666 05:09:50,735 --> 05:09:53,371 FLENT A WORSE -- PRESENT THIS A 6667 05:09:53,371 --> 05:09:54,239 WORSE FUNCTIONAL CLASS COMPARED 6668 05:09:54,239 --> 05:09:55,540 TO IPAH. 6669 05:09:55,540 --> 05:09:57,409 NEXT SLIDE, PLEASE. 6670 05:09:57,409 --> 05:09:59,911 MOREOVER, THE HEMODYNAMICS 6671 05:09:59,911 --> 05:10:05,417 APPEAR TO BE WORSE BASED ON RA 6672 05:10:05,417 --> 05:10:07,786 PRESSURE, CARDIAC OUTPUT LOWER 6673 05:10:07,786 --> 05:10:10,322 AS WELL AS STROKE VOLUME SO 6674 05:10:10,322 --> 05:10:11,856 WORSE HEMODYNAMICS WHICH MAY 6675 05:10:11,856 --> 05:10:14,259 EXPLAIN WHY THESE PATIENTS ARE 6676 05:10:14,259 --> 05:10:15,694 DOING -- HAVE A WORSE MORTALITY. 6677 05:10:15,694 --> 05:10:17,762 SO THE NEXT QUESTION IS, WELL, 6678 05:10:17,762 --> 05:10:19,297 ARE THEY GETTING TREATED? 6679 05:10:19,297 --> 05:10:22,367 NEXT SLIDE, PLEASE. 6680 05:10:22,367 --> 05:10:24,669 SO THEY ARE GETTING TREATED 6681 05:10:24,669 --> 05:10:26,938 EXCEPT THAT IN OUR COHORT, THIS 6682 05:10:26,938 --> 05:10:29,708 IS FROM OUR STANFORD STUDY, WHAT 6683 05:10:29,708 --> 05:10:33,745 WE FOUND IS THAT MOST METH 6684 05:10:33,745 --> 05:10:38,650 PATIENTS ARE GETTING 6685 05:10:38,650 --> 05:10:43,054 INHALED/ORAL THERAPIES, GET 6686 05:10:43,054 --> 05:10:44,856 IV/SQ BUT IN LESS NUMBERS 6687 05:10:44,856 --> 05:10:47,826 COMPARED TO THE IPAH WHERE YOU 6688 05:10:47,826 --> 05:10:49,094 CAN SEE THAT A GREATER NUMBER 6689 05:10:49,094 --> 05:10:51,796 ARE ON IV SUB Q COMPARED TOIN 6690 05:10:51,796 --> 05:10:52,897 HAILED ORAL, AND THERE'S A 6691 05:10:52,897 --> 05:10:55,200 REASON FOR THAT, AND IT IS DUE 6692 05:10:55,200 --> 05:10:59,704 TO THE FACT THAT THESE PATIENTS 6693 05:10:59,704 --> 05:11:01,973 WHO MAY BE STILL ACTIVELY USING 6694 05:11:01,973 --> 05:11:06,678 OR MAY NOT HAVE SOCIAL SUPPORT 6695 05:11:06,678 --> 05:11:08,847 AND OTHER REQUIREMENTS TO 6696 05:11:08,847 --> 05:11:11,282 MAINTAIN, TO BE ABLE TO USE THIS 6697 05:11:11,282 --> 05:11:13,017 DRUG SAFELY, UNFORTUNATELY, IT'S 6698 05:11:13,017 --> 05:11:15,320 DIFFICULT FOR US TO BE ABLE TO 6699 05:11:15,320 --> 05:11:18,056 OFFER THESE THERAPIES UNTIL THEY 6700 05:11:18,056 --> 05:11:21,459 ARE ABLE TO REGAIN A BETTER 6701 05:11:21,459 --> 05:11:22,861 FUNCTIONAL AND SOCIAL STATUS, 6702 05:11:22,861 --> 05:11:27,899 WHICH OF COURSE IS NOT EASY TO 6703 05:11:27,899 --> 05:11:29,434 ASK OR REGAIN. 6704 05:11:29,434 --> 05:11:31,202 NEXT SLIDE, PLEASE. 6705 05:11:31,202 --> 05:11:33,705 THIS IS FROM A STUDY THAT IS 6706 05:11:33,705 --> 05:11:35,240 CURRENTLY UNDER REVIEW, AND WHAT 6707 05:11:35,240 --> 05:11:36,975 YOU CAN SEE HERE IS THAT ACROSS 6708 05:11:36,975 --> 05:11:39,611 THE UNITED STATES, USING 6709 05:11:39,611 --> 05:11:40,812 INSURANCE DATABASE LOOKING FOR 6710 05:11:40,812 --> 05:11:43,415 THE DIAGNOSIS OF METH AND 6711 05:11:43,415 --> 05:11:44,749 PULMONARY HYPERTENSION, THE RATE 6712 05:11:44,749 --> 05:11:46,718 AT WHICH THESE PATIENTS ARE 6713 05:11:46,718 --> 05:11:48,353 BEING TREATED, AND THIS IS A 6714 05:11:48,353 --> 05:11:54,826 STUDY WHERE WE WENT FROM 2017 TO 6715 05:11:54,826 --> 05:11:56,327 2022 INSURANCE CLAIM DATABASE, 6716 05:11:56,327 --> 05:11:57,996 AGAIN THE LIGHTER BLUE MEANS 6717 05:11:57,996 --> 05:12:00,064 THESE PATIENTS ARE GEG, IT'S A 6718 05:12:00,064 --> 05:12:03,902 PERCENT OF PATIENTS THAT ARE 6719 05:12:03,902 --> 05:12:05,303 GETTING MEDICATION. 6720 05:12:05,303 --> 05:12:07,205 LIGHTER BLUE, MORE PATIENTS. 6721 05:12:07,205 --> 05:12:09,674 DARKER BLUE, LESS PATIENTS. 6722 05:12:09,674 --> 05:12:16,147 AND YOU CAN SEE THAT AS WE NEUF 6723 05:12:16,147 --> 05:12:18,216 THE EAST COAST THERE'S MORE OF 6724 05:12:18,216 --> 05:12:19,851 THE DARK BLUE LESS PATIENTS 6725 05:12:19,851 --> 05:12:21,719 BEING PRESCRIBED OR RECEIVING 6726 05:12:21,719 --> 05:12:23,455 MEDICATIONS, WE CANNOT SAY THAT 6727 05:12:23,455 --> 05:12:24,989 THEY'RE NOT BEING PRESCRIBED, OR 6728 05:12:24,989 --> 05:12:26,524 THEY'RE JUST NOT GETTING THE 6729 05:12:26,524 --> 05:12:29,294 MEDICATION, YOU CAN SEE FOR 6730 05:12:29,294 --> 05:12:32,197 EXAMPLE IN FLORIDA, NEW JERSEY, 6731 05:12:32,197 --> 05:12:34,299 THESE AREAS ARE NOT THE PATIENTS 6732 05:12:34,299 --> 05:12:35,733 THAT ARE THERE, EVEN THOUGH 6733 05:12:35,733 --> 05:12:37,869 THERE MAY BE LESS PREVALENT THAN 6734 05:12:37,869 --> 05:12:39,204 ON THE WEST COAST, THERE ARE 6735 05:12:39,204 --> 05:12:40,638 STILL PATIENTS THERE THAT ARE 6736 05:12:40,638 --> 05:12:42,073 GETTING DIAGNOSED BUT THEY'RE 6737 05:12:42,073 --> 05:12:42,807 NOT BEING TREATED. 6738 05:12:42,807 --> 05:12:45,210 AND WE CAN TALK ABOUT WHAT 6739 05:12:45,210 --> 05:12:46,978 FACTORS DETERMINE THAT. 6740 05:12:46,978 --> 05:12:51,249 BUT ULTIMATELY, THIS POINTS TO A 6741 05:12:51,249 --> 05:12:54,519 BIG DISCREPANCY THAT MAY 6742 05:12:54,519 --> 05:12:56,821 EVIDENCE THE DISPARITY AFFECTING 6743 05:12:56,821 --> 05:12:58,690 THIS PARTICULAR PATIENT GROUP. 6744 05:12:58,690 --> 05:12:59,991 NEXT SLIDE, PLEASE. 6745 05:12:59,991 --> 05:13:02,393 SO WHAT ARE THE SOURCES OF 6746 05:13:02,393 --> 05:13:05,363 HEALTH DISPARITIES FOR METH 6747 05:13:05,363 --> 05:13:06,798 PULMONARY ARTERIAL HYPERTENSION? 6748 05:13:06,798 --> 05:13:08,633 THERE ARE SOME THINGS THAT ARE 6749 05:13:08,633 --> 05:13:10,068 UNIQUE, AND I AM GOING TO FOCUS 6750 05:13:10,068 --> 05:13:10,635 ON THOSE. 6751 05:13:10,635 --> 05:13:14,138 I WANT TO REITERATE THAT THIS IN 6752 05:13:14,138 --> 05:13:17,408 NO MEANS TAKES OUT THE SEX OR 6753 05:13:17,408 --> 05:13:18,943 THE OTHER SOCIAL DETERMINANTS OF 6754 05:13:18,943 --> 05:13:20,245 HEALTH THAT WE'VE DISCUSSED. 6755 05:13:20,245 --> 05:13:21,679 I'M JUST GOING TO FOCUS ON THE 6756 05:13:21,679 --> 05:13:24,182 THINGS THAT ARE PARTICULARLY 6757 05:13:24,182 --> 05:13:26,084 IMPORTANT FOR THIS PATIENT 6758 05:13:26,084 --> 05:13:26,484 POPULATION. 6759 05:13:26,484 --> 05:13:27,785 THERE'S THE LACK OF PHYSICIAN 6760 05:13:27,785 --> 05:13:29,420 AND PATIENT AWARENESS. 6761 05:13:29,420 --> 05:13:31,389 NOT EVERYBODY KNOWS THAT METH 6762 05:13:31,389 --> 05:13:33,258 CAUSES PAH OR WANT TO BELIEVE 6763 05:13:33,258 --> 05:13:38,396 IT, SO THAT'S ALREADY A PROBLEM 6764 05:13:38,396 --> 05:13:40,164 THAT LEADS TO PROBLEMS IN TERMS 6765 05:13:40,164 --> 05:13:43,735 OF HOW TO ADDRESS SCREENING THIS 6766 05:13:43,735 --> 05:13:43,968 PATIENT. 6767 05:13:43,968 --> 05:13:45,603 THERE'S OF COURSE THE IMPLICIT 6768 05:13:45,603 --> 05:13:47,705 BIAS FROM BEAU THE PATIENT AND 6769 05:13:47,705 --> 05:13:48,907 THE PHYSICIAN -- FROM BOTH THE 6770 05:13:48,907 --> 05:13:50,108 PATIENT AND THE PHYSICIAN, THE 6771 05:13:50,108 --> 05:13:51,309 PATIENT MISTRUST, THESE ARE 6772 05:13:51,309 --> 05:13:54,579 PATIENTS THAT USUALLY ARE SEEN 6773 05:13:54,579 --> 05:13:57,849 AS BEING SOCIAL PARIAHS AND NOT 6774 05:13:57,849 --> 05:13:59,617 RESPECT THE PATIENT BY ITSELF IS 6775 05:13:59,617 --> 05:14:02,253 ALREADY GOING TO COME WITH 6776 05:14:02,253 --> 05:14:02,520 MISTRUST. 6777 05:14:02,520 --> 05:14:04,322 THERE IS ALSO THE ACCESS TO CARE 6778 05:14:04,322 --> 05:14:06,090 BASED ON WHETHER THE PATIENT IS 6779 05:14:06,090 --> 05:14:10,228 ON A RURAL OR URBAN AREA. 6780 05:14:10,228 --> 05:14:12,096 THERE'S STIGMA AND 6781 05:14:12,096 --> 05:14:12,463 CRIMINALIZATION. 6782 05:14:12,463 --> 05:14:13,498 THESE PATIENTS HAVE ALREADY BEEN 6783 05:14:13,498 --> 05:14:17,035 IN JAIL OR HAVE ALREADY BEEN 6784 05:14:17,035 --> 05:14:18,736 FINED, SO THESE PATIENTS ARE 6785 05:14:18,736 --> 05:14:21,472 ALREADY HIGHLY HESITANT TO ENTER 6786 05:14:21,472 --> 05:14:23,875 THE SYSTEM TO RECEIVE CARE. 6787 05:14:23,875 --> 05:14:26,311 THERE'S A LACK OF TOXICOLOGY 6788 05:14:26,311 --> 05:14:28,379 SCREENING, LACK OF ADDICTION 6789 05:14:28,379 --> 05:14:30,281 SERVICES IN AREAS WHERE THESE 6790 05:14:30,281 --> 05:14:31,249 PATIENTS LIVE. 6791 05:14:31,249 --> 05:14:34,285 SO THESE PATIENTS PROBABLY FEEL 6792 05:14:34,285 --> 05:14:38,122 LIKE, YOU KNOW, THEY CAN THROW 6793 05:14:38,122 --> 05:14:39,991 IN THE TOWM BECAUSE THEY'RE NOT 6794 05:14:39,991 --> 05:14:41,426 GOING -- IN THE TOWEL BECAUSE 6795 05:14:41,426 --> 05:14:42,060 THAIRNLTD GOING TO BE RECEIVING 6796 05:14:42,060 --> 05:14:43,828 ANY CARE, SO WHY EVEN TRY. 6797 05:14:43,828 --> 05:14:45,196 AND THEN THERE'S THE LACK OF 6798 05:14:45,196 --> 05:14:47,332 PUBLIC HEALTH INITIATIVES TO 6799 05:14:47,332 --> 05:14:50,501 TARGET THESE POPULATIONS, SO 6800 05:14:50,501 --> 05:14:53,538 THAT OBVIOUSLY COMES FROM OUR 6801 05:14:53,538 --> 05:14:54,872 SIDE, OUR GOVERNMENTS AND OUR 6802 05:14:54,872 --> 05:14:57,075 COMMUNITIES TO PROVIDE THIS, AND 6803 05:14:57,075 --> 05:14:58,443 THEY'RE NOT WIDELY AVAILABLE. 6804 05:14:58,443 --> 05:15:00,345 NEXT SLIDE, PLEASE. 6805 05:15:00,345 --> 05:15:03,615 SO HOW CAN WE BRIDGE THIS GAP 6806 05:15:03,615 --> 05:15:06,150 FOR OUR METH PAH PATIENTS? 6807 05:15:06,150 --> 05:15:10,321 NEXT SLIDE, PLEASE. 6808 05:15:10,321 --> 05:15:11,623 THESE ARE THE THINGS AWE'RE 6809 05:15:11,623 --> 05:15:13,558 DOING IN OUR GROUP AS WELL AS 6810 05:15:13,558 --> 05:15:15,860 OTHER GROUPS THAT ARE TAKING 6811 05:15:15,860 --> 05:15:18,429 CARE OF THESE PATIENTS. 6812 05:15:18,429 --> 05:15:20,999 WE ARE VERY CLEAR AND 6813 05:15:20,999 --> 05:15:22,567 NONJUDGMENTAL WHEN WE ASK 6814 05:15:22,567 --> 05:15:24,502 PATIENTS ABOUT THEIR CURRENT OR 6815 05:15:24,502 --> 05:15:26,070 PAST METH USE, AND WE'RE VERY 6816 05:15:26,070 --> 05:15:28,006 CAREFUL WITH HOW WE ASK THEM 6817 05:15:28,006 --> 05:15:30,208 THAT, BECAUSE WE DON'T TO WANT 6818 05:15:30,208 --> 05:15:35,313 MAKE THE PATIENT FEEL SELF-AWARE 6819 05:15:35,313 --> 05:15:37,649 OR EMBARRASSED. 6820 05:15:37,649 --> 05:15:40,718 THIS IS SOMETHING THAT IS 6821 05:15:40,718 --> 05:15:42,253 ROUTINE AND WE ENCOURAGE THE 6822 05:15:42,253 --> 05:15:43,788 PATIENT TO ESTABLISH THAT TRUST. 6823 05:15:43,788 --> 05:15:45,423 THIS IS REALLY IMPORTANT. 6824 05:15:45,423 --> 05:15:48,159 WE SCREEN FOR BOTH HIV AND LIVER 6825 05:15:48,159 --> 05:15:49,927 DISEASE BECAUSE THESE ARE 6826 05:15:49,927 --> 05:15:50,995 COMORBIDITIES THAT ARE 6827 05:15:50,995 --> 05:15:53,197 PARTICULARLY IMPORTANT WITH THIS 6828 05:15:53,197 --> 05:15:55,800 PATIENT POPULATION. 6829 05:15:55,800 --> 05:15:58,236 WE ACTUALLY RUN URINE AND BLOOD 6830 05:15:58,236 --> 05:15:59,971 TOXICOLOGY FOR EVERY PATIENT, SO 6831 05:15:59,971 --> 05:16:02,607 WE DON'T DISCRIMINATE IN TERMS 6832 05:16:02,607 --> 05:16:03,708 OF ORDERING THIS. 6833 05:16:03,708 --> 05:16:06,244 WE SCREEN FOR MENTAL DISORDERS 6834 05:16:06,244 --> 05:16:07,378 OTHER THAN ADDICTION. 6835 05:16:07,378 --> 05:16:09,847 YOU CAN IMAGINE THESE PATIENTS 6836 05:16:09,847 --> 05:16:13,017 COME WITH OTHER BASED ON THE 6837 05:16:13,017 --> 05:16:15,186 LEVEL OF ABUSE THEY MAY HAVE 6838 05:16:15,186 --> 05:16:16,521 EXPERIENCED, OTHER SOCIAL 6839 05:16:16,521 --> 05:16:18,690 STRESSORS, THEY COME WITH 6840 05:16:18,690 --> 05:16:20,258 DEPRESSION, BIPOLAR DISORDER, 6841 05:16:20,258 --> 05:16:22,193 IT'S VERY IMPORTANT BECAUSE THIS 6842 05:16:22,193 --> 05:16:24,996 IS GOING TO BE A HUGE ASPECT OF 6843 05:16:24,996 --> 05:16:26,264 THE CARE AND THE SUCCESS THAT 6844 05:16:26,264 --> 05:16:28,633 YOU'RE GOING TO HAVE IN TREATING 6845 05:16:28,633 --> 05:16:29,767 THESE PATIENTS. 6846 05:16:29,767 --> 05:16:31,169 WE ESTABLISH A MEDICAL CONTRACT, 6847 05:16:31,169 --> 05:16:33,237 AND THIS IS SOMETHING THAT I CAN 6848 05:16:33,237 --> 05:16:35,106 SPEAK OFFLINE, BUT IT IS A 6849 05:16:35,106 --> 05:16:36,641 DOCUMENT THAT WE DISCUSS WITH 6850 05:16:36,641 --> 05:16:38,810 THE PATIENT AND WE SIGN WHERE WE 6851 05:16:38,810 --> 05:16:40,044 DISCUSS WHAT WE'RE PREPARED TO 6852 05:16:40,044 --> 05:16:42,914 OFFER AND WHAT WE ARE EXPECTING 6853 05:16:42,914 --> 05:16:45,817 FOR THE PATIENT. 6854 05:16:45,817 --> 05:16:47,785 WE DO RANDOM URINE TOXICOLOGIES 6855 05:16:47,785 --> 05:16:48,753 AND WE TELL THE PATIENT THAT 6856 05:16:48,753 --> 05:16:50,088 THIS IS GOING TO BE PART OF THE 6857 05:16:50,088 --> 05:16:51,823 CARE, SO THAT'S IN THE MEDICAL 6858 05:16:51,823 --> 05:16:52,156 CONTRACT. 6859 05:16:52,156 --> 05:16:54,125 WE'RE MINDFUL ABOUT USING IV 6860 05:16:54,125 --> 05:16:54,392 THERAPIES. 6861 05:16:54,392 --> 05:16:55,993 WHAT DOES THAT MEAN? 6862 05:16:55,993 --> 05:16:57,195 DOES THAT MEAN THAT WE DO NOT 6863 05:16:57,195 --> 05:16:58,196 OFFER IT? 6864 05:16:58,196 --> 05:16:58,863 ABSOLUTELY NOT. 6865 05:16:58,863 --> 05:17:00,364 BUT WE'RE VERY CAREFUL AND WE'RE 6866 05:17:00,364 --> 05:17:01,766 VERY CLEAR WITH THE PATIENT THAT 6867 05:17:01,766 --> 05:17:03,534 AS LONG AS THEY'RE ACTIVELY 6868 05:17:03,534 --> 05:17:05,303 USING, WE CANNOT IN GOOD 6869 05:17:05,303 --> 05:17:06,938 CONSCIENCE OFFER THE THERAPY. 6870 05:17:06,938 --> 05:17:08,773 WE DEFINITELY WANT TO HELP THE 6871 05:17:08,773 --> 05:17:10,641 PATIENT, WHICH IS WHY WE INVOLVE 6872 05:17:10,641 --> 05:17:12,744 AN ADDICTION SPECIALIST AND 6873 05:17:12,744 --> 05:17:15,012 SOCIAL WORKER, WE TRY TO 6874 05:17:15,012 --> 05:17:17,081 IDENTIFY THE BARRIERS TO 6875 05:17:17,081 --> 05:17:18,349 SUCCESS, LIKE IS THE PATIENT 6876 05:17:18,349 --> 05:17:21,486 LIVING IN AN AREA, ARE THEY 6877 05:17:21,486 --> 05:17:22,787 HOMELESS, CAN WE DO SOMETHING 6878 05:17:22,787 --> 05:17:24,222 ABOUT THAT? 6879 05:17:24,222 --> 05:17:28,059 CAN WE IMPROVE TRANSPORTATION 6880 05:17:28,059 --> 05:17:28,926 ACCESS TO CENTER? 6881 05:17:28,926 --> 05:17:31,095 SO WE TRY TO HELP THE PATIENT 6882 05:17:31,095 --> 05:17:33,498 COME UP WITH A POINT WHERE THEY 6883 05:17:33,498 --> 05:17:35,366 ARE BETTER CONNECTED, THEY HAVE 6884 05:17:35,366 --> 05:17:38,302 MORE SUPPORT, AND ULTIMATELY WE 6885 05:17:38,302 --> 05:17:42,039 CAN ACTUALLY INTRODUCE THIS 6886 05:17:42,039 --> 05:17:43,274 THERAPEUTIC, BUT IN THE 6887 05:17:43,274 --> 05:17:43,941 MEANTIME, EVERYTHING ELSE THAT 6888 05:17:43,941 --> 05:17:45,143 WE CAN OFFER, WE OFFER. 6889 05:17:45,143 --> 05:17:46,444 SO THAT'S REALLY IMPORTANT. 6890 05:17:46,444 --> 05:17:47,845 YOU DO NOT WITHHOLD THERAPY FOR 6891 05:17:47,845 --> 05:17:48,679 THESE PATIENTS. 6892 05:17:48,679 --> 05:17:53,885 NEXT SLIDE, PLEASE. 6893 05:17:53,885 --> 05:17:55,953 THE LAST THING I'M GOING TO SAY 6894 05:17:55,953 --> 05:17:59,090 IS THAT, YOU KNOW, WE CANNOT -- 6895 05:17:59,090 --> 05:18:01,759 I WANT US TO ALSO START THINKING 6896 05:18:01,759 --> 05:18:04,595 THAT, YOU KNOW, METH DOES NOT 6897 05:18:04,595 --> 05:18:06,898 COME ALONG -- DOES NOT COME 6898 05:18:06,898 --> 05:18:07,398 ALONE. 6899 05:18:07,398 --> 05:18:09,300 PATIENTS WHO USE METH USUALLY 6900 05:18:09,300 --> 05:18:10,301 INVOLVE HIGH RISK SEXUAL 6901 05:18:10,301 --> 05:18:11,269 ACTIVITIES, THEY USE OTHER 6902 05:18:11,269 --> 05:18:13,371 DRUGS, SO THE FACT THAT HIV AND 6903 05:18:13,371 --> 05:18:14,872 METH CAN COME TOGETHER IS NO 6904 05:18:14,872 --> 05:18:15,139 SURPRISE. 6905 05:18:15,139 --> 05:18:16,974 THIS IS A HUGE PROBLEM HERE IN 6906 05:18:16,974 --> 05:18:20,144 THE BAY AREA WHERE MEN WHO HAVE 6907 05:18:20,144 --> 05:18:23,881 SESSION WITH MEN -- MEN WHO HAVE 6908 05:18:23,881 --> 05:18:27,418 SEX WITH MEN USE METHAMPHETAMINE 6909 05:18:27,418 --> 05:18:29,654 AS PART OF RECREATION, WHEN YOU 6910 05:18:29,654 --> 05:18:31,422 THINK OF THESE TWO GUYS COMING 6911 05:18:31,422 --> 05:18:32,824 TOGETHER, IT'S A DOUBLE HIT MADE 6912 05:18:32,824 --> 05:18:33,491 IN HELL. 6913 05:18:33,491 --> 05:18:34,592 NEXT SLIDE, PLEASE. 6914 05:18:34,592 --> 05:18:36,227 AND I'M GOING TO END UP BY 6915 05:18:36,227 --> 05:18:38,963 SHOWING YOU THIS, AND THIS IS 6916 05:18:38,963 --> 05:18:40,298 JUST FOOD FOR THOUGHT. 6917 05:18:40,298 --> 05:18:46,070 WHEN YOU LOOK AT THE PATIENTS 6918 05:18:46,070 --> 05:18:47,939 USE -- IDIOPATHIC USE OF 6919 05:18:47,939 --> 05:18:48,706 METHAMPHETAMINE IN THE GROUP, 6920 05:18:48,706 --> 05:18:51,843 YOU SEE OUT OF THIS GROUP 523, 6921 05:18:51,843 --> 05:18:55,279 33 INVESTIGATOR USED METH. 6922 05:18:55,279 --> 05:18:57,248 HIV PAH MUCH SMALLER BUT STILL A 6923 05:18:57,248 --> 05:18:57,882 HIGHER PROPORTION. 6924 05:18:57,882 --> 05:19:01,285 SO IS THERE A LINK BETWEEN THESE 6925 05:19:01,285 --> 05:19:03,888 TWO WELL-KNOWN CAUSES OF PAH? 6926 05:19:03,888 --> 05:19:06,424 THIS IS A SUBJECT FOR FUTURE 6927 05:19:06,424 --> 05:19:06,757 INVESTIGATION. 6928 05:19:06,757 --> 05:19:09,360 NEXT SLIDE, PLEASE. 6929 05:19:09,360 --> 05:19:12,430 SO AS I SAID, I THINK HOPEFULLY 6930 05:19:12,430 --> 05:19:14,298 AFTER FOCUSING ON DRUGS, I WANT 6931 05:19:14,298 --> 05:19:17,368 TO TAKE US BACK, I WANT TO ZOOM 6932 05:19:17,368 --> 05:19:20,438 OUT AND AGAIN PUT US BACK IN 6933 05:19:20,438 --> 05:19:20,972 PERSPECTIVE. 6934 05:19:20,972 --> 05:19:24,575 DRUG EXPOSURE IS AN IMPORTANT 6935 05:19:24,575 --> 05:19:30,147 PART OF WHAT DEFINES OUR 6936 05:19:30,147 --> 05:19:32,917 PATIENTS' ACCESS TO CARE, THEIR 6937 05:19:32,917 --> 05:19:35,419 OWN RESPONSE TO CARE, THEIR 6938 05:19:35,419 --> 05:19:37,188 TRUST, THEIR SUPPORT. 6939 05:19:37,188 --> 05:19:38,923 SO WE HAVE TO BE VERY CAREFUL 6940 05:19:38,923 --> 05:19:42,560 WHEN IT COMES TO THIS PATIENT 6941 05:19:42,560 --> 05:19:43,561 POPULATION BECAUSE IN ADDITION 6942 05:19:43,561 --> 05:19:45,296 TO EVERYTHING ELSE THAT WE HAVE 6943 05:19:45,296 --> 05:19:47,598 DEFINED SO FAR REGARDING 6944 05:19:47,598 --> 05:19:49,333 BARRIERS TO CARE AND 6945 05:19:49,333 --> 05:19:52,169 DETERMINANTS OF HEALTH, THIS BY 6946 05:19:52,169 --> 05:19:54,372 ITSELF CAN ALSO OPEN THE DOOR TO 6947 05:19:54,372 --> 05:19:57,408 OTHER COMPLEXITIES THAT WE AS 6948 05:19:57,408 --> 05:19:59,510 PHYSICIANS NEED TO BE AWARE, NOT 6949 05:19:59,510 --> 05:20:00,511 NECESSARILY BECAUSE WE CAN 6950 05:20:00,511 --> 05:20:02,580 TREAT, BUT ULTIMATELY AS WE TRY 6951 05:20:02,580 --> 05:20:05,316 TO THINK ABOUT HOW TO ADDRESS 6952 05:20:05,316 --> 05:20:07,518 THESE AND THINK ABOUT HOW TO 6953 05:20:07,518 --> 05:20:08,719 PROPERLY TREAT THESE PATIENTS, 6954 05:20:08,719 --> 05:20:10,588 HOW TO CONNECT THEM WITH THE 6955 05:20:10,588 --> 05:20:13,190 SYSTEM, WE ALSO HAVE TO THINK 6956 05:20:13,190 --> 05:20:15,860 ABOUT HOW ALL OF THESE FACTORS 6957 05:20:15,860 --> 05:20:21,098 INTERACT TOGETHER TO ULTIMATELY 6958 05:20:21,098 --> 05:20:22,300 DEFINE WHAT THIS INDIVIDUAL CAN 6959 05:20:22,300 --> 05:20:23,701 EXPECT FROM OUR SYSTEM AND WHAT 6960 05:20:23,701 --> 05:20:25,903 WE CAN EXPECT IN TERMS OF 6961 05:20:25,903 --> 05:20:27,204 OUTCOMES FOR THESE PATIENTS. 6962 05:20:27,204 --> 05:20:32,677 NEXT SLIDE, PLEASE. 6963 05:20:32,677 --> 05:20:35,313 VERY BRIEFLY, I HOPE I'VE 6964 05:20:35,313 --> 05:20:36,614 CONVINCED YOU THAT THIS IS AN 6965 05:20:36,614 --> 05:20:39,784 IMPORTANT FORM OF PULMONARY 6966 05:20:39,784 --> 05:20:41,986 HYPERTENSION, THINK ABOUT HIV 6967 05:20:41,986 --> 05:20:43,688 AND METHAMPHETAMINE, THEY NEED 6968 05:20:43,688 --> 05:20:45,589 TO BE SCREENED AT THE SAME TIME, 6969 05:20:45,589 --> 05:20:48,125 AND ALSO THIS IS A 6970 05:20:48,125 --> 05:20:50,594 MULTIDISCIPLINARY FORM OF PAH, 6971 05:20:50,594 --> 05:20:52,263 ALWAYS BE VERY CLEAR ABOUT 6972 05:20:52,263 --> 05:20:53,998 INVOLVING ADDICTION SPECIALISTS, 6973 05:20:53,998 --> 05:20:56,867 SOCIAL WORKERS, PSYCHIATRISTS, 6974 05:20:56,867 --> 05:20:58,069 BECAUSE ULTIMATELY THAT'S HOW 6975 05:20:58,069 --> 05:20:59,270 YOU'RE GOING TO SUCCESSFULLY 6976 05:20:59,270 --> 05:21:01,172 TREAT THESE PATIENTS. 6977 05:21:01,172 --> 05:21:04,408 SO WITH THAT, I BELIEVE MY NEXT 6978 05:21:04,408 --> 05:21:05,309 SLIDE IS COMING. 6979 05:21:05,309 --> 05:21:06,811 I WANT TO THANK YOU ALL. 6980 05:21:06,811 --> 05:21:08,546 I'M HAPPY TO TAKE QUESTIONS IF 6981 05:21:08,546 --> 05:21:15,252 THERE'S TIME. 6982 05:21:15,252 --> 05:21:17,521 >> THANK YOU, THAT WAS A 6983 05:21:17,521 --> 05:21:19,056 WONDERFUL OVERVIEW OF ESPECIALLY 6984 05:21:19,056 --> 05:21:21,892 A VERY PERTINENT TOPIC FOR US IN 6985 05:21:21,892 --> 05:21:22,626 THE SOUTHWEST. 6986 05:21:22,626 --> 05:21:26,497 YOU CAN ACTUALLY TRACK OUR 6987 05:21:26,497 --> 05:21:29,433 EPIDEMIC DOWN HERE, OUR IPH 6988 05:21:29,433 --> 05:21:31,302 POPULATION IS THIS, OUR METH 6989 05:21:31,302 --> 05:21:34,905 POPULATION IS THIS. 6990 05:21:34,905 --> 05:21:36,240 SO I'M SURE THERE ARE OTHER 6991 05:21:36,240 --> 05:21:37,942 CENTERS AS WELL. 6992 05:21:37,942 --> 05:21:39,944 I HAVE A QUICK QUESTION FOR YOU, 6993 05:21:39,944 --> 05:21:45,082 MAYBE NOT SO QUICK, BUT HOW MUCH 6994 05:21:45,082 --> 05:21:46,417 DO YOU THINK THAT THESE 6995 05:21:46,417 --> 05:21:48,152 DISPARITIES IN TREATMENT OF 6996 05:21:48,152 --> 05:21:49,553 METHAMPHETAMINE PATIENTS, YOU 6997 05:21:49,553 --> 05:21:51,389 SHOWED SORT OF THE NATIONAL MAP 6998 05:21:51,389 --> 05:21:53,624 AS WELL AS YOUR CENTERED, YOU 6999 05:21:53,624 --> 05:21:56,894 POINTED OUT THERE IS SOME 7000 05:21:56,894 --> 05:21:59,964 TREATMENT DISPARITY IN TERMS OF 7001 05:21:59,964 --> 05:22:04,535 PARENTERAL PROSTACYCLINS, HOW 7002 05:22:04,535 --> 05:22:05,536 MUCH OF THAT DO YOU THINK IS DUE 7003 05:22:05,536 --> 05:22:07,938 TO OUR OWN BIASES GOING INTO AND 7004 05:22:07,938 --> 05:22:12,643 ASKING OUR PATIENTS TO MODIFY 7005 05:22:12,643 --> 05:22:15,079 THEMSELVES OR THE WAY THAT WE 7006 05:22:15,079 --> 05:22:17,915 APPROACH PAH TREATMENT IN THEM, 7007 05:22:17,915 --> 05:22:20,217 AS OPPOSED TO US ADJUSTING OUR 7008 05:22:20,217 --> 05:22:23,387 OWN BIASES IN ACCORDANCE WITH 7009 05:22:23,387 --> 05:22:24,922 PERHAPS WHAT WILL WORK FOR THEM? 7010 05:22:24,922 --> 05:22:29,326 I'LL GIVE YOU AN EXAMPLE. 7011 05:22:29,326 --> 05:22:31,829 OUR PROGRAM HERE HAS A 7012 05:22:31,829 --> 05:22:33,230 MULTIDISCIPLINARY APPROACH TO 7013 05:22:33,230 --> 05:22:35,533 PATIENTS ALSO, BUT EVERY 7014 05:22:35,533 --> 05:22:37,168 PRACTITIONER SORT OF HAS 7015 05:22:37,168 --> 05:22:38,269 THEIR -- IN GRURNG HAS THEIR 7016 05:22:38,269 --> 05:22:40,671 SORT OF LEVEL OF OKAY THERE'S 7017 05:22:40,671 --> 05:22:43,741 THIS MUCH AMOUNT OF 7018 05:22:43,741 --> 05:22:44,708 SOCIOECONOMIC DISCORD IN A 7019 05:22:44,708 --> 05:22:46,544 PATIENT THAT WE BELIEVE THEY ARE 7020 05:22:46,544 --> 05:22:48,112 HIGH RISK FOR, SAY, PREANT 7021 05:22:48,112 --> 05:22:50,247 RESIDUAL THERAPY -- PA RENTED 7022 05:22:50,247 --> 05:22:51,715 RESIDUAL THERAPY, RIGHT? 7023 05:22:51,715 --> 05:22:53,484 WE'RE NOT GOING TO GO THAT FAR. 7024 05:22:53,484 --> 05:22:55,319 BUT DO WE HAVE THE DATA ACTUALLY 7025 05:22:55,319 --> 05:22:57,621 TO SHOW THAT THOSE PATIENTS ARE 7026 05:22:57,621 --> 05:22:59,623 ACTUALLY NOT GOING TO BE 7027 05:22:59,623 --> 05:23:02,460 ADHERENT TO PARENTERAL THERAPY, 7028 05:23:02,460 --> 05:23:06,497 SAY SUBCUTANEOUS THERAPY, IF A 7029 05:23:06,497 --> 05:23:08,599 GROUP OR A CENTER IS USED TO 7030 05:23:08,599 --> 05:23:11,669 GIVING IV THERAPY, THAT'S THEIR 7031 05:23:11,669 --> 05:23:13,170 PRACTICE PATTERN, RIGHT? 7032 05:23:13,170 --> 05:23:14,939 THEY MAY REFUSE THERAPY FOR A 7033 05:23:14,939 --> 05:23:17,007 PATIENT WHO USES 7034 05:23:17,007 --> 05:23:18,409 METHAMPHETAMINE, AS OPPOSED TO 7035 05:23:18,409 --> 05:23:20,511 MOVING TO SUBCUTANEOUS THERAPY 7036 05:23:20,511 --> 05:23:22,079 OR INHALED THERAPY, SOMETHING OF 7037 05:23:22,079 --> 05:23:23,547 THAT SORT. 7038 05:23:23,547 --> 05:23:26,250 SO JUST PUTTING THAT OUT THERE. 7039 05:23:26,250 --> 05:23:29,787 >> YEAH, THAT'S A VERY COMPLEX 7040 05:23:29,787 --> 05:23:31,288 YET RELEVANT QUESTION. 7041 05:23:31,288 --> 05:23:36,460 I WILL TELL YOU THAT ALL OF US 7042 05:23:36,460 --> 05:23:40,431 WHO WORK AT CENTERS WHERE THERE 7043 05:23:40,431 --> 05:23:43,934 IS HIGH EXPERTISE AND SUPPORT 7044 05:23:43,934 --> 05:23:46,770 FOR TREATING PULMONARY ARTERIAL 7045 05:23:46,770 --> 05:23:48,372 HYPERTENSION PATIENTS, WE WILL 7046 05:23:48,372 --> 05:23:51,142 ALL BE ABLE TO TAKE A LOOK AT 7047 05:23:51,142 --> 05:23:52,543 THESE PATIENTS, WE HAVE NURSES, 7048 05:23:52,543 --> 05:23:53,944 WE HAVE AN INFRASTRUCTURE THAT 7049 05:23:53,944 --> 05:24:01,752 WE CAN USE TO LEVERAGE TRYING TO 7050 05:24:01,752 --> 05:24:04,288 OFFER THESE PATIENTS THE MOST 7051 05:24:04,288 --> 05:24:10,327 IMPORTANT AND VITAL OPTIONS. 7052 05:24:10,327 --> 05:24:11,862 IN MY OWN EXPERIENCE AND I DON'T 7053 05:24:11,862 --> 05:24:13,364 KNOW DATD TO SAY THAT THESE 7054 05:24:13,364 --> 05:24:15,533 PATIENTS ARE NOT AS COMPLEX, 7055 05:24:15,533 --> 05:24:20,237 ALTHOUGH I CAN TELL YOU FROM OUR 7056 05:24:20,237 --> 05:24:22,873 STUDY, WHICH IS CURRENTLY UNDER 7057 05:24:22,873 --> 05:24:27,144 REVIEW, I CAN TELL YOU THAT WE 7058 05:24:27,144 --> 05:24:31,282 DID LOOK AT THE RATE OF 7059 05:24:31,282 --> 05:24:34,685 ADHERENCE OF PATIENTS, METH PAH 7060 05:24:34,685 --> 05:24:36,954 VERSUS NONMETH PAH IN THIS 7061 05:24:36,954 --> 05:24:38,956 PARTICULAR INSURANCE CLAIMS 7062 05:24:38,956 --> 05:24:39,290 ANALYSIS. 7063 05:24:39,290 --> 05:24:42,126 WE LOOKED AT MONOTHERAPY, DUAL 7064 05:24:42,126 --> 05:24:43,627 THERAPY AND TRIPLE THERAPY 7065 05:24:43,627 --> 05:24:45,062 ACROSS FROM THIS, AND WHAT WE 7066 05:24:45,062 --> 05:24:47,498 CAN TELL YOU, THOUGH, IS THAT AT 7067 05:24:47,498 --> 05:24:50,868 LEAST IN METH PAH, THERE IS 7068 05:24:50,868 --> 05:24:52,603 LOWER TREATMENT ADHERENCE BUT 7069 05:24:52,603 --> 05:24:54,138 NOT BY MUCH. 7070 05:24:54,138 --> 05:24:56,874 WE'RE TALKING ABOUT COMPARISON 7071 05:24:56,874 --> 05:24:59,610 BETWEEN WITH THE NON-METH PAH 7072 05:24:59,610 --> 05:25:04,415 THE DIFFERENCES ARE ABOUT 2.6, . 7073 05:25:04,415 --> 05:25:05,983 SO IT IS, IT IS SIGNIFICANT. 7074 05:25:05,983 --> 05:25:08,018 >> AS WE THOUGHT IT WOULD BE, 7075 05:25:08,018 --> 05:25:08,285 BASICALLY. 7076 05:25:08,285 --> 05:25:09,887 >> WELL, IT'S NOT LIKE WHAT YOU 7077 05:25:09,887 --> 05:25:13,691 WILL SAY, IT'S NOT REAL -- SO I 7078 05:25:13,691 --> 05:25:16,694 DON'T THINK THAT WE CAN USE THAT 7079 05:25:16,694 --> 05:25:24,335 TO JUSTIFY NOT OFFERING SYSTEMIC 7080 05:25:24,335 --> 05:25:25,202 PROSTEMOIDS TO A PATIENT. 7081 05:25:25,202 --> 05:25:26,837 WHAT I'M MORE SCARED ABOUT IS A 7082 05:25:26,837 --> 05:25:29,039 PATIENT WHO IS ACTIVELY USING 7083 05:25:29,039 --> 05:25:30,140 BECAUSE THESE PATIENTS USUALLY 7084 05:25:30,140 --> 05:25:34,511 DO NOT HAVE THE CAPACITY TO 7085 05:25:34,511 --> 05:25:38,115 MANAGE THE PROTOCOL REQUIRED TO 7086 05:25:38,115 --> 05:25:39,316 ADMINISTER THE DRUG. 7087 05:25:39,316 --> 05:25:41,752 IN SOME CASES, LIKE ONE OF THE 7088 05:25:41,752 --> 05:25:44,255 CASES I LIKE TO RELY ON, WE HAD 7089 05:25:44,255 --> 05:25:47,625 A PATIENT WITH AN INTRAVENOUS 7090 05:25:47,625 --> 05:25:50,261 LINE AND THEY USED TO INJECT 7091 05:25:50,261 --> 05:25:51,462 METHAMPHETAMINE THROUGH THAT 7092 05:25:51,462 --> 05:25:51,695 LINE. 7093 05:25:51,695 --> 05:25:53,764 AND SINCE, YOU KNOW, THAT'S ONLY 7094 05:25:53,764 --> 05:25:55,966 HAPPENED ONE TIME, WHICH IS WHY 7095 05:25:55,966 --> 05:25:57,701 FOR THESE PATIENTS, SO IF WE 7096 05:25:57,701 --> 05:25:59,470 HAVE A PATIENT, FOR EXAMPLE, A 7097 05:25:59,470 --> 05:26:02,039 METH USER WHO IS VERY, VERY, 7098 05:26:02,039 --> 05:26:05,242 VERY SICK, WE WILL PUT THEM ON 7099 05:26:05,242 --> 05:26:06,777 SUBCUTANEOUS THERAPY, AND WE 7100 05:26:06,777 --> 05:26:07,544 WILL SUPPORT THEM. 7101 05:26:07,544 --> 05:26:10,281 SO AGAIN, WE WILL NOT WITHHOLD. 7102 05:26:10,281 --> 05:26:13,350 BUT WE WILL BE VERY CAREFUL AND 7103 05:26:13,350 --> 05:26:13,617 SELECTIVE. 7104 05:26:13,617 --> 05:26:14,852 IF THERE'S NO OTHER CHOICE, THIS 7105 05:26:14,852 --> 05:26:17,821 IS A PATIENT WHOSE FUNCTIONAL 7106 05:26:17,821 --> 05:26:18,789 CLASS FOUR, THEY'RE GOING TO 7107 05:26:18,789 --> 05:26:20,557 DIE, WE WILL DEFINITELY START 7108 05:26:20,557 --> 05:26:20,958 THEM. 7109 05:26:20,958 --> 05:26:22,593 BUT ONCE WE STABILIZE THEM, IF 7110 05:26:22,593 --> 05:26:24,261 WE FEEL THAT THIS PATIENT IS NOT 7111 05:26:24,261 --> 05:26:25,929 A CANDIDATE TO BE AT HOME ON 7112 05:26:25,929 --> 05:26:27,331 THESE THERAPIES, THEN WE WILL 7113 05:26:27,331 --> 05:26:30,401 HAVE TO TRANSITION THEM 7114 05:26:30,401 --> 05:26:32,469 IN-HOUSE, WITH THE GOAL THAT 7115 05:26:32,469 --> 05:26:35,105 ULTIMATELY ONCE THE PATIENT IS 7116 05:26:35,105 --> 05:26:37,608 ABLE TO, YOU KNOW, BE ABLE TO BE 7117 05:26:37,608 --> 05:26:39,576 RESPONSIBLE AND SHOW THAT THEY 7118 05:26:39,576 --> 05:26:43,747 HAVE ADEQUATE SUPPORT AND A MORE 7119 05:26:43,747 --> 05:26:46,583 SOLID SOCIAL STRUCTURE AROUND 7120 05:26:46,583 --> 05:26:48,652 THEM, THEN WE CAN GO AHEAD. 7121 05:26:48,652 --> 05:26:50,754 BUT TO ADDRESS YOUR QUESTION, AT 7122 05:26:50,754 --> 05:26:53,057 THIS POINT IN TIME, IN MY OWN 7123 05:26:53,057 --> 05:26:53,924 EXPERIENCE, I THINK THESE 7124 05:26:53,924 --> 05:26:56,226 PATIENTS ARE INCREDIBLY 7125 05:26:56,226 --> 05:26:56,493 ADHERENT. 7126 05:26:56,493 --> 05:26:58,295 WE HAVEN'T HAD A PATIENT WHO HAS 7127 05:26:58,295 --> 05:27:00,397 BEEN LIKE -- IN FACT, ONCE THEY 7128 05:27:00,397 --> 05:27:03,567 ARE ON IV OR SUB Q MORE ADHERE 7129 05:27:03,567 --> 05:27:05,102 ENLT THAN WHEN THEY ARE ON ORALS 7130 05:27:05,102 --> 05:27:06,937 OR INHALES, TO BE PERFECTLY 7131 05:27:06,937 --> 05:27:07,504 HONEST WITH YOU. 7132 05:27:07,504 --> 05:27:09,039 BUT THAT'S MY OWN EXPERIENCE 7133 05:27:09,039 --> 05:27:10,841 WITH THESE PATIENTS. 7134 05:27:10,841 --> 05:27:11,442 >> GREAT. 7135 05:27:11,442 --> 05:27:11,809 THANK YOU. 7136 05:27:11,809 --> 05:27:12,976 WE NEED TO MOVE ON. 7137 05:27:12,976 --> 05:27:14,912 I APPRECIATE THAT VERY MUCH. 7138 05:27:14,912 --> 05:27:16,947 IT WAS AN EXCELLENT TALK AND 7139 05:27:16,947 --> 05:27:21,385 OVERVIEW ON PAH AND 7140 05:27:21,385 --> 05:27:22,386 METHAMPHETAMINE USE. 7141 05:27:22,386 --> 05:27:25,622 LET'S MOVE ON TO OUR NEXT TALK, 7142 05:27:25,622 --> 05:27:27,191 THAT IS PULMONARY VASCULAR 7143 05:27:27,191 --> 05:27:29,360 DISEASE AND SOCIAL DISPARITIES 7144 05:27:29,360 --> 05:27:32,096 AMONG THE UNHOUSED AND VETERAN 7145 05:27:32,096 --> 05:27:33,330 GROUPS. 7146 05:27:33,330 --> 05:27:35,666 DR. EVAN BRITAIN IS ASSOCIATE 7147 05:27:35,666 --> 05:27:38,769 PROFESSOR OF MEDICINE, HE'S A 7148 05:27:38,769 --> 05:27:39,870 CARDIOLOGIST AT VANDERBILT. 7149 05:27:39,870 --> 05:27:43,273 EVAN, GO AHEAD. 7150 05:27:43,273 --> 05:27:44,375 >> THANK YOU. 7151 05:27:44,375 --> 05:27:45,843 GOOD AFTERNOON, EVERYONE. 7152 05:27:45,843 --> 05:27:48,479 I APPRECIATE THE INVITATION FROM 7153 05:27:48,479 --> 05:27:52,216 THE CHAIRS AND THE NHLBI. 7154 05:27:52,216 --> 05:27:53,217 IT'S REALLY A PRIVILEGE TO BE 7155 05:27:53,217 --> 05:27:53,417 HERE. 7156 05:27:53,417 --> 05:27:54,551 I WAS ASKED TO SHARE SOME 7157 05:27:54,551 --> 05:27:56,053 THOUGHTS ON THE INTERSECTION OF 7158 05:27:56,053 --> 05:27:57,688 PULMONARY VASCULAR DISEASE, 7159 05:27:57,688 --> 05:27:59,656 SOCIAL DISPARITIES AMONG THE 7160 05:27:59,656 --> 05:28:01,859 HOMELESS AND VETERANS GROUP, AND 7161 05:28:01,859 --> 05:28:02,960 I INTERPRETED THAT AND TREAT 7162 05:28:02,960 --> 05:28:04,361 THOSE AS SEPARATE GROUPS, 7163 05:28:04,361 --> 05:28:05,462 ALTHOUGH CERTAINLY THERE'S SOME 7164 05:28:05,462 --> 05:28:06,563 OVERLAP AND I'LL TOUCH ON THAT 7165 05:28:06,563 --> 05:28:07,831 AS WELL. 7166 05:28:07,831 --> 05:28:10,601 ONE OF THE EARLY DISCLAIMERS IS 7167 05:28:10,601 --> 05:28:12,503 THAT THIS IS REALLY A DATA-FREE 7168 05:28:12,503 --> 05:28:15,739 ZONE WITH RESPECT TO HOMELESS 7169 05:28:15,739 --> 05:28:16,039 INDIVIDUALS. 7170 05:28:16,039 --> 05:28:18,809 SO IF YOU'LL INDULGE ME, I'LL 7171 05:28:18,809 --> 05:28:20,978 TRY TO CONNECT SOME DOTS BETWEEN 7172 05:28:20,978 --> 05:28:22,746 SOCIAL DISPARITIES, CHALLENGES 7173 05:28:22,746 --> 05:28:23,947 FAILED BY HOMELESS INDIVIDUALS 7174 05:28:23,947 --> 05:28:26,049 AND HOW THAT MIGHT CREATE THE 7175 05:28:26,049 --> 05:28:29,086 CONDITIONS FOR DEVELOPMENT OF 7176 05:28:29,086 --> 05:28:30,854 PULMONARY VASCULAR DISEASE. 7177 05:28:30,854 --> 05:28:31,288 NEXT SLIDE. 7178 05:28:31,288 --> 05:28:33,123 SO THIS IS A SNAPSHOT OF 7179 05:28:33,123 --> 05:28:34,792 HOMELESSNESS IN AMERICA, DRAWING 7180 05:28:34,792 --> 05:28:36,093 YOUR ATTENTION ON THE FIGURE ON 7181 05:28:36,093 --> 05:28:39,029 THE LEFT FIRST, THIS IS NUMBERS 7182 05:28:39,029 --> 05:28:41,865 OVER TIME OF CHRONIC 7183 05:28:41,865 --> 05:28:44,968 HOMELESSNESS DEFINED HERE AS 7184 05:28:44,968 --> 05:28:48,338 EXTENDED PERIOD OF BEING WITHOUT 7185 05:28:48,338 --> 05:28:49,106 THE SHELTER. 7186 05:28:49,106 --> 05:28:50,641 AND IF YOU CONSIDER ON ANY GIVEN 7187 05:28:50,641 --> 05:28:52,176 NIGHT, THE NUMBERS ARE ABOUT 7188 05:28:52,176 --> 05:28:54,745 THREE TO FOUR FOLDER HIGHER, BUT 7189 05:28:54,745 --> 05:28:57,314 THIS IS DATA FOR CHRONIC 7190 05:28:57,314 --> 05:28:57,648 HOMELESSNESS. 7191 05:28:57,648 --> 05:28:59,283 YOU CAN SEE THERE'S AN UPTICK 7192 05:28:59,283 --> 05:29:00,484 OVER THE LAST SEVERAL YEARS. 7193 05:29:00,484 --> 05:29:01,919 I DON'T THINK THERE'S ANY SINGLE 7194 05:29:01,919 --> 05:29:04,521 CAUSE OF THAT, BUT SOME 7195 05:29:04,521 --> 05:29:05,489 CONTRIBUTORS THAT HAVE BEEN 7196 05:29:05,489 --> 05:29:07,591 CITED AND SEEM TO BE SORT OF 7197 05:29:07,591 --> 05:29:09,560 CONSENSUS CONTRIBUTORS ARE 7198 05:29:09,560 --> 05:29:11,495 GENERAL ECONOMIC INSTABILITY 7199 05:29:11,495 --> 05:29:13,297 OVER THE LAST SEVERAL YEARS, 7200 05:29:13,297 --> 05:29:15,799 COUPLED WITH INFLATION, COVID 7201 05:29:15,799 --> 05:29:16,867 PANDEMIC, WHICH AFFECTED 7202 05:29:16,867 --> 05:29:18,869 INDIVIDUALS WHO WERE SORT OF ON 7203 05:29:18,869 --> 05:29:20,737 THE MARGINS IN TERMS OF ECONOMIC 7204 05:29:20,737 --> 05:29:22,706 STABILITY MORE SO THAN OTHERS, 7205 05:29:22,706 --> 05:29:24,875 WITHDRAWAL OF COVID ASSISTANCE 7206 05:29:24,875 --> 05:29:26,944 DURING THE PANDEMIC, AND SOME 7207 05:29:26,944 --> 05:29:29,546 OTHER CAUSES. 7208 05:29:29,546 --> 05:29:31,648 ONE OF THE DISPARITIES AMONG THE 7209 05:29:31,648 --> 05:29:32,649 HOMELESS THAT IS REALLY 7210 05:29:32,649 --> 05:29:34,952 IMPORTANT TO CONSIDER IS 7211 05:29:34,952 --> 05:29:36,053 DISPLAYED ON THE RIGHT. 7212 05:29:36,053 --> 05:29:39,523 HERE YOU SEE IN GREEN THE 7213 05:29:39,523 --> 05:29:42,626 DISTRIBUTION OF DIFFERENT RACIAL 7214 05:29:42,626 --> 05:29:44,361 GROUPS IN THE U.S., AND IN BLUE 7215 05:29:44,361 --> 05:29:46,997 IS THE DISTRIBUTION AMONG THE 7216 05:29:46,997 --> 05:29:47,764 HOMELESS POPULATION. 7217 05:29:47,764 --> 05:29:49,566 SO ANYWHERE THAT THE BLUE BAR IS 7218 05:29:49,566 --> 05:29:52,069 LONGER THAN THE GREEN BAR 7219 05:29:52,069 --> 05:29:53,270 ACCIDENT THERE'S A RACIAL 7220 05:29:53,270 --> 05:29:54,571 DISPARITY IN TERMS OF 7221 05:29:54,571 --> 05:29:55,873 REPRESENTATION AMONG THE 7222 05:29:55,873 --> 05:29:56,139 HOMELESS. 7223 05:29:56,139 --> 05:29:59,076 YOU SEE THAT AS PARTICULARLY 7224 05:29:59,076 --> 05:30:00,244 MARKED AMONG BLACK INDIVIDUALS, 7225 05:30:00,244 --> 05:30:01,245 HISPANICS AND OTHERS. 7226 05:30:01,245 --> 05:30:03,447 NEXT SLIDE. 7227 05:30:03,447 --> 05:30:07,050 THERE ARE SOME DATA AMONG 7228 05:30:07,050 --> 05:30:07,317 VETERANS. 7229 05:30:07,317 --> 05:30:08,919 THIS IS VETERANS EXPERIENCING 7230 05:30:08,919 --> 05:30:10,153 HOMELESSNESS IN THE U.S., AND 7231 05:30:10,153 --> 05:30:12,055 YOU CAN SEE THAT THIS IS A 7232 05:30:12,055 --> 05:30:14,057 LITTLE BIT MORE OF A POSITIVE 7233 05:30:14,057 --> 05:30:14,291 PICTURE. 7234 05:30:14,291 --> 05:30:15,559 THERE'S A DECLINE OVER THE LAST 7235 05:30:15,559 --> 05:30:16,793 TEN TO TWELVE YEARS. 7236 05:30:16,793 --> 05:30:18,962 THIS IS LARGELY ATTRIBUTED ON A 7237 05:30:18,962 --> 05:30:21,265 LARGE INVESTMENT FROM THE OBAMA 7238 05:30:21,265 --> 05:30:22,666 ADMINISTRATION AND HOUSING AND 7239 05:30:22,666 --> 05:30:23,800 URBAN DEVELOPMENT AND IS REALLY 7240 05:30:23,800 --> 05:30:27,604 CITED AS A SUCCESS STORY FOR 7241 05:30:27,604 --> 05:30:29,339 ALLEVIATING HOMELESS VETERANS. 7242 05:30:29,339 --> 05:30:33,176 NEXT SLIDE, PLEASE. 7243 05:30:33,176 --> 05:30:35,012 SO THERE'S A LOT ON THIS SLIDE, 7244 05:30:35,012 --> 05:30:36,213 AND THE DETAILS ARE LESS 7245 05:30:36,213 --> 05:30:37,548 IMPORTANT THAN THE OVERALL 7246 05:30:37,548 --> 05:30:38,815 MESSAGE, AND THIS IS PROBABLY 7247 05:30:38,815 --> 05:30:40,050 ONE OF THE MORE IMPORTANT POINTS 7248 05:30:40,050 --> 05:30:41,184 THAT I WANT TO MAKE. 7249 05:30:41,184 --> 05:30:42,252 REALLY IT'S JUST TO HIGHLIGHT 7250 05:30:42,252 --> 05:30:45,956 THE INTERACTIONS AMONG SOCIAL 7251 05:30:45,956 --> 05:30:49,059 DISPARITIES, HOMELESSNESS AND 7252 05:30:49,059 --> 05:30:50,594 CHRONIC HEALTH CONDITIONS. 7253 05:30:50,594 --> 05:30:53,530 THE KEY POINT IS THAT THE 7254 05:30:53,530 --> 05:30:54,965 CONDITIONS AMONG SOCIAL 7255 05:30:54,965 --> 05:30:58,135 DISPARITIES SUCH AS POVERTY, 7256 05:30:58,135 --> 05:30:59,636 TRAUMA, DISCRIMINATION, CREATE 7257 05:30:59,636 --> 05:31:01,071 THE CONDITIONS THAT INCREASE 7258 05:31:01,071 --> 05:31:03,373 RISK FOR HOMELESSNESS, AND THEY 7259 05:31:03,373 --> 05:31:05,776 ALSO INCREASE RISK FOR VARIOUS 7260 05:31:05,776 --> 05:31:08,545 CHRONIC DISEASES. 7261 05:31:08,545 --> 05:31:10,647 THE EXPERIENCE OF BEING HOMELESS 7262 05:31:10,647 --> 05:31:11,915 AND THE CHALLENGES WITH 7263 05:31:11,915 --> 05:31:13,350 RECEIVING MEDICAL CARE AND 7264 05:31:13,350 --> 05:31:14,184 TREATING CHRONIC CONDITIONS 7265 05:31:14,184 --> 05:31:15,953 REALLY MAKE IT MORE DIFFICULT TO 7266 05:31:15,953 --> 05:31:17,821 EMERGE FROM THE HOMELESS 7267 05:31:17,821 --> 05:31:19,356 CONDITION AND THE RESULT IS AN 7268 05:31:19,356 --> 05:31:21,091 INCREASE IN CHRONIC DISEASES 7269 05:31:21,091 --> 05:31:24,161 ACROSS THE HUMAN PHENOME AS WELL 7270 05:31:24,161 --> 05:31:25,796 AS MARKED INCREASE IN THE RATES 7271 05:31:25,796 --> 05:31:27,130 OF MENTAL HEALTH CONDITIONS AND 7272 05:31:27,130 --> 05:31:29,433 SUBSTANCE USE DISORDERS. 7273 05:31:29,433 --> 05:31:32,402 NEXT SLIDE, PLEASE. 7274 05:31:32,402 --> 05:31:34,805 THIS IS A LOOK AT UNMET 7275 05:31:34,805 --> 05:31:36,873 HEALTHCARE NEEDS AMONG HOMELESS 7276 05:31:36,873 --> 05:31:37,107 ADULTS. 7277 05:31:37,107 --> 05:31:40,043 THESE DATA ARE A LITTLE OLDER, 7278 05:31:40,043 --> 05:31:42,879 ABOUT 1,000 SURVEYED HOMELESS 7279 05:31:42,879 --> 05:31:43,180 INDIVIDUALS. 7280 05:31:43,180 --> 05:31:45,182 WHAT WE SEE IS ABOUT A THIRD OF 7281 05:31:45,182 --> 05:31:47,150 THOSE INDIVIDUALS HAD UNMET 7282 05:31:47,150 --> 05:31:49,553 MEDICAL OR SURGICAL CARE NEEDS, 7283 05:31:49,553 --> 05:31:50,887 ABOUT A THIRD NEEDED 7284 05:31:50,887 --> 05:31:53,156 PRESCRIPTIONS THAT WEREN'T 7285 05:31:53,156 --> 05:31:54,591 OBTAINED, AND PERHAPS SORT OF 7286 05:31:54,591 --> 05:31:56,893 OBVIOUS NOW THAT WE'RE SEEING IT 7287 05:31:56,893 --> 05:31:59,062 BUT IT CERTAINLY WASN'T ON THE 7288 05:31:59,062 --> 05:32:00,063 FOREFRONT OF WHAT I WAS 7289 05:32:00,063 --> 05:32:02,132 THINKING, THE BIGGEST NEEDS WERE 7290 05:32:02,132 --> 05:32:03,333 EYEGLASSES AND DENTAL CARE, 7291 05:32:03,333 --> 05:32:04,768 WHICH MAKES A LOT OF SENSE. 7292 05:32:04,768 --> 05:32:06,069 THOSE ARE MAJOR DRIVERS OF 7293 05:32:06,069 --> 05:32:08,805 QUALITY OF LIFE AND REALLY 7294 05:32:08,805 --> 05:32:11,108 IMPORTANT UNMET HEALTHCARE NEEDS 7295 05:32:11,108 --> 05:32:12,843 AMONG THE HOMELESS. 7296 05:32:12,843 --> 05:32:15,946 NEXT SLIDE. 7297 05:32:15,946 --> 05:32:18,548 SO LOOKING HERE AT ALL CAUSE 7298 05:32:18,548 --> 05:32:20,183 MORTALITY AMONG THE HOMELESS, 7299 05:32:20,183 --> 05:32:21,818 THESE ARE CENSUS DATA. 7300 05:32:21,818 --> 05:32:24,021 THE Y AXIS IS THE PROBABILITY OF 7301 05:32:24,021 --> 05:32:24,421 DEATH. 7302 05:32:24,421 --> 05:32:25,656 THOSE NUMBERS ARE QUITE LOW 7303 05:32:25,656 --> 05:32:27,290 BECAUSE IT'S JUST A SIX-MONTH 7304 05:32:27,290 --> 05:32:29,359 PERIOD, BUT YOU CAN EXTRAPOLATE 7305 05:32:29,359 --> 05:32:31,995 AND THE SEPARATION WOULD BE THE 7306 05:32:31,995 --> 05:32:32,195 SAME. 7307 05:32:32,195 --> 05:32:34,831 I THINK THE KEY TAKE AWAY HERE 7308 05:32:34,831 --> 05:32:39,202 IS THE WIDE GAP BETWEEN THE 7309 05:32:39,202 --> 05:32:40,203 HOMELESS POPULATION WHICH IS THE 7310 05:32:40,203 --> 05:32:42,472 TOP LINE AND THOSE WHO ARE POOR 7311 05:32:42,472 --> 05:32:45,342 BUT HAVE A HOME, AND THAT'S THE 7312 05:32:45,342 --> 05:32:47,411 SECOND LINE THERE, WHICH THEY DO 7313 05:32:47,411 --> 05:32:49,279 WORSE THAN INDIVIDUALS WHO ARE 7314 05:32:49,279 --> 05:32:53,116 NOT POOR, BUT THE BIG GAP REALLY 7315 05:32:53,116 --> 05:32:54,851 IS BETWEEN -- IS REALLY IMPOSED 7316 05:32:54,851 --> 05:32:57,921 BY VIRTUE OF BEING HOMELESS. 7317 05:32:57,921 --> 05:33:01,858 NEXT SLIDE, PLEASE. 7318 05:33:01,858 --> 05:33:02,426 OR ADVANCE. 7319 05:33:02,426 --> 05:33:03,260 THANK YOU. 7320 05:33:03,260 --> 05:33:06,129 THESE ARE DATA, ALL CAUSE 7321 05:33:06,129 --> 05:33:07,097 MORTALITY AMONG THE VETERAN 7322 05:33:07,097 --> 05:33:08,532 POPULATION USING NATIONAL DEATH 7323 05:33:08,532 --> 05:33:09,166 INDEX DATA. 7324 05:33:09,166 --> 05:33:11,068 THIS IS A MUCH LONGER TERM 7325 05:33:11,068 --> 05:33:12,369 STUDY, THE FOLLOW-UP IS LONGER 7326 05:33:12,369 --> 05:33:13,603 THAN TEN YEARS, AS YOU CAN SEE 7327 05:33:13,603 --> 05:33:16,073 ON THE X AXIS. 7328 05:33:16,073 --> 05:33:18,608 AND HERE THEY'VE STRATIFIED 7329 05:33:18,608 --> 05:33:20,911 BASED ON NOT JUST HOMELESS 7330 05:33:20,911 --> 05:33:23,213 STATUS BUT ALSO AGE. 7331 05:33:23,213 --> 05:33:24,948 NOT SURPRISINGLY, OLDER 7332 05:33:24,948 --> 05:33:26,683 INDIVIDUALS HAVE HIGHER 7333 05:33:26,683 --> 05:33:30,087 MORTALITY THAN YOUNGER 7334 05:33:30,087 --> 05:33:31,188 INDIVIDUALS, BUT YOU CAN SEE 7335 05:33:31,188 --> 05:33:33,256 THAT THE SOLID LINES ARE BOTH 7336 05:33:33,256 --> 05:33:34,691 VETERAN AND HOMELESS 7337 05:33:34,691 --> 05:33:36,326 POPULATIONS, THOSE ARE BOTH 7338 05:33:36,326 --> 05:33:38,295 SHIFT DOWN QUITE A BIT. 7339 05:33:38,295 --> 05:33:42,466 SO THE MEDIAN SURVIVAL IN OLDER 7340 05:33:42,466 --> 05:33:45,736 HOMELESS VETERANS IS ABOUT TEN 7341 05:33:45,736 --> 05:33:45,936 YEARS. 7342 05:33:45,936 --> 05:33:48,572 NEXT SLIDE. 7343 05:33:48,572 --> 05:33:50,574 SO GETTING CLOSER, TRYING AT 7344 05:33:50,574 --> 05:33:51,975 LEAST AND GETTING CLOSER TO 7345 05:33:51,975 --> 05:33:53,410 CONNECTING THE DOTS WITH 7346 05:33:53,410 --> 05:33:54,311 PULMONARY VASCULAR DISEASE, THIS 7347 05:33:54,311 --> 05:33:56,813 IS NOW LOOKING AT HOMELESS 7348 05:33:56,813 --> 05:33:58,115 INDIVIDUALS AND RISK OF HEART 7349 05:33:58,115 --> 05:33:58,348 DISEASE. 7350 05:33:58,348 --> 05:34:01,384 THIS IS A META-ANALYSIS OF NINE 7351 05:34:01,384 --> 05:34:01,718 STUDIES. 7352 05:34:01,718 --> 05:34:06,957 THESE ARE POPULATIONS ACROSS THE 7353 05:34:06,957 --> 05:34:07,290 WORLD. 7354 05:34:07,290 --> 05:34:08,925 SO MORE THAN JUST THE UNITED 7355 05:34:08,925 --> 05:34:09,159 STATES. 7356 05:34:09,159 --> 05:34:10,560 WHAT YOU SEE IS THERE'S AN 7357 05:34:10,560 --> 05:34:11,795 INCREASED RISK OF CARDIOVASCULAR 7358 05:34:11,795 --> 05:34:13,730 DISEASE AMONG THE HOMELESS, THE 7359 05:34:13,730 --> 05:34:15,398 BOTTOM SQUARE THERE SHOWS THAT 7360 05:34:15,398 --> 05:34:17,033 THE OVERALL ODDS OF 7361 05:34:17,033 --> 05:34:18,034 CARDIOVASCULAR DISEASE ARE ABOUT 7362 05:34:18,034 --> 05:34:19,936 TWO TO THREEFOLD HIGHER AMONG 7363 05:34:19,936 --> 05:34:22,806 THE HOMELESS COMPARED TO THOSE 7364 05:34:22,806 --> 05:34:24,040 WHO AREN'T. 7365 05:34:24,040 --> 05:34:27,410 NEXT SLIDE. 7366 05:34:27,410 --> 05:34:30,147 SO I THINK ONE OF THE MORE SORT 7367 05:34:30,147 --> 05:34:33,416 OF SUCCINCT AND CLEVER WAYS OF 7368 05:34:33,416 --> 05:34:35,418 PUTTING THIS WAS FROM ONE OF THE 7369 05:34:35,418 --> 05:34:36,486 EDITORIALS I CAME ACROSS WHICH 7370 05:34:36,486 --> 05:34:38,255 SAYS THAT HOMELESSNESS IS A 7371 05:34:38,255 --> 05:34:40,090 CAUSE OF THE CAUSES OF 7372 05:34:40,090 --> 05:34:41,124 CARDIOVASCULAR DISEASE, AND I'LL 7373 05:34:41,124 --> 05:34:44,261 TRY TO CONVINCE YOU THAT THAT'S 7374 05:34:44,261 --> 05:34:45,796 ALSO -- HOMELESSNESS IS ALSO A 7375 05:34:45,796 --> 05:34:47,864 CAUSE OF THE CAUSES OF PULMONARY 7376 05:34:47,864 --> 05:34:49,466 VASCULAR DISEASE. 7377 05:34:49,466 --> 05:34:51,601 THIS IS AN ILLUSTRATION FROM A 7378 05:34:51,601 --> 05:34:54,004 RECENT REALLY WELL DONE REVIEW 7379 05:34:54,004 --> 05:34:56,506 ARTICLE FROM JACK AND IT 7380 05:34:56,506 --> 05:34:58,041 DISCUSSES -- FROM JACC AND 7381 05:34:58,041 --> 05:34:59,142 DISCUSSES THAT HOMELESS 7382 05:34:59,142 --> 05:35:00,510 INDIVIDUALS HAVE TRADITIONAL 7383 05:35:00,510 --> 05:35:02,445 RISK FACTORS FOR CARDIOVASCULAR 7384 05:35:02,445 --> 05:35:04,815 DISEASE, ABOUT 06 TO 80% ARE 7385 05:35:04,815 --> 05:35:06,683 SMOKERS OR FORMER SMOKERS, THAT 7386 05:35:06,683 --> 05:35:08,385 DRIVES A LOT OF THE ISCHEMIC 7387 05:35:08,385 --> 05:35:09,519 HEART DISEASE IN THIS 7388 05:35:09,519 --> 05:35:10,821 POPULATION. 7389 05:35:10,821 --> 05:35:12,489 INTERESTINGLY, AT LEAST BY THE 7390 05:35:12,489 --> 05:35:15,225 REPORTS THAT ARE PUBLISHED, THE 7391 05:35:15,225 --> 05:35:16,726 PREVALENCE OF HYPERTENSION AND 7392 05:35:16,726 --> 05:35:18,495 DIABETES IS FAIRLY SIMILAR 7393 05:35:18,495 --> 05:35:20,463 BETWEEN HOMELESS INDIVIDUALS AND 7394 05:35:20,463 --> 05:35:21,998 THOSE WHO AREN'T HOMELESS, 7395 05:35:21,998 --> 05:35:22,999 ALTHOUGH I SUSPECT THERE'S 7396 05:35:22,999 --> 05:35:24,734 PROBABLY QUITE A BIT OF 7397 05:35:24,734 --> 05:35:26,369 UNDERDIAGNOSIS OR MISDIAGNOSIS 7398 05:35:26,369 --> 05:35:26,736 THERE. 7399 05:35:26,736 --> 05:35:29,306 BUT IT'S ALSO IMPORTANT THAT 7400 05:35:29,306 --> 05:35:30,974 THESE COMORBIDITIES ARE LESS 7401 05:35:30,974 --> 05:35:32,609 WELL CONTROLLED IN THE HOMELESS 7402 05:35:32,609 --> 05:35:34,144 POPULATION, THAT'S PRETTY WELL 7403 05:35:34,144 --> 05:35:34,477 ESTABLISHED. 7404 05:35:34,477 --> 05:35:36,213 AND THEN ON THE TOP RIGHT, THERE 7405 05:35:36,213 --> 05:35:38,181 ARE ALSO QUITE A BIT OF 7406 05:35:38,181 --> 05:35:40,050 HEIGHTENED NONTRADITIONAL RISK 7407 05:35:40,050 --> 05:35:41,151 FACTORS, INCLUDING CHRONIC 7408 05:35:41,151 --> 05:35:42,886 STRESS, AND WE'LL HEAR SOME 7409 05:35:42,886 --> 05:35:46,056 EXPERT COMMENTARY ON ALLOSTERIC 7410 05:35:46,056 --> 05:35:47,824 LOAD, INCREASED RISK OF 7411 05:35:47,824 --> 05:35:49,793 DEPRESSION, HEAVY ALCOHOL AND 7412 05:35:49,793 --> 05:35:52,729 COCAINE USE, AND THEN A SPECIAL 7413 05:35:52,729 --> 05:35:54,497 RISK FACTOR THAT'S HEIGHTENED 7414 05:35:54,497 --> 05:35:56,132 AMONG THE VETERANS -- OR THE 7415 05:35:56,132 --> 05:35:57,667 HOMELESS RATHER IS HIV, AND 7416 05:35:57,667 --> 05:35:58,869 SOMEWHERE BETWEEN TWO TO TEN 7417 05:35:58,869 --> 05:36:00,503 PERCENT OF HOMELESS INDIVIDUALS 7418 05:36:00,503 --> 05:36:02,606 ARE HIV POSITIVE DEPENDING ON 7419 05:36:02,606 --> 05:36:04,674 THE POPULATION THAT YOU STUDY. 7420 05:36:04,674 --> 05:36:07,077 SO YOU TAKE THESE INCREASED 7421 05:36:07,077 --> 05:36:08,278 CARDIOVASCULAR RISK FACTORS AND 7422 05:36:08,278 --> 05:36:10,013 YOU LAYER ON THAT THE DIFFICULTY 7423 05:36:10,013 --> 05:36:12,115 WITH DIAGNOSING CARDIOVASCULAR 7424 05:36:12,115 --> 05:36:13,950 DISEASE IN THIS POPULATION AND 7425 05:36:13,950 --> 05:36:16,052 THAT STEMS FROM CHALLENGES 7426 05:36:16,052 --> 05:36:17,888 AROUND THE LOGISTICS OF TESTING, 7427 05:36:17,888 --> 05:36:20,624 WHICH I'LL COMMENT ON, THE LACK 7428 05:36:20,624 --> 05:36:24,160 OF USUAL CARE SOURCES, AND OTHER 7429 05:36:24,160 --> 05:36:24,461 CAUSES. 7430 05:36:24,461 --> 05:36:26,429 SO EVEN IF YOU CAN DIAGNOSE 7431 05:36:26,429 --> 05:36:28,498 CARDIOVASCULAR DISEASE IN THIS 7432 05:36:28,498 --> 05:36:30,467 POPULATION, THEN YOU'RE FACING 7433 05:36:30,467 --> 05:36:33,336 DIFFICULT MANAGEMENT 7434 05:36:33,336 --> 05:36:33,703 CONSIDERATIONS. 7435 05:36:33,703 --> 05:36:36,072 THERE ARE ALL KINDS OF 7436 05:36:36,072 --> 05:36:39,009 CHALLENGES WITH OBTAINING 7437 05:36:39,009 --> 05:36:40,977 MEDICATIONS, STAYING ADHERENCE, 7438 05:36:40,977 --> 05:36:42,178 THERE'S FRAGMENTATION OF CARE 7439 05:36:42,178 --> 05:36:45,582 BECAUSE THE ACCESS TO CARE IS 7440 05:36:45,582 --> 05:36:47,550 LIMITED AMONG MANY OF THESE 7441 05:36:47,550 --> 05:36:47,851 POPULATIONS. 7442 05:36:47,851 --> 05:36:50,053 AND ALL OF THESE CONVERGE TO 7443 05:36:50,053 --> 05:36:51,788 INCREASE RISK OF CARDIOVASCULAR 7444 05:36:51,788 --> 05:36:54,090 DISEASE, WHICH IS A MAJOR 7445 05:36:54,090 --> 05:36:55,959 CONTRIBUTOR TO DEATH AMONG THE 7446 05:36:55,959 --> 05:36:56,693 HOMELESS POPULATION. 7447 05:36:56,693 --> 05:36:58,495 IF YOU LOOK ACROSS REALLY ALL 7448 05:36:58,495 --> 05:37:01,431 AGE GROUPS AMONG THE HOMELESS, 7449 05:37:01,431 --> 05:37:03,300 HEART DISEASE AND CANCER ARE 7450 05:37:03,300 --> 05:37:04,601 VIRTUALLY IDENTICAL, BUT THEY'RE 7451 05:37:04,601 --> 05:37:07,003 THE SECOND LEADING CAUSE OF 7452 05:37:07,003 --> 05:37:08,738 DEATH ACROSS ALL AGE GROUPS FOR 7453 05:37:08,738 --> 05:37:11,675 THE HOMELESS POPULATION. 7454 05:37:11,675 --> 05:37:16,112 NEXT SLIDE, PLEASE. 7455 05:37:16,112 --> 05:37:18,715 SO I HAVEN'T FORGOTTEN ABOUT THE 7456 05:37:18,715 --> 05:37:19,582 PULMONOLOGISTS IN THE GROUP. 7457 05:37:19,582 --> 05:37:21,318 THERE ALSO IS AN INCREASED RISK, 7458 05:37:21,318 --> 05:37:22,986 NOT SURPRISINGLY, IN PREVALENCE 7459 05:37:22,986 --> 05:37:25,588 OF PULMONARY DISEASE IN THE 7460 05:37:25,588 --> 05:37:25,855 HOMELESS. 7461 05:37:25,855 --> 05:37:27,891 THIS IS A NICE STUDY IN THE 7462 05:37:27,891 --> 05:37:35,432 GREATER LONDON AREA, I THINK 7463 05:37:35,432 --> 05:37:38,735 COMMON -- LOOKING AT CHRONIC 7464 05:37:38,735 --> 05:37:41,037 COMMON CO-MORE DID TIZ. 7465 05:37:41,037 --> 05:37:43,106 ONE IS LEAST DEPRIVED, FIVE IS 7466 05:37:43,106 --> 05:37:43,907 MOST DEPRIVED. 7467 05:37:43,907 --> 05:37:45,175 IF YOU SQUINT THERE'S A STEP 7468 05:37:45,175 --> 05:37:46,776 WISE INCREASE AS THE DEPRIVATION 7469 05:37:46,776 --> 05:37:48,545 INDEX WORSENS BUT THEN THERE'S 7470 05:37:48,545 --> 05:37:50,447 THIS HUGE JUMP WHEN IT COMES TO 7471 05:37:50,447 --> 05:37:51,648 HOMELESS STATUS. 7472 05:37:51,648 --> 05:37:53,950 YOU SEE THAT WITH HEART DISEASE, 7473 05:37:53,950 --> 05:37:56,119 BUT PARTICULARLY PRONOUNCED WITH 7474 05:37:56,119 --> 05:37:59,189 CHRONIC RESPIRATORY DISEASES, 7475 05:37:59,189 --> 05:38:01,257 PARTICULARLY COPD AND ASTHMA. 7476 05:38:01,257 --> 05:38:02,258 SO WHAT YOU FOUND IS THAT 7477 05:38:02,258 --> 05:38:03,660 THERE'S AN INCREASE BOTH WITH 7478 05:38:03,660 --> 05:38:05,095 CARDIOVASCULAR AND PULMONARY 7479 05:38:05,095 --> 05:38:06,963 DISEASE THAT WE KNOW ARE THE 7480 05:38:06,963 --> 05:38:08,932 MAJOR UNDERLYING RISK FACTORS 7481 05:38:08,932 --> 05:38:10,467 FOR MOST OF THE PULMONARY 7482 05:38:10,467 --> 05:38:12,736 HYPERTENSION IN THE U.S. AND 7483 05:38:12,736 --> 05:38:13,003 WORLDWIDE. 7484 05:38:13,003 --> 05:38:16,906 NEXT SLIDE. 7485 05:38:16,906 --> 05:38:18,775 SO THIS WAS MY ATTEMPT TO 7486 05:38:18,775 --> 05:38:20,410 CONNECT SOME DOTS IN THE 7487 05:38:20,410 --> 05:38:21,811 HOMELESS POPULATION WHERE THERE 7488 05:38:21,811 --> 05:38:23,780 REALLY IS NOT ANY DIRECT DAFT ON 7489 05:38:23,780 --> 05:38:24,681 PULMONARY VASCULAR DISEASE. 7490 05:38:24,681 --> 05:38:27,617 IF I MISS IT, ARE PLEASE BRING 7491 05:38:27,617 --> 05:38:30,120 IT UP IN THE DISCUSSION. 7492 05:38:30,120 --> 05:38:31,788 THIS IS ALSO NOT AN ATTEMPT 7493 05:38:31,788 --> 05:38:33,757 ALTHOUGH AN ATTEMPTED ACYCLIC 7494 05:38:33,757 --> 05:38:35,592 GRAVMENT I APOLOGIZE TO ANY OF 7495 05:38:35,592 --> 05:38:37,060 THE EPIDEMIOLOGISTS, THERE ARE 7496 05:38:37,060 --> 05:38:38,661 PROBABLY SOME MISSING ARROWS 7497 05:38:38,661 --> 05:38:40,296 HERE AND LOOPS I DIDN'T CONNECT. 7498 05:38:40,296 --> 05:38:41,831 BUT THE POINT I WANT TO MAKE IS 7499 05:38:41,831 --> 05:38:44,801 THAT SOCIAL DISPARITIES IN 7500 05:38:44,801 --> 05:38:46,302 HOMELESSNESS ARE RISK FACTORS 7501 05:38:46,302 --> 05:38:47,737 FOR ONE ANOTHER AND THEY 7502 05:38:47,737 --> 05:38:48,938 EXACERBATE ONE ANOTHER. 7503 05:38:48,938 --> 05:38:50,807 THEY BOTH CONTRIBUTE TO THE 7504 05:38:50,807 --> 05:38:53,643 DEVELOPMENT OF RISK FACTORS FOR 7505 05:38:53,643 --> 05:38:55,612 CARDIOVASCULAR AND PULMONARY 7506 05:38:55,612 --> 05:38:57,680 DISEASE, WHICH IN TURN ARE OF 7507 05:38:57,680 --> 05:38:59,983 COURSE THE GREATEST RISK FACTORS 7508 05:38:59,983 --> 05:39:01,418 FOR PULMONARY VASCULAR DISEASE. 7509 05:39:01,418 --> 05:39:03,286 SO I'VE TRIED TO MAKE THOSE SORT 7510 05:39:03,286 --> 05:39:05,889 OF LOGICAL EXTENSIONS. 7511 05:39:05,889 --> 05:39:07,657 JUST A BRIEF COMMENT ON SOME OF 7512 05:39:07,657 --> 05:39:08,858 THE SPECIAL CHALLENGES WITH 7513 05:39:08,858 --> 05:39:10,593 RESPECT TO PULMONARY VASCULAR 7514 05:39:10,593 --> 05:39:11,694 DISEASE DIAGNOSIS AND MANAGEMENT 7515 05:39:11,694 --> 05:39:13,563 IN THE HOMELESS POPULATION. 7516 05:39:13,563 --> 05:39:15,965 THOSE OF US WHO EVALUATE THESE 7517 05:39:15,965 --> 05:39:18,701 PATIENTS IN THE CLINIC KNOW THAT 7518 05:39:18,701 --> 05:39:20,003 THE EVALUATION OF COURSE 7519 05:39:20,003 --> 05:39:22,305 DEPENDING ON SORT OF UNDERLYING 7520 05:39:22,305 --> 05:39:23,606 CONSIDERATIONS IS 7521 05:39:23,606 --> 05:39:25,041 TIME-CONSUMING, IT'S OFTEN 7522 05:39:25,041 --> 05:39:27,110 COSTLY, AND IN MANY CASES TO GET 7523 05:39:27,110 --> 05:39:28,778 THE DEFINITIVE DIAGNOSIS 7524 05:39:28,778 --> 05:39:30,613 REQUIRES AN INVASIVE ASSESSMENT. 7525 05:39:30,613 --> 05:39:32,248 SO THERE ARE LOTS OF CHALLENGES 7526 05:39:32,248 --> 05:39:34,284 AROUND COMPLETING A THOROUGH 7527 05:39:34,284 --> 05:39:35,552 DIAGNOSTIC WORK-UP IN THE 7528 05:39:35,552 --> 05:39:37,053 HOMELESS POPULATION. 7529 05:39:37,053 --> 05:39:38,721 THEN THERE'S ALSO SOME 7530 05:39:38,721 --> 05:39:39,489 LIMITATIONS AROUND TREATMENT AND 7531 05:39:39,489 --> 05:39:42,425 A LOT OF THESE PATIENTS REQUIRE 7532 05:39:42,425 --> 05:39:43,626 FREQUENT DIURETIC ADJUSTMENTS 7533 05:39:43,626 --> 05:39:45,328 WHICH IN A PERFECT WORLD ALSO 7534 05:39:45,328 --> 05:39:47,697 COME ALONG WITH ELECTROLYTE 7535 05:39:47,697 --> 05:39:49,332 MONITORING AND FREQUENT 7536 05:39:49,332 --> 05:39:50,967 FOLLOW-UP, WHICH ISN'T ALWAYS 7537 05:39:50,967 --> 05:39:52,702 PRACTICAL AND OF COURSE SOME OF 7538 05:39:52,702 --> 05:39:57,207 THE MORE ADVANCED TREATMENTS FOR 7539 05:39:57,207 --> 05:39:59,175 PULMONARY ARTERIAL HYPERTENSION 7540 05:39:59,175 --> 05:40:00,276 IN PARTICULAR INCLUDING 7541 05:40:00,276 --> 05:40:01,478 INFUSIONS REPRESENT A PARTICULAR 7542 05:40:01,478 --> 05:40:08,785 CHALLENGE IN THIS POPULATION. 7543 05:40:08,785 --> 05:40:09,853 SO I'M GOING TO TRANSITION NOW 7544 05:40:09,853 --> 05:40:11,721 TO PULMONARY VASCULAR DISEASE 7545 05:40:11,721 --> 05:40:12,822 AMONG U.S. VETERANS WHICH WE 7546 05:40:12,822 --> 05:40:14,424 KNOW A LITTLE BIT MORE ABOUT BUT 7547 05:40:14,424 --> 05:40:15,758 FIRST I WANT TO GIVE SOME 7548 05:40:15,758 --> 05:40:18,261 BACKGROUND ABOUT U.S. VETERANS. 7549 05:40:18,261 --> 05:40:19,262 THE FIRST POINT IS THAT THERE 7550 05:40:19,262 --> 05:40:20,463 ARE A LOT OF THEM. 7551 05:40:20,463 --> 05:40:22,332 THERE ARE 18 MILLION VETERANS, 7552 05:40:22,332 --> 05:40:25,268 THAT'S ABOUT 1 IN 14 U.S. 7553 05:40:25,268 --> 05:40:25,502 ADULTS. 7554 05:40:25,502 --> 05:40:28,271 ABOUT HALF OF THE ADULTS OVER 65 7555 05:40:28,271 --> 05:40:30,406 ARE U.S. VETERANS, WHICH IS A 7556 05:40:30,406 --> 05:40:32,242 PRETTY STRIKING NUMBER, IF YOU 7557 05:40:32,242 --> 05:40:36,312 JUST PAUSE TO THINK ABOUT THAT. 7558 05:40:36,312 --> 05:40:36,546 ADVANCE. 7559 05:40:36,546 --> 05:40:40,150 ABOUT A QUARTER OF VETERANS ARE 7560 05:40:40,150 --> 05:40:42,018 MINORITIES, AND AMONG ACTIVE 7561 05:40:42,018 --> 05:40:46,289 DUTY VETERANS, SERVICE MEMBERS, 7562 05:40:46,289 --> 05:40:47,390 43 PERCENT ARE MINORITY. 7563 05:40:47,390 --> 05:40:49,792 SO MOST OF THOSE WHO ARE OVER 65 7564 05:40:49,792 --> 05:40:51,628 ARE WHITE, AND AS THEY PASS 7565 05:40:51,628 --> 05:40:54,364 AWAY, THE PROPORTION OF VETERANS 7566 05:40:54,364 --> 05:40:56,332 WHO ARE MINORITIES WILL GROW 7567 05:40:56,332 --> 05:40:59,402 SUBSTANTIALLY OVER THE COMING 7568 05:40:59,402 --> 05:40:59,836 YEARS. 7569 05:40:59,836 --> 05:41:00,403 ADVANCE, PLEASE. 7570 05:41:00,403 --> 05:41:02,572 SO IF YOU'LL FORGIVE THE SOAPBOX 7571 05:41:02,572 --> 05:41:05,308 MOMENT, I JUST WANT TO EMPHASIZE 7572 05:41:05,308 --> 05:41:06,543 HOW MANY WOMEN VETERANS THERE 7573 05:41:06,543 --> 05:41:07,010 ARE. 7574 05:41:07,010 --> 05:41:09,345 SO 10% OF VETERANS ARE WOMEN, 7575 05:41:09,345 --> 05:41:12,849 THAT'S ABOUT 2 MILLION WOMEN, 7576 05:41:12,849 --> 05:41:15,585 AND WITHOUT FAIL, WHEN WE 7577 05:41:15,585 --> 05:41:17,921 PRESENT DATA ON THE VETERAN 7578 05:41:17,921 --> 05:41:19,889 POPULATION FOR STUDYING 7579 05:41:19,889 --> 05:41:21,090 PULMONARY VASCULAR DISEASE, THE 7580 05:41:21,090 --> 05:41:23,059 CRITICISM IS THEY'RE MOSTLY MEN, 7581 05:41:23,059 --> 05:41:25,929 AND THAT'S TRUE AS A PERCENTAGE, 7582 05:41:25,929 --> 05:41:30,166 BUT THE ABSOLUTE NUMBER OF WOMEN 7583 05:41:30,166 --> 05:41:32,268 VETERANS IS MORE THAN 7584 05:41:32,268 --> 05:41:33,770 FRAMINGHAM, CARDIA, ERIC, MESA 7585 05:41:33,770 --> 05:41:37,273 AND OTHER NHLBI COHORT COMBINED. 7586 05:41:37,273 --> 05:41:40,009 SO I SORT OF BRISTLE WITH THE 7587 05:41:40,009 --> 05:41:41,444 NOTION THAT THE VETERAN 7588 05:41:41,444 --> 05:41:42,745 POPULATION IS INVALUABLE FOR 7589 05:41:42,745 --> 05:41:43,846 LEARNING ABOUT PULMONARY 7590 05:41:43,846 --> 05:41:47,116 VASCULAR DISEASE IN WOMEN. 7591 05:41:47,116 --> 05:41:50,286 NEXT SLIDE. 7592 05:41:50,286 --> 05:41:53,556 SO JUST A LITTLE BACKGROUND 7593 05:41:53,556 --> 05:41:55,291 ABOUT SOCIODEMOGRAPHICS OF U.S. 7594 05:41:55,291 --> 05:41:56,859 VETERANS, AS I JUST SHOWED YOU, 7595 05:41:56,859 --> 05:41:58,928 THEY TEND TO BE OLDER THAN 7596 05:41:58,928 --> 05:42:00,029 NONVETERANS, THEY'RE MORE LIKELY 7597 05:42:00,029 --> 05:42:03,299 TO BE MARRIED, THE EDUCATIONAL 7598 05:42:03,299 --> 05:42:06,002 PROFILE IS PRETTY INTERESTING. 7599 05:42:06,002 --> 05:42:08,538 SIMILAR RATES OF LESS THAN HIGH 7600 05:42:08,538 --> 05:42:10,173 SCHOOL EDUCATION, BUT 7601 05:42:10,173 --> 05:42:11,507 INTERESTINGLY THERE'S AN 7602 05:42:11,507 --> 05:42:14,110 INCREASED PROPORTION OF WHANS 7603 05:42:14,110 --> 05:42:15,878 WHO ARE COLLEGE EDUCATED IN 7604 05:42:15,878 --> 05:42:19,249 LIGHT OF ACCESS TO THE GI BILL. 7605 05:42:19,249 --> 05:42:20,550 THE UNEMPLOYMENT DATA ARE A 7606 05:42:20,550 --> 05:42:21,451 LITTLE BIT HARD TO INTERPRET 7607 05:42:21,451 --> 05:42:22,986 BECAUSE MANY OF THESE VETERANS 7608 05:42:22,986 --> 05:42:25,054 ARE RETIRED, BUT AMONG THOSE WHO 7609 05:42:25,054 --> 05:42:27,123 ARE NOT RETIRED, UNEMPLOYMENT 7610 05:42:27,123 --> 05:42:28,791 RATES ARE FAIRLY SIMILAR BETWEEN 7611 05:42:28,791 --> 05:42:31,961 VETERANS AND NONVETERANS. 7612 05:42:31,961 --> 05:42:33,463 HOUSEHOLD INCOME IS A LITTLE BIT 7613 05:42:33,463 --> 05:42:34,897 HIGHER AMONG VETERANS, PROBABLY 7614 05:42:34,897 --> 05:42:38,067 AGAIN REFLECTING AGE AND LONGER 7615 05:42:38,067 --> 05:42:39,702 EARNING POTENTIAL. 7616 05:42:39,702 --> 05:42:41,471 AND THEN THERE ARE INCREASED 7617 05:42:41,471 --> 05:42:43,873 RATES OF HOMELESSNESS AND 7618 05:42:43,873 --> 05:42:46,409 SUBSTANTIALLY INCREASED RATES OF 7619 05:42:46,409 --> 05:42:48,378 MENTAL HEALTH CONDITIONS, 7620 05:42:48,378 --> 05:42:50,647 DEPRESSION AND PTSD IN 7621 05:42:50,647 --> 05:42:54,284 PARTICULAR AS WELL AS SUBSTANCE 7622 05:42:54,284 --> 05:42:54,484 USE. 7623 05:42:54,484 --> 05:42:56,319 WHILE I'M ON THIS SLIDE, I GOT 7624 05:42:56,319 --> 05:42:57,220 SOME DATA THIS MORNING THAT I 7625 05:42:57,220 --> 05:42:58,454 DIDN'T HAVE TIME TO INTEGRATE 7626 05:42:58,454 --> 05:42:59,889 BUT I WANTED TO SHARE, WHICH IS 7627 05:42:59,889 --> 05:43:02,725 AMONG THE SOCIODEMOGRAPHIC 7628 05:43:02,725 --> 05:43:05,194 FEATURES THAT ARE RISK FACTORS 7629 05:43:05,194 --> 05:43:07,730 OR PROTECTIVE FOR PULMONARY 7630 05:43:07,730 --> 05:43:09,232 HYPERTENSION, THE STRONGEST 7631 05:43:09,232 --> 05:43:12,335 PROTECTIVE FEATURE AMONG U.S. 7632 05:43:12,335 --> 05:43:14,037 VETERANS AGAINST PULMONARY 7633 05:43:14,037 --> 05:43:15,938 HYPERTENSION RISK WAS BEING 7634 05:43:15,938 --> 05:43:18,107 MARRIED, AND IN A POPULATION 7635 05:43:18,107 --> 05:43:19,542 THAT'S PREDOMINANTLY MALE, I'LL 7636 05:43:19,542 --> 05:43:20,843 LET YOU MAKE YOUR OWN 7637 05:43:20,843 --> 05:43:24,013 INTERPRETATION OF THAT FINDING. 7638 05:43:24,013 --> 05:43:27,083 NEXT SLIDE, PLEASE. 7639 05:43:27,083 --> 05:43:28,084 THIS GIVES A LITTLE BIT MORE 7640 05:43:28,084 --> 05:43:31,421 ABOUT THE COMORBIDITY PROFILE 7641 05:43:31,421 --> 05:43:32,555 AMONG U.S. VETERANS. 7642 05:43:32,555 --> 05:43:36,159 YOU SEE INCREASED RATES OF COPD, 7643 05:43:36,159 --> 05:43:39,228 INCREASED RATES OF DIABETES, AND 7644 05:43:39,228 --> 05:43:40,797 PARTICULARLY HIGHER RATES OF 7645 05:43:40,797 --> 05:43:42,632 MENTAL HEALTH CONDITIONS, IN 7646 05:43:42,632 --> 05:43:46,135 PARTICULAR AS I SAID PTSD ON THE 7647 05:43:46,135 --> 05:43:47,136 FAR RIGHT. 7648 05:43:47,136 --> 05:43:49,539 NEXT SLIDE, PLEASE. 7649 05:43:49,539 --> 05:43:51,407 SO NOW I'M GOING TO SHOW YOU A 7650 05:43:51,407 --> 05:43:52,608 LITTLE BIT OF SORT OF THE RAW 7651 05:43:52,608 --> 05:43:54,677 DATA THAT WE KNOW ABOUT 7652 05:43:54,677 --> 05:43:56,446 PULMONARY VASCULAR DISEASE AND 7653 05:43:56,446 --> 05:43:58,114 PULMONARY HYPERTENSION IN THE 7654 05:43:58,114 --> 05:43:59,615 VETERAN POPULATIONS. 7655 05:43:59,615 --> 05:44:01,484 BY AND LARGE, THESE ARE 7656 05:44:01,484 --> 05:44:03,219 COMPARISONS OF VETERANS WITH THE 7657 05:44:03,219 --> 05:44:03,986 VANDERBILT POPULATION BECAUSE 7658 05:44:03,986 --> 05:44:05,888 THAT'S WHAT WE HAVE ACCESS TO 7659 05:44:05,888 --> 05:44:08,458 AND IS A LARGE TERTIARY CARE 7660 05:44:08,458 --> 05:44:10,993 CENTER OF PATIENTS SEEKING CARE. 7661 05:44:10,993 --> 05:44:12,762 AND THIS IS GOING TO BE A 7662 05:44:12,762 --> 05:44:14,163 COMPARISON OF INDIVIDUALS WHO 7663 05:44:14,163 --> 05:44:16,466 WERE REFERRED FOR 7664 05:44:16,466 --> 05:44:16,833 ECHOCARDIOGRAMS. 7665 05:44:16,833 --> 05:44:18,334 THIS IS NOT THE POPULATION IN 7666 05:44:18,334 --> 05:44:19,302 GENERAL, THESE ARE PATIENTS 7667 05:44:19,302 --> 05:44:20,737 SEEKING CARE AND THEIR PROVIDER 7668 05:44:20,737 --> 05:44:24,440 HAD SOME REASON TO ORDER AN 7669 05:44:24,440 --> 05:44:25,274 ECHOCARDIOGRAM. 7670 05:44:25,274 --> 05:44:27,744 SO PRESUMABLY SOME SUSPICION OF 7671 05:44:27,744 --> 05:44:29,946 CARDIOPULMONARY DISEASE. 7672 05:44:29,946 --> 05:44:31,381 THE AGE OF INDIVIDUALS REFERRED 7673 05:44:31,381 --> 05:44:34,650 FOR ECHO IS FAIRLY SIMILAR. 7674 05:44:34,650 --> 05:44:36,052 AGAIN, THE PROPORTION OF 7675 05:44:36,052 --> 05:44:39,122 VETERANS WHO ARE MALES IS MUCH 7676 05:44:39,122 --> 05:44:39,455 HIGHER. 7677 05:44:39,455 --> 05:44:41,324 VANDERBILT IS A LITTLE BIT MORE 7678 05:44:41,324 --> 05:44:41,591 BALANCED. 7679 05:44:41,591 --> 05:44:43,559 THE BMI IS SIMILAR. 7680 05:44:43,559 --> 05:44:45,661 THERE IS A HIGHER PROPORTION OF 7681 05:44:45,661 --> 05:44:46,863 BLACK AND HISPANIC INDIVIDUALS 7682 05:44:46,863 --> 05:44:48,664 AMONG VETERANS WHO WERE REFERRED 7683 05:44:48,664 --> 05:44:49,632 FOR ECHO. 7684 05:44:49,632 --> 05:44:51,501 HEART FAILURE RATES ARE FAIRLY 7685 05:44:51,501 --> 05:44:54,337 SIMILAR, AS YOU CAN SEE, 18 7686 05:44:54,337 --> 05:44:55,872 VERSUS 21-H THE SUBSTANTIALLY 7687 05:44:55,872 --> 05:44:57,640 MORE, MORE THAN TWICE AS HIGH, 7688 05:44:57,640 --> 05:45:00,910 PREVALENCE OF COPD AMONG 7689 05:45:00,910 --> 05:45:01,344 VETERANS. 7690 05:45:01,344 --> 05:45:02,445 LOTS OF PEOPLE HAVE 7691 05:45:02,445 --> 05:45:02,779 HYPERTENSION. 7692 05:45:02,779 --> 05:45:04,313 THIS IS AN OLDER POPULATION, SO 7693 05:45:04,313 --> 05:45:07,383 THOSE RATES ARE FAIRLY SIMILAR. 7694 05:45:07,383 --> 05:45:08,885 BUT THERE IS INTERESTINGLY A 7695 05:45:08,885 --> 05:45:11,087 MUCH HIGHER PREVALENCE OF 7696 05:45:11,087 --> 05:45:12,722 DIABETES AMONG VETERANS COMPARED 7697 05:45:12,722 --> 05:45:14,924 IN THIS CASE TO THE VANDERBILT 7698 05:45:14,924 --> 05:45:15,892 POPULATION. 7699 05:45:15,892 --> 05:45:17,760 I SUSPECT THERE ARE SORT OF 7700 05:45:17,760 --> 05:45:19,295 SCREENING AND DIAGNOSIS METRICS 7701 05:45:19,295 --> 05:45:20,830 WITHIN THE VA THAT THEY'RE 7702 05:45:20,830 --> 05:45:22,899 PROBABLY MORE VIGOROUS THAN 7703 05:45:22,899 --> 05:45:24,967 VANDERBILT IN THAT WAY, 7704 05:45:24,967 --> 05:45:26,636 EXPLAINING PART OF THAT 7705 05:45:26,636 --> 05:45:27,003 INCREASE. 7706 05:45:27,003 --> 05:45:31,140 NEXT SLIDE. 7707 05:45:31,140 --> 05:45:33,276 SO THIS IS LOOKING AT A LARGE 7708 05:45:33,276 --> 05:45:35,044 POPULATION OF VETERANS AND 7709 05:45:35,044 --> 05:45:37,780 VANDERBILT PATIENTS WHO HAVE AN 7710 05:45:37,780 --> 05:45:39,215 ECHO REFERRAL AS WELL AS A 7711 05:45:39,215 --> 05:45:41,617 PULMONARY PRESSURE ESTIMATE. 7712 05:45:41,617 --> 05:45:44,387 SO ABOUT 389,000 VETERANS. 7713 05:45:44,387 --> 05:45:46,322 I'LL NOTE THAT ABOUT 25,000 OF 7714 05:45:46,322 --> 05:45:50,026 THOSE INDIVIDUALS ARE WOMEN, AND 7715 05:45:50,026 --> 05:45:52,462 ABOUT 117,000 INDIVIDUALS FROM 7716 05:45:52,462 --> 05:45:52,762 VANDERBILT. 7717 05:45:52,762 --> 05:45:54,964 IF YOU LOOK AT THE PREVALENCE OF 7718 05:45:54,964 --> 05:45:56,866 PULMONARY HYPERTENSION, WHICH IS 7719 05:45:56,866 --> 05:45:58,134 IN A GIVEN INDIVIDUAL DO THEY 7720 05:45:58,134 --> 05:46:02,271 EVER HAVE A PH -- A PASP GREATER 7721 05:46:02,271 --> 05:46:03,806 THAN 35, THE PREVALENCE IS ABOUT 7722 05:46:03,806 --> 05:46:06,642 ONE IN THREE FOR BOTH 7723 05:46:06,642 --> 05:46:07,210 POPULATIONS. 7724 05:46:07,210 --> 05:46:09,278 AND YOU COULD CERTAINLY QUIBBLE 7725 05:46:09,278 --> 05:46:10,913 WITH 35 AS A CUTOFF. 7726 05:46:10,913 --> 05:46:12,348 MORE SENSITIVE, LESS SPECIFIC. 7727 05:46:12,348 --> 05:46:13,983 BUT THE RELATIVE PRO POURINGS 7728 05:46:13,983 --> 05:46:15,184 ARE FAIRLY SIMILAR BETWEEN 7729 05:46:15,184 --> 05:46:17,253 VETERANS AND NONVETERANS. 7730 05:46:17,253 --> 05:46:20,456 AND THEN I'M GOING TO GET INTO 7731 05:46:20,456 --> 05:46:22,625 THE INCIDENT RATES ON THE NEXT 7732 05:46:22,625 --> 05:46:24,160 SLIDE, AND I JUST WANT TO 7733 05:46:24,160 --> 05:46:25,461 HIGHLIGHT THAT MOST OF WHAT WE 7734 05:46:25,461 --> 05:46:28,664 KNOW FROM COHORT STUDIES AND 7735 05:46:28,664 --> 05:46:30,500 PULMONARY HYPERTENSION RELATES 7736 05:46:30,500 --> 05:46:32,502 PREVALENCE OF PULMONARY 7737 05:46:32,502 --> 05:46:33,436 HYPERTENSION, WE KNOW RELATIVELY 7738 05:46:33,436 --> 05:46:36,272 LESS ABOUT PH INCIDENTS. 7739 05:46:36,272 --> 05:46:36,806 -- INCIDENCE. 7740 05:46:36,806 --> 05:46:38,908 SO IN THIS STUDY WE IDENTIFIED 7741 05:46:38,908 --> 05:46:41,344 PEOPLE WHO HAD HAD AN ECHO WITH 7742 05:46:41,344 --> 05:46:43,746 A PULMONARY PRESSURE LESS THAN 7743 05:46:43,746 --> 05:46:46,148 35, SO EVIDENCE OF LACK OF 7744 05:46:46,148 --> 05:46:47,550 PULMONARY HYPERTENSION AT 7745 05:46:47,550 --> 05:46:49,318 BASELINE AND THEN LOOKED AT 7746 05:46:49,318 --> 05:46:52,588 SUBSEQUENTLY WHO WENT ON TO 7747 05:46:52,588 --> 05:46:54,557 DEVELOP PH ON A FUTURE ECHO. 7748 05:46:54,557 --> 05:46:57,293 AND THIS IS A BUSY TABLE, BUT 7749 05:46:57,293 --> 05:46:58,594 I'LL JUST DRAW YOUR ATTENTION TO 7750 05:46:58,594 --> 05:47:01,130 THE TWO RED BOXES. 7751 05:47:01,130 --> 05:47:02,865 THE TOABLGHTS INCIDENCE RATES 7752 05:47:02,865 --> 05:47:06,602 ARE -- TOTAL INCIDENCE RATES ARE 7753 05:47:06,602 --> 05:47:08,337 SIMILAR, 22 PER 1,000 PATIENT 7754 05:47:08,337 --> 05:47:09,972 YEARS VERSUS 25 PER 1,000 7755 05:47:09,972 --> 05:47:11,073 PATIENT YEARS. 7756 05:47:11,073 --> 05:47:12,375 FOR VISUALIZATION PURPOSES WE 7757 05:47:12,375 --> 05:47:13,175 STRATIFIED THESE INDIVIDUALS 7758 05:47:13,175 --> 05:47:16,445 BASED ON HEART FAILURE AND COPD 7759 05:47:16,445 --> 05:47:17,647 STATUS BECAUSE THAT'S FAR AND 7760 05:47:17,647 --> 05:47:20,049 AWAY THE MOST COMMON CAUSES OF 7761 05:47:20,049 --> 05:47:23,219 PH IN BOTH OF THESE POPULATIONS. 7762 05:47:23,219 --> 05:47:24,220 INTERESTINGLY WHAT YOU SEE IS 7763 05:47:24,220 --> 05:47:26,923 THAT THE INCIDENCE RATES OF PH 7764 05:47:26,923 --> 05:47:28,457 IS FAIRLY SIMILAR BETWEEN THESE 7765 05:47:28,457 --> 05:47:29,458 TWO POPULATIONS IF YOU CONSIDER 7766 05:47:29,458 --> 05:47:33,162 THAT IT'S PER 1,000 PATIENT 7767 05:47:33,162 --> 05:47:33,362 YEARS. 7768 05:47:33,362 --> 05:47:37,333 COPD IS HIGHER THAN NOT HAVING 7769 05:47:37,333 --> 05:47:38,568 COPD, HEART FAILURE IS HIGHER 7770 05:47:38,568 --> 05:47:40,703 THAN THE HAVING COPD AND THEN 7771 05:47:40,703 --> 05:47:42,471 THE COMBINATION IS ESSENTIALLY 7772 05:47:42,471 --> 05:47:42,738 ADDITIVE. 7773 05:47:42,738 --> 05:47:46,075 BUT AGAIN, ON A POPULATION LEVEL 7774 05:47:46,075 --> 05:47:47,510 FAIRLY SIMILAR RATES BETWEEN 7775 05:47:47,510 --> 05:47:49,412 THESE TWO COHORTS. 7776 05:47:49,412 --> 05:47:51,213 NEXT SLIDE. 7777 05:47:51,213 --> 05:47:52,748 BUT WHAT'S INTERESTING WHAT 7778 05:47:52,748 --> 05:47:55,351 HAPPENS AFTER THE DIAGNOSIS OF 7779 05:47:55,351 --> 05:47:56,352 INCIDENT PH. 7780 05:47:56,352 --> 05:47:58,988 SO THIS IS AN ALL CAUSE 7781 05:47:58,988 --> 05:48:00,957 MORTALITY CURVE STRATIFIED BY 7782 05:48:00,957 --> 05:48:04,794 HEART FAILURE AND COPD STATUS. 7783 05:48:04,794 --> 05:48:06,228 NEITHER IS THE CURVE ON THE TOP, 7784 05:48:06,228 --> 05:48:07,463 BOTH IS THE CURVE ON THE BOTTOM 7785 05:48:07,463 --> 05:48:08,864 FOR BOTH OF THESE, AND THE 7786 05:48:08,864 --> 05:48:10,633 SEPARATION IS FAIRLY SIMILAR 7787 05:48:10,633 --> 05:48:13,235 BASED ON HEART FAILURE AND COPD 7788 05:48:13,235 --> 05:48:14,870 STATUS, BUT WHAT YOU SEE IS THAT 7789 05:48:14,870 --> 05:48:16,405 THE VA CURVE ALL OF THOSE CURVES 7790 05:48:16,405 --> 05:48:18,941 ARE SHIFT SHIFTED DOWN. 7791 05:48:18,941 --> 05:48:20,676 SO THE PROGNOSIS AMONG VETERANS 7792 05:48:20,676 --> 05:48:24,080 AFTER A DIAGNOSIS OF PH IS 7793 05:48:24,080 --> 05:48:27,016 SUBSTANTIALLY WORSE COMPARED TO 7794 05:48:27,016 --> 05:48:28,451 THE CONTROL POPULATION, THE 7795 05:48:28,451 --> 05:48:31,020 CIVILIAN POPULATION, RATHER, AT 7796 05:48:31,020 --> 05:48:31,320 VANDERBILT. 7797 05:48:31,320 --> 05:48:33,356 SO THAT HAS SOME IMPLICATIONS 7798 05:48:33,356 --> 05:48:35,024 AROUND POTENTIALLY PH 7799 05:48:35,024 --> 05:48:37,093 RECOGNITION OR MANAGEMENT, 7800 05:48:37,093 --> 05:48:40,730 COMPETING RISKS, AND OTHER 7801 05:48:40,730 --> 05:48:43,132 INFLUENCES ON LARGER OUTCOMES. 7802 05:48:43,132 --> 05:48:49,138 NEXT SLIDE. 7803 05:48:49,138 --> 05:48:51,440 SO THAT WAS DATA ON ECHO 7804 05:48:51,440 --> 05:48:52,942 CARDIOGRAPHIC PULMONARY 7805 05:48:52,942 --> 05:48:53,909 HYPERTENSION AMONG VETERANS. 7806 05:48:53,909 --> 05:48:57,113 HERE WE'RE LOOKING AT PH 7807 05:48:57,113 --> 05:48:59,315 PREVALENCE AND PHENOTYPES AMONG 7808 05:48:59,315 --> 05:49:01,250 PATIENTS REFERRED FOR RIGHT 7809 05:49:01,250 --> 05:49:03,219 HEART CATHETERIZATION. 7810 05:49:03,219 --> 05:49:05,421 AGAIN, NOT AN UNSELECTED 7811 05:49:05,421 --> 05:49:06,622 POPULATION, THESE WERE PATIENTS 7812 05:49:06,622 --> 05:49:08,157 REFERRED FOR RIGHT HEART CATH 7813 05:49:08,157 --> 05:49:12,094 AND IF YOU LOOK AT CONSECUTIVE 7814 05:49:12,094 --> 05:49:13,629 INDIVIDUALS AT VANDERBILT AND 7815 05:49:13,629 --> 05:49:17,133 VA, SLIGHTLY HIGHER MILD PH 7816 05:49:17,133 --> 05:49:18,567 AMONG VETERANS, SLIGHTLY HIGHER 7817 05:49:18,567 --> 05:49:21,370 MORE SEVERE PH AMONG THE 7818 05:49:21,370 --> 05:49:23,239 VANDERBILT POPULATION. 7819 05:49:23,239 --> 05:49:25,341 AND THEN LOOKING SPECIFICKING AT 7820 05:49:25,341 --> 05:49:27,410 PULMONARY VASCULAR DISEASE USING 7821 05:49:27,410 --> 05:49:29,578 PVR AND AGAIN YOU CAN ARGUE 7822 05:49:29,578 --> 05:49:31,781 ABOUT THE CUTOFFS, SLIGHTLY 7823 05:49:31,781 --> 05:49:33,949 HIGHER AMONG VANDERBILT PATIENTS 7824 05:49:33,949 --> 05:49:37,153 FOR INCREASED RISK OF SEVERE 7825 05:49:37,153 --> 05:49:39,088 PULMONARY VASCULAR DISEASE. 7826 05:49:39,088 --> 05:49:41,390 NEXT SLIDE. 7827 05:49:41,390 --> 05:49:43,793 SO I JUST WANT TO END WITH A 7828 05:49:43,793 --> 05:49:45,761 COUPLE OF SPECIFIC RISK FACTORS 7829 05:49:45,761 --> 05:49:47,763 IN PH AND I'LL WRAP UP SHORTLY. 7830 05:49:47,763 --> 05:49:50,366 SO HIV IS A SPECIFIC RISK FACTOR 7831 05:49:50,366 --> 05:49:52,468 FOR PULMONARY ARTERIAL 7832 05:49:52,468 --> 05:49:54,403 HYPERTENSION WE KNOW AND THERE'S 7833 05:49:54,403 --> 05:49:56,939 SOME DATA FROM THE VA POPULATION 7834 05:49:56,939 --> 05:49:58,474 SUGGESTING THAT'S ALSO AN 7835 05:49:58,474 --> 05:49:59,675 INDEPENDENT RISK FACTOR FOR 7836 05:49:59,675 --> 05:50:02,745 OTHER CAUSES OF PH AMONG 7837 05:50:02,745 --> 05:50:03,012 VETERANS. 7838 05:50:03,012 --> 05:50:05,014 ON THE LEFT YOU CAN SEE THIS IS 7839 05:50:05,014 --> 05:50:07,450 COMPARING VETERANS WITH HIV TO 7840 05:50:07,450 --> 05:50:09,719 VETERANS WITHOUT HIV, HIGHER 7841 05:50:09,719 --> 05:50:12,354 INCIDENCE OF PH AMONG THOSE WITH 7842 05:50:12,354 --> 05:50:14,657 HIV, AND WHEN YOU DO A TIME 7843 05:50:14,657 --> 05:50:15,925 DEFINITIVE ANALYSIS ADJUSTING 7844 05:50:15,925 --> 05:50:17,526 FOR LOTS OF CO-VARIATES THAT 7845 05:50:17,526 --> 05:50:20,029 RISK IS INCREASED BY ABOUT 7846 05:50:20,029 --> 05:50:20,329 18 PERCENT. 7847 05:50:20,329 --> 05:50:24,500 NEXT SLIDE, PLEASE. 7848 05:50:24,500 --> 05:50:25,701 I WANT TO BRING ATTENTION TO 7849 05:50:25,701 --> 05:50:27,670 ANOTHER SORT OF EMERGING AND 7850 05:50:27,670 --> 05:50:30,039 NOVEL RISK FACTOR FOR PVD WHICH 7851 05:50:30,039 --> 05:50:31,807 IS NOT PARTICULARLY A SOCIAL 7852 05:50:31,807 --> 05:50:35,077 DISPARITY EXCEPT THAT IT'S A 7853 05:50:35,077 --> 05:50:37,279 RISK FACTOR THAT'S UNIQUE TO 7854 05:50:37,279 --> 05:50:40,116 VETERANS, AND THAT IS BURN PIT 7855 05:50:40,116 --> 05:50:40,549 EXPOSURE. 7856 05:50:40,549 --> 05:50:41,884 THIS FIRST GAINS SOME 7857 05:50:41,884 --> 05:50:44,620 RECOGNITION IN THE EARLY 2000S 7858 05:50:44,620 --> 05:50:46,489 AMONG SOLDIERS WHO ARE RETURNING 7859 05:50:46,489 --> 05:50:48,758 WITH UNEXPLAINED DYSPNEA FOUND 7860 05:50:48,758 --> 05:50:52,261 TO HAVE CONSTRICTIVE BRON YOA 7861 05:50:52,261 --> 05:50:54,363 LIGHTS AMONG LUNG BIOLOGY, 7862 05:50:54,363 --> 05:50:58,367 FOLLOWED UP BY PATHOLOGISTS AT 7863 05:50:58,367 --> 05:51:00,536 VANDERBILT WHO DID ANALYSIS OF 7864 05:51:00,536 --> 05:51:03,439 52 OPEN LUNG BIOPSIES, 7865 05:51:03,439 --> 05:51:04,974 UNEXPLAINED DYSPNEA HAD AN 7866 05:51:04,974 --> 05:51:07,042 APPROPRIATE WORK-UP, 7867 05:51:07,042 --> 05:51:07,810 NONDIAGNOSTIC LUNG BIOPSY, WHAT 7868 05:51:07,810 --> 05:51:09,678 YOU SEE IS THERE'S WHAT'S 7869 05:51:09,678 --> 05:51:13,482 DESCRIBED AS HYPERTENSIVE 7870 05:51:13,482 --> 05:51:14,817 VASCULOPATHY AS WELL AS FIBROSIS 7871 05:51:14,817 --> 05:51:17,987 OF AIRWAYS, PA RINK MA AND 7872 05:51:17,987 --> 05:51:20,723 PLEURA, AND I THINK THE 7873 05:51:20,723 --> 05:51:22,258 INTERESTING ASPECTS OF THIS, YOU 7874 05:51:22,258 --> 05:51:25,761 LOOK AT CLUSTER ONE IS 7875 05:51:25,761 --> 05:51:26,829 NONDEPLOYED INDIVIDUALS, 7876 05:51:26,829 --> 05:51:27,930 CLUSTERED TOGETHER THAT'S SORT 7877 05:51:27,930 --> 05:51:29,698 OF REASSURING, THERE'S SOME 7878 05:51:29,698 --> 05:51:32,201 INDIVIDUALS WHO HAD THIS POST 7879 05:51:32,201 --> 05:51:34,170 DEPLOYMENT RESPIRATORY SYNDROME 7880 05:51:34,170 --> 05:51:38,007 CLUSTERED WITH PULMONARILY -- 7881 05:51:38,007 --> 05:51:39,308 PATIENTS AND MOST OF THEM 7882 05:51:39,308 --> 05:51:41,076 CLUSTERED AS A UNIQUE ENTITY, 7883 05:51:41,076 --> 05:51:45,447 FIVE OF THOSE WENT ON TO HAVE 7884 05:51:45,447 --> 05:51:47,082 CATH ASSESSMENT, THREE OUT OF 7885 05:51:47,082 --> 05:51:49,251 FIVE OF WHOM WERE ULTIMATELY 7886 05:51:49,251 --> 05:51:50,452 DIAGNOSED WITH CLINICAL DPIEG 7887 05:51:50,452 --> 05:51:54,290 NOTICES OF PH. 7888 05:51:54,290 --> 05:51:55,324 SO -- DIAGNOSIS OF PH. 7889 05:51:55,324 --> 05:51:57,459 THIS IS A NOVEL ENTITY OF POST 7890 05:51:57,459 --> 05:51:58,661 DEPLOYMENT RESPIRATORY SYNDROME 7891 05:51:58,661 --> 05:51:59,995 WHICH AT LEAST IN THESE 7892 05:51:59,995 --> 05:52:02,064 INDIVIDUALS WASN'T A STRONG OR 7893 05:52:02,064 --> 05:52:04,033 OVERT CAUSE OF PULMONARY 7894 05:52:04,033 --> 05:52:05,334 HYPERTENSION PER SE BUT 7895 05:52:05,334 --> 05:52:09,271 CERTAINLY LED TO VASCULOPATHY ON 7896 05:52:09,271 --> 05:52:10,406 HISTO PATHOLOGY. 7897 05:52:10,406 --> 05:52:13,576 NEXT SLIDE. 7898 05:52:13,576 --> 05:52:15,377 SO SOME MORE OBSERVATIONAL DATA 7899 05:52:15,377 --> 05:52:17,046 IN THE VA POPULATION WHICH I'LL 7900 05:52:17,046 --> 05:52:19,348 SKIP OVER, BUT AGAIN, BURN PIT 7901 05:52:19,348 --> 05:52:21,984 EXPOSURE IS AN EMERGING RISK 7902 05:52:21,984 --> 05:52:23,619 FACTOR FOR CARDIOPULMONARY 7903 05:52:23,619 --> 05:52:23,853 DISEASE. 7904 05:52:23,853 --> 05:52:29,191 I'LL END ON THE NEXT SLIDE, 7905 05:52:29,191 --> 05:52:31,360 WHICH REALLY MIELTS UNDER 7906 05:52:31,360 --> 05:52:35,197 RECOGNITION AMONG VETERANS AND R 7907 05:52:35,197 --> 05:52:36,565 RECOGNITION AMONG U.S. VETERANS, 7908 05:52:36,565 --> 05:52:38,167 PROBABLY TRUE IN MOST OF OUR 7909 05:52:38,167 --> 05:52:40,135 MEDICAL SYSTEMS, FROM ABOUT A 7910 05:52:40,135 --> 05:52:44,039 DECADE AGO, FROM DR. MARON, 7911 05:52:44,039 --> 05:52:46,475 SHOWING 340 VETERANS WITH SEVERE 7912 05:52:46,475 --> 05:52:47,776 PULMONARILY HYPERTENSION BY 7913 05:52:47,776 --> 05:52:49,645 ECHO, PASP GREATER THAN 60, 7914 05:52:49,645 --> 05:52:51,046 RATES OF DIAGNOSTIC TESTING WERE 7915 05:52:51,046 --> 05:52:52,414 FAIRLY LOW AS YOU CAN SEE ON THE 7916 05:52:52,414 --> 05:52:54,884 RIGHT, ABOUT HALF GOT PFT'S, 7917 05:52:54,884 --> 05:52:56,218 ABOUT A THIRD GOT RIGHT HEART 7918 05:52:56,218 --> 05:52:58,220 CATHS AND THERE ARE REASONS WHY 7919 05:52:58,220 --> 05:52:59,188 SOME OF THESE INDIVIDUALS MAY 7920 05:52:59,188 --> 05:53:00,689 NOT GET A COMPLETE WORK-UP BUT I 7921 05:53:00,689 --> 05:53:02,124 THINK THE MOST STRIKING IS IF 7922 05:53:02,124 --> 05:53:05,160 YOU ADVANCE ON THIS SLIDE, THAT 7923 05:53:05,160 --> 05:53:06,829 ONLY 17 PERCENT OF THESE 7924 05:53:06,829 --> 05:53:08,264 INDIVIDUALS HAD PULMONARY 7925 05:53:08,264 --> 05:53:11,300 HYPERTENSION LISTED IN THE 7926 05:53:11,300 --> 05:53:12,735 PROBLEM LIST AND CONSIDERING 7927 05:53:12,735 --> 05:53:16,005 THAT A PASP OF GREATER THAN 60 7928 05:53:16,005 --> 05:53:16,805 CONSIDERING SYSTEMIC BLOOD 7929 05:53:16,805 --> 05:53:18,207 PRESSURE OF GREATER THAN 200 7930 05:53:18,207 --> 05:53:19,375 WHICH I SUSPECT WOULD SHOW UP ON 7931 05:53:19,375 --> 05:53:21,577 THE PROBLEM LIST OF ALL OF THESE 7932 05:53:21,577 --> 05:53:21,844 PATIENTS. 7933 05:53:21,844 --> 05:53:22,678 ADVANCE PLEASE. 7934 05:53:22,678 --> 05:53:23,545 THEN IF YOU LOOK AT THE 7935 05:53:23,545 --> 05:53:25,948 INDIVIDUALS WHO HAD PH BY ECHO 7936 05:53:25,948 --> 05:53:27,049 AND CROSS-REFERENCE THAT WITH 7937 05:53:27,049 --> 05:53:29,318 THE PRESENCE OF A CODE FOR PH 7938 05:53:29,318 --> 05:53:31,854 ONLY ABOUT 18 PERCENT OF 7939 05:53:31,854 --> 05:53:33,589 PATIENTS WITH PH BY ECHO 7940 05:53:33,589 --> 05:53:36,725 ACTUALLY HAD A CODE. 7941 05:53:36,725 --> 05:53:38,193 SO FURTHER EVIDENCE IT'S UNDER 7942 05:53:38,193 --> 05:53:40,496 RECOGNIZED IN THIS POPULATION 7943 05:53:40,496 --> 05:53:41,563 BUT FURTHER EVIDENCE THAT CODES 7944 05:53:41,563 --> 05:53:43,866 ARE NOT PARTICULARLY HELPFUL FOR 7945 05:53:43,866 --> 05:53:44,667 STUDYING CARDIOVASCULAR DISEASE 7946 05:53:44,667 --> 05:53:45,434 IN THESE PATIENTS. 7947 05:53:45,434 --> 05:53:50,239 SO NEXT SLIDE AND I'LL END 7948 05:53:50,239 --> 05:53:50,439 THERE. 7949 05:53:50,439 --> 05:53:51,974 I TRIED TO DEFENSE YOU THAT 7950 05:53:51,974 --> 05:53:53,175 HOMELESSNESS IS A CAUSE OF THE 7951 05:53:53,175 --> 05:53:54,810 CAUSE OF PULMONARY VASCULAR 7952 05:53:54,810 --> 05:53:55,978 DISEASE, ALTHOUGH I CONFESS I 7953 05:53:55,978 --> 05:53:57,446 DON'T HAVE ANY DIRECT DATA OF 7954 05:53:57,446 --> 05:53:58,914 THAT AND THEN THAT VETERANS 7955 05:53:58,914 --> 05:54:00,182 COMPRISE A LARGE AND VULNERABLE 7956 05:54:00,182 --> 05:54:01,717 POPULATION WITH RESPECT TO 7957 05:54:01,717 --> 05:54:10,526 PULMONARY HYPERTENSION RISK. 7958 05:54:10,526 --> 05:54:12,328 >> THANKS VERY MUCH, EVAN, I 7959 05:54:12,328 --> 05:54:13,062 APPRECIATE THAT TALK. 7960 05:54:13,062 --> 05:54:15,397 IT WAS WONDERFUL AND INSIGHTFUL. 7961 05:54:15,397 --> 05:54:17,099 I LEARNED A FEW THINGS FOR SURE. 7962 05:54:17,099 --> 05:54:22,371 I THINK FOR THE SAKE OF TIME, 7963 05:54:22,371 --> 05:54:23,605 DR. LEOPOLD, DID YOU HAVE A 7964 05:54:23,605 --> 05:54:23,906 QUESTION? 7965 05:54:23,906 --> 05:54:26,008 >> WELL, IF WE'RE STRETCHED FOR 7966 05:54:26,008 --> 05:54:29,278 TIME, WE'LL WAIT UNTIL THE 7967 05:54:29,278 --> 05:54:29,578 DISCUSSION. 7968 05:54:29,578 --> 05:54:31,146 >> LET'S MAYBE MOVE ON TO OUR 7969 05:54:31,146 --> 05:54:32,548 LAST TALK OF THE DAY, AND THEN 7970 05:54:32,548 --> 05:54:34,516 WE'LL HAVE SOME TIME FOR 7971 05:54:34,516 --> 05:54:34,817 DISCUSSION. 7972 05:54:34,817 --> 05:54:37,052 I'M SURE THERE WILL BE QUITE A 7973 05:54:37,052 --> 05:54:39,555 FEW QUESTIONS ON THESE SUBJECTS. 7974 05:54:39,555 --> 05:54:45,260 OUR NEXT SPEAKER IS DR. RACHEL 7975 05:54:45,260 --> 05:54:45,461 GOLD. 7976 05:54:45,461 --> 05:54:47,896 SHE IS TALKING ON SOCIAL 7977 05:54:47,896 --> 05:54:49,431 DETERMINANTS OF HEALTH SCREENING 7978 05:54:49,431 --> 05:54:52,901 AND REFERRALS: WHAT DO WE KNOW? 7979 05:54:52,901 --> 05:54:55,871 SHE IS, TO REITERATE, SHOWS A 7980 05:54:55,871 --> 05:54:58,507 SENIOR INVESTIGATOR AT KAISER 7981 05:54:58,507 --> 05:55:00,042 PERMANENTE, SHE'S ALSO LEAD 7982 05:55:00,042 --> 05:55:01,777 RESEARCH SCIENTIST AND PROGRAM 7983 05:55:01,777 --> 05:55:04,113 DIRECTOR AT THE NONPROFIT OCHIN. 7984 05:55:04,113 --> 05:55:05,381 GO AHEAD, RACHEL. 7985 05:55:05,381 --> 05:55:07,049 >> GREAT, THANKS SO MUCH FOR 7986 05:55:07,049 --> 05:55:07,516 HAVING ME. 7987 05:55:07,516 --> 05:55:09,218 I HOPE EVERYONE IS STILL AWAKE. 7988 05:55:09,218 --> 05:55:10,753 I KNOW YOU'VE ALL HAD A LONG DAY 7989 05:55:10,753 --> 05:55:12,421 OF TALKS, BUT I THINK THIS IS A 7990 05:55:12,421 --> 05:55:13,922 NICE ONE TO END WITH BECAUSE 7991 05:55:13,922 --> 05:55:14,757 THERE'S BEEN SO MUCH INTERESTING 7992 05:55:14,757 --> 05:55:16,558 DISCUSSION ABOUT THE WAY THAT 7993 05:55:16,558 --> 05:55:18,193 SOCIAL DETERMINANTS OR I PREFER 7994 05:55:18,193 --> 05:55:21,263 THE TERM SOCIAL RISKS, AFFECT 7995 05:55:21,263 --> 05:55:23,966 HEALTH AND CHRONIC DISEASE 7996 05:55:23,966 --> 05:55:24,767 MANAGEMENT, BUT I'M GOING TO 7997 05:55:24,767 --> 05:55:26,402 TALK ABOUT WHAT DO WE KNOW ABOUT 7998 05:55:26,402 --> 05:55:28,804 WHAT WE CAN DO TO MITIGATE THOSE 7999 05:55:28,804 --> 05:55:30,873 IMABLGHTS. 8000 05:55:30,873 --> 05:55:31,507 IMPACTS. 8001 05:55:31,507 --> 05:55:31,840 NEXT, PLEASE. 8002 05:55:31,840 --> 05:55:33,375 I'M NOT GOING TO SPEND TOO MUCH 8003 05:55:33,375 --> 05:55:35,044 TIME ON THE NEXT COUPLE SLIDES. 8004 05:55:35,044 --> 05:55:36,445 WE'VE HAD A NUMBER OF SPEAKERS 8005 05:55:36,445 --> 05:55:37,546 TODAY ALREADY COVER THIS. 8006 05:55:37,546 --> 05:55:40,149 AGAIN I PREFER THE TERM SOCIAL 8007 05:55:40,149 --> 05:55:41,050 RISKS MYSELF. 8008 05:55:41,050 --> 05:55:42,684 I THINK IT'S IMPORTANT TO 8009 05:55:42,684 --> 05:55:43,452 DIFFERENTIATED BETWEEN THOUGH 8010 05:55:43,452 --> 05:55:45,421 INSTEAD OF VERY DIRECTLY DRIVEN 8011 05:55:45,421 --> 05:55:46,822 BY POVERTY AND THOSE THAT ARE 8012 05:55:46,822 --> 05:55:48,257 NOT, IT CAN ALSO MEAN 8013 05:55:48,257 --> 05:55:49,992 NEIGHBORHOOD FACTORS AS WELL AS 8014 05:55:49,992 --> 05:55:53,962 INDIVIDUAL LEVEL FACTORS. 8015 05:55:53,962 --> 05:55:55,697 SINCE SO MUCH TIME HAS BEEN 8016 05:55:55,697 --> 05:55:56,899 SPENT ON THIS ALREADY, I DON'T 8017 05:55:56,899 --> 05:55:58,434 THINK YOU GUYS NEED ME TO 8018 05:55:58,434 --> 05:55:59,134 REITERATE THIS. 8019 05:55:59,134 --> 05:56:00,202 SO I'LL GO ON. 8020 05:56:00,202 --> 05:56:01,070 NEXT, PLEASE. 8021 05:56:01,070 --> 05:56:02,571 YOU ALL MAY HAVE SEEN THIS 8022 05:56:02,571 --> 05:56:04,339 BEFORE, BUT JUST VERY BROADLY 8023 05:56:04,339 --> 05:56:05,307 SPEAKING, THERE'S A LOT OF 8024 05:56:05,307 --> 05:56:06,742 EVIDENCE THAT MOST HEALTH 8025 05:56:06,742 --> 05:56:08,944 OUTCOMES ARE IN FACT DRIVEN BY 8026 05:56:08,944 --> 05:56:10,579 SOCIAL CONTEXT, SOCIAL RISKS, 8027 05:56:10,579 --> 05:56:12,881 AND THAT CLINICAL CARE IN A LOT 8028 05:56:12,881 --> 05:56:14,616 OF CASES IS REALLY ONLY TAKES 8029 05:56:14,616 --> 05:56:16,585 CARE OF A VERY SMALL PERCENTAGE 8030 05:56:16,585 --> 05:56:18,687 OF HEALTH OUTCOMES. 8031 05:56:18,687 --> 05:56:20,289 AGAIN, AS HAS BEEN DISCUSSED, 8032 05:56:20,289 --> 05:56:22,491 THE SOCIAL RISKS AFFECT SOCIAL 8033 05:56:22,491 --> 05:56:24,126 CIRCUMSTANCES, BEHAVIORS, HEALTH 8034 05:56:24,126 --> 05:56:25,461 BEHAVIORS, SOME ENVIRONMENTAL 8035 05:56:25,461 --> 05:56:26,762 EXPOSURES AND OF COURSE ACCESS 8036 05:56:26,762 --> 05:56:27,629 TO HEALTHCARE. 8037 05:56:27,629 --> 05:56:29,298 WE'RE GOING TO TALK A LITTLE BIT 8038 05:56:29,298 --> 05:56:31,033 THOUGH ABOUT EVEN HOW WHEN YOU 8039 05:56:31,033 --> 05:56:32,134 HAVE ACCESS TO HEALTHCARE, IT 8040 05:56:32,134 --> 05:56:33,202 DOESN'T ALWAYS MAKE A 8041 05:56:33,202 --> 05:56:33,502 DIFFERENCE. 8042 05:56:33,502 --> 05:56:35,170 I'LL GO ON IN A MOMENT. 8043 05:56:35,170 --> 05:56:36,939 NEXT, PLEASE. 8044 05:56:36,939 --> 05:56:38,040 I'M GOING TO GET A LITTLE MORE 8045 05:56:38,040 --> 05:56:38,540 INTO THIS. 8046 05:56:38,540 --> 05:56:40,542 I KNOW IT'S BEEN TOUCHED ON SOME 8047 05:56:40,542 --> 05:56:41,743 ALREADY TODAY BUT I THINK IT'S 8048 05:56:41,743 --> 05:56:42,744 FINANCIAL CORRESPONDENT 8049 05:56:42,744 --> 05:56:43,846 REITERATE THESE BECAUSE IT'S 8050 05:56:43,846 --> 05:56:44,713 REALLY IMPORTANT TO UNDERSTAND 8051 05:56:44,713 --> 05:56:46,115 THESE PATHWAYS. 8052 05:56:46,115 --> 05:56:47,449 SO ONE WAY THAT SOCIAL RISKS 8053 05:56:47,449 --> 05:56:49,284 AFFECT HEALTH IS BY FOLKS HAVE 8054 05:56:49,284 --> 05:56:51,453 LESS ACCESS TO AFFORDABLE CARE. 8055 05:56:51,453 --> 05:56:53,122 I DO MOST OF MY RESEARCH IN 8056 05:56:53,122 --> 05:56:55,190 PRIMARY CARE COMMUNITY HEALTH 8057 05:56:55,190 --> 05:56:56,959 CENTERS, IN WHICH PATIENTS ARE 8058 05:56:56,959 --> 05:56:59,561 EITHER UNINSURED OR PUBLICLY 8059 05:56:59,561 --> 05:57:02,764 INSURED AND PUBLIC INSURANCE IS 8060 05:57:02,764 --> 05:57:06,468 LIKE ADEQUATE BUT NOT GREAT. 8061 05:57:06,468 --> 05:57:09,104 IT INCREASES EXPOSURES TO RISKS, 8062 05:57:09,104 --> 05:57:10,506 AGAIN, HAS BEEN DISCUSSED SOME, 8063 05:57:10,506 --> 05:57:13,041 STRESS, DISCRIMINATION, UNSAFE 8064 05:57:13,041 --> 05:57:15,277 EMPLOYMENT, LESS HEALTH LI 8065 05:57:15,277 --> 05:57:17,212 LITERACY, MORE POTENTIAL FOR 8066 05:57:17,212 --> 05:57:18,380 ADVERSE CHILDHOOD EVENTS, ALL OF 8067 05:57:18,380 --> 05:57:20,916 WHICH CAN AFFECT HEALTH IN 8068 05:57:20,916 --> 05:57:21,183 ADULTHOOD. 8069 05:57:21,183 --> 05:57:23,752 THE STUFF THAT I FIND REALLY 8070 05:57:23,752 --> 05:57:25,154 IMPORTANT I THINK AND IN THE 8071 05:57:25,154 --> 05:57:26,688 CONTEXT ESPECIALLY OF CHRONIC 8072 05:57:26,688 --> 05:57:30,225 DISEASE MANAGEMENT IS HOW SOCIAL 8073 05:57:30,225 --> 05:57:32,161 RISKS IMPACT INDIVIDUAL 8074 05:57:32,161 --> 05:57:33,929 PATIENTS' ABILITY TO ENGAGE IN 8075 05:57:33,929 --> 05:57:35,330 HEALTHY BEHAVIORS, TO ADHERE TO 8076 05:57:35,330 --> 05:57:37,199 CARE PLANS, TO ACT ON CARE 8077 05:57:37,199 --> 05:57:38,400 RECOMMENDATIONS, AND AS WAS 8078 05:57:38,400 --> 05:57:40,402 NOTED BEFORE, THESE ELEMENTS CAN 8079 05:57:40,402 --> 05:57:48,677 INTERACT AND BE CUMULATIVE, SO 8080 05:57:48,677 --> 05:57:50,212 LET'S MOVE ON BECAUSE I THINK 8081 05:57:50,212 --> 05:57:51,647 YOU GUYS WILL REALLY WANT TO 8082 05:57:51,647 --> 05:57:53,482 HEAR ME TALK ABOUT HOW WE CAN 8083 05:57:53,482 --> 05:57:54,483 MITIGATE THIS STUFF. 8084 05:57:54,483 --> 05:57:55,350 NEXT, PLEASE. 8085 05:57:55,350 --> 05:57:55,551 OKAY. 8086 05:57:55,551 --> 05:57:56,785 I AM GOING TO TALK A LITTLE BIT 8087 05:57:56,785 --> 05:57:59,421 OF DETAIL ABOUT HOW CHRONIC 8088 05:57:59,421 --> 05:58:01,723 DISEASE RISK MANAGEMENT IS 8089 05:58:01,723 --> 05:58:03,592 AFFECTED BY HAD SOCIAL RISKS, 8090 05:58:03,592 --> 05:58:06,395 AND I'M A PVD PERSON, BUT I'M 8091 05:58:06,395 --> 05:58:08,163 BETTING THAT THESE VERY SAME 8092 05:58:08,163 --> 05:58:11,433 PATHWAYS DO AFFECT PVD. 8093 05:58:11,433 --> 05:58:13,535 MOST NUMBERS MORE FOCUSED ON 8094 05:58:13,535 --> 05:58:14,503 DIEBILITIES THAN CARDIOVASCULAR 8095 05:58:14,503 --> 05:58:15,704 DISEASE SPECIFICALLY BUT HERE IS 8096 05:58:15,704 --> 05:58:18,907 HOW THIS STUFF WORKS. 8097 05:58:18,907 --> 05:58:20,442 MANY CHRONIC DISEASE RISK 8098 05:58:20,442 --> 05:58:22,477 FACTORS ARE MANAGEABLE. 8099 05:58:22,477 --> 05:58:23,278 WE CAN MANAGE THEM. 8100 05:58:23,278 --> 05:58:25,347 FOR EXAMPLE, HYPERTENSION, WITH 8101 05:58:25,347 --> 05:58:26,882 CLINICAL AND BEHAVIORAL 8102 05:58:26,882 --> 05:58:28,317 INTERVENTIONS, MEDICATIONS, 8103 05:58:28,317 --> 05:58:29,585 DIET, EXERCISE, MOST OF THE 8104 05:58:29,585 --> 05:58:31,420 TIME, NOT ALL THE TIME, BUT MOST 8105 05:58:31,420 --> 05:58:34,556 OF THE TIME, THE RISK CAN BE 8106 05:58:34,556 --> 05:58:35,757 MANAGED IF THE PATIENT CAN 8107 05:58:35,757 --> 05:58:38,260 ENGAGE IN THOSE BEHAVIORS. 8108 05:58:38,260 --> 05:58:40,262 BUT SOCIAL RISKS DIRECTLY AFFECT 8109 05:58:40,262 --> 05:58:41,230 PEOPLE'S ABILITY TO DO THAT. 8110 05:58:41,230 --> 05:58:42,931 SO IF SOMEONE DOESN'T HAVE 8111 05:58:42,931 --> 05:58:45,367 AFFORDABLE CARE, FIRST OF ALL 8112 05:58:45,367 --> 05:58:47,135 THEIR DISEASE RISK MAY NOT BE 8113 05:58:47,135 --> 05:58:48,103 IDENTIFIED, IT'S CERTAINLY NOT 8114 05:58:48,103 --> 05:58:49,471 BEING MONITORED REGULARLY, IF 8115 05:58:49,471 --> 05:58:51,173 THEY HAVE TRANSPORTATION 8116 05:58:51,173 --> 05:58:52,708 INSECURITY, IT BECOMES HARD 8117 05:58:52,708 --> 05:58:54,343 TO -- TEN VISITS, MAYBE IT'S -- 8118 05:58:54,343 --> 05:58:55,410 HARD TO ATTEND VISITS, MAYBE 8119 05:58:55,410 --> 05:58:57,212 IT'S HARD TO FILL PRESCRIPTIONS. 8120 05:58:57,212 --> 05:58:59,047 EVEN IF YOU DO HAVE A STATE 8121 05:58:59,047 --> 05:59:00,349 MEDICAID OFFICE THAT WILL PAY 8122 05:59:00,349 --> 05:59:01,016 YOUR TRANSPORTATION THAT'S 8123 05:59:01,016 --> 05:59:02,117 USUALLY TO THE MEDICAL OFFICE 8124 05:59:02,117 --> 05:59:03,318 AND NOT NECESSARILY TO FILL A 8125 05:59:03,318 --> 05:59:04,519 PRESCRIPTION AND THAT CAN BE A 8126 05:59:04,519 --> 05:59:05,621 REAL PROBLEM FOR PEOPLE THAT 8127 05:59:05,621 --> 05:59:07,022 HAVE TRANSPORTATION BARRIERS. 8128 05:59:07,022 --> 05:59:08,123 ANOTHER PLACE TRANSPORTATION 8129 05:59:08,123 --> 05:59:09,458 BARRIERS REALLY PLAYS OUT AND 8130 05:59:09,458 --> 05:59:11,293 ENTER PLAYS WITH OTHER SOCIAL 8131 05:59:11,293 --> 05:59:12,861 RISKS FOR EXAMPLE IS, YOU KNOW, 8132 05:59:12,861 --> 05:59:14,263 IT'S ALL WELL AND GOOD TO REFER 8133 05:59:14,263 --> 05:59:16,031 A PATIENT WITH FOOD INSCRURT TO 8134 05:59:16,031 --> 05:59:17,799 A FOOD BANK BUT THEY NEED TO GO 8135 05:59:17,799 --> 05:59:19,201 BACK OVER AND OVER, YOU DON'T 8136 05:59:19,201 --> 05:59:20,936 JUST DID TO THE FOOD BANK ONCE, 8137 05:59:20,936 --> 05:59:22,137 AND THEN AGAIN, IF YOU DON'T 8138 05:59:22,137 --> 05:59:24,006 HAVE TRANSPORTATION, THEN THAT 8139 05:59:24,006 --> 05:59:25,907 BECOMES NOT REALLY A SOLUTION. 8140 05:59:25,907 --> 05:59:26,942 HOUSING FOOD AND FINANCIAL 8141 05:59:26,942 --> 05:59:29,044 INSECURITY CAN ALL MAKE IT HARD 8142 05:59:29,044 --> 05:59:31,113 TO EAT A HEALTHY DIET, HARD TO 8143 05:59:31,113 --> 05:59:32,981 GET EXERCISE, OTHER NEEDS ARE 8144 05:59:32,981 --> 05:59:34,616 PRIORITIZED WHICH MAKES A LOT OF 8145 05:59:34,616 --> 05:59:36,251 SENSE, AND AGAIN CAN IMPEDE 8146 05:59:36,251 --> 05:59:38,553 ABILITY TO PAY FOR MEDICATIONS 8147 05:59:38,553 --> 05:59:40,188 EVEN WHEN THERE'S A VERY LOCO 8148 05:59:40,188 --> 05:59:40,756 PAY. 8149 05:59:40,756 --> 05:59:42,924 SO OVER-- LOW CO-PAY. 8150 05:59:42,924 --> 05:59:44,226 OVERALL PATHWAY GOES LIKE THIS, 8151 05:59:44,226 --> 05:59:46,428 LOWER INCOME, LESS THIS SEASON K 8152 05:59:46,428 --> 05:59:49,364 DRIVES SOCIAL RISKS, SOCIAL 8153 05:59:49,364 --> 05:59:50,799 RISKS HAMPERS A PATIENT'S 8154 05:59:50,799 --> 05:59:52,434 ABILITY TO ENGAGE IN PREVENTIVE 8155 05:59:52,434 --> 05:59:53,635 BEHAVIORS AND OTHER 8156 05:59:53,635 --> 05:59:54,736 INTERVENTIONS, LEADS TO 8157 05:59:54,736 --> 05:59:55,604 UNMANAGED CHRONIC DISEASE AND 8158 05:59:55,604 --> 05:59:56,805 POOR OUTCOMES AND BETTING 8159 05:59:56,805 --> 05:59:57,806 ANYTHING THAT PATHWAY IS THE 8160 05:59:57,806 --> 06:00:00,776 SAME FOR PVD AS IT IS FOR 8161 06:00:00,776 --> 06:00:02,678 HYPERTENSION AND DIABETES. 8162 06:00:02,678 --> 06:00:05,280 NEXT, PLEASE. 8163 06:00:05,280 --> 06:00:05,714 OKAY. 8164 06:00:05,714 --> 06:00:08,016 AND I MENTIONED BEFORE THAT THIS 8165 06:00:08,016 --> 06:00:09,217 STUFF STILL HAPPENS, ACCESS TO 8166 06:00:09,217 --> 06:00:10,319 HEALTHCARE IS IMPORTANT, BUT 8167 06:00:10,319 --> 06:00:11,853 EVEN WHEN PATIENTS HAVE ACCESS 8168 06:00:11,853 --> 06:00:13,488 TO HEALTHCARE, TO DISEENT 8169 06:00:13,488 --> 06:00:15,791 QUALITY HEALTHCARE, IT -- DECENT 8170 06:00:15,791 --> 06:00:16,858 QUALITY HEALTHCARE, IT DOESN'T 8171 06:00:16,858 --> 06:00:18,627 SOLVE THE PROBLEM BY ITSELF. 8172 06:00:18,627 --> 06:00:21,196 THIS IS A STUDY FROM A COUPLE OF 8173 06:00:21,196 --> 06:00:24,299 YEARS AGO WHERE WE LOOKED AT 8174 06:00:24,299 --> 06:00:25,267 PATIENTS IN COMMUNITY HEALTH 8175 06:00:25,267 --> 06:00:26,802 CENTERS AND PRIMARY CARE 8176 06:00:26,802 --> 06:00:27,803 COMMUNITY HEALTH CENTERS AND 8177 06:00:27,803 --> 06:00:29,671 PUBLIC SAFETY NET OF PRIMARY 8178 06:00:29,671 --> 06:00:32,074 CARE WITH DIABETES AND WE LOOKED 8179 06:00:32,074 --> 06:00:33,942 AT WHETHER THEY HAD 8180 06:00:33,942 --> 06:00:36,545 TRANSPORTATION, HOUSING OR FOOD 8181 06:00:36,545 --> 06:00:40,115 INSECURITY IF THEY WERE MORE OR 8182 06:00:40,115 --> 06:00:41,883 LESS LIKELY TO BE UP TO DATED ON 8183 06:00:41,883 --> 06:00:42,718 THEIR DIABETES CARE AND THEN IF 8184 06:00:42,718 --> 06:00:44,419 THEY WERE, WERE THEY MORE OR 8185 06:00:44,419 --> 06:00:45,954 LESS LIKELY TO HAVE THEIR 8186 06:00:45,954 --> 06:00:47,155 DIABETES MANAGED AND WHAT WE 8187 06:00:47,155 --> 06:00:49,891 FOUND WAS THAT FOLKS WITH SOCIAL 8188 06:00:49,891 --> 06:00:52,294 RISKS HAD THE SAME QUALITY OF 8189 06:00:52,294 --> 06:00:52,728 CARE. 8190 06:00:52,728 --> 06:00:54,262 GOT THEIR SCREENINGS ON TIME AT 8191 06:00:54,262 --> 06:00:55,797 THE SAME LEVEL AS THOSE WHO DID 8192 06:00:55,797 --> 06:00:56,998 NOT REPORT THESE RISKS. 8193 06:00:56,998 --> 06:00:58,867 SO THEY'RE GETTING GOOD QUALITY 8194 06:00:58,867 --> 06:01:00,302 CARE, BUT EVEN AMONG THOSE UP TO 8195 06:01:00,302 --> 06:01:01,937 DATE ON THEIR PREVENTIVE CARE, 8196 06:01:01,937 --> 06:01:03,338 THOSE WITH FOOD INSECURITY HAD 8197 06:01:03,338 --> 06:01:05,774 LOWER RATES OF CONTROLLED A1C, 8198 06:01:05,774 --> 06:01:07,042 THOSE WITH TRANSPORTATION 8199 06:01:07,042 --> 06:01:08,477 INSECURITY HAD LOWER RATES OF 8200 06:01:08,477 --> 06:01:09,811 CONTROL, ALL THE BIOMARKERS WE 8201 06:01:09,811 --> 06:01:12,147 LOOKED AT, A1C, BLOOD PRESSURE, 8202 06:01:12,147 --> 06:01:14,483 LIPIDS, AND THOSE WITH HOUSING 8203 06:01:14,483 --> 06:01:15,584 INSECURITY NO DIFFERENCES. 8204 06:01:15,584 --> 06:01:17,352 WE THOUGHT THAT WAS REALLY 8205 06:01:17,352 --> 06:01:17,652 FASCINATING. 8206 06:01:17,652 --> 06:01:18,787 I WILL SAY THERE'S QUITE A 8207 06:01:18,787 --> 06:01:21,723 GROWING BODY OF RESEARCH SHOWING 8208 06:01:21,723 --> 06:01:22,758 THAT TRANSPORTATION BARRIERS ARE 8209 06:01:22,758 --> 06:01:25,660 ONE OF THE BIGGEST DRIVERS 8210 06:01:25,660 --> 06:01:26,728 COMPARED TO FOOD AND HOUSING, 8211 06:01:26,728 --> 06:01:28,697 ALL IMPORTANT, BUT 8212 06:01:28,697 --> 06:01:30,532 TRANSPORTATION IS MORE IMPORTANT 8213 06:01:30,532 --> 06:01:31,466 THAN -- MAYBE MORE IMPORTANT 8214 06:01:31,466 --> 06:01:32,467 THAN THE OTHERS. 8215 06:01:32,467 --> 06:01:34,770 DON'T TAKE ME ON THAT AS GOSPEL, 8216 06:01:34,770 --> 06:01:36,071 BUT THERE'S A PATTERN THAT'S 8217 06:01:36,071 --> 06:01:37,506 EMERGING IN THE LITERATURE AS I 8218 06:01:37,506 --> 06:01:38,173 PERCEIVE IT. 8219 06:01:38,173 --> 06:01:42,878 SO REALLY IMPORTANT TO NOTE HERE 8220 06:01:42,878 --> 06:01:45,247 THAT GUIDELINE IN IMPORTANT CARE 8221 06:01:45,247 --> 06:01:47,249 DOES NOT NECESSARILY GUIDE 8222 06:01:47,249 --> 06:01:49,017 OUTCOMES IF PATIENT HAS SOCIAL 8223 06:01:49,017 --> 06:01:49,317 RISKS. 8224 06:01:49,317 --> 06:01:50,552 WHAT CAN HEALTHCARE PROVIDERS DO 8225 06:01:50,552 --> 06:01:51,620 ABOUT THIS? 8226 06:01:51,620 --> 06:01:53,622 THERE'S A WONDERFUL 2019 8227 06:01:53,622 --> 06:01:54,790 NATIONAL ACADEMIES REPORT THAT 8228 06:01:54,790 --> 06:01:55,991 REALLY SUMMARIZED WHAT THEY CALL 8229 06:01:55,991 --> 06:01:57,859 THE FIVE A'S OF SOCIAL CARE 8230 06:01:57,859 --> 06:02:01,062 INTEGRATION OR FIVE A'S, FIVE 8231 06:02:01,062 --> 06:02:02,264 DIFFERENT THINGS THAT HEALTHCARE 8232 06:02:02,264 --> 06:02:04,232 PROVIDERS CAN DO TO TRY AND 8233 06:02:04,232 --> 06:02:06,301 MITIGATE HOW SOCIAL RISKS AFFECT 8234 06:02:06,301 --> 06:02:08,170 HEALTH OUTCOMES, AND SOME OF THE 8235 06:02:08,170 --> 06:02:10,005 THEM ARE FOCUS ODD COMMUNITY. 8236 06:02:10,005 --> 06:02:11,840 THE FIRST ONE IS AWARENESS, 8237 06:02:11,840 --> 06:02:12,741 FIRST AVE., YOU'VE GOT TO KNOW 8238 06:02:12,741 --> 06:02:14,943 WHAT'S GOING ON, THAT APPLIES TO 8239 06:02:14,943 --> 06:02:16,011 BOTH HEALTHCARE ACTIVITIES AND 8240 06:02:16,011 --> 06:02:17,345 COMMUNITY FACING ACTIVITIES, AND 8241 06:02:17,345 --> 06:02:19,314 I'LL TALK ABOUT THE ACTIVITIES 8242 06:02:19,314 --> 06:02:20,415 FOCUSED ON THE HEALTHCARE 8243 06:02:20,415 --> 06:02:21,917 SETTING BUT I JUST WANT TO NOTE 8244 06:02:21,917 --> 06:02:23,919 THAT THERE ARE COMMUNITY LEVEL 8245 06:02:23,919 --> 06:02:25,487 ALIGNMENT AND ADVOCACY ELEMENTS 8246 06:02:25,487 --> 06:02:26,655 AS WELL. 8247 06:02:26,655 --> 06:02:27,756 BUT FOR INDIVIDUAL PATIENTS, 8248 06:02:27,756 --> 06:02:29,391 WHAT CAN YOU DO IF YOU'RE A 8249 06:02:29,391 --> 06:02:31,893 PROVIDER, ONE WE TALK ABOUT IS 8250 06:02:31,893 --> 06:02:33,261 ADJUSTMENTS OR SOCIAL RISK 8251 06:02:33,261 --> 06:02:35,197 INFORMED CARE AND THAT INVOLVES 8252 06:02:35,197 --> 06:02:36,531 ADAPTING THE CARE PLAN TO 8253 06:02:36,531 --> 06:02:37,933 ACCOMMODATE A PATIENT'S SOCIAL 8254 06:02:37,933 --> 06:02:38,266 RISK. 8255 06:02:38,266 --> 06:02:40,101 THE OTHER IS ASSISTANCE, WHICH 8256 06:02:40,101 --> 06:02:41,770 IS TRYING TO MITIGATE SOCIAL 8257 06:02:41,770 --> 06:02:43,138 RISK ITSELF, EITHER GIVING 8258 06:02:43,138 --> 06:02:44,172 PATIENTS FOOD OR REFERRING THEM 8259 06:02:44,172 --> 06:02:46,341 ON A FOOD BANK ET CETERA, ET 8260 06:02:46,341 --> 06:02:48,777 CETERA, REFERRING THEM TO SOCIAL 8261 06:02:48,777 --> 06:02:49,211 SERVICES. 8262 06:02:49,211 --> 06:02:50,846 AND THE WORDS ADJUSTMENT AND 8263 06:02:50,846 --> 06:02:52,247 ASSISTANCE AND AWARENESS I'LL 8264 06:02:52,247 --> 06:02:53,482 USE A LOT THROUGHOUT THIS TALK, 8265 06:02:53,482 --> 06:02:54,950 SO AWARENESS AGAIN IS DO YOU 8266 06:02:54,950 --> 06:02:56,218 KNOW THIS IS GOING ON, 8267 06:02:56,218 --> 06:02:57,419 ADJUSTMENT IS ADAPTING THE CARE 8268 06:02:57,419 --> 06:02:58,720 PLAN TO MAKE IT SO THE PATIENT 8269 06:02:58,720 --> 06:03:00,388 IS MORE ABLE TO FOLLOW IT, 8270 06:03:00,388 --> 06:03:02,123 ASSISTANCE IS ACTUALLY TRYING TO 8271 06:03:02,123 --> 06:03:03,658 MITIGATE SOCIAL RISK ITSELF 8272 06:03:03,658 --> 06:03:04,493 THROUGH COMMUNITY REFERRAL OR 8273 06:03:04,493 --> 06:03:05,827 SOME OTHER METHOD. 8274 06:03:05,827 --> 06:03:07,496 NEXT, PLEASE. 8275 06:03:07,496 --> 06:03:07,696 OKAY. 8276 06:03:07,696 --> 06:03:09,764 SO WE TALKED ABOUT AWARENESS. 8277 06:03:09,764 --> 06:03:11,633 THE POINT I WANT TO MAKE HERE IS 8278 06:03:11,633 --> 06:03:12,934 BECAUSE IT'S SOMETHING I SEE 8279 06:03:12,934 --> 06:03:15,003 COME UP OVER AND OVER AGAIN AND 8280 06:03:15,003 --> 06:03:16,872 I SAW A LITTLE BIT OF IT TODAY, 8281 06:03:16,872 --> 06:03:18,740 FOLKS CAN I JUST USE COMMUNITY 8282 06:03:18,740 --> 06:03:20,609 LEVEL DATA, CAN I JUST USE 8283 06:03:20,609 --> 06:03:21,476 NEIGHBORHOOD CHARACTERISTICS TO 8284 06:03:21,476 --> 06:03:23,211 ASSUME I'M AWARE OF WHAT WI 8285 06:03:23,211 --> 06:03:24,145 GIVEN PATIENT NEEDS, AND THE 8286 06:03:24,145 --> 06:03:25,280 ANSWER IS NO. 8287 06:03:25,280 --> 06:03:26,615 THEY DO NOT ALIGN. 8288 06:03:26,615 --> 06:03:28,250 IT'S LIKE FLIPPING A COIN, 8289 06:03:28,250 --> 06:03:29,351 LOOKING AT A PATIENT'S COMMUNITY 8290 06:03:29,351 --> 06:03:30,785 LEVEL DATA TO UNDERSTAND WHAT 8291 06:03:30,785 --> 06:03:32,420 THEIR INDIVIDUAL NEEDS ARE. 8292 06:03:32,420 --> 06:03:34,055 A COUPLE DIFFERENT STUDIES HAVE 8293 06:03:34,055 --> 06:03:35,724 SHOWN THIS NOW. 8294 06:03:35,724 --> 06:03:36,892 NOW, THOSE COMMUNITY LEVEL DATA 8295 06:03:36,892 --> 06:03:38,360 ARE ABSOLUTELY USEFUL FOR 8296 06:03:38,360 --> 06:03:39,961 ALIGNMENT, FOR ADVOCACY, FOR 8297 06:03:39,961 --> 06:03:40,896 THINKING ABOUT WHAT'S GOING ON 8298 06:03:40,896 --> 06:03:42,163 AT THE COMMUNITY LEVEL BUT IN 8299 06:03:42,163 --> 06:03:44,032 TERMS OF POINT OF CARE, PATIENT 8300 06:03:44,032 --> 06:03:45,233 NEEDS, YOU HAVE TO ASK THEM WHAT 8301 06:03:45,233 --> 06:03:45,967 IS GOING ON. 8302 06:03:45,967 --> 06:03:47,202 AND I THINK IT'S REALLY 8303 06:03:47,202 --> 06:03:49,037 IMPORTANT THAT I WOULD LIKE TO 8304 06:03:49,037 --> 06:03:50,071 REALLY HAMMER THAT POINT ON 8305 06:03:50,071 --> 06:03:51,473 BECAUSE I SEE ALL THE TIME THIS 8306 06:03:51,473 --> 06:03:53,341 SORT OF INTEREST IN WE'LL JUST 8307 06:03:53,341 --> 06:03:54,643 USE COMMUNITY LEVEL DATA BUT YOU 8308 06:03:54,643 --> 06:03:55,310 REALLY CAN'T. 8309 06:03:55,310 --> 06:03:59,881 NEXT PLEASE. 8310 06:03:59,881 --> 06:04:02,751 SO THAT MEANS TO HAVE EFFECTIVE 8311 06:04:02,751 --> 06:04:03,618 AWARENESS PROCEDURES YOU REALLY 8312 06:04:03,618 --> 06:04:04,619 NEED TO SCREEN PATIENTS, YOU 8313 06:04:04,619 --> 06:04:07,455 HAVE TO ASK THEM WHAT'S GOING 8314 06:04:07,455 --> 06:04:08,990 ON, BUT THERE'S HUGE VARIATION 8315 06:04:08,990 --> 06:04:10,191 IN HOW MUCH THAT IS HAPPENING. 8316 06:04:10,191 --> 06:04:12,260 AGAIN IN A NATIONAL NETWORK WHEN 8317 06:04:12,260 --> 06:04:14,796 WE CONDUCTED IT OVER ABOUT IT'S 8318 06:04:14,796 --> 06:04:17,632 ABOUT 2,000 CLINICS NOW IN THE 8319 06:04:17,632 --> 06:04:19,034 NETWORK, WE HAVE ALMOST THREE 8320 06:04:19,034 --> 06:04:21,670 AND A HALF MILLION SOCIAL RISK 8321 06:04:21,670 --> 06:04:23,104 SCREENINGS EXPUCTD THIS IS AGAIN 8322 06:04:23,104 --> 06:04:24,172 IN SEVERAL -- CONDUCTED AND THIS 8323 06:04:24,172 --> 06:04:26,274 IS AGAIN IN SIX MILLION PATIENTS 8324 06:04:26,274 --> 06:04:27,642 BUT ONLY 20 PERCENT OF THE 8325 06:04:27,642 --> 06:04:29,010 PATIENTS HAVE EVER BEEN SCREENED 8326 06:04:29,010 --> 06:04:30,512 SO THERE ARE SOME CLINICS OR 8327 06:04:30,512 --> 06:04:31,413 CARE ORGANIZATIONS THAT ARE 8328 06:04:31,413 --> 06:04:32,814 DOING A GREAT JOB IN SCREENING 8329 06:04:32,814 --> 06:04:34,482 LOTS OF THEIR PATIENTS AND SOME 8330 06:04:34,482 --> 06:04:35,684 THAT HAVEN'T EVEN STARTED. 8331 06:04:35,684 --> 06:04:39,821 THERE'S TONS OF VARIATION HERE, 8332 06:04:39,821 --> 06:04:40,822 AND WHAT'S HAPPENING SOMETIMES 8333 06:04:40,822 --> 06:04:42,457 IS THAT FOLKS IT'S KIND OF 8334 06:04:42,457 --> 06:04:44,225 HAPPENING AT HOCK LIKE YOU'VE 8335 06:04:44,225 --> 06:04:46,394 GOT ONE CARE TEAM THAT'S REALLY 8336 06:04:46,394 --> 06:04:47,796 EXCITED ABOUT IT BUT THEN NO ONE 8337 06:04:47,796 --> 06:04:49,130 ELSE IS SCREENING FOR SOCIAL 8338 06:04:49,130 --> 06:04:50,665 RISKS AND REALLY THE BIG TAKE 8339 06:04:50,665 --> 06:04:51,833 HOME POINT I WANT TO MAKE IS 8340 06:04:51,833 --> 06:04:54,235 THERE'S A TON OF VARIATION, IT'S 8341 06:04:54,235 --> 06:04:56,004 ALMOST INCREASE IML THIS IS 8342 06:04:56,004 --> 06:04:57,339 HAPPENING AND -- INCREASINGLY 8343 06:04:57,339 --> 06:04:58,006 THIS IS HAPPENING AND THOSE 8344 06:04:58,006 --> 06:04:59,207 RATES ARE GOING UP BECAUSE 8345 06:04:59,207 --> 06:05:01,042 THERE'S MORE AND MORE 8346 06:05:01,042 --> 06:05:02,911 INITIATIVES SUPPORTING OR 8347 06:05:02,911 --> 06:05:04,212 INCENTIVIZING THE SCREENING BUT 8348 06:05:04,212 --> 06:05:05,880 IT'S STINLT HAPPENING ANYWHERE 8349 06:05:05,880 --> 06:05:08,383 NEAR AT THE -- IT'S STILL NOT 8350 06:05:08,383 --> 06:05:09,918 HAPPENING ANYWHERE NEAR AT THE 8351 06:05:09,918 --> 06:05:11,353 LEVEL WE WANT IT TO HAPPEN AND 8352 06:05:11,353 --> 06:05:13,188 IT'S REALLY INCONSISTENT. 8353 06:05:13,188 --> 06:05:14,923 THIS IS IN PRIMARY CARE I SHOULD 8354 06:05:14,923 --> 06:05:15,123 NOTE. 8355 06:05:15,123 --> 06:05:16,257 WHY IS THAT? 8356 06:05:16,257 --> 06:05:17,258 BECAUSE THERE ARE SUBSTANTIAL 8357 06:05:17,258 --> 06:05:18,426 BARRIERS TO IMPLEMENTING 8358 06:05:18,426 --> 06:05:20,962 SCREENING TO GET TO AWARENESS. 8359 06:05:20,962 --> 06:05:22,464 THOSE IDENTIFIED AT THAT 8360 06:05:22,464 --> 06:05:24,566 NATIONAL ACADEMIES REPORT AND 8361 06:05:24,566 --> 06:05:26,001 MANY OTHERS SINCE HAVE SHOWN THE 8362 06:05:26,001 --> 06:05:28,403 SAME THING AND I INTENTIONALLY 8363 06:05:28,403 --> 06:05:29,804 PUT A LOT OF STUFF ON THIS SLIDE 8364 06:05:29,804 --> 06:05:31,106 SO I REALLY WANT TO MAKE SURE 8365 06:05:31,106 --> 06:05:32,540 THAT THERE ARE LOTS OF BARRIERS 8366 06:05:32,540 --> 06:05:32,974 HERE. 8367 06:05:32,974 --> 06:05:34,943 CLINICS GOT COMPETING NEEDS, 8368 06:05:34,943 --> 06:05:36,077 COMPETING INITIATIVES, DON'T 8369 06:05:36,077 --> 06:05:37,312 HAVE ENOUGH RESOURCES TO DO IT, 8370 06:05:37,312 --> 06:05:38,346 THIS IS VERY IMPORTANT. 8371 06:05:38,346 --> 06:05:40,615 OH, I ALREADY KNOW MY PATIENTS 8372 06:05:40,615 --> 06:05:42,417 NEEDS, OH, MY STAFF DON'T FEEL 8373 06:05:42,417 --> 06:05:43,418 COMFORTABLE ASKING, WHY SCREEN 8374 06:05:43,418 --> 06:05:45,353 IF I CAN'T REFER, PEOPLE GET 8375 06:05:45,353 --> 06:05:46,655 VERY URVELG SOMETIMES ASKING 8376 06:05:46,655 --> 06:05:47,756 PEOPLE ABOUT THESE IMPORTANT 8377 06:05:47,756 --> 06:05:48,957 PARTS OF THEIR LIVES IF THEY 8378 06:05:48,957 --> 06:05:52,327 DON'T HAVE A SOLUTION TO 8379 06:05:52,327 --> 06:05:55,397 PROVIDE, WHICH I GET BUT THEN 8380 06:05:55,397 --> 06:06:00,001 YOU GET YOURSELF IN A PICKLE. 8381 06:06:00,001 --> 06:06:01,970 ROLES, SHOULD THE CLINICIAN BE 8382 06:06:01,970 --> 06:06:05,173 DOING T NO, DEFINITELY SUPPORT 8383 06:06:05,173 --> 06:06:07,542 STAFF, SMALL CLINICS, MAYBE THE 8384 06:06:07,542 --> 06:06:09,310 CLINICIAN COULD DO T THIS NEEDS 8385 06:06:09,310 --> 06:06:10,178 TO BE DEFINED. 8386 06:06:10,178 --> 06:06:11,379 THERE'S TENSION AROUND WE HEAR 8387 06:06:11,379 --> 06:06:12,914 THIS OVER AND OVER IN MY 8388 06:06:12,914 --> 06:06:14,349 RESEARCH THIS IS WHAT I STUDY 8389 06:06:14,349 --> 06:06:15,550 BETWEEN CLINICS LOOK THE STAFF 8390 06:06:15,550 --> 06:06:16,651 WHO ARE ASKING THE QUESTIONS 8391 06:06:16,651 --> 06:06:17,719 ABOUT THE SOCIAL RISKS ARE LIKE 8392 06:06:17,719 --> 06:06:19,087 I WANT TO TALK TO THE PATIENTS, 8393 06:06:19,087 --> 06:06:20,288 I WANT TO HAVE A CONVERSATION, I 8394 06:06:20,288 --> 06:06:21,456 DON'T WANT TO BE FILLING OUT A 8395 06:06:21,456 --> 06:06:23,525 CHECK BOX ABOUT LIKE OH HOUSING 8396 06:06:23,525 --> 06:06:24,726 INSECURITY, CHECK, THAT FEELS 8397 06:06:24,726 --> 06:06:28,797 TECIALT -- THAT FEELS TERRIBLE, 8398 06:06:28,797 --> 06:06:29,097 RIGHT? 8399 06:06:29,097 --> 06:06:31,199 STAFF TURNOVER, NEED TO HAVE THE 8400 06:06:31,199 --> 06:06:33,034 RIGHT TRAINING, HR IS NOT VERY 8401 06:06:33,034 --> 06:06:35,136 GOOD AT SCREEN DOCUMENTING 8402 06:06:35,136 --> 06:06:36,337 SCREENING RESULTS AND SO FORTH. 8403 06:06:36,337 --> 06:06:37,539 THESE ARE SOME OF THE REASONS 8404 06:06:37,539 --> 06:06:39,074 WHY WE HAVE BARRIERS TO 8405 06:06:39,074 --> 06:06:39,340 SCREENING. 8406 06:06:39,340 --> 06:06:40,175 NEXT PLEASE. 8407 06:06:40,175 --> 06:06:41,576 I'LL JUST QUICKLY THE RESULTS OF 8408 06:06:41,576 --> 06:06:44,045 A STUDY THAT MY TEAM DID ON HOW 8409 06:06:44,045 --> 06:06:46,181 CAN YOU SUPPORT AGAIN PRIMARY 8410 06:06:46,181 --> 06:06:47,916 CARE COMMUNITY CLINICS IN 8411 06:06:47,916 --> 06:06:49,017 IMPLEMENTING SOCIAL RISK 8412 06:06:49,017 --> 06:06:50,452 SCREENING, LONG STORY SHORT, WE 8413 06:06:50,452 --> 06:06:53,955 GAVE CLINICS SIX MONTHS OF 8414 06:06:53,955 --> 06:06:57,225 PERSONALIZED TECHNICAL SUPPORT, 8415 06:06:57,225 --> 06:06:59,627 EHR TOOLS CUSTOMIZED TO BE USED 8416 06:06:59,627 --> 06:07:01,362 FOR SOCIAL RISK SCREENING, COACH 8417 06:07:01,362 --> 06:07:02,697 WALK THEM THROUGH FIVE STEPS 8418 06:07:02,697 --> 06:07:04,232 SHOWN HERE ON THE RIGHT, WE MET 8419 06:07:04,232 --> 06:07:05,734 WITH THEM TWICE A MONTH FOR SIX 8420 06:07:05,734 --> 06:07:06,901 MONTHS, PEER TO PEER LEARNING, 8421 06:07:06,901 --> 06:07:08,269 EVERYTHING THAT THE LITERATURE 8422 06:07:08,269 --> 06:07:09,471 SUGGESTS WOULD BE HELPFUL WE 8423 06:07:09,471 --> 06:07:11,439 TRIED TO PROVIDE TO THE CLINICS 8424 06:07:11,439 --> 06:07:12,874 IN THIS STUDY TO SEE WHETHER 8425 06:07:12,874 --> 06:07:13,975 THAT LEVEL OF SUPPORT WOULD 8426 06:07:13,975 --> 06:07:15,376 IMPROVE THEIR SCREENING LEVELS. 8427 06:07:15,376 --> 06:07:16,811 NOW, I WILL NOTE THAT THE 8428 06:07:16,811 --> 06:07:17,779 PANDEMIC HIT RIGHT IN THE MIDDLE 8429 06:07:17,779 --> 06:07:19,881 OF THIS STUDY, WHICH I'M SURE 8430 06:07:19,881 --> 06:07:21,516 ANY OF YOU WHO WERE DOING ON THE 8431 06:07:21,516 --> 06:07:23,518 GROUND RESEARCH DURING THE 8432 06:07:23,518 --> 06:07:24,119 PANDEMIC UNDERSTAND HOW MUCH 8433 06:07:24,119 --> 06:07:25,353 THAT AFFECTED RESULTS. 8434 06:07:25,353 --> 06:07:26,087 NEXT PLEASE. 8435 06:07:26,087 --> 06:07:27,856 BUT THE OVERALL FINDING HERE, 8436 06:07:27,856 --> 06:07:29,290 OUR OVERALL FINDING FROM THIS 8437 06:07:29,290 --> 06:07:30,592 STUDY WAS THAT WHILE THE 8438 06:07:30,592 --> 06:07:33,128 SCREENING DID SIGNIFICANTLY 8439 06:07:33,128 --> 06:07:34,863 INCREASE DURING THE INTERVENTION 8440 06:07:34,863 --> 06:07:37,165 PERIOD COMPARED TO 8441 06:07:37,165 --> 06:07:38,333 PREINTERVENTION, THAT IMPACT WAS 8442 06:07:38,333 --> 06:07:39,334 NOT SUSTAINED AFTER THAT SICK 8443 06:07:39,334 --> 06:07:40,869 MONTHS OF INTENSIVE SUPPORT. 8444 06:07:40,869 --> 06:07:42,403 WE SAW NO DIFFERENCE IN REFERRAL 8445 06:07:42,403 --> 06:07:44,038 RATES AT ALL, THIS WAS A COUPLE 8446 06:07:44,038 --> 06:07:45,373 YEARS AGO, SO THOSE WERE HARDER 8447 06:07:45,373 --> 06:07:47,642 TO DO THEN, BUT THEY'RE STILL 8448 06:07:47,642 --> 06:07:47,909 NOT EASY. 8449 06:07:47,909 --> 06:07:50,478 I'M SURE IF WE SHOULD HAVE 8450 06:07:50,478 --> 06:07:52,247 PROVIDED MORE LONGER MORE THAN 8451 06:07:52,247 --> 06:07:53,782 SIX MONTHS TO FOLKS, MAYBE WE 8452 06:07:53,782 --> 06:07:55,183 DIDN'T SOMEHOW ADDRESS THE 8453 06:07:55,183 --> 06:07:56,618 BARRIERS FOR SUSTAINED 8454 06:07:56,618 --> 06:07:56,985 IMPLEMENTATION. 8455 06:07:56,985 --> 06:07:58,253 I THINK THE TAKE HOME HERE IS 8456 06:07:58,253 --> 06:07:59,621 THAT COMMUNITY CLINICS 8457 06:07:59,621 --> 06:08:00,889 ESPECIALLY IN PRIMARY CARE 8458 06:08:00,889 --> 06:08:01,856 CLINICS IN GENERAL THAT DON'T 8459 06:08:01,856 --> 06:08:03,024 HAVE A LOT OF RESOURCES ARE 8460 06:08:03,024 --> 06:08:04,692 GOING TO REALLY STRUGGLE TO 8461 06:08:04,692 --> 06:08:06,094 CONDUCT SOCIAL RISK SCREENING IF 8462 06:08:06,094 --> 06:08:07,228 THEY'RE NOT GIVEN REALLY 8463 06:08:07,228 --> 06:08:08,530 SUBSTANTIAL SUPPORT AND 8464 06:08:08,530 --> 06:08:09,798 IMPLEMENTING IT AS A PRACTICE. 8465 06:08:09,798 --> 06:08:11,699 IT IS NOT EASY TO IMPLEMENT. 8466 06:08:11,699 --> 06:08:13,468 IT IS ASKING A LOT FROM CLINICS 8467 06:08:13,468 --> 06:08:15,103 TO DO, ESPECIALLY BECAUSE OF 8468 06:08:15,103 --> 06:08:16,738 THIS ISSUE AROUND REFERRAL AND 8469 06:08:16,738 --> 06:08:18,373 FOLKS NOT WANT TO GO AND 8470 06:08:18,373 --> 06:08:19,574 SOMETHING THAT THEY'RE NOT SET 8471 06:08:19,574 --> 06:08:20,341 UP TO SUPPORT. 8472 06:08:20,341 --> 06:08:22,210 BUT WE'LL TALK ABOUT THAT IN A 8473 06:08:22,210 --> 06:08:22,777 SECOND. 8474 06:08:22,777 --> 06:08:22,977 OKAY. 8475 06:08:22,977 --> 06:08:28,783 NEXT PLEASE. 8476 06:08:28,783 --> 06:08:28,983 OKAY. 8477 06:08:28,983 --> 06:08:31,052 I JUST WANTED TO GIVE YOU JUST A 8478 06:08:31,052 --> 06:08:33,254 RESOURCE HERE IN CASE THIS IS OF 8479 06:08:33,254 --> 06:08:33,488 USE. 8480 06:08:33,488 --> 06:08:35,256 WE DID FIND AGAIN THAT THESE 8481 06:08:35,256 --> 06:08:37,192 CLINICS DO FACE THESE REAL 8482 06:08:37,192 --> 06:08:38,927 BARRIERS TO IMPLEMENTING THIS 8483 06:08:38,927 --> 06:08:42,864 WORK, BUT WE DO HAVE AN 8484 06:08:42,864 --> 06:08:44,299 IMPLEMENTATION GUIDE THAT WE 8485 06:08:44,299 --> 06:08:47,569 MADE AVAILABLE THROUGH THE 8486 06:08:47,569 --> 06:08:52,073 NETWORK SIREN NETWORK, SOCIAL 8487 06:08:52,073 --> 06:08:53,608 RESEARCH INTERVENTION, YOU'LL 8488 06:08:53,608 --> 06:08:55,243 LOVE THEIR WEBSITE, IT IS AN 8489 06:08:55,243 --> 06:08:56,344 ABSOLUTE GOLD MINE OF 8490 06:08:56,344 --> 06:08:57,412 INFORMATION, WE HAVE A VERY 8491 06:08:57,412 --> 06:08:59,180 PRACTICING MACTD APPLIED 8492 06:08:59,180 --> 06:08:59,948 IMPLEMENTATION GUIDE HERE THAT 8493 06:08:59,948 --> 06:09:01,816 WE THINK CAN BE USED ACROSS 8494 06:09:01,816 --> 06:09:04,219 SETTINGS BUT WAS DESIGNED FOR 8495 06:09:04,219 --> 06:09:05,086 PRIMARY CARE, IT'S AVAILABLE 8496 06:09:05,086 --> 06:09:06,721 RKTS IT'S FREE, PLEASE USE IT. 8497 06:09:06,721 --> 06:09:08,456 NEXT, PLEASE. 8498 06:09:08,456 --> 06:09:12,827 LY JUST SECOND DOWN, JUST WALK A 8499 06:09:12,827 --> 06:09:14,495 GIVEN CARE PROVIDER CLINIC OR 8500 06:09:14,495 --> 06:09:16,664 SEGHTD STEP BY STEP THROUGH WHAT 8501 06:09:16,664 --> 06:09:17,899 THEY NEED TO DO TO PROVIDE 8502 06:09:17,899 --> 06:09:20,101 SOCIAL SCREENING, PROVIDES A LOT 8503 06:09:20,101 --> 06:09:22,570 OF RESOURCES. 8504 06:09:22,570 --> 06:09:23,371 ACCOUNTABLE HEALTH COMMUNITIES 8505 06:09:23,371 --> 06:09:25,006 PROJECT WAS A NATIONAL PROJECT 8506 06:09:25,006 --> 06:09:27,175 LED BY CMS SAME SET OF 8507 06:09:27,175 --> 06:09:28,509 QUESTIONS, WHAT IF WE PROVIDE 8508 06:09:28,509 --> 06:09:30,678 MONEY TO CLINICS TO HELP THEM 8509 06:09:30,678 --> 06:09:33,314 CONDUCT SOCIAL RISK SCREENING, 8510 06:09:33,314 --> 06:09:37,919 AND THEY FOUND THAT THE THINGS 8511 06:09:37,919 --> 06:09:40,855 THAT WORKED WERE A CULTURALLY 8512 06:09:40,855 --> 06:09:42,457 TAILORED APPROACH TO MAKE SURE 8513 06:09:42,457 --> 06:09:44,125 THERE WAS TRUST AND PATIENT 8514 06:09:44,125 --> 06:09:45,460 ENGAGEMENT, THIS RELATIONAL 8515 06:09:45,460 --> 06:09:46,661 PIECE BETWEEN THE PERSON ASKING 8516 06:09:46,661 --> 06:09:48,930 ABOUT THE SOCIAL RISKS AND THE 8517 06:09:48,930 --> 06:09:50,598 PATIENT, USING SCREENING DATA TO 8518 06:09:50,598 --> 06:09:51,900 DRIVE IMPROVEMENT IN THEIR 8519 06:09:51,900 --> 06:09:54,068 SCREENING RATES, TRYING 8520 06:09:54,068 --> 06:09:54,869 DIFFERENT MODALITIES OF GETTING 8521 06:09:54,869 --> 06:09:56,371 THE PATIENT OF DOING THE 8522 06:09:56,371 --> 06:09:56,938 SCREENING, BECAUSE SOMETIMES 8523 06:09:56,938 --> 06:09:59,340 DOING IT BY TEXT OR E-MAIL OR 8524 06:09:59,340 --> 06:10:00,842 PATIENT PORTAL MIGHT BE A LITTLE 8525 06:10:00,842 --> 06:10:01,843 MORE COMFORTABLE FOR FOLKS THAN 8526 06:10:01,843 --> 06:10:03,478 DOING IT IN PERSON, IT'S MORE 8527 06:10:03,478 --> 06:10:04,846 EFFICIENT, HAVING A DEDICATED 8528 06:10:04,846 --> 06:10:06,748 SCREENER ROLE WAS HELPFUL AT A 8529 06:10:06,748 --> 06:10:07,882 CLINIC, INTEGRATING THE 8530 06:10:07,882 --> 06:10:09,050 SCREENING INTO EXISTING 8531 06:10:09,050 --> 06:10:10,218 WORKFLOWS IF THAT'S HOW YOU WANT 8532 06:10:10,218 --> 06:10:12,020 TO DO IT, TALKING ABOUT WHAT IS 8533 06:10:12,020 --> 06:10:13,454 THE IMPACT OF SCREENING, THAT'S 8534 06:10:13,454 --> 06:10:14,856 REALLY IMPORTANT, WE TALK ABOUT 8535 06:10:14,856 --> 06:10:16,291 THAT IN THAT GUIDEBOOK I SHARED 8536 06:10:16,291 --> 06:10:17,625 WITH YOU AND MAKING SURE THERE'S 8537 06:10:17,625 --> 06:10:19,160 A WAY FOR THE TEAM TO REALLY 8538 06:10:19,160 --> 06:10:20,662 CONNECT ABOUT WHAT THEY'RE DOING 8539 06:10:20,662 --> 06:10:22,530 SO I THINK THAT WAS AN 8540 06:10:22,530 --> 06:10:23,665 INTERESTING PARALLEL TO THE 8541 06:10:23,665 --> 06:10:25,166 STUDY WHERE WE WERE LIKE WHAT IF 8542 06:10:25,166 --> 06:10:26,868 WE JUST PROVIDE REALLY INTENSIVE 8543 06:10:26,868 --> 06:10:27,669 ONE ON ONE SUPPORT AND THESE 8544 06:10:27,669 --> 06:10:29,137 GUYS WHAT IF WE JUST PROVIDE 8545 06:10:29,137 --> 06:10:33,474 MONEY AND WE'LL SEE WHAT 8546 06:10:33,474 --> 06:10:34,242 HAPPENS. 8547 06:10:34,242 --> 06:10:35,677 NEXT, PLEASE. 8548 06:10:35,677 --> 06:10:38,413 SO ASSISTANCE I'VE TALKED ABOUT, 8549 06:10:38,413 --> 06:10:39,714 TALKING ABOUT REFERRALS, THAT'S 8550 06:10:39,714 --> 06:10:41,149 REALLY WHAT WE MEAN BY 8551 06:10:41,149 --> 06:10:41,783 ASSISTANCE, CAN YOU REFER A 8552 06:10:41,783 --> 06:10:43,184 PATIENT TO HOUSING SUPPORT, ET 8553 06:10:43,184 --> 06:10:44,986 CETERA, ET CETERA, AND HERE IS 8554 06:10:44,986 --> 06:10:45,954 WHAT THE LITERATURE SAYS ABOUT 8555 06:10:45,954 --> 06:10:48,022 THE IMPACT OF ASSISTANCE 8556 06:10:48,022 --> 06:10:50,158 INTERVENTIONS, RIGHT? 8557 06:10:50,158 --> 06:10:51,726 THAT THESE INTERVENTIONS BE IT 8558 06:10:51,726 --> 06:10:53,261 THE CLINICS PROVIDING AN 8559 06:10:53,261 --> 06:10:55,129 INTERNAL SOMETHING WHERE THE 8560 06:10:55,129 --> 06:10:56,331 CLINICS PROVIDING TRANSPORTATION 8561 06:10:56,331 --> 06:10:57,765 OR AN EXTERNAL REFERRAL WHERE 8562 06:10:57,765 --> 06:10:59,467 WE'RE GETTING YOU IN TOUCH WITH 8563 06:10:59,467 --> 06:11:03,871 A MEDICAL SERVICE 8564 06:11:03,871 --> 06:11:07,175 CAN MODESTLY IMPROVE HEALTH 8565 06:11:07,175 --> 06:11:08,276 OUTCOMES. 8566 06:11:08,276 --> 06:11:13,147 STUDIED IN 2017 BY GOTTLIEB ET 8567 06:11:13,147 --> 06:11:14,615 AL. EVIDENCE REVIEW FOUND AS 8568 06:11:14,615 --> 06:11:16,250 ANSWER ASSOCIATED WITH IMPROVED 8569 06:11:16,250 --> 06:11:17,819 WITH A NUMBER OF THESE METRICS 8570 06:11:17,819 --> 06:11:19,454 AND ANOTHER STUDY FOUND NO 8571 06:11:19,454 --> 06:11:20,421 SIGNIFICANT IMPROVEMENTS AND A 8572 06:11:20,421 --> 06:11:22,056 MORE RECENT REVIEW IN HEALTH 8573 06:11:22,056 --> 06:11:23,591 EQUITY ALSO FOUND VERY MIXED 8574 06:11:23,591 --> 06:11:25,760 EVIDENCE ON HOW THESE -- ON THE 8575 06:11:25,760 --> 06:11:27,195 IMPACT OF ASSISTANCE EFFECT. 8576 06:11:27,195 --> 06:11:29,163 THIS IS FASCINATING, RIGHT, 8577 06:11:29,163 --> 06:11:30,264 BECAUSE WE'VE BEEN, THERE'S A 8578 06:11:30,264 --> 06:11:34,102 TON OF EMPHASIS ON LIKE, WELL, 8579 06:11:34,102 --> 06:11:34,869 GET PATIENTS REFERRED BUT 8580 06:11:34,869 --> 06:11:36,070 THERE'S NOT A LOT OF EVIDENCE ON 8581 06:11:36,070 --> 06:11:38,139 IT WORKING OR IT'S VERY MIXED. 8582 06:11:38,139 --> 06:11:40,775 SO WHAT MAKES AN ASSISTANCE 8583 06:11:40,775 --> 06:11:41,642 INTERVENTION EFFECTIVE, WE HAVE 8584 06:11:41,642 --> 06:11:42,877 A LOT TO LEARN HERE. 8585 06:11:42,877 --> 06:11:44,612 ONE THING THAT DOES SEEM TO BE 8586 06:11:44,612 --> 06:11:46,347 TRUE IS THAT HAVING A NAVIGATOR 8587 06:11:46,347 --> 06:11:48,316 CAN REALLY HELP, SOMEONE WHOSE 8588 06:11:48,316 --> 06:11:50,952 JOB IT IS TO SAY TO A PATIENT 8589 06:11:50,952 --> 06:11:52,453 HEY WE GAVE YOU THIS INFORMATION 8590 06:11:52,453 --> 06:11:54,222 ABOUT A FOOD BANK, CAN I HELP 8591 06:11:54,222 --> 06:11:55,656 YOU MAKE A CONNECTION, THAT 8592 06:11:55,656 --> 06:11:57,191 EXTRA SET OF HELPING HANDS CAN 8593 06:11:57,191 --> 06:11:58,059 MAKE A DIFFERENCE. 8594 06:11:58,059 --> 06:11:59,494 BUT AGAIN, NONE OF THIS IS 8595 06:11:59,494 --> 06:12:00,795 MAKING A BIG DIFFERENCE AND 8596 06:12:00,795 --> 06:12:01,996 THAT'S REALLY IMPORTANT. 8597 06:12:01,996 --> 06:12:02,330 NEXT. 8598 06:12:02,330 --> 06:12:03,531 JUST THE ASSUMPTION, THIS GETS 8599 06:12:03,531 --> 06:12:05,066 TO WHERE I'M GOING WITH THIS IS 8600 06:12:05,066 --> 06:12:06,467 THE ASSUMPTION OF ALL THIS 8601 06:12:06,467 --> 06:12:08,336 EMPHASIS ON MAKING THESE 8602 06:12:08,336 --> 06:12:09,303 REFERRALS, THIS ASSISTANCE 8603 06:12:09,303 --> 06:12:10,505 INTERVENTIONS IS THAT YOU IF 8604 06:12:10,505 --> 06:12:11,606 SCREEN FOR SOCIAL RISKS AND 8605 06:12:11,606 --> 06:12:12,607 REFER PATIENTS TO SERVICES AND 8606 06:12:12,607 --> 06:12:13,808 THE PATIENTS ARE GOING TO GET 8607 06:12:13,808 --> 06:12:15,109 THE SERVICES, THEY'RE GOING ON 8608 06:12:15,109 --> 06:12:16,110 RESOLVE THE RISKS AND THAT'S 8609 06:12:16,110 --> 06:12:17,311 GOING TO LEAD TO IMPROVED HEALTH 8610 06:12:17,311 --> 06:12:19,280 BUT WE DON'T KNOW THAT'S TRUE, 8611 06:12:19,280 --> 06:12:20,381 THERE'S NOT STRONG EVIDENCE FOR 8612 06:12:20,381 --> 06:12:21,983 SUPPORTING THIS PATHWAY, WHAT 8613 06:12:21,983 --> 06:12:23,751 THERE IS EVIDENCE FOR IS A FAR 8614 06:12:23,751 --> 06:12:26,054 MORE COMPLEX PATHWAY THAT REALLY 8615 06:12:26,054 --> 06:12:28,556 INVOLVES THE PATIENT AND CARE 8616 06:12:28,556 --> 06:12:30,224 TEAM RELATIONSHIP. 8617 06:12:30,224 --> 06:12:31,959 OH, I MENTIONED THE NAVIGATION. 8618 06:12:31,959 --> 06:12:33,728 LET'S GO TO THE NEXT SLIDE 8619 06:12:33,728 --> 06:12:37,565 BECAUSE THIS IS A NEXT SLIDE 8620 06:12:37,565 --> 06:12:39,634 FROM GOTLIEB OF THE ALL, WHAT IS 8621 06:12:39,634 --> 06:12:40,768 REALLY THE PATHWAY. 8622 06:12:40,768 --> 06:12:42,904 I WANT FOINT OUT HERE THE 8623 06:12:42,904 --> 06:12:46,207 IMPORTANCE -- POINTED OUT HERE 8624 06:12:46,207 --> 06:12:48,709 THE IMPORTANCE OF IMPROVING 8625 06:12:48,709 --> 06:12:49,777 EMOTIONAL SUPPORT, CONNECTING 8626 06:12:49,777 --> 06:12:51,646 PATIENTS WITH A NAVIGATOR, THE 8627 06:12:51,646 --> 06:12:53,181 PATIENT FEELS MORE CARED FOR, 8628 06:12:53,181 --> 06:12:55,917 THIS IS JUST A MORE COMPLEX SET 8629 06:12:55,917 --> 06:12:58,820 OF PATHWAYS THAN JUST CONNECTED 8630 06:12:58,820 --> 06:13:00,621 WITH SERVICES, THEY GET BETTER, 8631 06:13:00,621 --> 06:13:00,855 RIGHT? 8632 06:13:00,855 --> 06:13:02,390 THAT'S ONE OF THEM, BUT ANOTHER 8633 06:13:02,390 --> 06:13:03,591 IS THEY FEEL MORE SUPPORTED, 8634 06:13:03,591 --> 06:13:06,194 ANOTHER IS THAT THERE'S MORE 8635 06:13:06,194 --> 06:13:08,062 HEALTHCARE SERVICES ARE 8636 06:13:08,062 --> 06:13:09,931 ACCESSED, IT'S MUCH MORE COMPLEX 8637 06:13:09,931 --> 06:13:12,333 THAN JUST REFER AND HOPE. 8638 06:13:12,333 --> 06:13:14,068 AND I HIGHLY RECOMMEND THIS 8639 06:13:14,068 --> 06:13:14,268 PAPER. 8640 06:13:14,268 --> 06:13:15,837 IT'S VERY, VERY HELPFUL TO THINK 8641 06:13:15,837 --> 06:13:17,371 ABOUT WHAT WE'RE DOING RIGHT AND 8642 06:13:17,371 --> 06:13:19,340 WHAT WE'RE DOING WRONG. 8643 06:13:19,340 --> 06:13:21,509 NEXT, PLEASE. 8644 06:13:21,509 --> 06:13:21,742 OKAY. 8645 06:13:21,742 --> 06:13:22,477 AND GUESS WHAT? 8646 06:13:22,477 --> 06:13:24,145 THERE ARE BARRIERS TO 8647 06:13:24,145 --> 06:13:25,680 IMPLEMENTING THESE ASSISTANCE 8648 06:13:25,680 --> 06:13:26,681 REFERRALS, EVEN AS WE KNOW 8649 06:13:26,681 --> 06:13:28,516 THEY'RE NOT THAT GREAT, THERE'S 8650 06:13:28,516 --> 06:13:30,718 NOT MUCH ELSE OUT THERE RIGHT 8651 06:13:30,718 --> 06:13:32,353 NOW, THEY'RE KIND OF THE BEST 8652 06:13:32,353 --> 06:13:34,455 BAND-AID WE'VE GOT, BUT PATIENTS 8653 06:13:34,455 --> 06:13:35,857 WHO ARE OFFERED REFERRALS DON'T 8654 06:13:35,857 --> 06:13:36,724 ALWAYS WANT THEM. 8655 06:13:36,724 --> 06:13:38,392 MAYBE THEY'VE ALREADY TRIED 8656 06:13:38,392 --> 06:13:39,994 THEM, THERE'S A FEAR OF STIGMA, 8657 06:13:39,994 --> 06:13:40,795 DISCRIMINATION, ET CETERA, ET 8658 06:13:40,795 --> 06:13:42,296 CETERA, OUR TEAM FOUND THAT 8659 06:13:42,296 --> 06:13:43,731 ALMOST 80 PERCENT OF COMMUNITY 8660 06:13:43,731 --> 06:13:45,166 HEALTH CENTER PATIENTS WITH 8661 06:13:45,166 --> 06:13:46,467 REPORTED RISK DECLINED A 8662 06:13:46,467 --> 06:13:47,902 REFERRAL THEY WERE OFFERED AND 8663 06:13:47,902 --> 06:13:50,404 THAT RATE OF DECLINATION HAS 8664 06:13:50,404 --> 06:13:53,241 BEEN SHOWN BY OTHERS WITH A TON 8665 06:13:53,241 --> 06:13:56,744 OF VARIATION IN HOW OFTEN FOLKS 8666 06:13:56,744 --> 06:13:59,580 ARE WILLING OR WANT THAT 8667 06:13:59,580 --> 06:14:01,816 INFORMATION, WANT THE REFERRAL, 8668 06:14:01,816 --> 06:14:03,084 THIS IS REALLY IMPORTANT. 8669 06:14:03,084 --> 06:14:07,188 NEXT, PLEASE. 8670 06:14:07,188 --> 06:14:09,257 AND AGAIN, ONE OF THESE BIG 8671 06:14:09,257 --> 06:14:10,758 BARRIERS AS I THINK I ALLUDED TO 8672 06:14:10,758 --> 06:14:12,193 EARLIER IS SORT OF LIKE WELL, 8673 06:14:12,193 --> 06:14:13,594 OKAY, WE'RE TRYING AT THE TIME 8674 06:14:13,594 --> 06:14:15,463 GET PATIENTS TO CONNECT WITH A 8675 06:14:15,463 --> 06:14:16,664 SOCIAL SERVICE BUT ARE THE 8676 06:14:16,664 --> 06:14:17,665 RESOURCES AVAILABLE? 8677 06:14:17,665 --> 06:14:20,601 DO YOU HAVE A HOUSING -- WHERE I 8678 06:14:20,601 --> 06:14:21,836 LIVE, REFERRING PATIENTS TO 8679 06:14:21,836 --> 06:14:23,004 HOUSING SUPPORT THEY'LL BE ON A 8680 06:14:23,004 --> 06:14:24,539 WAITING LIST FOR A FEW YEARS. 8681 06:14:24,539 --> 06:14:26,374 DOES THAT ADDRESS THEIR NEED? 8682 06:14:26,374 --> 06:14:27,408 NOT IMMEDIATELY. 8683 06:14:27,408 --> 06:14:28,376 THAT'S IN A BIG CITY. 8684 06:14:28,376 --> 06:14:31,012 WHAT HAPPENS IF YOU'RE OUT IN A 8685 06:14:31,012 --> 06:14:31,879 MORE RURAL AREA? 8686 06:14:31,879 --> 06:14:33,414 THERE MAY NOT BE RESOURCES WITH 8687 06:14:33,414 --> 06:14:36,050 WHICH TO ADDRESS THE PATIENT'S 8688 06:14:36,050 --> 06:14:37,552 NEED, AND THEN AGAIN THERE'S 8689 06:14:37,552 --> 06:14:39,086 REAL COMPLEXITY AROUND LIKE WHO 8690 06:14:39,086 --> 06:14:41,189 DOES THE REFERRING AND WHEN. 8691 06:14:41,189 --> 06:14:42,924 UNLESS THERE'S SOME KIND OF 8692 06:14:42,924 --> 06:14:44,258 MEDICAID REIMBURSEMENT, AT LEAST 8693 06:14:44,258 --> 06:14:45,893 IN LOW-INCOME CLINICS, IF YOU 8694 06:14:45,893 --> 06:14:47,195 DON'T HAVE SOMEONE ON STAFF WHO 8695 06:14:47,195 --> 06:14:50,364 HAS GOT THE TIME TO DO IT, THEN 8696 06:14:50,364 --> 06:14:52,233 HOW -- IF IT'S NOT REIMBURSABLE, 8697 06:14:52,233 --> 06:14:53,868 IT'S BECOMING MORE REIMBURSABLE, 8698 06:14:53,868 --> 06:14:55,303 AND THAT'S GREAT, THAT WILL MAKE 8699 06:14:55,303 --> 06:14:56,470 A BIG DIFFERENCE I THINK, BUT 8700 06:14:56,470 --> 06:14:57,605 THAT HAS BEEN A BARRIER IN THE 8701 06:14:57,605 --> 06:14:59,440 PAST AND IT'S STILL NOT THE CASE 8702 06:14:59,440 --> 06:15:00,441 EVERYWHERE THAT THERE'S SOMEONE 8703 06:15:00,441 --> 06:15:01,642 PAYING THE STAFF TO DO THE 8704 06:15:01,642 --> 06:15:02,677 REFERRAL AND THE STAFF NEED TO 8705 06:15:02,677 --> 06:15:04,679 KNOW THE LOCAL COMMUNITY-BASED 8706 06:15:04,679 --> 06:15:06,180 ORGANIZATIONS, CBO'S, THEY NEED 8707 06:15:06,180 --> 06:15:07,515 TO KNOW -- AND THESE COMMUNITY 8708 06:15:07,515 --> 06:15:08,182 ORGANIZATIONS SOME OF THEM 8709 06:15:08,182 --> 06:15:09,717 CHANGE A LOT, RIGHT, SO THEY'VE 8710 06:15:09,717 --> 06:15:11,786 GOT TO HAVE AN UP TO DATE LIST. 8711 06:15:11,786 --> 06:15:13,754 I THINK I'M GETTING INTO MY NEXT 8712 06:15:13,754 --> 06:15:13,955 SLIDE. 8713 06:15:13,955 --> 06:15:14,555 PLEASE GO. 8714 06:15:14,555 --> 06:15:16,057 NEXT ONE, PLEASE. 8715 06:15:16,057 --> 06:15:17,058 OH, OKAY. 8716 06:15:17,058 --> 06:15:18,693 SO THAT GETS TO THE ISSUE OF 8717 06:15:18,693 --> 06:15:19,894 WELL HOW DO YOU MAKE SURE YOU 8718 06:15:19,894 --> 06:15:20,995 EVEN KNOW WHAT RESOURCES ARE 8719 06:15:20,995 --> 06:15:21,262 AVAILABLE. 8720 06:15:21,262 --> 06:15:23,197 A LOT OF FOLKS ARE INTERESTED IN 8721 06:15:23,197 --> 06:15:24,799 THESE SOCIAL SERVICE RESOURCE 8722 06:15:24,799 --> 06:15:26,367 LOCATORS AND THERE'S A 8723 06:15:26,367 --> 06:15:27,768 TECHNOLOGY THAT I THINK HAS A 8724 06:15:27,768 --> 06:15:29,503 LOT OF PROMISE IN HELPING TO 8725 06:15:29,503 --> 06:15:31,806 HAVE AN UPDATED SEARCHABLE LIST 8726 06:15:31,806 --> 06:15:33,574 AND SOMETIMES CONNECTIBLE 8727 06:15:33,574 --> 06:15:35,643 INTERFACE FOR CONNECTING FOLKS 8728 06:15:35,643 --> 06:15:37,845 WITH SOCIAL SERVICES BUT THEY'RE 8729 06:15:37,845 --> 06:15:39,580 NOT NECESSARILY CHEAP OR IF THEY 8730 06:15:39,580 --> 06:15:41,749 ARE CHEAP, THEY MAY NOT BE UP TO 8731 06:15:41,749 --> 06:15:42,783 DATE, SOMETIMES EVEN IF THEY'RE 8732 06:15:42,783 --> 06:15:44,719 NOT CHEAP, THEY'RE NOT UP TO 8733 06:15:44,719 --> 06:15:48,889 DATE AND WE'VE HEARD SOMETIMES 8734 06:15:48,889 --> 06:15:50,758 ONES WITH EHR SOMETIMES THEY 8735 06:15:50,758 --> 06:15:53,594 HAVE A LOT OF GLICHES, THERE'S 8736 06:15:53,594 --> 06:15:55,463 TOO MANY OPTIONS IN CASES, I 8737 06:15:55,463 --> 06:15:56,664 DON'T KNOW WHICH ONE TO GO WITH 8738 06:15:56,664 --> 06:15:57,765 AND COMMUNITY BASE THE 8739 06:15:57,765 --> 06:15:58,966 ORGANIZATIONS HAVE TO BE WILLING 8740 06:15:58,966 --> 06:16:00,401 TO ENGAGE RIGHT BECAUSE YOU'LL 8741 06:16:00,401 --> 06:16:01,469 HEAR PEOPLE SAYING I WANT TO 8742 06:16:01,469 --> 06:16:03,004 CLOSE THE LOOP ON SOCIAL SERVICE 8743 06:16:03,004 --> 06:16:04,205 REMPLEZ BUFORT YOU CAN'T CLOSE 8744 06:16:04,205 --> 06:16:05,740 THE LOOP UNLESS SOMEONE ON YOUR 8745 06:16:05,740 --> 06:16:07,041 TEAM CALLS THE PATIENT AND SAYS 8746 06:16:07,041 --> 06:16:08,142 DID YOU MAKE IT, DID YOU GET 8747 06:16:08,142 --> 06:16:09,677 THAT SERVICE, OR YOU'VE GOT TO 8748 06:16:09,677 --> 06:16:11,312 SOMEHOW ADDRESS THE BARRIERS OF 8749 06:16:11,312 --> 06:16:12,079 THESE COMMUNITY-BASED 8750 06:16:12,079 --> 06:16:12,947 ORGANIZATIONS THAT JUST LIKE 8751 06:16:12,947 --> 06:16:14,248 THEY MAY NOT HAVE TIME, WHAT ARE 8752 06:16:14,248 --> 06:16:15,916 THEY GETTING OUT OF IT IF YOU'RE 8753 06:16:15,916 --> 06:16:18,219 NOT PAYING THEM THEN WHY ARE 8754 06:16:18,219 --> 06:16:19,287 THEY GOING TO CLOSE THE LOOP? 8755 06:16:19,287 --> 06:16:21,055 THIS IS A BARRIER I'VE SEEN THIS 8756 06:16:21,055 --> 06:16:23,024 MULTIPLE SETTINGS IN MULTIPLE 8757 06:16:23,024 --> 06:16:24,225 SITUATIONS WHERE THE COMMUNITY 8758 06:16:24,225 --> 06:16:25,826 ORGANIZATIONS ARE JUST LIKE WHY 8759 06:16:25,826 --> 06:16:28,129 ARE YOU -- THIS IS NOT MY 8760 06:16:28,129 --> 06:16:29,363 PROBLEM, LIKE THEY'LL TAKE THE 8761 06:16:29,363 --> 06:16:30,898 PATIENTS BUT THEY DON'T FEEL 8762 06:16:30,898 --> 06:16:32,667 OBLIGATED TO CLOSE THIS LOOP, 8763 06:16:32,667 --> 06:16:34,302 AND THEN HOW DIST CLINIC KNOW 8764 06:16:34,302 --> 06:16:36,137 FLT PATIENT CLOSED THE LOOP? 8765 06:16:36,137 --> 06:16:38,239 SO THIS IS VERY COMPLEX. 8766 06:16:38,239 --> 06:16:39,473 NEXT H PLEASE. 8767 06:16:39,473 --> 06:16:40,775 I DO AGAIN HAVE SOME RESOURCES 8768 06:16:40,775 --> 06:16:43,110 TO OFFER YOU ON HOW TO IMPLEMENT 8769 06:16:43,110 --> 06:16:44,912 THESE KIND OF ASSISTANCE 8770 06:16:44,912 --> 06:16:45,179 REFERRALS. 8771 06:16:45,179 --> 06:16:47,882 ONE IS AGAIN FROM SIREN, THE 8772 06:16:47,882 --> 06:16:48,849 COMMUNITY RESOURCE REFERRAL 8773 06:16:48,849 --> 06:16:50,284 PLATFORM GUIDE, AGAIN THINKING 8774 06:16:50,284 --> 06:16:51,686 ABOUT THE DIFFERENT KINDS OF 8775 06:16:51,686 --> 06:16:53,120 SOCIAL SERVICE RESOURCE LOCATORS 8776 06:16:53,120 --> 06:16:55,089 AND ANOTHER IS IMPLEMENTATION 8777 06:16:55,089 --> 06:16:57,958 TOOLKIT FOR SOCIAL RISK 8778 06:16:57,958 --> 06:16:59,160 REFERRALS FOR PRIMARY CARE MY 8779 06:16:59,160 --> 06:17:00,461 TEAM RECENTLY COMPLETED AND MADE 8780 06:17:00,461 --> 06:17:01,662 AVAILABLE THROUGH SIREN AND THE 8781 06:17:01,662 --> 06:17:02,897 SHRINK RIGHT THERE AND THIS IS 8782 06:17:02,897 --> 06:17:05,499 AGAIN A VERY PRAGMATIC APPLIED 8783 06:17:05,499 --> 06:17:07,702 GUIDE TO THINKING ABOUT THE 8784 06:17:07,702 --> 06:17:09,003 DECISION YOU'LL MAKE AND WHAT 8785 06:17:09,003 --> 06:17:10,538 YOUR OPTIONS ARE IF YOU WANT TO 8786 06:17:10,538 --> 06:17:11,972 CONDUCT SOCIAL RISK REFERRAL 8787 06:17:11,972 --> 06:17:12,406 MAKING. 8788 06:17:12,406 --> 06:17:13,074 NEXT, PLEASE. 8789 06:17:13,074 --> 06:17:15,576 I REALLY WANT TO GET TO 8790 06:17:15,576 --> 06:17:15,876 ADJUSTMENT. 8791 06:17:15,876 --> 06:17:17,144 SO I'VE BEEN TALKING ABOUT 8792 06:17:17,144 --> 06:17:18,512 REFERRALS BUT THEN THERE'S ALSO 8793 06:17:18,512 --> 06:17:19,380 THIS IDEA OF ADJUSTMENT. 8794 06:17:19,380 --> 06:17:20,848 CAN YOU ADAPT THE CARE PLAN TO 8795 06:17:20,848 --> 06:17:22,683 MAKE IT MORE FEASIBLE FOR THE 8796 06:17:22,683 --> 06:17:24,218 PATIENT TO ADHERE TO THE CARE 8797 06:17:24,218 --> 06:17:24,418 PLAN? 8798 06:17:24,418 --> 06:17:24,919 GOT IT. 8799 06:17:24,919 --> 06:17:25,619 THANK YOU. 8800 06:17:25,619 --> 06:17:28,689 I'M RIGHT ON TIME. 8801 06:17:28,689 --> 06:17:29,890 ADJUSTMENTS MIGHT MEAN LIKE 8802 06:17:29,890 --> 06:17:32,326 MAKING SURE THAT THEY'VE GOT A 8803 06:17:32,326 --> 06:17:33,494 GENERIC MEDICATION THAT IS MORE 8804 06:17:33,494 --> 06:17:35,162 AFFORDABLE THAN A NONGENERIC, 8805 06:17:35,162 --> 06:17:36,664 MAKING SURE THEY'RE GETTING A 8806 06:17:36,664 --> 06:17:38,432 POLYPILL TO REDUCE THE CO-PAY, 8807 06:17:38,432 --> 06:17:40,501 CAN YOU MAIL THE PRESCRIPTION TO 8808 06:17:40,501 --> 06:17:41,936 THEIR HOME IF THEY HAVE 8809 06:17:41,936 --> 06:17:43,671 TRANSPORTATION BARRIERS, BUT IS 8810 06:17:43,671 --> 06:17:45,106 THAT A SAFE THING TO DO TO MAIL 8811 06:17:45,106 --> 06:17:46,974 IT TO THEIR HOME, LIKE WILL THEY 8812 06:17:46,974 --> 06:17:48,476 GET THE MEDS IF THEY'RE DROPPED 8813 06:17:48,476 --> 06:17:50,444 OFF ON THEIR DOOR, THERE'S 8814 06:17:50,444 --> 06:17:51,245 COMPLEXITY THERE. 8815 06:17:51,245 --> 06:17:53,314 IF THE PERSON HAS TRANSPORTATION 8816 06:17:53,314 --> 06:17:54,615 INSECURITY, CAN FOLLOW-UP CARE 8817 06:17:54,615 --> 06:17:57,351 BE VIA TELEHEALTH, DOES THE 8818 06:17:57,351 --> 06:17:59,653 PATIENT HAVE ACCESS TO 8819 06:17:59,653 --> 06:18:01,088 TELEHEALTH, WE'RE FINDING THAT 8820 06:18:01,088 --> 06:18:03,124 TELEHEALTH ACCESS IS LESS OF A 8821 06:18:03,124 --> 06:18:05,326 BARRIER THAN IT USED TO BE 8822 06:18:05,326 --> 06:18:06,660 BEFORE THE PANDEMIC BUT 8823 06:18:06,660 --> 06:18:07,862 NEVERTHELESS HAVE TO MAKE SURE 8824 06:18:07,862 --> 06:18:08,529 THAT'S AN OPTION. 8825 06:18:08,529 --> 06:18:09,497 FOR EXAMPLE IF THE PATIENT 8826 06:18:09,497 --> 06:18:11,132 DESCRNT A PLACE TO REFRIGERATE 8827 06:18:11,132 --> 06:18:12,233 THE MEDICATION YOU NEED TO MAKE 8828 06:18:12,233 --> 06:18:14,001 SURE YOU GIVE THEM A MEDICATION 8829 06:18:14,001 --> 06:18:15,269 THAT DOES NOT NEED TO BE 8830 06:18:15,269 --> 06:18:16,504 REFRIGERATED, IF THEY'RE FOOD 8831 06:18:16,504 --> 06:18:17,571 INSECURE AND THEY HAVE DIABETES 8832 06:18:17,571 --> 06:18:18,873 YOU NEED TO THINK ABOUT HOW MUCH 8833 06:18:18,873 --> 06:18:20,441 FOOD THEY'LL HAVE AT THE END OF 8834 06:18:20,441 --> 06:18:22,510 THE MONTH IF THEIR MONTHLY FOOD 8835 06:18:22,510 --> 06:18:23,677 BENEFIT RUNS OUT AND MAYBE HAVE 8836 06:18:23,677 --> 06:18:24,812 TOO MUCH INSULIN, YOU HAVE TO 8837 06:18:24,812 --> 06:18:25,713 THINK ABOUT THAT PIECE. 8838 06:18:25,713 --> 06:18:27,214 THERE IS SOME EMERGING EVIDENCE 8839 06:18:27,214 --> 06:18:29,283 THAT SAYS DO GET BETTER CLINICAL 8840 06:18:29,283 --> 06:18:31,051 OUTCOMES IF YOU MAKE THESE CARE 8841 06:18:31,051 --> 06:18:33,220 PLAN ADJUSTMENTS, MOSTLY WORK 8842 06:18:33,220 --> 06:18:37,858 DONE BY SHALLWEI NEXT R AT THE 8843 06:18:37,858 --> 06:18:39,693 UNIVERSITY OF CHICAGO BUT FOUND 8844 06:18:39,693 --> 06:18:40,861 ADJUSTMENTS ONLY HAPPENING LESS 8845 06:18:40,861 --> 06:18:41,996 THAN 25 PERCENT OF THE TIME IN 8846 06:18:41,996 --> 06:18:43,397 LOTS OF DIFFERENT SETTINGS. 8847 06:18:43,397 --> 06:18:45,065 SO HOW CAN YOU PRESENT SOCIAL 8848 06:18:45,065 --> 06:18:47,001 RISK INFORMATION IN A WAY THAT 8849 06:18:47,001 --> 06:18:48,436 DOES IMPROVE ADJUSTMENT 8850 06:18:48,436 --> 06:18:49,537 PROVISION, COULD WE USE TOOLS IN 8851 06:18:49,537 --> 06:18:51,372 THE EHR, MY TEAM IS RUNNING A 8852 06:18:51,372 --> 06:18:54,775 TRIAL RIGHT NOW ON A SET SET OF 8853 06:18:54,775 --> 06:18:56,510 EHR TOOLS WE DESIGNED WITH 8854 06:18:56,510 --> 06:18:58,279 COMMUNITY MEMBERS PILOTED IN 8855 06:18:58,279 --> 06:19:00,247 COMMUNITY CLINICS, REVISED TOOLS 8856 06:19:00,247 --> 06:19:02,883 ACCORDING TO THE PILOT CLINIC'S 8857 06:19:02,883 --> 06:19:04,051 INPUT AND I'LL TELL YOU RIGHT 8858 06:19:04,051 --> 06:19:05,152 NOW WHAT IS HAPPENING IS THAT NO 8859 06:19:05,152 --> 06:19:07,021 ONE IS USING TOOLS, EVEN THOUGH 8860 06:19:07,021 --> 06:19:07,888 WE DID EVERYTHING RIGHT. 8861 06:19:07,888 --> 06:19:09,290 THEY JUST DON'T, THEY'RE NOT 8862 06:19:09,290 --> 06:19:10,090 USING THEM. 8863 06:19:10,090 --> 06:19:11,058 SO THERE'S A LOT WE HAVE TO 8864 06:19:11,058 --> 06:19:12,726 FIGURE OUT ABOUT HOW TO REALLY 8865 06:19:12,726 --> 06:19:13,794 SUPPORT ADJUSTMENT OCCURRING. 8866 06:19:13,794 --> 06:19:14,361 NEXT, PLEASE. 8867 06:19:14,361 --> 06:19:16,096 I THINK IT'S MY LAST SLIDE, SO 8868 06:19:16,096 --> 06:19:17,631 IF YOU'RE ALL FALLING ASLEEP, 8869 06:19:17,631 --> 06:19:19,300 BEAR WITH ME. 8870 06:19:19,300 --> 06:19:20,601 YES, I THINK THIS IS THE LAST 8871 06:19:20,601 --> 06:19:23,971 ONE, OR NO, SECOND-TO-LAST. 8872 06:19:23,971 --> 06:19:26,073 SO JUST ANOTHER JUST POINTED 8873 06:19:26,073 --> 06:19:28,042 ABOUT ADJUSTMENT, IT'S KIND OF 8874 06:19:28,042 --> 06:19:29,677 INTERESTING THAT WHEN CLINICIANS 8875 06:19:29,677 --> 06:19:31,212 DO HAVE INFORMATION ABOUT THE 8876 06:19:31,212 --> 06:19:34,515 PATIENT'S SOCIAL RISKS, ONE 8877 06:19:34,515 --> 06:19:35,916 SURVEY THAT WE CONDUCTED FOUND 8878 06:19:35,916 --> 06:19:37,551 THAT AND THIS WASN'T A HUGE 8879 06:19:37,551 --> 06:19:38,619 NUMBER, BUT IT WAS STILL RIGHT 8880 06:19:38,619 --> 06:19:40,187 AT THE POINT OF CARE WHICH WAS 8881 06:19:40,187 --> 06:19:42,590 COOL, THAT THE CLINICIANS DID 8882 06:19:42,590 --> 06:19:49,029 REPORT THAT THE PATIENT SOCIAL 8883 06:19:49,029 --> 06:19:52,099 RISKS INFLUENCE -- POINT OF 8884 06:19:52,099 --> 06:19:54,168 INFLUENCED CARE ABOUT A THIRD OF 8885 06:19:54,168 --> 06:19:56,136 THE DISPIEM INTERESTING IN 8886 06:19:56,136 --> 06:19:56,904 CONVERSATION FROM THE PATIENT 8887 06:19:56,904 --> 06:19:57,905 ONLY ABOUT HALF THE TIME FROM 8888 06:19:57,905 --> 06:20:00,975 THE EHR SO OUR WHOLE FAMILY SIS 8889 06:20:00,975 --> 06:20:02,142 ON AWARE NGS AND GETTING THAT 8890 06:20:02,142 --> 06:20:03,911 DATA INTO EHR THAT MIGHT BE 8891 06:20:03,911 --> 06:20:05,312 USEFUL FOR REPORTING PURPOSES 8892 06:20:05,312 --> 06:20:07,314 BUT MAYBE THAT'S NOT THE WAY 8893 06:20:07,314 --> 06:20:08,949 THAT CARETAKERS WANT TO GET THAT 8894 06:20:08,949 --> 06:20:09,717 INFORMATION AND I THINK THIS IS 8895 06:20:09,717 --> 06:20:11,018 A REALLY IMPORTANT POINT TWHEAF 8896 06:20:11,018 --> 06:20:12,186 NOT DIALED IN YET. 8897 06:20:12,186 --> 06:20:13,988 LAST SLIDE, PLEASE. 8898 06:20:13,988 --> 06:20:15,623 WHAT DO WE STILL NEED TO KNOW? 8899 06:20:15,623 --> 06:20:18,359 WELL, THE ANSWER IS A LOT. 8900 06:20:18,359 --> 06:20:21,395 WE DON'T REALLY KNOW WHAT 8901 06:20:21,395 --> 06:20:24,365 PATHWAYS TO FOLLOW TO ENSURE 8902 06:20:24,365 --> 06:20:26,000 THAT SOCIAL RISK SCREENING AND 8903 06:20:26,000 --> 06:20:27,268 REFERLINGS LEAD TO IMPROVED 8904 06:20:27,268 --> 06:20:28,135 HEALTH OUTCOMES. 8905 06:20:28,135 --> 06:20:29,937 WE CAN MAKE A LITTLE IMPROVEMENT 8906 06:20:29,937 --> 06:20:31,472 BUNLT A BIG IMPROVEMENT AND A 8907 06:20:31,472 --> 06:20:33,107 LITTLE IMPROVEMENT IS MAYBE NOT 8908 06:20:33,107 --> 06:20:33,541 ENOUGH. 8909 06:20:33,541 --> 06:20:35,843 WHAT PREACHES TO ADDRESSING 8910 06:20:35,843 --> 06:20:37,578 SOCIAL RISKS ARE MOST EE FICTIVE 8911 06:20:37,578 --> 06:20:39,346 AND FOR WHICH PATIENTS, VARIETY 8912 06:20:39,346 --> 06:20:40,581 THERE, WE HAVEN'T SCRATCHED THE 8913 06:20:40,581 --> 06:20:41,549 SURFACE OF THAT. 8914 06:20:41,549 --> 06:20:43,117 WHAT METHODS, AGAIN THIS IS 8915 06:20:43,117 --> 06:20:44,652 WHERE I'M INTERESTED AS 8916 06:20:44,652 --> 06:20:46,353 COMMUNITY HEALTH CENTER WHAT 8917 06:20:46,353 --> 06:20:47,688 METHODS EFFECTIVE FOR DOING THIS 8918 06:20:47,688 --> 06:20:49,089 IN COMMUNITY HEALTH CENTER 8919 06:20:49,089 --> 06:20:50,624 SETTINGS, ARE THERE POTENTIAL 8920 06:20:50,624 --> 06:20:51,959 HARMS FOR THE SCREENING? 8921 06:20:51,959 --> 06:20:53,394 REMEMBER THE CHECKLIST IF YOU'RE 8922 06:20:53,394 --> 06:20:54,361 A PATIENT AND YOU DW AND YOU 8923 06:20:54,361 --> 06:20:57,431 FEEL LIKE YOUR PROVIDER IS 8924 06:20:57,431 --> 06:20:59,166 HOUSING INSECURE, NOT ENOUGH TO 8925 06:20:59,166 --> 06:21:01,135 EAT, THAT COULD ALSO IMPACTED 8926 06:21:01,135 --> 06:21:02,102 NEGATIVELY YOUR TRUST, THAT 8927 06:21:02,102 --> 06:21:03,203 DOESN'T FEEL GOOD. 8928 06:21:03,203 --> 06:21:04,405 AGAIN, HOW MUCH IMPACT CAN WE 8929 06:21:04,405 --> 06:21:06,040 EVEN THINK WE'RE GOING TO MAKE 8930 06:21:06,040 --> 06:21:08,242 WITH SCREENING AND REFERRALS 8931 06:21:08,242 --> 06:21:09,777 SPECIFICALLY GIVEN HOW 8932 06:21:09,777 --> 06:21:10,978 INADEQUATELY THIS COUNTRY FUNDS 8933 06:21:10,978 --> 06:21:11,912 SOCIAL SERVICES? 8934 06:21:11,912 --> 06:21:14,648 I MEAN, AND WE COULD TALK ABOUT 8935 06:21:14,648 --> 06:21:16,850 THAT YOU ADAY IF YOU WANT. 8936 06:21:16,850 --> 06:21:18,018 AND I WOULD PUT TO THIS 8937 06:21:18,018 --> 06:21:21,021 GRURNTION HOW -- GROUP HOW ARE 8938 06:21:21,021 --> 06:21:21,755 THESE IMPACTS DIFFERENT OR 8939 06:21:21,755 --> 06:21:24,592 SPECIFIC TO PVD. 8940 06:21:24,592 --> 06:21:27,995 I BELIEVE THAT IS THE LAST 8941 06:21:27,995 --> 06:21:29,396 SLIDE. 8942 06:21:29,396 --> 06:21:29,597 NEXT. 8943 06:21:29,597 --> 06:21:30,297 LET'S CHECK. 8944 06:21:30,297 --> 06:21:31,599 MAKE SURE I DIDN'T LEAVE 8945 06:21:31,599 --> 06:21:32,466 SOMETHING OUT. 8946 06:21:32,466 --> 06:21:33,901 YES. 8947 06:21:33,901 --> 06:21:34,101 GREAT. 8948 06:21:34,101 --> 06:21:37,304 ALL RIGHT. 8949 06:21:37,304 --> 06:21:40,174 >> THANK YOU SO MUCH, DR. GOLD. 8950 06:21:40,174 --> 06:21:42,109 THAT WAS EXCELLENT. 8951 06:21:42,109 --> 06:21:44,178 VERY PRACTICAL TALK FOR US. 8952 06:21:44,178 --> 06:21:46,380 I'M SURE PEOPLE TOOK A LOT FROM 8953 06:21:46,380 --> 06:21:46,680 THAT. 8954 06:21:46,680 --> 06:21:48,782 ONE QUESTION I HAD FOR YOU SINCE 8955 06:21:48,782 --> 06:21:50,284 YOU'RE THE LAST ONE, YOU'LL BE 8956 06:21:50,284 --> 06:21:52,052 THE FIRST ONE UP FOR THE 8957 06:21:52,052 --> 06:21:54,455 QUESTION SESSION. 8958 06:21:54,455 --> 06:21:58,325 SO WHEN IT COMES TO, WHEN DID 8959 06:21:58,325 --> 06:22:00,127 YOU CALM IT, NOT SOCIAL 8960 06:22:00,127 --> 06:22:00,794 DETERMINANTS BUT -- 8961 06:22:00,794 --> 06:22:01,929 >> I PREFER SOCIAL RISKS. 8962 06:22:01,929 --> 06:22:03,864 >> SOCIAL RISKS. 8963 06:22:03,864 --> 06:22:04,131 VERY GOOD. 8964 06:22:04,131 --> 06:22:05,933 >> I CAN TELL YOU WHY, BUT WE 8965 06:22:05,933 --> 06:22:07,234 DON'T NEED TO GO INTO IT. 8966 06:22:07,234 --> 06:22:07,434 YEAH. 8967 06:22:07,434 --> 06:22:10,871 >> SO WE'VE HAD MULTIPLE 8968 06:22:10,871 --> 06:22:12,906 DISCUSSANTS ASK ME, WHAT -- AND 8969 06:22:12,906 --> 06:22:17,745 I WOULD LIKE TO GET YOUR OPINIOF 8970 06:22:17,745 --> 06:22:19,847 MEASUREMENT TOOL, SORT OF 8971 06:22:19,847 --> 06:22:20,581 STANDARDIZED MEASUREMENT TOOL 8972 06:22:20,581 --> 06:22:21,682 WOULD YOU RECOMMEND FOR PEOPLE 8973 06:22:21,682 --> 06:22:23,984 WHO ARE TRYING TO IMPLEMENT THIS 8974 06:22:23,984 --> 06:22:25,185 INTO THEIR CLINIC? 8975 06:22:25,185 --> 06:22:26,453 >> GREAT QUESTION AND I HEAR IT 8976 06:22:26,453 --> 06:22:27,154 ALL THE TIME. 8977 06:22:27,154 --> 06:22:29,123 SO FIRST OF ALL, I WOULD JUST 8978 06:22:29,123 --> 06:22:30,658 SAY THAT IN ONE OF THE GUIDES ON 8979 06:22:30,658 --> 06:22:32,626 THE IMPLEMENTATION GUIDE I GAVE 8980 06:22:32,626 --> 06:22:34,061 YOU, WE TALK ABOUT THAT QUITE A 8981 06:22:34,061 --> 06:22:34,228 BIT. 8982 06:22:34,228 --> 06:22:36,563 THIS IS AN INTERESTING QUESTION. 8983 06:22:36,563 --> 06:22:37,865 OVERALL, I WOULD SAY USE 8984 06:22:37,865 --> 06:22:39,199 WHATEVER TOOL IS MORE 8985 06:22:39,199 --> 06:22:41,368 COMFORTABLE FOR YOU, LIKE IF 8986 06:22:41,368 --> 06:22:42,670 YOUR STAFF LIKES ONE TOOL, 8987 06:22:42,670 --> 06:22:43,904 THERE'S A WHOLE BUNCH OF 8988 06:22:43,904 --> 06:22:44,672 DIFFERENT TOOLS OUT THERE, IF 8989 06:22:44,672 --> 06:22:46,206 YOU REQUEST TO THE SIREN WEBSITE 8990 06:22:46,206 --> 06:22:47,941 THEY'VE GOT A WHOLE PAGE THAT 8991 06:22:47,941 --> 06:22:49,243 COMPARES DIFFERENT SOCIAL RISK 8992 06:22:49,243 --> 06:22:50,577 SCREENERS THAT ARE OUT THERE, 8993 06:22:50,577 --> 06:22:52,212 NONE OF THEM HAVE -- THE FOLKS 8994 06:22:52,212 --> 06:22:57,451 WHO CREATED THE PREPARE TOOL, 8995 06:22:57,451 --> 06:22:59,186 PREPARE, THEY CLAIM THAT IT HAS 8996 06:22:59,186 --> 06:23:00,621 BEEN VALIDATED. 8997 06:23:00,621 --> 06:23:02,489 I WOULD SAY THEIR DEFINITION OF 8998 06:23:02,489 --> 06:23:04,224 VALIDATED IS NOT MY DEFINITION 8999 06:23:04,224 --> 06:23:06,326 OF VALIDATED, AND IT'S A LONG 9000 06:23:06,326 --> 06:23:08,495 TOOL, AND I'VE HEARD MANY USERS 9001 06:23:08,495 --> 06:23:09,596 SAY I DON'T WANT TO USE THAT 9002 06:23:09,596 --> 06:23:10,898 TOOL, IT'S TOO LONG. 9003 06:23:10,898 --> 06:23:12,332 NOW, YOU MIGHT JUST HAVE TO USE 9004 06:23:12,332 --> 06:23:13,634 THE SCREENING TOOL THAT YOU'RE 9005 06:23:13,634 --> 06:23:16,403 REQUIRED TO USE IF IT'S TIED TO 9006 06:23:16,403 --> 06:23:18,806 REIMBURSEMENT LIKE THE 9007 06:23:18,806 --> 06:23:19,440 ACCOUNTABILITY HEALTH 9008 06:23:19,440 --> 06:23:20,641 COMMUNITY'S TOOL THERE'S A FOUR 9009 06:23:20,641 --> 06:23:21,742 QUESTION EXPRERGS A LOT OF FOLKS 9010 06:23:21,742 --> 06:23:23,043 NOW IF YOU'RE TRYING TO DO THIS 9011 06:23:23,043 --> 06:23:25,245 AS PART OF A PROJECT WITH CMS 9012 06:23:25,245 --> 06:23:26,580 YOU'LL PROBABLY HAVE TO USE 9013 06:23:26,580 --> 06:23:27,548 THEIR TOOL AND I THINK THAT'S 9014 06:23:27,548 --> 06:23:28,415 FINE AS WELL. 9015 06:23:28,415 --> 06:23:30,184 BUT MY OVERARCHING ADVICE ON 9016 06:23:30,184 --> 06:23:31,251 THIS IS JUST LOOK AT THE 9017 06:23:31,251 --> 06:23:32,252 DIFFERENT TOOLS THAT ARE OUT 9018 06:23:32,252 --> 06:23:33,587 THERE AND USE WHICHEVER ONE 9019 06:23:33,587 --> 06:23:34,988 FEELS LIKE IT'S GOING TO WORK 9020 06:23:34,988 --> 06:23:36,423 BETTER FOR YOUR PATIENTS. 9021 06:23:36,423 --> 06:23:37,591 MAYBE YOU WANT TO RUN DIFFERENT 9022 06:23:37,591 --> 06:23:38,826 TOOLS BY YOUR PATIENTS AND SEE 9023 06:23:38,826 --> 06:23:40,260 WHAT THEY FEEL MORE COMFORTABLE 9024 06:23:40,260 --> 06:23:40,461 WITH. 9025 06:23:40,461 --> 06:23:43,297 THERE IS NO ONE TOOL THAT IS 9026 06:23:43,297 --> 06:23:44,598 HIGHLY BETTER THAN THE OTHERS, 9027 06:23:44,598 --> 06:23:45,666 THERE IS NO EVIDENCE THAT ANY OF 9028 06:23:45,666 --> 06:23:48,602 THE TOOLS ARE BETTER THAN THE 9029 06:23:48,602 --> 06:23:48,836 OTHERS. 9030 06:23:48,836 --> 06:23:49,870 I DON'T THINK -- HOW DO YOU EVEN 9031 06:23:49,870 --> 06:23:51,505 LIKE VALIDATE SOMEONE BEING 9032 06:23:51,505 --> 06:23:52,973 HOMELESS OR HOUSING INSECURE? 9033 06:23:52,973 --> 06:23:55,542 I DON'T KNOW IF THAT EVEN CAN BE 9034 06:23:55,542 --> 06:23:55,743 DONE. 9035 06:23:55,743 --> 06:23:56,443 >> GOOD POINT. 9036 06:23:56,443 --> 06:23:58,512 >> MY ANSWER TO THAT IS IT 9037 06:23:58,512 --> 06:23:59,813 DOESN'T REALLY MATTER BUT I 9038 06:23:59,813 --> 06:24:00,914 HIGHLY RECOMMEND GOING TO THE 9039 06:24:00,914 --> 06:24:02,015 SIREN WEBSITE AND LOOKING AT 9040 06:24:02,015 --> 06:24:02,983 THEIR COMPARISON OF THE 9041 06:24:02,983 --> 06:24:05,285 DIFFERENT TOOLS BECAUSE THAT'S A 9042 06:24:05,285 --> 06:24:07,554 USEFUL RESOURCE. 9043 06:24:07,554 --> 06:24:10,390 >> JUST A GREAT TALK. 9044 06:24:10,390 --> 06:24:12,159 YOU KNOW, I HAVE A COUPLE 9045 06:24:12,159 --> 06:24:12,426 QUESTIONS. 9046 06:24:12,426 --> 06:24:13,927 YOU BROUGHT UP THE WHOLE POINT 9047 06:24:13,927 --> 06:24:15,796 ABOUT THE ASSISTANCE 9048 06:24:15,796 --> 06:24:17,464 INTERVENTIONS AND LOOKING AT THE 9049 06:24:17,464 --> 06:24:19,933 POINT THAT THE PATIENT CAN BE 9050 06:24:19,933 --> 06:24:21,702 REFERRED BUT THERE MAY NOT BE 9051 06:24:21,702 --> 06:24:22,770 ADEQUATE RESOURCES. 9052 06:24:22,770 --> 06:24:24,638 HAS ANYBODY LOOKED IN THE 9053 06:24:24,638 --> 06:24:25,939 PARTICULAR COMMUNITY AT THE 9054 06:24:25,939 --> 06:24:29,476 RATIO OF, SAY, REFERRALS TO 9055 06:24:29,476 --> 06:24:29,743 RESOURCES? 9056 06:24:29,743 --> 06:24:31,779 SO TO SAY, YOU KNOW, GEE, WE 9057 06:24:31,779 --> 06:24:33,647 KIND OF DID WHAT WE WERE TRYING 9058 06:24:33,647 --> 06:24:35,149 TO DO BUT IT WASN'T THERE? 9059 06:24:35,149 --> 06:24:37,451 >> THAT IS A GREAT QUESTION. 9060 06:24:37,451 --> 06:24:39,753 IF ANYONE HAS -- I'M NOT -- IF 9061 06:24:39,753 --> 06:24:41,588 ANYONE HAS, I'M NOT AWARE OF IT, 9062 06:24:41,588 --> 06:24:43,223 THAT DOESN'T MEAN IT'S NOT OUT 9063 06:24:43,223 --> 06:24:43,423 THERE. 9064 06:24:43,423 --> 06:24:45,325 I'M WORKING WITH SOME COLLEAGUES 9065 06:24:45,325 --> 06:24:46,927 RIGHT NOW TO SEE IF WE CAN STUDY 9066 06:24:46,927 --> 06:24:47,194 THAT. 9067 06:24:47,194 --> 06:24:49,363 I'M NOT AWARE OF ANYONE WHO HAS 9068 06:24:49,363 --> 06:24:51,331 DONE THAT YET BUT THAT MAY MEAN 9069 06:24:51,331 --> 06:24:52,666 THAT I'VE MISSED ARCH ARTICLE OR 9070 06:24:52,666 --> 06:24:52,933 SOMETHING. 9071 06:24:52,933 --> 06:24:54,067 >> THEN I GUESS THE SECOND 9072 06:24:54,067 --> 06:24:55,602 QUESTION, BECAUSE I HEAR ABOUT 9073 06:24:55,602 --> 06:24:58,906 THIS TOO, IS, HAS ANYBODY SHOWN 9074 06:24:58,906 --> 06:25:00,507 THAT, YOU KNOW, IMPLEMENTING 9075 06:25:00,507 --> 06:25:02,476 THESE KINDS OF PROGRAMS, SAY 9076 06:25:02,476 --> 06:25:04,878 EVEN SOMETHING AS SIMPLE AS JUST 9077 06:25:04,878 --> 06:25:06,113 IMPLEMENTING THE NAVIGATOR, HAS 9078 06:25:06,113 --> 06:25:08,515 LED TO A REDUCTION IN HEALTHCARE 9079 06:25:08,515 --> 06:25:08,715 COSTS? 9080 06:25:08,715 --> 06:25:12,219 AND I ASK THAT BECAUSE THAT IS 9081 06:25:12,219 --> 06:25:14,388 WHAT WILL GET PEOPLE'S ATTENTION 9082 06:25:14,388 --> 06:25:15,122 TO MAKE CHANGES. 9083 06:25:15,122 --> 06:25:16,156 >> YES. 9084 06:25:16,156 --> 06:25:17,591 I VERY RECENTLY SAW AN ARTICLE 9085 06:25:17,591 --> 06:25:20,661 ON THE ROI OF SOCIAL RISK 9086 06:25:20,661 --> 06:25:20,994 INTERVENTION. 9087 06:25:20,994 --> 06:25:22,095 I WILL TRY AND FIND THAT FOR YOU 9088 06:25:22,095 --> 06:25:24,031 AND PUT IT IN THE CHAT 9089 06:25:24,031 --> 06:25:24,331 MOMENTARILY. 9090 06:25:24,331 --> 06:25:25,899 IF I CANNOT FIND IT QUICKLY, I 9091 06:25:25,899 --> 06:25:26,934 WILL E-MAIL IT. 9092 06:25:26,934 --> 06:25:28,635 THERE IS A RECENT ARTICLE ON 9093 06:25:28,635 --> 06:25:28,836 THAT. 9094 06:25:28,836 --> 06:25:30,170 I DON'T HAVE IT AT MY 9095 06:25:30,170 --> 06:25:32,239 FINGERTIPS, BUT I'LL TRY AND 9096 06:25:32,239 --> 06:25:33,607 FIND IT FOR YOU. 9097 06:25:33,607 --> 06:25:36,510 >> BECAUSE I THINK, YOU KNOW, 9098 06:25:36,510 --> 06:25:38,812 EVEN TOO, YOU KNOW, THINKING 9099 06:25:38,812 --> 06:25:40,981 ABOUT THIS FOR SOMEONE WHO 9100 06:25:40,981 --> 06:25:43,183 LIVES, THINKING IN A PRECISION 9101 06:25:43,183 --> 06:25:44,384 MEDICINE WORLD, THIS IS ALMOST 9102 06:25:44,384 --> 06:25:47,120 LIKE YOU HAVE TO TAKE A 9103 06:25:47,120 --> 06:25:49,423 PERSONALIZED OR INDIVIDUALIZED 9104 06:25:49,423 --> 06:25:52,693 APPROACH TO EACH PERSON TO 9105 06:25:52,693 --> 06:25:54,761 IDENTIFY, YOU KNOW, THE SOCIAL 9106 06:25:54,761 --> 06:25:57,064 RISKS AND THEN TO IMPLEMENT SOME 9107 06:25:57,064 --> 06:25:59,499 KIND OF PROGRAM THAT WORKS FOR 9108 06:25:59,499 --> 06:26:01,468 THAT PARTICULAR PERSON. 9109 06:26:01,468 --> 06:26:02,069 >> YEAH. 9110 06:26:02,069 --> 06:26:03,737 THE NEED FOR IT TO BE 9111 06:26:03,737 --> 06:26:05,405 PERSONALIZED IS OBVIOUS, RIGHT? 9112 06:26:05,405 --> 06:26:06,607 I MEAN, AND YET -- 9113 06:26:06,607 --> 06:26:07,307 >> ABSOLUTELY. 9114 06:26:07,307 --> 06:26:11,612 >> AND YET IT CAN BE SOMEWHAT 9115 06:26:11,612 --> 06:26:13,380 SYSTEM MATIZED, RIGHT? 9116 06:26:13,380 --> 06:26:18,418 THAT'S THE NICE THING ABOUT JUST 9117 06:26:18,418 --> 06:26:19,286 HAVING -- MY RECOMMENDATION 9118 06:26:19,286 --> 06:26:21,021 AGAIN WILL BE, CLINICS HAVE TO 9119 06:26:21,021 --> 06:26:22,556 DO WHAT WORKS FOR THEM, BUT I 9120 06:26:22,556 --> 06:26:24,424 WOULD SAY, AND THIS IS BASED ON 9121 06:26:24,424 --> 06:26:26,727 THE RESEARCH THAT I'VE READ IS 9122 06:26:26,727 --> 06:26:30,764 LIKE ASK ABOUT FOOD, HOUSING, 9123 06:26:30,764 --> 06:26:32,733 TRANSPORTATION AND MEDICATION 9124 06:26:32,733 --> 06:26:33,634 AFFORDABILITY. 9125 06:26:33,634 --> 06:26:33,901 RIGHT? 9126 06:26:33,901 --> 06:26:35,569 BECAUSE GETTING MEDS IN THE BODY 9127 06:26:35,569 --> 06:26:38,839 IS FAR HARDER THAN YOU THINK, 9128 06:26:38,839 --> 06:26:39,406 RIGHT? 9129 06:26:39,406 --> 06:26:41,141 BECAUSE OF ALL THESE OTHER 9130 06:26:41,141 --> 06:26:42,142 BARRIERS, HOUSING, 9131 06:26:42,142 --> 06:26:44,211 TRANSPORTATION, OH, GOD, I CAN'T 9132 06:26:44,211 --> 06:26:46,747 GET MY PRESCRIPTION, BLAH, BLAH, 9133 06:26:46,747 --> 06:26:47,114 BLAH. 9134 06:26:47,114 --> 06:26:48,048 SO YOU COULD START WITH SOME 9135 06:26:48,048 --> 06:26:49,583 SORT OF BASIC BUILDING BLOCKS 9136 06:26:49,583 --> 06:26:51,652 THERE AND THEN ONCE YOU HAVE AN 9137 06:26:51,652 --> 06:26:52,953 INDIVIDUAL PATIENT WHO IS LIKE 9138 06:26:52,953 --> 06:26:54,488 YEAH ACTUALLY THEIR FOOD IS AN 9139 06:26:54,488 --> 06:26:55,689 ISSUE, THEN YOU COULD SORT OF 9140 06:26:55,689 --> 06:26:56,189 PERSONALIZE IT. 9141 06:26:56,189 --> 06:26:57,457 THIS IS WHY THAT PERSONAL 9142 06:26:57,457 --> 06:26:59,826 CONVERSATION IS SO IMPORTANT, 9143 06:26:59,826 --> 06:27:00,060 RIGHT? 9144 06:27:00,060 --> 06:27:01,828 AND IT'S WHY PATIENTS DON'T LIKE 9145 06:27:01,828 --> 06:27:03,597 BEING TREATED LIKE CHECK BOX IN 9146 06:27:03,597 --> 06:27:05,132 TERMS OF MY SOCIAL NEEDS AND 9147 06:27:05,132 --> 06:27:07,301 IT'S WHY CLINIC STAFF AT LEAST 9148 06:27:07,301 --> 06:27:08,735 THOSE WHO WORK WITH LOW-INCOME 9149 06:27:08,735 --> 06:27:11,038 PATIENT AS A CALLING DON'T FEEL 9150 06:27:11,038 --> 06:27:12,372 GREAT ABOUT IT, LIKE WE NEED TO 9151 06:27:12,372 --> 06:27:13,674 HAVE THAT CONVERSATION. 9152 06:27:13,674 --> 06:27:15,509 WHY HAVING A NAVIGATOR CAN 9153 06:27:15,509 --> 06:27:16,743 REALLY BE HELPFUL BECAUSE THEN 9154 06:27:16,743 --> 06:27:18,145 THAT PERSON IS GETTING THAT 9155 06:27:18,145 --> 06:27:19,212 PERSONALIZED CARE. 9156 06:27:19,212 --> 06:27:22,149 I DID FIND THAT ROI ARTICLE, I 9157 06:27:22,149 --> 06:27:24,284 CAN PUT IT IN THE THE CHA, IT'S 9158 06:27:24,284 --> 06:27:25,686 A VERY RECENT ARTICLE SO THAT 9159 06:27:25,686 --> 06:27:27,487 SHOULD ANSWER YOUR QUESTION. 9160 06:27:27,487 --> 06:27:28,455 >> THAT'S GREAT. 9161 06:27:28,455 --> 06:27:30,390 THANK YOU. 9162 06:27:30,390 --> 06:27:32,859 >> RACHEL, DO YOU THINK THAT, IS 9163 06:27:32,859 --> 06:27:34,828 IT IMPORTANT, DO YOU THINK, TO 9164 06:27:34,828 --> 06:27:36,730 HAVE SOMEONE IN THE COMMUNITY 9165 06:27:36,730 --> 06:27:38,932 LIKE A COMMUNITY HEALTH WORKER 9166 06:27:38,932 --> 06:27:43,203 INTERACTING WITH THE NAVIGATOR 9167 06:27:43,203 --> 06:27:43,403 TO -- 9168 06:27:43,403 --> 06:27:45,906 >> OR BEING THE NAVIGATOR. 9169 06:27:45,906 --> 06:27:47,541 >> BEING THE NAVIGATOR, OKAY. 9170 06:27:47,541 --> 06:27:49,576 >> THAT'S A GREAT QUESTION. 9171 06:27:49,576 --> 06:27:51,411 WE ARE ACTIVELY CONDUCTING A 9172 06:27:51,411 --> 06:27:54,448 TRIAL RIGHT NOW IN, WELL, WE'RE 9173 06:27:54,448 --> 06:27:55,782 RECRUITING FOR A TRIAL, THAT 9174 06:27:55,782 --> 06:27:58,185 WILL BE IN 26 COMMUNITY HEALTH 9175 06:27:58,185 --> 06:28:00,153 CENTERS WHRKS WE HIT RECRUIT -- 9176 06:28:00,153 --> 06:28:02,222 WHEN WE HIT RECRUITMENT, THAT IS 9177 06:28:02,222 --> 06:28:04,291 LOOKING AT WHAT DOES IT TAKE TO 9178 06:28:04,291 --> 06:28:06,626 IMPLEMENT SOCIAL RISK SCREENING 9179 06:28:06,626 --> 06:28:07,928 AND REFERRAL MAKING THAT IS 9180 06:28:07,928 --> 06:28:09,329 DRIVEN BY COMMUNITY HEALTH 9181 06:28:09,329 --> 06:28:09,796 WORKERS. 9182 06:28:09,796 --> 06:28:11,765 I THEORIZE, I HYPOTHESIZE THAT 9183 06:28:11,765 --> 06:28:12,966 COMMUNITY HEALTH WORKERS ARE A 9184 06:28:12,966 --> 06:28:14,167 BIG PART OF THE SOLUTION HERE, 9185 06:28:14,167 --> 06:28:15,902 THAT WE SHOULD JUST BE LIKE, 9186 06:28:15,902 --> 06:28:17,571 YEAH, THIS IS NOT FOR THE 9187 06:28:17,571 --> 06:28:18,739 PROVIDER, THIS MAYBE ISN'T EVEN 9188 06:28:18,739 --> 06:28:20,607 FOR THE MA, THIS IS A ROLE FOR 9189 06:28:20,607 --> 06:28:22,676 THE COMMUNITY HEALTH WORKER OR 9190 06:28:22,676 --> 06:28:23,677 THE SOCIAL WORKER AND THEY HAVE 9191 06:28:23,677 --> 06:28:25,412 TO FIGURE OUT A WORKFLOW SO THAT 9192 06:28:25,412 --> 06:28:26,646 PATIENT IS GETTING CONTACTED AND 9193 06:28:26,646 --> 06:28:27,614 SUPPORTED BUT I THINK A 9194 06:28:27,614 --> 06:28:28,615 COMMUNITY HEALTH WORKER IS 9195 06:28:28,615 --> 06:28:29,816 PROBABLY A REALLY GREAT SOLUTION 9196 06:28:29,816 --> 06:28:31,451 TO THIS PROBLEM, THEY'RE NOT 9197 06:28:31,451 --> 06:28:32,452 EXPENSIVE, THEY'RE LESS 9198 06:28:32,452 --> 06:28:33,553 EXPENSIVE, AND THEY'RE PART OF 9199 06:28:33,553 --> 06:28:34,654 THE COMMUNITY AND THEY'RE GOING 9200 06:28:34,654 --> 06:28:35,956 TO BE ABLE TO PROVIDE THAT 9201 06:28:35,956 --> 06:28:36,823 PERSONALIZED CARE. 9202 06:28:36,823 --> 06:28:38,458 I'LL LET YOU KNOW WHAT WE FIND 9203 06:28:38,458 --> 06:28:40,293 WITH THE STUDY, BUT I SUSPECT 9204 06:28:40,293 --> 06:28:41,628 THE COMMUNITY HEALTH WORKERS ARE 9205 06:28:41,628 --> 06:28:44,097 A BIG PART OF THE SOLUTION. 9206 06:28:44,097 --> 06:28:44,364 >> GREAT. 9207 06:28:44,364 --> 06:28:46,533 >> WHAT WE NEED THOUGH IS THEN 9208 06:28:46,533 --> 06:28:48,301 TO PAY FOR THEM. 9209 06:28:48,301 --> 06:28:49,636 THEN THEY HAVE TO BE REIMBURSED 9210 06:28:49,636 --> 06:28:50,704 AND THAT WILL BE MOST OF THE 9211 06:28:50,704 --> 06:28:52,806 TIME THROUGH MEDICAID OR 9212 06:28:52,806 --> 06:28:54,207 MEDICARE AND THEN THE STATE 9213 06:28:54,207 --> 06:28:55,642 VARIATION WHAT THEY'LL PAY FOR 9214 06:28:55,642 --> 06:28:57,277 IS GOING TO BE MORE AND MORE 9215 06:28:57,277 --> 06:29:00,580 LIKE STATE, YOU KNOW, STATE 9216 06:29:00,580 --> 06:29:02,115 DISPARITIES, AS WE'VE SHOWN MANY 9217 06:29:02,115 --> 06:29:03,950 TIMES WITH FOR EXAMPLE MEDICAID 9218 06:29:03,950 --> 06:29:05,819 EXPANSION, PATIENTS IN MEDICAID 9219 06:29:05,819 --> 06:29:06,787 EXPANSION STATES HAVE MUCH 9220 06:29:06,787 --> 06:29:08,555 BETTER OUTCOMES THAN THOSE THAT 9221 06:29:08,555 --> 06:29:08,789 DON'T. 9222 06:29:08,789 --> 06:29:09,956 MANY ARTICLES ON THIS. 9223 06:29:09,956 --> 06:29:11,825 >> DO YOU KNOW, IS THERE A 9224 06:29:11,825 --> 06:29:12,826 CREDENTIALING PROCESS FOR 9225 06:29:12,826 --> 06:29:13,860 COMMUNITY HEALTH WORKERS? 9226 06:29:13,860 --> 06:29:14,828 >> YES, THERE IS. 9227 06:29:14,828 --> 06:29:16,096 I DON'T THINK IT'S VERY 9228 06:29:16,096 --> 06:29:18,331 COMPLICATED, THOUGH. 9229 06:29:18,331 --> 06:29:19,266 I COULD BE WRONG. 9230 06:29:19,266 --> 06:29:20,467 DON'T QUOTE ME ON THAT. 9231 06:29:20,467 --> 06:29:21,802 BUT I DON'T THINK IT'S VERY 9232 06:29:21,802 --> 06:29:22,069 DIFFICULT. 9233 06:29:22,069 --> 06:29:24,504 >> OKAY. 9234 06:29:24,504 --> 06:29:26,073 JANE, YOU HAD A QUESTION I THINK 9235 06:29:26,073 --> 06:29:26,940 FOR DR. BRITAIN. 9236 06:29:26,940 --> 06:29:27,774 >> I DID. 9237 06:29:27,774 --> 06:29:29,342 I WAS JUST GOING TO BRING THAT 9238 06:29:29,342 --> 06:29:30,644 UP, IF HE WAS AROUND. 9239 06:29:30,644 --> 06:29:31,545 >> YES. 9240 06:29:31,545 --> 06:29:32,946 >> HI. 9241 06:29:32,946 --> 06:29:36,750 SO YEAH, I DID WANT TO ASK YOU, 9242 06:29:36,750 --> 06:29:39,386 YOU KNOW, I REALLY LOVE THE VA 9243 06:29:39,386 --> 06:29:39,619 STUDIES. 9244 06:29:39,619 --> 06:29:42,456 CAN YOU TELL ME, DO YOU KNOW 9245 06:29:42,456 --> 06:29:44,991 WHAT PERCENTAGE OF U.S. VETSZ 9246 06:29:44,991 --> 06:29:46,860 ACTUALLY AK -- VETS ACTUALLY 9247 06:29:46,860 --> 06:29:49,329 ACCESS NEWS, THE V -- ACTUALLY 9248 06:29:49,329 --> 06:29:51,698 ACCESS AND USE THE VA SYSTEM AND 9249 06:29:51,698 --> 06:29:52,966 WOULD BE INCLUDED IN YOUR 9250 06:29:52,966 --> 06:29:53,400 DATABASE? 9251 06:29:53,400 --> 06:29:54,334 >> THAT'S A GOOD QUESTION. 9252 06:29:54,334 --> 06:29:55,936 I THINK YOU'RE GETTING TO THE 9253 06:29:55,936 --> 06:29:57,904 NOTION THAT THEY HAVE ACCESS AND 9254 06:29:57,904 --> 06:30:04,377 SEEK CARE OUTSIDE OF VA ACCESS. 9255 06:30:04,377 --> 06:30:05,846 I DON'T KNOW HARD NUMBERS. 9256 06:30:05,846 --> 06:30:09,082 I WILL SAY THAT FOR COMORBIDITY 9257 06:30:09,082 --> 06:30:10,717 AND OUTCOME DATA IN THOSE 9258 06:30:10,717 --> 06:30:11,885 STUDIES, WE DO INCORPORATE 9259 06:30:11,885 --> 06:30:14,054 MEDICARE AND MEDICAID DATA AND 9260 06:30:14,054 --> 06:30:16,022 FEE FOR SERVICE DATA, WHICH IS 9261 06:30:16,022 --> 06:30:17,824 ONE OF THE REASONS SOME OF THOSE 9262 06:30:17,824 --> 06:30:18,892 STUDIES LOOK A LITTLE OUT OF 9263 06:30:18,892 --> 06:30:21,995 DATE BECAUSE THERE'S A DELAY IN 9264 06:30:21,995 --> 06:30:23,396 GAINING ACCESS TO MEDICARE AND 9265 06:30:23,396 --> 06:30:25,932 FEE FOR SERVICE DATA, SO THE 9266 06:30:25,932 --> 06:30:27,334 STUDIES THAT WE PUBLISH 9267 06:30:27,334 --> 06:30:29,836 INCORPORATE THAT, BUT I DON'T 9268 06:30:29,836 --> 06:30:31,505 KNOW OFF HAND WHAT THOSE 9269 06:30:31,505 --> 06:30:32,372 PROPORTIONS ARE. 9270 06:30:32,372 --> 06:30:32,839 >> YEAH. 9271 06:30:32,839 --> 06:30:34,341 I MEAN, AND I ASK THIS BECAUSE 9272 06:30:34,341 --> 06:30:35,976 THE LAST THAT I HAD HEARD AS 9273 06:30:35,976 --> 06:30:38,812 WELL WAS THAT IT WAS OFTEN IN 9274 06:30:38,812 --> 06:30:40,780 THE LOWER, YOU KNOW, IT WAS 9275 06:30:40,780 --> 06:30:43,950 ABOUT 30% WHO SOUGHT ALL ROUTINE 9276 06:30:43,950 --> 06:30:45,185 HEALTHCARE AT THE VA HEALTHCARE 9277 06:30:45,185 --> 06:30:46,686 SYSTEM AND THAT WHEN PEOPLE 9278 06:30:46,686 --> 06:30:48,455 LOOKED AT SOCIOECONOMIC STATUS, 9279 06:30:48,455 --> 06:30:51,925 THAT IT WAS THE INDIVIDUALS WHO, 9280 06:30:51,925 --> 06:30:53,460 YOU KNOW, TENDED TO SCALE UP THE 9281 06:30:53,460 --> 06:30:54,694 LOWER END. 9282 06:30:54,694 --> 06:30:56,863 SO I JUST THINK THAT EVEN 9283 06:30:56,863 --> 06:30:58,298 REGARDLESS OF WHAT IT IS, THE 9284 06:30:58,298 --> 06:31:01,034 FACT THAT YOU'RE FINDING SO 9285 06:31:01,034 --> 06:31:02,602 CLOSELY MIRROR WHAT'S SEEN AT 9286 06:31:02,602 --> 06:31:04,538 VANDERBILT IS REALLY 9287 06:31:04,538 --> 06:31:04,838 FASCINATING. 9288 06:31:04,838 --> 06:31:07,908 >> YEAH, THAT WAS ONE OF THE 9289 06:31:07,908 --> 06:31:09,009 TAKE-HOMES AND IT'S BEEN A 9290 06:31:09,009 --> 06:31:10,977 SURPRISE FOR ME IS HOW SIMILAR 9291 06:31:10,977 --> 06:31:12,412 THE COMORBIDITY PROFILES ARE, 9292 06:31:12,412 --> 06:31:14,147 WITH A COUPLE OF EXCEPTIONS THAT 9293 06:31:14,147 --> 06:31:17,584 I NOTED, AND THE PH PROFILES. 9294 06:31:17,584 --> 06:31:18,051 >> YEAH. 9295 06:31:18,051 --> 06:31:19,052 THE OTHER THING THOUGH THAT WAS 9296 06:31:19,052 --> 06:31:20,453 INTERESTING WAS THE STUDY YOU 9297 06:31:20,453 --> 06:31:22,088 WERE SHOWING AS WELL LOOKING AT 9298 06:31:22,088 --> 06:31:24,391 HEART FAILURE AND COPD WITH 9299 06:31:24,391 --> 06:31:28,328 HEART FAILURE INCREASING RISK. 9300 06:31:28,328 --> 06:31:31,398 IS THAT ALL CAUSED -- ALL HEART 9301 06:31:31,398 --> 06:31:35,001 FAILURE, OR IS THAT MOSTLY 9302 06:31:35,001 --> 06:31:35,802 HEF PEF? 9303 06:31:35,802 --> 06:31:38,505 >> IT'S EHR PHENOTYPING SO TAKE 9304 06:31:38,505 --> 06:31:40,473 THAT WHAT IT'S WORTH. 9305 06:31:40,473 --> 06:31:41,374 THAT WAS LUMPING. 9306 06:31:41,374 --> 06:31:43,210 WE DO HAVE SUBGROUP ANALYSIS 9307 06:31:43,210 --> 06:31:46,613 THAT SPLITS THAT OUT IN THAT 9308 06:31:46,613 --> 06:31:49,683 PAPER, AND HEF REF HAD HIGHER 9309 06:31:49,683 --> 06:31:52,285 INCIDENCE RATES THAN HEF PEF, 9310 06:31:52,285 --> 06:31:53,820 NOT DRAMATICALLY DIFFERENT. 9311 06:31:53,820 --> 06:31:55,121 >> INTERESTING. 9312 06:31:55,121 --> 06:31:55,488 YEAH. 9313 06:31:55,488 --> 06:32:02,162 SO THAT'S REALLY GOOD. 9314 06:32:02,162 --> 06:32:03,597 I THINK GABBY HAS A QUESTION. 9315 06:32:03,597 --> 06:32:04,664 >> YES, PLEASE. 9316 06:32:04,664 --> 06:32:08,034 I WAS REALLY FASCINATED BY THE 9317 06:32:08,034 --> 06:32:12,739 VETERANS TALK AS WELL, AND WHAT 9318 06:32:12,739 --> 06:32:17,777 STRUCK ME IS THIS ONE SLIDE THAT 9319 06:32:17,777 --> 06:32:20,280 YOU SHOWED THAT ALTHOUGH 9320 06:32:20,280 --> 06:32:22,349 PULMONARY HYPERTENSION WAS 9321 06:32:22,349 --> 06:32:24,784 STRONGLY SUGGESTED BY ECHO, IT 9322 06:32:24,784 --> 06:32:26,186 WASN'T CODED. 9323 06:32:26,186 --> 06:32:28,922 DOES THAT MEAN THAT IF IT'S NOT 9324 06:32:28,922 --> 06:32:31,224 CODED, THEN PATIENTS DON'T GET 9325 06:32:31,224 --> 06:32:33,627 MANAGEMENT FOR PULMONARY 9326 06:32:33,627 --> 06:32:33,960 HYPERTENSION? 9327 06:32:33,960 --> 06:32:36,229 I ASSUME. 9328 06:32:36,229 --> 06:32:37,764 >> THAT'S A GREAT QUESTION. 9329 06:32:37,764 --> 06:32:40,433 I MEAN, FROM PERSONAL 9330 06:32:40,433 --> 06:32:42,168 EXPERIENCE, I KNOW I MISCODE 9331 06:32:42,168 --> 06:32:42,902 PROBABLY ALL THE TIME. 9332 06:32:42,902 --> 06:32:44,404 WE SORT OF DO THAT A LITTLE BIT 9333 06:32:44,404 --> 06:32:45,872 OUT OF CONVENIENCE AND WHAT'S 9334 06:32:45,872 --> 06:32:47,407 SORT OF THE PROXIMAL DIAGNOSIS 9335 06:32:47,407 --> 06:32:48,708 THAT WE'RE SEEING THE PROBLEM 9336 06:32:48,708 --> 06:32:49,376 THAT DAY. 9337 06:32:49,376 --> 06:32:52,979 SO SOME OF THAT IS, YOU KNOW, 9338 06:32:52,979 --> 06:32:56,383 JUST SORT OF USUAL CLINICAL 9339 06:32:56,383 --> 06:32:56,583 CARE. 9340 06:32:56,583 --> 06:32:58,585 I DON'T KNOW FOR SURE WHETHER 9341 06:32:58,585 --> 06:33:01,321 THE ABSENCE OF A CODE EQUALS THE 9342 06:33:01,321 --> 06:33:02,522 ABSENCE OF TREATMENT OF 9343 06:33:02,522 --> 06:33:03,590 CARDIOVASCULAR DISEASE, BUT ALSO 9344 06:33:03,590 --> 06:33:06,226 KEEP IN MIND THAT AMONG THE 9345 06:33:06,226 --> 06:33:12,132 VETERANS, YOU KNOW, GROUP ONE 9346 06:33:12,132 --> 06:33:14,467 PH'S IS LESS COMMON IN GENERAL. 9347 06:33:14,467 --> 06:33:17,804 >> YEAH. 9348 06:33:17,804 --> 06:33:18,071 THANK YOU. 9349 06:33:18,071 --> 06:33:21,775 >> I'LL ASK SOMEWHAT OF IKS A 9350 06:33:21,775 --> 06:33:23,276 CONTROVERSIAL QUESTION, EVAN. 9351 06:33:23,276 --> 06:33:24,944 THIS IS FOR YOU, BUT ANYBODY CAN 9352 06:33:24,944 --> 06:33:28,315 ANSWER, I SUPPOSE, AS WELL. 9353 06:33:28,315 --> 06:33:30,850 SO YOU BROUGHT UP THE POINT, 9354 06:33:30,850 --> 06:33:33,353 OBVIOUSLY EVEN OUTSIDE OF PH, 9355 06:33:33,353 --> 06:33:37,490 THE DIFFICULTY IN RESEARCHING 9356 06:33:37,490 --> 06:33:37,957 HOMELESSNESS. 9357 06:33:37,957 --> 06:33:39,693 I'M ASSUMING THAT THAT WAS AN 9358 06:33:39,693 --> 06:33:43,063 ISSUE OUTSIDE OF PH ALSO. 9359 06:33:43,063 --> 06:33:46,599 YOU KNOW, RECENTLY, THE SUPREME 9360 06:33:46,599 --> 06:33:49,536 COURT HAS SOMEWHAT CRIMINALIZED 9361 06:33:49,536 --> 06:33:49,869 HOMELESSNESS. 9362 06:33:49,869 --> 06:33:51,504 DO YOU FEEL LIKE THAT THESE 9363 06:33:51,504 --> 06:33:53,039 ISSUES THAT WE ARE MOVING 9364 06:33:53,039 --> 06:33:55,975 TOWARDS AS A SOCIETY MIGHT BE AN 9365 06:33:55,975 --> 06:33:58,812 IMPEDIMENT TO STUDYING EVEN MORE 9366 06:33:58,812 --> 06:34:02,682 THE HOMELESS POPULATION? 9367 06:34:02,682 --> 06:34:04,551 >> SO GREAT QUESTION. 9368 06:34:04,551 --> 06:34:06,586 I'LL START WITH A DISCLAIMER 9369 06:34:06,586 --> 06:34:09,356 THAT I'M AN EXPERT AT ALL ON THE 9370 06:34:09,356 --> 06:34:10,323 SOCIAL ISSUES AROUND 9371 06:34:10,323 --> 06:34:11,958 HOMELESSNESS OR THE INHERENT 9372 06:34:11,958 --> 06:34:14,060 POLITICAL ISSUES THERE EITHER. 9373 06:34:14,060 --> 06:34:16,563 YOU KNOW, BUT I DO THINK THAT 9374 06:34:16,563 --> 06:34:18,198 THERE ARE OBVIOUSLY INHERENT 9375 06:34:18,198 --> 06:34:19,165 CHALLENGES WITH UNDERSTANDING 9376 06:34:19,165 --> 06:34:23,002 ANY CHRONIC DISEASE IN THAT 9377 06:34:23,002 --> 06:34:26,840 POPULATION, SO FOCUSING ON PH 9378 06:34:26,840 --> 06:34:27,807 SPECIFICALLY IS A LITTLE BIT 9379 06:34:27,807 --> 06:34:29,676 SORT OF HARD TO JUSTIFY WHEN 9380 06:34:29,676 --> 06:34:31,544 THERE IS PROBABLY LOWER HANGING 9381 06:34:31,544 --> 06:34:33,847 FRUIT TO UNDERSTAND AROUND 9382 06:34:33,847 --> 06:34:35,048 CARDIOPULMONARY AND 9383 06:34:35,048 --> 06:34:37,784 CARDIOVASCULAR DISEASE. 9384 06:34:37,784 --> 06:34:39,853 BUT OTHERWISE, I FEEL SORT OF 9385 06:34:39,853 --> 06:34:41,187 UNQUALIFIED TO HAVE A STRONG 9386 06:34:41,187 --> 06:34:44,557 OPINION ON SORT OF THE POLITICAL 9387 06:34:44,557 --> 06:34:47,293 ASPECTS. 9388 06:34:47,293 --> 06:34:47,660 OTHERS MAY NOT. 9389 06:34:47,660 --> 06:34:49,929 >> WELL, I CAN TELL YOU IT'S 9390 06:34:49,929 --> 06:34:52,332 BEEN AN ISSUE HERE TRYING TO 9391 06:34:52,332 --> 06:34:53,867 STUDY METHAMPHETAMINE USE, I 9392 06:34:53,867 --> 06:34:56,836 MEAN, IT BEING CRIMINALIZED, OF 9393 06:34:56,836 --> 06:34:57,070 COURSE. 9394 06:34:57,070 --> 06:35:01,508 SO IT'S BEEN AN ISSUE FOR US. 9395 06:35:01,508 --> 06:35:03,510 ANY OTHER QUESTIONS FOR THE 9396 06:35:03,510 --> 06:35:05,678 GROUP FROM THE DISCUSSANTS? 9397 06:35:05,678 --> 06:35:08,848 I DON'T SEE ANYTHING IN THE 9398 06:35:08,848 --> 06:35:17,824 CHAT. 9399 06:35:17,824 --> 06:35:23,830 I HAVE A QUICK QUESTION FOR 9400 06:35:23,830 --> 06:35:26,666 DR. BERNARDO. 9401 06:35:26,666 --> 06:35:29,536 IS HE STILL THERE? 9402 06:35:29,536 --> 06:35:34,240 SORRY. 9403 06:35:34,240 --> 06:35:36,743 IS THERE BERNARDO STILL THERE? 9404 06:35:36,743 --> 06:35:38,611 >> I DON'T SEE HIM IN THE 9405 06:35:38,611 --> 06:35:40,313 ATTENDEE LIST. 9406 06:35:40,313 --> 06:35:44,083 >> YOU DO NOT OR -- SORRY, 9407 06:35:44,083 --> 06:35:44,517 JACKIE? 9408 06:35:44,517 --> 06:35:45,051 >> I DO. 9409 06:35:45,051 --> 06:35:45,852 >> I'M STILL ON. 9410 06:35:45,852 --> 06:35:48,788 >> OH, OKAY. 9411 06:35:48,788 --> 06:35:51,724 SO ROBERTO YOU SHOWED A MAP OF 9412 06:35:51,724 --> 06:35:52,826 SEGREGATION IN THE U.S., 9413 06:35:52,826 --> 06:35:56,095 ALTHOUGH YOU ALLUDED TO THAT 9414 06:35:56,095 --> 06:35:59,098 BEING A FAIRLY OLD MAP. 9415 06:35:59,098 --> 06:36:02,368 I'M GOING TO ADVOCATE SLIGHTLY 9416 06:36:02,368 --> 06:36:04,204 FOR THE NATIVE AMERICAN 9417 06:36:04,204 --> 06:36:07,707 POPULATION HERE BECAUSE WE 9418 06:36:07,707 --> 06:36:09,676 HAVEN'T DISCUSSED MUCH IN THAT 9419 06:36:09,676 --> 06:36:11,511 REGARD, BUT IN ARIZONA, I'M SURE 9420 06:36:11,511 --> 06:36:15,014 YOU KNOW, YOU TRAINED HERE, MANY 9421 06:36:15,014 --> 06:36:18,651 PEOPLE DO KNOW THAT THE NATIVE 9422 06:36:18,651 --> 06:36:21,921 AMERICAN POPULATION IS A 9423 06:36:21,921 --> 06:36:22,622 SIGNIFICANT PRESENCE. 9424 06:36:22,622 --> 06:36:24,757 IN FACT, I HAVE A CLINIC AT THE 9425 06:36:24,757 --> 06:36:26,192 APACHE RESERVATION. 9426 06:36:26,192 --> 06:36:29,662 WE SEE PATIENTS FROM THE NAVAJO, 9427 06:36:29,662 --> 06:36:31,865 THE APACHE RESERVATIONS. 9428 06:36:31,865 --> 06:36:36,669 IT STRIKES ME THAT ALTHOUGH 9429 06:36:36,669 --> 06:36:41,207 ARIZONA IS A NONSEGREGATED AREA 9430 06:36:41,207 --> 06:36:43,810 THAT IF YOU LOOK AT THE 9431 06:36:43,810 --> 06:36:50,717 DISPARITY THAT IS WE SEE BETWEEE 9432 06:36:50,717 --> 06:36:51,584 SEE OF THE NATIVE AMERICANS WHO 9433 06:36:51,584 --> 06:36:54,754 LIVE ON THE RESERVATION VERSUS 9434 06:36:54,754 --> 06:36:56,623 THOSE WHO DO NOT THERE STILL 9435 06:36:56,623 --> 06:36:57,590 SEEMS TO BE SUBSTANTIAL 9436 06:36:57,590 --> 06:36:58,825 SEGREGATION IN THAT REGARD. 9437 06:36:58,825 --> 06:37:00,159 CAN YOU COMMENT IN REGARD TO 9438 06:37:00,159 --> 06:37:03,396 WHAT YOU THINK IS A BUT WAY FOR 9439 06:37:03,396 --> 06:37:06,432 US TO CAPTURE NATIVE AMERICAN 9440 06:37:06,432 --> 06:37:08,201 INTERESTS, ESPECIALLY THOSE WHO 9441 06:37:08,201 --> 06:37:11,604 LIVE OR DO NOT LIVE ON THE 9442 06:37:11,604 --> 06:37:14,440 RESERVATION WITH REGARD TO 9443 06:37:14,440 --> 06:37:17,310 SEGREGATION? 9444 06:37:17,310 --> 06:37:19,579 >> THAT'S A COMPLICATED 9445 06:37:19,579 --> 06:37:21,981 QUESTION, FRANZ. 9446 06:37:21,981 --> 06:37:25,351 I WISH NINA WERE STILL IN THE 9447 06:37:25,351 --> 06:37:26,252 AUDIENCE BECAUSE SHE COULD ALSO 9448 06:37:26,252 --> 06:37:27,654 CONTRIBUTE TO THIS DISCUSSION, 9449 06:37:27,654 --> 06:37:29,389 BUT NATIVE AMERICANS IS A 9450 06:37:29,389 --> 06:37:31,157 HISTORICALLY NEGLECTED 9451 06:37:31,157 --> 06:37:33,226 POPULATION IN MUCH NEED OF MORE 9452 06:37:33,226 --> 06:37:34,561 DETAILED RESEARCH WHEN IT COMES 9453 06:37:34,561 --> 06:37:39,165 TO RARE DISEASES, SUCH AS PH. 9454 06:37:39,165 --> 06:37:41,901 LTS VERY CHALLENGING TO GET -- 9455 06:37:41,901 --> 06:37:44,070 IT IS VERY CHALLENGING TO GET 9456 06:37:44,070 --> 06:37:45,371 PERMISSION TO DO RESEARCH WITH 9457 06:37:45,371 --> 06:37:46,806 THIS SPECIFIC GRURP BEING AS YOU 9458 06:37:46,806 --> 06:37:48,775 PROBABLY KNOW. 9459 06:37:48,775 --> 06:37:50,743 -- WITH THIS SPECIFIC GROUP, AS 9460 06:37:50,743 --> 06:37:51,711 YOU PROBABLY KNOW. 9461 06:37:51,711 --> 06:37:52,845 THERE ARE MANY APPROVAL FORMS 9462 06:37:52,845 --> 06:37:54,681 THAT YOU NEED TO GET TO BE 9463 06:37:54,681 --> 06:37:59,252 AUTHORIZED TO BE ABLE TO WORK 9464 06:37:59,252 --> 06:38:05,024 WITH THE NATIVE AMERICAN 9465 06:38:05,024 --> 06:38:08,394 POPULATIONS, AND WHICH ONE OF US 9466 06:38:08,394 --> 06:38:10,063 HAS BEEN ABLE TO TAKE CARE OF 9467 06:38:10,063 --> 06:38:11,965 SOME OF THESE PATIENTS, I DID 9468 06:38:11,965 --> 06:38:13,933 WHEN I WAS LIVING IN OKLAHOMA, 9469 06:38:13,933 --> 06:38:15,902 IT'S JUST VERY CHALLENGING BUT 9470 06:38:15,902 --> 06:38:19,706 THE HEALTHCARE SYSTEM THEY HAVE, 9471 06:38:19,706 --> 06:38:20,940 I CAN'T REMEMBER THE NAME, BUT 9472 06:38:20,940 --> 06:38:22,041 THE HEALTHCARE SYSTEM THEY HAVE 9473 06:38:22,041 --> 06:38:23,443 IS VERY RESTRICTIVE. 9474 06:38:23,443 --> 06:38:25,011 YOU NEED TO GET APPROVAL FOR -- 9475 06:38:25,011 --> 06:38:26,045 >> IHS. 9476 06:38:26,045 --> 06:38:29,582 >> IHS, THAT IS CORRECT, FOR 9477 06:38:29,582 --> 06:38:31,551 EVERY SINGLE TESTING OR 9478 06:38:31,551 --> 06:38:36,889 PRESCRIPTION YOU WANT TO DO, IS 9479 06:38:36,889 --> 06:38:40,293 WE THINK A RARE DISEASE, 9480 06:38:40,293 --> 06:38:43,029 CERTAINLY HAS A DETRIMENTAL 9481 06:38:43,029 --> 06:38:44,897 EFFECT ON MINORITIES, NATIVE 9482 06:38:44,897 --> 06:38:47,066 AMERICANS ARE BY FAR I THINK THE 9483 06:38:47,066 --> 06:38:49,802 MOST DISADVANTAGED GROUP. 9484 06:38:49,802 --> 06:38:51,237 AND I DON'T HAVE A CLEAR ANSWER 9485 06:38:51,237 --> 06:38:55,608 TO YOU ABOUT HOW TO SUCCESSFULLY 9486 06:38:55,608 --> 06:38:57,710 PROCEED WITH RESEARCHING THIS 9487 06:38:57,710 --> 06:38:59,212 POPULATION, BUT I THINK WE 9488 06:38:59,212 --> 06:39:02,815 SHOULD CERTAINLY CONSIDER DOING 9489 06:39:02,815 --> 06:39:03,049 THAT. 9490 06:39:03,049 --> 06:39:09,155 AND I WOULD SAY I BELIEVE 9491 06:39:09,155 --> 06:39:11,791 PD-OMICS -- PROTEOMICS, EVEN 9492 06:39:11,791 --> 06:39:13,593 THOSE 14 PAGES WOULD BE 9493 06:39:13,593 --> 06:39:15,294 SOMETHING THAT WOULD BE WORTH 9494 06:39:15,294 --> 06:39:16,729 PURSUING FURTHER INVESTIGATION 9495 06:39:16,729 --> 06:39:18,464 BECAUSE IN REALITY WE HAVE 9496 06:39:18,464 --> 06:39:19,899 NOTHING, NOTHING TO COMMENT 9497 06:39:19,899 --> 06:39:21,467 ABOUT WHAT'S THE REALITY OF 9498 06:39:21,467 --> 06:39:22,635 NATIVE AMERICAN PATIENTS WITH 9499 06:39:22,635 --> 06:39:27,373 PH. 9500 06:39:27,373 --> 06:39:28,875 >> OKAY. 9501 06:39:28,875 --> 06:39:30,076 ANY OTHER QUESTIONS, COMMENTS IS 9502 06:39:30,076 --> 06:39:32,378 IT THANK YOU, DR. BERNARDO FOR 9503 06:39:32,378 --> 06:39:36,215 THAT. 9504 06:39:36,215 --> 06:39:38,484 >> MY ONLY COMMENT IS, I'M YOUR 9505 06:39:38,484 --> 06:39:41,220 NEIGHBOR TO THE NORTH, RIGHT? 9506 06:39:41,220 --> 06:39:46,059 AND, YOU KNOW, IT'S A UNIQUE 9507 06:39:46,059 --> 06:39:48,194 HISTORY WITH NATIVE AMERICANS, 9508 06:39:48,194 --> 06:39:53,266 AND I MENTOR A PHYSICIAN, A 9509 06:39:53,266 --> 06:39:54,467 PULMONARY PHYSICIAN OF NATIVE 9510 06:39:54,467 --> 06:39:56,569 AMERICAN DESCENT WHO MOVED HERE 9511 06:39:56,569 --> 06:39:59,372 FROM ROCHESTER, MAYO CLINIC, AND 9512 06:39:59,372 --> 06:40:01,674 I LEARNED A LOT BY WORKING 9513 06:40:01,674 --> 06:40:03,142 ALONGSIDE OF HER, THINGS I 9514 06:40:03,142 --> 06:40:04,210 DIDN'T KNOW AS SOMEBODY WHO 9515 06:40:04,210 --> 06:40:05,945 WORKED A LOT WITH HEALTH 9516 06:40:05,945 --> 06:40:07,814 DISPARITY RESEARCH, THE NATURE 9517 06:40:07,814 --> 06:40:09,982 OF THE SOVEREIGN STATE, THE 9518 06:40:09,982 --> 06:40:13,486 COMMUNITY AND HOW, YOU KNOW, YOU 9519 06:40:13,486 --> 06:40:14,921 REALLY DO -- AND I WOULD SAY 9520 06:40:14,921 --> 06:40:16,222 WITH ANY MINORITY COMMUNITY, BUT 9521 06:40:16,222 --> 06:40:17,857 THEY GIVE US A GOOD REMINDER 9522 06:40:17,857 --> 06:40:19,859 THAT IF YOU WANT TO COME AND DO 9523 06:40:19,859 --> 06:40:21,394 RESEARCH IN A COMMUNITY THAT'S 9524 06:40:21,394 --> 06:40:22,595 UNDERREPRESENTED CIALG THE BEST 9525 06:40:22,595 --> 06:40:25,331 IDEA IS -- THE BEST IDEA STONT 9526 06:40:25,331 --> 06:40:27,834 SAY I WANT TO DO RESEARCH ON 9527 06:40:27,834 --> 06:40:29,368 THIS POPULATION, THE BEST 9528 06:40:29,368 --> 06:40:30,436 APPROACH IS TO COME IN AND 9529 06:40:30,436 --> 06:40:31,237 UNDERSTAND WHAT THEIR THOUGHTS 9530 06:40:31,237 --> 06:40:32,405 AND WHAT THEIR LEADER AND 9531 06:40:32,405 --> 06:40:33,172 COMMUNITY IS THINKING AND THEN 9532 06:40:33,172 --> 06:40:34,607 AFTER THAT, YOU KNOW, TRY TO 9533 06:40:34,607 --> 06:40:35,908 PARTNER WITH THEM AND THEN BRING 9534 06:40:35,908 --> 06:40:37,043 ON RESEARCH LATER. 9535 06:40:37,043 --> 06:40:39,345 IT'S NOT, YOU KNOW -- AND I 9536 06:40:39,345 --> 06:40:41,414 THINK THERE'S A I'VE LANDER A 9537 06:40:41,414 --> 06:40:42,915 LOT OF LESSONS FROM THOSE 9538 06:40:42,915 --> 06:40:44,350 APPROACHES AND WE DO EMPLOY SOME 9539 06:40:44,350 --> 06:40:46,552 OF THOSE APPROACHES WITH OUR 9540 06:40:46,552 --> 06:40:47,420 COHORT AND I THINK YOU'RE 9541 06:40:47,420 --> 06:40:52,125 FAMILIAR WITH THAT -- 4,000 9542 06:40:52,125 --> 06:40:54,093 MEXICAN AMERICANS FROM MOUNTAIN 9543 06:40:54,093 --> 06:40:57,497 PARK HEALTH CENTER, LARRY 9544 06:40:57,497 --> 06:40:59,098 MANDARINO OVER THERE WAS THE 9545 06:40:59,098 --> 06:41:00,767 STAT STARTER OF THAT, I'M NOW 9546 06:41:00,767 --> 06:41:02,001 SUPPORTING THAT, AND WE CONTINUE 9547 06:41:02,001 --> 06:41:03,603 THAT KIND OF APPROACH WITH DMUNT 9548 06:41:03,603 --> 06:41:05,571 AS WELL, WHERE WE DON'T COME IN 9549 06:41:05,571 --> 06:41:06,939 AND SAY WE WANT TO DO RESEARCH. 9550 06:41:06,939 --> 06:41:08,808 WE COME IN AND POSE QUESTIONS 9551 06:41:08,808 --> 06:41:09,642 ABOUT THINGS THAT MIGHT BE 9552 06:41:09,642 --> 06:41:10,943 RELEVANT TO THE COMMUNITY AND 9553 06:41:10,943 --> 06:41:12,578 THEN WE ENGAGE THEM AND SPEAK 9554 06:41:12,578 --> 06:41:14,881 WITH THEM AND THEN BRING UP 9555 06:41:14,881 --> 06:41:16,282 RESEARCH AT A LATER TIME. 9556 06:41:16,282 --> 06:41:18,251 YOU KNOW, I THINK THAT THOSE ARE 9557 06:41:18,251 --> 06:41:19,986 THE KIND OF THINGS THAT HELP 9558 06:41:19,986 --> 06:41:21,654 BREAK BARRIERS OF DISTRUST 9559 06:41:21,654 --> 06:41:22,955 ESPECIALLY IN POPULATIONS THAT 9560 06:41:22,955 --> 06:41:25,691 WERE TARGETED FOR ANNIHILATION 9561 06:41:25,691 --> 06:41:26,459 GENERATIONS AGO. 9562 06:41:26,459 --> 06:41:28,027 WE REALLY HAVE TO DO THE HARD 9563 06:41:28,027 --> 06:41:29,829 WORK TO ENGAGE THOSE COMMUNITIES 9564 06:41:29,829 --> 06:41:32,732 IN A DIFFERENT WAY BECAUSE WE 9565 06:41:32,732 --> 06:41:35,368 JUST -- IT'S THE RIGHT THING TO 9566 06:41:35,368 --> 06:41:35,735 DO. 9567 06:41:35,735 --> 06:41:41,140 AND THIS POPULATION IS NO 9568 06:41:41,140 --> 06:41:42,008 EXCEPTION. 9569 06:41:42,008 --> 06:41:42,675 IN PULMONARY HYPERTENSION. 9570 06:41:42,675 --> 06:41:44,944 >> LET ME JUST ADD ON TO THAT, 9571 06:41:44,944 --> 06:41:46,813 ONE PARTICULARLY VULNERABLE 9572 06:41:46,813 --> 06:41:48,014 POPULATION, ROBERTO, I DON'T 9573 06:41:48,014 --> 06:41:51,851 KNOW IF YOU'VE ENCOUNTERED THE 9574 06:41:51,851 --> 06:41:53,719 CHOCTAW POPULATION BUT THEIR 9575 06:41:53,719 --> 06:41:56,122 RATES OF SCLERODERMA OR FIVE TO 9576 06:41:56,122 --> 06:41:57,657 TEN TIMES HIGHER THAN THE 9577 06:41:57,657 --> 06:42:01,060 GENERAL POPULATION AND THINKING 9578 06:42:01,060 --> 06:42:03,229 ABOUT PULMONARY VASK ALREADY 9579 06:42:03,229 --> 06:42:05,631 DISEASE, BASED IN OKLAHOMA, 9580 06:42:05,631 --> 06:42:06,632 PARTICULARLY SOUTHEAST, I DON'T 9581 06:42:06,632 --> 06:42:07,934 KNOW IF YOU HAD ANY EXPERIENCE 9582 06:42:07,934 --> 06:42:10,136 IN YOUR TIME IN OKLAHOMA, 9583 06:42:10,136 --> 06:42:11,971 ROBERTO, BUT THAT MIGHT BE A 9584 06:42:11,971 --> 06:42:12,839 PARTICULARLY VULNERABLE 9585 06:42:12,839 --> 06:42:14,173 POPULATION FOR VASCULAR DISEASE 9586 06:42:14,173 --> 06:42:15,608 THAT WE COULD CONSIDER AS A 9587 06:42:15,608 --> 06:42:18,644 PRIORITY IN OUR PRIORITY 9588 06:42:18,644 --> 06:42:18,945 STATEMENTS. 9589 06:42:18,945 --> 06:42:21,714 >> THAT'S A GREAT IDEA, STEVE. 9590 06:42:21,714 --> 06:42:22,715 YES. 9591 06:42:22,715 --> 06:42:24,350 THE FREQUENCY OF CONNECTIVE 9592 06:42:24,350 --> 06:42:25,885 TISSUE DISEASE WAS CERTAINLY 9593 06:42:25,885 --> 06:42:28,120 HIGHER THAN OTHER POPULATIONS, 9594 06:42:28,120 --> 06:42:30,356 AT LEAST IN OKLAHOMA THE 9595 06:42:30,356 --> 06:42:33,092 FREQUENCY OF METHAMPHETAMINE USE 9596 06:42:33,092 --> 06:42:35,161 WAS ALSO HIGHER THAN WHAT I 9597 06:42:35,161 --> 06:42:37,363 WOULD HAVE EXPECTED. 9598 06:42:37,363 --> 06:42:41,400 SO I BELIEVE NATIVE AMERICANS 9599 06:42:41,400 --> 06:42:42,835 HAVE MULTIPLE -- CERTAINLY 9600 06:42:42,835 --> 06:42:44,604 CONNECTIVE TISSUE DISEASE WAS A 9601 06:42:44,604 --> 06:42:46,339 FREQUENT PHENOTYPE WE 9602 06:42:46,339 --> 06:42:47,707 ENCOUNTERED AND I THINK WE 9603 06:42:47,707 --> 06:42:49,709 SHOULD PARTNER TO STUDY THIS 9604 06:42:49,709 --> 06:42:56,449 POPULATION IN MUCH MORE DETAIL. 9605 06:42:56,449 --> 06:42:58,918 >> ALL RIGHT. 9606 06:42:58,918 --> 06:43:01,821 WELL, WITH THAT, I'M GOING TO 9607 06:43:01,821 --> 06:43:06,359 MOVE ON TO JUST A SHORT OVERVIEW 9608 06:43:06,359 --> 06:43:07,260 OF TOMORROW. 9609 06:43:07,260 --> 06:43:08,361 WE'RE A LITTLE OVER TIME. 9610 06:43:08,361 --> 06:43:10,196 IT'S BEEN A GREAT DAY. 9611 06:43:10,196 --> 06:43:12,398 I HAVE TO SAY, WITH SOME 9612 06:43:12,398 --> 06:43:13,733 EXCELLENT SPEAKERS, EXCELLENT 9613 06:43:13,733 --> 06:43:16,602 TALKS AND EXCELLENT DISCUSSION. 9614 06:43:16,602 --> 06:43:18,537 TOMORROW WE WILL CONTINUE WITH 9615 06:43:18,537 --> 06:43:20,840 HEALTH DISPARITIES IN PULMONARY 9616 06:43:20,840 --> 06:43:22,375 VASCULAR DISEASE LOOKING 9617 06:43:22,375 --> 06:43:24,010 SPECIFICALLY AT HEAT EXPOSURE 9618 06:43:24,010 --> 06:43:27,380 WITH DR. MARON, DR. LIM AND 9619 06:43:27,380 --> 06:43:29,815 THERE MATHAI WILL GIVE US SOME 9620 06:43:29,815 --> 06:43:31,550 MORE INSIGHTS INTO 9621 06:43:31,550 --> 06:43:32,084 IMPLEMENTATION SCIENCE. 9622 06:43:32,084 --> 06:43:36,255 AND THEN WE'LL MOVE ON TO THE 9623 06:43:36,255 --> 06:43:39,425 OMICS PRESENTATIONS AND GENOMICS 9624 06:43:39,425 --> 06:43:44,897 WHICH I'M REALLY EXCITED TO SEE, 9625 06:43:44,897 --> 06:43:50,803 WITH DR. ORTEGA AND DR. GLEN AND 9626 06:43:50,803 --> 06:43:52,104 DR. DESAI AND LASTLY WE'LL 9627 06:43:52,104 --> 06:43:56,809 FINISH THINGS UP WITH THE 9628 06:43:56,809 --> 06:43:58,110 PVD OMICS SESSION BEFORE WE MOVE 9629 06:43:58,110 --> 06:44:00,646 TO IT A DISCUSSION SESSION. 9630 06:44:00,646 --> 06:44:01,514 DR. LEOPOLD, DO YOU HAVE ANY 9631 06:44:01,514 --> 06:44:02,581 OTHER COMMENTS FOR THE DAY? 9632 06:44:02,581 --> 06:44:04,784 >> I JUST WANT TO SAY IT REALLY 9633 06:44:04,784 --> 06:44:07,520 HAS BEEN A FANTASTIC DAY OF 9634 06:44:07,520 --> 06:44:09,055 TALKS, AND I'M REALLY LOOKING 9635 06:44:09,055 --> 06:44:11,357 FORWARD TO CONTINUING THE 9636 06:44:11,357 --> 06:44:11,958 DISCUSSION TOMORROW. 9637 06:44:11,958 --> 06:44:15,061 AND MANY THANKS TO TODAY'S 9638 06:44:15,061 --> 06:44:17,763 SPEAKERS. 9639 06:44:17,763 --> 06:44:23,836 >> DR. X I AO? 9640 06:44:23,836 --> 06:44:24,737 >> NOTHING TO ADD. 9641 06:44:24,737 --> 06:44:26,672 JUST TO ECHO WHAT JANE SAID, 9642 06:44:26,672 --> 06:44:28,541 THIS IS A REALLY WONDERFUL 9643 06:44:28,541 --> 06:44:29,742 MEETING AND I LEARNED A LOT FROM 9644 06:44:29,742 --> 06:44:30,776 ALL THE SPEAKERS. 9645 06:44:30,776 --> 06:44:32,578 THANK YOU TO EVERYONE'S EFFORT. 9646 06:44:32,578 --> 06:44:33,679 I'M LOOKING FORWARD FOR 9647 06:44:33,679 --> 06:44:34,947 TOMORROW'S MEETING. 9648 06:44:34,947 --> 06:44:35,982 >> ALL RIGHT. 9649 06:44:35,982 --> 06:44:36,182 GREAT. 9650 06:44:36,182 --> 06:44:38,384 WE WILL SEE EVERYONE AT 9651 06:44:38,384 --> 06:44:39,485 10:00 A.M. EASTERN TIME 9652 06:44:39,485 --> 06:44:39,752 TOMORROW. 9653 06:44:39,752 --> 06:44:41,220 THANKS AGAIN. 9654 06:44:41,220 --> 06:44:41,754 HAVE A GOOD DAY. 9655 06:44:41,754 --> 06:44:43,122 >> ALL RIGHT. 9656 06:44:43,122 --> 06:44:43,356 THANKS. 9657 06:44:43,356 --> 06:44:46,125 >> BYE-BYE. 9658 06:44:46,125 --> 06:44:48,694 [THE MEETING CONCLUDED AT 9659 06:44:48,694 --> 06:44:58,938 5:38 P.M. EST]